Psyllid ID: psy4396
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 271 | 2.2.26 [Sep-21-2011] | |||||||
| O88445 | 282 | Aurora kinase C OS=Mus mu | yes | N/A | 0.730 | 0.702 | 0.513 | 6e-56 | |
| O01427 | 305 | Aurora/IPL1-related prote | yes | N/A | 0.730 | 0.649 | 0.486 | 2e-55 | |
| Q61XD3 | 302 | Aurora/IPL1-related prote | N/A | N/A | 0.745 | 0.668 | 0.477 | 6e-55 | |
| Q9N0X0 | 344 | Aurora kinase B OS=Sus sc | yes | N/A | 0.730 | 0.575 | 0.493 | 8e-55 | |
| Q7YRC6 | 344 | Aurora kinase B OS=Bos ta | yes | N/A | 0.730 | 0.575 | 0.488 | 1e-54 | |
| O14965 | 403 | Aurora kinase A OS=Homo s | yes | N/A | 0.763 | 0.513 | 0.454 | 1e-54 | |
| A5GFW1 | 402 | Aurora kinase A OS=Sus sc | no | N/A | 0.712 | 0.480 | 0.470 | 4e-54 | |
| Q2TA06 | 402 | Aurora kinase A OS=Bos ta | no | N/A | 0.712 | 0.480 | 0.470 | 4e-54 | |
| Q6DE08 | 361 | Aurora kinase B-A OS=Xeno | N/A | N/A | 0.697 | 0.523 | 0.465 | 4e-54 | |
| Q9UQB9 | 309 | Aurora kinase C OS=Homo s | no | N/A | 0.715 | 0.627 | 0.504 | 5e-54 |
| >sp|O88445|AURKC_MOUSE Aurora kinase C OS=Mus musculus GN=Aurkc PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 217 bits (553), Expect = 6e-56, Method: Compositional matrix adjust.
Identities = 114/222 (51%), Positives = 141/222 (63%), Gaps = 24/222 (10%)
Query: 71 PNKSYR--WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVH 128
P+ S R + ++DFE+G PLG GKFG VYLA+ K ++ALKVL+K EI E + HQ+
Sbjct: 3 PSTSTRKHFTINDFEIGRPLGRGKFGRVYLARLKENHFIVALKVLFKSEIEKEGLEHQLR 62
Query: 129 RERCCQVHL-------------SSSRRHPLLSSEEGYSLYTE---------KDAAKYIYQ 166
RE Q HL +R + +L G LY E + A I +
Sbjct: 63 REVEIQAHLQHRNILRLYNYFYDDTRIYLILEYAPGGELYKELQRHQKLDQQRTATIIQE 122
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPE 226
++DA+ YCH+KKVIHRDIKPENLLL ++ +VKISDFGWSVH PSL RKTMCGTLDYLPPE
Sbjct: 123 LSDALTYCHEKKVIHRDIKPENLLLGLNGEVKISDFGWSVHTPSLRRKTMCGTLDYLPPE 182
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
M+ + Y + VD WCIG+L YE LVGKPPFES T RI
Sbjct: 183 MIAQKPYNEMVDLWCIGVLCYELLVGKPPFESSTSSETYRRI 224
|
Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Plays also a role in meiosis and more particularly in spermatogenesis. Has redundant cellular functions with AURKB and can rescue an AURKB knockdown. Like AURKB, AURKC phosphorylates histone H3 at 'Ser-10' and 'Ser-28'. Phosphorylates TACC1, another protein involved in cell division, at 'Ser-228'. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O01427|AIR2_CAEEL Aurora/IPL1-related protein kinase 2 OS=Caenorhabditis elegans GN=air-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 107/220 (48%), Positives = 141/220 (64%), Gaps = 22/220 (10%)
Query: 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE 130
P K ++ ++DFE+G PLG GKFG VYLA+ KT +A+KVL+K ++I+ + HQ+ RE
Sbjct: 19 PQKGGKFTINDFEIGRPLGKGKFGSVYLARTKTGHFHVAIKVLFKSQLISGGVEHQLERE 78
Query: 131 RCCQVHLS-------------SSRRHPLLSSEEGYSLY---------TEKDAAKYIYQVA 168
Q HL+ + + + +L G +Y +E AAKY+Y++A
Sbjct: 79 IEIQSHLNHPNIIKLYTYFWDAKKIYLVLEYAPGGEMYKQLTVSKRFSEPTAAKYMYEIA 138
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMV 228
DA+ YCH+K VIHRDIKPENLL+ ++KI DFGWSVHAPS R+TMCGT+DYLPPEMV
Sbjct: 139 DALSYCHRKNVIHRDIKPENLLIGSQGELKIGDFGWSVHAPSNKRQTMCGTMDYLPPEMV 198
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ VD W IG+L YEFLVGKPPFE +DQ T I
Sbjct: 199 NGADHSDAVDLWAIGVLCYEFLVGKPPFEHEDQSKTYAAI 238
|
Serine/threonine-protein kinase which mediates both meiotic and mitotic chromosome segregation. Required for histone H3 'Ser-10' phosphorylation. Phosphorylates tlk-1 at 'Ser-634', which enhances its activity. Phosphorylates zen-4 at 'Ser-680'. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q61XD3|AIR2_CAEBR Aurora/IPL1-related protein kinase 2 OS=Caenorhabditis briggsae GN=air-2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (544), Expect = 6e-55, Method: Compositional matrix adjust.
Identities = 107/224 (47%), Positives = 140/224 (62%), Gaps = 22/224 (9%)
Query: 67 AREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQ 126
++ PNK + ++DFE+G PLG GKFG VYLA+ KT A+KVL+K ++I+ + HQ
Sbjct: 12 SKNTPNKGGKLSINDFEIGRPLGKGKFGSVYLARTKTGHFHCAIKVLFKSQLISGGVEHQ 71
Query: 127 VHRERCCQVHL-------------SSSRRHPLLSSEEGYSLY---------TEKDAAKYI 164
+ RE Q HL + + + +L G +Y TE A KY+
Sbjct: 72 LEREIEIQSHLQHPNIIRLYNYFWDAKKIYLILEYAPGGEMYKQLTTQKRFTEAMAGKYM 131
Query: 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLP 224
Y++ADA+ YCH+K VIHRDIKPENLL+ ++KI DFGWSVHAPS R+TMCGT+DYLP
Sbjct: 132 YEIADALSYCHRKNVIHRDIKPENLLIGAQGELKIGDFGWSVHAPSNKRQTMCGTMDYLP 191
Query: 225 PEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
PEMV + VD W IG+L YEFLVGKPPFE ++Q T I
Sbjct: 192 PEMVNGNSHSDAVDLWAIGVLCYEFLVGKPPFEHENQADTYSAI 235
|
Serine/threonine-protein kinase which mediates both meiotic and mitotic chromosome segregation. Required for histone H3 'Ser-10' phosphorylation. Phosphorylates tlk-1 and zen-4. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9N0X0|AURKB_PIG Aurora kinase B OS=Sus scrofa GN=AURKB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 214 bits (544), Expect = 8e-55, Method: Compositional matrix adjust.
Identities = 109/221 (49%), Positives = 140/221 (63%), Gaps = 23/221 (10%)
Query: 71 PNKSYR-WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHR 129
PN S R + + DFE+G PLG GKFG+VYLA+EK + ++ALKVL+K +I E + HQ+ R
Sbjct: 65 PNFSTRSFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRR 124
Query: 130 ERCCQVHLSS----------------------SRRHPLLSSEEGYSLYTEKDAAKYIYQV 167
E Q HL + R L + + E+ A + ++
Sbjct: 125 EIEIQAHLQHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKCRTFDEQRTATIMEEL 184
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEM 227
ADA+ YCH KKVIHRDIKPENLLL + ++KI+DFGWSVHAPSL RKTMCGTLDYLPPEM
Sbjct: 185 ADALIYCHGKKVIHRDIKPENLLLGLQGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEM 244
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ + + ++VD WCIG+L YE LVG PPFES + T RI
Sbjct: 245 IEGRTHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 285
|
Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Involved in the bipolar attachment of spindle microtubules to kinetochores and is a key regulator for the onset of cytokinesis during mitosis. Required for central/midzone spindle assembly and cleavage furrow formation. AURKB phosphorylates the CPC complex subunits BIRC5/survivin, CDCA8/borealin and INCENP. Phosphorylation of INCENP leads to increased AURKB activity. Other known AURKB substrates involved in centromeric functions and mitosis are CENPA, DES/desmin, GPAF, KIF2C, NSUN2, RACGAP1, SEPT1, VIM/vimentin, GSG2/Haspin and histone H3. A positive feedback loop involving GSG2 and AURKB contributes to localization of CPC to centromeres. Phosphorylation of VIM controls vimentin filament segregation in cytokinetic process, whereas histone H3 is phosphorylated at 'Ser-10' and 'Ser-28' during mitosis. AURKB is also required for kinetochore localization of BUB1 and SGOL1. Phosphorylation of p53/TP53 negatively regulates its transcriptional activity. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7YRC6|AURKB_BOVIN Aurora kinase B OS=Bos taurus GN=AURKB PE=2 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (543), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 108/221 (48%), Positives = 139/221 (62%), Gaps = 23/221 (10%)
Query: 71 PNKSYR-WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHR 129
PN R + + DFE+G PLG GKFG+VYLA+EK + ++ALKVL+K +I E + HQ+ R
Sbjct: 65 PNIPKRSFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRR 124
Query: 130 ERCCQVHLSS----------------------SRRHPLLSSEEGYSLYTEKDAAKYIYQV 167
E Q HL + R L + + E+ A + ++
Sbjct: 125 EIEIQAHLQHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSRTFDEQRTATIMEEL 184
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEM 227
ADA+ YCH KKVIHRDIKPENLLL + ++KI+DFGWSVHAPSL RKTMCGTLDYLPPEM
Sbjct: 185 ADALTYCHAKKVIHRDIKPENLLLGLRGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEM 244
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ + + ++VD WCIG+L YE LVG PPFES + T RI
Sbjct: 245 IEGRTHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 285
|
Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Involved in the bipolar attachment of spindle microtubules to kinetochores and is a key regulator for the onset of cytokinesis during mitosis. Required for central/midzone spindle assembly and cleavage furrow formation. AURKB phosphorylates the CPC complex subunits BIRC5/survivin, CDCA8/borealin and INCENP. Phosphorylation of INCENP leads to increased AURKB activity. Other known AURKB substrates involved in centromeric functions and mitosis are CENPA, DES/desmin, GPAF, KIF2C, NSUN2, RACGAP1, SEPT1, VIM/vimentin, GSG2/Haspin and histone H3. A positive feedback loop involving GSG2 and AURKB contributes to localization of CPC to centromeres. Phosphorylation of VIM controls vimentin filament segregation in cytokinetic process, whereas histone H3 is phosphorylated at 'Ser-10' and 'Ser-28'during mitosis. AURKB is also required for kinetochore localization of BUB1 and SGOL1. Phosphorylation of p53/TP53 negatively regulates its transcriptional activity. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O14965|AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 110/242 (45%), Positives = 148/242 (61%), Gaps = 35/242 (14%)
Query: 53 NVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKV 112
N EE L Q + ++ K +W + DFE+G PLG GKFG+VYLA+EK ++ ++ALKV
Sbjct: 109 NPEEELASKQKNEES-----KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV 163
Query: 113 LYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-------------------- 152
L+K ++ + HQ+ RE Q HL RHP + GY
Sbjct: 164 LFKAQLEKAGVEHQLRREVEIQSHL----RHPNILRLYGYFHDATRVYLILEYAPLGTVY 219
Query: 153 ------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206
S + E+ A YI ++A+A+ YCH K+VIHRDIKPENLLL ++KI+DFGWSV
Sbjct: 220 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 279
Query: 207 HAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266
HAPS R T+CGTLDYLPPEM+ + + ++VD W +G+L YEFLVGKPPFE+ T +
Sbjct: 280 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 339
Query: 267 RI 268
RI
Sbjct: 340 RI 341
|
Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A5GFW1|AURKA_PIG Aurora kinase A OS=Sus scrofa GN=AURKA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 105/223 (47%), Positives = 141/223 (63%), Gaps = 30/223 (13%)
Query: 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER 131
+K +W + DFE+G PLG GKFG+VYLA+EK ++ ++ALKVL+K ++ + HQ+ RE
Sbjct: 123 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKTQLEKAGVEHQLRREV 182
Query: 132 CCQVHLSSSRRHPLLSSEEGY--------------------------SLYTEKDAAKYIY 165
Q HL RHP + GY S + E+ A YI
Sbjct: 183 EIQSHL----RHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYIT 238
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPP 225
++A+A+ YCH K+VIHRDIKPENLLL ++KI+DFGWSVHAPS R T+CGTLDYLPP
Sbjct: 239 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 298
Query: 226 EMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
EM+ + + ++VD W +G+L YEFLVGKPPFE+ T +RI
Sbjct: 299 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 341
|
Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2TA06|AURKA_BOVIN Aurora kinase A OS=Bos taurus GN=AURKA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (537), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 105/223 (47%), Positives = 140/223 (62%), Gaps = 30/223 (13%)
Query: 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER 131
+K +W + DFE+G PLG GKFG+VYLA+EK ++ ++ALKVL+K ++ + HQ+ RE
Sbjct: 123 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 182
Query: 132 CCQVHLSSSRRHPLLSSEEGY--------------------------SLYTEKDAAKYIY 165
Q HL RHP + GY S + E+ A YI
Sbjct: 183 EIQSHL----RHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYIT 238
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPP 225
++A+A+ YCH K+VIHRDIKPENLLL ++KI+DFGWSVHAPS R T+CGTLDYLPP
Sbjct: 239 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 298
Query: 226 EMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
EM+ + + ++VD W +G+L YEFLVGKPPFE+ T RI
Sbjct: 299 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEADTYQETYRRI 341
|
Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6DE08|AUKBA_XENLA Aurora kinase B-A OS=Xenopus laevis GN=aurkb-a PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (537), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 102/219 (46%), Positives = 141/219 (64%), Gaps = 30/219 (13%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV 135
++ + DF++G PLG GKFG+VYLA+EK + ++ALKVL+K ++ E + HQ+ RE Q
Sbjct: 87 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 146
Query: 136 HLSSSRRHP--------------------------LLSSEEGYSLYTEKDAAKYIYQVAD 169
HL RHP L + + + E+ +A ++ ++AD
Sbjct: 147 HL----RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 202
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVT 229
A+HYCH++KVIHRDIKPENLL+ ++KI+DFGWSVHAPSL R+TMCGTLDYLPPEM+
Sbjct: 203 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIE 262
Query: 230 SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ + ++VD WC G+L YEFLVG PPF+S T RI
Sbjct: 263 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 301
|
Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Involved in the bipolar attachment of spindle microtubules to kinetochores and is a key regulator for the onset of cytokinesis during mitosis. Required for central/midzone spindle assembly and cleavage furrow formation. Phosphorylates 'Ser-10' of histone H3 during mitosis. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UQB9|AURKC_HUMAN Aurora kinase C OS=Homo sapiens GN=AURKC PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (537), Expect = 5e-54, Method: Compositional matrix adjust.
Identities = 109/216 (50%), Positives = 134/216 (62%), Gaps = 22/216 (10%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV 135
R + DFE+G PLG GKFG+VYLA+ K + ++ALKVL+K +I E + HQ+ RE Q
Sbjct: 37 RLTVDDFEIGRPLGKGKFGNVYLARLKESHFIVALKVLFKSQIEKEGLEHQLRREIEIQA 96
Query: 136 HL-------------SSSRRHPLLSSEEGYSLYTE---------KDAAKYIYQVADAIHY 173
HL + R + +L LY E + A I ++ADA+ Y
Sbjct: 97 HLQHPNILRLYNYFHDARRVYLILEYAPRGELYKELQKSEKLDEQRTATIIEELADALTY 156
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
CH KKVIHRDIKPENLLL +VKI+DFGWSVH PSL RKTMCGTLDYLPPEM+ + Y
Sbjct: 157 CHDKKVIHRDIKPENLLLGFRGEVKIADFGWSVHTPSLRRKTMCGTLDYLPPEMIEGRTY 216
Query: 234 GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
++VD WCIG+L YE LVG PPFES T RI
Sbjct: 217 DEKVDLWCIGVLCYELLVGYPPFESASHSETYRRIL 252
|
Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Plays also a role in meiosis and more particularly in spermatogenesis. Has redundant cellular functions with AURKB and can rescue an AURKB knockdown. Like AURKB, AURKC phosphorylates histone H3 at 'Ser-10' and 'Ser-28'. Phosphorylates TACC1, another protein involved in cell division, at 'Ser-228'. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 271 | ||||||
| 383847346 | 305 | PREDICTED: aurora kinase B-like [Megachi | 0.778 | 0.691 | 0.524 | 1e-62 | |
| 307198830 | 309 | Serine/threonine-protein kinase Ial [Har | 0.782 | 0.686 | 0.518 | 6e-61 | |
| 328707281 | 322 | PREDICTED: serine/threonine-protein kina | 0.822 | 0.692 | 0.488 | 7e-61 | |
| 193666952 | 309 | PREDICTED: serine/threonine-protein kina | 0.822 | 0.721 | 0.488 | 9e-61 | |
| 380015744 | 633 | PREDICTED: ATP-binding cassette sub-fami | 0.767 | 0.328 | 0.510 | 5e-60 | |
| 242013765 | 312 | cAMP-dependent protein kinase catalytic | 0.756 | 0.657 | 0.481 | 1e-59 | |
| 340721266 | 305 | PREDICTED: serine/threonine-protein kina | 0.778 | 0.691 | 0.512 | 2e-59 | |
| 66562764 | 304 | PREDICTED: serine/threonine-protein kina | 0.778 | 0.694 | 0.504 | 2e-59 | |
| 350406810 | 305 | PREDICTED: aurora kinase B-like [Bombus | 0.778 | 0.691 | 0.512 | 3e-59 | |
| 170073697 | 310 | serine/threonine-protein kinase 6 [Culex | 0.863 | 0.754 | 0.442 | 5e-59 |
| >gi|383847346|ref|XP_003699315.1| PREDICTED: aurora kinase B-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 245 bits (626), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 129/246 (52%), Positives = 156/246 (63%), Gaps = 35/246 (14%)
Query: 51 KENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIAL 110
KE + + L KM+ H +AR Y+W +SDFE+G PLG GKFG VYLA+EKTTQ M+AL
Sbjct: 18 KEIIHDTLCKMEEHVEAR---GSRYQWSLSDFEIGAPLGRGKFGRVYLAREKTTQYMVAL 74
Query: 111 KVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP----LLS------------------- 147
K LYK+E++ R+ QV RE Q HL RHP +L+
Sbjct: 75 KTLYKIELMKGRVEKQVMREIEIQTHL----RHPHILQMLTYFHDHKRIYLVLEFAARGE 130
Query: 148 -----SEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202
+ Y + E +AKY YQVADA+ YCH+ VIHRDIKPENLLLT DVK++DF
Sbjct: 131 LYKELKRQPYERFNEHLSAKYTYQVADALEYCHRNNVIHRDIKPENLLLTYEGDVKLADF 190
Query: 203 GWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262
GWSVHAPS R T+CGTLDYLPPEMVT Q Y VD+WC+GIL YEFLVG+PPF S Q
Sbjct: 191 GWSVHAPSSKRNTLCGTLDYLPPEMVTGQKYDIYVDHWCLGILCYEFLVGRPPFLSDSQQ 250
Query: 263 TTLERI 268
T +I
Sbjct: 251 ETYVKI 256
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307198830|gb|EFN79606.1| Serine/threonine-protein kinase Ial [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 240 bits (612), Expect = 6e-61, Method: Compositional matrix adjust.
Identities = 128/247 (51%), Positives = 153/247 (61%), Gaps = 35/247 (14%)
Query: 50 NKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIA 109
+KE + + + KM H + R Y+W + DFEVG PLG GKFG VYLA+EKTTQ M+A
Sbjct: 17 HKEAIHDTIYKMMEHINNR---GLRYQWSLDDFEVGSPLGRGKFGRVYLAREKTTQYMVA 73
Query: 110 LKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP-----------------LLSSEEGY 152
LK LYKVE+I R+ QV RE Q HL RHP +L G
Sbjct: 74 LKTLYKVELIKGRVEKQVMREIEIQTHL----RHPHILQLLTYFHDNKRIYLVLEFAAGG 129
Query: 153 SLY-----------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISD 201
LY +E +AKY YQVADA+ YCH+ VIHRDIKPENLLLT D+K++D
Sbjct: 130 ELYKELKRQPNERFSEHLSAKYTYQVADALEYCHRNNVIHRDIKPENLLLTYDGDIKLAD 189
Query: 202 FGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261
FGWSVHAPS R T+CGTLDYLPPEM+T Q Y VD+WC+GIL YEFL G+PPF S Q
Sbjct: 190 FGWSVHAPSSKRNTLCGTLDYLPPEMLTGQTYDIYVDHWCLGILCYEFLTGQPPFLSSSQ 249
Query: 262 DTTLERI 268
T +I
Sbjct: 250 QETYAKI 256
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328707281|ref|XP_003243352.1| PREDICTED: serine/threonine-protein kinase 6-A-like isoform 2 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 239 bits (611), Expect = 7e-61, Method: Compositional matrix adjust.
Identities = 122/250 (48%), Positives = 159/250 (63%), Gaps = 27/250 (10%)
Query: 43 EGLTEGTNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEK 102
E LT + E V KKM+ Y R + +++W++SDFE+G PLG GKFG VYLA+EK
Sbjct: 19 EKLTTESQNEVVHHIEKKMKEIYSKRPS---NHQWKLSDFEIGTPLGRGKFGRVYLAREK 75
Query: 103 TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS--------------S 148
T+ M+ALK+++K E++ + M HQV RE Q HL+ +L+ +
Sbjct: 76 NTEYMVALKMMFKSELVKDHMEHQVRREIEIQTHLTHPNILKMLTYFWDEKKIYLILEFA 135
Query: 149 EEG----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVK 198
+EG + + E AA Y+ QVADA+ YCH + VIHRDIKPENLLL H +K
Sbjct: 136 QEGELFKVLNAQPHKRFDEPTAAYYLRQVADALRYCHSQSVIHRDIKPENLLLFSHHVIK 195
Query: 199 ISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
++DFGWSVHAPS R TMCGT+DYLPPEMV SQ Y + VDNWC+G+L YEFL G PPFES
Sbjct: 196 LADFGWSVHAPSKCRSTMCGTIDYLPPEMVDSQTYNEYVDNWCLGVLCYEFLCGSPPFES 255
Query: 259 KDQDTTLERI 268
+Q T +I
Sbjct: 256 SEQAETFRKI 265
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|193666952|ref|XP_001946900.1| PREDICTED: serine/threonine-protein kinase 6-A-like isoform 3 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 239 bits (610), Expect = 9e-61, Method: Compositional matrix adjust.
Identities = 122/250 (48%), Positives = 159/250 (63%), Gaps = 27/250 (10%)
Query: 43 EGLTEGTNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEK 102
E LT + E V KKM+ Y R + +++W++SDFE+G PLG GKFG VYLA+EK
Sbjct: 6 EKLTTESQNEVVHHIEKKMKEIYSKRPS---NHQWKLSDFEIGTPLGRGKFGRVYLAREK 62
Query: 103 TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS--------------S 148
T+ M+ALK+++K E++ + M HQV RE Q HL+ +L+ +
Sbjct: 63 NTEYMVALKMMFKSELVKDHMEHQVRREIEIQTHLTHPNILKMLTYFWDEKKIYLILEFA 122
Query: 149 EEG----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVK 198
+EG + + E AA Y+ QVADA+ YCH + VIHRDIKPENLLL H +K
Sbjct: 123 QEGELFKVLNAQPHKRFDEPTAAYYLRQVADALRYCHSQSVIHRDIKPENLLLFSHHVIK 182
Query: 199 ISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
++DFGWSVHAPS R TMCGT+DYLPPEMV SQ Y + VDNWC+G+L YEFL G PPFES
Sbjct: 183 LADFGWSVHAPSKCRSTMCGTIDYLPPEMVDSQTYNEYVDNWCLGVLCYEFLCGSPPFES 242
Query: 259 KDQDTTLERI 268
+Q T +I
Sbjct: 243 SEQAETFRKI 252
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380015744|ref|XP_003691856.1| PREDICTED: ATP-binding cassette sub-family B member 10, mitochondrial-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 237 bits (604), Expect = 5e-60, Method: Compositional matrix adjust.
Identities = 124/243 (51%), Positives = 150/243 (61%), Gaps = 35/243 (14%)
Query: 54 VEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL 113
V + L KM+ H +AR Y+W + DFE+G PLG GKFG VYLA+EKTT M+ALK L
Sbjct: 349 VLDTLYKMEEHVEAR---GLRYQWNLDDFEIGAPLGRGKFGRVYLAREKTTHYMVALKTL 405
Query: 114 YKVEIINERMTHQVHRERCCQVHLSSSRRHP-----------------LLSSEEGYSLYT 156
YK+E++ R+ QV RE Q HL RHP +L LY
Sbjct: 406 YKIELMKGRVEKQVMREIEIQTHL----RHPHILQMLTYFHDHKRIYLVLEFAARGELYK 461
Query: 157 EKD-----------AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205
E +AKY YQVADA+ YCH+ VIHRDIKPENLLLT ++K++DFGWS
Sbjct: 462 ELKRQPNERFNEHLSAKYTYQVADALEYCHKNNVIHRDIKPENLLLTYEGNIKLADFGWS 521
Query: 206 VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265
VHAPS R T+CGTLDYLPPEMV+ Q Y VD+WC+GIL YEFLVG+PPF S Q T
Sbjct: 522 VHAPSSKRNTLCGTLDYLPPEMVSGQTYDIYVDHWCLGILCYEFLVGRPPFLSDSQQETY 581
Query: 266 ERI 268
+I
Sbjct: 582 AKI 584
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242013765|ref|XP_002427571.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212511986|gb|EEB14833.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 235 bits (600), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 115/239 (48%), Positives = 157/239 (65%), Gaps = 34/239 (14%)
Query: 58 LKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVE 117
++KM+ H R + Y W + DF++G PLG G+FG VYLA+++ T ++ ALK+L+K E
Sbjct: 25 IEKMKAHIINRNG--RPYEWSIHDFDIGTPLGRGRFGRVYLARDRHTNVVFALKLLHKSE 82
Query: 118 IINERMTHQVHRERCCQVHLSSSRRHP-----------------LLSSEEGYSLY----- 155
II + QV RE HL +HP +L G LY
Sbjct: 83 IIKSNVQRQVLREIEINCHL----KHPNILNMFTYFDDKRFIYLVLEYAAGGELYRKMNS 138
Query: 156 ------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209
+EK +AKY+YQV +A++YCH+K+VIHRDIKPEN+LL+ ++D+K+SDFGWSVHAP
Sbjct: 139 LPEKHFSEKQSAKYLYQVVNALNYCHKKRVIHRDIKPENILLSANDDIKLSDFGWSVHAP 198
Query: 210 SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ R+TMCGTLDYLPPEMV ++Y ++VDNWCIG+L YEFLVG+PPFES D T ++I
Sbjct: 199 NSTRRTMCGTLDYLPPEMVLKENYNEKVDNWCIGVLCYEFLVGQPPFESSVADATYQKI 257
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340721266|ref|XP_003399045.1| PREDICTED: serine/threonine-protein kinase Ial-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 235 bits (599), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 126/246 (51%), Positives = 150/246 (60%), Gaps = 35/246 (14%)
Query: 51 KENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIAL 110
KE V + L KM+ H + R Y+W + DFE+G PLG GKFG VYLA+EK+T M+AL
Sbjct: 18 KEIVLDTLCKMEDHVETR---GSRYQWNLDDFEIGAPLGRGKFGRVYLAREKSTHYMVAL 74
Query: 111 KVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------------------ 152
K LYKVE++ R+ QV RE Q HL RHP + Y
Sbjct: 75 KTLYKVELMKGRVEKQVMREIEIQTHL----RHPNILQMLTYFHDHKRIYLVLEFAARGE 130
Query: 153 ----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202
+ E +AKY YQVADA+ YCH+ VIHRDIKPENLLLT +VK++DF
Sbjct: 131 LYKELKRQPNERFNEHLSAKYTYQVADALEYCHRNNVIHRDIKPENLLLTYEGNVKLADF 190
Query: 203 GWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262
GWSVHAPS R T+CGTLDYLPPEMVT Q Y VD+WC+GIL YEFLVGKPPF S Q
Sbjct: 191 GWSVHAPSSKRNTLCGTLDYLPPEMVTGQTYDIYVDHWCLGILCYEFLVGKPPFLSDSQQ 250
Query: 263 TTLERI 268
T +I
Sbjct: 251 ETYVKI 256
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|66562764|ref|XP_625111.1| PREDICTED: serine/threonine-protein kinase Ial [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 234 bits (598), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 124/246 (50%), Positives = 151/246 (61%), Gaps = 35/246 (14%)
Query: 51 KENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIAL 110
K+ V + L KM+ H +AR Y+W + DFE+G PLG GKFG VYLA+EKTT M+AL
Sbjct: 18 KDIVLDTLYKMEEHVEAR---GLRYQWNLDDFEIGAPLGRGKFGRVYLAREKTTHYMVAL 74
Query: 111 KVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------------------ 152
K LYKVE++ R+ QV RE Q HL RHP + Y
Sbjct: 75 KTLYKVELMKGRVEKQVMREIEIQTHL----RHPHILQMLTYFHDHKRIYLVLEFAARGE 130
Query: 153 ----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202
+ E +AKY YQVADA+ YCH+ VIHRDIKPENLLLT ++K++DF
Sbjct: 131 LYKELKRQPNERFNEHLSAKYTYQVADALEYCHKNNVIHRDIKPENLLLTYEGNIKLADF 190
Query: 203 GWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262
GWSVHAPS R T+CGTLDYLPPEMV+ Q Y VD+WC+GIL YEFLVG+PPF S Q
Sbjct: 191 GWSVHAPSSKRNTLCGTLDYLPPEMVSGQTYDIYVDHWCLGILCYEFLVGRPPFLSDSQQ 250
Query: 263 TTLERI 268
T +I
Sbjct: 251 ETYAKI 256
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350406810|ref|XP_003487892.1| PREDICTED: aurora kinase B-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 234 bits (597), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 126/246 (51%), Positives = 150/246 (60%), Gaps = 35/246 (14%)
Query: 51 KENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIAL 110
KE V + L KM+ H + R Y+W + DFE+G PLG GKFG VYLA+EK+T M+AL
Sbjct: 18 KEIVLDTLCKMEDHVETR---GSRYQWNLDDFEIGAPLGRGKFGRVYLAREKSTHYMVAL 74
Query: 111 KVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------------------ 152
K LYKVE++ R+ QV RE Q HL RHP + Y
Sbjct: 75 KTLYKVELMKGRVEKQVMREIEIQTHL----RHPNILQMLTYFHDHKRIYLVLEFAARGE 130
Query: 153 ----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202
+ E +AKY YQVADA+ YCH+ VIHRDIKPENLLLT +VK++DF
Sbjct: 131 LYKELKRQPNERFNEHLSAKYTYQVADALEYCHRNNVIHRDIKPENLLLTHEGNVKLADF 190
Query: 203 GWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262
GWSVHAPS R T+CGTLDYLPPEMVT Q Y VD+WC+GIL YEFLVGKPPF S Q
Sbjct: 191 GWSVHAPSSKRNTLCGTLDYLPPEMVTGQTYDIYVDHWCLGILCYEFLVGKPPFLSDSQQ 250
Query: 263 TTLERI 268
T +I
Sbjct: 251 ETYVKI 256
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|170073697|ref|XP_001870417.1| serine/threonine-protein kinase 6 [Culex quinquefasciatus] gi|167870364|gb|EDS33747.1| serine/threonine-protein kinase 6 [Culex quinquefasciatus] | Back alignment and taxonomy information |
|---|
Score = 233 bits (595), Expect = 5e-59, Method: Compositional matrix adjust.
Identities = 120/271 (44%), Positives = 165/271 (60%), Gaps = 37/271 (13%)
Query: 26 VQTTEKNYTITNMKEYFEGLTEGTNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVG 85
++T + YT+ ++ + EG++ N V +Y+ M +H A + YRW +FE+G
Sbjct: 1 METVTRPYTMDDLPQLIEGVSS-ENVVGVTQYIVNMMSH----PAYGRQYRWSKDNFELG 55
Query: 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP- 144
CPLG GKFG VYLA+E+ T+ M+A+KV++K E++ R+ Q+ RE V + S +HP
Sbjct: 56 CPLGRGKFGRVYLARERHTKFMVAMKVMFKSELVKGRVEKQMLRE----VEIQSRLKHPH 111
Query: 145 -------------------LLSSEEGY--------SLYTEKDAAKYIYQVADAIHYCHQK 177
L S E Y + E+ +AKY YQVADA++YCH
Sbjct: 112 ILRLYTWFQDDRRIYLALELASQGELYKHLKASPNGRFNEQRSAKYTYQVADALNYCHAN 171
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEV 237
VIHRD+KPEN+LLT ++VK++DFGWS H S RKTMCGTLDYLPPEMV + Y V
Sbjct: 172 NVIHRDLKPENILLTDDDNVKLADFGWSAHTNSNRRKTMCGTLDYLPPEMVDGKIYDDSV 231
Query: 238 DNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
D WC+GIL YEFLVG PPFES+ + T ++I
Sbjct: 232 DQWCLGILCYEFLVGFPPFESETTEATYDKI 262
|
Source: Culex quinquefasciatus Species: Culex quinquefasciatus Genus: Culex Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 271 | ||||||
| MGI|MGI:894678 | 395 | Aurka "aurora kinase A" [Mus m | 0.428 | 0.293 | 0.586 | 7.6e-53 | |
| WB|WBGene00000099 | 305 | air-2 [Caenorhabditis elegans | 0.420 | 0.373 | 0.631 | 1.1e-52 | |
| UNIPROTKB|O01427 | 305 | air-2 "Aurora/IPL1-related pro | 0.420 | 0.373 | 0.631 | 1.1e-52 | |
| UNIPROTKB|E2QZL4 | 344 | AURKB "Uncharacterized protein | 0.420 | 0.331 | 0.622 | 1.1e-52 | |
| MGI|MGI:1321119 | 282 | Aurkc "aurora kinase C" [Mus m | 0.413 | 0.397 | 0.651 | 1.4e-52 | |
| UNIPROTKB|I3LFX5 | 344 | AURKB "Aurora kinase B" [Sus s | 0.420 | 0.331 | 0.622 | 1.8e-52 | |
| UNIPROTKB|Q9N0X0 | 344 | AURKB "Aurora kinase B" [Sus s | 0.420 | 0.331 | 0.622 | 1.8e-52 | |
| UNIPROTKB|Q08DN4 | 344 | AURKB "Aurora kinase B" [Bos t | 0.420 | 0.331 | 0.622 | 2.9e-52 | |
| UNIPROTKB|Q7YRC6 | 344 | AURKB "Aurora kinase B" [Bos t | 0.420 | 0.331 | 0.622 | 2.9e-52 | |
| UNIPROTKB|B4DNM4 | 303 | AURKB "Aurora kinase B" [Homo | 0.420 | 0.376 | 0.622 | 1.3e-51 |
| MGI|MGI:894678 Aurka "aurora kinase A" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 378 (138.1 bits), Expect = 7.6e-53, Sum P(3) = 7.6e-53
Identities = 68/116 (58%), Positives = 87/116 (75%)
Query: 153 SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212
S + E+ A YI ++A+A+ YCH K+VIHRDIKPENLLL + ++KI+DFGWSVHAPS
Sbjct: 217 SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR 276
Query: 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
R TMCGTLDYLPPEM+ + + ++VD W +G+L YEFLVG PPFE+ T RI
Sbjct: 277 RTTMCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI 332
|
|
| WB|WBGene00000099 air-2 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 406 (148.0 bits), Expect = 1.1e-52, Sum P(2) = 1.1e-52
Identities = 72/114 (63%), Positives = 87/114 (76%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214
++E AAKY+Y++ADA+ YCH+K VIHRDIKPENLL+ ++KI DFGWSVHAPS R+
Sbjct: 125 FSEPTAAKYMYEIADALSYCHRKNVIHRDIKPENLLIGSQGELKIGDFGWSVHAPSNKRQ 184
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
TMCGT+DYLPPEMV + VD W IG+L YEFLVGKPPFE +DQ T I
Sbjct: 185 TMCGTMDYLPPEMVNGADHSDAVDLWAIGVLCYEFLVGKPPFEHEDQSKTYAAI 238
|
|
| UNIPROTKB|O01427 air-2 "Aurora/IPL1-related protein kinase 2" [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 406 (148.0 bits), Expect = 1.1e-52, Sum P(2) = 1.1e-52
Identities = 72/114 (63%), Positives = 87/114 (76%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214
++E AAKY+Y++ADA+ YCH+K VIHRDIKPENLL+ ++KI DFGWSVHAPS R+
Sbjct: 125 FSEPTAAKYMYEIADALSYCHRKNVIHRDIKPENLLIGSQGELKIGDFGWSVHAPSNKRQ 184
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
TMCGT+DYLPPEMV + VD W IG+L YEFLVGKPPFE +DQ T I
Sbjct: 185 TMCGTMDYLPPEMVNGADHSDAVDLWAIGVLCYEFLVGKPPFEHEDQSKTYAAI 238
|
|
| UNIPROTKB|E2QZL4 AURKB "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 398 (145.2 bits), Expect = 1.1e-52, Sum P(2) = 1.1e-52
Identities = 71/114 (62%), Positives = 88/114 (77%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214
+ E+ A + ++ADA+ YCH KKVIHRDIKPENLLL + ++KI+DFGWSVHAPSL RK
Sbjct: 172 FDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLQGELKIADFGWSVHAPSLRRK 231
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
TMCGTLDYLPPEM+ + + ++VD WCIG+L YE LVG PPFES + T RI
Sbjct: 232 TMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 285
|
|
| MGI|MGI:1321119 Aurkc "aurora kinase C" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 1.4e-52, Sum P(2) = 1.4e-52
Identities = 73/112 (65%), Positives = 87/112 (77%)
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM 216
++ A I +++DA+ YCH+KKVIHRDIKPENLLL ++ +VKISDFGWSVH PSL RKTM
Sbjct: 113 QQRTATIIQELSDALTYCHEKKVIHRDIKPENLLLGLNGEVKISDFGWSVHTPSLRRKTM 172
Query: 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
CGTLDYLPPEM+ + Y + VD WCIG+L YE LVGKPPFES T RI
Sbjct: 173 CGTLDYLPPEMIAQKPYNEMVDLWCIGVLCYELLVGKPPFESSTSSETYRRI 224
|
|
| UNIPROTKB|I3LFX5 AURKB "Aurora kinase B" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 397 (144.8 bits), Expect = 1.8e-52, Sum P(2) = 1.8e-52
Identities = 71/114 (62%), Positives = 88/114 (77%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214
+ E+ A + ++ADA+ YCH KKVIHRDIKPENLLL + ++KI+DFGWSVHAPSL RK
Sbjct: 172 FDEQRTATIMEELADALIYCHGKKVIHRDIKPENLLLGLQGELKIADFGWSVHAPSLRRK 231
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
TMCGTLDYLPPEM+ + + ++VD WCIG+L YE LVG PPFES + T RI
Sbjct: 232 TMCGTLDYLPPEMIEGRTHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 285
|
|
| UNIPROTKB|Q9N0X0 AURKB "Aurora kinase B" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 397 (144.8 bits), Expect = 1.8e-52, Sum P(2) = 1.8e-52
Identities = 71/114 (62%), Positives = 88/114 (77%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214
+ E+ A + ++ADA+ YCH KKVIHRDIKPENLLL + ++KI+DFGWSVHAPSL RK
Sbjct: 172 FDEQRTATIMEELADALIYCHGKKVIHRDIKPENLLLGLQGELKIADFGWSVHAPSLRRK 231
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
TMCGTLDYLPPEM+ + + ++VD WCIG+L YE LVG PPFES + T RI
Sbjct: 232 TMCGTLDYLPPEMIEGRTHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 285
|
|
| UNIPROTKB|Q08DN4 AURKB "Aurora kinase B" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 399 (145.5 bits), Expect = 2.9e-52, Sum P(2) = 2.9e-52
Identities = 71/114 (62%), Positives = 88/114 (77%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214
+ E+ A + ++ADA+ YCH KKVIHRDIKPENLLL + ++KI+DFGWSVHAPSL RK
Sbjct: 172 FDEQRTATIMEELADALTYCHAKKVIHRDIKPENLLLGLRGELKIADFGWSVHAPSLRRK 231
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
TMCGTLDYLPPEM+ + + ++VD WCIG+L YE LVG PPFES + T RI
Sbjct: 232 TMCGTLDYLPPEMIEGRTHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 285
|
|
| UNIPROTKB|Q7YRC6 AURKB "Aurora kinase B" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 399 (145.5 bits), Expect = 2.9e-52, Sum P(2) = 2.9e-52
Identities = 71/114 (62%), Positives = 88/114 (77%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214
+ E+ A + ++ADA+ YCH KKVIHRDIKPENLLL + ++KI+DFGWSVHAPSL RK
Sbjct: 172 FDEQRTATIMEELADALTYCHAKKVIHRDIKPENLLLGLRGELKIADFGWSVHAPSLRRK 231
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
TMCGTLDYLPPEM+ + + ++VD WCIG+L YE LVG PPFES + T RI
Sbjct: 232 TMCGTLDYLPPEMIEGRTHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 285
|
|
| UNIPROTKB|B4DNM4 AURKB "Aurora kinase B" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 397 (144.8 bits), Expect = 1.3e-51, Sum P(2) = 1.3e-51
Identities = 71/114 (62%), Positives = 88/114 (77%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214
+ E+ A + ++ADA+ YCH KKVIHRDIKPENLLL + ++KI+DFGWSVHAPSL RK
Sbjct: 131 FDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK 190
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
TMCGTLDYLPPEM+ + + ++VD WCIG+L YE LVG PPFES + T RI
Sbjct: 191 TMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRI 244
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8SRL5 | IPL1_ENCCU | 2, ., 7, ., 1, 1, ., 1 | 0.3906 | 0.6642 | 0.6617 | yes | N/A |
| O01427 | AIR2_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.4863 | 0.7306 | 0.6491 | yes | N/A |
| O88445 | AURKC_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.5135 | 0.7306 | 0.7021 | yes | N/A |
| Q9VKN7 | AURKB_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.4285 | 0.7859 | 0.6474 | yes | N/A |
| Q683C9 | AUR2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4692 | 0.7195 | 0.6914 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 271 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-57 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-47 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-45 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-44 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-44 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-40 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-39 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-34 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-30 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-29 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-29 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-29 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-28 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-28 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-27 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-27 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-26 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-26 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-25 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-25 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-25 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-25 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-24 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-24 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-24 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-24 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-23 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-22 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-22 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-21 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-21 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-21 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-19 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-19 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-19 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-17 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-15 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 0.003 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 6e-57
Identities = 74/214 (34%), Positives = 109/214 (50%), Gaps = 33/214 (15%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
+E+ LG G FG VYLA++K T ++A+KV+ K +I +R ++ RE L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKL---- 54
Query: 142 RHP----LLSSEE-------------GYSLY---------TEKDAAKYIYQVADAIHYCH 175
+HP L E G L+ +E +A Y+ Q+ A+ Y H
Sbjct: 55 KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFGWSVH-APSLHRKTMCGTLDYLPPEMVTSQHYG 234
K ++HRD+KPEN+LL VK++DFG + P T GT +Y+ PE++ + YG
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
K VD W +G++ YE L GKPPF DQ L +
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKK 208
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-47
Identities = 71/213 (33%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS-- 139
+E+ LG+G FG VY AK K T ++A+K+L K + RE LS
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 140 ---------SRRHPLLSSE--EGYSLY---------TEKDAAKYIYQVADAIHYCHQKKV 179
+ H L E EG L+ +E +A K Q+ + Y H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 180 IHRDIKPENLLLTMHEDVKISDFGWSV--HAPSLHRKTMCGTLDYLPPE-MVTSQHYGKE 236
IHRD+KPEN+LL + VKI+DFG + S T GT Y+ PE ++ YG +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
VD W +G++ YE L GKPPF ++ L+ I
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-45
Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 32/209 (15%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147
LG G FG V L ++K T + A+KVL K +II + ER + HP +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTER--NILSRI--NHPFIV 56
Query: 148 S-----EEGYSLY---------------------TEKDAAKYIYQVADAIHYCHQKKVIH 181
+ LY +E+ A Y ++ A+ Y H +I+
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMCGTLDYLPPEMVTSQHYGKEVDN 239
RD+KPEN+LL +K++DFG + S T CGT +YL PE++ + YGK VD
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 240 WCIGILAYEFLVGKPPFESKDQDTTLERI 268
W +G+L YE L GKPPF ++D+ E+I
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 5e-44
Identities = 77/215 (35%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
DFE LGTG FG V L + K + ALK+L K +I+ + V E+ +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEK----RILQ 56
Query: 140 SRRHPLL-----SSEEGYSLY---------------------TEKDAAKYIYQVADAIHY 173
S RHP L S ++ +LY E A Y QV A+ Y
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
H +++RD+KPENLLL +KI+DFG++ T+CGT +YL PE++ S+ Y
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-RTYTLCGTPEYLAPEIILSKGY 175
Query: 234 GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
GK VD W +GIL YE L G PPF + E+I
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 7e-44
Identities = 69/240 (28%), Positives = 102/240 (42%), Gaps = 55/240 (22%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
DF+ G +G G F V LAKEK T A+K+L K ++I E+ V E+ L+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV---LTR 57
Query: 140 SRRHPLL--------SSEEGYSLYT------------------EKDAAKYIYQVADAIHY 173
HP + E Y + EK Y ++ A+ Y
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 174 CHQKKVIHRDIKPENLLLT--MHEDVKISDFGWSVHAPSL-------------------- 211
H K +IHRD+KPEN+LL MH +KI+DFG +
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 212 --HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+ GT +Y+ PE++ + GK D W +G + Y+ L GKPPF ++ T ++I
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 6e-40
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 32/210 (15%)
Query: 91 GKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS----------- 139
G +G V+LAK+K+T + A+KV+ K ++I + QV ER S
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 140 SRRHPLLSSE--EGYSLYT---------EKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188
+++ L E G L + E A YI ++ A+ Y H +IHRD+KP+N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 189 LLLTMHEDVKISDFGWS----------VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVD 238
+L+ + +K++DFG S ++ K + GT DY+ PE++ Q + K VD
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVD 183
Query: 239 NWCIGILAYEFLVGKPPFESKDQDTTLERI 268
W +G + YEFLVG PPF + + + I
Sbjct: 184 WWSLGCILYEFLVGIPPFHGETPEEIFQNI 213
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-39
Identities = 82/214 (38%), Positives = 114/214 (53%), Gaps = 23/214 (10%)
Query: 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVH 136
W++SDFE+G LGTG FG V +AK K T A+K L K EI+ + V +E+ +
Sbjct: 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 137 LS-------------SSRRHPLLSSEEGYSLYTE--------KDAAK-YIYQVADAIHYC 174
LS +R + LL G L+T D AK Y ++ A Y
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYG 234
H K +I+RD+KPENLLL VK++DFG++ P T+CGT +YL PE++ S+ +G
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-RTFTLCGTPEYLAPEVIQSKGHG 193
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
K VD W +G+L YEF+ G PPF E+I
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI 227
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-37
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 35/217 (16%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
D E +GTG FG V+L +++ ++ ALKV+ E+I + VH E+ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK----RVLK 56
Query: 140 SRRHPLL-----SSEEGYSLY---------------------TEKDAAKYIYQVADAIHY 173
HP + + + LY + Y ++ A+ Y
Sbjct: 57 EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT--MCGTLDYLPPEMVTSQ 231
H K++++RD+KPEN+LL +K++DFG+ A L +T +CGT +YL PE++ S+
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGF---AKKLRDRTWTLCGTPEYLAPEVIQSK 173
Query: 232 HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ K VD W +GIL YE LVG PPF + E+I
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-34
Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 35/204 (17%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
FE+ +G G FG VY A+ K T +A+KV+ + ++ E + +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES---KEKKEKIINE----IQILKK 53
Query: 141 RRHP---------LLSSE--------EGYSLY----------TEKDAAKYIYQVADAIHY 173
+HP L E G SL TE A ++ + Y
Sbjct: 54 CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH-APSLHRKTMCGTLDYLPPEMVTSQH 232
H +IHRDIK N+LLT +VK+ DFG S + + R TM GT ++ PE++ +
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 233 YGKEVDNWCIGILAYEFLVGKPPF 256
Y + D W +GI A E GKPP+
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 7e-34
Identities = 57/189 (30%), Positives = 93/189 (49%), Gaps = 29/189 (15%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS-------- 139
LG G FG VYLA++K T +A+K++ K + + + ++ RE L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 140 ---SRRHPLLSSE--EGYSLY----------TEKDAAKYIYQVADAIHYCHQKKVIHRDI 184
H L E EG SL +E + + + Q+ + + Y H +IHRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 185 KPENLLLTMHED-VKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQH-YGKEVDNW 240
KPEN+LL VK++DFG S + + KT+ GT Y+ PE++ + Y ++ D W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 241 CIGILAYEF 249
+G++ YE
Sbjct: 179 SLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 8e-34
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 31/206 (15%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
FE+ +G G FG V + +++ T+ M A+K + K + + + V ER +
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNER----RILQEL 57
Query: 142 RHPLL-----SSEEGYSLY---------------------TEKDAAKYIYQVADAIHYCH 175
HP L S ++ ++Y +E+ +I ++ A+ Y H
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFGWSVH-APSLHRKTMCGTLDYLPPEMVTSQHYG 234
K +IHRDIKP+N+LL V I+DF + P + GT Y+ PE++ Q Y
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKD 260
VD W +G+ AYE L GK P+
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-33
Identities = 65/198 (32%), Positives = 96/198 (48%), Gaps = 23/198 (11%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER-----------CCQVH 136
LG G FG V L K K+ ALK + K I+ + E+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 137 LSSSRRHP--LLSSEEGYSLYT--------EKDAAK-YIYQVADAIHYCHQKKVIHRDIK 185
+++ L+ G L+T ++ A+ YI V A Y H + +I+RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 186 PENLLLTMHEDVKISDFGWSVHAPSLHR-KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGI 244
PENLLL + VK+ DFG++ S + T CGT +Y+ PE++ ++ Y VD W +GI
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180
Query: 245 LAYEFLVGKPPFESKDQD 262
L YE L G+PPF D+D
Sbjct: 181 LLYELLTGRPPFGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-31
Identities = 62/207 (29%), Positives = 84/207 (40%), Gaps = 27/207 (13%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE--------- 130
SD E LG G G VY + K T + ALK ++ R Q+ RE
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCES 58
Query: 131 ----RCCQVHLSSSRRHPLLSSEEGYSL---------YTEKDAAKYIYQVADAIHYCHQK 177
+C +L +G SL E A Q+ + Y H K
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 178 -KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMCGTLDYLPPEMVTSQHYG 234
+IHRDIKP NLL+ +VKI+DFG S + T GT+ Y+ PE + + Y
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYS 178
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQ 261
D W +G+ E +GK PF Q
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQ 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-31
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147
LG G FG V LA+ K T + A+KVL K I+ V + L+ + +HP L+
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVIL---QDDDVECTMTEKRVLALAGKHPFLT 59
Query: 148 SE--------------------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIH 181
+ + E A Y ++ + + H++ +I+
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDN 239
RD+K +N+LL +KI+DFG + T CGT DY+ PE+++ Q YG VD
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179
Query: 240 WCIGILAYEFLVGKPPFESKDQDTTLERI 268
W +G+L YE L G+ PFE D+D + I
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 70/210 (33%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147
+G G FG V LAK K A+KVL K I+ ++ + ER L + +HP L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV---LLKNVKHPFLV 59
Query: 148 SEEGYSLYT---------------------------EKDAAKYIYQVADAIHYCHQKKVI 180
YS T E A Y ++A A+ Y H +I
Sbjct: 60 GLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPEMVTSQHYGKEVD 238
+RD+KPEN+LL V ++DFG S T CGT +YL PE++ Q Y + VD
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVD 178
Query: 239 NWCIGILAYEFLVGKPPFESKDQDTTLERI 268
WC+G + YE L G PPF S+D + I
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-30
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 39/214 (18%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQ-VHLSSSRRHPLL 146
+G G FG VYL + K+ + LK EI M+ + RE V + HP +
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLK-----EIDLSNMSEK-EREDALNEVKILKKLNHPNI 61
Query: 147 -----SSEEGYSLY-------------------------TEKDAAKYIYQVADAIHYCHQ 176
S EE L E+ + Q+ A+ Y H
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQHYG 234
+K++HRDIKP+N+ LT + VK+ DFG S + + KT+ GT YL PE+ ++ Y
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN 181
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ D W +G + YE K PFE ++ +I
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGENLLELALKI 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-30
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 38/221 (17%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
++ G LG G FG VYLA +K T ++A+K + E + + RE + + SS
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE-ALERE----IRILSS 55
Query: 141 RRHP----LLSSEE-----GYSLY-------------------TEKDAAKYIYQVADAIH 172
+HP SE +++ E KY Q+ + +
Sbjct: 56 LQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLA 115
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH----APSLHRKTMCGTLDYLPPEMV 228
Y H ++HRDIK N+L+ VK++DFG + ++ GT ++ PE++
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPF-ESKDQDTTLERI 268
+ YG+ D W +G E GKPP+ E + L +I
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 2e-29
Identities = 70/210 (33%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL- 146
+G G FG V LAK K+ A+KVL K I+ ++ + + ER L + +HP L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV---LLKNLKHPFLV 59
Query: 147 -------SSEEGYSL------------------YTEKDAAKYIYQVADAIHYCHQKKVIH 181
++E+ Y + + E A Y +VA AI Y H +I+
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDN 239
RD+KPEN+LL V ++DFG P T CGT +YL PE++ + Y + VD
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 240 WCIGILAYEFLVGKPPFESKDQDTTLERIF 269
WC+G + YE L G PPF S+D + I
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 36/211 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEII-NERMTHQVHRERCCQVHLSSSRRHPLL 146
LG G FG V L +EK T A+K+L K II + + H + R Q + RHP L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQ-----NTRHPFL 57
Query: 147 SSEEGYS---------------------------LYTEKDAAKYIYQVADAIHYCHQKKV 179
++ + YS +++E A Y ++ A+ Y H V
Sbjct: 58 TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 180 IHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR--KTMCGTLDYLPPEMVTSQHYGKEV 237
++RD+K ENL+L +KI+DFG S KT CGT +YL PE++ YG+ V
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 238 DNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
D W +G++ YE + G+ PF ++D + E I
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 69/243 (28%), Positives = 98/243 (40%), Gaps = 55/243 (22%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
DFEV +G G FG V+L ++K T + A+KVL K ++I V ER S
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 140 SRRHPLLSS--EEGYSLY---------------------TEKDAAKYIYQVADAIHYCHQ 176
L S +E + LY E+ A YI ++ A+ H+
Sbjct: 61 PWIVKLYYSFQDEEH-LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGWS---------------------------VHAP 209
IHRDIKP+N+L+ +K++DFG
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 210 SLHRKTMC----GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265
R+ GT DY+ PE++ YG E D W +G++ YE L G PPF S T
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 266 ERI 268
+I
Sbjct: 240 NKI 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (282), Expect = 5e-29
Identities = 62/227 (27%), Positives = 88/227 (38%), Gaps = 41/227 (18%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
+ + LG G FG VYLA+++ +ALKVL K + + RE L+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 141 RRHP--------------------------LLSSEEGYSLYTEKDAAKYIYQVADAIHYC 174
LL +E +A + Q+ A+ Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 175 HQKKVIHRDIKPENLLLTMHED-VKISDFGWSVHAPSLH--------RKTMCGTLDYLPP 225
H K +IHRDIKPEN+LL VK+ DFG + P T GT Y+ P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 226 EMVTS---QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
E++ + D W +GI YE L G PPFE + + +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224
|
Length = 384 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 38/213 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR-RHPLL 146
LG G FG V LA+ K T + A+K L K +II + E+ ++ +++ RHP L
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK--RIFETANSERHPFL 64
Query: 147 SSEEG-------------YS------------LYTEKDAAKYIYQVADAIHYCHQKKVIH 181
+ Y+ +++E A Y V + Y H+ K+++
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVY 124
Query: 182 RDIKPENLLLTMHEDVKISDFG------WSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGK 235
RD+K +NLLL VKI+DFG T CGT ++L PE++T Y +
Sbjct: 125 RDLKLDNLLLDTEGFVKIADFGLCKEGMG----FGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 236 EVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
VD W +G+L YE LVG+ PF D++ + I
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147
LG G FG V LA+ K T + A+KVL K I+ + V + L+ + +HP L+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD---DDVDCTMTEKRILALAAKHPFLT 59
Query: 148 SEEGYSLYTEKD----------------------------AAKYIYQVADAIHYCHQKKV 179
+ + + KD + Y +V A+ + H+ V
Sbjct: 60 AL--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV 117
Query: 180 IHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPEMVTSQHYGKEV 237
I+RD+K +N+LL K++DFG + T CGT DY+ PE++ YG V
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 238 DNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
D W +G+L YE + G+PPFE+ ++D E I
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 74/248 (29%), Positives = 117/248 (47%), Gaps = 34/248 (13%)
Query: 50 NKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIA 109
+N++ +L + Y+ R + DF+V +G G FG V L + K+++ + A
Sbjct: 17 KNKNIDNFLSR----YEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYA 72
Query: 110 LKVLYKVEIIN---------ER--MTHQVHRERCCQVHLS-SSRRHPLLSSE--EGYSLY 155
+K+L K E+I ER M H + E Q+H + ++ + E G L
Sbjct: 73 MKLLSKFEMIKRSDSAFFWEERDIMAH-ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV 131
Query: 156 T--------EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207
EK A Y +V A+ H IHRD+KP+N+LL +K++DFG +
Sbjct: 132 NLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 208 APS---LHRKTMCGTLDYLPPEMVTSQ----HYGKEVDNWCIGILAYEFLVGKPPFESKD 260
+ + T GT DY+ PE++ SQ +YG+E D W +G+ YE LVG PF +
Sbjct: 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 261 QDTTLERI 268
T +I
Sbjct: 252 LVGTYSKI 259
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER--------- 131
DF LG G FG V LA+ K T + A+K+L K II + E+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 132 --CCQVH---LSSSRRHPLLSSEEGYSL---------YTEKDAAKYIYQVADAIHYCHQK 177
Q+H + R + ++ G L + E A Y ++A + + H K
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRKTMCGTLDYLPPEMVTSQHYGK 235
+I+RD+K +N++L +KI+DFG +T CGT DY+ PE++ Q YGK
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 236 EVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
VD W G+L YE L G+PPF+ +D+D + I
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-27
Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYK-VEIINERMTHQVHRERCCQVHLSSSRRHPLL 146
LG G FG V L +EK T A+K+L K V I + + H V R Q + RHP L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-----NTRHPFL 57
Query: 147 SS-----------------EEGYSLY---------TEKDAAKYIYQVADAIHYCHQKKVI 180
++ G L+ TE+ A Y ++ A+ Y H + V+
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMCGTLDYLPPEMVTSQHYGKEVD 238
+RDIK ENL+L +KI+DFG S KT CGT +YL PE++ YG+ VD
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 239 NWCIGILAYEFLVGKPPFESKDQDTTLERI 268
W +G++ YE + G+ PF ++D + E I
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 3e-27
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 31/201 (15%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL- 146
+G G FG V LAK K A+KVL K ++N + + ER L + +HP L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV---LLKNVKHPFLV 59
Query: 147 -------SSEEGYSL------------------YTEKDAAKYIYQVADAIHYCHQKKVIH 181
++E+ Y + + E A Y ++A A+ Y H +++
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHAPSLH--RKTMCGTLDYLPPEMVTSQHYGKEVDN 239
RD+KPEN+LL V ++DFG + T CGT +YL PE++ Q Y VD
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179
Query: 240 WCIGILAYEFLVGKPPFESKD 260
WC+G + YE L G PPF +D
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-26
Identities = 69/205 (33%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL 146
P+ G FG VYLAK+++T A+KVL K ++I + V ER + S L
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 147 --SSEEGYSLY---------------------TEKDAAKYIYQVADAIHYCHQKKVIHRD 183
S + LY E A +YI +V + HQ+ +IHRD
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122
Query: 184 IKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIG 243
IKPENLL+ +K++DFG S + L K GT DYL PE + K D W +G
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRNG--LENKKFVGTPDYLAPETILGVGDDKMSDWWSLG 180
Query: 244 ILAYEFLVGKPPFESKDQDTTLERI 268
+ +EFL G PPF ++ D + I
Sbjct: 181 CVIFEFLFGYPPFHAETPDAVFDNI 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 69/220 (31%), Positives = 97/220 (44%), Gaps = 47/220 (21%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER-------- 131
DFE + G +G VYL + K T+ A+K + K +I QV ER
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 132 -------CCQVHLSSSRRHPLLSSE--EGYSLYT--------EKDAAK-YIYQVADAIHY 173
C ++RH + E EG T D A+ Y + A+ Y
Sbjct: 61 PFVVSMFCS----FETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEY 116
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-----------------VHAPSLHRKTM 216
H ++HRD+KP+NLL+T +K++DFG S K +
Sbjct: 117 LHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
CGT +Y+ PE++ Q YGK VD W +GI+ YEFLVG PF
Sbjct: 177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-26
Identities = 65/214 (30%), Positives = 111/214 (51%), Gaps = 38/214 (17%)
Query: 88 LGTGKFGHVYLAKEKT---TQIMIALKVLYKVEII-NERMTHQVHRERCCQVHLSSSRRH 143
LG G +G V+ ++ T T + A+KVL K I+ N++ T ER ++ + +H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER----NILEAVKH 59
Query: 144 P--------------------------LLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQK 177
P L E ++ E A Y+ +++ A+ + HQ+
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGW---SVHAPSLHRKTMCGTLDYLPPEMVTSQHYG 234
+I+RD+KPEN+LL VK++DFG S+H ++ T CGT++Y+ PE++ +G
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV-THTFCGTIEYMAPEILMRSGHG 178
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
K VD W +G L Y+ L G PPF ++++ T+++I
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-26
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL- 146
+G G FG V LA+ K + A+KVL K I+ ++ + ER L + +HP L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV---LLKNVKHPFLV 59
Query: 147 --------------------SSEEGYSL-----YTEKDAAKYIYQVADAIHYCHQKKVIH 181
E Y L + E A Y ++A A+ Y H +++
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDN 239
RD+KPEN+LL + ++DFG + T CGT +YL PE++ Q Y + VD
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 240 WCIGILAYEFLVGKPPFESKDQDTTLERIF 269
WC+G + YE L G PPF S++ + I
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER--------- 131
DF LG G FG V LA+ K T + A+K+L K +I + E+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 132 --CCQVH---LSSSRRHPLLSSEEGYSL---------YTEKDAAKYIYQVADAIHYCHQK 177
Q+H + R + ++ G L + E A Y ++A + + H K
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFG------WSVHAPSLHRKTMCGTLDYLPPEMVTSQ 231
+I+RD+K +N++L +KI+DFG W + KT CGT DY+ PE++ Q
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD----GVTTKTFCGTPDYIAPEIIAYQ 176
Query: 232 HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
YGK VD W G+L YE L G+ PFE +D+D + I
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 52/220 (23%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP--- 144
LG G +G VY A++K T ++ALK + +++ E + RE L +HP
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKEL----KHPNIV 61
Query: 145 -LLS---SEEGYSL---YTEKDAAKYI----------------YQVADAIHYCHQKKVIH 181
LL +E L Y + D KY+ YQ+ + YCH +++H
Sbjct: 62 KLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG-----------TLDYLPPE-MVT 229
RD+KP+N+L+ +K++DFG L R G TL Y PE ++
Sbjct: 122 RDLKPQNILINRDGVLKLADFG-------LARA--FGIPLRTYTHEVVTLWYRAPEILLG 172
Query: 230 SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
S+HY VD W +G + E + GKP F + L +IF
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK--VEIINERMTHQVHRERCCQVHL 137
DF++ +G G +G V+LAK+K T ++ALK + K + +NE V ER +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTER----DI 54
Query: 138 SSSRRHP-----LLSSEEGYSLY---------------------TEKDAAKYIYQVADAI 171
++ + L + ++ LY +E A Y+ ++ +A+
Sbjct: 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQ 231
H+ IHRD+KPEN L+ +K++DFG S + ++ G+ DY+ PE++ +
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-ANSVVGSPDYMAPEVLRGK 173
Query: 232 HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y VD W +G + YEFL G PPF + T E +
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 45/224 (20%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVH--RERCCQVHLSS 139
+E +G G +G VY A+ K T ++ALK K+ + NE+ + RE + L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPITAIRE----IKLLQ 53
Query: 140 SRRHP-------LLSSEEGYSLY---------------------TEKDAAKYIYQVADAI 171
RHP +++S+ S+Y TE Y+ Q+ + +
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGL 113
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW-----SVHAPSLHRKTMCGTLDYLPPE 226
Y H ++HRDIK N+L+ +K++DFG ++ + + TL Y PPE
Sbjct: 114 QYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPE 171
Query: 227 MVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
++ + YG EVD W +G + E +GKP F+ + LE+IF
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 67/250 (26%), Positives = 103/250 (41%), Gaps = 67/250 (26%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
F+ LG G G V+L + K T + ALKVL K E+I +V E+ + +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQ----EILA 56
Query: 140 SRRHPLL-----SSEEGYSLY-----------------------TEKDAAKYIYQVADAI 171
+ HP L S + L +E+ A Y +V A+
Sbjct: 57 TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 172 HYCHQKKVIHRDIKPENLLLTMHED--VKISDFGWSVHA--------PSLHRKT------ 215
Y H +++RD+KPEN+LL HE + +SDF S + +L + +
Sbjct: 117 EYLHLLGIVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 216 -----------------MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
GT +Y+ PE+++ +G VD W +GIL YE L G PF+
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234
Query: 259 KDQDTTLERI 268
++D T I
Sbjct: 235 SNRDETFSNI 244
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER--------- 131
DF LG G FG V LA+ K T + A+K+L K +I + E+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 132 --CCQVH---LSSSRRHPLLSSEEGYSL---------YTEKDAAKYIYQVADAIHYCHQK 177
Q+H + R + ++ G L + E A Y +++ + + H++
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRKTMCGTLDYLPPEMVTSQHYGK 235
+I+RD+K +N++L +KI+DFG + +T CGT DY+ PE++ Q YGK
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 236 EVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
VD W G+L YE L G+PPF+ +D+D + I
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 44/216 (20%)
Query: 88 LGTGKFGHVYLAKEKT---TQIMIALKVLYKVEI-INERMTHQVHRERCCQVHLSSSRRH 143
LG G FG V+L ++ T + A+KVL K + + +R+ ++ R+ +V+ H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------H 57
Query: 144 PL-----------------------------LSSEEGYSLYTEKDAAKYIYQVADAIHYC 174
P LS E ++TE+D Y+ ++A A+ +
Sbjct: 58 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHL 114
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT--MCGTLDYLPPEMVTSQH 232
H +I+RD+KPEN+LL +K++DFG S + +K CGT++Y+ PE+V +
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 233 YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ + D W G+L +E L G PF+ KD+ T+ I
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 7e-25
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 33/204 (16%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
++++G +G G FG VY T +A+K +I E++ + + ++ L +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIK-----QISLEKIKEEALKSIMQEIDLLKN 55
Query: 141 RRHP-----LLSSEEGYSLY---------------------TEKDAAKYIYQVADAIHYC 174
+HP + S E SLY E A Y+YQV + Y
Sbjct: 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH--RKTMCGTLDYLPPEMVTSQH 232
H++ VIHRDIK N+L T VK++DFG + + ++ GT ++ PE++
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 233 YGKEVDNWCIGILAYEFLVGKPPF 256
D W +G E L G PP+
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 69/226 (30%), Positives = 102/226 (45%), Gaps = 38/226 (16%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
DF+V +G G FG V + +EK T + A+KV+ K ++ + ER +S
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 141 -------------------RRHP---LLSSEEGYSLYTEKDAAK-YIYQVADAIHYCHQK 177
P LLS Y ++D A+ Y+ ++ AIH HQ
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMC------GTLDYLPPEMVTSQ 231
+HRDIKPEN+L+ +K++DFG A L M GT DY+ PE++T+
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFG---SAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 232 H------YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFWF 271
+ YG E D W +G++AYE + G+ PF T I F
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF 224
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 1e-24
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 36/212 (16%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYK-VEIINERMTHQVHRERCCQVHLSSSRRHPLL 146
LG G FG V L +EK + A+K+L K V I + + H + R + + RHP L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK-----NTRHPFL 57
Query: 147 SSEEGYS---------------------------LYTEKDAAKYIYQVADAIHYCHQKKV 179
+S + YS +++E Y ++ A+ Y H K+
Sbjct: 58 TSLK-YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 180 IHRDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRKTMCGTLDYLPPEMVTSQHYGKEV 237
++RD+K ENL+L +KI+DFG + KT CGT +YL PE++ YG+ V
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 238 DNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
D W +G++ YE + G+ PF ++D + E I
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-24
Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 37/213 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYK-VEIINERMTHQVHRERCCQVHLSSSRRHPLL 146
LG G FG V L KEK T A+K+L K V + + + H + R Q + RHP L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-----NSRHPFL 57
Query: 147 SSEEGYS---------------------------LYTEKDAAKYIYQVADAIHYCH-QKK 178
++ + YS +++E A Y ++ A+ Y H +K
Sbjct: 58 TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRKTMCGTLDYLPPEMVTSQHYGKE 236
V++RD+K ENL+L +KI+DFG KT CGT +YL PE++ YG+
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
VD W +G++ YE + G+ PF ++D + E I
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 73/254 (28%), Positives = 102/254 (40%), Gaps = 63/254 (24%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER-------- 131
DFE +G G FG V L ++K T + A+K L K E++ + V ER
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 132 CCQVHLSSSRRHP--------------LLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQK 177
V L S + +++ +TE++ YI + AI H+
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFG----------------WSVHAPSLHRKTMC---- 217
IHRDIKP+NLLL +K+SDFG S PS +
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 218 --------------------GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257
GT DY+ PE+ Y KE D W +G++ YE LVG PPF
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 258 SKD-QDTTLERIFW 270
S + Q+T + I W
Sbjct: 241 SDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-24
Identities = 74/247 (29%), Positives = 113/247 (45%), Gaps = 32/247 (12%)
Query: 56 EYLKKMQTH----YDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIM-IAL 110
++LK +Q H D+ + P + + + DF LGTG FG V LA K +A+
Sbjct: 2 QFLKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAI 61
Query: 111 KVLYKVEIINERMTHQVHRER----------CCQVHLS---SSRRHPLLSSEEGYSLYTE 157
K K +II ++ V ER C ++ S S + +L G +T
Sbjct: 62 KRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTF 121
Query: 158 KDAAK---------YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208
K Y Q+ Y +++RD+KPENLLL +K++DFG++
Sbjct: 122 LRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA-KV 180
Query: 209 PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ----DTT 264
T+CGT +Y+ PE++ + +GK D W +GI YE LVG PPF + +
Sbjct: 181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240
Query: 265 LERIFWF 271
LE I +F
Sbjct: 241 LEGIIYF 247
|
Length = 340 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-24
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147
LG G FG V LA+ K + + A+KVL K I+ + E+ LS +R HP L+
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRI---LSLARNHPFLT 59
Query: 148 S-----------------EEGYSL---------YTEKDAAKYIYQVADAIHYCHQKKVIH 181
G L + E A Y ++ A+ + H K +I+
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDN 239
RD+K +N+LL K++DFG T CGT DY+ PE++ YG VD
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 240 WCIGILAYEFLVGKPPFESKDQDTTLERIF 269
W +G+L YE L G PFE++++D E I
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-24
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 32/220 (14%)
Query: 81 DFEVGCPLGTGKFGHVYLAKE---KTTQIMIALKVLYKVEIINERMTHQVHR-ERCCQVH 136
+FE+ LGTG +G V+L ++ + A+KVL K I+ + T + R ER
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 137 L--------------SSSRRHPLLSSEEGYSLYT---------EKDAAKYIYQVADAIHY 173
+ + ++ H +L G L+T E + YI ++ A+ +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRK-TMCGTLDYLPPEMVT- 229
HQ +I+RDIK EN+LL V ++DFG S A R + CGT++Y+ PE++
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
Query: 230 -SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
S + K VD W +G+L +E L G PF + + I
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 4e-23
Identities = 61/200 (30%), Positives = 89/200 (44%), Gaps = 25/200 (12%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL---YKVEIINE------RMTHQVHRERC 132
+EV +G G +G V + K T ++A+K E + + ++ Q+ E
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 133 CQ---VHLSSSR--------RHPLLSSEEGYSLYTEKDAAK-YIYQVADAIHYCHQKKVI 180
R LL E DA + YI+Q+ AI YCH +I
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII 122
Query: 181 HRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRKT-MCGTLDYLPPE-MVTSQHYGKE 236
HRDIKPEN+L++ +K+ DFG+ ++ A T T Y PE +V +YGK
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 237 VDNWCIGILAYEFLVGKPPF 256
VD W IG + E L G+P F
Sbjct: 183 VDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 5e-23
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 51/224 (22%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL------------YKVEI-INER 122
RWQ + +G G FG VY A T ++A+K + E+ + E
Sbjct: 1 RWQRGNK-----IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLEL 55
Query: 123 MTH---------QVHRER-------CCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQ 166
+ H +VHRE+ C L H + E +YT Q
Sbjct: 56 LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYT--------LQ 107
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV----HAPSLHR--KTMCGTL 220
+ + + Y H ++HRDIKP N+ L + +K+ DFG +V + ++ +++ GT
Sbjct: 108 LLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 221 DYLPPEMVTSQ---HYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261
Y+ PE++T +G+ D W +G + E GK P+ D
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 9e-23
Identities = 48/225 (21%), Positives = 82/225 (36%), Gaps = 47/225 (20%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS- 139
+++ +G G G V+ AK++ T +ALK + + + + +Q RE
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59
Query: 140 -------------------------------SRRHPLLSSEEGYSLYTEKDAAKYIYQVA 168
PL E Y+ +
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPL----------PEAQVKSYMRMLL 109
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM---CGTLDYLPP 225
+ Y H ++HRD+KP NLL++ +KI+DFG + + T Y P
Sbjct: 110 KGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
Query: 226 EMV-TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
E++ ++ Y VD W +G + E L G P F ++ L +F
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF 214
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 69/245 (28%), Positives = 114/245 (46%), Gaps = 32/245 (13%)
Query: 52 ENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALK 111
+N++ +L + Y+ + + + D++V +G G FG V L + K++Q + A+K
Sbjct: 19 KNIDNFLNR----YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMK 74
Query: 112 VLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS-EEGYSLYT-------------- 156
+L K E+I + ER +S L + ++ LY
Sbjct: 75 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM 134
Query: 157 ------EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210
EK A Y +V A+ H +IHRD+KP+N+LL H +K++DFG +
Sbjct: 135 SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194
Query: 211 ---LHRKTMCGTLDYLPPEMVTSQ----HYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263
+ T GT DY+ PE++ SQ +YG+E D W +G+ +E LVG PF +
Sbjct: 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254
Query: 264 TLERI 268
T +I
Sbjct: 255 TYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 3e-22
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 49/210 (23%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVE------IINERMTHQVHRERCCQV 135
++ +G G G VY A ++ T +A+K + ++ IINE +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINE-------------I 66
Query: 136 HLSSSRRHP---------LLSSE--------EGYSL----------YTEKDAAKYIYQVA 168
+ +HP L+ E +G SL E A +V
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL 126
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPE 226
+ Y H + VIHRDIK +N+LL+ VK++DFG++ R ++ GT ++ PE
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
++ + YG +VD W +GI+ E G+PP+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-22
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 36/205 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER-MTHQVHRERCCQVHLSSSRRHPLL 146
+G G FG VY ++K T+ + A+KVL K EI+ ++ + H + + P +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVR--TLLDESPFI 58
Query: 147 -----SSEEGYSLY---------------------TEKDAAKYIYQVADAIHYCHQKKVI 180
S + LY +E A YI ++ A+ + H+ ++
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR----KTMCGTLDYLPPEMVTSQH-YGK 235
+RD+KPEN+LL + + DFG S +L T CGT +YL PE++ + Y K
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 236 EVDNWCIGILAYEFLVGKPPFESKD 260
VD W +G+L +E G PF ++D
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-22
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALK--------VLYKVEIINE-RMTHQ----- 126
DFE+ +G G FG V+ K + + A+K + E I+E R+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 127 --------VHRERCCQV--HLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQ 176
+ + + V + + H LL + G L E ++ Q+ + + H
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL-PEDQVWRFFIQILLGLAHLHS 119
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRKTMCGTLDYLPPEMVTSQHYG 234
KK++HRDIK NL L +++VKI D G + + T+ GT YL PE+ + Y
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
++ D W +G++ YE GK PF++ +Q + +I
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 6e-22
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 80 SDFEVGCPLGT--GKFGHVYLAKEKTTQIMIALKVLYKVEIIN--ERMTHQVHRERCCQV 135
+ E+ L GKFG V + K K TQ + K++ K + N E M HQ+ ++ +
Sbjct: 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKII-KAKNFNAIEPMVHQLMKDNPNFI 72
Query: 136 HL----SSSRRH-------------PLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKK 178
L ++ + H LL E L +E + K I Q+ +A++ H+
Sbjct: 73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KL-SEAEVKKIIRQLVEALNDLHKHN 129
Query: 179 VIHRDIKPENLLLTMHED-VKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQHYGK 235
+IH DIK EN+L +D + + D+G + PS + GTLDY PE + +Y
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPEKIKGHNYDV 185
Query: 236 EVDNWCIGILAYEFLVGKPPFE-SKDQDTTLE 266
D W +G+L YE L GK PF+ +D++ LE
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217
|
Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-22
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147
LG G FG V LA+ K T A+K L K ++ + ER +V L+ + HP L+
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVER--RV-LALAWEHPFLT 59
Query: 148 -------SEE----------GYSL---------YTEKDAAKYIYQVADAIHYCHQKKVIH 181
++E G L + E A Y ++ + + H+K +I+
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK--TMCGTLDYLPPEMVTSQHYGKEVDN 239
RD+K +N+LL +KI+DFG + K T CGT DY+ PE++ Q Y + VD
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179
Query: 240 WCIGILAYEFLVGKPPFESKDQDTTLERI 268
W G+L YE L+G+ PF +D+D + I
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 7e-22
Identities = 72/227 (31%), Positives = 107/227 (47%), Gaps = 38/227 (16%)
Query: 55 EEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL- 113
EE L+K++T + P K Y FE +G G G VY A + T +A+K +
Sbjct: 2 EEILEKLRTIVSVGD-PKKKYT----RFE---KIGQGASGTVYTAIDVATGQEVAIKQMN 53
Query: 114 -----YKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---------GYSL----- 154
K IINE + + ++ +L S L +E G SL
Sbjct: 54 LQQQPKKELIINEILVMRENKHPNIVNYLDS-----YLVGDELWVVMEYLAGGSLTDVVT 108
Query: 155 ---YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW--SVHAP 209
E A + A+ + H +VIHRDIK +N+LL M VK++DFG+ +
Sbjct: 109 ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168
Query: 210 SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
R TM GT ++ PE+VT + YG +VD W +GI+A E + G+PP+
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-22
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYK-VEIINERMTHQVHRERCCQVHLSSSRRHPLL 146
LG G FG V+LA+ K T A+K L K V ++++ + + +R LS + HP L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV----LSLAWEHPFL 58
Query: 147 SSEEGYSLYTEKD----------------------------AAKYIYQVADAIHYCHQKK 178
+ Y + K+ A Y ++ + + H K
Sbjct: 59 T--HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT--MCGTLDYLPPEMVTSQHYGKE 236
+++RD+K +N+LL +KI+DFG KT CGT DY+ PE++ Q Y
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
VD W G+L YE L+G+ PF D++ + I
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERC 132
+ R + D+EV +G G FG V L + K+T+ + A+K+L K E+I + ER
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 133 CQVHLSSSRRHPLLSS-EEGYSLYT--------------------EKDAAKYIYQVADAI 171
+S L + ++ LY EK A Y +V A+
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFG--WSVHAPSLHR-KTMCGTLDYLPPEMV 228
H IHRD+KP+N+LL +K++DFG ++ + R T GT DY+ PE++
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 229 TSQ----HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
SQ +YG+E D W +G+ YE LVG PF + T +I
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 5e-21
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 33/200 (16%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL- 146
+G G FG VY A +K T ++A+KV+ +E + + + +E + S R P +
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIE-DIQQE----IQFLSQCRSPYIT 62
Query: 147 ----SSEEGYSLY--------------------TEKDAAKYIYQVADAIHYCHQKKVIHR 182
S +G L+ E A + +V + Y H++ IHR
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHR 122
Query: 183 DIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNW 240
DIK N+LL+ DVK++DFG S + R T GT ++ PE++ Y ++ D W
Sbjct: 123 DIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIW 182
Query: 241 CIGILAYEFLVGKPPFESKD 260
+GI A E G+PP
Sbjct: 183 SLGITAIELAKGEPPLSDLH 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 7e-21
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 44/227 (19%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
D+EV +G G FG V + K+ ++ K EI MT + ++ +V++
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWK-----EIDYGNMTEKEKQQLVSEVNILRE 55
Query: 141 RRHP---------LLSSEEGYSLYTE--------------KDAAKYI---------YQVA 168
+HP + S + + E K KYI Q+
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 169 DAIHYCH-----QKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLD 221
A++ CH V+HRD+KP N+ L + +VK+ DFG + + S KT GT
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 222 YLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y+ PE + Y ++ D W +G L YE PPF +++Q +I
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-21
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 31/207 (14%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS- 139
DFE+ +G G FG V + K K T + A+K+L K E++ T ER V+
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61
Query: 140 --SRRHPLLSSEE----------GYSLYT----------EKDAAKYIYQVADAIHYCHQK 177
+ H E G L T E A Y+ ++ AI HQ
Sbjct: 62 WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHA---PSLHRKTMCGTLDYLPPEMVTSQ--- 231
+HRDIKP+N+LL + ++++DFG + ++ GT DY+ PE++ +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 232 --HYGKEVDNWCIGILAYEFLVGKPPF 256
YG E D W +G+ YE L G+ PF
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-21
Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 31/219 (14%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERC------CQ 134
DFE+ +G G FG V + K K T+ + A+K+L K E++ T ER CQ
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 135 ----VHLSSSRRHPLLSSEEGY---------SLYTEK---DAAK-YIYQVADAIHYCHQK 177
+H + + L + Y S + ++ D A+ YI ++ AIH HQ
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHA---PSLHRKTMCGTLDYLPPEMVTSQH-- 232
+HRDIKP+N+LL M+ ++++DFG + ++ GT DY+ PE++ +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 233 ---YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
YG E D W +G+ YE L G+ PF ++ T +I
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 9e-21
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 41/203 (20%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRH---- 143
LG G +G VY A++ +TQ+ IA+K ++ + R +H E + L S +H
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIK---EIPERDSRYVQPLHEE----IALHSYLKHRNIV 68
Query: 144 -------------------------PLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKK 178
LL S+ G E+ Y Q+ + + Y H +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 179 VIHRDIKPENLLLTMHEDV-KISDFGWSVHAPSLH--RKTMCGTLDYLPPEMVTS--QHY 233
++HRDIK +N+L+ + V KISDFG S ++ +T GTL Y+ PE++ + Y
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 234 GKEVDNWCIGILAYEFLVGKPPF 256
G D W +G E GKPPF
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 9e-21
Identities = 50/147 (34%), Positives = 80/147 (54%), Gaps = 22/147 (14%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQ------ 134
+F + P+ G FG VYL ++K + A+KV+ K ++IN+ M HQV ER
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 135 --VHL-----SSSRRHPLLSSEEG---------YSLYTEKDAAKYIYQVADAIHYCHQKK 178
VHL S++ + ++ G Y + E+ A KYI +VA A+ Y H+
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG 124
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWS 205
+IHRD+KP+N+L++ +K++DFG S
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-20
Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 36/225 (16%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKT---TQIMIALKVLYKVEIINE-RMTHQVHRERCCQVH 136
+FE+ LGTG +G V+L ++ + + + A+KVL K I+ + + T ER H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 137 LSSS--------------RRHPLLSSEEGYSLYT---------EKDAAKYIYQVADAIHY 173
+ S + H +L G L+T E++ Y ++ A+ +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRK-TMCGTLDYLPPEMVTS 230
H+ +I+RDIK EN+LL + V ++DFG S H + R + CGT++Y+ P++V
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 231 QHYG--KEVDNWCIGILAYEFLVGKPPF----ESKDQDTTLERIF 269
G K VD W +G+L YE L G PF E Q RI
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-20
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 35/210 (16%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
DF+V LG G +G VY K + ALK +V++ + M+ + + ++ + +S
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALK---EVDLGS--MSQKEREDAVNEIRILAS 55
Query: 141 RRHPLLSS------------------------------EEGYSLYTEKDAAKYIYQVADA 170
HP + S ++ L E++ + Q+
Sbjct: 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTS 230
+ H++K++HRD+K N+LL ++ VKI D G S KT GT Y+ PE+
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKG 175
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
+ Y + D W +G L YE PPFE++
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARS 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKT---TQIMIALKVLYKVEIINERMTHQVHR-ERCCQVH 136
+FE+ LGTG +G V+L ++ T T + A+KVL K ++ + T + R ER H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 137 LSSS--------------RRHPLLSSEEGYSLYT---------EKDAAKYIYQVADAIHY 173
+ S + H +L G ++T E + Y ++ A+ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK---TMCGTLDYLPPEMVTS 230
H+ +++RDIK EN+LL V ++DFG S S ++ + CGT++Y+ PE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 231 QH-YGKEVDNWCIGILAYEFLVGKPPF----ESKDQDTTLERIF 269
+ +GK VD W +GIL +E L G PF E Q RI
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-20
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE-RMTHQV-HRERCCQVHL-------- 137
+G G FG V +++ TQ + ALK + K I++ +TH + R QV+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 138 ---SSSRRHPLLSSEEGYSLY---------TEKDAAKYIYQVADAIHYCHQKKVIHRDIK 185
S + + +L+ G L+ A Y ++ A+ H+ VI+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 186 PENLLLTMHEDVKISDFGWSV--HAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIG 243
PEN+LL + + DFG T CGT +YL PE++ Y K VD W +G
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180
Query: 244 ILAYEFLVGKPPFESKDQDTTLERIF 269
+L YE L G PPF ++ + +I
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKIL 206
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 7e-20
Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 35/201 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERC-CQVHLSSSRRHPLL 146
LG G FG VYL + T +A+K +V + + C++ L + +H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVK---QVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 147 SSEEG--------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVI 180
G Y TE KY Q+ + + Y H ++
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 181 HRDIKPENLLLTMHEDVKISDFGWS-----VHAPSLHRKTMCGTLDYLPPEMVTSQHYGK 235
HRDIK N+L +VK+ DFG S + + K++ GT ++ PE+++ + YG+
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186
Query: 236 EVDNWCIGILAYEFLVGKPPF 256
+ D W +G E L KPP+
Sbjct: 187 KADVWSVGCTVVEMLTEKPPW 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 9e-20
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYK------------------VEIINERM------ 123
LG G FG V + + T M A K L K +E +N R
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 124 THQVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRD 183
++ C + L + G + + E A Y ++ + HQ+++++RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 184 IKPENLLLTMHEDVKISDFGWSVHAPSLHR-KTMCGTLDYLPPEMVTSQHYGKEVDNWCI 242
+KPEN+LL H ++ISD G +VH P K GT+ Y+ PE+V ++ Y D W +
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL 187
Query: 243 GILAYEFLVGKPPFESKDQDTTLERI 268
G L YE + G+ PF+ + + E +
Sbjct: 188 GCLLYEMIAGQSPFQQRKKKIKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-19
Identities = 63/206 (30%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLY---------KVEIINERMTHQVHRERCCQVHLS 138
+G G +G V K K T ++A+K K+ + RM Q+ E + +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL-IE 67
Query: 139 SSRR------------HPLLSSEEGYSL-YTEKDAAKYIYQVADAIHYCHQKKVIHRDIK 185
RR H +L E Y E KY++Q+ I +CH +IHRDIK
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIK 127
Query: 186 PENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEM-VTSQHYGKEVDNWCI 242
PEN+L++ VK+ DFG++ + AP T Y PE+ V YG+ VD W +
Sbjct: 128 PENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAV 187
Query: 243 GILAYEFLVGKPPFESKDQDTTLERI 268
G L E L G+P F L I
Sbjct: 188 GCLVTEMLTGEPLFPGDSDIDQLYHI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-19
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 37/210 (17%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVH-RERCCQ 134
RW+ + LG+G FG VY A+K V + ++ T Q ++ +
Sbjct: 1 RWRKGEL-----LGSGSFGSVYEGLNLDDGDFFAVKE---VSLADDGQTGQEAVKQLEQE 52
Query: 135 VHLSSSRRHP--------------------------LLSSEEGYSLYTEKDAAKYIYQVA 168
+ L S +HP L + Y + E Y Q+
Sbjct: 53 IALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL 112
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-HRKTMCGTLDYLPPEM 227
+ Y H + +HRDIK N+L+ + VK++DFG + K+ G+ ++ PE+
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172
Query: 228 VTSQH-YGKEVDNWCIGILAYEFLVGKPPF 256
+ Q YG D W +G E GKPP+
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-19
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 43/215 (20%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV----------HL 137
LG G + VY + K T ++ALK EI R+ H+ C + H
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALK-----EI---RLEHE-EGAPCTAIREVSLLKDLKHA 64
Query: 138 SSSRRHPLLSSEEGYSL---YTEKDAAKYI----------------YQVADAIHYCHQKK 178
+ H ++ +E+ +L Y +KD +Y+ +Q+ ++YCH++K
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MVTSQHYG 234
V+HRD+KP+NLL+ ++K++DFG + A S+ KT TL Y PP+ ++ S Y
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
++D W +G + YE G+P F + L IF
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 69/247 (27%), Positives = 100/247 (40%), Gaps = 59/247 (23%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
DFE +G G FG V L ++K T + A+K+L K +++ + + ER V S
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 141 RRHPLLSS-EEGYSLY---------------------TEKDAAKYIYQVADAIHYCHQKK 178
+ S ++ +LY TE++ YI + AI HQ
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK------------------------ 214
IHRDIKP+NLLL VK+SDFG HR
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 215 -------------TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261
+ GT DY+ PE+ Y K D W +G++ YE L+G PPF S+
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 262 DTTLERI 268
T +++
Sbjct: 242 QETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 41/105 (39%), Positives = 62/105 (59%), Gaps = 6/105 (5%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW----SVHAPSL 211
E+ A V A+ + H + VIHRDIK +++LLT VK+SDFG+ S P
Sbjct: 113 NEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170
Query: 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
RK++ GT ++ PE+++ YG EVD W +GI+ E + G+PP+
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-19
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 24/197 (12%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALK---------VLYKVEIINERMTHQVHRERC 132
+E +G G +G V+ + + T ++A+K V+ K+ + RM Q+
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 133 CQVH--LSSSRRHPLLSSEEGYSLYTEKDA----------AKYIYQVADAIHYCHQKKVI 180
+ R+ L+ +++ E + K I+Q A+++CH+ I
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122
Query: 181 HRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEM-VTSQHYGKEV 237
HRD+KPEN+L+T +K+ DFG++ + P T Y PE+ V YG V
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPV 182
Query: 238 DNWCIGILAYEFLVGKP 254
D W IG + E L G+P
Sbjct: 183 DVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 67/247 (27%), Positives = 98/247 (39%), Gaps = 59/247 (23%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
DFE +G G FG V L ++K T + A+K+L K +++ + + ER V +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 141 RRHPLLSS-EEGYSLY---------------------TEKDAAKYIYQVADAIHYCHQKK 178
+ S ++ +LY +E+ YI + AI HQ
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK------------------------ 214
IHRDIKP+NLLL VK+SDFG HR
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 215 -------------TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261
+ GT DY+ PE+ Y K D W +G++ YE L+G PPF S+
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 262 DTTLERI 268
T ++
Sbjct: 242 QETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 44/215 (20%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQ-VHL 137
+ +F++ +G G+F VY A ++ALK KV+I M R+ C + + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALK---KVQIFE--MMDAKARQDCLKEIDL 55
Query: 138 SSSRRHP----LLSS--------------------------EEGYSLYTEKDAAKYIYQV 167
HP L+S ++ L E+ KY Q+
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM-----CGTLDY 222
A+ + H K+++HRDIKP N+ +T VK+ D G S KT GT Y
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGTPYY 172
Query: 223 LPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257
+ PE + Y + D W +G L YE + PF
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-19
Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 45/204 (22%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP-LL 146
LG G FG VY A+ K T + A K++ ++E E V ++ + S +HP ++
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII-QIESEEELEDFMV------EIDILSECKHPNIV 65
Query: 147 SSEEGYSL--------------------------YTEKDAAKYIYQVADAIHYCHQKKVI 180
E Y TE Q+ +A+++ H KVI
Sbjct: 66 GLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMV-----TSQ 231
HRD+K N+LLT+ DVK++DFG V A + R T GT ++ PE+V
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFG--VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 232 HYGKEVDNWCIGILAYEFLVGKPP 255
Y + D W +GI E +PP
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 3e-19
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 55 EEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL- 113
EE L+K+++ + P K Y + FE +G G G VY A + T +A+K +
Sbjct: 2 EEILEKLRSIVSVGD-PKKKY----TRFE---KIGQGASGTVYTAIDIATGQEVAIKQMN 53
Query: 114 -----YKVEIINERMTHQVHRERCCQVHLSS----SRRHPLLSSEEGYSL--------YT 156
K IINE + + ++ +L S ++ G SL
Sbjct: 54 LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD 113
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRK 214
E A + A+ + H +VIHRDIK +N+LL M VK++DFG+ + R
Sbjct: 114 EGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
TM GT ++ PE+VT + YG +VD W +GI+A E + G+PP+
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-19
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 35/219 (15%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---------RMTHQVHRERC 132
FEV +G G +G V + K T+ ++A+K E E +M + +E
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 133 CQVHLSSSRRHPLLSSEEGYSLYTEKD----------------AAKYIYQVADAIHYCHQ 176
++ + RR L E Y EK+ YIYQ+ AIH+CH+
Sbjct: 63 VELKEAFRRRGKLYLVFE----YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGWS---VHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
++HRDIKPENLL++ ++ +K+ DFG++ + + T Y PE++ Y
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 234 GKEVDNWCIGILAYEFLVGKP--PFESK-DQDTTLERIF 269
GK VD W +G + E G+P P ES+ DQ T++++
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 47/213 (22%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQ--VHRERCCQVH 136
+S+ E +G+G G VY + T + ALKV+Y H+ V R+ C ++
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG--------NHEDTVRRQICREIE 124
Query: 137 LSSSRRHP-----------------LLS-----SEEGYSLYTEKDAAKYIYQVADAIHYC 174
+ HP LL S EG + E+ A Q+ I Y
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYL 184
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM--C----GTLDYLPPEMV 228
H++ ++HRDIKP NLL+ ++VKI+DFG S + +TM C GT+ Y+ PE +
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGVS----RILAQTMDPCNSSVGTIAYMSPERI 240
Query: 229 TS-----QHYGKEVDNWCIGILAYEFLVGKPPF 256
+ + G D W +G+ EF +G+ PF
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 4e-19
Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 49/226 (21%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
+E G LG G + VY A++K T ++A+K K+++ + ++ ++ R
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIK---KIKLGERKEAK-------DGINFTALR 51
Query: 142 --------RHP----LL---SSEEGYSL-------------------YTEKDAAKYIYQV 167
+HP LL + +L T D Y+
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMT 111
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK--TMCGTLDYLPP 225
+ Y H ++HRD+KP NLL+ +K++DFG + S +RK T Y P
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171
Query: 226 EMV-TSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
E++ ++HYG VD W +G I A E L+ P L +IF
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFA-ELLLRVPFLPGDSDIDQLGKIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 5e-19
Identities = 41/102 (40%), Positives = 61/102 (59%), Gaps = 2/102 (1%)
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRK 214
E A + A+ + H +VIHRDIK +N+LL M VK++DFG+ + R
Sbjct: 114 EAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
TM GT ++ PE+VT + YG +VD W +GI+A E + G+PP+
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-19
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 35/203 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL-- 145
+G G FG V+L + K Q ++ +K +I E+MT + + HP
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIK-----QIPVEQMTKDERLAAQNECQVLKLLSHPNII 62
Query: 146 --------------------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKV 179
+ SL E + Q+ A+H+ H K +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI 122
Query: 180 IHRDIKPENLLLTMHEDV-KISDFGWSVHAPSLHRK-TMCGTLDYLPPEMVTSQHYGKEV 237
+HRD+K +N+LL H+ V KI DFG S S + T+ GT Y+ PE+ + Y ++
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKS 182
Query: 238 DNWCIGILAYEFLVGKPPFESKD 260
D W +G + YE K FE+ +
Sbjct: 183 DIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-19
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 29/201 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVL-------------YKVEIINERMTHQVHRERCCQ 134
+G G +G VY K T ++ALK++ +V ++++ Q +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP--PNITK 66
Query: 135 VH---LSSSRRHPLLSSEEGYSLYT--------EKDAAKYIYQVADAIHYCHQKKVIHRD 183
+ L R ++ EG S+ T EK + I +V A+ Y H+ VIHRD
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRD 126
Query: 184 IKPENLLLTMHEDVKISDFG--WSVHAPSLHRKTMCGTLDYLPPEMVTS-QHYGKEVDNW 240
IK N+L+T +VK+ DFG ++ S R T GT ++ PE++T ++Y + D W
Sbjct: 127 IKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIW 186
Query: 241 CIGILAYEFLVGKPPFESKDQ 261
+GI YE G PP+ D
Sbjct: 187 SLGITIYEMATGNPPYSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-19
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 39/213 (18%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYK-VEIINERMTHQVHRERCCQVHLSSSRRHPLL 146
LG G FG V LA+ K A+K L K V +I++ + + +R L+ + +P L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRV----LALAWENPFL 58
Query: 147 SSEEGYSLYTEKD----------------------------AAKYIYQVADAIHYCHQKK 178
+ Y + K+ A Y ++ + + H K
Sbjct: 59 T--HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGW---SVHAPSLHRKTMCGTLDYLPPEMVTSQHYGK 235
+I+RD+K +N++L +KI+DFG +V + T CGT DY+ PE++ Y
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTFCGTPDYIAPEILQGLKYTF 175
Query: 236 EVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
VD W G+L YE L+G+ PF D+D E I
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 9e-19
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 50/221 (22%)
Query: 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQ------VHRERCCQVHLSS 139
LG G + VY + K T ++ALK + R+ H+ RE L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEI--------RLEHEEGAPFTAIRE----ASLLK 58
Query: 140 SRRHP-------LLSSEEGYSL---YTEKDAAKYI----------------YQVADAIHY 173
+H ++ +++ +L Y + D +Y+ +Q+ + Y
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MVT 229
CHQ++V+HRD+KP+NLL++ ++K++DFG + A S+ KT TL Y PP+ ++
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 230 SQHYGKEVDNWCIGILAYEFLVGKPPFE-SKDQDTTLERIF 269
S Y +D W +G + YE G+P F S D + L +IF
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 43/215 (20%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV----------HL 137
LG G + V+ + K T+ ++ALK EI R+ H+ C + H
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALK-----EI---RLEHE-EGAPCTAIREVSLLKDLKHA 64
Query: 138 SSSRRHPLLSSEEGYSL---YTEKDAAKY----------------IYQVADAIHYCHQKK 178
+ H ++ +++ +L Y +KD +Y +YQ+ + YCH++K
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MVTSQHYG 234
V+HRD+KP+NLL+ ++K++DFG + A S+ KT TL Y PP+ ++ S Y
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
++D W +G + +E G+P F + L IF
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 44/117 (37%), Positives = 68/117 (58%), Gaps = 6/117 (5%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW----SVHAPSL 211
E+ A V A+ Y H + VIHRDIK +++LLT+ VK+SDFG+ S P
Sbjct: 115 NEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK- 173
Query: 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
RK++ GT ++ PE+++ YG EVD W +GI+ E + G+PP+ S ++R+
Sbjct: 174 -RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-18
Identities = 36/115 (31%), Positives = 64/115 (55%), Gaps = 1/115 (0%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR- 213
+ E+ A Y ++ + H++++++RD+KPEN+LL + ++ISD G +V P
Sbjct: 99 FDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158
Query: 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ GT+ Y+ PE+V ++ Y D W +G L YE + GK PF + + E +
Sbjct: 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEI---------INER-MTHQVH-RERCCQVH 136
LG G FG V + K T M A K L K + +NE+ + +V R +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 137 LSSSRRHPLLS-------------SEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRD 183
++ L G + E A Y Q+ + + HQ+++++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 184 IKPENLLLTMHEDVKISDFGWSVHAPSLHR-KTMCGTLDYLPPEMVTSQHYGKEVDNWCI 242
+KPEN+LL H +V+ISD G +V + K GT Y+ PE++ + Y VD + +
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180
Query: 243 GILAYEFLVGKPPFESK 259
G YE + G+ PF +
Sbjct: 181 GCTLYEMIAGRSPFRQR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 2e-18
Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 55 EEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL- 113
EE L+K+++ + P K Y + FE +G G G VY A + T +A++ +
Sbjct: 3 EEILEKLRSIVSVGD-PKKKY----TRFE---KIGQGASGTVYTAMDVATGQEVAIRQMN 54
Query: 114 -----YKVEIINERMTHQVHRERCCQVHLSS----SRRHPLLSSEEGYSL--------YT 156
K IINE + + ++ +L S ++ G SL
Sbjct: 55 LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD 114
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRK 214
E A + A+ + H +VIHRDIK +N+LL M VK++DFG+ + R
Sbjct: 115 EGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
TM GT ++ PE+VT + YG +VD W +GI+A E + G+PP+
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-18
Identities = 37/110 (33%), Positives = 57/110 (51%), Gaps = 3/110 (2%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRKTMCGTL 220
Y+YQ+ + +CH ++HRD+KPENLL+ +K++DFG S +P T
Sbjct: 103 YLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR 162
Query: 221 DYLPPE-MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
Y PE ++ + Y VD W +G + E L +P F K + L +IF
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-18
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALK-------------------VLYKVEIINERMTHQ-V 127
LG G + V+ + K T+ ++ALK +L ++ N H +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 128 HRERCCQV---HLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDI 184
H ERC + +L S + L + S++ K +++Q+ + YCH++K++HRD+
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVK---IFMFQLLRGLSYCHKRKILHRDL 129
Query: 185 KPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MVTSQHYGKEVDNW 240
KP+NLL+ ++K++DFG + A S+ KT TL Y PP+ ++ S Y +D W
Sbjct: 130 KPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMW 188
Query: 241 CIGILAYEFLVGKPPFESKDQDTTLERIF 269
+G + YE G+P F L IF
Sbjct: 189 GVGCILYEMATGRPMFPGSTVKEELHLIF 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-18
Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 45/236 (19%)
Query: 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALK-------------------------- 111
++ D+E+ LG G FG VY A++ T ++ALK
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 112 ---VLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSL-YTEKDAAKYIYQV 167
V+ +++ ER + R+R ++ H L E S+ TE Y+ Q+
Sbjct: 66 HPNVVPLIDMAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSLHRKTMCGTLDYL 223
+ I+Y H+ ++HRDIK N+L+ +KI+DFG + P+ GT Y
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 224 ---------PPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
PPE++ + Y VD W IG + E +P + K L IF
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 4e-18
Identities = 60/215 (27%), Positives = 85/215 (39%), Gaps = 56/215 (26%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKV----LYKV-EIINER-------MT----- 124
++V LG G FG VYLA+ K T ++A+K Y E +N R +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 125 ---HQVHRER--------CCQ---VHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADA 170
+V RE + L R+ S E IYQ+
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFS---------ESVIRSIIYQILQG 111
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMC--------GTLDY 222
+ + H+ HRD+KPENLL++ E VKI+DFG L R+ T Y
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEVVKIADFG-------LAREIRSRPPYTDYVSTRWY 164
Query: 223 LPPEMV-TSQHYGKEVDNWCIGILAYEFLVGKPPF 256
PE++ S Y VD W +G + E +P F
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-18
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 24/196 (12%)
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVL---YKVEIINERMTHQVHRER---------CCQ 134
P+G G FG V A+++ T +A+K + + ++ +R ++ +
Sbjct: 17 PVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 135 VHLSSSRRHPLLSSEEGYSLYT-------EKDAAKY-IYQVADAIHYCHQKKVIHRDIKP 186
+ +S ++ G L+ EK +Y +YQ+ + Y H V+HRD+KP
Sbjct: 77 IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKP 136
Query: 187 ENLLLTMHEDVKISDFGWSVHAPSLHRKT-MCGTLDYLPPE-MVTSQHYGKEVDNWCIGI 244
N+L+ + D+KI DFG + + T T Y PE M+T Q Y EVD W G
Sbjct: 137 SNILINENCDLKICDFGLA--RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGC 194
Query: 245 LAYEFLVGKPPFESKD 260
+ E L GKP F KD
Sbjct: 195 IFAEMLEGKPLFPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-18
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 88 LGTGKFGHVYLAKEKTT-QIMIALK----------------------VLYKVEIINERMT 124
LG+G FG VY ++K Q ++ALK ++ +V II E++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 125 H-QVHRERCCQVHLSSSRRHPLLSSEEGYSL-------------YTEKDAAKYIYQVADA 170
H + R + L + R + ++ EG L +TE+ Q+ A
Sbjct: 68 HPNIVRYY--KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 171 IHYCH-QKKVIHRDIKPENLLLTMHEDVKISDFGWSVH-APSLHRKTMCGTLDYLPPEMV 228
+ Y H +K+++HRD+ P N++L + V I+DFG + P ++ GT+ Y PE+V
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
++ YG++ D W G + Y+ +PPF S
Sbjct: 186 KNEPYGEKADVWAFGCILYQMCTLQPPFYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 8e-18
Identities = 42/114 (36%), Positives = 66/114 (57%), Gaps = 2/114 (1%)
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRK 214
E+ A V A+ Y H + VIHRDIK +++LLT +K+SDFG+ V RK
Sbjct: 117 EEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
++ GT ++ PE+++ YG EVD W +GI+ E + G+PP+ ++ + RI
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-18
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER--MTHQVHRERCCQVHLSS 139
+E +G G +G VY A++ T +ALK KV + + RE L S
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK---KVRVPLSEEGIPLSTLREIALLKQLES 57
Query: 140 SRRHP----LLS------SEEGYSL-----YTEKDAAKYI-----------------YQV 167
HP LL ++ L + ++D A Y+ Q+
Sbjct: 58 FE-HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHRKTMCGTLDYLPPE 226
+ + H +++HRD+KP+N+L+T VKI+DFG + +++ + ++ TL Y PE
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPE 176
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
++ Y VD W +G + E +P F + L++IF
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-17
Identities = 66/232 (28%), Positives = 91/232 (39%), Gaps = 67/232 (28%)
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVH-----RERCCQVHLSSSR 141
P+G+G +G V A +K T +A+K + V + RE HL
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVF------DDLIDAKRILREIKLLRHL---- 56
Query: 142 RHP----LL------SSEEGYSLY--TE-----------------KDAAKYI-YQVADAI 171
RH LL S E+ +Y TE D +Y YQ+ +
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLD---------- 221
Y H VIHRD+KP N+L+ + D+KI DFG L R +
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFG-------LARGVDPDEDEKGFLTEYVVT 169
Query: 222 --YLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
Y PE +++S Y K +D W +G I A E L KP F +D L I
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFA-ELLTRKPLFPGRDYIDQLNLIV 220
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
DFE+ +G G FG V + K K + A+K+L K E++ T ER V+ +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 141 RRHPL-LSSEEGYSLYTEKD----------------------AAKYIYQVADAIHYCHQK 177
L + ++ +LY D A Y+ ++ AI HQ
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSV---HAPSLHRKTMCGTLDYLPPEMVTSQH-- 232
+HRDIKP+N+L+ M+ ++++DFG + ++ GT DY+ PE++ +
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 233 ---YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
YG E D W +G+ YE L G+ PF ++ T +I
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
++FE +G G +G VY A++ T+ ++ALK KV + NER + R ++ L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALK---KVRMDNERDGIPISSLR--EITLLL 61
Query: 140 SRRHP----LLSSEEGYSL--------YTEKDAAKYIY----------------QVADAI 171
+ RHP L G L Y E+D A + Q+ +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVT 229
Y H+ +IHRD+K NLLLT +KI+DFG + P+ TL Y PE++
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 230 -SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y +D W +G + E L KP K + L+ I
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 55/219 (25%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER---------------- 131
+G G + V L + K T+ + A+KV+ K + ++ V E+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 132 -CCQV------------------HLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIH 172
C Q H+ R+ P E+ A Y +++ A++
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP------------EEHARFYSAEISLALN 110
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRKTMCGTLDYLPPEMVTS 230
+ H++ +I+RD+K +N+LL +K++D+G P T CGT +Y+ PE++
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPF------ESKDQDT 263
+ YG VD W +G+L +E + G+ PF ++ DQ+T
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 41/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR- 213
+ E +A QV A+H+ H K +IHRDIK N+LL + VK+ DFG+S +
Sbjct: 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199
Query: 214 ---KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267
+T CGT Y+ PE+ + Y K+ D + +G+L YE L K PF+ ++ + + +
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 28/200 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVL----------YKVEIINERMTHQVH--------- 128
LG G FG V + + T + A K L Y+ ++ +R+ +VH
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 129 ----RERCCQVHL---SSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIH 181
+ C V R+ + + +E + E A Y Q+ + + HQ+++I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT--MCGTLDYLPPEMVTSQHYGKEVDN 239
RD+KPEN+LL +V+ISD G +V KT GT ++ PE++ + Y VD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180
Query: 240 WCIGILAYEFLVGKPPFESK 259
+ +G+ YE + + PF ++
Sbjct: 181 FALGVTLYEMIAARGPFRAR 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 39/214 (18%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVH-RERCCQVHLSSSRRHP-- 144
LG G + VY + +TT ++ALK + + E T RE + L +H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKE---IHLDAEEGTPSTAIRE----ISLMKELKHENI 60
Query: 145 -----LLSSEEGYSL---YTEKDAAKYI------------------YQVADAIHYCHQKK 178
++ +E L Y +KD KY+ YQ+ I +CH+ +
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRKTMCGTLDYLPPE-MVTSQHYGK 235
V+HRD+KP+NLL+ ++K++DFG + P TL Y P+ ++ S+ Y
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180
Query: 236 EVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+D W +G + E + G+P F + + L +IF
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 35/110 (31%), Positives = 59/110 (53%), Gaps = 2/110 (1%)
Query: 154 LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSL 211
L+ E+ Y++Q+ A+ Y H+ ++HRDIK N+ LT +K+ DFG S + +
Sbjct: 97 LFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156
Query: 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261
+T+ GT Y+ PE+ Y + D W +G + YE L K F++ +
Sbjct: 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 67/244 (27%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
S F +G G FG V L ++ T + A+K L K +++ V ER +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 140 SRRHPLLSS-EEGYSLYT--------------------EKDAAK-YIYQVADAIHYCHQK 177
L S ++ +LY E+D A+ YI ++ AI H+
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFG------WS----VHAPSLHRK------------- 214
IHRDIKP+N+L+ +K++DFG W+ + H +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 215 ----------------------TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVG 252
++ GT +Y+ PE++ Y + D W +G++ YE LVG
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 253 KPPF 256
+PPF
Sbjct: 241 QPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 3e-17
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 41/219 (18%)
Query: 85 GCPLGTGKFGHVYLAK----EKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
G LG G FG VY K ++ +A+K L + + + RE +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE--EFLRE----ARIMRK 57
Query: 141 RRHP----LL---SSEEGYSLYTE--------------------KDAAKYIYQVADAIHY 173
HP LL + EE + E D + Q+A + Y
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMC-GTLDYLPPEMVTS 230
K IHRD+ N L+ + VKISDFG S +RK + ++ PE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 231 QHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ + D W G+L +E F +G+ P+ + LE +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 3e-17
Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 43/222 (19%)
Query: 87 PLGTGKFGHVYLAK---EKTTQIMIALKVL-------YKVEIINE-RMTHQVH------- 128
LG G FG VY K + +A+K L + + + E R+ ++
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 129 ------RERCCQV-----------HLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAI 171
E V +L SR P+ S E +L + KD + Q+A +
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSR--PVFPSPEKSTL-SLKDLLSFAIQIAKGM 118
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV-HAPSLHRKTMCGTLD---YLPPEM 227
Y KK +HRD+ N L+ VKISDFG S + + G ++ PE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 228 VTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ + + D W G+L +E F +G P+ + LE +
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 67/259 (25%), Positives = 96/259 (37%), Gaps = 71/259 (27%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
DF +G G FG V L ++K T + A+K L K E+ + V ER S
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 141 RRHPLLSSEEG----------------------YSLYTEKDAAKYIYQVADAIHYCHQKK 178
L S + Y ++E Y+ + AI H+
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-------------------------- 212
IHRDIKP+N+L+ +K+SDFG S H
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 213 -------------------RKTMC----GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEF 249
R+ M GT DY+ PE+ Q YG+E D W +G + +E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241
Query: 250 LVGKPPFESKDQDTTLERI 268
L+G PPF S++ T +I
Sbjct: 242 LIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-17
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 49/216 (22%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEI---INER-------MTHQVHRERCCQVHL 137
+G G +G VYLA TT M+A+K +VE+ I R M + E L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVK---QVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 138 SSSRRHPLL-------SSEEGYSLYTEKDAAKYI-------------------YQVADAI 171
H + ++EE S++ E I QV + +
Sbjct: 66 D----HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL 121
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK----TMCGTLDYLPPEM 227
Y H K ++HRD+K +NLL+ KISDFG S + ++ +M G++ ++ PE+
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 228 VTSQH--YGKEVDNWCIGILAYEFLVGKPPFESKDQ 261
+ S Y +VD W +G + E G+ P+ ++
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 4e-17
Identities = 52/220 (23%), Positives = 81/220 (36%), Gaps = 42/220 (19%)
Query: 85 GCPLGTGKFGHVYLAK----EKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
G LG G FG VY ++ +A+K L + + + RE +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE--EFLRE----ARIMRK 57
Query: 141 RRHP----LL---SSEEGYSLYTE---------------------KDAAKYIYQVADAIH 172
HP LL + EE + E D + Q+A +
Sbjct: 58 LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDYLPPEMVT 229
Y K IHRD+ N L+ + VKISDFG S + G + ++ PE +
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 230 SQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ + D W G+L +E F +G+ P+ LE +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-17
Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 54/221 (24%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
FE+ +G G +G VY A+ K T ++A+K++ +E E + + + R S+
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILR----KYSN- 61
Query: 141 RRHPLLSSEEGYSLYTEKDA--------------------------------------AK 162
HP ++ Y + +K+ A
Sbjct: 62 --HPNIA--TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTL 220
+ + + Y H+ KVIHRDIK +N+LLT + +VK+ DFG S + R T GT
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTP 177
Query: 221 DYLPPEMVTS-----QHYGKEVDNWCIGILAYEFLVGKPPF 256
++ PE++ Y D W +GI A E GKPP
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-17
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 39/221 (17%)
Query: 85 GCPLGTGKFGHVYLAKEKTTQIMIALK--VLYKVEIINER--------------MTHQVH 128
G +G+G FG VYL ++ ++A+K L V ++ + ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 129 RERCCQVHLSSSRRHPL---LSSEEG---------YSLYTEKDAAKYIYQVADAIHYCHQ 176
E Q SS L L G Y + E ++ Q+ ++Y H
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSL------HRKTMCGTLDYLPPEMV 228
+ +IHRDIK N+L+ +KISDFG S + A SL R ++ G++ ++ PE+V
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
Y ++ D W +G L E L GK PF Q L+ IF
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIF 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-17
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS---RRHP 144
+G G +G V+ AK + T ++ALK + +++ +E + RE C L R +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 145 LLSSEEGYSL---YTEKDAAKY----------------IYQVADAIHYCHQKKVIHRDIK 185
+L S++ +L Y ++D KY ++Q+ + +CH V+HRD+K
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLK 126
Query: 186 PENLLLTMHEDVKISDFGW--SVHAPSLHRKTMCGTLDYLPPE-MVTSQHYGKEVDNWCI 242
P+NLL+ + ++K++DFG + P TL Y PP+ + ++ Y +D W
Sbjct: 127 PQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 186
Query: 243 G-ILAYEFLVGKPPFESKDQDTTLERIF 269
G I A G+P F D D L+RIF
Sbjct: 187 GCIFAELANAGRPLFPGNDVDDQLKRIF 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-17
Identities = 40/102 (39%), Positives = 60/102 (58%), Gaps = 2/102 (1%)
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRK 214
E+ A V A+ H + VIHRDIK +++LLT VK+SDFG+ V RK
Sbjct: 115 EEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
++ GT ++ PE+++ YG EVD W +GI+ E + G+PP+
Sbjct: 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-17
Identities = 39/103 (37%), Positives = 54/103 (52%), Gaps = 2/103 (1%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHR 213
TE++ A +YQ + Y H K IHRDIK N+LL K++DFG S R
Sbjct: 97 TEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156
Query: 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
T+ GT ++ PE++ Y + D W +GI A E GKPP+
Sbjct: 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 9e-17
Identities = 55/213 (25%), Positives = 77/213 (36%), Gaps = 42/213 (19%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
D+E+ +G G VY A +A+K + +E + +V S
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRK-----EVQAMS 54
Query: 140 SRRHPLL-----SSEEGYSLYT------------------------EKDAAKYIYQVADA 170
HP + S G L+ E A + +V
Sbjct: 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS------VHAPSLHRKTMCGTLDYLP 224
+ Y H IHRDIK N+LL VKI+DFG S RKT GT ++
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 225 PEMVTSQH-YGKEVDNWCIGILAYEFLVGKPPF 256
PE++ H Y + D W GI A E G P+
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 35/206 (16%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVE-------IINE-RMTHQVHRER 131
D+E+ +G+G +G VY A++ T ++A+KV+ K+E I E M +
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKECRHPN 61
Query: 132 CCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADA-----------------IHYC 174
S RR L E Y + + IYQV + Y
Sbjct: 62 IVAYFGSYLRRDKLWIVME----YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQH 232
H+ IHRDIK N+LLT DVK++DFG S + A RK+ GT ++ PE+ +
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 233 ---YGKEVDNWCIGILAYEFLVGKPP 255
Y + D W +GI A E +PP
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-16
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALK-VLYKVE--------------------I 118
+++ +G LG G FG VYL + T +A+K V + E +
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 119 INERMTH-----QVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHY 173
++ER+ + ER + + + + Y TE KY Q+ + + Y
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-----HRKTMCGTLDYLPPEMV 228
H ++HRDIK N+L +VK+ DFG S ++ K++ GT ++ PE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPF 256
+ + YG++ D W +G E L KPP+
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-16
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 40/221 (18%)
Query: 85 GCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP 144
G LGTG F Y A++ T ++A+K + V +V ++ L + HP
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRN-TSSEQEEVVEALRKEIRLMARLNHP 63
Query: 145 -----------------------------LLSSEEGYSLYTEKDAAKYIYQVADAIHYCH 175
LLS Y + E Y Q+ + Y H
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLH 120
Query: 176 QKKVIHRDIKPENLLL-TMHEDVKISDFGWSVHAPS------LHRKTMCGTLDYLPPEMV 228
+ ++IHRD+K NLL+ + + ++I+DFG + + + + GT+ ++ PE++
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+ YG+ D W +G + E KPP+ ++ L IF
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 37/210 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER---------------- 131
+G G + V L + K T+ + A+KV+ K + ++ V E+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 132 -CCQVHLSSSRRHPLLSSEEGYSLY---------TEKDAAKYIYQVADAIHYCHQKKVIH 181
C Q + SR ++ G L E+ A Y +++ A++Y H++ +I+
Sbjct: 63 SCFQ---TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDN 239
RD+K +N+LL +K++D+G P T CGT +Y+ PE++ + YG VD
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 240 WCIGILAYEFLVGKPPF------ESKDQDT 263
W +G+L +E + G+ PF ++ DQ+T
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 34/103 (33%), Positives = 62/103 (60%), Gaps = 2/103 (1%)
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRK 214
E+ A Y ++ A+++ H++ +I+RD+K +N+LL +K++D+G P
Sbjct: 95 EEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257
T CGT +Y+ PE++ + YG VD W +G+L +E + G+ PF+
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 7/111 (6%)
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSLHRKTMCGT 219
+ Q+ + + H ++HRD+K NLLL +KI DFG + + + T
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--T 169
Query: 220 LDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
L Y PE++ Y +D W +G + E L KP F K + L +IF
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP--- 144
+G G +G VY + K T ++A+K + ++E E + RE + L +HP
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIRE----ISLLKELQHPNIV 62
Query: 145 ----LLSSEEGYSL--------------------YTEKDAAK-YIYQVADAIHYCHQKKV 179
+L E L Y + + K Y+YQ+ I +CH ++V
Sbjct: 63 CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 180 IHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRKTMCGTLDYLPPE-MVTSQHYGKE 236
+HRD+KP+NLL+ +K++DFG + P TL Y PE ++ S Y
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
VD W IG + E KP F + L RIF
Sbjct: 183 VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIF 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 46/119 (38%), Positives = 62/119 (52%), Gaps = 9/119 (7%)
Query: 159 DAAKY-IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAP-SLHRKT 215
D +Y +YQ+ + Y H V+HRD+KP NLLL + D+KI DFG + + P H
Sbjct: 106 DHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165
Query: 216 M---CGTLDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
+ T Y PE M+ S+ Y K +D W +G ILA E L +P F KD L I
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILA-EMLSNRPLFPGKDYLHQLNLIL 223
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-16
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147
+G G +G VY A++K T ++ALK + ++E +E + RE + L HP +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIRE----ISLLKELNHPNIV 61
Query: 148 S-----EEGYSLY-------------------TEKDAA---KYIYQVADAIHYCHQKKVI 180
LY T D Y+YQ+ I YCH +V+
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MVTSQHYGKE 236
HRD+KP+NLL+ +K++DFG + A + +T TL Y PE ++ S+ Y
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTP 180
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
VD W IG + E + +P F + L RIF
Sbjct: 181 VDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIF 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-16
Identities = 35/115 (30%), Positives = 62/115 (53%), Gaps = 1/115 (0%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR- 213
+ E+ A Y ++ + H++ ++RD+KPEN+LL + ++ISD G +V P
Sbjct: 99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158
Query: 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ GT+ Y+ PE++ +Q Y D W +G L YE + G+ PF + + E +
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-16
Identities = 56/223 (25%), Positives = 86/223 (38%), Gaps = 41/223 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
D E LG G G V + T ++A+K + +EI NE + Q+ RE +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEI-NEAIQKQILRE--LDILHKC 56
Query: 140 SRRHPLLSSEEGYSLYTEKDA----------------------------AKYIYQVADAI 171
P + G + Y D K V +
Sbjct: 57 --NSPYIVGFYG-AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGL 113
Query: 172 HYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTS 230
Y H+K K+IHRD+KP N+L+ +K+ DFG S + KT GT Y+ PE +
Sbjct: 114 TYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQG 173
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT-----LERI 268
Y + D W +G+ E G+ P+ ++ L+ I
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-16
Identities = 37/102 (36%), Positives = 49/102 (48%)
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM 216
EK K V + Y H +K+IHRDIKP N+LLT VK+ DFG S + T
Sbjct: 104 EKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF 163
Query: 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
GT Y+ PE + + Y D W +G+ E + PF
Sbjct: 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-16
Identities = 51/189 (26%), Positives = 90/189 (47%), Gaps = 21/189 (11%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLY------KVEIINERMT-----HQVHRERCCQVH 136
+G G FG V+ + TQ ++A+K++ ++E I + +T + + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 137 LSSSRRHPLLSSEEGYSL--------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188
L ++ ++ G S + E A + ++ + Y H +K IHRDIK N
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAAN 131
Query: 189 LLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILA 246
+LL+ DVK++DFG + + + R T GT ++ PE++ Y + D W +GI A
Sbjct: 132 VLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITA 191
Query: 247 YEFLVGKPP 255
E G+PP
Sbjct: 192 IELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-15
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 34/207 (16%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
+ V +G G FG L + + A+K EI + + V R V L+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK-----EIRLPKSSSAVEDSRKEAVLLAKM 55
Query: 141 RRHPLLSSEEGYS---------------------------LYTEKDAAKYIYQVADAIHY 173
+ +++ +E + L+ E ++ Q+ + +
Sbjct: 56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQ 231
H+K+V+HRDIK +N+ LT + VK+ DFG + + +P + T GT Y+PPE+ +
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 232 HYGKEVDNWCIGILAYEFLVGKPPFES 258
Y + D W +G + YE K PF++
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 35/201 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL- 146
+G G FG L K K +K EI +M+ + E +V + S+ +HP +
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIK-----EINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 147 ----SSEEGYSLY-----------------------TEKDAAKYIYQVADAIHYCHQKKV 179
S EE +LY E + Q+ A+ + H +K+
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122
Query: 180 IHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEV 237
+HRDIK +N+ LT +K+ DFG + +++ +T GT YL PE+ ++ Y +
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKS 182
Query: 238 DNWCIGILAYEFLVGKPPFES 258
D W +G + YE K FE+
Sbjct: 183 DIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV-----H 136
F++ +G G +G VY A++K T ++ALK KV + NE+ + R ++ H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 137 LSSSRRHPLLSS-----------------------------EEGYSLYTEKDAAKYIYQV 167
+ +++ E G ++E ++ Q+
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSLHRKTMCGTLDYL 223
+ ++YCH+K +HRDIK N+LL +K++DFG ++ + + TL Y
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYR 184
Query: 224 PPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
PPE++ + YG +D W G + E KP F++ + LE I
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-15
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 34/212 (16%)
Query: 86 CPLGTGKFGHVYLAKEKTTQIMIALKVL---YKVEIINER-------MTHQVHRE--RCC 133
+G+G +G V A +K T +A+K L ++ EI +R + H H
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 134 QVHLSSSRRHPL-------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVI 180
V S+ L G+ L +K +YQ+ + Y H +I
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK-VQYLVYQMLCGLKYIHSAGII 139
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPEMVTS-QHYGKE 236
HRD+KP NL + ++KI DFG + HA + M G T Y PE++ + HY +
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILNWMHYNQT 195
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
VD W +G + E L GK F+ KD L +I
Sbjct: 196 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 63/243 (25%), Positives = 97/243 (39%), Gaps = 66/243 (27%)
Query: 84 VGCPLGTGKFGHVYLAKEKTTQI--MIALKVLYKVEIINERMT-------------HQVH 128
GC +G G +G VY AK K + A+K K + E+ T ++
Sbjct: 5 EGC-IGRGTYGRVYKAKRKNGKDGKEYAIK---KFKGDKEQYTGISQSACREIALLRELK 60
Query: 129 RE---RCCQVHLSSSRRHPLLSSEEGYSLYTEKD-----------AAKYI---------Y 165
E +V L + + L + Y E D I +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFD-----YAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLT----MHEDVKISDFGWS--VHAPS---LHRKTM 216
Q+ + +HY H V+HRD+KP N+L+ VKI D G + +AP +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 217 CGTLDYLPPE-MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD---------QDTTLE 266
T+ Y PE ++ ++HY K +D W IG + E L +P F+ ++ Q LE
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235
Query: 267 RIF 269
RIF
Sbjct: 236 RIF 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-15
Identities = 39/108 (36%), Positives = 57/108 (52%), Gaps = 8/108 (7%)
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-----VHAPSLHR--- 213
KY Q+ D + Y H V+HRDIK N++L + +K+ DFG + V H
Sbjct: 106 KYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261
K+M GT ++ PE++ YG++ D W IG +E GKPP S D+
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 63/256 (24%), Positives = 105/256 (41%), Gaps = 74/256 (28%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER----------CCQVHL 137
LG G FG V LA + T + A+K L K +++N V ER +++
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 138 SSSRRHPL------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIK 185
S + L +S ++ E A YI ++ AI H+ IHRDIK
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIK 128
Query: 186 PENLLLTMHEDVKISDFG------WSVHAPSLHRK------------------------- 214
P+N+L+ + +K++DFG W+ H ++K
Sbjct: 129 PDNILIDLDGHIKLTDFGLCTGFRWT-HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187
Query: 215 -------------------TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPP 255
++ GT +Y+ PE++ + Y + D W +G++ +E LVG+PP
Sbjct: 188 RLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247
Query: 256 FESKD-QDTTLERIFW 270
F + +T L+ I W
Sbjct: 248 FLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-15
Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCC---QV 135
M +E +G G +G VY A+++ T IALK + ++E +E + RE
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQ 59
Query: 136 HLSSSRRHPLLSSEEGYSL---YTEKDAAK-----------------YIYQVADAIHYCH 175
H + R ++ SE+ L Y + D K Y+YQ+ I YCH
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 176 QKKVIHRDIKPENLLLTMHED-VKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MVTS 230
+V+HRD+KP+NLL+ + +K++DFG + A + +T TL Y PE ++ S
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLA-RAFGIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+HY VD W +G + E + KP F + L +IF
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217
|
Length = 294 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 9e-15
Identities = 43/117 (36%), Positives = 59/117 (50%), Gaps = 13/117 (11%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--------VHAPSLHRK 214
+IYQ+ + Y H V+HRD+KP NLL+ ++KI DFG + +A
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG--FMT 167
Query: 215 TMCGTLDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
T Y PE M++ Q Y K +D W +G ILA E L KP F+ KD L +I
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILA-ELLGRKPVFKGKDYVDQLNQIL 223
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-15
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 35/209 (16%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
++ +G LG G FG VYL + T +A+K + + ++ + +V+ C ++ L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQV-PFDPDSQETSKEVNALEC-EIQLLKN 60
Query: 141 RRHP--------LLSSEE--------------------GYSLYTEKDAAKYIYQVADAIH 172
RH L EE Y TE +Y Q+ +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR-----KTMCGTLDYLPPEM 227
Y H ++HRDIK N+L +VK+ DFG S ++ K++ GT ++ PE+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
++ + YG++ D W + E L KPP+
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-15
Identities = 51/190 (26%), Positives = 89/190 (46%), Gaps = 21/190 (11%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLY------KVEIINERMT-----HQVHRERCCQVH 136
+G G FG VY + T+ ++A+K++ ++E I + +T + R +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 137 LSSSRRHPLLSSEEGYSLY--------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188
L ++ ++ G S E A + ++ + Y H ++ IHRDIK N
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAAN 131
Query: 189 LLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILA 246
+LL+ DVK++DFG + + + R T GT ++ PE++ Y + D W +GI A
Sbjct: 132 VLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITA 191
Query: 247 YEFLVGKPPF 256
E G+PP
Sbjct: 192 IELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 52/219 (23%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYK----VEIINE--------RMTHQVHRERCCQV 135
+G G F V A+ + T A+K + K +E +N R++ + R +V
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 136 HLSSS---------------------RRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYC 174
R+ PL EK Y+YQ+ ++ +
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGRKRPL----------PEKRVKSYMYQLLKSLDHM 116
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK----TMCGTLDYLPPE-MVT 229
H+ + HRDIKPEN+L+ + +K++DFG ++ K T Y PE ++T
Sbjct: 117 HRNGIFHRDIKPENILI-KDDILKLADFG---SCRGIYSKPPYTEYISTRWYRAPECLLT 172
Query: 230 SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+YG ++D W +G + +E L P F ++ + +I
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEI---------INE-RMTHQVHRERCCQVHL 137
LG G FG V + + T M A K L K I +NE R+ +V+ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 138 SSSRRHPL---LSSEEGYSL-----------YTEKDAAKYIYQVADAIHYCHQKKVIHRD 183
+ + L L+ G L + E+ A Y ++ + ++++++RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127
Query: 184 IKPENLLLTMHEDVKISDFGWSVHAPSLHR-KTMCGTLDYLPPEMVTSQHYGKEVDNWCI 242
+KPEN+LL ++ISD G +V P + GT+ Y+ PE++ ++ Y D W +
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGL 187
Query: 243 GILAYEFLVGKPPFESKDQDTTLERI 268
G L YE + G+ PF + + E +
Sbjct: 188 GCLIYEMIQGQSPFRKRKERVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-14
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCC---QVHLSSSRRH 143
+G G +G V L + +T +K L + + RER + L S +H
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKL--------NLRNASRRERKAAEQEAQLLSQLKH 58
Query: 144 P------------------LLSSEEGYSLY-----------TEKDAAKYIYQVADAIHYC 174
P ++ EG LY E ++ Q+A A+ Y
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQH 232
H+K ++HRD+K +N+ LT +K+ D G + + T+ GT Y+ PE+ +++
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP 178
Query: 233 YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y + D W +G YE K F +KD ++ + RI
Sbjct: 179 YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-14
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR---RHP 144
LG G + VY K K ++ALKV+ E E RE L + H
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 145 LLSSEEGYSL---YTEKDAAKY----------------IYQVADAIHYCHQKKVIHRDIK 185
++ ++E +L Y D +Y ++Q+ + Y HQ+ ++HRD+K
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130
Query: 186 PENLLLTMHEDVKISDFGW--SVHAPSLHRKTMCGTLDYLPPE-MVTSQHYGKEVDNWCI 242
P+NLL++ ++K++DFG + PS TL Y PP+ ++ S Y +D W +
Sbjct: 131 PQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGV 190
Query: 243 GILAYEFLVGKPPFES-KDQDTTLERIF 269
G + E + G F KD LERIF
Sbjct: 191 GCIFVEMIQGVAAFPGMKDIQDQLERIF 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-14
Identities = 54/189 (28%), Positives = 90/189 (47%), Gaps = 21/189 (11%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLY------KVEIINERMT--HQVHRERCCQVHLSS 139
+G G FG V+ + TQ ++A+K++ ++E I + +T Q + + S
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 140 SRRHPLLSSEE----GYSL-------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188
+ L E G +L E A + ++ + Y H +K IHRDIK N
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAAN 131
Query: 189 LLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILA 246
+LL+ H +VK++DFG + + + R T GT ++ PE++ Y + D W +GI A
Sbjct: 132 VLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 191
Query: 247 YEFLVGKPP 255
E G+PP
Sbjct: 192 IELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-14
Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 5/112 (4%)
Query: 150 EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209
+ Y TE KY Q+ + + Y H ++HRDIK N+L +VK+ DFG S
Sbjct: 98 KAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157
Query: 210 SL-----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
++ +++ GT ++ PE+++ + YG++ D W +G E L KPP+
Sbjct: 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-14
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 40/212 (18%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
+++F++ +G G+F VY A + +ALK KV+I E M + ++ ++ L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALK---KVQIF-EMMDAKARQDCVKEIDLL 56
Query: 139 SSRRHP------------------------------LLSSEEGYSLYTEKDAAKYIYQVA 168
HP + ++ L E+ KY Q+
Sbjct: 57 KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSLHRKTMCGTLDYLP 224
A+ + H ++V+HRDIKP N+ +T VK+ D G +S + H ++ GT Y+
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH--SLVGTPYYMS 174
Query: 225 PEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
PE + Y + D W +G L YE + PF
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYK---VEIINER----------MTH-------- 125
P+G+G +G V A + T +A+K L + I +R M H
Sbjct: 22 PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 126 ----QVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEK---DAAKYI-YQVADAIHYCHQK 177
E V+L + L+ ++ + +K D +++ YQ+ + Y H
Sbjct: 82 VFTPASSLEDFQDVYLVT----HLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA 137
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MVTSQHY 233
+IHRD+KP N+ + ++KI DFG + H M G T Y PE M+ HY
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHY 193
Query: 234 GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ VD W +G + E L GK F D L+RI
Sbjct: 194 NQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 37/120 (30%), Positives = 63/120 (52%), Gaps = 4/120 (3%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH---APSL 211
+ E + YQ+ A+ H +K++HRD+K N+ L +K+ DFG+S + SL
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 212 H-RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270
+ CGT YL PE+ + Y K+ D W +G++ YE L PF+ Q ++++ +
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285
|
Length = 478 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-14
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
+E+ +G G FG +YLAK K+ +K EI +M + +V L +
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIK-----EIDLTKMPVKEKEASKKEVILLAKM 56
Query: 142 RHPLLSS------EEGY----------------------SLYTEKDAAKYIYQVADAIHY 173
+HP + + E G L++E + Q++ + +
Sbjct: 57 KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKH 116
Query: 174 CHQKKVIHRDIKPENLLLTMHEDV-KISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTS 230
H +K++HRDIK +N+ L+ + V K+ DFG + ++ T GT YL PE+ +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
+ Y + D W +G + YE K PFE +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 7e-14
Identities = 45/124 (36%), Positives = 58/124 (46%), Gaps = 25/124 (20%)
Query: 162 KYI-YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTL 220
+YI YQ+ A+ Y H VIHRD+KP N+LL VK++DFG L R
Sbjct: 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG-------LARSLSELEE 162
Query: 221 D--------------YLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTT 264
+ Y PE ++ S Y K VD W +G IL E L+GKP F
Sbjct: 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILG-EMLLGKPLFPGTSTLNQ 221
Query: 265 LERI 268
LE+I
Sbjct: 222 LEKI 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-14
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 43/216 (19%)
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRH--- 143
+G+G +G V A ++ T +A+K LY+ +E + +RE + L +H
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRE----LRLLKHMKHENV 76
Query: 144 -----------------------PLLSSEEGYSLYTEK---DAAKY-IYQVADAIHYCHQ 176
P + ++ G + EK D ++ +YQ+ + Y H
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA 136
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPEMVTS-QH 232
+IHRD+KP NL + ++KI DFG + S M G T Y PE++ + H
Sbjct: 137 AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS----EMTGYVVTRWYRAPEVILNWMH 192
Query: 233 YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y + VD W +G + E L GKP F+ D L I
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-14
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP--- 144
+G G +G VY A+ K T ++ALK K+ + E T V ++ L HP
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALK---KIRLDTE--TEGVPSTAIREISLLKELNHPNIV 62
Query: 145 ----LLSSEEGYSL---YTEKDAAK-----------------YIYQVADAIHYCHQKKVI 180
++ +E L + +D K Y++Q+ + +CH +V+
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MVTSQHYGKE 236
HRD+KP+NLL+ +K++DFG + A + +T TL Y PE ++ ++Y
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
VD W +G + E + + F + L RIF
Sbjct: 182 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 41/208 (19%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
+E+ LG G FG VY AK K T + A KV+ E + + + ++ + ++
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVI-------ETKSEEELEDYMVEIEILATC 66
Query: 142 RHPLLSSEEGYSLY---------------------------TEKDAAKYIYQVADAIHYC 174
HP + G + TE Q+ +A+ Y
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWSV-HAPSLHRK-TMCGTLDYLPPEMVTSQH 232
H K+IHRD+K N+LLT+ D+K++DFG S + +L R+ + GT ++ PE+V +
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 233 -----YGKEVDNWCIGILAYEFLVGKPP 255
Y + D W +GI E +PP
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-13
Identities = 63/209 (30%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL----------YKVEIINERM 123
S R DFE+ +G+G +G VY A+ T + A+KV+ + EII M
Sbjct: 3 SRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEII---M 59
Query: 124 THQVHRERCCQVHLSSSRRHPLLSSEE---GYSL---------YTEKDAAKYIYQVADAI 171
S RR L E G SL +E A + +
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVT 229
+Y H K +HRDIK N+LLT + VK++DFG S + A RK+ GT ++ PE+
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179
Query: 230 SQH---YGKEVDNWCIGILAYEFLVGKPP 255
+ Y + D W +GI A E +PP
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 167 VADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM-CGTLDYLP 224
+ A+ Y H K VIHRD+KP N+L+ + VK+ DFG S + KT+ G Y+
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMA 171
Query: 225 PEMV----TSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
PE + + Y + D W +GI E G+ P++S
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 56/196 (28%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALK-VLYK--------VEIINE-RMTHQVHRERCCQVHL 137
+G G FG VY A++ T ++A+K + Y +II E R Q+ +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 138 SSSRRHPLLSSEEGYSLYT-------------EKDAAKYIYQVADAIHYCHQKKVIHRDI 184
R H E Y L + E + A + + Y H + IHRDI
Sbjct: 83 CYLREHTAWLVME-YCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDI 141
Query: 185 KPENLLLTMHEDVKISDFG-WSVHAPSLHRKTMCGTLDYLPPEMVTSQ---HYGKEVDNW 240
K N+LLT VK++DFG S+ +P+ + GT ++ PE++ + Y +VD W
Sbjct: 142 KAGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 241 CIGILAYEFLVGKPPF 256
+GI E KPP
Sbjct: 199 SLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 57/234 (24%)
Query: 76 RWQM--SDFEVGCPLGTGKFGHVYLAKEKTT-----QIMIALKVLYK-------VEIINE 121
W++ +G PLG G FG V A+ +A+K+L ++++E
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE 65
Query: 122 RMTHQV---HR-------------------ERCCQVHLSS---SRRHPLLSSEEGYSL-- 154
++ H+ E +L +RR P E S
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPP----GEYASPDD 121
Query: 155 -------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-- 205
T+KD + YQVA + + KK IHRD+ N+L+T +KI+DFG +
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
Query: 206 VHAPSLHRKTMCGTLDY--LPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
+H +RKT G L + PE + + Y + D W G+L +E F +G P+
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLY-------KVEIINE-RMTHQVHRE-- 130
DFE LG G G V + K + +++A K+++ + +II E ++ H+ +
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 131 -------------RCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQK 177
C H+ +L + E+ K V + Y +K
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP---EEILGKVSIAVLRGLAYLREK 122
Query: 178 -KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKE 236
+++HRD+KP N+L+ ++K+ DFG S + GT Y+ PE + HY +
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
D W +G+ E +G+ P D LE IF
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDA-KELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 43/236 (18%)
Query: 68 REAPNKSYRWQMSD-FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK--VEIINERMT 124
R+ NK+ W++ + ++ P+G+G +G V A + T + +A+K L + II+ + T
Sbjct: 5 RQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 63
Query: 125 HQVHRERCCQVHLSSSRRH-----------PLLSSEEGYSLY------------------ 155
++ ++ L +H P S EE +Y
Sbjct: 64 YR-------ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 116
Query: 156 -TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214
T+ IYQ+ + Y H +IHRD+KP NL + ++KI DFG + H
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMT 175
Query: 215 TMCGTLDYLPPE-MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
T Y PE M+ HY + VD W +G + E L G+ F D L+ I
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 5/110 (4%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM-CGTLD 221
Y Q+ I + H +++RD+KPEN+LL + ++SD G +V T GT
Sbjct: 100 YSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159
Query: 222 YLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF----ESKDQDTTLER 267
Y+ PE++ + Y VD + +G YE + G+ PF E ++ R
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-13
Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 41/221 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM-------THQVHRERC 132
+F + LG+G FG V+ K + +A+K+L +++ ++ ++ +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 133 CQVHLSSSRRHP---------------LLSSEEGYSLYTEKDAAKYIY---QVADAIHYC 174
+ S P L S EG L A I QVA+ + Y
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVL----PVASLIDMACQVAEGMAYL 120
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGW------SVHAPSLHRKTMCGTLDYLPPEMV 228
++ IHRD+ N+L+ K++DFG V+ S + T PE
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAA 176
Query: 229 TSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ + + D W GIL YE F G+ P+ + ++I
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-13
Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 32/216 (14%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLY---KVEIINERMTHQVHRE-----R 131
DFE LG G G V + + +++A K+++ K I N Q+ RE
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-----QIIRELKVLHE 55
Query: 132 CCQVHL--------SSSRRHPLLSSEEGYSL---------YTEKDAAKYIYQVADAIHYC 174
C ++ S + +G SL E K V + Y
Sbjct: 56 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYL 115
Query: 175 HQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
+K K++HRD+KP N+L+ ++K+ DFG S + GT Y+ PE + HY
Sbjct: 116 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 234 GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+ D W +G+ E +G+ P D LE +F
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-13
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALK--------------VLYKVEIINERMTHQVHRER-C 132
+G G +G VY A++K T ++ALK L ++ ++ + ++ ++ R
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLL-QMLSESIYIVRLL 67
Query: 133 CQVHLSSSRRHPLL----------------SSEEGYSLYTEKDAAK-YIYQVADAIHYCH 175
H+ P L S+ G K ++YQ+ + +CH
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 176 QKKVIHRDIKPENLLLTMHEDV-KISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MVTS 230
+ V+HRD+KP+NLL+ + + KI+D G A S+ K+ TL Y PE ++ S
Sbjct: 128 KHGVMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIPVKSYTHEIVTLWYRAPEVLLGS 186
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
HY VD W +G + E +P F + L IF
Sbjct: 187 THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-13
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 27/201 (13%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL----------YKVEIINERMTHQVHRER 131
+E+ LG G FG VY A+ K T ++ A KV+ Y VEI + +
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66
Query: 132 CCQVHLSSSRRHPLLSSEEGYSL----------YTEKDAAKYIYQVADAIHYCHQKKVIH 181
+ L+ G ++ TE Q +A++Y H+ K+IH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 182 RDIKPENLLLTMHEDVKISDFGWSV-HAPSLHRK-TMCGTLDYLPPEMV---TSQH--YG 234
RD+K N+L T+ D+K++DFG S + ++ R+ + GT ++ PE+V TS+ Y
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 235 KEVDNWCIGILAYEFLVGKPP 255
+ D W +GI E +PP
Sbjct: 187 YKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 72/255 (28%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER----------CCQVHL 137
LG G FG V LA++ T+ + A+K L K +++ V ER +++
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 138 SSSRRHPL------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIK 185
S + L +S ++ E A YI ++ A+ H+ IHRDIK
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIK 128
Query: 186 PENLLLTMHEDVKISDFG------WS---------------------------------- 205
P+N+L+ +K++DFG W+
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDR 188
Query: 206 -----VHAPSLHRK----TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
A H++ ++ GT +Y+ PE++ Y + D W +G++ YE LVG+PPF
Sbjct: 189 LKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248
Query: 257 ESKDQ-DTTLERIFW 270
++ +T ++ I W
Sbjct: 249 LAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-13
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE-----RCCQV 135
DFE LG G G V+ K + +++A K+++ +EI + +Q+ RE C
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH-LEI-KPAIRNQIIRELQVLHECNSP 63
Query: 136 HL--------SSSRRHPLLSSEEGYSL---------YTEKDAAKYIYQVADAIHYCHQK- 177
++ S + +G SL E+ K V + Y +K
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 123
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEV 237
K++HRD+KP N+L+ ++K+ DFG S + GT Y+ PE + HY +
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 238 DNWCIGILAYEFLVGK---PPFESKDQDTTLERIF 269
D W +G+ E +G+ PP ++K+ LE +F
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKE----LELMF 214
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-13
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 82 FEVGCPLGTGKFGHVYLAKE-KTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
+E +G G +G V+ A++ K +ALK + +V+ E M RE HL +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 141 RRHPLL------------SSEEGYSL---YTEKDAAKYI-----------------YQVA 168
HP + E +L + ++D Y+ +Q+
Sbjct: 62 E-HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHRKTMCGTLDYLPPEM 227
+ + H +V+HRD+KP+N+L+T +K++DFG + +++ + ++ TL Y PE+
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+ Y VD W +G + E KP F L +I
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-13
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 35/206 (16%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEI---------INER---------------- 122
+G G FG VY ++ T M A+K L K I +NER
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 123 MTHQVHR-ERCCQVH--LSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKV 179
MT+ H ++ C + ++ H LS + +++EK+ Y ++ + + H + V
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 180 IHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTS-QHYGKEVD 238
++RD+KP N+LL H V+ISD G + GT Y+ PE++ Y D
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSAD 178
Query: 239 NWCIGILAYEFLVGKPPF---ESKDQ 261
+ +G + ++ L G PF ++KD+
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-13
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 32/208 (15%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER----------MTHQVH 128
+++F + +G G+F VY A + +ALK + ++++ + + Q++
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 129 RERCCQVHLSSSRRHPL-----------LSS-----EEGYSLYTEKDAAKYIYQVADAIH 172
+ + S + L LS ++ L EK KY Q+ A+
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSLHRKTMCGTLDYLPPEMV 228
+ H ++V+HRDIKP N+ +T VK+ D G +S + H ++ GT Y+ PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH--SLVGTPYYMSPERI 178
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPF 256
Y + D W +G L YE + PF
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 55/245 (22%)
Query: 63 THYDAREAPNKSYRWQMSD--FEVGCPLGTGKFGHVYLA------KEKTTQIM-IALKVL 113
+ Y+ E P RW++ +G PLG G FG V +A KEK ++ +A+K+L
Sbjct: 3 SEYELPEDP----RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML 58
Query: 114 YK-------VEIINE-RMTHQVHRER--------CCQ-------VHLSS---------SR 141
++I+E M + + + C Q V +S +R
Sbjct: 59 KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 118
Query: 142 RHPLLS-----SEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED 196
R P + ++ + KD YQVA + Y KK IHRD+ N+L+T
Sbjct: 119 RPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 178
Query: 197 VKISDFGWS--VHAPSLHRKTMCGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLV 251
+KI+DFG + +H ++KT G L ++ PE + + Y + D W G+L +E F +
Sbjct: 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
Query: 252 GKPPF 256
G P+
Sbjct: 239 GGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 71/243 (29%), Positives = 102/243 (41%), Gaps = 68/243 (27%)
Query: 85 GCPLGTGKFGHVYLAKEKTTQ--IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRR 142
GC +G G +GHVY AK K + ALK ++E M+ C ++ L +
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALK---QIEGTGISMS------ACREIALLRELK 56
Query: 143 HPLLSSEEGYSL------------YTEKD---------AAK---------------YIYQ 166
HP + S + L Y E D A+K +YQ
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHED-----VKISDFGW-----SVHAPSLHRKTM 216
+ D IHY H V+HRD+KP N+L+ M E VKI+D G+ S P +
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 217 CGTLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT---------TLE 266
T Y PE++ ++HY K +D W IG + E L +P F + +D L+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235
Query: 267 RIF 269
RIF
Sbjct: 236 RIF 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 2e-12
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKT----TQIMIALKVL-------YKVEIINE-RMTHQVHR 129
E+G LG G FG VY K T+ +A+K L + E + E + ++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 130 ERCCQVH-LSSSRRHPLLSSE--EGYSLY----------TEKDAAKYIYQVADAIHYCHQ 176
++ + + + +E G L T KD + Q+A + Y
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL--DYLPPEMVTSQH 232
K +HRD+ N L+T + VKISDFG S ++ +RK G L ++ PE +
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 233 YGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ + D W G+L +E F +G+ P+ + LE +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217
|
Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 29/195 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLY-KVEIINERMTHQVHRERCCQVHLSSSR---RH 143
LG G + VY + ++ALKV+ K E E + RE L + H
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLH 69
Query: 144 PLLSSEEGYSL---YTEKDAAKYIYQVADAIH----------------YCHQKKVIHRDI 184
++ ++E + Y D A+Y+ Q +H Y H + ++HRD+
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 185 KPENLLLTMHEDVKISDFGW--SVHAPSLHRKTMCGTLDYLPPE-MVTSQHYGKEVDNWC 241
KP+NLL++ ++K++DFG + PS + TL Y PP+ ++ + Y +D W
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWG 189
Query: 242 IGILAYEFLVGKPPF 256
G + E L G+P F
Sbjct: 190 AGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 36/109 (33%), Positives = 51/109 (46%), Gaps = 19/109 (17%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDY 222
++YQ+ + Y H V+HRD+KP NLLL + D+KI DFG L R T D+
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-------LAR-TTSEKGDF 164
Query: 223 L-----------PPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
+ P ++ Y +D W +G + E L KP F KD
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 4/110 (3%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAP--SLHRKTMCGT 219
++YQ+ + Y H ++HRDIKP NLL+ + +KI DFG + V P S H T
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167
Query: 220 LDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y PE++ S+HY VD W +G + E L + F+++ L+ I
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-12
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 39/195 (20%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEI--INERMTHQVHRERCCQVHLSSSRRHPL 145
LG G FG VYL K+K LKVL ++ + +N T Q ++E L S HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDHPA 63
Query: 146 LS-------SEEGYSLYTE--------------KDAAK---------YIYQVADAIHYCH 175
+ + + + TE K K + Q+ +HY H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
Q++++HRD+K +N+ L + +KI DFG S + T GT Y+ PE + Q Y
Sbjct: 124 QRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGY 182
Query: 234 GKEVDNWCIGILAYE 248
+ D W +G + YE
Sbjct: 183 DSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 36/210 (17%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQV-------HRERCCQ 134
FE+ +G G +G VY + T + A+KV+ E + ++ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 135 VHLSSSRRHP---------------------LLSSEEGYSLYTEKDAAKYIYQVADAIHY 173
+ + +++P L+ + +G +L E+ A ++ + +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL-KEEWIAYICREILRGLSH 126
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTMCGTLDYLPPEMVTSQ 231
HQ KVIHRDIK +N+LLT + +VK+ DFG S R T GT ++ PE++
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 232 H-----YGKEVDNWCIGILAYEFLVGKPPF 256
Y + D W +GI A E G PP
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 70/243 (28%), Positives = 102/243 (41%), Gaps = 68/243 (27%)
Query: 85 GCPLGTGKFGHVYLAKEK--TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRR 142
GC +G G +GHVY AK K + ALK ++E M+ C ++ L +
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALK---QIEGTGISMS------ACREIALLRELK 56
Query: 143 HPLLSSEEGYSL------------YTEKD---------AAK---------------YIYQ 166
HP + + + L Y E D A+K +YQ
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHED-----VKISDFGW-----SVHAPSLHRKTM 216
+ D IHY H V+HRD+KP N+L+ M E VKI+D G+ S P +
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 217 CGTLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT---------TLE 266
T Y PE++ ++HY K +D W IG + E L +P F + +D L+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235
Query: 267 RIF 269
RIF
Sbjct: 236 RIF 238
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 54/212 (25%), Positives = 83/212 (39%), Gaps = 37/212 (17%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
D E LG G G V K T ++A KV++ + + Q+ RE + +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH-IGA-KSSVRKQILRE----LQIMH 58
Query: 140 SRRHPLLSSEEGYSL----------YTEKDAAKYIYQVADAI------------------ 171
R P + S G L + + + IY+ I
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 172 -HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTS 230
+ H +++HRDIKP N+L+ +K+ DFG S + T GT Y+ PE +
Sbjct: 119 LYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQG 176
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262
Y + D W +GI E +GK PF + D
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNID 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-12
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 38/211 (18%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQV-------HRERCCQ 134
FE+ +G G +G VY + T + A+KV+ E E + ++ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 135 VHLSSSRRHP---------------------LLSSEEGYSLYTEKDAAKYI-YQVADAIH 172
+ + ++ P L+ + +G +L ++D YI ++ +
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL--KEDWIAYICREILRGLA 135
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTMCGTLDYLPPEMVTS 230
+ H KVIHRDIK +N+LLT + +VK+ DFG S R T GT ++ PE++
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 231 QH-----YGKEVDNWCIGILAYEFLVGKPPF 256
Y D W +GI A E G PP
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-12
Identities = 37/104 (35%), Positives = 56/104 (53%), Gaps = 5/104 (4%)
Query: 158 KDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKT 215
KD YQVA + Y ++ IHRD+ N+L+T +KI+DFG + VH ++KT
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 216 MCGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
G L ++ PE + + Y + D W GIL +E F +G P+
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-12
Identities = 32/90 (35%), Positives = 48/90 (53%)
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPE 226
V + Y K++HRD+KP N+L+ VK+ DFG S + KT GT Y+ PE
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE 163
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
++ + YG D W +GI E +G+ P+
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-12
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 26/200 (13%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE--RMTHQVHRERCCQVHLS 138
D+E+ +G+G +G VY A+ T + A+K++ K+E ++ + ++ + C+
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 139 SSRRHPLLSSEE---------GYSL---------YTEKDAAKYIYQVADAIHYCHQKKVI 180
+ LS E+ G SL +E A + + Y H K +
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128
Query: 181 HRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQH---YGK 235
HRDIK N+LLT + DVK++DFG + + A RK+ GT ++ PE+ + Y +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 236 EVDNWCIGILAYEFLVGKPP 255
D W +GI A E +PP
Sbjct: 189 LCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-12
Identities = 38/112 (33%), Positives = 53/112 (47%), Gaps = 7/112 (6%)
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMCGTLD 221
+Y + + H ++IHRD+K N+LLT VK+ DFG S S L R T GT
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 193
Query: 222 YLPPEMVTSQH-----YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
++ PE++ + Y D W +GI A E G PP TL +I
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 52/204 (25%), Positives = 82/204 (40%), Gaps = 25/204 (12%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQ--------------V 127
+ V L G G V++A + + LK+ K + E M Q V
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLV 127
Query: 128 HRERCCQV--HLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIK 185
C V H SS L + A Q+ + + Y H +++IHRD+K
Sbjct: 128 SGAITCMVLPHYSSDLYTYLTKRSRPLPI---DQALIIEKQILEGLRYLHAQRIIHRDVK 184
Query: 186 PENLLLTMHEDVKISDFG---WSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCI 242
EN+ + + V I D G + V AP+ + GT++ PE++ Y + D W
Sbjct: 185 TENIFINDVDQVCIGDLGAAQFPVVAPAFL--GLAGTVETNAPEVLARDKYNSKADIWSA 242
Query: 243 GILAYEFLVGKPPFESKDQDTTLE 266
GI+ +E L P +D +T E
Sbjct: 243 GIVLFEML-AYPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHR 213
T KD YQVA + Y +K IHRD+ N+L+T +KI+DFG + VH ++
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 214 KTMCGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
KT G L ++ PE + + Y + D W G+L +E F +G P+
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 35/94 (37%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMCGTLDYLPPEM 227
+ + H K IHRD+K N+LLT VK+ DFG S S L R T GT ++ PE+
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 228 VTSQH-----YGKEVDNWCIGILAYEFLVGKPPF 256
+ + Y D W +GI A E G PP
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 4/120 (3%)
Query: 151 GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAP 209
G T KD + Q + + H ++HRD+KPEN+L+T VK++DFG + +++
Sbjct: 104 GLPAETIKDLMR---QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160
Query: 210 SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+ + TL Y PE++ Y VD W +G + E KP F + L +IF
Sbjct: 161 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 68/245 (27%), Positives = 110/245 (44%), Gaps = 59/245 (24%)
Query: 65 YDAREAPNKSYRWQMS--DFEVGCPLGTGKFGHVYLA------KEKTTQ-IMIALKVLYK 115
Y+ E P RW+ S +G PLG G FG V +A K+K + + +A+K+L
Sbjct: 2 YELPEDP----RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD 57
Query: 116 -------VEIINE-RMTHQVHRER--------CCQ-------VHLSS---------SRRH 143
++++E M + + + C Q V +S +RR
Sbjct: 58 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 117
Query: 144 PLLSSEEGYSL-------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED 196
P + E Y + T KD YQVA + Y +K IHRD+ N+L+T +
Sbjct: 118 PGM--EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV 175
Query: 197 VKISDFGWS--VHAPSLHRKTMCGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLV 251
+KI+DFG + V+ ++KT G L ++ PE + + Y + D W G+L +E F +
Sbjct: 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
Query: 252 GKPPF 256
G P+
Sbjct: 236 GGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 32/208 (15%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEI---------INER---------------- 122
+G G FG VY ++ T M A+K L K I +NER
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 123 MTHQVHR-ERCCQVH--LSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKV 179
M++ H ++ + ++ H LS + +++E + Y ++ + + H + V
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 180 IHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQ-HYGKEVD 238
++RD+KP N+LL H V+ISD G + GT Y+ PE++ Y D
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 178
Query: 239 NWCIGILAYEFLVGKPPFESKDQDTTLE 266
+ +G + ++ L G PF E
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 38/199 (19%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALK-VLYKVEI------------INERMTHQ--VHRERC 132
+G G FG V+ A+ K T+ ++ALK VL + E I + + H+ V+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 133 CQVHLSSSRR-------------HPL--LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQK 177
C+ + R H L L S + +T + K + + + ++Y H+
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN 138
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWS-----VHAPSLHRKT-MCGTLDYLPPEMVTS- 230
K++HRD+K N+L+T +K++DFG + +R T TL Y PPE++
Sbjct: 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198
Query: 231 QHYGKEVDNWCIGILAYEF 249
+ YG +D W G + E
Sbjct: 199 RDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYK--VEIINERMTHQVHR--------------- 129
P+G+G +G V A + + +A+K L + +I+ R T++ R
Sbjct: 22 PVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 130 --------ERCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIH 181
E +V+L ++ L++ +++ IYQ+ + Y H +IH
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIH 141
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MVTSQHYGKEV 237
RD+KP N+ + +++I DFG + A M G T Y PE M+ HY + V
Sbjct: 142 RDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTV 197
Query: 238 DNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
D W +G + E L GK F D L+RI
Sbjct: 198 DIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 51/232 (21%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR------ 141
LG G +G V A + T ++A+K + +EI N+ T C +H ++ R
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDV-TKDRQLVGMCGIHFTTLRELKIMN 75
Query: 142 --RHPLLSS------EEGY----SLYTEKDAAKYI---------------YQVADAIHYC 174
+H + E + D K + Q+ + ++
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWS-------VHAPSLHRKTMCG--------- 218
H+ +HRD+ P N+ + KI+DFG + +TM
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV 195
Query: 219 TLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
TL Y PE++ ++ Y VD W +G + E L GKP F +++ L RIF
Sbjct: 196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247
|
Length = 335 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-11
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 12/94 (12%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG--------WSVHAPSLHRKTMC 217
Q+ AI Y H + +IHRDIK EN+L+ ED+ + DFG WS +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY----GIA 323
Query: 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV 251
GT+D PE++ Y VD W G++ +E V
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV 357
|
Length = 461 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 5/101 (4%)
Query: 161 AKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM-CG 218
K A++Y ++ K+IHRD+KP N+LL + ++K+ DFG S KT G
Sbjct: 110 GKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG 169
Query: 219 TLDYLPPEMVTS---QHYGKEVDNWCIGILAYEFLVGKPPF 256
Y+ PE + Y D W +GI YE GK P+
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 4/95 (4%)
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMC----GTLDYLP 224
+A+ Y H + +IHRD+K EN+ L E+ + DFG + + C GTL+
Sbjct: 196 EALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS 255
Query: 225 PEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259
PE++ Y + D W G++ +E V K
Sbjct: 256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290
|
Length = 392 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 38/121 (31%), Positives = 56/121 (46%), Gaps = 11/121 (9%)
Query: 157 EKDAAKYIYQVADAIHYCHQKK-VIHRDIKPENLLLTMHEDVKISDFGWS---VHAPSLH 212
E K + A+HY +K VIHRD+KP N+LL +VK+ DFG S V + +
Sbjct: 113 EDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172
Query: 213 RKTMCGTLDYLPPEMVTSQH----YGKEVDNWCIGILAYEFLVGKPPFESKDQD-TTLER 267
R C Y+ PE + Y D W +GI E G+ P+++ + L +
Sbjct: 173 RSAGCAA--YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK 230
Query: 268 I 268
I
Sbjct: 231 I 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 32/97 (32%), Positives = 46/97 (47%), Gaps = 3/97 (3%)
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM---CGTLDYL 223
V AI Y H+ ++IHRDIK EN+ + DV + DFG + ++ GT+
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250
Query: 224 PPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
PE++ YG VD W GI+ +E KD
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS---VHAPSLHRKTM--- 216
++YQ+ + Y H VIHRD+KP NLL+ +++I DFG + +P+ H+ M
Sbjct: 112 FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 217 CGTLDYLPPE-MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
T Y PE +++ Y +D W +G + E L + F K+
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 37/199 (18%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147
+G G FG VY A T ++A+K + + + T++ ++ +V +HP
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS----YSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 148 SEEG-------------YSLYTEKDA-------------AKYIYQVADAIHYCHQKKVIH 181
+G Y L + D A + + Y H +IH
Sbjct: 85 EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 144
Query: 182 RDIKPENLLLTMHEDVKISDFG-WSVHAPSLHRKTMCGTLDYLPPEMVTSQ---HYGKEV 237
RDIK N+LLT VK++DFG S +P+ + GT ++ PE++ + Y +V
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPA---NSFVGTPYWMAPEVILAMDEGQYDGKV 201
Query: 238 DNWCIGILAYEFLVGKPPF 256
D W +GI E KPP
Sbjct: 202 DVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 54/212 (25%), Positives = 85/212 (40%), Gaps = 39/212 (18%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVL-YKVEIINERMTHQVHRERCCQVHLSSSRRHPLL 146
+G G FG VY A++ ++A+K + Y + NE+ + +V RHP
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK-----EVRFLQKLRHPNT 77
Query: 147 SSEEGYSL--------------------------YTEKDAAKYIYQVADAIHYCHQKKVI 180
G L E + A + + Y H +I
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 181 HRDIKPENLLLTMHEDVKISDFG-WSVHAPSLHRKTMCGTLDYLPPEMVTSQ---HYGKE 236
HRD+K N+LL+ VK+ DFG S+ AP+ GT ++ PE++ + Y +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
VD W +GI E KPP + + + L I
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 3/109 (2%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGWSVHAPSLHRKT--MCGT 219
Y YQ+ A+ Y H K + HRD+KP+NLL+ + +K+ DFG + + + R +C
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 220 LDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
P M+ + +Y +D W +G + E ++G P F + L RI
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283
|
Length = 440 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-10
Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKV-----LYKVEIINE-RMTHQVHRERCCQVHLSSSR 141
LGTG+FG V K + Q +A+K+ + + E I E ++ ++ E+ Q++ ++
Sbjct: 12 LGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 142 RHPL------LSS-------EEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188
+ P+ +S+ E + + V + + Y K+ IHRD+ N
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN 130
Query: 189 LLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDYLPPEMVTSQHYGKEVDNWCIGIL 245
L+ VK+SDFG S + + G+ + + PPE++ + + D W G+L
Sbjct: 131 CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVL 190
Query: 246 AYE-FLVGKPPFESKDQDTTLERI 268
+E + +GK P+E + T+E++
Sbjct: 191 MWEVYSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 36/105 (34%), Positives = 51/105 (48%), Gaps = 7/105 (6%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VH----APSLHRKTMC 217
++YQ+ A+ Y H V HRD+KP+N+L +KI DFG + V ++
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 218 GTLDYLPPEMVTS--QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
T Y PE+ S Y +D W IG + E L GKP F K+
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 36/107 (33%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV-KISDFGWS--VHAPSLHR 213
E+ A ++YQ+ + Y H V+HRD+KP N+ + + V KI DFG + V H+
Sbjct: 113 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172
Query: 214 KTMCGTLD---YLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPF 256
+ L Y P ++ S +Y K +D W G + E L GKP F
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALK-----VLYKVEIINE-RMTHQVHRERCCQVHLSSSR 141
LG+G+FG V+L K + QI +A+K + + + I E ++ ++ + Q++ ++
Sbjct: 12 LGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 142 RHPLLS----SEEGYSL--------YTEKDAAKYIYQ-VADAIHYCHQKKVIHRDIKPEN 188
+ PL E G L KD + Q V + + Y + IHRD+ N
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN 130
Query: 189 LLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDYLPPEMVTSQHYGKEVDNWCIGIL 245
L++ VK+SDFG + + + G + + PPE+ Y + D W G+L
Sbjct: 131 CLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVL 190
Query: 246 AYE-FLVGKPPFESKDQDTTLERI 268
+E F GK PFE K +E I
Sbjct: 191 MWEVFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 59/203 (29%), Positives = 83/203 (40%), Gaps = 40/203 (19%)
Query: 88 LGTGKFGHV----YLAKEKTTQIMIALKVLY-------KVEIINE-RMTHQVHRERCCQV 135
LG G FG V YL K ++ +A+K L K E + E + Q+ + C V
Sbjct: 3 LGHGNFGSVVKGVYLMK-SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--DHPCIV 59
Query: 136 HL-------------SSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHR 182
L + PLL + D + +QVA + Y K +HR
Sbjct: 60 RLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 183 DIKPENLLLTMHEDVKISDFGWS--VHAPS-LHRKTMCGT--LDYLPPEMVTSQHYGK-- 235
D+ N+LL KISDFG S + A S +R T G L + PE +YGK
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE---CINYGKFS 176
Query: 236 -EVDNWCIGILAYE-FLVGKPPF 256
+ D W G+ +E F G P+
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 32/115 (27%), Positives = 50/115 (43%), Gaps = 12/115 (10%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--------SLHRK 214
Y Q+A+ + Y K+ IHRD+ N+LL + VKI DFG P H K
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ PE + ++ + D W G+ +E F G+ P+ L++I
Sbjct: 162 V---PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS---VHAPSLH 212
T +D Y +QVA + + +K IHRD+ N+LL+ + VKI DFG + P
Sbjct: 172 TMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 231
Query: 213 RKTMCG-TLDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
RK L ++ PE + + Y + D W G+L +E F +G P+
Sbjct: 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVL-YKVEIINERMTHQVHRERCCQ--VHLSSS---- 140
+G G FG VY A++ T ++A+K + Y + NE+ + + Q H +S
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 141 ---RRHP--------LLSSEEGYSLYT----EKDAAKYIYQVADAIHYCHQKKVIHRDIK 185
R H L S+ + ++ E + A + + Y H +IHRDIK
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 152
Query: 186 PENLLLTMHEDVKISDFG-WSVHAPSLHRKTMCGTLDYLPPEMVTSQ---HYGKEVDNWC 241
N+LLT VK++DFG S+ +P+ + GT ++ PE++ + Y +VD W
Sbjct: 153 AGNILLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWS 209
Query: 242 IGILAYEFLVGKPPFESKDQDTTLERI 268
+GI E KPP + + + L I
Sbjct: 210 LGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 29/211 (13%)
Query: 79 MSDFEVGCPLGTGKFGHVY----LAKEKTTQIMIALKVLYK-------VEIINER--MTH 125
++ E LG+G FG VY + + + +I +A+KVL + EI++E M
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS 65
Query: 126 QVHRERCCQVHLSSSRRHPLLSS--EEGYSL-YTEKDAAK--------YIYQVADAIHYC 174
H + + S + L++ G L Y + Q+A + Y
Sbjct: 66 VDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSLHRKTMCGTLDYLPPEMVTS 230
+K+++HRD+ N+L+ + VKI+DFG V H + + ++ E +
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 231 QHYGKEVDNWCIGILAYEFLV-GKPPFESKD 260
+ Y + D W G+ +E + G P+E
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 9e-09
Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 63/260 (24%)
Query: 61 MQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN 120
M YD E+ +++++EV +G G+FG V+L K K TQ K + +
Sbjct: 1 MPGKYDDGES-------RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAI-SYRGLK 52
Query: 121 ERMTHQ------VHRE-------RCCQVHLSSSRRHPLLSSE------------EGYSLY 155
ER Q V RE R L+ + + + E + Y ++
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 156 ---TEKDAAKYIYQVADAIHYCHQ-------KKVIHRDIKPENLLLTM------------ 193
E Q+ A+ YCH ++V+HRD+KP+N+ L+
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 194 -----HEDVKISDFGWSVHAPSLHRKTMC-GTLDYLPPEMV--TSQHYGKEVDNWCIGIL 245
KI DFG S + C GT Y PE++ ++ Y + D W +G +
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 246 AYEFLVGKPPFESKDQDTTL 265
YE GK PF + + L
Sbjct: 233 IYELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS---VHAPSLH 212
T +D Y +QVA + + +K IHRD+ N+LL+ + VKI DFG + P
Sbjct: 177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236
Query: 213 RKTMCG-TLDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
RK L ++ PE + + Y + D W G+L +E F +G P+
Sbjct: 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 53/226 (23%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147
+G G G VYLA + +ALK + + N + + RE L P+ S
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 148 SE-------------EGYSLYT------EKDAAK--------------YIYQVADAIHYC 174
EGY+L + +K++ +++ I Y
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFG----------------WSVHAPSLHRKT--- 215
H K V+HRD+KP+N+LL + +V I D+G T
Sbjct: 130 HSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPG 189
Query: 216 -MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
+ GT DY+ PE + + D + +G++ Y+ L P+ K
Sbjct: 190 KIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
|
Length = 932 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 43/217 (19%)
Query: 75 YRWQMSDFEVGCPLGTGKFGHVYLA---KEKTTQIMIALKVLYKVEIINERMTHQVHRER 131
Y Q D +G +G G+FG VY + +I +A+K K RE+
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKT-CKNCTSPSV------REK 53
Query: 132 CCQ-VHLSSSRRHPLL--------------------SSEEGYSLYTEKDA------AKYI 164
Q ++ HP + E L K + Y
Sbjct: 54 FLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113
Query: 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL-- 220
YQ++ A+ Y K+ +HRDI N+L++ + VK+ DFG S + S ++ + G L
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK-GKLPI 172
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPF 256
++ PE + + + D W G+ +E L+ G PF
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALK-----VLYKVEIINE-RMTHQVHRERCCQVHLSSSR 141
LG+G+FG V+L K + +I +A+K + + + I E ++ ++ Q++ ++
Sbjct: 12 LGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 142 RHPLLSSEEGYSL---------YTEKDAAKYIY----QVADAIHYCHQKKVIHRDIKPEN 188
+ P+ E + K +++ V +A+ Y IHRD+ N
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN 130
Query: 189 LLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDYLPPEMVTSQHYGKEVDNWCIGIL 245
L+ VK+SDFG + + + GT + + PPE+ + + D W G+L
Sbjct: 131 CLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVL 190
Query: 246 AYE-FLVGKPPFESKDQDTTLERI 268
+E F GK P+E +E +
Sbjct: 191 MWEVFSEGKMPYERFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 63/255 (24%), Positives = 96/255 (37%), Gaps = 70/255 (27%)
Query: 54 VEEYLKKMQTHYDAREAPNKSYRWQM--SDFEVGCPLGTGKFGHVY------LAKEKTTQ 105
+E + D + P +W+ ++ G LG G FG V L+K
Sbjct: 8 IESINGNEYVYIDPTQLPYDL-KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAV- 65
Query: 106 IMIALKVLYKVEIINER---------MTH--------------------QVHRERCCQ-- 134
+ +A+K+L +ER M+H V E CC
Sbjct: 66 MKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 135 -VHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM 193
++ +R L+ E D + YQVA + + K IHRD+ N+LLT
Sbjct: 126 LLNFLRRKRESFLTLE---------DLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH 176
Query: 194 HEDVKISDFGWSVHAPSLHRKTMCGT-----------LDYLPPEMVTSQHYGKEVDNWCI 242
+ VKI DFG L R M + + ++ PE + + Y E D W
Sbjct: 177 GKIVKICDFG-------LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 229
Query: 243 GILAYE-FLVGKPPF 256
GIL +E F +G P+
Sbjct: 230 GILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 148 SEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-- 205
E T +D Y +QVA + + +K IHRD+ N+LL+ + VKI DFG +
Sbjct: 163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 222
Query: 206 -VHAPSLHRKTMCG-TLDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
P RK L ++ PE + + Y + D W G+L +E F +G P+
Sbjct: 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 37/118 (31%), Positives = 54/118 (45%), Gaps = 9/118 (7%)
Query: 158 KDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS------VHAPSL 211
K+ + + A + Y K IHRD+ N L+T +KISDFG S V+A +
Sbjct: 94 KELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153
Query: 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
K + + + PE + Y E D W GIL +E F +G P+ + T E I
Sbjct: 154 GMKQI--PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH-APSLHRKTMCGTLD--Y 222
QV + H+ ++HRDIKPENLL+T+ VKI DFG +V ++ + G LD Y
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376
Query: 223 LPP-EMVTSQHYGKEVDNWCIGILA-YEFLVGKP 254
PP E+V Q + +L+ + +L G+P
Sbjct: 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRP 410
|
Length = 507 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 1/98 (1%)
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA-PSLHRKTMCGTLDY 222
+YQ+ I + H +IHRD+KP N+++ +KI DFG + A S T Y
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 191
Query: 223 LPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
PE++ Y + VD W +G + E + G F D
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-08
Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 88 LGTGKFGHVYLA----KEKTTQIMIALKVLYKVEIINE-RMTHQVHRERCCQVHLSSSRR 142
+G+G+FG V+L K K I + + + I E ++ ++ + Q++ + R
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 143 HPL---------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPE 187
P+ L ++ G ++++ V + + Y VIHRD+
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAAR 129
Query: 188 NLLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDYLPPEMVTSQHYGKEVDNWCIGI 244
N L+ ++ VK+SDFG + + GT + + PE+ + Y + D W G+
Sbjct: 130 NCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGV 189
Query: 245 LAYE-FLVGKPPFESKDQDTTLERI 268
L +E F GK P+E++ +E I
Sbjct: 190 LMWEVFSEGKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 1/99 (1%)
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT-MCGTLDY 222
+YQ+ I + H +IHRD+KP N+++ +KI DFG + A + T T Y
Sbjct: 129 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYY 188
Query: 223 LPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261
PE++ Y + VD W +G + E + G F+ D
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 5/125 (4%)
Query: 146 LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205
L S++G T D + YQVA + + K +HRD+ N+LL + VKI DFG +
Sbjct: 225 LLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA 284
Query: 206 ---VHAPS-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKD 260
+H + + + + + ++ PE + Y D W GIL +E F +G P+
Sbjct: 285 RDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344
Query: 261 QDTTL 265
D+T
Sbjct: 345 VDSTF 349
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 56/220 (25%), Positives = 81/220 (36%), Gaps = 40/220 (18%)
Query: 87 PLGTGKFGHVYLA-----KEKTTQIMIALKVLYKV-------EIINER--MTHQVHRE-- 130
LG G FG VY ++ +A+K L + + + E M+ H+
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 131 RCCQVHLSSSRRHPLLSSEEG----------------YSLYTEKDAAKYIYQVADAIHYC 174
R V R LL G S T KD VA Y
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 175 HQKKVIHRDIKPENLLLTMH---EDVKISDFGWS--VHAPSLHRKTMCGTL--DYLPPEM 227
+ IHRDI N LLT KI+DFG + ++ S +RK L ++PPE
Sbjct: 133 EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEA 192
Query: 228 VTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLE 266
+ + D W G+L +E F +G P+ + +E
Sbjct: 193 FLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-08
Identities = 37/113 (32%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 149 EEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208
E+ +L TE D + YQVA + + K IHRD+ N+LLT KI DFG +
Sbjct: 206 EDELALDTE-DLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264
Query: 209 PSLHRKTMCGT----LDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
+ + G + ++ PE + + Y E D W GIL +E F +G P+
Sbjct: 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 28/101 (27%), Positives = 47/101 (46%), Gaps = 12/101 (11%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHAPSLH--------RK 214
QV DA+ H + ++HRD+KP+N++++ K+ DFG P + R
Sbjct: 87 QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146
Query: 215 T-MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKP 254
T + GT Y PE + + D + G++ E L G+
Sbjct: 147 TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-08
Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 30/207 (14%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALK-------------VLYKVEIINERMTHQ 126
+ EV LG G +G VY + T + +A+K ++ +++I+++ ++
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 127 V-------HRERC---CQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYC-H 175
+ E C ++ + L + E + Y V + +
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQH--- 232
+ +IHRD+KP N+L+ + VK+ DFG S + + KT G Y+ PE + S
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 233 ---YGKEVDNWCIGILAYEFLVGKPPF 256
Y + D W +G+ E +G+ P+
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 119 INERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKK 178
+NE + H+ R +C H +SS R + + QVA + Y ++K
Sbjct: 95 LNEFLRHRSPRAQCSLSHSTSSARKCG----LNPLPLSCTEQLCIAKQVAAGMAYLSERK 150
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLD--YLPPEMVTSQHYG 234
+HRD+ N L+ + VKI+DFG S +++ ++ + + ++PPE + Y
Sbjct: 151 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT 210
Query: 235 KEVDNWCIGILAYE-FLVGKPPF 256
E D W G++ +E F G P+
Sbjct: 211 TESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 45/198 (22%), Positives = 71/198 (35%), Gaps = 38/198 (19%)
Query: 88 LGTGKFGHVYLAK----EKTTQIMIALKVL-----------YKVEI-INERMTHQ--VHR 129
LG G FG V L + T +A+K L ++ EI I + H+ V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 130 ERCCQVHLSSSRRHPLLSSE----EGYSLYTEKDAAK--------YIYQVADAIHYCHQK 177
+ C+ R L E Y ++ + + Q+ + Y +
Sbjct: 72 KGVCE---KPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLP-----PEMVTSQH 232
+ IHRD+ N+L+ + VKISDFG + P P PE + +
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 233 YGKEVDNWCIGILAYEFL 250
+ D W G+ YE
Sbjct: 189 FSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 1/98 (1%)
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA-PSLHRKTMCGTLDY 222
+YQ+ I + H +IHRD+KP N+++ +KI DFG + A S T Y
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184
Query: 223 LPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
PE++ Y + VD W +G + E + K F +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-07
Identities = 35/108 (32%), Positives = 49/108 (45%), Gaps = 9/108 (8%)
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS------VHAPSLHRKTMCGTLD 221
A + Y K IHRD+ N L+ + +KISDFG S ++ S K + +
Sbjct: 103 AAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIK 160
Query: 222 YLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ PE + Y E D W GIL +E F +G P+ T ERI
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 4/52 (7%)
Query: 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
GT DYL PE++ + +G VD W +G+ +EFL G PPF D T +++F
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF----NDETPQQVF 589
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 35/117 (29%), Positives = 57/117 (48%), Gaps = 5/117 (4%)
Query: 144 PLLSSEEGY-SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202
P + E G S T + ++ VA + Y +K+ IHRD+ N+L+ + KI+DF
Sbjct: 104 PAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADF 163
Query: 203 GWSVHAPSLHRKTMCGTLD--YLPPEMVTSQHYGKEVDNWCIGILAYEFL-VGKPPF 256
G S +KTM G L ++ E + Y + D W G+L +E + +G P+
Sbjct: 164 GLSRGEEVYVKKTM-GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHR---KTMCGTL 220
Q+A + Y + +HRD+ N L+ + VKI DFG S V++ +R TM +
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-PI 189
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
++PPE + + + E D W G++ +E F GK P+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHR---KTMCGTL 220
Q+A + Y +HRD+ N L+ VKI DFG S +++ +R +TM +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-PI 188
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
++PPE + + + E D W G++ +E F GK P+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-07
Identities = 33/109 (30%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHR---KTMCGTL 220
Q+A + Y + +HRD+ N L+ + VKI DFG S V++ +R TM +
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PI 186
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
++PPE + + + E D W +G++ +E F GK P+ + +E I
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 15/105 (14%)
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG----- 218
+YQ+ I + H +IHRD+KP N+++ +KI DFG L R
Sbjct: 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-------LARTAGTSFMMTP 176
Query: 219 ---TLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
T Y PE++ Y + VD W +G + E + G F D
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 34/112 (30%), Positives = 49/112 (43%), Gaps = 19/112 (16%)
Query: 159 DAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG 218
D ++ QVA + + K IHRD+ N+LLT KI DFG L R M
Sbjct: 213 DLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFG-------LARDIMND 265
Query: 219 T-----------LDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFES 258
+ + ++ PE + Y + D W GIL +E F +GK P+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 29/106 (27%), Positives = 53/106 (50%), Gaps = 5/106 (4%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHR 213
T D + +Q++ + Y + K++HRD+ N+L+ +KISDFG S V+ +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 214 KTMCGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYEFL-VGKPPF 256
K G + ++ E + Y + D W G+L +E + +G P+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 56/218 (25%), Positives = 81/218 (37%), Gaps = 55/218 (25%)
Query: 88 LGTGKFGHVYLAKEKTT------QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
LG+G FG VY I +A+K L K E+ +E + HL S+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK------KEFLKEAHLMSNF 56
Query: 142 RHP--------------------------LLS-------SEEGYSLYTEKDAAKYIYQVA 168
HP LLS G L T K+ VA
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHED-----VKISDFGWS--VHAPSLHRKTMCGTLD 221
Y Q IHRD+ N L++ VKI DFG + ++ +RK G L
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 222 --YLPPEMVTSQHYGKEVDNWCIGILAYEFL-VGKPPF 256
++ PE + + + D W G+L +E L +G+ P+
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 7/108 (6%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG-----WSVHAPS 210
T KD + QVA + Y KK +HRD+ N +L VK++DFG + S
Sbjct: 96 TVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155
Query: 211 LHRKTMCG-TLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPF 256
+H T + ++ E + +Q + + D W G+L +E + G PP+
Sbjct: 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 25/87 (28%), Positives = 44/87 (50%), Gaps = 4/87 (4%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLD-- 221
++AD + Y KK +HRD+ N ++ VKI DFG + ++ +RK G L
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 222 YLPPEMVTSQHYGKEVDNWCIGILAYE 248
++ PE + + + D W G++ +E
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWE 213
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 27/98 (27%), Positives = 41/98 (41%), Gaps = 5/98 (5%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-----RKTMCGTL 220
Q+ + + Y H + IHRD+ N+LL VKI DFG + P H R+ +
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
+ E + + D W G+ YE L +S
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 53/200 (26%), Positives = 83/200 (41%), Gaps = 32/200 (16%)
Query: 88 LGTGKFGHVY--LAKEKTTQIMIALKVLYKVE---IINERMT-----HQ------VHRER 131
LG+G FG V + K + QI +A+KVL + +E M HQ V
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 132 CCQVH--------LSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRD 183
C+ S + LS ++ T + + ++QV+ + Y K +HRD
Sbjct: 63 VCEAEALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 184 IKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCG---TLDYLPPEMVTSQHYGKEVD 238
+ N+LL KISDFG S + A + K L + PE + + + D
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSD 180
Query: 239 NWCIGILAYE-FLVGKPPFE 257
W GI +E F G+ P++
Sbjct: 181 VWSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 27/194 (13%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVL----YKVEIINER--MTHQVHRERCCQVHLSSSR 141
LG G+FG V++ + +A+K L V+ E + + ++ +++ ++
Sbjct: 14 LGAGQFGEVWMGYYNNST-KVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 142 RHPL---------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKP 186
P+ L S+EG + K + Q+A+ + Y +K IHRD++
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK-LIDFSAQIAEGMAYIERKNYIHRDLRA 131
Query: 187 ENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDYLPPEMVTSQHYGKEVDNWCIG 243
N+L++ KI+DFG + G + + PE + + + D W G
Sbjct: 132 ANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 191
Query: 244 ILAYEFLV-GKPPF 256
IL YE + GK P+
Sbjct: 192 ILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 25/99 (25%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTL- 220
++ VA+ + Y KK++HRD+ N+L++ K+SDFG + + + +
Sbjct: 104 QFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA----RVGSMGVDNSKL 159
Query: 221 --DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
+ PE + + + + D W G+L +E F G+ P+
Sbjct: 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 3e-06
Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 5/117 (4%)
Query: 144 PLLSSEEGY-SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202
P + S + + + VA + Y QK+ IHRD+ N+L+ + KI+DF
Sbjct: 97 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156
Query: 203 GWSVHAPSLHRKTMCGTLD--YLPPEMVTSQHYGKEVDNWCIGILAYEFL-VGKPPF 256
G S +KTM G L ++ E + Y D W G+L +E + +G P+
Sbjct: 157 GLSRGQEVYVKKTM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 6/107 (5%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT 215
TEK+ + ++QV+ + Y + +HRD+ N+LL KISDFG S +
Sbjct: 93 TEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152
Query: 216 MCGT-----LDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
T + + PE + + + D W G+L +E F G+ P+
Sbjct: 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 33/115 (28%), Positives = 51/115 (44%), Gaps = 19/115 (16%)
Query: 154 LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213
+ D + YQVA+ + + K +HRD+ N+L+ + VKI DFG L R
Sbjct: 235 ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFG-------LAR 287
Query: 214 KTMCGT-----------LDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
M + L ++ PE + + Y D W GIL +E F +G P+
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-06
Identities = 33/118 (27%), Positives = 52/118 (44%), Gaps = 10/118 (8%)
Query: 158 KDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS------VHAPSL 211
K K+ A + Y K IHRD+ N L+ + +KISDFG S +++ S
Sbjct: 93 KQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152
Query: 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
++ + + PE + Y E D W GIL +E F +G P+ E++
Sbjct: 153 LKQI---PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 2/96 (2%)
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLD 221
K+ V +A+ Y +HRD+ N+L++ K+SDFG + A S + T +
Sbjct: 106 KFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVK 164
Query: 222 YLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
+ PE + + + + D W GIL +E + G+ P+
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 45/209 (21%), Positives = 79/209 (37%), Gaps = 44/209 (21%)
Query: 79 MSDFEVGCPLGTGKFGHVYL---AKEKTTQIMIALKVL-----YKVEIINER--MTHQVH 128
+ ++G +G G+FG V L +K +A+K L + E MT H
Sbjct: 5 SKELKLGATIGKGEFGDVMLGDYRGQK-----VAVKCLKDDSTAAQAFLAEASVMTTLRH 59
Query: 129 RERCCQVHLSSSRRHPLLSSE-------------EGYSLYTEKDAAKYIYQVADAIHYCH 175
+ + + +E G ++ T + V + + Y
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLD--YLP-----PEMV 228
+K +HRD+ N+L++ K+SDFG + K D LP PE +
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLA--------KEASQGQDSGKLPVKWTAPEAL 171
Query: 229 TSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
+ + + D W GIL +E + G+ P+
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-06
Identities = 31/131 (23%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 147 SSEEGYSLYTEKDAAKYIY---QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203
SS+E ++ + D +++ Q+A + Y +H+D+ N+L+ VKISD G
Sbjct: 110 SSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLG 169
Query: 204 WS--VHAPSLHR---KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFE 257
S +++ +R K++ + ++PPE + + + D W G++ +E F G P+
Sbjct: 170 LSREIYSADYYRVQPKSLL-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228
Query: 258 SKDQDTTLERI 268
+E +
Sbjct: 229 GFSNQEVIEMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 3/88 (3%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV--HAPSLHRK-TMCGTLDY 222
Q+ A+ Y H KK+IHRDIK EN+ L + + DFG ++ GT+
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334
Query: 223 LPPEMVTSQHYGKEVDNWCIGILAYEFL 250
PE++ Y + D W G++ + L
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 40/218 (18%)
Query: 88 LGTGKFGHVY--LAK-----EKTTQIMI-----ALKVLYKVEIINERMT------HQVHR 129
LG G FG VY +AK E T++ I A + ++E +NE H V R
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 130 ---------------ERCCQVHLSSSRR--HPLLSSEEGYSLYTEKDAAKYIYQVADAIH 172
E + L S R P + + + + K + ++AD +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLD--YLPPEMV 228
Y + K +HRD+ N ++ VKI DFG + ++ +RK G L ++ PE +
Sbjct: 134 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 193
Query: 229 TSQHYGKEVDNWCIGILAYEF-LVGKPPFESKDQDTTL 265
+ D W G++ +E + + P++ + L
Sbjct: 194 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 43/217 (19%)
Query: 82 FEVGCPLGTGKFGHV---YLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCC----- 133
F +G LG G+FG V L E + +A+K+L K +I + + RE C
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 134 ----------QVHLSSSRRHP-----------------LLSSEEGYSLYT--EKDAAKYI 164
+ + R P LL S G +T + +++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL-- 220
+A + Y K IHRD+ N +L + V ++DFG S +++ +R+ L
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPF 256
+L E + Y D W G+ +E + G+ P+
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 5/109 (4%)
Query: 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLD- 221
Q+A + Y +HRD+ N L+ VKISDFG S +++ +R L
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 222 -YLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
++PPE + + E D W G++ +E F G P+ +E I
Sbjct: 191 RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLD--YLP 224
VA + Y QK+ IHRD+ N+L+ + KI+DFG S +KTM G L ++
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWMA 191
Query: 225 PEMVTSQHYGKEVDNWCIGILAYEFL-VGKPPF 256
E + Y D W G+L +E + +G P+
Sbjct: 192 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 45/203 (22%), Positives = 84/203 (41%), Gaps = 42/203 (20%)
Query: 88 LGTGKFGHVY----LAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRH 143
LG+G FG VY + + +T +I +A+K+L NE + + E + + +S H
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKIL------NETTGPKANVEFMDEALIMASMDH 68
Query: 144 PLLSSEEGYSL--------------------YTEKDAA------KYIYQVADAIHYCHQK 177
P L G L + KD + Q+A + Y ++
Sbjct: 69 PHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 128
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG----TLDYLPPEMVTSQHY 233
+++HRD+ N+L+ VKI+DFG + ++ + ++ E + + +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 234 GKEVDNWCIGILAYEFLV--GKP 254
+ D W G+ +E + GKP
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 44/217 (20%), Positives = 85/217 (39%), Gaps = 43/217 (19%)
Query: 82 FEVGCPLGTGKFGHVY---LAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQ---- 134
++G LG G+FG V L+++ +Q+ +A+K + K++I + E C
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD 59
Query: 135 -----------VHLSSSRRHP-----------------LLSS--EEGYSLYTEKDAAKYI 164
SS ++ P LL S + K++
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL-- 220
+A + Y + IHRD+ N +L V ++DFG S +++ +R+ +
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPF 256
++ E + + Y + D W G+ +E G+ P+
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 41/205 (20%), Positives = 89/205 (43%), Gaps = 41/205 (20%)
Query: 88 LGTGKFGHVY----LAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRH 143
LG+G FG VY + + + +I +A+K L E + + ++E + ++ +S +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL------REATSPKANKEILDEAYVMASVDN 68
Query: 144 PLLSSEEGYSLYT----------------------EKDAAKYIY----QVADAIHYCHQK 177
P + G L + + ++Y+ Q+A ++Y ++
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER 128
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWS----VHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
+++HRD+ N+L+ + VKI+DFG + H + + ++ E + + Y
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 234 GKEVDNWCIGILAYEFLV-GKPPFE 257
+ D W G+ +E + G P++
Sbjct: 189 THQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 51/218 (23%), Positives = 84/218 (38%), Gaps = 51/218 (23%)
Query: 88 LGTGKFGHVYLAK-EKTTQIMIALKVLYKVEIINE------RMTHQVHRERCCQVHLSSS 140
LG G+FG V++ TT++ A+K L + E ++ ++ ++ Q++ S
Sbjct: 14 LGAGQFGEVWMGTWNGTTKV--AVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 141 RRHPL---------------LSSEEGYSLYTEK--DAAKYIYQVADAIHYCHQKKVIHRD 183
P+ L S EG L + D A Q+A+ + Y + IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA---QIAEGMAYLESRNYIHRD 128
Query: 184 IKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLP------------PEMVTSQ 231
+ N+L+ + KI+DFG L R +Y PE
Sbjct: 129 LAARNILVGENLVCKIADFG-------LARLIEDD--EYTAREGAKFPIKWTAPEAANYG 179
Query: 232 HYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ + D W GIL E G+ P+ LE++
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 7/107 (6%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHR 213
T + Q+A + Y + +HRD+ N L+ VKI DFG S V+ +R
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 214 ---KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
TM + ++PPE + + + E D W G++ +E F GK P+
Sbjct: 180 VGGHTML-PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 32/126 (25%), Positives = 55/126 (43%), Gaps = 24/126 (19%)
Query: 155 YTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHED----------------V 197
++ + A+ I+Q A+ Y H + ++H D+KPEN+L+ + V
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287
Query: 198 KISDFGWSV---HAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKP 254
+I D G H+ R + T Y PE+V + D W +G + YE GK
Sbjct: 288 RICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343
Query: 255 PFESKD 260
+++ D
Sbjct: 344 LYDTHD 349
|
Length = 467 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 6/109 (5%)
Query: 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS----LHRKTMCGTL 220
Q+A + + + +HRD+ N L++ +VK+S S + R + L
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PL 182
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+L PE V + + D W G+L +E F G+ PF + L R+
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-05
Identities = 40/206 (19%), Positives = 82/206 (39%), Gaps = 41/206 (19%)
Query: 88 LGTGKFGHVY----LAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRH 143
LG+G FG VY + + +I +A+KVL E + + ++E + ++ +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVL------RENTSPKANKEILDEAYVMAGVGS 68
Query: 144 PLLSSEEGYSLYT--------------------------EKDAAKYIYQVADAIHYCHQK 177
P + G L + +D + Q+A + Y +
Sbjct: 69 PYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWS----VHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
+++HRD+ N+L+ VKI+DFG + + H + ++ E + + +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 234 GKEVDNWCIGILAYEFLV-GKPPFES 258
+ D W G+ +E + G P++
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-05
Identities = 34/135 (25%), Positives = 61/135 (45%), Gaps = 11/135 (8%)
Query: 118 IINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQK 177
++ E M H + +L S R P + G T ++ + ++AD + Y + K
Sbjct: 86 VVMELMAHGDLKS-----YLRSLR--PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK 138
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL--DYLPPEMVTSQHY 233
K +HRD+ N ++ VKI DFG + ++ +RK G L ++ PE + +
Sbjct: 139 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 198
Query: 234 GKEVDNWCIGILAYE 248
D W G++ +E
Sbjct: 199 TTSSDMWSFGVVLWE 213
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 5/116 (4%)
Query: 145 LLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204
L S+EG K + Q+A+ + + Q+ IHRD++ N+L++ KI+DFG
Sbjct: 90 FLKSDEGSKQPLPK-LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 148
Query: 205 S---VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPF 256
+ R+ + + PE + + + D W GIL E + G+ P+
Sbjct: 149 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 26/101 (25%), Positives = 42/101 (41%), Gaps = 15/101 (14%)
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRK 214
E++ Q A+ H++ K N+LLT D + G SV P R
Sbjct: 16 EEEIWAVCLQCLGALRELHRQA------KSGNILLTW--DGLLKLDG-SVAFKTPEQSR- 65
Query: 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPP 255
++ PE++ Q Y ++ D + +GI YE L + P
Sbjct: 66 ---PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 27/198 (13%)
Query: 77 WQM--SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK-----VEIINER-MTHQVH 128
W+M +D + LG G++G VY K + +A+K L + E + E + ++
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK 60
Query: 129 RERCCQVHLSSSRRHPLLSSEEGYSLY------------TEKDAAKYIY---QVADAIHY 173
Q+ +R P E + Y E +A +Y Q++ A+ Y
Sbjct: 61 HPNLVQLLGVCTREPPFYIITE-FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDYLPPEMVTS 230
+K IHRD+ N L+ + VK++DFG S G + + PE +
Sbjct: 120 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 179
Query: 231 QHYGKEVDNWCIGILAYE 248
+ + D W G+L +E
Sbjct: 180 NKFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 11/96 (11%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHED--------VKISDFGWSVHAPSLHRKTMC 217
Q+A A+H+ K + H ++ +N+LL ED +K+SD G S+ L ++ +
Sbjct: 108 QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV--LPKEILL 165
Query: 218 GTLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVG 252
+ ++PPE + Q+ D W G +E G
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 45/196 (22%), Positives = 82/196 (41%), Gaps = 32/196 (16%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE------RMTHQVHRERCCQVHLSSSR 141
LG G+FG V++ +A+K L + + E + Q+ R +++ ++
Sbjct: 14 LGAGQFGEVWMGYYNGHT-KVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 142 RHPL---------------LSSEEGYSLYTEK--DAAKYIYQVADAIHYCHQKKVIHRDI 184
P+ L + EG L K D A Q+A+ + + +K IHRD+
Sbjct: 73 E-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA---QIAEGMAFIERKNYIHRDL 128
Query: 185 KPENLLLTMHEDVKISDFGWS---VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWC 241
+ N+L++ KI+DFG + R+ + + PE + + + D W
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 242 IGILAYEFLV-GKPPF 256
GIL E + G+ P+
Sbjct: 189 FGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 5/97 (5%)
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR--KTMCG--TLDY 222
+A + Y + +HRD+ N+L+ + K+SDFG S T G + +
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174
Query: 223 LPPEMVTSQHYGKEVDNWCIGILAYEFL-VGKPPFES 258
PE + + + D W GI+ +E + G+ P+
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 28/107 (26%), Positives = 47/107 (43%), Gaps = 4/107 (3%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDY 222
Q+AD + Y + IHRD++ N+L+ + KI+DFG + G + +
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 223 LPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
PE + + D W GIL E + G+ P+ LE++
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 33/110 (30%), Positives = 49/110 (44%), Gaps = 13/110 (11%)
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH---------APSLHRKTMC 217
V +A+ Y H K IHR +K ++LL+ V +S +SV K+
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169
Query: 218 GTLDYLPPEMVTS--QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265
L +L PE++ Q Y ++ D + +GI A E G PF KD T
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF--KDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 24/100 (24%), Positives = 48/100 (48%), Gaps = 5/100 (5%)
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGT 219
K++ +A + Y K IHRD+ N +L + +V ++DFG S ++ +R+
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175
Query: 220 L--DYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPF 256
+ ++ E + + Y + D W G+ +E G+ P+
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 8e-04
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 4/95 (4%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDY 222
QVA + Y + IHRD+ N+L+ + K++DFG + + G + +
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKW 170
Query: 223 LPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPF 256
PE + + D W GIL E + G+ P+
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 9e-04
Identities = 25/91 (27%), Positives = 41/91 (45%), Gaps = 5/91 (5%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP---SLHRKTMCGT 219
Y Q+ + Y K+ +HRD+ N+L+ VKI DFG + P ++ G
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172
Query: 220 --LDYLPPEMVTSQHYGKEVDNWCIGILAYE 248
+ + PE +T + D W G++ YE
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYE 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 7/116 (6%)
Query: 159 DAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRKTM 216
D + Q+A + + V+H+D+ N+L+ +VKISD G V+A + K M
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY-KLM 183
Query: 217 CGTL---DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+L ++ PE + + + D W G++ +E F G P+ +E I
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 3/90 (3%)
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG-WSVHAPSLHRKTMCGTLDYLPPEMV 228
A+ H++ ++ RD+ P N+LL ++++ F WS S + + Y PE+
Sbjct: 97 ALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM--YCAPEVG 154
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
+ D W +G + +E L GK E
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVEC 184
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 24/112 (21%), Positives = 44/112 (39%), Gaps = 12/112 (10%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHE-------DVKISDFGWSVHAPSLHRKTMCG 218
Q+A A+HY KK++H ++ +N+L+ + +K+SD G + L R+
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVE 166
Query: 219 TLDYLPPEMV--TSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLER 267
+ ++ PE + D W G E G+ P +
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 4/107 (3%)
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDY 222
QVA + Y + IHRD++ N+L+ KI+DFG + G + +
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 223 LPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
PE + + D W GIL E + G+ P+ + LE++
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 7/99 (7%)
Query: 158 KDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-LHRKTM 216
K KY Q+ + Y ++ +HRD+ N+L+ VKI DFG + + T+
Sbjct: 109 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168
Query: 217 CGTLD-----YLPPEMVTSQHYGKEVDNWCIGILAYEFL 250
LD Y P ++ S+ Y D W G+ YE L
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 32/108 (29%), Positives = 50/108 (46%), Gaps = 17/108 (15%)
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR---------- 213
++ ++Y HQ IHR+IK ++L++ D +S G S H SL R
Sbjct: 107 LFGALRGLNYLHQNGYIHRNIKASHILIS--GDGLVSLSGLS-HLYSLVRNGQKAKVVYD 163
Query: 214 --KTMCGTLDYLPPEMVTSQHYGKEV--DNWCIGILAYEFLVGKPPFE 257
+ L +L PE++ YG V D + +GI A E G+ PF+
Sbjct: 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.003
Identities = 24/96 (25%), Positives = 43/96 (44%), Gaps = 6/96 (6%)
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLP-- 224
+A + Y +HRD+ N+L+ + + K+SDFG S T + +P
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 225 ---PEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPF 256
PE + + + D W GI+ +E + G+ P+
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 271 | |||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0986|consensus | 591 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0983|consensus | 391 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0984|consensus | 282 | 100.0 | ||
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.98 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.98 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| KOG4721|consensus | 904 | 99.98 | ||
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| KOG1095|consensus | 1025 | 99.98 | ||
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| KOG0586|consensus | 596 | 99.97 | ||
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG1989|consensus | 738 | 99.97 | ||
| KOG4279|consensus | 1226 | 99.97 | ||
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| KOG0664|consensus | 449 | 99.97 | ||
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG2345|consensus | 302 | 99.97 | ||
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0579|consensus | 1187 | 99.97 | ||
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0671|consensus | 415 | 99.97 | ||
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0604|consensus | 400 | 99.97 | ||
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| KOG0584|consensus | 632 | 99.97 | ||
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| KOG0669|consensus | 376 | 99.97 | ||
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1035|consensus | 1351 | 99.97 | ||
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| KOG0666|consensus | 438 | 99.97 | ||
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0574|consensus | 502 | 99.97 | ||
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0199|consensus | 1039 | 99.97 | ||
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0603|consensus | 612 | 99.97 | ||
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| KOG1152|consensus | 772 | 99.97 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0196|consensus | 996 | 99.96 | ||
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| KOG4645|consensus | 1509 | 99.96 | ||
| KOG0607|consensus | 463 | 99.96 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| KOG0596|consensus | 677 | 99.96 | ||
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4278|consensus | 1157 | 99.96 | ||
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG1151|consensus | 775 | 99.96 | ||
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG2052|consensus | 513 | 99.96 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0665|consensus | 369 | 99.96 | ||
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| KOG4257|consensus | 974 | 99.96 | ||
| KOG3653|consensus | 534 | 99.96 | ||
| KOG0670|consensus | 752 | 99.96 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| KOG0668|consensus | 338 | 99.96 | ||
| KOG1094|consensus | 807 | 99.96 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| KOG0200|consensus | 609 | 99.94 | ||
| KOG1025|consensus | 1177 | 99.94 | ||
| KOG0587|consensus | 953 | 99.94 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1290|consensus | 590 | 99.94 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG1345|consensus | 378 | 99.93 | ||
| KOG1027|consensus | 903 | 99.92 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| KOG1163|consensus | 341 | 99.91 | ||
| KOG1164|consensus | 322 | 99.91 | ||
| KOG1167|consensus | 418 | 99.91 | ||
| KOG1165|consensus | 449 | 99.9 | ||
| KOG0576|consensus | 829 | 99.9 | ||
| KOG1024|consensus | 563 | 99.89 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG0606|consensus | 1205 | 99.88 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0603|consensus | 612 | 99.83 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1166|consensus | 974 | 99.81 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0195|consensus | 448 | 99.78 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG0590|consensus | 601 | 99.77 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| KOG4158|consensus | 598 | 99.73 | ||
| KOG1240|consensus | 1431 | 99.71 | ||
| KOG1033|consensus | 516 | 99.7 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.53 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.5 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.48 | |
| KOG0590|consensus | 601 | 99.46 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.44 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.33 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.29 | |
| KOG0606|consensus | 1205 | 99.23 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.17 | |
| KOG1023|consensus | 484 | 99.16 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.08 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.08 | |
| KOG0601|consensus | 524 | 98.99 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| KOG0601|consensus | 524 | 98.91 | ||
| KOG1243|consensus | 690 | 98.83 | ||
| KOG2137|consensus | 700 | 98.8 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.79 | |
| KOG3087|consensus | 229 | 98.77 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.49 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.37 | |
| KOG1266|consensus | 458 | 98.3 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.28 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.2 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.15 | |
| KOG3741|consensus | 655 | 97.95 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.9 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.88 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.86 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.65 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.14 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.92 | |
| KOG2270|consensus | 520 | 96.86 | ||
| KOG1235|consensus | 538 | 96.74 | ||
| KOG0576|consensus | 829 | 96.58 | ||
| KOG2268|consensus | 465 | 96.49 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.05 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.81 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.74 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.66 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.5 | |
| KOG1826|consensus | 2724 | 95.47 | ||
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.46 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.18 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.01 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.99 | |
| KOG1035|consensus | 1351 | 94.85 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 94.78 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.74 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.63 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.59 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.46 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 94.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 94.07 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.02 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.63 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.54 | |
| PLN02236 | 344 | choline kinase | 93.48 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.3 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.88 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.2 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.16 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 91.53 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 90.93 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 90.75 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 90.66 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 90.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 90.04 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 89.74 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 88.86 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 88.01 |
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=307.10 Aligned_cols=216 Identities=36% Similarity=0.626 Sum_probs=183.5
Q ss_pred CCcccHHHHHHHHhhhhccccCCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhh
Q psy4396 49 TNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVH 128 (271)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~ 128 (271)
.+.+...+.+.+....+..+......-...+++|+.++.||.|+||+|.+++.+.++..+|+|++++..+..-...++..
T Consensus 13 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~ 92 (355)
T KOG0616|consen 13 NSKESVKEFLDKAREDFPKKWANTPQNPYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTH 92 (355)
T ss_pred cchhHHHHHHHHHHHhhhhhhcCCCCCCcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHh
Confidence 34455566666665555444333322236789999999999999999999999999999999999998887777777777
Q ss_pred ceeeeEEecCcCCCcceeeeccCc--------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy4396 129 RERCCQVHLSSSRRHPLLSSEEGY--------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHR 182 (271)
Q Consensus 129 ~~~~~~~~~~~~~~~~~l~~~~~~--------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHr 182 (271)
+|. .+.....||+++.+.+. +.|++..++.++.||+.||+|||+++|++|
T Consensus 93 nEk----~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYR 168 (355)
T KOG0616|consen 93 NEK----RVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYR 168 (355)
T ss_pred hHH----HHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeec
Confidence 763 44444468877665422 458999999999999999999999999999
Q ss_pred cCCCCceEeCCCCCEEEeeccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 183 DIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 183 Dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
||||+|||+|.+|.+||+|||+|+...+. +.+.||||.|+|||++..++|+.++|.||||+++|||+.|.+||.+.++.
T Consensus 169 DLKPENiLlD~~G~iKitDFGFAK~v~~r-T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~ 247 (355)
T KOG0616|consen 169 DLKPENLLLDQNGHIKITDFGFAKRVSGR-TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI 247 (355)
T ss_pred cCChHHeeeccCCcEEEEeccceEEecCc-EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence 99999999999999999999999988776 77899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhc
Q psy4396 263 TTLERIF 269 (271)
Q Consensus 263 ~~~~~I~ 269 (271)
+++++|+
T Consensus 248 ~iY~KI~ 254 (355)
T KOG0616|consen 248 QIYEKIL 254 (355)
T ss_pred HHHHHHH
Confidence 9999996
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=318.34 Aligned_cols=191 Identities=35% Similarity=0.611 Sum_probs=166.0
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC----
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG---- 151 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---- 151 (271)
....++|++++.||+|+||.|+.++.+.+++.||+|++++..........+...|+. ++...+||+|+.+..
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~----IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERN----ILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHH----HHHhCCCCcEeeeEEeccc
Confidence 345689999999999999999999999999999999999887776655555556643 333358887765321
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 152 ----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 ----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
.+.|+++.++.++.+|+.||.|||++|||||||||+|||++.+|+++|+|||+|+..-
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 1458999999999999999999999999999999999999999999999999997433
Q ss_pred --CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 210 --SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
+..+.++|||+.|||||++.+.+|+.++|+||||+++|||++|.+||.+.+..+++++|+.
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~ 239 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK 239 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc
Confidence 3455668999999999999999999999999999999999999999999999999999874
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=311.83 Aligned_cols=195 Identities=37% Similarity=0.566 Sum_probs=162.9
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE- 150 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~- 150 (271)
.+..++.+++|++++.||+|+||.||+|+.+.||..+|+|+++++.........++..|+..... ...|+++.++
T Consensus 133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~----~ds~~vVKLyY 208 (550)
T KOG0605|consen 133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE----VDSPWVVKLYY 208 (550)
T ss_pred hccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh----cCCCcEEEEEE
Confidence 34446788999999999999999999999999999999999999888777766666666433322 2444443322
Q ss_pred ----------------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 151 ----------------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 151 ----------------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
|+ ..|+++.++.++.+++.||+.||+.|+|||||||+|+|||..|++||+|||||
T Consensus 209 sFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 209 SFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred EecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecccccc
Confidence 22 44899999999999999999999999999999999999999999999999997
Q ss_pred ccCC------------------------CCC-----c--------------------ccccccccccCcceeccCCCCCc
Q psy4396 206 VHAP------------------------SLH-----R--------------------KTMCGTLDYLPPEMVTSQHYGKE 236 (271)
Q Consensus 206 ~~~~------------------------~~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~ 236 (271)
.... +.. . .+.+|||.|+|||++.+++|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 3110 000 0 13469999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 237 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
||+||||||+|||+.|.+||.+.++++++.+|+.
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n 402 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVN 402 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999999999999999999999863
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=316.03 Aligned_cols=193 Identities=35% Similarity=0.580 Sum_probs=168.3
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-- 152 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-- 152 (271)
..+.+++|.++++||+|+||.|++|..+++++.+|||++++..++..+..+....|..+. .+ ...||+++.+.+.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~-~l--a~~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIF-EL--ANRHPFLVNLFSCFQ 439 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHH-HH--hccCCeEeecccccc
Confidence 466789999999999999999999999999999999999998777665555544443221 11 1278877665443
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..|++..++.++..++.||.|||++|||+||||.+|||+|.+|.+||+|||+++..-
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 348999999999999999999999999999999999999999999999999997643
Q ss_pred --CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 210 --SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
+..+.++||||.|+|||++.+..|+.++|+|||||+||||+.|+.||++.+++++++.|+.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 5567789999999999999999999999999999999999999999999999999999874
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=309.19 Aligned_cols=186 Identities=33% Similarity=0.585 Sum_probs=168.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
.+|..++.||+|||+++|++++..+|+.||+|++.+..+......+.+.+| +.+.....||+|+.+.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~E----IeIHr~L~HpnIV~f~~~FEDs~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNE----IEIHRSLKHPNIVQFYHFFEDSNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHH----HHHHHhcCCCcEEeeeeEeecCCce
Confidence 679999999999999999999999999999999988777776666666666 566677789998887654
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CC
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SL 211 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~ 211 (271)
..++|.+++.++.||+.||.|||+++|+|||||..|+|++++.++||+|||||.... +.
T Consensus 94 YivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 348999999999999999999999999999999999999999999999999996654 35
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
...+.||||-|.|||++....++..+||||+||++|.|+.|++||...+-++++.+|-
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik 231 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK 231 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH
Confidence 5677999999999999999999999999999999999999999999999999999984
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=293.48 Aligned_cols=186 Identities=31% Similarity=0.614 Sum_probs=154.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
.+++|.+.+.||+|+||+||+|+++.++..||||.+.+..+ +....+.+..| ..+....+||+++.+...
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~E----i~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSE----IKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHH----HHHHHhcCCcceeeEEEEEecCC
Confidence 35789999999999999999999999999999999976643 22233333344 233334457766654432
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC------CCEEEeecccc
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH------EDVKISDFGWS 205 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~------~~~kl~Dfg~a 205 (271)
+.+++..++.++.|++.||++||+++||||||||+|||++.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 347999999999999999999999999999999999999765 45899999999
Q ss_pred ccCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 206 VHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 206 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
+..... -..+.||++-|||||++....|+-|+|+||+|+|+|++++|++||...+..|++.+|
T Consensus 163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~ 226 (429)
T KOG0595|consen 163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI 226 (429)
T ss_pred hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 887653 345689999999999999999999999999999999999999999999999887654
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=303.77 Aligned_cols=191 Identities=35% Similarity=0.580 Sum_probs=158.5
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc------
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------ 150 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------ 150 (271)
....+|.+++.||.|+|++|++|+.+.++++||||++.+.-++.+....-+.+|......+. .||-++.+.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~---~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS---GHPGIVKLYFTFQDE 146 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh---CCCCeEEEEEEeecc
Confidence 34689999999999999999999999999999999998876665554444444322211111 555443322
Q ss_pred --------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 151 --------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 151 --------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
.++.|.+..++.++.||+.||+|||++|||||||||+|||++.+|+++|+|||.|+..++
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 225588999999999999999999999999999999999999999999999999864332
Q ss_pred C---------------CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 211 L---------------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 211 ~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
. .+.+++||..|.+||++.....+..+|+|+||||||.|+.|++||.+.++.-++++|+.
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA 301 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence 1 12457899999999999999999999999999999999999999999999999999975
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=280.66 Aligned_cols=186 Identities=29% Similarity=0.490 Sum_probs=158.7
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
...+|++++.||+|+||+||++.+..+++.+|.|.++-.. .+.........| +.++...+|||++...+.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~E----i~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKE----ISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHH----HHHHHhcCCchHHHHHHHhhhcc
Confidence 4578999999999999999999999999999999886322 222223333344 566677799988776552
Q ss_pred ---------------------------ccCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCceEeCCCCCEEEee
Q psy4396 153 ---------------------------SLYTEKDAAKYIYQVADAIHYCHQ--KK--VIHRDIKPENLLLTMHEDVKISD 201 (271)
Q Consensus 153 ---------------------------~~~~~~~~~~~~~qi~~~L~~LH~--~~--iiHrDikp~Nili~~~~~~kl~D 201 (271)
..+++..+++++.|++.||.++|+ .. ++||||||.||+++.+|.+||+|
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence 348999999999999999999999 44 99999999999999999999999
Q ss_pred ccccccCCCCC--cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 202 FGWSVHAPSLH--RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 202 fg~a~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
||+++...+.. ..+.+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+-.++.++|
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI 240 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI 240 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH
Confidence 99998776543 34678999999999999999999999999999999999999999999998888877
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=268.08 Aligned_cols=194 Identities=55% Similarity=0.968 Sum_probs=177.2
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
.....+.+++|++++.||+|.||.||.|+.+.++..||+|++.++.+......+++.+|.. +.....||+|...++
T Consensus 14 ~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiE----Iqs~L~hpnilrlY~ 89 (281)
T KOG0580|consen 14 RATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIE----IQSHLRHPNILRLYG 89 (281)
T ss_pred ccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeE----eecccCCccHHhhhh
Confidence 3445678999999999999999999999999999999999999999888888888888844 445558998877665
Q ss_pred c----------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 152 Y----------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 152 ~----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
+ ..+++..+..++.|++.||.|+|.+++|||||||+|+|++.+|.+|++|||
T Consensus 90 ~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 90 YFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred heeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence 5 337788899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 204 WSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 204 ~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.+...+...+.+.|||..|.+||+..+..++.++|+|++|++.||++.|.+||......+++++|.
T Consensus 170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~ 235 (281)
T KOG0580|consen 170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR 235 (281)
T ss_pred ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH
Confidence 999999888999999999999999999999999999999999999999999999999999999985
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=290.63 Aligned_cols=189 Identities=30% Similarity=0.504 Sum_probs=153.6
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
...+.|+.++.||+|.||.||+|++..+++.||+|.+...... +....-..+| +.++....||+++.+.+.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~RE----I~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIRE----IKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHH----HHHHHhcCCCcccceeeEEEec
Confidence 3457799999999999999999999999999999987543211 1111111222 344444566665544332
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
-.|++.+++.++.|++.||+|||++||+|||||.+||||+.+|.+||+|||+|+..
T Consensus 189 ~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 23799999999999999999999999999999999999999999999999999865
Q ss_pred CCCC---cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 209 PSLH---RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 209 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
.... .+..+-|++|+|||++.+ ..|+.++|+||.||||.||++|++.|++.++.+++.+|+.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk 334 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK 334 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence 5433 445667999999998876 5699999999999999999999999999999999999974
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=286.81 Aligned_cols=187 Identities=33% Similarity=0.528 Sum_probs=152.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH----hhhhhhceeeeEEecCcCCCcceeeeccCc--
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER----MTHQVHRERCCQVHLSSSRRHPLLSSEEGY-- 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-- 152 (271)
.+.|.+.+.||+|+||.|-+|..+.+++.||||++++....... ....+.+| ..++....||+++.+.+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~E----ieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNE----IEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHH----HHHHHhcCCCCEEEEeeeee
Confidence 45688999999999999999999999999999999775443211 11112233 556667789987775543
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC---CCEEEeecccc
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH---EDVKISDFGWS 205 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~---~~~kl~Dfg~a 205 (271)
..+.+...+.+++|++.|+.|||++||+||||||+|||+..+ -.+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 336788899999999999999999999999999999999766 56899999999
Q ss_pred ccCC-CCCcccccccccccCcceeccCCC---CCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHhhc
Q psy4396 206 VHAP-SLHRKTMCGTLDYLPPEMVTSQHY---GKEVDNWCIGILAYEFLVGKPPFESKDQDT-TLERIF 269 (271)
Q Consensus 206 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~I~ 269 (271)
+..+ .....+.||||.|.|||++.++.+ ..++|+|||||+||-+++|.+||.+...+. ..++|+
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~ 395 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL 395 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh
Confidence 8765 445678999999999999977653 348899999999999999999998877766 666664
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=277.04 Aligned_cols=188 Identities=32% Similarity=0.481 Sum_probs=154.2
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc---
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY--- 152 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--- 152 (271)
.+..++++.++.||+|..|+||+++++.+++.+|+|++... .++....++.+| ..+.....+|+++..+|.
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rE----l~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRE----LEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHH----HHHHhhCCCCCeeeEeEEEEe
Confidence 34566888999999999999999999999999999998321 112222233333 333344456665554332
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
+.++|..+..++.++++||.|||+ ++||||||||+|+|+++.|.+||+|||.+..
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 337899999999999999999996 8999999999999999999999999999988
Q ss_pred CCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHhhc
Q psy4396 208 APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK-----DQDTTLERIF 269 (271)
Q Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~I~ 269 (271)
.......++.||..|||||.+.+..|+.++||||||+.++|+++|+.||... +..+++..|+
T Consensus 229 lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv 295 (364)
T KOG0581|consen 229 LVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV 295 (364)
T ss_pred hhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh
Confidence 7777778899999999999999999999999999999999999999999874 5666666664
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=270.92 Aligned_cols=184 Identities=31% Similarity=0.497 Sum_probs=146.5
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
+.|+.+..+|+|+||+||+++++.+|+.||||.+..+... +....-..+| ..+....+|+|++.+..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd-~~VkKIAlRE----IrmLKqLkH~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD-PVVKKIALRE----IRMLKQLKHENLVNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc-HHHHHHHHHH----HHHHHhcccchHHHHHHHHHhccee
Confidence 5688899999999999999999999999999998543211 1111111122 33444445555443221
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--C
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--L 211 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~ 211 (271)
...++++.++.+++|++.|+.|+|++++|||||||+||||+..|.+||+|||+|+.... .
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 13378899999999999999999999999999999999999999999999999987653 2
Q ss_pred CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.-+-.+.|.+|+|||++.+ ..|...+||||+||++.||++|.+.|++.++-+++-.|
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I 214 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLI 214 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHH
Confidence 3334567999999999987 78999999999999999999999999999988876655
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=271.40 Aligned_cols=189 Identities=29% Similarity=0.442 Sum_probs=152.2
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
..+++|+.+..|++|.||.||+|+++.+++.||+|.++-.... ...-....+| +.+.....||+|+.....
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLRE----IniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLRE----INILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHH----HHHHHhcCCCCeeeeEEEEecc
Confidence 3578899999999999999999999999999999998643210 0000001111 222223346665443211
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..|...+++.++.|+++|++|||++.|+||||||+|+|+...|.+||+|||+|+..
T Consensus 148 ~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 148 NMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred ccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 35889999999999999999999999999999999999999999999999999987
Q ss_pred CCCC--cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 209 PSLH--RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 209 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
++.. .+..+-|.+|+|||++.+ ..|+.+.|+||+|||+.|++++++.|++..+..++++|+.
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence 7653 345567999999998876 5699999999999999999999999999999999999973
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=259.11 Aligned_cols=185 Identities=29% Similarity=0.497 Sum_probs=147.4
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
.+|...+.||+|.||.||+|++..+|+.||||.++..+...- ......+| ..+.....|++++.+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talRE----IK~Lqel~h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALRE----IKLLQELKHPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHH----HHHHHHccCcchhhhhhhccCCCce
Confidence 468889999999999999999999999999999865432211 00111111 22222334554433221
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
.-.++..+++.++.++++||+|||++.|+||||||.|+|++++|.+||+|||+|+...+...
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 13378899999999999999999999999999999999999999999999999987765443
Q ss_pred c--cccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 214 K--TMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 214 ~--~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. ..+.|.+|+|||++.+ ..|+..+|+||.|||+.||+-|.+.|++.++-+++..|+
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If 215 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF 215 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH
Confidence 2 2367999999998865 569999999999999999999999999999999999886
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=284.01 Aligned_cols=186 Identities=28% Similarity=0.519 Sum_probs=157.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+..... ...+.+.++ +.+....+||+++.+...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~e----v~i~r~lkHpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQE----VRILRSLKHPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHH----HHHHHhcCCcchhhHHHhhcccceE
Confidence 67889999999999999999999999999999987644322 223344444 556666688877654321
Q ss_pred ------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--C
Q psy4396 153 ------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--H 212 (271)
Q Consensus 153 ------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~ 212 (271)
+.++|+.++.++.+++.||.|||+.+|+|||+||+|||++..|++|++|||+|+..... .
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 44899999999999999999999999999999999999999999999999999765432 2
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
.+...|||-|||||+..+.+|+..+|+||||||+||+++|++||....--++.+.|+.
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~ 214 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK 214 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc
Confidence 3456799999999999999999999999999999999999999998888888887763
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=276.05 Aligned_cols=192 Identities=31% Similarity=0.502 Sum_probs=155.6
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhh-----------hhhhceeeeEEecCcCCCc
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT-----------HQVHRERCCQVHLSSSRRH 143 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 143 (271)
-+..+++|++++.||+|.||.|.+|++..+++.||||++.+......... +...+| +.++..+.|
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~E----IailKkl~H 167 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRRE----IAILKKLHH 167 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHH----HHHHHhcCC
Confidence 34467899999999999999999999999999999999977654332111 122222 445556677
Q ss_pred ceeeeccCc---------------------------cc-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC
Q psy4396 144 PLLSSEEGY---------------------------SL-YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE 195 (271)
Q Consensus 144 ~~l~~~~~~---------------------------~~-~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~ 195 (271)
|+++.+... +. +++.++++++.+++.||+|||.+|||||||||+|+|++++|
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 776654322 23 78999999999999999999999999999999999999999
Q ss_pred CEEEeeccccccCCCC-------CcccccccccccCcceeccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 196 DVKISDFGWSVHAPSL-------HRKTMCGTLDYLPPEMVTSQH----YGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 196 ~~kl~Dfg~a~~~~~~-------~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
++||+|||.+...+.. .-...+|||.|+|||++.++. -+.+.||||+||+||.++.|+.||-+....++
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999988644211 112367999999999997632 25689999999999999999999999999999
Q ss_pred HHhhcc
Q psy4396 265 LERIFW 270 (271)
Q Consensus 265 ~~~I~~ 270 (271)
+++|+.
T Consensus 328 ~~KIvn 333 (576)
T KOG0585|consen 328 FDKIVN 333 (576)
T ss_pred HHHHhc
Confidence 999975
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=266.73 Aligned_cols=191 Identities=35% Similarity=0.613 Sum_probs=162.1
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec------
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE------ 149 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~------ 149 (271)
.+.+++|..+++||+|.||.|.+++-+.+++.||||++++..++......+-..| -+++...+||++..+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE----~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTE----NRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhH----HHHHHhccCcHHHHhhhhhcc
Confidence 4567899999999999999999999999999999999988766555444333333 233344466654322
Q ss_pred --------------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 150 --------------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 150 --------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
.....|+++.++.+..+|+.||.|||+++||.||||.+|.|+|.+|++||+|||+++..-
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 122448999999999999999999999999999999999999999999999999997643
Q ss_pred --CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 210 --SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
+....++||||.|+|||++....|+.++|+|.+||++|||++|+.||.+.+.+.+++.|+.
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ 382 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM 382 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh
Confidence 3456779999999999999999999999999999999999999999999999999999874
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=277.20 Aligned_cols=189 Identities=33% Similarity=0.642 Sum_probs=151.3
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH--HhhhhhhceeeeEEecCcCCC-cceeeecc---
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE--RMTHQVHRERCCQVHLSSSRR-HPLLSSEE--- 150 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~--- 150 (271)
...++|.+++.||+|+||.|+.|.+..++..||+|++++...... .....+.+|. ....... ||++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi----~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREI----SILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHH----HHHHHhccCCCEeEEEEEE
Confidence 446899999999999999999999999999999998766421100 1111222221 2222223 55443321
Q ss_pred --------------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCEEEeeccccc
Q psy4396 151 --------------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGWSV 206 (271)
Q Consensus 151 --------------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-~~~kl~Dfg~a~ 206 (271)
+ ...+.|..++.++.|++.|++|||++||+||||||+|||++.+ +++||+|||++.
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 1 1458899999999999999999999999999999999999999 999999999998
Q ss_pred cC--CCCCcccccccccccCcceeccCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 207 HA--PSLHRKTMCGTLDYLPPEMVTSQH-YG-KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 207 ~~--~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||...+...++.+|.
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~ 236 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR 236 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 76 345667789999999999999988 85 78999999999999999999999988888887764
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=275.68 Aligned_cols=191 Identities=27% Similarity=0.463 Sum_probs=156.9
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
...+.++..++.+.+.||+|+||+||+|.++++.. ||+|++......... ...+.+| +.++...+|||++.+.|
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~-~~~f~~E----~~il~~l~HpNIV~f~G 106 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDES-RKAFRRE----ASLLSRLRHPNIVQFYG 106 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHH-HHHHHHH----HHHHHhCCCCCeeeEEE
Confidence 34556667778888889999999999999997643 999999765543333 3344444 56666678888877665
Q ss_pred c-----------------------------ccCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEeCCCC-CEEEe
Q psy4396 152 Y-----------------------------SLYTEKDAAKYIYQVADAIHYCHQKK-VIHRDIKPENLLLTMHE-DVKIS 200 (271)
Q Consensus 152 ~-----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~-iiHrDikp~Nili~~~~-~~kl~ 200 (271)
. ..++...+..++.||++||+|||+++ ||||||||+|+|++.++ ++||+
T Consensus 107 ~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 107 ACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred EEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEEC
Confidence 4 23678889999999999999999999 99999999999999997 99999
Q ss_pred eccccccCCC--CCcccccccccccCcceec--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 201 DFGWSVHAPS--LHRKTMCGTLDYLPPEMVT--SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 201 Dfg~a~~~~~--~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
|||+++.... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||.+....++...+
T Consensus 187 DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v 258 (362)
T KOG0192|consen 187 DFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV 258 (362)
T ss_pred CCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999976554 3444478999999999999 669999999999999999999999999999986655443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=277.57 Aligned_cols=186 Identities=35% Similarity=0.572 Sum_probs=144.5
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee-----------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS----------- 148 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~----------- 148 (271)
++|++++.||+|+||+||+|.+..+++.||+|++.+...........+..|.. +.....||+++.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~----il~~~~~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERD----ILVEADSLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHH----HHHhCCCCCcceEEEEEecCCeE
Confidence 47899999999999999999999999999999997644332222222222211 111112332211
Q ss_pred ----c--cC---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 149 ----E--EG---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 149 ----~--~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
. .+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 1 11 1347899999999999999999999999999999999999999999999999986432110
Q ss_pred ------------------------------------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy4396 213 ------------------------------------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256 (271)
Q Consensus 213 ------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 256 (271)
....+||+.|+|||++.+..++.++|+|||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 12347999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhc
Q psy4396 257 ESKDQDTTLERIF 269 (271)
Q Consensus 257 ~~~~~~~~~~~I~ 269 (271)
.+.+..+.+.+|.
T Consensus 237 ~~~~~~~~~~~i~ 249 (363)
T cd05628 237 CSETPQETYKKVM 249 (363)
T ss_pred CCCCHHHHHHHHH
Confidence 9999888887764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=277.96 Aligned_cols=189 Identities=25% Similarity=0.391 Sum_probs=150.7
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH------Hhhhhhh----ceeeeEEecCcCCCcce---ee
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE------RMTHQVH----RERCCQVHLSSSRRHPL---LS 147 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~----~~~~~~~~~~~~~~~~~---l~ 147 (271)
+|++++.||+|+||.|.+|.+..+++.||||++++...... ...+.+. ......+++.....|.+ ++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 78999999999999999999999999999999976432111 1111111 11222334333333332 22
Q ss_pred e------------ccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC--CEEEeeccccccCCCCCc
Q psy4396 148 S------------EEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE--DVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 148 ~------------~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~--~~kl~Dfg~a~~~~~~~~ 213 (271)
. ...+..++...++.++.||+.||..||+.||||+||||+|||+..-+ .+||+|||+|+.......
T Consensus 267 fELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy 346 (586)
T KOG0667|consen 267 FELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY 346 (586)
T ss_pred ehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce
Confidence 2 22335589999999999999999999999999999999999996543 699999999988776555
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
+...+.-|+|||++.+.+|+.+.||||||||++||++|.+.|++.++.+++.+|.-
T Consensus 347 -tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e 402 (586)
T KOG0667|consen 347 -TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE 402 (586)
T ss_pred -eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence 56678899999999999999999999999999999999999999999999999863
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=267.83 Aligned_cols=187 Identities=28% Similarity=0.474 Sum_probs=152.1
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH----------hhhhhhce--------------
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER----------MTHQVHRE-------------- 130 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~~~~~~-------------- 130 (271)
..+..+.|..-+.||+||||.|+-+.-+.+|+.||+|.+.+..+..+. +...+...
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 344567788999999999999999999999999999999776554331 11111111
Q ss_pred eeeEEecCcCCCcceeeeccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 131 RCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 131 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
.+....++......+..+..|...|++..+..++.+|++||++||+++||.||+||+|||+|+.|+++|+|+|+|...+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 22233444444444555555666799999999999999999999999999999999999999999999999999988776
Q ss_pred CCc-ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 211 LHR-KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 211 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
... ...+||.+|||||++.++.|+.+.|.|||||++|||+.|+.||.....
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 544 345899999999999999999999999999999999999999975544
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=261.80 Aligned_cols=190 Identities=26% Similarity=0.392 Sum_probs=143.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH---------HHHHhhhhhhceeeeEEecC---cCCC----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI---------INERMTHQVHRERCCQVHLS---SSRR---- 142 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~~~~~~~~~~~~---~~~~---- 142 (271)
...|+.++.||+|+||+||+|+.+.+|+.||+|.+.-... ......+.+..... .+.+. ....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~-iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANH-IVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcc-eEEEEeeeeecccccc
Confidence 4668888899999999999999999999999999753321 01111122222110 11111 0000
Q ss_pred c-c-eeeecc----------Cc----ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 143 H-P-LLSSEE----------GY----SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 143 ~-~-~l~~~~----------~~----~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
+ . .++... .. ..++...++.++.||+.||+|||+++|+||||||+||||+++|.+||+|||+|+
T Consensus 89 ~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred cceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 0 0 011110 00 235678899999999999999999999999999999999999999999999997
Q ss_pred cCC--CCCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 207 HAP--SLHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 207 ~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
... ...-+...+|..|+|||++.+. .|+..+||||+|||++||+++++.|++..+.+++.+|+
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If 234 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIF 234 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 544 2234556789999999998776 79999999999999999999999999999999998886
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=271.03 Aligned_cols=187 Identities=30% Similarity=0.467 Sum_probs=149.3
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
-.++|.+++.||.|.||.||+|+.+.++..||||.+++.-..-++.. ++ +|. ..+.....||+|+.+.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nL-REv---ksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NL-REV---KSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HH-HHH---HHHHhcCCCCcchhhHHHhhccC
Confidence 45789999999999999999999999999999999876432211110 01 110 1111112244433221
Q ss_pred --------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 151 --------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 151 --------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+|++..++.|++||++||+|+|.+|+.|||+||+|||+.....+||+|||+|+...+
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 125589999999999999999999999999999999999999899999999999998876
Q ss_pred CCc-ccccccccccCccee-ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 LHR-KTMCGTLDYLPPEMV-TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~~~-~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
... +..+.|.+|+|||++ ...-|+.++|+||+|||++|+++-++.|++.++.+.+-+|.
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc 223 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC 223 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH
Confidence 544 445689999999977 46678999999999999999999999999999999888875
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=280.17 Aligned_cols=187 Identities=25% Similarity=0.451 Sum_probs=155.1
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
+...|++..++..++..||+|+||+||+|+|.++ ||||+++-..... ...+.+.+| +......+|.||..+.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~-~qlqaFKnE----Va~lkkTRH~NIlLFM 454 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTP-EQLQAFKNE----VAVLKKTRHENILLFM 454 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCH-HHHHHHHHH----HHHHhhcchhhheeee
Confidence 3478888899999999999999999999999986 9999996544333 355566666 5666666888887777
Q ss_pred Cccc--------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 151 GYSL--------------------------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 151 ~~~~--------------------------~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
|++. |.......|+.|+++|+.|||.++|||||||..||++.++++|||+|||+
T Consensus 455 G~~~~p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 455 GACMNPPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred hhhcCCceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence 7643 56788899999999999999999999999999999999999999999999
Q ss_pred cc----cCCCCCcccccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 205 SV----HAPSLHRKTMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 205 a~----~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
+. ...+.......|...|||||++. ..+|++.+||||||+++|||++|..||.....++++
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi 602 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII 602 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE
Confidence 83 23334444566888999999884 567999999999999999999999999966665543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.84 Aligned_cols=191 Identities=39% Similarity=0.658 Sum_probs=151.0
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-- 151 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-- 151 (271)
...+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+| ..+.....||+++...+
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~iv~~~~~~ 87 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE----KSILMELSHPFIVNMMCSF 87 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHH----HHHHHhCCCCCCCcEEEEE
Confidence 345567899999999999999999999999999999999876543222222222222 12222234444332211
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 152 ------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 152 ------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 88 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 88 QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 12368888999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 208 APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
..... ....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+++++|.
T Consensus 168 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 228 (329)
T PTZ00263 168 VPDRT-FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228 (329)
T ss_pred cCCCc-ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 54432 34578999999999999999999999999999999999999999988887777653
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=259.34 Aligned_cols=178 Identities=27% Similarity=0.424 Sum_probs=143.2
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-------- 152 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-------- 152 (271)
.|.-.+++|+|+||.||+|....+++.||||..........+. ..++....|||++.+.-+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrE-----------l~im~~l~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRE-----------LQIMRKLDHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHH-----------HHHHHhcCCcCeeeEEEEEEecCCCc
Confidence 4778899999999999999999999999999875432211111 223335578877664322
Q ss_pred --------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCEEEeecccc
Q psy4396 153 --------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGWS 205 (271)
Q Consensus 153 --------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-~~~kl~Dfg~a 205 (271)
..++.-.++-+..||++||+|||+.||+||||||+|+|+|.+ |.+||+|||.|
T Consensus 94 ~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 94 EVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 124555677889999999999999999999999999999987 89999999999
Q ss_pred ccCCC-CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 206 VHAPS-LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 206 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+.... ....+...|.-|+|||++.+ ..|+.+.||||.||++.||+-|++.|++.+...++..|+
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi 239 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII 239 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH
Confidence 76543 33344556889999998765 679999999999999999999999999999999888775
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=259.53 Aligned_cols=193 Identities=31% Similarity=0.524 Sum_probs=161.7
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
...+..+.|++++.||.|.-|+||+++.++++..+|+|++.+..+..+....+...| ..++....||++..++..
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE----~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTE----REILSLLDHPFLPTLYASF 146 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHH----HHHHHhcCCCccchhhhee
Confidence 344567889999999999999999999999999999999998777655444444444 445566688877654432
Q ss_pred ---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 153 ---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 153 ---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
..|++..++.++.+++.||+|||-.|||+|||||+||||.++|++-|+||.++
T Consensus 147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccc
Confidence 33899999999999999999999999999999999999999999999999986
Q ss_pred ccCC----------------------------------C-C-----------------------CcccccccccccCcce
Q psy4396 206 VHAP----------------------------------S-L-----------------------HRKTMCGTLDYLPPEM 227 (271)
Q Consensus 206 ~~~~----------------------------------~-~-----------------------~~~~~~gt~~y~aPE~ 227 (271)
.... . . ...+++||-+|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 3210 0 0 0123568999999999
Q ss_pred eccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 228 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
+.+...+.++|+|+||+++|||+.|..||.+.+.++++..|+.
T Consensus 307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~ 349 (459)
T KOG0610|consen 307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG 349 (459)
T ss_pred eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc
Confidence 9999999999999999999999999999999999999998873
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=268.17 Aligned_cols=196 Identities=31% Similarity=0.550 Sum_probs=152.7
Q ss_pred cCCCCcccccccCeEEecccccCCceEEEEEEEcCCC-eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceee
Q psy4396 69 EAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ-IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147 (271)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 147 (271)
..+........++|++.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+| ..+.....||+++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~Iv 94 (340)
T PTZ00426 19 KEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE----RKILNYINHPFCV 94 (340)
T ss_pred cccccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHH----HHHHHhCCCCCCc
Confidence 3455667778899999999999999999999977654 6899999876543322222222222 1222223444433
Q ss_pred eccC--------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEee
Q psy4396 148 SEEG--------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISD 201 (271)
Q Consensus 148 ~~~~--------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~D 201 (271)
...+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred ceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEec
Confidence 3221 12368888999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 202 FGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 202 fg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||++..... ......||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+...++++|.
T Consensus 175 FG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 241 (340)
T PTZ00426 175 FGFAKVVDT-RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL 241 (340)
T ss_pred CCCCeecCC-CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 999876543 2334678999999999999889999999999999999999999999988877776653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=261.74 Aligned_cols=185 Identities=34% Similarity=0.591 Sum_probs=145.6
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+| ........||+++...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~iv~~~~~~~~~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNE----KRVLKEVSHPFIIRLFWTEHDQRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHH----HHHHHhCCCCcHhhhHhhhccCCeE
Confidence 468999999999999999999999999999999865433222222222222 12222234444332211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~ 155 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-T 155 (291)
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-c
Confidence 123678889999999999999999999999999999999999999999999998765432 2
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++++.|.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~ 211 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 34568999999999999999999999999999999999999999988887777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=272.16 Aligned_cols=185 Identities=31% Similarity=0.526 Sum_probs=141.5
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
+.|++++.||+|+||+||+|++..+++.||||++.+...........+..|. .+.....||+++...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~----~il~~l~h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAER----DILAEADNEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHH----HHHHhcCCCCeeeeEEEEecCCEE
Confidence 3689999999999999999999999999999999765433322222222221 111222333332221
Q ss_pred --------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 151 --------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 151 --------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
+ ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 1 133688889999999999999999999999999999999999999999999987422100
Q ss_pred -----------------------------------------------CcccccccccccCcceeccCCCCCchhHHHHHH
Q psy4396 212 -----------------------------------------------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGI 244 (271)
Q Consensus 212 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 244 (271)
.....+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 012346899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 245 LAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 245 il~el~~g~~pf~~~~~~~~~~~I 268 (271)
++|||++|+.||...+..+...+|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i 260 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKV 260 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHH
Confidence 999999999999988877665554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=271.03 Aligned_cols=186 Identities=37% Similarity=0.598 Sum_probs=144.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++.+.||+|+||+||+|++..+++.||||++.............+.+|. .+.....||+++...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~----~il~~l~h~~iv~~~~~~~~~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAER----DILAEADNPWVVKLYYSFQDENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH----HHHHhCCCCCCcceEEEEEcCCeE
Confidence 4799999999999999999999999999999999765432222222222221 111222344332221
Q ss_pred --------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 151 --------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 151 --------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 77 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred EEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 1 1347899999999999999999999999999999999999999999999999885432110
Q ss_pred ---------------------------------------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCC
Q psy4396 213 ---------------------------------------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGK 253 (271)
Q Consensus 213 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 253 (271)
....+||+.|+|||++.+..++.++|+|||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 11246899999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHhhc
Q psy4396 254 PPFESKDQDTTLERIF 269 (271)
Q Consensus 254 ~pf~~~~~~~~~~~I~ 269 (271)
.||.+.+..+.+..++
T Consensus 237 ~Pf~~~~~~~~~~~i~ 252 (364)
T cd05599 237 PPFCSDNPQETYRKII 252 (364)
T ss_pred CCCCCCCHHHHHHHHH
Confidence 9999988887776653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=258.17 Aligned_cols=186 Identities=32% Similarity=0.469 Sum_probs=143.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
..|..++.||+|+||.|..|.++.+++.||||.+...-. +.....+..+| +.+....+|++++...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~-~~~~akRtlRE----lklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE-NQIDAKRTLRE----LKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh-chHHHHHHHHH----HHHHHHhcCCCcceEEeeccccccc
Confidence 345557999999999999999999999999998753211 11111111111 1122222233322211
Q ss_pred ---------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 151 ---------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 ---------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
....++++.++.+++|+++||.|+|+.+++||||||+|+|++.+..+||+|||+|+...
T Consensus 97 ~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 97 KFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred ccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 11238899999999999999999999999999999999999999999999999998875
Q ss_pred ----CCCcccccccccccCccee-ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 210 ----SLHRKTMCGTLDYLPPEMV-TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 210 ----~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
....+..+.|.+|+|||++ ....||.+.||||.|||+.||++|++.|++.+.-.+++.|+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 3333455679999999976 457799999999999999999999999999999999998874
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.44 Aligned_cols=186 Identities=34% Similarity=0.579 Sum_probs=144.0
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|.+++.||+|+||.||+|.+..+++.||||++.+...........+.+|. .+.....||+++...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~----~il~~l~hp~iv~~~~~~~~~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAER----DVLAESDSPWVVSLYYSFQDAQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHH----HHHHhCCCCCcceEEEEEEcCCee
Confidence 4689999999999999999999999999999998664433222222222221 222223444433221
Q ss_pred --------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 151 --------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 151 --------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 1 133678889999999999999999999999999999999999999999999998522110
Q ss_pred -----------------------------------------------CcccccccccccCcceeccCCCCCchhHHHHHH
Q psy4396 212 -----------------------------------------------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGI 244 (271)
Q Consensus 212 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 244 (271)
.....+||+.|+|||++.+..++.++|+|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 001246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 245 LAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 245 il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
++|||++|..||.+.+..+.+.+|.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999999888877776653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=270.75 Aligned_cols=212 Identities=32% Similarity=0.517 Sum_probs=156.7
Q ss_pred CcccHHHHHHHHhhhhccccCCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhc
Q psy4396 50 NKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHR 129 (271)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~ 129 (271)
+.++++.++...+..... ........++|++.+.||+|+||.||+|+++.+++.+|+|++.+...........+.+
T Consensus 17 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~ 92 (371)
T cd05622 17 KNKNIDNFLNRYKDTINK----IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 92 (371)
T ss_pred ccchHHHHHHHhhhHhhH----HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHH
Confidence 344666666665544332 2234556689999999999999999999999999999999986543322211111111
Q ss_pred eeeeEEecCcCCCcceeeecc-----------------Cc--------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q psy4396 130 ERCCQVHLSSSRRHPLLSSEE-----------------GY--------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDI 184 (271)
Q Consensus 130 ~~~~~~~~~~~~~~~~l~~~~-----------------~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDi 184 (271)
+ ..+.....||+++... +. ..+++..+..++.|++.||+|||++||+||||
T Consensus 93 e----~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDL 168 (371)
T cd05622 93 E----RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 168 (371)
T ss_pred H----HHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 1 1111122333322211 11 23678889999999999999999999999999
Q ss_pred CCCceEeCCCCCEEEeeccccccCCCC---CcccccccccccCcceeccCC----CCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 185 KPENLLLTMHEDVKISDFGWSVHAPSL---HRKTMCGTLDYLPPEMVTSQH----YGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 185 kp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
||+|||++.++.+||+|||++...... .....+||+.|+|||++.+.. ++.++|+|||||++|||++|+.||.
T Consensus 169 kp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred CHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 999999999999999999998755432 223467999999999986543 7889999999999999999999999
Q ss_pred CCCHHHHHHhhc
Q psy4396 258 SKDQDTTLERIF 269 (271)
Q Consensus 258 ~~~~~~~~~~I~ 269 (271)
+.+....+.+|+
T Consensus 249 ~~~~~~~~~~i~ 260 (371)
T cd05622 249 ADSLVGTYSKIM 260 (371)
T ss_pred CCCHHHHHHHHH
Confidence 988887777764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=271.82 Aligned_cols=186 Identities=30% Similarity=0.521 Sum_probs=141.4
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+..|. .+.....||+++...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~----~il~~~~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAER----DILAEADNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHH----HHHHhCCCCcCCeEEEEEEeCCEE
Confidence 3689999999999999999999999999999998765432222222222221 111112233222111
Q ss_pred --------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC---
Q psy4396 151 --------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--- 210 (271)
Q Consensus 151 --------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--- 210 (271)
+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 1 13468889999999999999999999999999999999999999999999998742110
Q ss_pred ----------------------------------------------CCcccccccccccCcceeccCCCCCchhHHHHHH
Q psy4396 211 ----------------------------------------------LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGI 244 (271)
Q Consensus 211 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 244 (271)
......+||+.|+|||++.+..++.++|+|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 0011246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 245 LAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 245 il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
++|||++|+.||.+.+..+...+|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~ 261 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVI 261 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999888877665553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=269.64 Aligned_cols=190 Identities=33% Similarity=0.517 Sum_probs=146.0
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC----
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG---- 151 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---- 151 (271)
....++|++.+.||+|+||.||+|++..+++.+|+|++.+...........+.++ ..+.....||+++...+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e----~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHH----HHHHHhCCCCCEeeEEEEEEc
Confidence 3446789999999999999999999999999999999865433222111111122 11222223443332211
Q ss_pred -------------c--------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 -------------Y--------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 -------------~--------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 1 2367888999999999999999999999999999999999999999999999876432
Q ss_pred C---CcccccccccccCcceeccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 L---HRKTMCGTLDYLPPEMVTSQH----YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. .....+||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+.+.+|+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2 223567999999999986543 7889999999999999999999999988887777664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=265.10 Aligned_cols=184 Identities=32% Similarity=0.587 Sum_probs=144.6
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++.+.||+|+||.||+|++..+++.||+|++++...........+..|. .+.....||+++...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~----~~l~~~~h~~iv~~~~~~~~~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTER----DILTTTKSEWLVKLLYAFQDDEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHH----HHHHhCCCCCCccEEEEEEcCCEE
Confidence 4699999999999999999999999999999999765332211111222221 111122233322211
Q ss_pred --------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 151 --------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 151 --------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~ 155 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YA 155 (333)
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-cc
Confidence 1 13468899999999999999999999999999999999999999999999999876544 33
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
....||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+.+..+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 210 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence 4467899999999999999999999999999999999999999998888776654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=256.82 Aligned_cols=190 Identities=29% Similarity=0.439 Sum_probs=156.9
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
+...+....+.|++...||.|..++||+|+...++..||||+++-....+. .+.+.+| +..+....|||++...
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE----~~~msl~~HPNIv~~~ 90 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKE----VQTMSLIDHPNIVTYH 90 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHH----HHHhhhcCCCCcceEE
Confidence 455677778999999999999999999999999999999999976554333 3445555 5666777899876643
Q ss_pred Cc----------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeec
Q psy4396 151 GY----------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 151 ~~----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
.. ..+.|..+..+++++++||.|||.+|-||||||+.||||+.+|.+||+||
T Consensus 91 ~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 91 CSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred EEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCc
Confidence 32 22789999999999999999999999999999999999999999999999
Q ss_pred cccccCCC-----CCc-ccccccccccCcceec--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 203 GWSVHAPS-----LHR-KTMCGTLDYLPPEMVT--SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 203 g~a~~~~~-----~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
|.+..... ..+ +.+.||++|||||++. ..+|+.|+||||||++..|+++|..||....+.+.+-
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl 242 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL 242 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 97633211 112 4568999999999964 3579999999999999999999999999998877643
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=269.53 Aligned_cols=186 Identities=34% Similarity=0.562 Sum_probs=143.4
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec----------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE---------- 149 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---------- 149 (271)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+..+.. +.....||+++..
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~----~l~~l~~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERD----ILVEADGAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHH----HHHhCCCCCEeeEEEEEEcCCEE
Confidence 46899999999999999999999999999999997544322222222222211 1111122322211
Q ss_pred -------cC---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 150 -------EG---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 150 -------~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 11 1347889999999999999999999999999999999999999999999999975432110
Q ss_pred ------------------------------------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy4396 213 ------------------------------------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256 (271)
Q Consensus 213 ------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 256 (271)
....+||+.|+|||++.+..++.++|+|||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 11346899999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhc
Q psy4396 257 ESKDQDTTLERIF 269 (271)
Q Consensus 257 ~~~~~~~~~~~I~ 269 (271)
.+.+..+.+.+|.
T Consensus 237 ~~~~~~~~~~~i~ 249 (360)
T cd05627 237 CSETPQETYRKVM 249 (360)
T ss_pred CCCCHHHHHHHHH
Confidence 9998888777654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=263.05 Aligned_cols=189 Identities=34% Similarity=0.571 Sum_probs=142.3
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhce---------eeeEEec---CcCCCcceeee
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE---------RCCQVHL---SSSRRHPLLSS 148 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~---------~~~~~~~---~~~~~~~~l~~ 148 (271)
+|.+.+.||+|+||.||+|++..+++.||+|++.+..............+ ......+ .....+.+++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999876432211111000000 0000000 00111111221
Q ss_pred cc-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccc
Q psy4396 149 EE-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKT 215 (271)
Q Consensus 149 ~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~ 215 (271)
.. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++... ......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 11 11347889999999999999999999999999999999999999999999999987543 223344
Q ss_pred ccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 216 MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+++..|.
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~ 214 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214 (323)
T ss_pred CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 678999999999999999999999999999999999999999998888777654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=271.55 Aligned_cols=187 Identities=32% Similarity=0.611 Sum_probs=153.2
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
.++-|++++.||.|+-|.|-+|++..||+..|||++.+...........+.+| ..++....||++...+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerE----IviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIERE----IVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhh----hHHHHHhcCCCeeeeeeeeccCc
Confidence 35779999999999999999999999999999999976532222222222233 3334444566543332
Q ss_pred ----------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc-CCC
Q psy4396 151 ----------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH-APS 210 (271)
Q Consensus 151 ----------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~-~~~ 210 (271)
++ +.+++.++.+++.||+.|+.|+|..+|+|||+||+|+|++..+++||+|||+|.. .++
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 11 4589999999999999999999999999999999999999999999999999854 445
Q ss_pred CCcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.--.+.||+|.|+|||++.+.+| +.++||||+|||||.|++|+.||.+++-..++.+|
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV 224 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV 224 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 56678899999999999999998 57999999999999999999999998888888775
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=270.14 Aligned_cols=185 Identities=29% Similarity=0.525 Sum_probs=140.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee-----------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS----------- 148 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~----------- 148 (271)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|. .+.....||+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~----~il~~l~h~~iv~~~~~~~~~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAER----DILAEADNEWVVKLYYSFQDKDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHH----HHHHhCCCCCcceEEEEEEcCCEE
Confidence 4699999999999999999999999999999998654332221111121211 1111112222211
Q ss_pred ----c--c---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC---
Q psy4396 149 ----E--E---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--- 210 (271)
Q Consensus 149 ----~--~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--- 210 (271)
. . ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+|.....
T Consensus 77 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 1 1 113468888999999999999999999999999999999999999999999998742110
Q ss_pred ------------------------------------------CCcccccccccccCcceeccCCCCCchhHHHHHHHHHH
Q psy4396 211 ------------------------------------------LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYE 248 (271)
Q Consensus 211 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 248 (271)
......+||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 00112468999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHhh
Q psy4396 249 FLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 249 l~~g~~pf~~~~~~~~~~~I 268 (271)
|++|+.||.+.+..+...++
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i 256 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKV 256 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHH
Confidence 99999999988877765554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=286.97 Aligned_cols=199 Identities=32% Similarity=0.509 Sum_probs=158.8
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcC-----------
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS----------- 140 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 140 (271)
....+...++|.+++.||+|+||.|..++.+++++.||+|++++...........+..|+.+.+.....
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 345566778999999999999999999999999999999999887665544444444443222211110
Q ss_pred -----------CCcceeeeccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 141 -----------RRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 141 -----------~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
...+++.-+..+..++++.++.++..|+.||..||+.|+|||||||+|||+|..|++||+|||.+....
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 011111112223458999999999999999999999999999999999999999999999999985443
Q ss_pred ---CCCcccccccccccCcceec----c-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 210 ---SLHRKTMCGTLDYLPPEMVT----S-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 210 ---~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
.......+|||.|.+||++. + +.|++.||+||+||++|||+.|..||...+--++|.+|+.
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence 23455678999999999984 2 5689999999999999999999999999999999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=263.35 Aligned_cols=180 Identities=36% Similarity=0.631 Sum_probs=139.1
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||.||+|++..+++.||+|++++.............+| ..+.....||+++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e----~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTE----SRVLQNTRHPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHH----HHHHHhCCCCCCCCEEEEEEcCCEEEEEEeC
Confidence 369999999999999999999999999976543222211112122 1112222344332211
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--CCccccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMC 217 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~ 217 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......+
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccccee
Confidence 1 13468889999999999999999999999999999999999999999999999875322 2233467
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+.......|.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999999999888877766553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=267.32 Aligned_cols=191 Identities=33% Similarity=0.523 Sum_probs=145.5
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---- 150 (271)
.....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+..+ +.+.....||+++...
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e----~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE----RDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHH----HHHHHhCCCCCcceEEEEEe
Confidence 34557899999999999999999999999999999999875433222111111111 1111122333222211
Q ss_pred -------------Cc--------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 151 -------------GY--------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 -------------~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 11 236788899999999999999999999999999999999999999999999986543
Q ss_pred CC---CcccccccccccCcceeccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL---HRKTMCGTLDYLPPEMVTSQ----HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. .....+||+.|+|||++.+. .++.++|+|||||++|||++|+.||.+.+..+.+..|+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 22 22346789999999998653 37899999999999999999999999988887777764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=260.40 Aligned_cols=189 Identities=34% Similarity=0.582 Sum_probs=141.4
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhce---------eeeEEecC---cCCCcceeee
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE---------RCCQVHLS---SSRRHPLLSS 148 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~---------~~~~~~~~---~~~~~~~l~~ 148 (271)
+|++++.||+|+||.||+|++..+++.||||++.+..............+ ....+.+. ....+.+++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58899999999999999999999999999999875432211111111111 00001000 0011111221
Q ss_pred cc-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccc
Q psy4396 149 EE-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKT 215 (271)
Q Consensus 149 ~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~ 215 (271)
.. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.... ......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 11 11346889999999999999999999999999999999999999999999999986432 223334
Q ss_pred ccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 216 MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+.+..|.
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (324)
T ss_pred ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 568999999999999999999999999999999999999999888887776653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=267.51 Aligned_cols=190 Identities=34% Similarity=0.569 Sum_probs=163.6
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc---
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY--- 152 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--- 152 (271)
...+++++.+..||-||||+|-++..++....+|+|++++..+......+++..|.. ++.....|+|+.++..
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~----Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERN----IMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHH----HHHhcCchHHHHHHHHhcc
Confidence 345688899999999999999999988877679999999888777666666666633 3333345665543321
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
+.|.+..++.++..++.|++|||++|||+|||||+|.+++.+|.+||.|||+|+...
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 347889999999999999999999999999999999999999999999999998765
Q ss_pred -CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 -SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+..+.++||||.|.|||++.++..+.++|.||||+++||+++|.+||++.++..+++.||
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 456778999999999999999999999999999999999999999999999999999987
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=254.75 Aligned_cols=177 Identities=27% Similarity=0.463 Sum_probs=134.4
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceee-------------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS------------- 147 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~------------- 147 (271)
.|+..+.||+|+||.||+|.+..+++.||+|.+.+.............+| ..+.....|++++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E----~~il~~l~~~~iv~~~~~~~~~~~~~ 76 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE----KRILEKVNSRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHH----HHHHHhcCCCcEEEEEEEEccCCeEE
Confidence 37888999999999999999999999999999865433221111111111 0111111122111
Q ss_pred --e--cc-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 148 --S--EE-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 148 --~--~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
. .. ....+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 1 11 1124678889999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 22345689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=259.91 Aligned_cols=187 Identities=35% Similarity=0.588 Sum_probs=144.2
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC----------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG---------- 151 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---------- 151 (271)
|++.+.||+|+||.||+|.+..+++.||||++++...........+..+... ........||++....+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~-~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRI-FETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH-HHhccccCCCChhceeeEEEcCCEEEE
Confidence 6788999999999999999999999999999976543222211122111100 01112223444333221
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--CCcc
Q psy4396 152 ---------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRK 214 (271)
Q Consensus 152 ---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~ 214 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++..... ....
T Consensus 80 v~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 80 VMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 13478999999999999999999999999999999999999999999999999865332 2234
Q ss_pred cccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
..+|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+++..|.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~ 214 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214 (324)
T ss_pred ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4678999999999999999999999999999999999999999988887776653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=265.32 Aligned_cols=186 Identities=34% Similarity=0.616 Sum_probs=144.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|.+.+.||+|+||+||+|++..+++.||||++.............+..+. .+.....||++....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~----~~l~~~~~~~i~~~~~~~~~~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAER----DILADADSPWIVKLYYSFQDEEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHH----HHHHhcCCCCccchhhheecCCeE
Confidence 4799999999999999999999999999999999765432211111121211 111111233322211
Q ss_pred --------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 151 --------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 151 --------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
+ ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 1 1347889999999999999999999999999999999999999999999999986544322
Q ss_pred ------------------------------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 213 ------------------------------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 213 ------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 23456899999999999999999999999999999999999999998887
Q ss_pred HHHHhhc
Q psy4396 263 TTLERIF 269 (271)
Q Consensus 263 ~~~~~I~ 269 (271)
+.+.+|.
T Consensus 237 ~~~~~i~ 243 (350)
T cd05573 237 ETYNKII 243 (350)
T ss_pred HHHHHHh
Confidence 7776664
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=258.18 Aligned_cols=180 Identities=37% Similarity=0.630 Sum_probs=138.8
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------------- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------------- 151 (271)
+.||+|+||.||++++..+++.||+|++...............+| ..+.....||+++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE----SRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHH----HHHHHhCCCCCCcceeeEEecCCEEEEEEeC
Confidence 468999999999999999999999999876433222111111111 11222223443322211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--CCccccc
Q psy4396 152 ------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMC 217 (271)
Q Consensus 152 ------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~ 217 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++..... .......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 77 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccccc
Confidence 12368899999999999999999999999999999999999999999999999865322 2223456
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+....+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 8999999999999999999999999999999999999999888877766653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=256.50 Aligned_cols=192 Identities=35% Similarity=0.607 Sum_probs=157.3
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee------
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS------ 148 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~------ 148 (271)
-.+...+|..+.+||+|+||.|.+|..+++.+.+|||++++..+++....+.-..|-. .+....+.|+++.
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKr---vLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKR---VLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhh---heecCCCCchHHHHHHHhh
Confidence 3566789999999999999999999999999999999998766554433222111111 1111223333222
Q ss_pred --------------------ccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc-
Q psy4396 149 --------------------EEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH- 207 (271)
Q Consensus 149 --------------------~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~- 207 (271)
+...+.+.+..+..++.+|+-||-+||++|||.||||.+|||++.+|++||+|||+++.
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 12235578999999999999999999999999999999999999999999999999965
Q ss_pred -CCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 208 -APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 208 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.....+.++||||.|+|||++...+|+.++|+||+||+||||+.|++||.+.+++++++.|.
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ 563 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM 563 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 34556678999999999999999999999999999999999999999999999999999885
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=259.94 Aligned_cols=180 Identities=35% Similarity=0.638 Sum_probs=138.8
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||.||++++..+++.||+|++.+.............++ ..+.....||+++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTE----SRVLKNTRHPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHH----HHHHHhCCCCCCcceEEEEEcCCEEEEEEeC
Confidence 368999999999999999999999999976433222111111122 1122222344332211
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--CCccccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMC 217 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~ 217 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......+
T Consensus 77 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 77 VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccccc
Confidence 1 12378889999999999999999999999999999999999999999999999875332 2233457
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+..+.+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~ 208 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc
Confidence 8999999999999999999999999999999999999999888877776653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=256.25 Aligned_cols=173 Identities=33% Similarity=0.563 Sum_probs=135.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
..++..++.||+|+||.||++.+..++...|||.+....... ...+.+| ..++....||+|+...|.
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~E----i~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLERE----IRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHH----HHHHHhCCCCCEEeeCCccccccC
Confidence 356788999999999999999999989999999986531100 1111222 222222234444443331
Q ss_pred ----------------------c-cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCEEEeeccccccC
Q psy4396 153 ----------------------S-LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM-HEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ----------------------~-~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~-~~~~kl~Dfg~a~~~ 208 (271)
+ .+++..++.+..|++.||+|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 1 4899999999999999999999999999999999999999 699999999998765
Q ss_pred CC-----CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 209 PS-----LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 209 ~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
.. .......||+.|||||++..+ ....++|||||||++.||+||+.||..
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 52 223457899999999999853 344599999999999999999999987
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=257.12 Aligned_cols=189 Identities=33% Similarity=0.602 Sum_probs=141.6
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhcee---------eeEEec---CcCCCcceeee
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER---------CCQVHL---SSSRRHPLLSS 148 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~---------~~~~~~---~~~~~~~~l~~ 148 (271)
+|+..+.||+|+||+||+|.+..+++.||+|++.+..............+. .....+ .......+++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999999999999999998754322111111111110 000000 00011112221
Q ss_pred c--cC---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--CCccc
Q psy4396 149 E--EG---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKT 215 (271)
Q Consensus 149 ~--~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~ 215 (271)
. .+ ...+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||+++.... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 1 11 13478999999999999999999999999999999999999999999999999865332 22334
Q ss_pred ccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 216 MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
..||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..++++.|+
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (323)
T ss_pred ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 568999999999999999999999999999999999999999988887777654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=256.24 Aligned_cols=178 Identities=30% Similarity=0.534 Sum_probs=138.1
Q ss_pred cccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC----------------
Q psy4396 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG---------------- 151 (271)
Q Consensus 88 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---------------- 151 (271)
||+|+||.||+|++..+++.||+|++.+..............| ..+.....||+++...+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAE----RTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHH----HHHHHhCCCCcEeceeeEEecCCeEEEEEcCCC
Confidence 7999999999999999999999999875433222211122222 11222224444333211
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--CCccccccc
Q psy4396 152 ----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMCGT 219 (271)
Q Consensus 152 ----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~gt 219 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++.... ......+||
T Consensus 77 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 77 GGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence 12368889999999999999999999999999999999999999999999999875322 223345789
Q ss_pred ccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 220 LDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 220 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+.+++++
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 206 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999888887776654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=256.37 Aligned_cols=180 Identities=34% Similarity=0.593 Sum_probs=137.3
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||.||+|++..+++.||+|+++...............+.. .+.....||+++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~---~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERR---VLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHH---HHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 36999999999999999999999999987643222111111111100 000111333332211
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.... .......+
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 1 1347888999999999999999999999999999999999999999999999986532 22334467
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+++..|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i 208 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 899999999999999999999999999999999999999998888777665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=264.47 Aligned_cols=188 Identities=24% Similarity=0.412 Sum_probs=148.4
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
...|.++.+.+.+++.||+|-||.|+.|+++++. .||+|.++........ +.+| ..++....|++|+.+.+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~~----f~~E----a~iMk~L~H~~lV~l~g 268 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPEA----FLRE----AQIMKKLRHEKLVKLYG 268 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChhH----HHHH----HHHHHhCcccCeEEEEE
Confidence 3455666677888999999999999999999864 3999998764332211 1111 23333334444444332
Q ss_pred ----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 152 ----------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 152 ----------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
...+...+...++.|||+|++||+++++|||||.++|||++++..+||+|||
T Consensus 269 V~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 269 VCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred EEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccc
Confidence 2346778899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcc---cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 204 WSVHAPSLHRK---TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 204 ~a~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+|+...+.... ....+..|.|||.+....++.|+||||||++|||++| |+.||.+++..+++++|
T Consensus 349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l 417 (468)
T KOG0197|consen 349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL 417 (468)
T ss_pred cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH
Confidence 99954443322 2234678999999999999999999999999999999 99999999999998876
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=257.29 Aligned_cols=186 Identities=32% Similarity=0.516 Sum_probs=139.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcce--------------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL-------------- 145 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 145 (271)
++|++++.||+|+||+||++++..+++.||+|++.+...........+.++.. +.....|++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~----~l~~~~~~~i~~~~~~~~~~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERD----VLVNGDRRWITNLHYAFQDENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHH----HHHhCCCCCCCceEEEEecCCeE
Confidence 47999999999999999999999999999999987533222211111111110 001112222
Q ss_pred -eeecc--C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 146 -LSSEE--G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 146 -l~~~~--~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
++... + ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 22111 1 1247888999999999999999999999999999999999999999999999986543221
Q ss_pred ---cccccccccccCcceecc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 213 ---RKTMCGTLDYLPPEMVTS-----QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 213 ---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.....||+.|+|||++.. ..++.++|+|||||++|+|++|+.||.+.+..+.+.+|.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 223468999999999863 457889999999999999999999999888777766653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=258.71 Aligned_cols=190 Identities=33% Similarity=0.520 Sum_probs=140.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeee--------EE---ecCcCCCcceeee
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCC--------QV---HLSSSRRHPLLSS 148 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~--------~~---~~~~~~~~~~l~~ 148 (271)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+..+... .+ .......+.+++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999875432222111111111000 00 0000111112222
Q ss_pred cc--C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC---c
Q psy4396 149 EE--G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH---R 213 (271)
Q Consensus 149 ~~--~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~---~ 213 (271)
.. + ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 11 1 1346888999999999999999999999999999999999999999999999986544322 2
Q ss_pred ccccccccccCcceecc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 214 KTMCGTLDYLPPEMVTS-----QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
....||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+.+.+|.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH
Confidence 23568999999998865 467889999999999999999999999888877776653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=257.18 Aligned_cols=181 Identities=38% Similarity=0.653 Sum_probs=138.6
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||+||+|++..+++.||+|++.+...........+..+.. .+.....||+++...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~---~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERN---VLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHH---HHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 46999999999999999999999999987643322211111111100 011122344332211
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.... .......+
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 1 1236788899999999999999999999999999999999999999999999986532 22233456
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+.++.|+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 209 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 8999999999999999999999999999999999999999988888777664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=246.33 Aligned_cols=186 Identities=34% Similarity=0.603 Sum_probs=154.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|++-+.||+|.|+.|+++.+..+|+.+|+|+++...+... ..+.+.+| ..+.....||+|+.+...
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rE----arIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLERE----ARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHH----HHHHHhcCCCcEeehhhhhcccce
Confidence 3678899999999999999999999999999999865544333 33344444 344555688887765322
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC---CCEEEeeccccccCC
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH---EDVKISDFGWSVHAP 209 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~---~~~kl~Dfg~a~~~~ 209 (271)
..++|..+..++.||+.+|.|+|.+||||||+||.|+|+.+. .-+||+|||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 126788888999999999999999999999999999999654 348999999998766
Q ss_pred CCC-cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SLH-RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+.. ...+.|||+|||||++...+|+..+||||.||+||-++.|++||.+.+...++++|.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~ 225 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK 225 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 433 334779999999999999999999999999999999999999999999999999985
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.38 Aligned_cols=181 Identities=36% Similarity=0.614 Sum_probs=137.5
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||+||+|+++.+++.||+|++.+..............+.. .+.....||+++...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~---~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKR---ILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHH---HHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 36899999999999999999999999987543221111111111100 000011233222211
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||+++... ........
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 1 1347888999999999999999999999999999999999999999999999986532 22334467
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..++++.|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 209 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 8999999999999999999999999999999999999999998888877664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=251.59 Aligned_cols=184 Identities=26% Similarity=0.497 Sum_probs=139.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
+++|++.+.||.|+||.||+|.+..+++.||+|+++...... ......+| ........||+++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E----~~~l~~l~h~niv~~~~~~~~~~~ 77 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIRE----VSLLKNLKHANIVTLHDIIHTERC 77 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHH----HHHHHhCCCCCEeeEEEEEcCCCe
Confidence 578999999999999999999999999999999885321100 00001111 11112223333222111
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 78 LTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 123678889999999999999999999999999999999999999999999998654322
Q ss_pred -CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 -HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2233567899999998865 56899999999999999999999999998887776654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=256.72 Aligned_cols=186 Identities=32% Similarity=0.540 Sum_probs=140.3
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcc---------------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP--------------- 144 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 144 (271)
++|++.+.||+|+||+||+++++.+++.+|+|++.+...........+..+. .+.....|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~----~~l~~~~~~~i~~~~~~~~~~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER----DVLVNGDNQWITTLHYAFQDENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHH----HHHhhCCCCCEeeEEEEEecCCEE
Confidence 4789999999999999999999999999999998654322221111111111 011111222
Q ss_pred eeeecc--C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 145 LLSSEE--G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 145 ~l~~~~--~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
+++..+ + ...+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 222111 1 134688889999999999999999999999999999999999999999999998653221
Q ss_pred --CcccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 212 --HRKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 212 --~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
......||+.|+|||++. ...++.++|+|||||++|||++|+.||...+..+.+.+|.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 222356899999999886 3457899999999999999999999999988888777663
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=256.40 Aligned_cols=181 Identities=35% Similarity=0.641 Sum_probs=137.5
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||+||+|++..+++.||+|++.+..............+.. .+.....||+++...
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~---~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERN---VLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHH---HHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 36999999999999999999999999987543322111111111100 011112333332211
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++... .......+
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 1 1236788889999999999999999999999999999999999999999999986532 22234467
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+.++.|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 8999999999999999999999999999999999999999988888776653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=255.95 Aligned_cols=181 Identities=35% Similarity=0.614 Sum_probs=137.4
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||.||+|++..+++.||+|++.+..............+... +.....||++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i---l~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRI---LALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHH---HHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 369999999999999999999999999876432211111111111000 00011233222211
Q ss_pred -----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 151 -----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 151 -----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.... ........
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 11336788899999999999999999999999999999999999999999999986532 22233456
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+.++.|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~ 209 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 8999999999999899999999999999999999999999999888877764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=263.57 Aligned_cols=191 Identities=24% Similarity=0.375 Sum_probs=137.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH---HhhhhhhceeeeEE------ecCcCCC---ccee
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---RMTHQVHRERCCQV------HLSSSRR---HPLL 146 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~---~~~l 146 (271)
..+|++++.||+|+||.||+|.+..+++.||||.+........ .....+........ ....... ..++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 4679999999999999999999999999999998754221111 01111111100000 0000000 0001
Q ss_pred eec--------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CEEEeeccccccCCC-
Q psy4396 147 SSE--------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPS- 210 (271)
Q Consensus 147 ~~~--------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~~~~- 210 (271)
+.. .....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence 110 0123467888999999999999999999999999999999998665 699999999976543
Q ss_pred CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.......||+.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+..+.+.+|+
T Consensus 225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 22334568999999998865 468999999999999999999999999988777666553
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=255.64 Aligned_cols=181 Identities=37% Similarity=0.631 Sum_probs=138.1
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------------- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------------- 151 (271)
+.||+|+||.||+|++..+++.||+|++.+...........+..+.. .+.....||+++...+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~---~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERN---VLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHH---HHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 36999999999999999999999999987543322111111111100 0111223443332211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 152 ------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 152 ------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++... .......+
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 1236788899999999999999999999999999999999999999999999986532 22233456
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+.++.|+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence 8999999999999899999999999999999999999999988877777654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=256.68 Aligned_cols=181 Identities=36% Similarity=0.629 Sum_probs=138.6
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||+||+|++..+++.||+|++.+..............+.. .+.....||+++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~---~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERN---VLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH---HHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 46999999999999999999999999986543222111111111100 011122333332211
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++... .......+
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 1 1347889999999999999999999999999999999999999999999999986532 22234456
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+++++++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~ 209 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence 8999999999999999999999999999999999999999988888777664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=251.92 Aligned_cols=186 Identities=34% Similarity=0.649 Sum_probs=164.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
..+|++.+.||+|.||.|-+|.....++.||||.+.+..+..+...-++++| ..++...+||+|..++..
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRRE----IeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRRE----IEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHH----HHHHhhcCCCceeehhhhhcCCce
Confidence 3679999999999999999999999999999999988877766666666666 567777789987665432
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC-CC
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP-SL 211 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~-~~ 211 (271)
..+++.+++.++.||..|+.|+|.++++|||||.+|||+|.++++||+|||++.... ..
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 448999999999999999999999999999999999999999999999999985443 44
Q ss_pred CcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.-.++||+|-|.+||++.+.+| .+.+|-||||++||.++.|..||.+.+...++.+|
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI 265 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI 265 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh
Confidence 5567999999999999999998 57899999999999999999999999998888776
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=255.79 Aligned_cols=183 Identities=25% Similarity=0.339 Sum_probs=139.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|++.+.||+|+||.||++.+..+++.||+|++........ ......++ ..+.....||+++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E----~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT-HAKRAYRE----LVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchh-HHHHHHHH----HHHHHhCCCCCEeeeeeeeccCCC
Confidence 5789999999999999999999999999999999854311100 00111111 11112223333322211
Q ss_pred ---------------c-------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 152 ---------------Y-------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 ---------------~-------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 95 LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccccceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 0 125788889999999999999999999999999999999999999999999986543
Q ss_pred C-CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 210 S-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 210 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
. .......+|+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+....+.
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2 22334568999999999999999999999999999999999999999887665444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=252.82 Aligned_cols=183 Identities=31% Similarity=0.518 Sum_probs=135.4
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhcee---------eeEEe---cCcCCCcceeeecc--C
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER---------CCQVH---LSSSRRHPLLSSEE--G 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~---------~~~~~---~~~~~~~~~l~~~~--~ 151 (271)
+.||+|+||.||+|+++.+++.||+|++++..............+. ...+. ......+.+++... +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999998764321111000000000 00000 00011111222111 1
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCcccccccc
Q psy4396 152 ---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMCGTL 220 (271)
Q Consensus 152 ---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~gt~ 220 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++... .......+||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 1346888899999999999999999999999999999999999999999999986432 22334467899
Q ss_pred cccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 221 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..++++.|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~ 208 (316)
T cd05620 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208 (316)
T ss_pred CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999988887776654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=256.59 Aligned_cols=180 Identities=36% Similarity=0.639 Sum_probs=137.3
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||.||++.+..+++.||+|++.+..............+ ..+.....||++....
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e----~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE----NRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHH----HHHHHhCCCCCCCceEEEEEcCCEEEEEEeC
Confidence 468999999999999999999999999976433221111111111 1111122333322211
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeeccccccCCC--CCcccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTM 216 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~ 216 (271)
+ ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 77 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccc
Confidence 1 1347889999999999999999998 7999999999999999999999999999865332 222345
Q ss_pred cccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.++....|.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~ 209 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh
Confidence 68999999999999999999999999999999999999999888877766653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=256.78 Aligned_cols=186 Identities=34% Similarity=0.591 Sum_probs=141.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee-------------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL------------- 146 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------------- 146 (271)
++|.+.+.||+|+||+||+|++..+++.||+|+++............+.++. .+.....||++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~----~i~~~~~~~~i~~~~~~~~~~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEER----DILSISNSPWIPQLQYAFQDKDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH----HHHHhCCCCCCcceeeEEecCCeE
Confidence 4689999999999999999999999999999999765432221111111111 11111122222
Q ss_pred --eecc--Cc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 147 --SSEE--GY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 147 --~~~~--~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
+... +. ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 2111 11 347888999999999999999999999999999999999999999999999987544322
Q ss_pred ---cccccccccccCcceec------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 213 ---RKTMCGTLDYLPPEMVT------SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 213 ---~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.....||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+.+.+|+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 222 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH
Confidence 22346899999999986 4567899999999999999999999999888877777664
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=251.75 Aligned_cols=180 Identities=33% Similarity=0.580 Sum_probs=136.4
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||+||+|++..+++.||||+++...............+.. .+.....||++....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~---~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKR---VLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHH---HHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 46999999999999999999999999987643211111111111100 001112333332211
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.... ........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 1 1246888899999999999999999999999999999999999999999999986532 22334466
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..++++.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i 208 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 899999999999989999999999999999999999999988887776654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=256.04 Aligned_cols=186 Identities=23% Similarity=0.331 Sum_probs=142.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|++.+.||+|+||.||+|.+..+++.||||++......... .....++ ..+.....||++....+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E----~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRE----LVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh-HHHHHHH----HHHHHhcCCCCccccceeeccccc
Confidence 57899999999999999999999999999999998642111000 0011111 11111222333222111
Q ss_pred --------------c--------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 152 --------------Y--------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 --------------~--------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccccCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 0 125678888999999999999999999999999999999999999999999997654
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ......+|+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+.+.+++
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 238 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 32 2234568999999999999999999999999999999999999999988877776654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=259.60 Aligned_cols=190 Identities=24% Similarity=0.438 Sum_probs=139.4
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH------Hhhhhhhce-------eeeEEe-cCcCCCc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE------RMTHQVHRE-------RCCQVH-LSSSRRH 143 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~~~-------~~~~~~-~~~~~~~ 143 (271)
..++|++.+.||+|+||+||+|.+..+++.||||+++....... .....+... ...... ......|
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 35789999999999999999999999999999999854211100 011111100 000000 0111122
Q ss_pred ceeeecc-C---------cccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCC----------------C
Q psy4396 144 PLLSSEE-G---------YSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHE----------------D 196 (271)
Q Consensus 144 ~~l~~~~-~---------~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~----------------~ 196 (271)
..++... + ...+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .
T Consensus 207 ~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 2222211 1 2347888999999999999999998 5999999999999998765 4
Q ss_pred EEEeeccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 197 VKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 197 ~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..|
T Consensus 287 vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 287 VRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred EEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999998754332 233467899999999999999999999999999999999999999988877665544
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=247.23 Aligned_cols=182 Identities=29% Similarity=0.507 Sum_probs=138.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|++.+.||+|+||.||+|+++.+++.||+|++....... .......+| +.+.....||+++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRE----LKMLRTLKQENIVELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHH----HHHHHhCCCccccchhhhEecCCEE
Confidence 46999999999999999999999999999999986432110 001111111 11112223333222111
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 124788899999999999999999999999999999999999999999999998765332
Q ss_pred -CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 212 -HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~ 211 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2223468999999999998889999999999999999999999999877655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=249.21 Aligned_cols=188 Identities=23% Similarity=0.389 Sum_probs=138.6
Q ss_pred cCeEEecccccCCceEEEEEEEcC-CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKT-TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
++|++.+.||+|+||.||+|++.. +++.||+|.+......... .....++... ........||+++...+
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~-l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAV-LRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-hHHHHHHHHH-HHhhcccCCCCcceEEEEEecccC
Confidence 468999999999999999999854 4678999987532111000 0000000000 00001112232222110
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 152 -------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 152 -------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 79 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 1236788999999999999999999999999999999999999999999999986
Q ss_pred cCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 207 HAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 207 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
..... ......||+.|+|||++.+..++.++|+|||||++|||++|++||.+.+..+.+..|+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~ 222 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 54432 2334568999999999988899999999999999999999999999988887776664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=252.49 Aligned_cols=180 Identities=29% Similarity=0.437 Sum_probs=135.2
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---------- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---------- 150 (271)
+|++.+.||+|+||.||+|.+..+++.||||.+........ ....+.+| ..+.....||+++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E----~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRILRE----IKLLRLLRHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccch-hHHHHHHH----HHHHHhCCCCCEeeecceEeccCCCC
Confidence 58999999999999999999999999999998853211000 00011111 1111122333332211
Q ss_pred --------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 151 --------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 151 --------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 76 FKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred CceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 112378899999999999999999999999999999999999999999999999865432
Q ss_pred CC-----cccccccccccCcceecc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 211 LH-----RKTMCGTLDYLPPEMVTS--QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 211 ~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~ 217 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 11 123468999999999865 67899999999999999999999999887765443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=256.73 Aligned_cols=183 Identities=32% Similarity=0.532 Sum_probs=148.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec---------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE--------- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--------- 149 (271)
...|...+.||+|+.|.||.|+...+++.||||.+.......++ -+.+| +.++....|++++.+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke---LilnE----i~Vm~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE---LLLNE----ILVMRDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh---hhHHH----HHHHHhccchHHHHHHHHhcccce
Confidence 45688889999999999999999999999999998543221111 11111 223333344443322
Q ss_pred --------cCc--------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--C
Q psy4396 150 --------EGY--------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--L 211 (271)
Q Consensus 150 --------~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~ 211 (271)
.+. ..++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..... .
T Consensus 345 LWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred eEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 222 3478999999999999999999999999999999999999999999999999976554 3
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.+.+.+|||.|||||+...+.|++++||||||++++||+.|.+||-..++-..+.+|
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI 481 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 481 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH
Confidence 567788999999999999999999999999999999999999999988887776665
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=254.66 Aligned_cols=185 Identities=24% Similarity=0.314 Sum_probs=140.8
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
..++|++.+.||+|+||.||+|.+..+++.||+|.+........ ......+| ..+.....||+++...+.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E----~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-HAKRAYRE----LVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH-HHHHHHHH----HHHHHHhCCCchhceeeeeeccc
Confidence 35789999999999999999999999999999999864211110 00111111 111112233333221110
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 90 SLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred cccccceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 12577888899999999999999999999999999999999999999999999765
Q ss_pred CCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 209 PSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
... ......+|+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+.+..
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 433 22345689999999999999999999999999999999999999998876665544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=262.48 Aligned_cols=192 Identities=30% Similarity=0.456 Sum_probs=142.5
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhce--------eeeEEecCc-----CCCc
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE--------RCCQVHLSS-----SRRH 143 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~-----~~~~ 143 (271)
...++|.+.+.||+|+||+||+|++..+++.||||++.......... ....+| ....+.... ...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~-~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADK-NRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHH-HHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34579999999999999999999999999999999985432111100 000000 000011000 0000
Q ss_pred c------eeee--cc-------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeec
Q psy4396 144 P------LLSS--EE-------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 144 ~------~l~~--~~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
+ .++. .. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 0 0111 11 1134788889999999999999999999999999999999999999999999
Q ss_pred cccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 203 GWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 203 g~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
|+++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++.+++
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 998654321 2234678999999999999999999999999999999999999999988877776653
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=250.70 Aligned_cols=180 Identities=35% Similarity=0.620 Sum_probs=136.8
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------------- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------------- 151 (271)
+.||+|+||+||+|++..+++.||+|++.+..............+... +.....||++....+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i---l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRV---LALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHH---HHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999999999999999999976533221111111111000 000012333322211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 152 ------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 152 ------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||+++... .......+
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 1247899999999999999999999999999999999999999999999999986532 22233456
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+.+..|
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i 208 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 899999999999999999999999999999999999999988887776655
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=252.01 Aligned_cols=183 Identities=27% Similarity=0.421 Sum_probs=140.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++++.||+|+||+||+|.+..+++.||+|.+........ ......+| +.......||+++...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLI-HARRTYRE----LRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhH-HHHHHHHH----HHHHHhcCCCchhhhhhhhcccccc
Confidence 679999999999999999999999999999999864321110 00111111 1112222333322211
Q ss_pred ---------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 151 ---------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 ---------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 11347899999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.. .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++
T Consensus 170 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 170 DE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 42 234568999999999876 56899999999999999999999999887766655543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.54 Aligned_cols=186 Identities=33% Similarity=0.563 Sum_probs=157.5
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
+-|.+.+.||+|.|++|-+|++.-+|+.||||++.+..+..-.. .++..| +.++..-.|||++.++..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st-~hlfqE----VRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST-GHLFQE----VRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh-hHHHHH----HHHHHHhcCcCeeeeeehhcccceE
Confidence 56889999999999999999999999999999998765433222 233333 444445578887765532
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC-CCCCEEEeecccc-ccCCC
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT-MHEDVKISDFGWS-VHAPS 210 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~-~~~~~kl~Dfg~a-~~~~~ 210 (271)
..+.++.+++++.||+.||.|+|+..+|||||||+|+.+- .-|.+||.|||++ +..++
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 2378999999999999999999999999999999998764 4589999999998 55667
Q ss_pred CCcccccccccccCcceeccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYG-KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
..-++.||++.|.|||++.+..|+ +++||||||||||.+++|++||+..++-|++..|++
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD 233 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD 233 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc
Confidence 777889999999999999999986 689999999999999999999999999999998875
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=252.97 Aligned_cols=181 Identities=30% Similarity=0.491 Sum_probs=144.4
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
..|+.++.||+|+||.||+|.+..+++.||+|++.-.....+ .+.+..+ +.+...++++++...++.
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqe----i~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQE----ISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHH----HHHHHhcCcchHHhhhhheeecccH
Confidence 457778999999999999999999999999999865432221 1112222 223333344554333322
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--C
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--L 211 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~ 211 (271)
..+.+..+..++.+++.||.|||.++.+|||||+.|||+..+|.+||+|||.+...+. .
T Consensus 87 wiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 2247888888999999999999999999999999999999999999999999866543 3
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
.+.+++|||.|||||++.+..|+.++||||||++.+||++|.+|+....++..+-
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf 221 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF 221 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence 4477899999999999999999999999999999999999999999888865443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=248.01 Aligned_cols=176 Identities=26% Similarity=0.433 Sum_probs=132.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++.+.||+|+||.||+|++..+++.||+|++........ .....+| ........||+++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E----~~~l~~l~h~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIRE----ASLLKGLKHANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHH----HHHHhhCCCCCcCeEEEEEecCCe
Confidence 4789999999999999999999999999999999854221000 0000011 1111111233222111
Q ss_pred ------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 151 ------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 151 ------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 78 LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 1133678899999999999999999999999999999999999999999999998654322
Q ss_pred -CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 212 -HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
......+|+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 2233567899999998865 457899999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=249.88 Aligned_cols=180 Identities=32% Similarity=0.626 Sum_probs=136.7
Q ss_pred cccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHH-HhhhhhhceeeeEEecCcCCCcceeeeccC----------
Q psy4396 86 CPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINE-RMTHQVHRERCCQVHLSSSRRHPLLSSEEG---------- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---------- 151 (271)
+.||+|+||.||++++. .+++.||+|++++...... ........| ..+.....||+++...+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E----~~il~~l~hp~iv~~~~~~~~~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAE----RNILEAVKHPFIVDLIYAFQTGGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHH----HHHHHhCCCCchhceeeEEecCCeEEE
Confidence 57999999999999874 4678899999876443211 111111122 11222234444433211
Q ss_pred ----------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCc
Q psy4396 152 ----------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHR 213 (271)
Q Consensus 152 ----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~ 213 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++... ....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 1236788888999999999999999999999999999999999999999999986432 2223
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.+.+|+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~ 213 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 34568999999999999889999999999999999999999999888877766653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=252.49 Aligned_cols=187 Identities=37% Similarity=0.626 Sum_probs=152.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCC-cceeeeccCc-----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRR-HPLLSSEEGY----- 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~----- 152 (271)
...|++.+.||+|.||.||+++.+.+++.+|+|++.+...........+.+| +.++.... ||+++.+.+.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~E----v~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRRE----VAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHH----HHHHHhccCCCCEEEEEEEEEcCC
Confidence 4679999999999999999999999999999999977655433322233333 22222222 6655443221
Q ss_pred -------------------cc-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC----CCEEEeeccccccC
Q psy4396 153 -------------------SL-YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH----EDVKISDFGWSVHA 208 (271)
Q Consensus 153 -------------------~~-~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~----~~~kl~Dfg~a~~~ 208 (271)
.. +++..+..++.|++.+++|||+.|++||||||+|+|+... +.+|++|||+|...
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 12 8999999999999999999999999999999999999644 47999999999876
Q ss_pred CC-CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 209 PS-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ......+||+.|+|||++...+|+..+|+||+|+++|.|++|.+||.+.+..++...|+
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~ 251 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL 251 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH
Confidence 65 34566889999999999999999999999999999999999999999999999887775
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=259.26 Aligned_cols=196 Identities=29% Similarity=0.502 Sum_probs=152.1
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCC---------Ccc
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR---------RHP 144 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 144 (271)
.-..+.+-|..++.||-|+||+|.+++...+...||+|.+.+.+++.+....++..|+.+.......+ .-.
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 33445677999999999999999999999999999999999888877655544444432221111110 011
Q ss_pred ----eeeeccCc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 145 ----LLSSEEGY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 145 ----~l~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
.+.++.|+ +.|+|+.++.++.++.+|+++.|..|+|||||||+|||||.+|++||.||||+......
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 11222222 44889999999999999999999999999999999999999999999999997421100
Q ss_pred Cc--------------------------------------------ccccccccccCcceeccCCCCCchhHHHHHHHHH
Q psy4396 212 HR--------------------------------------------KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAY 247 (271)
Q Consensus 212 ~~--------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 247 (271)
+. ...+||+.|+|||++....|+..||+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00 1346899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHhhc
Q psy4396 248 EFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 248 el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+.|++||....+-++..+|+
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~ 884 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVI 884 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeee
Confidence 9999999999888877765553
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=232.79 Aligned_cols=193 Identities=25% Similarity=0.433 Sum_probs=151.0
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
.+.+..++++++.+..||+|..|+|++++.++++...|||.+.+.... +...++.... -.+......|+|+...|
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk--ee~kRILmDl---dvv~~s~dcpyIV~c~G 158 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK--EENKRILMDL---DVVLKSHDCPYIVQCFG 158 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH--HHHHHHHHhh---hHHhhccCCCeeeeeee
Confidence 345566778889999999999999999999999999999999654321 1111111111 11222234678877766
Q ss_pred c--------------------------ccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 152 Y--------------------------SLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 152 ~--------------------------~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
+ .+++|..+-++...++.||.||-++ ||+|||+||+|||+|+.|++||+|||+
T Consensus 159 yFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 159 YFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred EEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccc
Confidence 5 3478888889999999999999875 899999999999999999999999999
Q ss_pred cccCCC-CCcccccccccccCcceecc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHhhc
Q psy4396 205 SVHAPS-LHRKTMCGTLDYLPPEMVTS---QHYGKEVDNWCIGILAYEFLVGKPPFESKD-QDTTLERIF 269 (271)
Q Consensus 205 a~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~I~ 269 (271)
+-...+ ...+..+|-+.|||||.+.- ..|+.++||||||++++|++||+.||.+++ +.+++.+|+
T Consensus 239 sGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl 308 (391)
T KOG0983|consen 239 SGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL 308 (391)
T ss_pred cceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH
Confidence 965544 44455678999999999854 468999999999999999999999999854 455666664
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=254.47 Aligned_cols=169 Identities=24% Similarity=0.368 Sum_probs=134.4
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG----- 151 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----- 151 (271)
+...+|.+++.||+|+||.||+|.+..+++.||+|.........+ +.+.....||+++...+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E-------------~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATE-------------AHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHH-------------HHHHHhCCCCCCCCEeEEEEEC
Confidence 345689999999999999999999999999999998654322211 11112223443332221
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS- 210 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~- 210 (271)
...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 156 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 156 KFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred CeeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 13367888999999999999999999999999999999999999999999999865332
Q ss_pred --CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 211 --LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
.......||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 222345799999999999999999999999999999999999988754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=251.35 Aligned_cols=109 Identities=28% Similarity=0.528 Sum_probs=93.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceecc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTS 230 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~ 230 (271)
+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... .....+++.|+|||++.+
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 250 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc
Confidence 6677888999999999999999999999999999999999999999999987543221 122345678999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 231 QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 231 ~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
..++.++|||||||++|||++ |..||.+....+
T Consensus 251 ~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~ 284 (338)
T cd05102 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284 (338)
T ss_pred CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 999999999999999999997 999998765443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=241.68 Aligned_cols=183 Identities=28% Similarity=0.460 Sum_probs=135.3
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhh----------hhhhceeeeEEe-cCcCCCcceeeec
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT----------HQVHRERCCQVH-LSSSRRHPLLSSE 149 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~----------~~~~~~~~~~~~-~~~~~~~~~l~~~ 149 (271)
+|++.+.||+|+||.||++.+..+++.||+|++........... ..+......... ......+..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 47889999999999999999999999999999865332211111 111111100000 0001111111111
Q ss_pred c-------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-Cccc
Q psy4396 150 E-------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-HRKT 215 (271)
Q Consensus 150 ~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~ 215 (271)
. ....+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 1 1134788899999999999999999999999999999999999999999999998764332 2234
Q ss_pred ccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 216 MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
..|++.|+|||++.+..++.++|+||+||++|++++|+.||.+.+...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 568999999999998889999999999999999999999998776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=249.64 Aligned_cols=169 Identities=29% Similarity=0.584 Sum_probs=128.5
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||.||+|++..+++.||+|++++...........+..+... +.....||+++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i---l~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV---FETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHH---HHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 368999999999999999999999999976433222111111111000 00001233222111
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++... .......+
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 1 1347899999999999999999999999999999999999999999999999986432 22334467
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 8999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=249.81 Aligned_cols=169 Identities=29% Similarity=0.575 Sum_probs=128.5
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------------- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------------- 151 (271)
+.||+|+||.||+|++..+++.||+|++++...........+..+... +.....||+++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~---l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHV---FEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHH---HHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 469999999999999999999999999876432211111111111000 001112333222111
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCccccc
Q psy4396 152 ------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMC 217 (271)
Q Consensus 152 ------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~ 217 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++... ........
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 1347888999999999999999999999999999999999999999999999986532 22233467
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 8999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=243.99 Aligned_cols=188 Identities=25% Similarity=0.394 Sum_probs=137.5
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--------HH-Hhhhhhhc-eeeeEEecCcC--------CC
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--------NE-RMTHQVHR-ERCCQVHLSSS--------RR 142 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~-~~~~~~~~-~~~~~~~~~~~--------~~ 142 (271)
+|++.+.||+|+||+||+|.+..+++.||+|.++..... .+ .....+.. .....+.+... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999999999999999987532110 00 00001100 00000110000 00
Q ss_pred cceeeecc------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 143 HPLLSSEE------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 143 ~~~l~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
+..++... ....+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 01111110 012368899999999999999999999999999999999999999999999999875543
Q ss_pred C-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 L-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
. ......+|+.|+|||++.+..++.++|+|||||++|+|++|++||.+....+.+.+|
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 219 (288)
T ss_pred cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH
Confidence 2 223356789999999999888999999999999999999999999888777666554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=252.69 Aligned_cols=182 Identities=33% Similarity=0.567 Sum_probs=133.7
Q ss_pred cccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhcee-----------eeEEec---CcCCCcceeeecc--C
Q psy4396 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER-----------CCQVHL---SSSRRHPLLSSEE--G 151 (271)
Q Consensus 88 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~~~~~~~l~~~~--~ 151 (271)
||+|+||+||+|++..+++.||+|++.+..............+. ...+.+ .....+.+++... +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998654332211111110000 000000 0001111222111 1
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCcccccccc
Q psy4396 152 ---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMCGTL 220 (271)
Q Consensus 152 ---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~gt~ 220 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.... .......+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 1347889999999999999999999999999999999999999999999999986532 22334567999
Q ss_pred cccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 221 DYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 221 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+.++.|.
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~ 210 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH
Confidence 99999998754 47999999999999999999999999988888776653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=247.85 Aligned_cols=173 Identities=28% Similarity=0.541 Sum_probs=128.9
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceee---------eEEec---CcCCCcceeeec--cC
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERC---------CQVHL---SSSRRHPLLSSE--EG 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~---------~~~~~---~~~~~~~~l~~~--~~ 151 (271)
+.||+|+||.||+|++..+++.||+|++.+...........+..+.. ..+.+ .....+.+++.. .+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997643322211111111100 00000 001111112111 11
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--CCCcccccccc
Q psy4396 152 ---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--SLHRKTMCGTL 220 (271)
Q Consensus 152 ---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~~~~~~~~gt~ 220 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.... .......+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 1347899999999999999999999999999999999999999999999999986532 22334567899
Q ss_pred cccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 221 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=252.84 Aligned_cols=186 Identities=28% Similarity=0.480 Sum_probs=157.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|..++++|+|+||.++.++++.+++.+++|.+.-.....+.. .....| +.+.....||+++.+.+.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E----~~lis~~~hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQE----MDLLSKLLHPNIVEYKDSFEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHH----HHHHHhccCCCeeeeccchhcCCc
Confidence 578999999999999999999999999999999986443322211 122222 455555688877654322
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..|+++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.++|.|||+|+...
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 237999999999999999999999999999999999999999999999999998776
Q ss_pred CC--CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL--HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ...+..||+.|++||++.+.+|+.|+|||||||++|||++-+++|.+.+...+..+|.
T Consensus 158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~ 219 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN 219 (426)
T ss_pred CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh
Confidence 54 4566789999999999999999999999999999999999999999999999988875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=245.49 Aligned_cols=181 Identities=26% Similarity=0.435 Sum_probs=140.9
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
..++|++.+.||+|+||.||++++..++..+|+|++..... ......+.+| +.......||+++...+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRE----LQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHH----HHHHHHCCCCCCCeEEEEEEECC
Confidence 45789999999999999999999999999999999854211 0111111111 11222223333322211
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 12367888999999999999999986 699999999999999999999999999876655
Q ss_pred CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
.......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+.
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 210 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 444556789999999999999999999999999999999999999987776554
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=237.58 Aligned_cols=206 Identities=26% Similarity=0.373 Sum_probs=159.1
Q ss_pred cccHHHHHHHHhhhhccccCCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhce
Q psy4396 51 KENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE 130 (271)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~ 130 (271)
..+.++.++++.......+.+...+.+.-++++-+..||.|+||+|++..++.+|+..|||.+....... ...++..+
T Consensus 35 ~~~~~~~lr~~s~g~l~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k--eq~rll~e 112 (361)
T KOG1006|consen 35 NMPEEERLRSYSTGTLKLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK--EQKRLLME 112 (361)
T ss_pred ccchHHHHHHhccCceecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH--HHHHHHHH
Confidence 3455666666666655556666778888889999999999999999999999999999999986543311 11222222
Q ss_pred eeeEEecCcCCCcceeeeccCcc------------------------------cCCHHHHHHHHHHHHHHHHHHHHC-Cc
Q psy4396 131 RCCQVHLSSSRRHPLLSSEEGYS------------------------------LYTEKDAAKYIYQVADAIHYCHQK-KV 179 (271)
Q Consensus 131 ~~~~~~~~~~~~~~~l~~~~~~~------------------------------~~~~~~~~~~~~qi~~~L~~LH~~-~i 179 (271)
.. ..+...+.|+|+.++|.. .++|..+-.+....+.||.||-.. .|
T Consensus 113 ~d---~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lki 189 (361)
T KOG1006|consen 113 HD---TVMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKI 189 (361)
T ss_pred HH---HHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhh
Confidence 11 233445678888776652 256777777777789999999864 89
Q ss_pred eeccCCCCceEeCCCCCEEEeeccccccCC-CCCcccccccccccCcceec--cCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy4396 180 IHRDIKPENLLLTMHEDVKISDFGWSVHAP-SLHRKTMCGTLDYLPPEMVT--SQHYGKEVDNWCIGILAYEFLVGKPPF 256 (271)
Q Consensus 180 iHrDikp~Nili~~~~~~kl~Dfg~a~~~~-~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf 256 (271)
||||+||+|||++..|.+||+|||++-... +...+..+|-..|||||.+. +.+|+.++|+||||++|||++||+.||
T Consensus 190 IHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPy 269 (361)
T KOG1006|consen 190 IHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPY 269 (361)
T ss_pred hhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCc
Confidence 999999999999999999999999985543 33444567888999999884 446999999999999999999999999
Q ss_pred CCCCH
Q psy4396 257 ESKDQ 261 (271)
Q Consensus 257 ~~~~~ 261 (271)
++.+.
T Consensus 270 r~w~s 274 (361)
T KOG1006|consen 270 RKWDS 274 (361)
T ss_pred chHHH
Confidence 98765
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=249.42 Aligned_cols=184 Identities=28% Similarity=0.407 Sum_probs=137.4
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec-----------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE----------- 149 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~----------- 149 (271)
+|++++.||+|+||.||+|.+..+++.||||.+....... .....+.+| +.+.....||+++..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E----~~~l~~l~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL-VSCKRVFRE----LKMLCFFKHDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch-HHHHHHHHH----HHHHHhCCCCCcCCHhheecCCCccc
Confidence 4788999999999999999999899999999885321100 000011111 011111122222111
Q ss_pred -------------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 150 -------------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 150 -------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
.....+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 76 FEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred cceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 1123478899999999999999999999999999999999999999999999999875432
Q ss_pred C---CcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 L---HRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. ......+++.|+|||++.+. .++.++|+|||||++|||++|+.||.+.+..+.++.|.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 2 22234578899999998764 47899999999999999999999999988877776653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=240.46 Aligned_cols=182 Identities=18% Similarity=0.214 Sum_probs=128.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhH--HHHHHh-hhhhhc-eeeeEEecCcCCCcceeeecc-
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVE--IINERM-THQVHR-ERCCQVHLSSSRRHPLLSSEE- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~l~~~~- 150 (271)
-++|.+.+.||+|+||.||+|.+..+ +..+|+|+..... ...+.. ...... .............|+++....
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999998877 6678888642111 000000 000000 000000000011122111100
Q ss_pred ----------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeec
Q psy4396 151 ----------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 151 ----------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
.....++..+..++.|++.||+|||+++++||||||+|||++.++.++|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 0112467778899999999999999999999999999999999999999999
Q ss_pred cccccCCC---------CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 203 GWSVHAPS---------LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 203 g~a~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
|+|+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99865421 11223468999999999999999999999999999999999999998774
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=238.58 Aligned_cols=173 Identities=28% Similarity=0.465 Sum_probs=127.3
Q ss_pred cccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhh----------hhhhceeeeEEe-cCcCCCcceeeec--c----
Q psy4396 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT----------HQVHRERCCQVH-LSSSRRHPLLSSE--E---- 150 (271)
Q Consensus 88 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~----------~~~~~~~~~~~~-~~~~~~~~~l~~~--~---- 150 (271)
||+|+||+||++.+..+++.||+|.+........... ..+......... ......+..++.. .
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999999999999999865432211111 111111110000 0001111111111 1
Q ss_pred ---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Cccccccc
Q psy4396 151 ---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTMCGT 219 (271)
Q Consensus 151 ---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~gt 219 (271)
....+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... ......||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 1123688899999999999999999999999999999999999999999999998654432 22335689
Q ss_pred ccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 220 LDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 220 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
+.|+|||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=242.51 Aligned_cols=184 Identities=27% Similarity=0.504 Sum_probs=137.4
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|.+.+.||+|+||.||+|++..+++.||+|.++....... .....+| +.......||+++...+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~ 78 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIRE----VSLLKDLKHANIVTLHDIVHTDKS 78 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHH----HHHHHhCCCCCcceEEEEEeeCCe
Confidence 4789999999999999999999999999999999853221000 0000011 11111112332222111
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 79 LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 123678889999999999999999999999999999999999999999999998654322
Q ss_pred -CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 -HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
......+|+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 2223457899999998865 45889999999999999999999999988876665544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=247.24 Aligned_cols=175 Identities=33% Similarity=0.590 Sum_probs=128.6
Q ss_pred CeEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHH-HhhhhhhceeeeEEecCcCCCcceeee--------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINE-RMTHQVHRERCCQVHLSSSRRHPLLSS-------- 148 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~-------- 148 (271)
+|++++.||+|+||.||++++. .+++.||+|++.+...... ........+..... ....||++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~---~l~~~~~i~~~~~~~~~~ 77 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE---HVRQSPFLVTLHYAFQTE 77 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHH---hccCCCCcccEEEEEecC
Confidence 5889999999999999999874 4678999999875432211 11111111100000 0001222111
Q ss_pred ---------ccC---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 149 ---------EEG---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 149 ---------~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 78 AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 111 13478899999999999999999999999999999999999999999999999865322
Q ss_pred ---CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 211 ---LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 122345789999999998765 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=235.59 Aligned_cols=185 Identities=28% Similarity=0.542 Sum_probs=147.5
Q ss_pred CCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 70 APNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
....++.+.+++|.+++.||+|+|+.|.+++.+++.+.||+|++++......+..+=+..|.. ......++|+++-+
T Consensus 240 g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~---vfe~asn~pflvgl 316 (593)
T KOG0695|consen 240 GIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKH---VFEQASNNPFLVGL 316 (593)
T ss_pred ccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHH---HHHhccCCCeEEeh
Confidence 344667788899999999999999999999999999999999997754322211110111100 01112234433222
Q ss_pred --------------------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 150 --------------------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 150 --------------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
.....++++.++.+..+|+.||.|||++|||.||||.+|+|++..|.+||.|+|
T Consensus 317 hscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdyg 396 (593)
T KOG0695|consen 317 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 396 (593)
T ss_pred hhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccc
Confidence 122448999999999999999999999999999999999999999999999999
Q ss_pred ccccC--CCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 204 WSVHA--PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 204 ~a~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
.++.. ++..+.++||||.|.|||++.+..|..++|+|+|||+++||+.|+.||.
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 99754 3456678999999999999999999999999999999999999999995
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=236.99 Aligned_cols=179 Identities=28% Similarity=0.467 Sum_probs=134.1
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee---------------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL--------------- 146 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--------------- 146 (271)
|+..+.||+|+||+||+|.+..+++.+|+|.+...............+|. .+.....|+++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~----~il~~l~~~~i~~~~~~~~~~~~~~l 77 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEK----QILEKVNSQFVVNLAYAYETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHH----HHHHHcCCcCceeEEEEEecCCEEEE
Confidence 67788899999999999999999999999998653321111100111110 01111111111
Q ss_pred ee--cc-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-C
Q psy4396 147 SS--EE-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-H 212 (271)
Q Consensus 147 ~~--~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-~ 212 (271)
+. .. +...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... .
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 11 11 1124788899999999999999999999999999999999999999999999998654322 2
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
.....|++.|+|||.+.+..++.++|+||||+++|++++|..||........
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~ 209 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2345689999999999988999999999999999999999999987766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=252.89 Aligned_cols=198 Identities=26% Similarity=0.448 Sum_probs=160.2
Q ss_pred ccCCCCcccccccCeEEecccccCCceEEEEEEEcCCC----eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCc
Q psy4396 68 REAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ----IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRH 143 (271)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (271)
.+.+...|.+..++-.+.+.||+|+||.||+|+.+..+ ..||+|..+............+.+| .+++....|
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~E----ArvMr~l~H 220 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKE----ARVMRQLNH 220 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHH----HHHHHhCCC
Confidence 45567788888999999999999999999999987542 2389999875322222222222233 566666789
Q ss_pred ceeeeccCcc---------------------------cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC
Q psy4396 144 PLLSSEEGYS---------------------------LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED 196 (271)
Q Consensus 144 ~~l~~~~~~~---------------------------~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~ 196 (271)
||++.++|.. .++..+...++.+.++||+|||++++|||||..+|+|++.++.
T Consensus 221 ~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 221 PNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV 300 (474)
T ss_pred CCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe
Confidence 9988887752 2678889999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCccc--ccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 197 VKISDFGWSVHAPSLHRKT--MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 197 ~kl~Dfg~a~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
+||+|||+++......... ..-+..|+|||.+....|+.++|||||||++||+++ |..||++....++..+|+
T Consensus 301 vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~ 376 (474)
T KOG0194|consen 301 VKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV 376 (474)
T ss_pred EEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence 9999999998775322221 235679999999999999999999999999999998 899999999999998883
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=263.57 Aligned_cols=181 Identities=25% Similarity=0.428 Sum_probs=134.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
+++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+| +.......||+++...+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrE----i~ILs~L~HPNIVkl~~v~~d~~~ 76 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLRE----AKIAADLIHPGIVPVYSICSDGDP 76 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHH----HHHHHhCCCcCcCeEEEEEeeCCE
Confidence 3689999999999999999999999999999999864321111111112222 11222223443322211
Q ss_pred ----------c--------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEee
Q psy4396 152 ----------Y--------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISD 201 (271)
Q Consensus 152 ----------~--------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~D 201 (271)
. ..++...+..++.|++.||+|||++||+||||||+|||++.++.++|+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 1 1123455678899999999999999999999999999999999999999
Q ss_pred ccccccCCC--------------------CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 202 FGWSVHAPS--------------------LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 202 fg~a~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
||+++.... .......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 999865411 001124689999999999999999999999999999999999999987655
Q ss_pred HH
Q psy4396 262 DT 263 (271)
Q Consensus 262 ~~ 263 (271)
.+
T Consensus 237 ~k 238 (932)
T PRK13184 237 RK 238 (932)
T ss_pred hh
Confidence 43
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=251.23 Aligned_cols=182 Identities=27% Similarity=0.430 Sum_probs=150.9
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-------- 152 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-------- 152 (271)
.|.-++.||.|+||.||-|++..+.+.||||.+.-+-.........+..+ +......+||+.+.+.|+
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKE----VrFL~~l~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKE----VRFLRQLRHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHH----HHHHHhccCCCcccccceeeccchHH
Confidence 46778889999999999999999999999999854332222223333344 566667789998776665
Q ss_pred ------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcc
Q psy4396 153 ------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214 (271)
Q Consensus 153 ------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 214 (271)
.++.+.++..+..+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|....+ .+
T Consensus 103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--An 180 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--AN 180 (948)
T ss_pred HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--hh
Confidence 2367888889999999999999999999999999999999999999999998865544 45
Q ss_pred cccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 215 TMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
+++|||.|||||++. .+.|+-++||||||++..|+..+++|+.+++.+..+--|
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI 237 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 237 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH
Confidence 689999999999874 467999999999999999999999999999988765443
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=249.71 Aligned_cols=179 Identities=28% Similarity=0.431 Sum_probs=142.4
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCcc
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYS 153 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 153 (271)
.+....++|.....||+|+||.||+|....+ ..||||.+....... ..++.+| +.......|||++.+.|+|
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~E----i~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNE----VEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHH----HHHHhcCCCcCcccEEEEE
Confidence 3444567888889999999999999997765 679999876432210 1123333 4555555677666655531
Q ss_pred -----------------------------cCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEeCCCCCEEEee
Q psy4396 154 -----------------------------LYTEKDAAKYIYQVADAIHYCHQKK---VIHRDIKPENLLLTMHEDVKISD 201 (271)
Q Consensus 154 -----------------------------~~~~~~~~~~~~qi~~~L~~LH~~~---iiHrDikp~Nili~~~~~~kl~D 201 (271)
.+++..+.+|+.++++||+|||... ||||||||+|||+|++..+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 4689999999999999999999854 99999999999999999999999
Q ss_pred ccccccCCC-CCc-ccc-cccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 202 FGWSVHAPS-LHR-KTM-CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 202 fg~a~~~~~-~~~-~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
||+|+..+. ... ... .||.+|+|||....+..+.++||||||++|.|+++|+.|.....
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 999977764 322 222 79999999999999999999999999999999999998887543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=244.88 Aligned_cols=178 Identities=31% Similarity=0.561 Sum_probs=136.5
Q ss_pred cccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-----------
Q psy4396 86 CPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG----------- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----------- 151 (271)
+.||+|+||.||++++. .+++.||+|++.+........ .....| ..+.....||+++...+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~~E----~~~l~~l~h~niv~~~~~~~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDR-VRTKME----RDILAEVNHPFIVKLHYAFQTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhH-HHHHHH----HHHHHhCCCCCcccEEEEEEcCCEEEEE
Confidence 57999999999999863 567899999997644321111 111111 11222223443322211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Ccc
Q psy4396 152 ---------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRK 214 (271)
Q Consensus 152 ---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~ 214 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence 123788999999999999999999999999999999999999999999999998654332 233
Q ss_pred cccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
...||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+.+..|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 457899999999999888999999999999999999999999988887777655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=235.08 Aligned_cols=184 Identities=40% Similarity=0.645 Sum_probs=142.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++.+.||+|+||.||++.+..+++.+|+|++.............+.++ ........||++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNE----KRILQSIRHPFLVNLYGSFQDDSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHH----HHHHHhCCCCCccceeeEEEcCCeE
Confidence 478999999999999999999999999999999865433222111112121 1111112233322211
Q ss_pred -----------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 151 -----------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 151 -----------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... .
T Consensus 77 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~ 155 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-T 155 (290)
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-C
Confidence 1134788999999999999999999999999999999999999999999999998765544 3
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..+++
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 210 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3456889999999998888899999999999999999999999888876666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=215.79 Aligned_cols=187 Identities=26% Similarity=0.465 Sum_probs=144.0
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
.+|...+.||+|.||+||+|++..+.+.||+|.+.-.....- .-....+| ..+....+|.++++...
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalre----icllkelkhknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALRE----ICLLKELKHKNIVRLHDVLHSDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHH----HHHHHHhhhcceeehhhhhccCcee
Confidence 346677889999999999999999999999998743211000 00001111 11222223444333221
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
.+.+..+.++.++.|+++||.++|++++.|||+||+|.||+.+|.+||+|||+++-.+...
T Consensus 77 tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 1337788999999999999999999999999999999999999999999999997655433
Q ss_pred -cccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhccC
Q psy4396 213 -RKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIFWF 271 (271)
Q Consensus 213 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~~~ 271 (271)
-...+-|..|++|.++.+. -|+++.|+||.|||+.|+.. |++.|++.+.++.+.+|++.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~ 218 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH
Confidence 2335579999999988764 58999999999999999985 99999999999999999873
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=251.86 Aligned_cols=184 Identities=22% Similarity=0.404 Sum_probs=142.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCC-CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTT-QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
...|.+.+.||+|++|.||+|....+ +..||+|.+...... ....+..| +.+.....||+++...+.
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~---~~~~~~~E----~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER---QAAYARSE----LHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH---HHHHHHHH----HHHHHhCCCCCEeEEEEEEEECC
Confidence 34599999999999999999998877 778999976332111 11111222 223333345544332211
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 2367888899999999999999999999999999999999999999999999976
Q ss_pred CCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 208 APSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 208 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..++
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~ 284 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5432 1234568999999999999999999999999999999999999999888887777654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=243.74 Aligned_cols=177 Identities=31% Similarity=0.486 Sum_probs=131.2
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG----- 151 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----- 151 (271)
...++|+.++.||+|+||.||+|++..+++.||||++...... .....+.+| ..+.....|++++...+
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICRE----IEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH--HHHHHHHHH----HHHHHhCCCCCcceeeeEeccC
Confidence 3467889999999999999999999999999999998532110 001111111 11122223333322211
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--C
Q psy4396 152 -----------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--H 212 (271)
Q Consensus 152 -----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~ 212 (271)
.....+..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 145 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CeEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 122467778899999999999999999999999999999999999999999998754332 2
Q ss_pred cccccccccccCcceecc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 213 RKTMCGTLDYLPPEMVTS-----QHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||...
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 234578999999998743 23456899999999999999999999743
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=216.21 Aligned_cols=191 Identities=25% Similarity=0.360 Sum_probs=147.7
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
.++++.+++.-+..||+|++|.|-+.++..+|...|+|.+.... +.+..++...+... .+..-..|+.+.++|.
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi---~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDI---IMRTVDCPFTVHFYGAL 114 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhh---hccCCCCCeEEEeehhh
Confidence 35566677777889999999999999999999999999985432 12222222232221 1222356777766654
Q ss_pred ----------------------------ccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeecc
Q psy4396 153 ----------------------------SLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 153 ----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
...+|..+-+++..+..||.|||++ .+||||+||+||||+.+|++|++|||
T Consensus 115 ~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 115 FREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred hccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence 2368888999999999999999986 89999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccccCcceec----cCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhc
Q psy4396 204 WSVHAPSLHR-KTMCGTLDYLPPEMVT----SQHYGKEVDNWCIGILAYEFLVGKPPFESK-DQDTTLERIF 269 (271)
Q Consensus 204 ~a~~~~~~~~-~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~I~ 269 (271)
++-...++-. +...|-..|||||.+. ...|+.++||||||+++.||++++.||... ++.+++.+++
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 9876554433 3366888999999874 347999999999999999999999999764 4556666653
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=239.43 Aligned_cols=182 Identities=20% Similarity=0.362 Sum_probs=135.0
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCe----EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQI----MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
...+|++.+.||+|+||.||+|++..++. .||+|+++...... ....+.++ ........||++....+.
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e----~~~l~~l~h~niv~~~g~~ 78 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDE----AYVMASVDNPHVCRLLGIC 78 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHH--HHHHHHHH----HHHHHhCCCCCCCeEEEEE
Confidence 45789999999999999999999866554 38999985321110 01111111 112222344444333221
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..++...+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 79 LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred cCCCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 1256778889999999999999999999999999999999999999999999976
Q ss_pred CCCCCc----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy4396 208 APSLHR----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTL 265 (271)
Q Consensus 208 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 265 (271)
...... ....++..|+|||.+.+..++.++|+||||+++||+++ |..||.+....++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~ 221 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 543221 12234678999999999999999999999999999997 99999887766543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=235.09 Aligned_cols=180 Identities=31% Similarity=0.502 Sum_probs=132.4
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH----------hhhhhhceeeeEE-ecCcCCCcceeeec
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER----------MTHQVHRERCCQV-HLSSSRRHPLLSSE 149 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~~~~~~~~~~~-~~~~~~~~~~l~~~ 149 (271)
.|+..+.||+|+||.||++.+..+++.||+|.+......... ....+........ .......+..++..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788899999999999999999999999998653221111 1111111100000 00001111222211
Q ss_pred c--C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-Cccc
Q psy4396 150 E--G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-HRKT 215 (271)
Q Consensus 150 ~--~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~ 215 (271)
. + ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 1 1 123678889999999999999999999999999999999999999999999998654432 2233
Q ss_pred ccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 216 MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
..|++.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 568999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=232.37 Aligned_cols=169 Identities=27% Similarity=0.419 Sum_probs=127.0
Q ss_pred cccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----------------
Q psy4396 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----------------- 150 (271)
Q Consensus 88 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----------------- 150 (271)
||+|+||.||++++..+++.||+|.+................| ..+.....||++....
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E----~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLE----KEILEKVNSPFIVNLAYAFESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHH----HHHHHhcCCCcEEEEEEEEecCCeEEEEEecCC
Confidence 7999999999999999999999999865332211101011111 1111222333332211
Q ss_pred C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-Ccccccc
Q psy4396 151 G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-HRKTMCG 218 (271)
Q Consensus 151 ~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~g 218 (271)
+ ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...... ......|
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence 1 112567778889999999999999999999999999999999999999999998655432 2233568
Q ss_pred cccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 219 TLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 219 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
++.|+|||++.+..++.++|+|||||++|||++|+.||....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=230.76 Aligned_cols=173 Identities=37% Similarity=0.647 Sum_probs=134.5
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec------------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE------------ 149 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~------------ 149 (271)
|++++.||+|+||+||++++..+++.||+|++............. ..+ ........||++...
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~-~~e----~~~~~~l~~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREEN-IRE----IKILRRLRHPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHH-HHH----HHHHHHHTBTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchh-hhh----hhccccccccccccccccccccccccc
Confidence 789999999999999999999999999999986653322211100 001 001111122222111
Q ss_pred -----c---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc--CCCCCc
Q psy4396 150 -----E---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHR 213 (271)
Q Consensus 150 -----~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~--~~~~~~ 213 (271)
. ....+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.. ......
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1 124478899999999999999999999999999999999999999999999999875 333344
Q ss_pred ccccccccccCcceec-cCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 214 KTMCGTLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
....+++.|+|||++. +..++.++|+||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4567899999999998 888999999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=238.66 Aligned_cols=181 Identities=27% Similarity=0.448 Sum_probs=137.2
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
..++|++.+.||+|+||.||+|.+..++..+|+|++...... .....+.+| +.......||+++...
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP--AIRNQIIRE----LQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHH----HHHHHHCCCCcccceeEEEEECC
Confidence 457899999999999999999999999999999987542110 000111111 1111111233222211
Q ss_pred ----------C---------cccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 151 ----------G---------YSLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 151 ----------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
+ ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 1 12367788889999999999999985 799999999999999999999999999876554
Q ss_pred CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
.......+++.|+|||++.+..++.++|+|||||++|+|++|+.||......+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 210 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210 (333)
T ss_pred hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 444456789999999999988899999999999999999999999987665443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=233.11 Aligned_cols=173 Identities=29% Similarity=0.477 Sum_probs=134.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+| +.......||+++...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSE----LEILYKCDSPYIIGFYGAFFVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH--HHHHHHHH----HHHHHhCCCCCeeeEEEEEEECCEE
Confidence 36788999999999999999999999999999985431110 01111111 11111223333322211
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCccccc
Q psy4396 152 --------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMC 217 (271)
Q Consensus 152 --------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 217 (271)
...+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++............
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 75 SICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred EEEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 123678888999999999999999999999999999999999999999999998765554455567
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
+|..|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 89999999999999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=243.06 Aligned_cols=109 Identities=28% Similarity=0.446 Sum_probs=93.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcc----cccccccccCcceecc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK----TMCGTLDYLPPEMVTS 230 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~----~~~gt~~y~aPE~~~~ 230 (271)
+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||+++........ ...+++.|+|||++.+
T Consensus 209 l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 288 (374)
T cd05106 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD 288 (374)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC
Confidence 577888999999999999999999999999999999999999999999998754332211 2234567999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 231 QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 231 ~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
..++.++|+|||||++|+|++ |+.||......+
T Consensus 289 ~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~ 322 (374)
T cd05106 289 CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322 (374)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence 899999999999999999997 999998766544
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=251.17 Aligned_cols=182 Identities=26% Similarity=0.440 Sum_probs=134.9
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH--------HhhhhhhceeeeE-------EecCcCCCcce
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE--------RMTHQVHRERCCQ-------VHLSSSRRHPL 145 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~~~~~~~-------~~~~~~~~~~~ 145 (271)
.+..-+.||+||||.||+++++.+|+.||||.+++...... +..+.+.....+. .......++|.
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35566789999999999999999999999999865321111 0111111000000 00011123444
Q ss_pred eeeccCc--------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC--CCCC--EEEeecccccc
Q psy4396 146 LSSEEGY--------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT--MHED--VKISDFGWSVH 207 (271)
Q Consensus 146 l~~~~~~--------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~--~~~~--~kl~Dfg~a~~ 207 (271)
++..++. +.+++.+...++.++..||.|||++||+||||||.||++- .+|+ .||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 4333322 4489999999999999999999999999999999999983 3343 69999999987
Q ss_pred CCC-CCcccccccccccCcceec-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 208 APS-LHRKTMCGTLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 208 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
..+ ....+..||+.|.+||+.. .+.|+..+|.|||||++|+++||..||......
T Consensus 174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 765 3456788999999999998 488999999999999999999999999755443
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=237.79 Aligned_cols=176 Identities=31% Similarity=0.514 Sum_probs=122.2
Q ss_pred ecccccCCceEEEEEEEc--CCCeEEEEEEcchhHHHHH-----HhhhhhhceeeeEE---ecCcCCCcceeeecc----
Q psy4396 85 GCPLGTGKFGHVYLAKEK--TTQIMIALKVLYKVEIINE-----RMTHQVHRERCCQV---HLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 85 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~---- 150 (271)
++.||+|+||+||+|+++ .+++.||+|.+........ .....+........ .......+.+++...
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 467999999999999975 3668899999864321110 11111111100000 000000011111100
Q ss_pred ---------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe----CCCCCEEEeeccccccCCCC
Q psy4396 151 ---------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL----TMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 151 ---------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili----~~~~~~kl~Dfg~a~~~~~~ 211 (271)
....+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 01237888899999999999999999999999999999999 45678999999999754332
Q ss_pred -----CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 212 -----HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 212 -----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
......+|+.|+|||++.+ ..++.++|+||+||++|+|++|++||....
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 1234568999999999876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=247.84 Aligned_cols=170 Identities=32% Similarity=0.550 Sum_probs=139.6
Q ss_pred ecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------------
Q psy4396 85 GCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------------- 151 (271)
Q Consensus 85 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------------- 151 (271)
-+.||+|.||+||-|+++.+|+.||||++.+........ .++++| +.++....||=++.+..
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~E----VaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNE----VAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHH----HHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 467999999999999999999999999998765543222 344444 34444445554433322
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC---CCEEEeeccccccCCC-CCc
Q psy4396 152 --------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH---EDVKISDFGWSVHAPS-LHR 213 (271)
Q Consensus 152 --------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~---~~~kl~Dfg~a~~~~~-~~~ 213 (271)
.+.+++...+.++.||+.||+|||.++|+|+||||+|||+.+. ..+||+|||+|+..++ ..+
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 1458899999999999999999999999999999999999654 4699999999998775 456
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.+.+|||.|+|||++..+.|+.+.|+||.|||+|--++|..||..+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 6788999999999999999999999999999999999999999643
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=226.18 Aligned_cols=186 Identities=31% Similarity=0.528 Sum_probs=144.6
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH-----HHHhhhhhhceeeeEEecCcCCCcceeeeccCc--
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII-----NERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-- 152 (271)
..|...+.||.|..++|.++..+.++..+|+|++...... ..++.+.-..|..+ +.....||+|..+...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~I---LRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISI---LRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHH---HHHhcCCCcEEEeeeecc
Confidence 4566778899999999999999999999999998532110 11122222222211 1122367776654332
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..++++..+.++.|++.|++|||.++|+||||||+|||++++.+++|+|||+|+..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 22689999999999999999999999999999999999999999999999999776
Q ss_pred CCC-CcccccccccccCcceecc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 209 PSL-HRKTMCGTLDYLPPEMVTS------QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
... .-...||||+|+|||.+.. .+|+..+|+||+|||+|.++.|.+||....+.-.+..|
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I 240 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI 240 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence 543 4456899999999998853 56889999999999999999999999887776666555
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=241.83 Aligned_cols=183 Identities=19% Similarity=0.314 Sum_probs=132.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcC--CCeEEEEEEcchhHHHHH--HhhhhhhceeeeEE-ecCcCCCccee-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKT--TQIMIALKVLYKVEIINE--RMTHQVHRERCCQV-HLSSSRRHPLL------- 146 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l------- 146 (271)
..+|.+++.||.|+||.||++.... +++.||+|.+........ .....+........ .......+..+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCC
Confidence 4579999999999999999997643 467899999864322111 11111111100000 00000000111
Q ss_pred ---eeccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----ccccccc
Q psy4396 147 ---SSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGT 219 (271)
Q Consensus 147 ---~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt 219 (271)
........+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++....... .....||
T Consensus 171 ~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt 250 (392)
T PHA03207 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250 (392)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccc
Confidence 111122457899999999999999999999999999999999999999999999999986544321 2235689
Q ss_pred ccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 220 LDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 220 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+.
T Consensus 251 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 999999999999999999999999999999999999977653
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=256.13 Aligned_cols=190 Identities=26% Similarity=0.406 Sum_probs=157.1
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceee
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 147 (271)
....+...+....+.||+|+||.||+|+..+ ....||||.++..... ....++++| ..+...+.||+|+
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~RE----aeLla~l~H~nIV 552 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRRE----AELLAELQHPNIV 552 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHH----HHHHHhccCCCeE
Confidence 3445667788899999999999999998653 3578999999765422 233345555 5677777899888
Q ss_pred eccCccc----------------------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q psy4396 148 SEEGYSL----------------------------------------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPE 187 (271)
Q Consensus 148 ~~~~~~~----------------------------------------~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~ 187 (271)
.+.|.|. ++..+...++.||+.|++||-++.+|||||..+
T Consensus 553 rLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 553 RLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 8766522 677889999999999999999999999999999
Q ss_pred ceEeCCCCCEEEeeccccccCCCCCccc----ccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy4396 188 NLLLTMHEDVKISDFGWSVHAPSLHRKT----MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQD 262 (271)
Q Consensus 188 Nili~~~~~~kl~Dfg~a~~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~ 262 (271)
|+||+++..|||+|||+++..-+..-.. ..-+.+|||||.+..++||.++||||+||+|||+++ |+.||.+..++
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 9999999999999999998654432222 234679999999999999999999999999999998 99999999999
Q ss_pred HHHHhh
Q psy4396 263 TTLERI 268 (271)
Q Consensus 263 ~~~~~I 268 (271)
|+++.|
T Consensus 713 EVIe~i 718 (774)
T KOG1026|consen 713 EVIECI 718 (774)
T ss_pred HHHHHH
Confidence 999876
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=233.17 Aligned_cols=184 Identities=27% Similarity=0.493 Sum_probs=136.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
+++|.+.+.||+|+||.||+|++..+++.||+|.+........ .....+| +.......||++....+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E----~~~l~~l~h~nI~~~~~~~~~~~~ 78 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIRE----VSLLKDLKHANIVTLHDIIHTEKS 78 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHH----HHHHHhcCCCCcceEEEEEecCCe
Confidence 5789999999999999999999999999999999753211000 0000011 11111112332221111
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 79 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 79 LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 123678889999999999999999999999999999999999999999999998654321
Q ss_pred -CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 -HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
......+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...+..+....+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2223456889999998865 45788999999999999999999999988876665443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=229.14 Aligned_cols=186 Identities=17% Similarity=0.271 Sum_probs=137.2
Q ss_pred ccccCeEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
++.++|++.+.||+|+||.||+|.++ ..+..||+|.++....... ...+.++ +.......||+++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~--~~~~~~e----~~~l~~l~h~~iv~~~~~~ 75 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ--RRGFLAE----ALTLGQFDHSNIVRLEGVI 75 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHH--HHHHHHH----HHHHhcCCCCCcCeEEEEE
Confidence 34578999999999999999999875 3467899999864321110 1111111 111122234443322111
Q ss_pred --------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 153 --------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 153 --------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
..+++..+..++.|++.||+|||++|++||||||+|||++.++.++++|||.+.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 76 TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred ecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 246888999999999999999999999999999999999999999999999875
Q ss_pred cCCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 207 HAPSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 207 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
...... .....++..|+|||.+.+..++.++|+|||||++||+++ |..||...+..+..+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 432211 112234678999999999999999999999999999775 99999988877766544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=239.94 Aligned_cols=109 Identities=29% Similarity=0.499 Sum_probs=93.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc----ccccccccccCcceecc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR----KTMCGTLDYLPPEMVTS 230 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~ 230 (271)
+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++....... ....++..|+|||++.+
T Consensus 211 l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 290 (375)
T cd05104 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN 290 (375)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC
Confidence 56778889999999999999999999999999999999999999999999875443221 12234567999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 231 QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 231 ~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
..++.++|+|||||++|||++ |..||.......
T Consensus 291 ~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~ 324 (375)
T cd05104 291 CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324 (375)
T ss_pred CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence 999999999999999999998 999998765443
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=230.87 Aligned_cols=176 Identities=13% Similarity=0.156 Sum_probs=134.2
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------------- 152 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------------- 152 (271)
..||+|++|.||+|.+ +++.||||.++..........+.+.+| +..+....||+++...+.
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENE----IKNLRRIDSNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHH----HHHHHhcCCCCEEEEeeeEEecccCCCceEE
Confidence 5689999999999998 467899999865432222222222222 222233344444433221
Q ss_pred -----------------ccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeeccccccCCCCCcc
Q psy4396 153 -----------------SLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214 (271)
Q Consensus 153 -----------------~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 214 (271)
..+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..... ..
T Consensus 100 v~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-~~ 178 (283)
T PHA02988 100 ILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-PF 178 (283)
T ss_pred EEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-cc
Confidence 2256778889999999999999984 9999999999999999999999999998754432 23
Q ss_pred cccccccccCcceecc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 215 TMCGTLDYLPPEMVTS--QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+++..+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i 234 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 3567899999999976 67899999999999999999999999999888877665
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=229.58 Aligned_cols=183 Identities=19% Similarity=0.331 Sum_probs=133.3
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCe----EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQI----MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE---- 149 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---- 149 (271)
..++|++.+.||+|+||+||+|++..++. .||+|+++....... ...+.++. .......||++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~--~~~~~~e~----~~l~~~~~~~i~~~~~~~ 78 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA--NKEILDEA----YVMAGVGSPYVCRLLGIC 78 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHH--HHHHHHHH----HHHHhcCCCCCceEEEEE
Confidence 34689999999999999999999876665 489998753211100 00111110 01111122222111
Q ss_pred ------------cC----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 150 ------------EG----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 150 ------------~~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
.+ ...+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 79 LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred cCCCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 11 13478889999999999999999999999999999999999999999999999876
Q ss_pred CCCCCc----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy4396 208 APSLHR----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLE 266 (271)
Q Consensus 208 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~ 266 (271)
...... ....+++.|+|||.+.+..++.++|+|||||++||+++ |..||......++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 222 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 222 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 543221 11234678999999988889999999999999999998 999998777665443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=238.02 Aligned_cols=110 Identities=29% Similarity=0.525 Sum_probs=94.6
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceec
Q psy4396 154 LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVT 229 (271)
Q Consensus 154 ~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~ 229 (271)
.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++....... .....++..|+|||++.
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 248 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence 46788899999999999999999999999999999999999999999999987643221 12234567899999999
Q ss_pred cCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 230 SQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 230 ~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
+..++.++|+|||||++|||++ |..||.+....+
T Consensus 249 ~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~ 283 (337)
T cd05054 249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283 (337)
T ss_pred CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH
Confidence 9999999999999999999998 999998655433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-33 Score=244.21 Aligned_cols=177 Identities=25% Similarity=0.480 Sum_probs=142.5
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
...-|++.++...-++=||+|+-|.||+|+.++ +.||||.++.-+..... ++ ..++||||+.+.
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~n--etVAVKKV~elkETdIK---HL-----------RkLkH~NII~Fk 178 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHN--ETVAVKKVRELKETDIK---HL-----------RKLKHPNIITFK 178 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccC--ceehhHHHhhhhhhhHH---HH-----------HhccCcceeeEe
Confidence 345677777877788889999999999999875 46999976432211111 11 112455554444
Q ss_pred Cc--------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 151 GY--------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 151 ~~--------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
|. ..++......|..+|+.|+.|||.+.|||||||.-||||+.+..+||+|||.
T Consensus 179 GVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 179 GVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred eeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence 33 2367888889999999999999999999999999999999999999999999
Q ss_pred cccCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 205 SVHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 205 a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
++..... ....++||..|||||++...+.+.|+|||||||+||||+||..||.+-+...
T Consensus 259 S~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA 318 (904)
T KOG4721|consen 259 SKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA 318 (904)
T ss_pred hHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence 9776654 3456899999999999999999999999999999999999999998766543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=236.18 Aligned_cols=185 Identities=25% Similarity=0.331 Sum_probs=139.4
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcce-------------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL------------- 145 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 145 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+...... ......+| +.+.....||+
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT-HAKRAYRE----LVLMKLVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChh-HHHHHHHH----HHHHHhcCCCCCcceeeeeccCCC
Confidence 4789999999999999999999999999999999853211000 00001011 01111112222
Q ss_pred --------eeeccCc--------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 146 --------LSSEEGY--------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 146 --------l~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
++..... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++...
T Consensus 90 ~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 90 LEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccccCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 2221110 126788899999999999999999999999999999999999999999999997654
Q ss_pred CCC-cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SLH-RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+....+.++
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 229 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 432 23345788999999999999999999999999999999999999988776665554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=231.96 Aligned_cols=183 Identities=21% Similarity=0.348 Sum_probs=132.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcC----------------CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCC
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKT----------------TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (271)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++........ ...+.+| +......
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E----~~~l~~l 76 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNA--RNDFLKE----VKILSRL 76 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHH--HHHHHHH----HHHHhhc
Confidence 35789999999999999999998643 345799999864321110 1111111 1112222
Q ss_pred CcceeeeccCc---------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHH
Q psy4396 142 RHPLLSSEEGY---------------------------------------------SLYTEKDAAKYIYQVADAIHYCHQ 176 (271)
Q Consensus 142 ~~~~l~~~~~~---------------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~ 176 (271)
.||+++...+. ..+++..+..++.|++.||+|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 34433222110 123556778999999999999999
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV- 251 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~- 251 (271)
.||+||||||+|||++.++.+||+|||+++...... .....++..|+|||++.+..++.++|+||||+++|||++
T Consensus 157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 999999999999999999999999999986543221 122345778999999988889999999999999999986
Q ss_pred -CCCCCCCCCHHHHHH
Q psy4396 252 -GKPPFESKDQDTTLE 266 (271)
Q Consensus 252 -g~~pf~~~~~~~~~~ 266 (271)
+..||...+..+.+.
T Consensus 237 ~~~~p~~~~~~~~~~~ 252 (304)
T cd05096 237 CKEQPYGELTDEQVIE 252 (304)
T ss_pred cCCCCCCcCCHHHHHH
Confidence 678998877766554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=230.07 Aligned_cols=183 Identities=17% Similarity=0.280 Sum_probs=133.8
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCe----EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQI----MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
..++|++++.||+|+||+||+|.+..++. .+++|.+...... .....+..+ ........||+++...+.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~----~~~l~~l~h~~iv~~~~~~ 78 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDH----MLAMGSLDHAYIVRLLGIC 78 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch--HHHHHHHHH----HHHHhcCCCCCcceEEEEE
Confidence 35688999999999999999999977665 4777776432110 000111111 001112233333222111
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 79 PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred CCCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 2367888999999999999999999999999999999999999999999999865
Q ss_pred CCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy4396 208 APSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLE 266 (271)
Q Consensus 208 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~ 266 (271)
..... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||.+....+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~ 222 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 43221 122346678999999988889999999999999999998 999998887765433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=229.93 Aligned_cols=186 Identities=25% Similarity=0.377 Sum_probs=136.9
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCC-----eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQ-----IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE- 150 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~- 150 (271)
++.++|++.+.||+|+||.||+|.....+ ..||+|.+....... ....+.++ +.......||++....
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~--~~~~~~~e----i~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQE----AELMSDLQHPNIVCLLG 75 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHH--HHHHHHHH----HHHHHhcCCcccceEEE
Confidence 35678999999999999999999987655 679999985422110 00011111 0011111122111100
Q ss_pred ----------------C-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q psy4396 151 ----------------G-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENL 189 (271)
Q Consensus 151 ----------------~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Ni 189 (271)
+ ...+++..+..++.|++.||.|||++|++||||||+||
T Consensus 76 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 155 (283)
T cd05048 76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC 155 (283)
T ss_pred EEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceE
Confidence 0 02356788889999999999999999999999999999
Q ss_pred EeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy4396 190 LLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTT 264 (271)
Q Consensus 190 li~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~ 264 (271)
+++.++.++|+|||++...... ......+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..++
T Consensus 156 l~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred EEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999998654321 1223446788999999988889999999999999999998 9999998888877
Q ss_pred HHhh
Q psy4396 265 LERI 268 (271)
Q Consensus 265 ~~~I 268 (271)
...|
T Consensus 236 ~~~i 239 (283)
T cd05048 236 IEMI 239 (283)
T ss_pred HHHH
Confidence 6654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=236.07 Aligned_cols=166 Identities=25% Similarity=0.374 Sum_probs=129.4
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
..+|.+++.||+|+||.||+|++..+++.||+|+........+.. +.....||+++...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~-------------~l~~l~h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM-------------LLQNVNHPSVIRMKDTLVSGAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHH-------------HHHhCCCCCCcChhheEEeCCe
Confidence 357999999999999999999999999999999865432221111 11111222222211
Q ss_pred ------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-C
Q psy4396 151 ------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-L 211 (271)
Q Consensus 151 ------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-~ 211 (271)
....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.... .
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 123478899999999999999999999999999999999999999999999999865332 2
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhC-CCCCC
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVG-KPPFE 257 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~ 257 (271)
......||+.|+|||++.+..++.++|+|||||++|||+++ ..+|.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 23345689999999999999999999999999999999985 44444
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=223.99 Aligned_cols=183 Identities=28% Similarity=0.480 Sum_probs=137.8
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH--HHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN--ERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
++|.+.+.||+|++|.||+|.+..+++.+|+|.+....... ......+.+| ........||++....+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e----~~~l~~l~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECE----IQLLKNLQHERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHH----HHHHHhCCCCCeeeeEEEEccCC
Confidence 56889999999999999999999889999999875432111 0111112222 112222234433332211
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 23577888999999999999999999999999999999999999999999998654322
Q ss_pred Cc-----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 212 HR-----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 212 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
.. ....++..|+|||++.+..++.++|+||||+++|++++|+.||...+..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 217 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH
Confidence 11 23457789999999999889999999999999999999999998766655443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-33 Score=258.03 Aligned_cols=185 Identities=26% Similarity=0.413 Sum_probs=148.0
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCC-----eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQ-----IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
+...+.++.+.||+|+||.||.|...... ..||||.+.+... ......+.+| ..++..+.|||++...|
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~--~~~~~~Fl~E----a~~m~~f~HpNiv~liG 762 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS--EQEVSDFLKE----ALLMSKFDHPNIVSLIG 762 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC--HHHHHHHHHH----HHHHhcCCCcceeeEEE
Confidence 34567888999999999999999986543 3489998865321 2222233333 56777778888877665
Q ss_pred cc---------------------------------cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEE
Q psy4396 152 YS---------------------------------LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVK 198 (271)
Q Consensus 152 ~~---------------------------------~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~k 198 (271)
.+ .++..++..++.|+++|+.||+++++|||||..+|+|++....+|
T Consensus 763 v~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 763 VCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred eecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEE
Confidence 42 267889999999999999999999999999999999999999999
Q ss_pred EeeccccccCCCCCccc----ccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 199 ISDFGWSVHAPSLHRKT----MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 199 l~Dfg~a~~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
|+|||+|+..-...... ..-...|||||.+....+|.++|||||||+|||++| |..||++.++.+++.-
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~ 916 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD 916 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH
Confidence 99999998433222111 123568999999999999999999999999999999 9999999999998763
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=226.04 Aligned_cols=177 Identities=28% Similarity=0.489 Sum_probs=133.3
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|++.+.||+|+||.||+|++..+++.||||.+.............+.+| ........||++....+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE----IDLLKQLNHPNVIKYLDSFIEDNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHH----HHHHHhCCCcceeeeeeeEEECCeE
Confidence 689999999999999999999999999999998753221111111111111 11111222332222111
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 152 ----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 ----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 1236778889999999999999999999999999999999999999999999887654
Q ss_pred CCC--cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 210 SLH--RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 210 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 322 123457889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=230.43 Aligned_cols=185 Identities=34% Similarity=0.558 Sum_probs=138.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcce--------------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL-------------- 145 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 145 (271)
++|++.+.||+|++|.||+|.+..+++.||+|.+.............+..+. .......||+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~----~~l~~l~~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQ----EILATLDHPFLPTLYASFQTETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHH----HHHHhCCCCCchhheeeeecCCEE
Confidence 4689999999999999999999999999999998654322111111111110 0111111221
Q ss_pred -eeec--cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 146 -LSSE--EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 146 -l~~~--~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
++.. .+ ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 1111 11 134788889999999999999999999999999999999999999999999987543211
Q ss_pred C-------------------------------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 212 H-------------------------------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 212 ~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
. .....||..|+|||++.+..++.++|+||||+++|+|++|+.||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 0 112357889999999998889999999999999999999999999888
Q ss_pred HHHHHHhh
Q psy4396 261 QDTTLERI 268 (271)
Q Consensus 261 ~~~~~~~I 268 (271)
..+.+..+
T Consensus 237 ~~~~~~~~ 244 (316)
T cd05574 237 RDETFSNI 244 (316)
T ss_pred hHHHHHHH
Confidence 77766554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=224.33 Aligned_cols=193 Identities=21% Similarity=0.337 Sum_probs=138.9
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh------hhhhhceeeeE-EecCcCCCcceeee
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM------THQVHRERCCQ-VHLSSSRRHPLLSS 148 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~------~~~~~~~~~~~-~~~~~~~~~~~l~~ 148 (271)
.+...+|.+.+.||+|+||.||+|.+..+++.||+|++.......... ...+....... ...........++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 455678999999999999999999999989999999986432211110 01111000000 00000001111111
Q ss_pred c--c-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcc-
Q psy4396 149 E--E-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK- 214 (271)
Q Consensus 149 ~--~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~- 214 (271)
. . ....+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 1 0 1123678888999999999999999999999999999999999999999999998665432211
Q ss_pred --cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 215 --TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 215 --~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
...++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.++....+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~ 218 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 1223568999999999999999999999999999998 99999988877766554
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=230.30 Aligned_cols=187 Identities=22% Similarity=0.346 Sum_probs=137.2
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCC-----CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTT-----QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
+...+|.+.+.||+|+||.||+|.+..+ ++.||+|+++...... ....+..+ ..+.....||+++...+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e----~~~~~~l~h~~iv~~~~ 75 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP--LREEFKHE----AMMRSRLQHPNIVCLLG 75 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHH--HHHHHHHH----HHHHhcCCCCCcCeEEE
Confidence 3456788999999999999999987643 5789999986432110 00111111 11111122332221110
Q ss_pred ------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q psy4396 152 ------------------------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENL 189 (271)
Q Consensus 152 ------------------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Ni 189 (271)
...+++..+..++.|++.||+|||++|++||||||+||
T Consensus 76 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Ni 155 (283)
T cd05091 76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNV 155 (283)
T ss_pred EEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhhe
Confidence 12367778889999999999999999999999999999
Q ss_pred EeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy4396 190 LLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTT 264 (271)
Q Consensus 190 li~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~ 264 (271)
+++.++.+||+|||+++...... .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+....++
T Consensus 156 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 156 LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred EecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999986543221 122345678999999988889999999999999999998 9999999888887
Q ss_pred HHhhc
Q psy4396 265 LERIF 269 (271)
Q Consensus 265 ~~~I~ 269 (271)
++.|.
T Consensus 236 ~~~i~ 240 (283)
T cd05091 236 IEMIR 240 (283)
T ss_pred HHHHH
Confidence 77653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=233.02 Aligned_cols=184 Identities=28% Similarity=0.468 Sum_probs=132.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH--HHHH------hhhhhhceeeeEEecCc--------CCCc
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI--INER------MTHQVHRERCCQVHLSS--------SRRH 143 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~------~~~~~~~~~~~~~~~~~--------~~~~ 143 (271)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .... ....+..... +.+.. ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI--IGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCc--Cchhheeecccccccce
Confidence 689999999999999999999999999999999853110 0000 0011111100 00000 0011
Q ss_pred ceeeecc---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--
Q psy4396 144 PLLSSEE---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-- 212 (271)
Q Consensus 144 ~~l~~~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 212 (271)
.+++... ....+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 1111111 11347889999999999999999999999999999999999999999999999986543221
Q ss_pred ---cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 213 ---RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 213 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.....
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~ 219 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL 219 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 122457889999998654 56899999999999999999999999877654433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=223.81 Aligned_cols=193 Identities=19% Similarity=0.355 Sum_probs=137.4
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhceeeeEE-ecCcCCCcceee
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRERCCQV-HLSSSRRHPLLS 147 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~l~ 147 (271)
|.+..++|++++.||+|+||.||+|.+.. +..||+|.+......... ....+........ ..........++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 34567899999999999999999999764 456999987643221111 1111111111110 011111111222
Q ss_pred ec--cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc-
Q psy4396 148 SE--EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR- 213 (271)
Q Consensus 148 ~~--~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 213 (271)
.. .+ ...++...+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 11 11 12356778888999999999999999999999999999999999999999999876543221
Q ss_pred --ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 214 --KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
....++..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 22335678999999988889999999999999999998 99999888777665544
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=231.67 Aligned_cols=176 Identities=32% Similarity=0.521 Sum_probs=122.0
Q ss_pred ecccccCCceEEEEEEEcC--CCeEEEEEEcchhHHHHH-----HhhhhhhceeeeEE---ecCcCCCcceeeecc----
Q psy4396 85 GCPLGTGKFGHVYLAKEKT--TQIMIALKVLYKVEIINE-----RMTHQVHRERCCQV---HLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 85 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~---- 150 (271)
...||+|+||.||+|+... ++..||+|.+........ .....+........ .......+.+++...
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 3579999999999999754 567899998864321110 11111111111000 000000111111110
Q ss_pred ---------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe----CCCCCEEEeeccccccCCCC
Q psy4396 151 ---------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL----TMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 151 ---------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili----~~~~~~kl~Dfg~a~~~~~~ 211 (271)
....+++..+..++.|++.||.|||+.|++||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 01236788899999999999999999999999999999999 55678999999999754332
Q ss_pred -----CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 212 -----HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 212 -----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
......+|+.|+|||++.+ ..++.++|+|||||++|||++|++||....
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 1223467899999999876 457999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=240.36 Aligned_cols=188 Identities=31% Similarity=0.578 Sum_probs=157.2
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
..+..|.+.+.||+|.|+.|.+|++..++..||||++++.......... +.+| +..+....||++++....
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k-~~re----v~imk~l~HPnIvkl~~v~~t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQK-LGRE----VDIMKSLNHPNIVKLFSVIETE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHH-HHHH----HHHHHhcCCcceeeeeeeeeec
Confidence 3467899999999999999999999999999999999876554333222 3344 556666688887665433
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
+.+.+..++.++.|+..|++|||+++|+|||||++|+|++.+.++||+|||++.....
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence 3356788999999999999999999999999999999999999999999999976553
Q ss_pred -CCcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 -LHRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
....+.||++.|+|||++.+..| ++.+|+||+|++||.|++|..||.+.+-.+.-.+++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl 268 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL 268 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe
Confidence 34567899999999999999887 579999999999999999999999888777665543
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=226.43 Aligned_cols=185 Identities=35% Similarity=0.606 Sum_probs=138.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcce--------------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL-------------- 145 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 145 (271)
++|++.+.||+|+||.||++.+..+++.||+|.+.............+..+. .+.....||+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~----~~l~~~~~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER----DILTFAENPFVVSMFCSFETKRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHH----HHHHhCCCCCeeeeEEEEecCCEE
Confidence 4689999999999999999999999999999998654321111111111110 0111112222
Q ss_pred -eeec--cC---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 146 -LSSE--EG---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 146 -l~~~--~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
++.. .+ ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++.....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 2211 11 133678888999999999999999999999999999999999999999999987632110
Q ss_pred ---------------CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 ---------------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
......++..|+|||.+.+..++.++|+||||+++||+++|..||.+.+..+.+.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011234678999999998888999999999999999999999999988887766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=226.08 Aligned_cols=184 Identities=26% Similarity=0.415 Sum_probs=131.2
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--------HH-HhhhhhhceeeeE-EecCcCCCcceeeec-
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--------NE-RMTHQVHRERCCQ-VHLSSSRRHPLLSSE- 149 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~-~~~~~~~~~~~~~-~~~~~~~~~~~l~~~- 149 (271)
+|++.+.||+|++|.||+|++..++..||+|.+...... .+ .....+....... ........+.+++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999999999999999987532110 00 0001111100000 000000111111111
Q ss_pred ------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--ccc
Q psy4396 150 ------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH--RKT 215 (271)
Q Consensus 150 ------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~ 215 (271)
.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence 111347889999999999999999999999999999999999999999999999986543221 223
Q ss_pred ccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 216 MCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 216 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
..+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+....
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~ 210 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 4568899999988654 478899999999999999999999987765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=223.37 Aligned_cols=187 Identities=29% Similarity=0.486 Sum_probs=133.4
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH-------H----H-HhhhhhhceeeeEEec--CcC-CCcc
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII-------N----E-RMTHQVHRERCCQVHL--SSS-RRHP 144 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~----~-~~~~~~~~~~~~~~~~--~~~-~~~~ 144 (271)
.+|++.+.||+|+||.||+|.+..+++.||||.+...... . + .....+.......... ... ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999999999999999987421100 0 0 0111111111100000 000 0001
Q ss_pred eee--eccC---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC---
Q psy4396 145 LLS--SEEG---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--- 210 (271)
Q Consensus 145 ~l~--~~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--- 210 (271)
.++ ...+ ...+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 111 1111 12367788899999999999999999999999999999999999999999998865332
Q ss_pred --CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 211 --LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
.......++..|+|||++.+..++.++|+||||+++|++++|+.||...+....+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 219 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF 219 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH
Confidence 11223457889999999988889999999999999999999999998765555443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=240.09 Aligned_cols=179 Identities=23% Similarity=0.327 Sum_probs=129.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH-HhhhhhhceeeeEEe-cCcCCCcceeeec-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE-RMTHQVHRERCCQVH-LSSSRRHPLLSSE------- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~~------- 149 (271)
...|.+.+.||+|+||.||+|.+..+++.||||........++ .....+.....+... .........++..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~ 247 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLY 247 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHH
Confidence 4579999999999999999999999999999997532222111 111111111100000 0000011111110
Q ss_pred ---c-CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----ccccccccc
Q psy4396 150 ---E-GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLD 221 (271)
Q Consensus 150 ---~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~ 221 (271)
. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++...... .....||+.
T Consensus 248 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~ 327 (461)
T PHA03211 248 TYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327 (461)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcC
Confidence 0 11247889999999999999999999999999999999999999999999999986543221 123568999
Q ss_pred ccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 222 YLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 222 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 328 Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 328 TNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred CcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 999999999999999999999999999999876553
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=227.87 Aligned_cols=173 Identities=26% Similarity=0.446 Sum_probs=125.1
Q ss_pred ccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH---------Hhhhhhhc--eeeeEEec---CcCCCcceeeec--c
Q psy4396 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---------RMTHQVHR--ERCCQVHL---SSSRRHPLLSSE--E 150 (271)
Q Consensus 87 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~~~--~~~~~~~~---~~~~~~~~l~~~--~ 150 (271)
.||+|+||.||++.+..+++.+|+|.+.+...... ........ .......+ .....+..++.. .
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999998854321100 00000000 00000000 000111111111 1
Q ss_pred ---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCccccccccc
Q psy4396 151 ---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLD 221 (271)
Q Consensus 151 ---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~ 221 (271)
....+++..+..++.|++.||+|||+.+++||||||+|||+++++.++|+|||++............|++.
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 160 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcC
Confidence 11347889999999999999999999999999999999999999999999999986554444444568999
Q ss_pred ccCcceec-cCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 222 YLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 222 y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
|+|||.+. +..++.++|+||+||++|+|++|+.||...
T Consensus 161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred ccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 99999886 456899999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=226.42 Aligned_cols=173 Identities=27% Similarity=0.454 Sum_probs=126.3
Q ss_pred ccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH---------HHh-hhhhhc-eeeeEEecC---cCCCcceeeec--c
Q psy4396 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN---------ERM-THQVHR-ERCCQVHLS---SSRRHPLLSSE--E 150 (271)
Q Consensus 87 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~-~~~~~~-~~~~~~~~~---~~~~~~~l~~~--~ 150 (271)
.||+|+||.||+|.+..+++.||+|++.+..... ... ...... .....+.+. .......++.. .
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999885432110 000 000000 000001000 00111111111 1
Q ss_pred ---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCccccccccc
Q psy4396 151 ---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLD 221 (271)
Q Consensus 151 ---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~ 221 (271)
....+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++............|+..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 160 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence 11347899999999999999999999999999999999999999999999999987655444445678999
Q ss_pred ccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 222 YLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 222 y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
|+|||++.+. .++.++|+||+|+++|+|++|+.||...
T Consensus 161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 9999998754 6899999999999999999999999766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=245.96 Aligned_cols=182 Identities=29% Similarity=0.422 Sum_probs=138.1
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCC-CcceeeeccC
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR-RHPLLSSEEG 151 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~ 151 (271)
....+.-.++++.+.|.+|||+.||+|.+...+..||+|++...+ +.....+.+|. ..+..+ .|++|+.+.+
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d---e~~L~~v~~EI----~~MK~L~gh~nIV~yid 102 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND---EEALNAVKREI----DIMKLLSGHKNIVSYID 102 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC---HHHHHHHHHHH----HHHHHhcCCCceeeEec
Confidence 444555667889999999999999999999987889999975432 11222222331 111111 2555444333
Q ss_pred c-----------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCC
Q psy4396 152 Y-----------------------------------SLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTMH 194 (271)
Q Consensus 152 ~-----------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~~ 194 (271)
. ..|++.++++|+.|+++|+++||..+ |||||||-+||||+.+
T Consensus 103 ss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~ 182 (738)
T KOG1989|consen 103 SSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD 182 (738)
T ss_pred cccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC
Confidence 1 22789999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccccccCCCCC-cc----------cccccccccCccee---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 195 EDVKISDFGWSVHAPSLH-RK----------TMCGTLDYLPPEMV---TSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 195 ~~~kl~Dfg~a~~~~~~~-~~----------~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
|..||||||.+....... .. ....|+.|+|||++ .+.+.+.|+|||||||+||-|+....||....
T Consensus 183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 999999999885432211 11 12358999999987 57788999999999999999999999998764
Q ss_pred H
Q psy4396 261 Q 261 (271)
Q Consensus 261 ~ 261 (271)
.
T Consensus 263 ~ 263 (738)
T KOG1989|consen 263 K 263 (738)
T ss_pred c
Confidence 4
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-33 Score=246.74 Aligned_cols=170 Identities=34% Similarity=0.586 Sum_probs=134.1
Q ss_pred ccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--------------
Q psy4396 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-------------- 152 (271)
Q Consensus 87 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-------------- 152 (271)
+||+|.||+||.|++..++..+|||.+.... .+....+++| ..+....+|.||+++.|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEE----IaLH~~LrHkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEE----IALHSTLRHKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHH----HHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence 6999999999999999999999999884321 1222222232 333344456655554433
Q ss_pred -------------ccC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC-CCCCEEEeeccccccCCC--CCcc
Q psy4396 153 -------------SLY--TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT-MHEDVKISDFGWSVHAPS--LHRK 214 (271)
Q Consensus 153 -------------~~~--~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~-~~~~~kl~Dfg~a~~~~~--~~~~ 214 (271)
+++ .+.+...+.+||+.||.|||++.|||||||-+|+||+ -.|.+||+|||.+++..+ +.+.
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 234 5788889999999999999999999999999999995 458899999999977654 3456
Q ss_pred cccccccccCcceeccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 215 TMCGTLDYLPPEMVTSQ--HYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
++.||..|||||++..+ +|..++|||||||++.||+||++||......+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq 785 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ 785 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh
Confidence 78899999999999764 58999999999999999999999997665543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=219.98 Aligned_cols=183 Identities=27% Similarity=0.448 Sum_probs=138.7
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC---------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG--------- 151 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--------- 151 (271)
+|.+.+.||+|++|.||+|.+..+++.|++|.+........ ....+..+ ........||++....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDE----ARVLAKLDSSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH-HHHHHHHH----HHHHHhcCCCCeehheeeeccCCEEE
Confidence 47888999999999999999999999999999754321111 11111111 11111223333222111
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 1236778888999999999999999999999999999999999999999999886544322
Q ss_pred --cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 213 --RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+...++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 213 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23346788999999999988999999999999999999999999988877665554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-33 Score=222.84 Aligned_cols=185 Identities=30% Similarity=0.426 Sum_probs=142.4
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec-----------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE----------- 149 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~----------- 149 (271)
+.+--+.||-|+||.||.+++..+++.||+|.+.+..- +-.....+.++ ..+....+|.|+...
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-~L~s~krvFre----~kmLcfFkHdNVLSaLDILQPph~df 128 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-NLASCKRVFRE----IKMLSSFRHDNVLSLLDILQPANPSF 128 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH-HHHHHHHHHHH----HHHHHhhccccHHHHHHhcCCCCchH
Confidence 44556789999999999999999999999998754211 11111122222 122222233322111
Q ss_pred -------------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 150 -------------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 150 -------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..-..++.+.++-+++||++||.|||+.+|+||||||.|.|++++..+||+|||+++....
T Consensus 129 FqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 129 FQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 1123478899999999999999999999999999999999999999999999999976543
Q ss_pred ---CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 211 ---LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 211 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
.+.+..+-|-.|+|||++.+ ..|+.+.||||.|||+.|++.++..|+..++-+.++.|..
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 33444567889999999987 4689999999999999999999999999999999998864
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=226.54 Aligned_cols=182 Identities=25% Similarity=0.436 Sum_probs=131.8
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---------- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---------- 150 (271)
+|++.+.||+|+||.||+|++..+++.||+|.+....... .....+.+| +.......||++....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~e----i~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALRE----ICLLKELKHKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHH----HHHHHhcCCCCeeeHHHHhccCCceE
Confidence 5888999999999999999999999999999985421110 000001111 1111112233222110
Q ss_pred ----------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--C
Q psy4396 151 ----------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--H 212 (271)
Q Consensus 151 ----------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~ 212 (271)
....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 1134788999999999999999999999999999999999999999999999998654322 1
Q ss_pred cccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHh
Q psy4396 213 RKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPF-ESKDQDTTLER 267 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~ 267 (271)
.....+++.|+|||++.+. .++.++|+|||||++|+|++|..|| .+.+..+.+++
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence 2234568899999988764 4789999999999999999988775 55554444443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=221.34 Aligned_cols=192 Identities=19% Similarity=0.294 Sum_probs=136.7
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhceeeeE-EecCcCCCcceeee
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRERCCQ-VHLSSSRRHPLLSS 148 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~l~~ 148 (271)
++..++|++.+.||+|++|.||+|.+.. ++.||+|.++........ ....+....... ...........++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 4556789999999999999999999765 467999998643211111 111111110000 00000011111111
Q ss_pred cc-------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCccc
Q psy4396 149 EE-------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT 215 (271)
Q Consensus 149 ~~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 215 (271)
.. ....+++..+..++.|++.||.+||+.|++||||||+||++++++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 00 01246788999999999999999999999999999999999999999999999987654322221
Q ss_pred cc---ccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 216 MC---GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 216 ~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.. .+..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+..+.+..+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 22 2457999999998889999999999999999999 99999988887766554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=230.19 Aligned_cols=183 Identities=28% Similarity=0.444 Sum_probs=136.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ ....+.++ +.......||+++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E----i~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRE----LRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH-HHHHHHHH----HHHHHHcCCCcccceeeeeeeccc
Confidence 3789999999999999999999999999999999864321100 00011111 0111111222221111
Q ss_pred --------------C--------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 151 --------------G--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 151 --------------~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
+ ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 91 ~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 91 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 1 123788899999999999999999999999999999999999999999999998764
Q ss_pred CCCCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 209 PSLHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+..+.+..
T Consensus 171 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (345)
T cd07877 171 DDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229 (345)
T ss_pred ccc-ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 432 233467889999998866 5678999999999999999999999987776655443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=215.37 Aligned_cols=179 Identities=23% Similarity=0.327 Sum_probs=133.0
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec---
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE--- 149 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--- 149 (271)
....+.-++|++.+.||.|||+-||+++...++..||+|.+.-...... +...+| .......+||++...
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~---e~~~rE----id~~rkf~s~~vl~l~dh 86 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDI---EEALRE----IDNHRKFNSPNVLRLVDH 86 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHH---HHHHHH----HHHHHhhCCcchHHHHHH
Confidence 3345567899999999999999999999999999999998743321110 000011 011111122221111
Q ss_pred --------------------------------cCcccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCC
Q psy4396 150 --------------------------------EGYSLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTMHE 195 (271)
Q Consensus 150 --------------------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~~~ 195 (271)
.....+++.++..++.++++||++||+.. +.||||||.|||+++.+
T Consensus 87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG 166 (302)
T ss_pred HHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC
Confidence 11234799999999999999999999998 99999999999999999
Q ss_pred CEEEeeccccccCCCCCc-----------ccccccccccCcceeccC---CCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 196 DVKISDFGWSVHAPSLHR-----------KTMCGTLDYLPPEMVTSQ---HYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 196 ~~kl~Dfg~a~~~~~~~~-----------~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
.++|.|||.+...+-.-. .....|..|+|||++.-+ ..+.++|||||||+||+|+.|..||..
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 999999998865442111 123468999999998643 457899999999999999999999963
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=224.52 Aligned_cols=174 Identities=28% Similarity=0.389 Sum_probs=129.6
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++.+.||+|+||.||+|.+..+++.||+|.++......... ....+.. .......||+++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~e~~---~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK--RLLMDLD---ISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH--HHHHHHH---HHHHHcCCCCeeeeeEEEecCCcE
Confidence 47899999999999999999999999999999886432111000 0000000 000111222222111
Q ss_pred --------------------CcccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 151 --------------------GYSLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 --------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 113478899999999999999999997 99999999999999999999999999987654
Q ss_pred CCC-cccccccccccCcceecc----CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 210 SLH-RKTMCGTLDYLPPEMVTS----QHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 210 ~~~-~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 322 223557889999998864 4568899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=224.37 Aligned_cols=188 Identities=20% Similarity=0.326 Sum_probs=137.5
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCC-----CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTT-----QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
|++..++|++.+.||+|+||.||+|.+... +..||+|.+........ ...+.++ ........||++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e----~~~l~~~~~~~i~~~ 74 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE--RIEFLNE----ASVMKEFNCHHVVRL 74 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHH--HHHHHHH----HHHHHhCCCCceeEE
Confidence 355678999999999999999999998754 37899999754321110 0011111 111111122222211
Q ss_pred cCc------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC
Q psy4396 150 EGY------------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM 193 (271)
Q Consensus 150 ~~~------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~ 193 (271)
.+. ..+++..+..++.|++.||.|||+.+++||||||+||+++.
T Consensus 75 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~ 154 (277)
T cd05032 75 LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154 (277)
T ss_pred EEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence 110 12456678889999999999999999999999999999999
Q ss_pred CCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 194 HEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 194 ~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
++.++|+|||+++..... ......++..|+|||.+.+..++.++|+|||||++||+++ |..||...+..+..+.+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 999999999998654322 1223446788999999988889999999999999999998 99999988877766544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=222.12 Aligned_cols=192 Identities=20% Similarity=0.325 Sum_probs=137.2
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
.+..++|++.+.||+|+||.||+|++..++ .||+|.+......... ....+..................++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e 80 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 80 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEE
Confidence 345678999999999999999999987765 5999998653221111 111111111110000000011111111
Q ss_pred --cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc---
Q psy4396 150 --EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR--- 213 (271)
Q Consensus 150 --~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~--- 213 (271)
.+ ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 11 12357788999999999999999999999999999999999999999999999865432221
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
....++..|+|||...+..++.++|+||||+++|++++ |..||.+....+++..+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~ 216 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Confidence 12335678999999988889999999999999999999 89999988887776654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=228.40 Aligned_cols=191 Identities=26% Similarity=0.386 Sum_probs=139.0
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--------HH-HhhhhhhceeeeE-Eec--CcCCCcce
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--------NE-RMTHQVHRERCCQ-VHL--SSSRRHPL 145 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~-~~~~~~~~~~~~~-~~~--~~~~~~~~ 145 (271)
..++|++.+.||+|+||.||+|.+..+++.||+|.+...... .+ .....+....... ... .......+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 467899999999999999999999999999999998532110 00 1111111111000 000 00001111
Q ss_pred eeecc-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--C
Q psy4396 146 LSSEE-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--H 212 (271)
Q Consensus 146 l~~~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~ 212 (271)
++... ....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... .
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 11111 0134788999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 213 RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~ 221 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 222345788999998865 55789999999999999999999999998888776654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=227.02 Aligned_cols=178 Identities=26% Similarity=0.432 Sum_probs=136.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++.+.||+|+||.||++.+..++..+|+|.+..... ......+.+| +.......||+++...
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRE----LKVLHECNSPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHH----HHHHHhCCCCCCCeEEEEEeeCCEE
Confidence 468999999999999999999999999999998753211 0011111111 1111222333332221
Q ss_pred --------C---------cccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 151 --------G---------YSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 151 --------~---------~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
+ ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 1 1336788899999999999999998 589999999999999999999999999987654444
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 205 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 445678999999999988889999999999999999999999997665443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=223.91 Aligned_cols=181 Identities=29% Similarity=0.501 Sum_probs=134.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++.+.||+|++|.||+|.+..+++.||+|++....... .....+.++ +.......||++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e----~~~l~~~~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALRE----IRMLKQLKHPNLVNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHH----HHHHHhCCCCCEeeeeeEEeeCCEE
Confidence 46899999999999999999999999999999875321100 000000011 0111111222221111
Q ss_pred -----------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 151 -----------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 151 -----------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
....+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 11237889999999999999999999999999999999999999999999999987654332
Q ss_pred -cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 213 -RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 213 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~ 210 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 223457889999998876 45789999999999999999999999887765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=224.09 Aligned_cols=177 Identities=28% Similarity=0.487 Sum_probs=133.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++.+.||+|++|.||+|.+..++..+|||.+.............+.+| ........||++....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e----~~~l~~~~h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLKQLNHPNVIKYYASFIEDNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHH----HHHHHHccCCchhhhhheeEeCCeE
Confidence 578899999999999999999998999999998754322211111111111 1111111222221111
Q ss_pred --------C-------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 151 --------G-------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 --------~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
+ ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 1 1236788899999999999999999999999999999999999999999999886543
Q ss_pred CCC--cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 210 SLH--RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 210 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 321 223468889999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=218.21 Aligned_cols=188 Identities=24% Similarity=0.412 Sum_probs=136.9
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH---------HhhhhhhceeeeEEe--cCcCCCcceeeec
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---------RMTHQVHRERCCQVH--LSSSRRHPLLSSE 149 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~~~~~~~~~~--~~~~~~~~~l~~~ 149 (271)
+|++.+.||+|++|.||++.+..+++.+|+|.+........ .....+......... ........+++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999999999999999854321110 001111111111000 0000001111111
Q ss_pred c--C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Ccc
Q psy4396 150 E--G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRK 214 (271)
Q Consensus 150 ~--~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~ 214 (271)
. + ...+++.++..++.|++.||++||+.|++||||+|+||+++.++.++|+|||++...... ...
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 1 1 123688899999999999999999999999999999999999999999999998654322 223
Q ss_pred cccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
...+++.|+|||++.+..++.++|+||||++++++++|+.||...+.......+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~ 214 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 345789999999999999999999999999999999999999887776655443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=222.72 Aligned_cols=187 Identities=18% Similarity=0.316 Sum_probs=132.3
Q ss_pred eEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHH---------hhhhhhceeeeEEe-cC------cCCC
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINER---------MTHQVHRERCCQVH-LS------SSRR 142 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~---------~~~~~~~~~~~~~~-~~------~~~~ 142 (271)
|.+++.||+|+||.||+|....+ +..||+|.++........ ....+......... .. ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987653 478999998643211110 00111111111000 00 0001
Q ss_pred cceeeecc-----------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 143 HPLLSSEE-----------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 143 ~~~l~~~~-----------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
++.++... ....+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 12222110 0123678889999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 206 VHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 206 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+...... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..++++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7543221 112234678999999988889999999999999999999 99999988887776654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=250.47 Aligned_cols=185 Identities=29% Similarity=0.497 Sum_probs=133.7
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee--------
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL-------- 146 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-------- 146 (271)
....+++|.+++.||+|+||+||+|++..++..+|+|++........ ....+..| +.+.....||++
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~-~~~~~~~E----I~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-EKSQLVIE----VNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH-HHHHHHHH----HHHHHHcCCCCcCeEEEEEE
Confidence 34457899999999999999999999999999999999864221111 00111111 111111122221
Q ss_pred ---------eecc--C-------------cccCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCceEeCC--
Q psy4396 147 ---------SSEE--G-------------YSLYTEKDAAKYIYQVADAIHYCHQK-------KVIHRDIKPENLLLTM-- 193 (271)
Q Consensus 147 ---------~~~~--~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~-------~iiHrDikp~Nili~~-- 193 (271)
+... + ...+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 1111 1 12478899999999999999999994 4999999999999964
Q ss_pred ---------------CCCEEEeeccccccCCCC-CcccccccccccCcceecc--CCCCCchhHHHHHHHHHHHHhCCCC
Q psy4396 194 ---------------HEDVKISDFGWSVHAPSL-HRKTMCGTLDYLPPEMVTS--QHYGKEVDNWCIGILAYEFLVGKPP 255 (271)
Q Consensus 194 ---------------~~~~kl~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~p 255 (271)
.+.+||+|||++...... ......||+.|+|||++.+ ..++.++|||||||+||+|++|+.|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 234899999998765432 2234568999999999854 4588999999999999999999999
Q ss_pred CCCCCHHHH
Q psy4396 256 FESKDQDTT 264 (271)
Q Consensus 256 f~~~~~~~~ 264 (271)
|...+....
T Consensus 243 F~~~~~~~q 251 (1021)
T PTZ00266 243 FHKANNFSQ 251 (1021)
T ss_pred CCcCCcHHH
Confidence 986655443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=221.50 Aligned_cols=177 Identities=32% Similarity=0.581 Sum_probs=138.6
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---------- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---------- 150 (271)
+|++.+.||.|+||.||+|.+..+++.||+|++.+...........+.+|. .......||++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~----~~l~~l~h~~i~~~~~~~~~~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNER----RILQELNHPFLVNLWYSFQDEENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHH----HHHHhCCCCChHHHHHhhcCCCeEE
Confidence 588999999999999999999988999999998754432222222222221 122222444332211
Q ss_pred -------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-Cc
Q psy4396 151 -------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-HR 213 (271)
Q Consensus 151 -------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~ 213 (271)
+ ...+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++...... ..
T Consensus 77 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred EEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence 1 125788999999999999999999999999999999999999999999999988655433 23
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 345678899999999888899999999999999999999999987773
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=228.82 Aligned_cols=192 Identities=22% Similarity=0.332 Sum_probs=133.8
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCe--EEEEEEcchhHH--HHHH------hhhhh-hceeeeE-EecCcCCCcc
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQI--MIALKVLYKVEI--INER------MTHQV-HRERCCQ-VHLSSSRRHP 144 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~--~~~~------~~~~~-~~~~~~~-~~~~~~~~~~ 144 (271)
+..++|++.+.||+|+||.||+|.+..++. .+|+|.++.... .... ....+ ....... .........+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 456789999999999999999999877664 457777643110 0000 00111 1110000 0000011111
Q ss_pred eeeecc--C-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCE
Q psy4396 145 LLSSEE--G-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV 197 (271)
Q Consensus 145 ~l~~~~--~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~ 197 (271)
.++... + ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 111110 0 1246788899999999999999999999999999999999999999
Q ss_pred EEeeccccccCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 198 KISDFGWSVHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 198 kl~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+|+|||++...... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+..+.+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 99999998643221 1122234668999999988889999999999999999998 99999888777766544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=229.81 Aligned_cols=183 Identities=29% Similarity=0.411 Sum_probs=136.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|.+.+.||+|+||.||+|.+..+++.||+|.+.+..... .....+.++ ..+.....||++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e----~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRE----LTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHH----HHHHHhcCCCCccchhheecccccC
Confidence 67999999999999999999999899999999985421100 000001111 0111111222221111
Q ss_pred --------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 151 --------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 151 --------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
....+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++....
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 90 DEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred CCCceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 012478889999999999999999999999999999999999999999999999875433
Q ss_pred CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
. .....+++.|+|||.+.+ ..++.++|+||||+++|||++|+.||.+.+....+..+
T Consensus 170 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~ 227 (342)
T cd07879 170 E-MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227 (342)
T ss_pred C-CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2 233457889999998866 46889999999999999999999999988766655544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=222.52 Aligned_cols=186 Identities=18% Similarity=0.340 Sum_probs=130.7
Q ss_pred EEecccccCCceEEEEEEEcCCCe--EEEEEEcchhHHHHH---------HhhhhhhceeeeEE-ec----C--cCCCcc
Q psy4396 83 EVGCPLGTGKFGHVYLAKEKTTQI--MIALKVLYKVEIINE---------RMTHQVHRERCCQV-HL----S--SSRRHP 144 (271)
Q Consensus 83 ~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~---------~~~~~~~~~~~~~~-~~----~--~~~~~~ 144 (271)
.+.+.||+|+||.||+|.+..++. .+|+|.++....... .....+........ .. . ....++
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467889999999999999877664 589998754211000 00011111100000 00 0 001112
Q ss_pred eeeec--c---------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 145 LLSSE--E---------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 145 ~l~~~--~---------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
.++.. . ....+++..+..++.|++.||+|||+++|+||||||+|||+++++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 22111 0 112367888999999999999999999999999999999999999999999999875
Q ss_pred CCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 208 APSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 208 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..... .....+++.|+|||.+.+..++.++|+||||+++|||++ |+.||.+....++.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 227 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 43221 122345678999999999999999999999999999999 89999887777665543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=221.28 Aligned_cols=189 Identities=27% Similarity=0.482 Sum_probs=135.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH--HHHH----------hhhhhhceeeeEEe--cCcC-CCcc
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI--INER----------MTHQVHRERCCQVH--LSSS-RRHP 144 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~----------~~~~~~~~~~~~~~--~~~~-~~~~ 144 (271)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+..... .... ....+......... .... ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478999999999999999999999999999998642100 0000 01111111100000 0000 0001
Q ss_pred eee--eccC---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 145 LLS--SEEG---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 145 ~l~--~~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
.++ ...+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 111 1111 123678888999999999999999999999999999999999999999999998654321
Q ss_pred ---CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 ---HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
......++..|+|||.+.+..++.++|+|||||++|++++|+.||......+...++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 221 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI 221 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH
Confidence 112345788999999999888999999999999999999999999877666655443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=223.92 Aligned_cols=185 Identities=22% Similarity=0.381 Sum_probs=133.9
Q ss_pred cccCeEEecccccCCceEEEEEEEc----CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEK----TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-- 151 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-- 151 (271)
+.++|++.+.||+|+||.||+|.+. .++..+|+|.+........ ...+.+| ........||++....+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~E----~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQE----ASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHH--HHHHHHH----HHHHhhCCCCCeeeEEEEE
Confidence 4578999999999999999999863 3457899999864211100 0011111 01111112222211110
Q ss_pred -----------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q psy4396 152 -----------------------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLL 190 (271)
Q Consensus 152 -----------------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nil 190 (271)
...+++..+..++.|++.||+|||++|++||||||+|||
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil 156 (283)
T cd05090 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL 156 (283)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence 112567778889999999999999999999999999999
Q ss_pred eCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy4396 191 LTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTL 265 (271)
Q Consensus 191 i~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 265 (271)
++.++.+||+|||+++...... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.+.+..++.
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999986543221 122345678999999988889999999999999999998 99999887776665
Q ss_pred Hhh
Q psy4396 266 ERI 268 (271)
Q Consensus 266 ~~I 268 (271)
+.+
T Consensus 237 ~~~ 239 (283)
T cd05090 237 EMV 239 (283)
T ss_pred HHH
Confidence 544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=222.95 Aligned_cols=185 Identities=28% Similarity=0.454 Sum_probs=134.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH-H------hhhhhhceeee-EEecCcCCCcceeeec-
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE-R------MTHQVHRERCC-QVHLSSSRRHPLLSSE- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~------~~~~~~~~~~~-~~~~~~~~~~~~l~~~- 149 (271)
..+|++.+.||+|++|.||+|.+..+++.||+|.+........ . ........... .........+..++..
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4689999999999999999999999999999998864321111 0 00000000000 0000000111222211
Q ss_pred -cCc--------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--cccccc
Q psy4396 150 -EGY--------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH--RKTMCG 218 (271)
Q Consensus 150 -~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~g 218 (271)
.+. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... .....+
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 178 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccC
Confidence 111 236788899999999999999999999999999999999999999999999886543321 223468
Q ss_pred cccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 219 TLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 219 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+
T Consensus 179 ~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~ 223 (296)
T cd06654 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (296)
T ss_pred CccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 899999999988889999999999999999999999998776544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-33 Score=242.68 Aligned_cols=182 Identities=31% Similarity=0.523 Sum_probs=149.0
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
+-|.++..||.|+||.||+|.++.++-..|-|++.-.. ... ...+.+...++..+.||+++.+.+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEE----LEDylVEIeILa~CdHP~ivkLl~ayy~enkL 104 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEE----LEDYLVEIEILAECDHPVIVKLLSAYYFENKL 104 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhH----HhhhhhhhhhhhcCCChHHHHHHHHHhccCce
Confidence 34678899999999999999999888777778763211 111 1223444667777789977654332
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--C
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP--S 210 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~--~ 210 (271)
..+++.++..+++|++.||.|||+++|||||||..|||++.+|.++|+|||.+.... -
T Consensus 105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 348999999999999999999999999999999999999999999999999875433 2
Q ss_pred CCcccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 LHRKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
..+.++.|||.|||||+.. ..+|+.++||||||++|.||+.+.+|-...+++.++-+|
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi 247 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 247 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH
Confidence 3556789999999999874 467999999999999999999999999999998887665
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=224.53 Aligned_cols=180 Identities=25% Similarity=0.423 Sum_probs=132.5
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec----------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE---------- 149 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---------- 149 (271)
++|++++.||+|+||.||+|.+..++..||+|.+....... ....+.++ ........||+++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~e----~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES--KFNQIIME----LDILHKAVSPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH--HHHHHHHH----HHHHHhcCCCcHHhhhhheecCCeE
Confidence 46889999999999999999999899999999875321000 00011111 000011112211110
Q ss_pred -------cC------------cccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 150 -------EG------------YSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 150 -------~~------------~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
.+ ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 00 1257889999999999999999997 599999999999999999999999999987655
Q ss_pred CCCcccccccccccCcceeccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTSQ------HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
........+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 216 (286)
T cd06622 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF 216 (286)
T ss_pred CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH
Confidence 4444455688899999988544 3588999999999999999999999766554433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=222.35 Aligned_cols=183 Identities=26% Similarity=0.425 Sum_probs=136.3
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---------- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---------- 150 (271)
+|++.+.||+|++|.||+|.+..+++.||+|++........ ....+.++ ........||++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~e----~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALRE----IKALQACQHPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch-hhHHHHHH----HHHHHhCCCCCCcceeeEEecCCeeE
Confidence 58899999999999999999998899999999864321110 00011111 0111111122221111
Q ss_pred ------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--
Q psy4396 151 ------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-- 212 (271)
Q Consensus 151 ------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 212 (271)
+ ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 1 1336888999999999999999999999999999999999999999999999986554322
Q ss_pred -cccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 213 -RKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..+.+.++
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 213 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH
Confidence 2345688999999988654 4689999999999999999999999888776665554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=222.96 Aligned_cols=182 Identities=32% Similarity=0.495 Sum_probs=137.8
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++.+.||.|++|.||+|.+..+++.||+|++........ ...+..+ ........||++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQE----IQFLSQCRSPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchH--HHHHHHH----HHHHHHcCCCCeeeeeEEEEECCeE
Confidence 468889999999999999999999999999999854321000 0011111 0111111222221111
Q ss_pred --------C--------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--C
Q psy4396 151 --------G--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--H 212 (271)
Q Consensus 151 --------~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~ 212 (271)
+ ...+++..+..++.|++.||.|||+.+++||||+|+||++++++.++|+|||+++..... .
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 1 125789999999999999999999999999999999999999999999999998665432 2
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~ 209 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL 209 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 3345678899999999988899999999999999999999999987766555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=223.86 Aligned_cols=181 Identities=31% Similarity=0.461 Sum_probs=134.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.+.|++++.||+|+||.||+|++..+++.+|+|++....... ...+..+ +.......||++....+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYMVE----IEILATCNHPYIVKLLGAFYWDGK 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHH---HHHHHHH----HHHHHhCCCCcEeeeEEEEEeCCe
Confidence 467999999999999999999999999999999985432110 0111111 01111112222222111
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 123688899999999999999999999999999999999999999999999988653322
Q ss_pred --CcccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 212 --HRKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 212 --~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
......+++.|+|||++. ...++.++|+|||||++|+|++|..||...+..+.+.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 225 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 225 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH
Confidence 223345788999999984 3456889999999999999999999998776655443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=219.68 Aligned_cols=190 Identities=25% Similarity=0.405 Sum_probs=135.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhceeeeEEe-cCcCCCcceeeec--
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRERCCQVH-LSSSRRHPLLSSE-- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~l~~~-- 149 (271)
.++|++.+.||+|+||.||++.++.. ..+|+|.+......... ....+......... .........++..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccC-ceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 46789999999999999999988654 46999987643221111 11111111100000 0000111111111
Q ss_pred cC----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc---ccc
Q psy4396 150 EG----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR---KTM 216 (271)
Q Consensus 150 ~~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~~~ 216 (271)
.+ ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++....... ...
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 00 12367888999999999999999999999999999999999999999999998875432221 122
Q ss_pred cccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
.++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+..+.+..|.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~ 215 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 34568999999988889999999999999999999 999999888887776653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=220.72 Aligned_cols=189 Identities=23% Similarity=0.385 Sum_probs=134.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH------HhhhhhhceeeeEEe-cCcCCCcceeeec--
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE------RMTHQVHRERCCQVH-LSSSRRHPLLSSE-- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~l~~~-- 149 (271)
..+|++.+.||+|+||.||+|.+.. +..+|+|.+.+...... .....+......... ........+++..
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 4568899999999999999998864 55799999864322111 111111111111110 1011111122211
Q ss_pred cCc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcccc---
Q psy4396 150 EGY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM--- 216 (271)
Q Consensus 150 ~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~--- 216 (271)
.+. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++..........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 111 2367888999999999999999999999999999999999999999999999875543222222
Q ss_pred cccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+..+....+
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 23457999999998899999999999999999998 89999888777766554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=220.25 Aligned_cols=177 Identities=24% Similarity=0.398 Sum_probs=127.9
Q ss_pred ccccCCceEEEEEEE--cCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------------
Q psy4396 87 PLGTGKFGHVYLAKE--KTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------------- 150 (271)
Q Consensus 87 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------------- 150 (271)
.||+|+||.||+|.+ ..++..+|+|+++..... ......+..+ ........||++....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-PALKDELLRE----ANVMQQLDNPYIVRMIGICEAESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-HHHHHHHHHH----HHHHHhCCCCCcceEEEEEcCCCcEEEEec
Confidence 589999999999965 456788999998543211 1111111111 1111111222221111
Q ss_pred -----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc-----c
Q psy4396 151 -----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR-----K 214 (271)
Q Consensus 151 -----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~-----~ 214 (271)
....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........ .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 112368889999999999999999999999999999999999999999999999865443221 1
Q ss_pred cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
...+++.|+|||.+....++.++|+||||+++|||++ |+.||...+..++.+.|
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i 211 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 1233578999999988889999999999999999998 99999988777665544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=223.35 Aligned_cols=191 Identities=24% Similarity=0.391 Sum_probs=135.9
Q ss_pred cccCeEEecccccCCceEEEEEEEc-----CCCeEEEEEEcchhHHH------HH-HhhhhhhceeeeEE-ecCcCCCcc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYKVEII------NE-RMTHQVHRERCCQV-HLSSSRRHP 144 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~------~~-~~~~~~~~~~~~~~-~~~~~~~~~ 144 (271)
...+|.+.+.||+|+||.||++... .++..+|+|.+...... .+ .....+........ .......++
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3467999999999999999999863 34567999998542211 11 01111111111000 000111122
Q ss_pred eeeecc--C----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEe
Q psy4396 145 LLSSEE--G----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKIS 200 (271)
Q Consensus 145 ~l~~~~--~----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~ 200 (271)
+++... + ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 222211 0 0137888999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 201 DFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 201 Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
|||++....... .....+++.|+|||++.+..++.++|+|||||++|+|++ |..||......+....|
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999987543221 122335678999999998899999999999999999998 99999888877766554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=224.08 Aligned_cols=185 Identities=24% Similarity=0.409 Sum_probs=135.7
Q ss_pred cccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcc--------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP-------- 144 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 144 (271)
..++|.+.+.||+|+||.||+|.+.. +++.||+|.++...... ....+.+|. .......||
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~----~~l~~l~~~~i~~~~~~ 76 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREA----ELLTNFQHENIVKFYGV 76 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH--HHHHHHHHH----HHHHhcCCCCchheeeE
Confidence 35678999999999999999998753 35789999986432110 001111110 011111222
Q ss_pred -------eeeecc-------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC
Q psy4396 145 -------LLSSEE-------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT 192 (271)
Q Consensus 145 -------~l~~~~-------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~ 192 (271)
.++... ....+++..+..++.|++.||.+||++|++||||||+||+++
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~ 156 (280)
T cd05049 77 CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156 (280)
T ss_pred EecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc
Confidence 222110 012357788899999999999999999999999999999999
Q ss_pred CCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 193 MHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 193 ~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
.++.++|+|||++....... .....+++.|+|||++.+..++.++|+||||+++|||++ |..||...+..+..+.
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999986543211 123345788999999999999999999999999999998 9999988888776665
Q ss_pred h
Q psy4396 268 I 268 (271)
Q Consensus 268 I 268 (271)
+
T Consensus 237 ~ 237 (280)
T cd05049 237 I 237 (280)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=222.35 Aligned_cols=194 Identities=19% Similarity=0.336 Sum_probs=134.9
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHH--------HhhhhhhceeeeE-EecCcC
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINE--------RMTHQVHRERCCQ-VHLSSS 140 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~ 140 (271)
|.+..++|++.+.||+|+||.||+|.+.+ ++..||+|.+........ .....+....... ......
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34556789999999999999999998753 356799998753211100 0011111111100 001111
Q ss_pred CCcceeeecc--Cc-------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEE
Q psy4396 141 RRHPLLSSEE--GY-------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKI 199 (271)
Q Consensus 141 ~~~~~l~~~~--~~-------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl 199 (271)
..++.++... +. ..++...+..++.|++.||+|||+.|++||||||+||++++++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 1122221111 00 11345677889999999999999999999999999999999999999
Q ss_pred eeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 200 SDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 200 ~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+|||++....... .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+..+.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999986543211 112335678999999998889999999999999999998 79999988877766543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=218.45 Aligned_cols=181 Identities=37% Similarity=0.583 Sum_probs=133.5
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhce---------eeeEEecC---cCCCcceeeecc--C
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE---------RCCQVHLS---SSRRHPLLSSEE--G 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~---------~~~~~~~~---~~~~~~~l~~~~--~ 151 (271)
+.||+|+||.||+|.+..+++.||+|++.+..............+ ....+.+. ....+++++... +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 569999999999999999999999999865432211111010010 00000000 011122222211 1
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcccccccccc
Q psy4396 152 ---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDY 222 (271)
Q Consensus 152 ---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y 222 (271)
...+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++..... .....++..|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~y 159 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTPDY 159 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCcCc
Confidence 13478899999999999999999999999999999999999999999999998865443 2234578899
Q ss_pred cCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 223 LPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 223 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
+|||.+.+..++.++|+||||+++|++++|..||...+..+.+.++
T Consensus 160 ~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 205 (260)
T cd05611 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205 (260)
T ss_pred cChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999998888899999999999999999999999888877766544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=224.96 Aligned_cols=191 Identities=26% Similarity=0.469 Sum_probs=146.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH------Hhhhhhh----ceeeeEEecCcC---CCcc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE------RMTHQVH----RERCCQVHLSSS---RRHP 144 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~----~~~~~~~~~~~~---~~~~ 144 (271)
-.++|.+...+|+|.||.|.++.+..++..||||+++....-.+ .....+. +....++.+... ..|-
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 36789999999999999999999999999999999976533221 1111110 111222333222 2222
Q ss_pred eeee------------ccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-------------------
Q psy4396 145 LLSS------------EEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM------------------- 193 (271)
Q Consensus 145 ~l~~------------~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~------------------- 193 (271)
-|+. ..++..++.+.++.++.|++.++++||+.+++|.||||+|||+.+
T Consensus 167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 1221 224456899999999999999999999999999999999999832
Q ss_pred -CCCEEEeeccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHhhc
Q psy4396 194 -HEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT---TLERIF 269 (271)
Q Consensus 194 -~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~I~ 269 (271)
.-.++|+|||.|......+ ...+.|..|+|||++.+-+++..|||||+||||+|+++|...|+..++.| .+++|+
T Consensus 247 ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIl 325 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERIL 325 (415)
T ss_pred CCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhh
Confidence 1248999999998766655 45677999999999999999999999999999999999999999998777 455554
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=224.13 Aligned_cols=176 Identities=30% Similarity=0.510 Sum_probs=134.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
..+|++++.||+|+||.||+|.+..+++.||+|.+......... .+.++ ........||++....+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~e----~~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE---LIINE----ILVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHH---HHHHH----HHHHHhCCCCCEeeEEEEEecCCE
Confidence 47899999999999999999999988999999998543211110 11111 01111122332222111
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
...+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred EEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 1236778899999999999999999999999999999999999999999999986544322
Q ss_pred -cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 213 -RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 213 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.....+++.|+|||.+.+..++.++|+|||||++|++++|+.||...+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2234678899999999988899999999999999999999999976654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=220.41 Aligned_cols=192 Identities=21% Similarity=0.329 Sum_probs=136.7
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
.+..++|++.+.||+|+||.||+|.+.. +..+|+|.+......... ....+.................+++..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e 80 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTE 80 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEE
Confidence 4556789999999999999999998765 456999998653221111 111111111100000000111111111
Q ss_pred --cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc---
Q psy4396 150 --EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR--- 213 (271)
Q Consensus 150 --~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~--- 213 (271)
.+ ...+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 11 12367888999999999999999999999999999999999999999999999865433221
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.+..+....+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 12234568999999988889999999999999999999 99999988877766655
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=218.75 Aligned_cols=170 Identities=34% Similarity=0.561 Sum_probs=133.7
Q ss_pred cCeEE-ecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec---------
Q psy4396 80 SDFEV-GCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE--------- 149 (271)
Q Consensus 80 ~~~~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--------- 149 (271)
++|.+ .+.||-|-.|.|..+.++.+++.+|+|++.....-.++...+. + ...||+++.+
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw----------~-~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHW----------M-ASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhh----------h-hcCCCceEEeehhhhhhcc
Confidence 56665 4679999999999999999999999999854332211111110 0 0123322221
Q ss_pred ------------cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCEEEeecc
Q psy4396 150 ------------EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM---HEDVKISDFG 203 (271)
Q Consensus 150 ------------~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~---~~~~kl~Dfg 203 (271)
.| ...|+|.++..++.||+.|+.|||+.+|.||||||+|+|... +..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 11 134899999999999999999999999999999999999964 3568999999
Q ss_pred ccccCC-CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 204 WSVHAP-SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 204 ~a~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
+|+... .....+.|.||.|.|||++..+.|+..+|+||+||++|-|++|.+||.+.-
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 998766 344567889999999999999999999999999999999999999997653
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=218.81 Aligned_cols=193 Identities=20% Similarity=0.349 Sum_probs=137.9
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh------hhhhhceeeeEEe-cCcCCCcceee
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM------THQVHRERCCQVH-LSSSRRHPLLS 147 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~l~ 147 (271)
|++..++|.+.+.||+|+||.||+|.+.. +..+|||.+.......... ...+......... .........++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 35667899999999999999999999765 4679999986432211110 0111111100000 00000111111
Q ss_pred ec--cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc-
Q psy4396 148 SE--EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR- 213 (271)
Q Consensus 148 ~~--~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 213 (271)
.. .+ ...++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 11 11 12467888999999999999999999999999999999999999999999999865543211
Q ss_pred --ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 214 --KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
....++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+..+.++.+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 12224568999999998889999999999999999998 99999988887776665
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=219.92 Aligned_cols=191 Identities=20% Similarity=0.338 Sum_probs=135.9
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
++..++|++++.||+|+||.||+|.... ++.||+|.+......... ....+..................++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 80 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITE 80 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEE
Confidence 4556789999999999999999998654 567999988643221111 111111111000000000111111111
Q ss_pred c-------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC---c
Q psy4396 150 E-------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH---R 213 (271)
Q Consensus 150 ~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~---~ 213 (271)
. ....++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 0 11236778889999999999999999999999999999999999999999999986544211 1
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
....++..|+|||++....++.++|+||||+++||+++ |+.||.+.+..+....
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 215 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN 215 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence 12335678999999998889999999999999999998 9999988877666554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=223.48 Aligned_cols=180 Identities=28% Similarity=0.442 Sum_probs=135.3
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
..|.+.+.||+|+||.||+|.+..+++.||+|.+.............+.+| +.+.....||+++...+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~E----i~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE----VRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHH----HHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 568899999999999999999998899999998853221111111111111 11122223443332211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 124688889999999999999999999999999999999999999999999998655432
Q ss_pred ccccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 214 KTMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
....+++.|+|||++. ...++.++|+||||+++|||++|+.||...+.....
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~ 223 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH
Confidence 2345788999999874 456889999999999999999999999877665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=218.29 Aligned_cols=179 Identities=30% Similarity=0.464 Sum_probs=136.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|++.+.||.|+||.||+|.+..+++.+|+|++....... ...+.++ ..+.....||++....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~e----~~~l~~~~h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD---FEIIQQE----ISMLKECRHPNIVAYFGSYLRRDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhh---HHHHHHH----HHHHHhCCCCChhceEEEEEeCCE
Confidence 367999999999999999999999888999999986432110 1111111 11112223333222111
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 134788899999999999999999999999999999999999999999999998654432
Q ss_pred --CcccccccccccCcceeccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 212 --HRKTMCGTLDYLPPEMVTSQ---HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 212 --~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~ 212 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA 212 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 22334678899999999776 789999999999999999999999987665443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=220.31 Aligned_cols=187 Identities=28% Similarity=0.470 Sum_probs=133.5
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--H---------H-HhhhhhhceeeeEEec---CcCCCcc
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--N---------E-RMTHQVHRERCCQVHL---SSSRRHP 144 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~---------~-~~~~~~~~~~~~~~~~---~~~~~~~ 144 (271)
.+|+..+.||+|+||.||+|.+..++..||+|.+...... . + .....+.......... .......
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999999999999999987532110 0 0 0111111111110000 0000111
Q ss_pred eeee--ccC---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 145 LLSS--EEG---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 145 ~l~~--~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
.+.. ..+ ...+++.....++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 1111 111 123678888899999999999999999999999999999999999999999998644321
Q ss_pred ---CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 212 ---HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
......++..|+|||.+.+..++.++|+|||||++||+++|+.||...+..+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~ 219 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH
Confidence 1123457889999999998889999999999999999999999998776555443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=242.75 Aligned_cols=101 Identities=29% Similarity=0.473 Sum_probs=88.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC---cccccccccccCcceeccCCC
Q psy4396 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH---RKTMCGTLDYLPPEMVTSQHY 233 (271)
Q Consensus 157 ~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 233 (271)
...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... .....||+.|+|||++.+..+
T Consensus 266 ~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 345 (501)
T PHA03210 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345 (501)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC
Confidence 45677899999999999999999999999999999999999999999997654322 224578999999999999999
Q ss_pred CCchhHHHHHHHHHHHHhCCC-CCC
Q psy4396 234 GKEVDNWCIGILAYEFLVGKP-PFE 257 (271)
Q Consensus 234 ~~~~DiwslG~il~el~~g~~-pf~ 257 (271)
+.++|||||||++|||++|.. ||.
T Consensus 346 ~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 346 CEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 999999999999999999875 443
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=222.06 Aligned_cols=178 Identities=29% Similarity=0.491 Sum_probs=136.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
.+|++.+.||.|++|.||+|.+..+++.||+|.+........ ..+.++ ........||+++...+.
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINE----ILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchH---HHHHHH----HHHHHhcCCCceeeeeeeEecCceE
Confidence 569999999999999999999999999999998854221110 011111 111111233332222111
Q ss_pred ------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--
Q psy4396 153 ------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-- 212 (271)
Q Consensus 153 ------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 212 (271)
..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 236889999999999999999999999999999999999999999999999886543322
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
.....+++.|+|||.+.+..++.++|+|||||++|++++|+.||...+..+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~ 223 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2334678899999999988899999999999999999999999988776544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=224.65 Aligned_cols=190 Identities=25% Similarity=0.384 Sum_probs=138.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH---------HhhhhhhceeeeEE-e--cCcCCCccee
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---------RMTHQVHRERCCQV-H--LSSSRRHPLL 146 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~~~~~~~~~-~--~~~~~~~~~l 146 (271)
.++|++.+.||+|+||.||+|.+..+++.+|+|.++....... .....+........ . ......++++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4679999999999999999999999999999999864321110 00011111110000 0 0000022222
Q ss_pred eeccC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Cc
Q psy4396 147 SSEEG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HR 213 (271)
Q Consensus 147 ~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~ 213 (271)
+.... ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 21110 123788999999999999999999999999999999999999999999999998765442 22
Q ss_pred ccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 214 KTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+.+.++
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 234578899999988654 4688999999999999999999999988877766554
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=219.80 Aligned_cols=188 Identities=25% Similarity=0.409 Sum_probs=136.8
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH--HH------hhhhhhceeeeE-EecCcCCCcceeeecc-
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN--ER------MTHQVHRERCCQ-VHLSSSRRHPLLSSEE- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~------~~~~~~~~~~~~-~~~~~~~~~~~l~~~~- 150 (271)
+|++.+.||.|+||.||++.+..+++.+|+|.++...... .. ....+....... ........+.+++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999999999999999875321110 00 001111110000 0000011111111111
Q ss_pred ------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Ccccc
Q psy4396 151 ------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTM 216 (271)
Q Consensus 151 ------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~ 216 (271)
....+++..+..++.|++.||.+||++|++|+||||+||++++++.++|+|||++...... .....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 1123678889999999999999999999999999999999999999999999998654332 22335
Q ss_pred cccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 212 (255)
T cd08219 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212 (255)
T ss_pred cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH
Confidence 6888999999999888999999999999999999999999988776655443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=222.28 Aligned_cols=182 Identities=30% Similarity=0.502 Sum_probs=134.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+| +.......||++....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMRE----IRMLKQLRHENLVNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHH----HHHHHhcCCcchhhHHHhcccCCeE
Confidence 46899999999999999999999889999999875432111 011111111 11122223333222111
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
...+++..+..++.|++.||+|||+.|++||||+|+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 123688999999999999999999999999999999999999999999999998654332
Q ss_pred CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 212 HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
......++..|+|||++.+ ..++.++|+||||+++|||++|+.||...+..+...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~ 211 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY 211 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence 1223457889999998865 346889999999999999999999998776654433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=224.72 Aligned_cols=189 Identities=25% Similarity=0.434 Sum_probs=134.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH--------H-HhhhhhhceeeeE-EecCcC-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN--------E-RMTHQVHRERCCQ-VHLSSS------- 140 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~-~~~~~~~~~~~~~-~~~~~~------- 140 (271)
.+++|++.+.||+|+||.||+|.+..+++.||||.+....... + .....+....... ......
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4678999999999999999999999999999999874321100 0 0111111110000 000000
Q ss_pred -CCcceeeeccC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 141 -RRHPLLSSEEG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 141 -~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..+.+++.... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 00111111111 124788999999999999999999999999999999999999999999999998644
Q ss_pred CCCC------cccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 209 PSLH------RKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 209 ~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~ 234 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT 234 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 3211 1234467889999988664 46889999999999999999999998877665443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=224.77 Aligned_cols=182 Identities=20% Similarity=0.342 Sum_probs=133.9
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCe----EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQI----MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
..++|+..+.||+|+||.||+|.+..++. .+|+|.+......... ..+.++ ........||+++...+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e----~~~~~~l~h~niv~~~~~~ 78 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN--VEFMDE----ALIMASMDHPHLVRLLGVC 78 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHH--HHHHHH----HHHHHhCCCCCcccEEEEE
Confidence 45778999999999999999999877665 4788887543211100 011111 111222234433322211
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 79 ~~~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 79 LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred cCCCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 1357788899999999999999999999999999999999999999999999875
Q ss_pred CCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy4396 208 APSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTL 265 (271)
Q Consensus 208 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 265 (271)
..... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||.+....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~ 221 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP 221 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 43221 112335678999999998889999999999999999997 99999877665543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=222.49 Aligned_cols=179 Identities=28% Similarity=0.405 Sum_probs=133.6
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
..++|.+.+.||+|+||.||+|++..+++.||+|+++....... ..+.++ ........||++....
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~e----~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF---AVVQQE----IIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHH---HHHHHH----HHHHHhCCCCCeeeEEEEEEeCC
Confidence 34679999999999999999999999999999999754321110 001111 0111111233221111
Q ss_pred -------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 151 -------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 151 -------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 1134788999999999999999999999999999999999999999999999998654322
Q ss_pred --CcccccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 212 --HRKTMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 212 --~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
......|++.|+|||++. ...++.++|+|||||++|+|++|..||....+..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~ 216 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh
Confidence 223356899999999874 4568899999999999999999999997655433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=221.03 Aligned_cols=186 Identities=29% Similarity=0.387 Sum_probs=134.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH-----HHH-HhhhhhhceeeeEEecCcC---------CCc
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI-----INE-RMTHQVHRERCCQVHLSSS---------RRH 143 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~~---------~~~ 143 (271)
.+.|++.+.||+|+||.||+|.+..+++.||+|++..... ..+ .....+... ...+..... ..+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h-~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHH-RNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCC-CCeeeEeeEEeecCCCCCCcE
Confidence 4678889999999999999999999999999999854211 111 011111000 000110000 011
Q ss_pred ceeeecc-------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 144 PLLSSEE-------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 144 ~~l~~~~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
.+++... ....+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 1122111 113478888999999999999999999999999999999999999999999999865432
Q ss_pred --CCcccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 211 --LHRKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.......|++.|+|||++. ...++.++|+|||||++|||++|+.||.........
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~ 225 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 2233456889999999885 345788999999999999999999999766554433
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=221.63 Aligned_cols=178 Identities=27% Similarity=0.399 Sum_probs=132.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++.+.||+|+||.||+|++..+++.||+|++......... ...+| +.......||++....
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~---~~~~e----~~~l~~~~h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS---LIQQE----IFMVKECKHCNIVAYFGSYLSREK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHH---HHHHH----HHHHHhcCCCCeeeeeEEEEeCCE
Confidence 46799999999999999999999999999999998542111000 01111 0111111222222111
Q ss_pred ------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 151 ------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 151 ------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 1134678889999999999999999999999999999999999999999999998755322
Q ss_pred -CcccccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 212 -HRKTMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
......+++.|+|||.+. ...++.++|+|||||++|||++|+.||...++.+
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~ 216 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh
Confidence 223456788999999874 3457889999999999999999999997655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=222.66 Aligned_cols=183 Identities=22% Similarity=0.409 Sum_probs=130.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH-------HHH-HhhhhhhceeeeEE-ecCcCCCcceeeec
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI-------INE-RMTHQVHRERCCQV-HLSSSRRHPLLSSE 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~~ 149 (271)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... .++ .....+........ .......+..++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 3679999999999999999999999899999999853211 000 01111111110000 00001111111111
Q ss_pred c-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Ccccc
Q psy4396 150 E-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTM 216 (271)
Q Consensus 150 ~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~ 216 (271)
. ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++..... .....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07870 84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163 (291)
T ss_pred cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence 0 0123567788899999999999999999999999999999999999999999998654322 22334
Q ss_pred cccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 217 CGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 217 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 57889999999875 4578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=219.60 Aligned_cols=184 Identities=21% Similarity=0.349 Sum_probs=135.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----- 150 (271)
.++|++.+.||+|+||.||+|.+..+ ...||+|.++....... ...+..| +.......||++....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~--~~~~~~e----~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ--RLDFLTE----ASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHH--HHHHHHH----HHHHHhCCCCCcceEeEEEec
Confidence 46799999999999999999998643 45799998754321110 0011111 1111112233222111
Q ss_pred ------------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 151 ------------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 151 ------------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
+ ...+++..+..++.|++.||+|||+++++||||||+||++++++.++|+|||++...
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 1 124688899999999999999999999999999999999999999999999998765
Q ss_pred CCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 209 PSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.... .....+++.|+|||.+.+..++.++|+||||+++|++++ |..||......+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 3111 112234678999999998899999999999999999998 99999888877766654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=236.83 Aligned_cols=185 Identities=24% Similarity=0.411 Sum_probs=152.8
Q ss_pred cCe-EEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH-HHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 80 SDF-EVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-ERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 80 ~~~-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
++| .....||+|+|-+||+|.+..+|.+||--.++-..+.. +...+.+..| ++++..+.||+|++++..
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~E----v~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSE----VHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHH----HHHHccCCCCceeeeeeheecCC
Confidence 344 45678999999999999999999989876554443332 3334455555 778888899999887654
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCC-CCEEEeeccccc
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTMH-EDVKISDFGWSV 206 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~~-~~~kl~Dfg~a~ 206 (271)
..+..+.++.|++||++||.|||++. |||||||.+||+|+.+ |.|||+|+|+|.
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence 22567889999999999999999985 9999999999999754 899999999998
Q ss_pred cCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHhhc
Q psy4396 207 HAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ-DTTLERIF 269 (271)
Q Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~I~ 269 (271)
.....+.....|||.|||||+.. +.|+..+||||||+++.||+|+.-||..+.. .++|+++.
T Consensus 195 l~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~ 257 (632)
T KOG0584|consen 195 LLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT 257 (632)
T ss_pred HhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH
Confidence 87777777789999999999998 7799999999999999999999999988764 45677664
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=220.28 Aligned_cols=182 Identities=29% Similarity=0.528 Sum_probs=134.4
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH------HHHhhhhhhceeeeEEecCcCCCcceeeecc----
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII------NERMTHQVHRERCCQVHLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---- 150 (271)
+|.+.+.||+|++|.||+|.+..+++.+|+|.+...... .......+.++ ........||++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE----IALLKELQHENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHH----HHHHHhcCCCCeeeEEEEEE
Confidence 467788999999999999999888899999987532111 00111111111 1111122233222211
Q ss_pred -------------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 151 -------------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 151 -------------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
+ ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 1 134678888999999999999999999999999999999999999999999988654
Q ss_pred CCC--------CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 209 PSL--------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 209 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH
Confidence 321 1122357889999999998889999999999999999999999998776655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=224.65 Aligned_cols=185 Identities=29% Similarity=0.459 Sum_probs=135.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
+++|++.+.||+|+||.||+|.+..+++.+|+|.+........ ......+| ........||++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALRE----IKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHH----HHHHHhcCCCCccchhhheecccc
Confidence 6899999999999999999999999999999998743211000 00000000 0011111222211110
Q ss_pred --------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 151 --------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 151 --------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
....+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||+
T Consensus 82 ~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 113478999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCc-------------ccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLHR-------------KTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~~-------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
+........ ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|++||.+.+.....+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 864332111 12345788999998765 45789999999999999999999999988776665544
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=218.85 Aligned_cols=176 Identities=28% Similarity=0.481 Sum_probs=131.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcce--------------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL-------------- 145 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 145 (271)
++|++.+.||+|+||.||+|.+..+++.||+|.++............+.+|. .......|++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei----~~l~~~~~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEI----DLLKQLDHPNVIKYLASFIENNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHH----HHHHhCCCCCeeeeeeeeecCCeE
Confidence 5799999999999999999999989999999987532211111111111110 0111111221
Q ss_pred -eee--cc-------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 146 -LSS--EE-------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 146 -l~~--~~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
++. .. ....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 111 11 11236788899999999999999999999999999999999999999999999986543
Q ss_pred CC--CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 210 SL--HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 32 223346788999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=220.50 Aligned_cols=181 Identities=27% Similarity=0.427 Sum_probs=133.7
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC---------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG--------- 151 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--------- 151 (271)
+|++++.||.|++|.||+|++..+++.||||.+....... .....+.+| +.......||++....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E----~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIRE----ISLLKELNHPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHH----HHHHHhcCCCCCcchhhhcccCCcEE
Confidence 4889999999999999999999999999999885322110 000011111 11111222333222111
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 1346788899999999999999999999999999999999999999999999986543221
Q ss_pred -cccccccccccCcceeccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 213 -RKTMCGTLDYLPPEMVTSQH-YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 213 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||.+.+..+...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 22334688999999887654 5889999999999999999999998877655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=222.71 Aligned_cols=182 Identities=25% Similarity=0.477 Sum_probs=131.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH-------HH-HhhhhhhceeeeEE-ecCcCCCcceeeec
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII-------NE-RMTHQVHRERCCQV-HLSSSRRHPLLSSE 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~~ 149 (271)
+++|++.+.||+|++|.||+|.++.+++.||+|.+...... ++ .....+........ .......++.++..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999999988999999997532110 00 11111111111000 01111112222211
Q ss_pred cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Ccccc
Q psy4396 150 EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTM 216 (271)
Q Consensus 150 ~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~ 216 (271)
.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++..... .....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07844 84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE 163 (291)
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccccc
Confidence 10 124678899999999999999999999999999999999999999999999998654321 11223
Q ss_pred cccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 217 CGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 217 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
.++..|+|||++.+ ..++.++|+||+|+++|+|++|+.||.+..
T Consensus 164 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 46789999998865 457899999999999999999999997665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=224.47 Aligned_cols=196 Identities=22% Similarity=0.378 Sum_probs=136.4
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCC-------CeEEEEEEcchhHHHH--HHh------hhhh-hceeeeE-
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT-------QIMIALKVLYKVEIIN--ERM------THQV-HRERCCQ- 134 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~--~~~------~~~~-~~~~~~~- 134 (271)
...+.+..++|.+.+.||+|+||.||+|.+... ...+|+|.++...... ... ...+ .......
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 345666778999999999999999999987532 2469999986431100 000 0001 0000000
Q ss_pred EecCcCCCcceeeecc--C-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q psy4396 135 VHLSSSRRHPLLSSEE--G-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPE 187 (271)
Q Consensus 135 ~~~~~~~~~~~l~~~~--~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~ 187 (271)
..........+++... + ...++...+..++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 0000000111111110 0 013677888999999999999999999999999999
Q ss_pred ceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy4396 188 NLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQD 262 (271)
Q Consensus 188 Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~ 262 (271)
||+++.++.++|+|||++....... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...+..
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999999986543211 111224568999999988889999999999999999998 99999888776
Q ss_pred HHHHh
Q psy4396 263 TTLER 267 (271)
Q Consensus 263 ~~~~~ 267 (271)
+..+.
T Consensus 250 ~~~~~ 254 (307)
T cd05098 250 ELFKL 254 (307)
T ss_pred HHHHH
Confidence 66554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=221.31 Aligned_cols=179 Identities=30% Similarity=0.474 Sum_probs=133.0
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC----------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG---------- 151 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---------- 151 (271)
|++.+.||+|+||.||+|.+..++..+|+|.+........ ..+.++ +.......||++....+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~e----~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL---EDYMVE----IDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHH---HHHHHH----HHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 6788899999999999999999999999999854321110 001111 01111112222221110
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--C
Q psy4396 152 -----------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--H 212 (271)
Q Consensus 152 -----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~ 212 (271)
...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... .
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 134688899999999999999999999999999999999999999999999998654332 2
Q ss_pred cccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 213 RKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
.....+++.|+|||++. +..++.++|+|||||++|+|++|+.||...+..+....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 219 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH
Confidence 23356889999999884 44578899999999999999999999988776655443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=222.55 Aligned_cols=184 Identities=28% Similarity=0.457 Sum_probs=135.5
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--HHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--NERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... .......+..+ ........|++++...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e----~~~l~~~~h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALRE----IKLLQELKHPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHH----HHHHhhcCCCCChhhhheeecCCE
Confidence 478889999999999999999988999999998654321 00000011111 0111111222221111
Q ss_pred -----------------Cc-ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 151 -----------------GY-SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 151 -----------------~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 77 INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 11 25789999999999999999999999999999999999999999999999998765432
Q ss_pred -CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 -HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+.++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~ 215 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH
Confidence 2223346788999998854 45789999999999999999999999887776655544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=217.48 Aligned_cols=190 Identities=22% Similarity=0.396 Sum_probs=135.7
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH-----HhhhhhhceeeeEEe--cCcCCCcceeee
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE-----RMTHQVHRERCCQVH--LSSSRRHPLLSS 148 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 148 (271)
.+...+|++.+.||+|+||.||++... +..+|+|.++....... .....+......... ........+++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 345678999999999999999999876 45699999864322111 111111111111000 000111122221
Q ss_pred cc--C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCccc
Q psy4396 149 EE--G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT 215 (271)
Q Consensus 149 ~~--~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 215 (271)
.. + ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 158 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DT 158 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-CC
Confidence 11 1 1236778889999999999999999999999999999999999999999999987544332 22
Q ss_pred ccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 216 MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+..++...+
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~ 212 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 212 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 344678999999988889999999999999999997 99999887776665443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=223.15 Aligned_cols=190 Identities=24% Similarity=0.428 Sum_probs=137.1
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEc-------CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCC-Ccc
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEK-------TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR-RHP 144 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 144 (271)
..+.+...+|.+.+.||+|+||.||+|+.. .++..||+|.+........ ...+..|. ...... .||
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~--~~~~~~E~----~~l~~l~~h~ 81 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEM----EMMKMIGKHK 81 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHH--HHHHHHHH----HHHHhhccCC
Confidence 356777889999999999999999999753 2345799998854211100 00011110 000000 122
Q ss_pred eeeecc-----------------C-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy4396 145 LLSSEE-----------------G-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHR 182 (271)
Q Consensus 145 ~l~~~~-----------------~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHr 182 (271)
++.... + ...++...+..++.|++.||.|||++|++||
T Consensus 82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred CchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 211110 0 0125667788899999999999999999999
Q ss_pred cCCCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy4396 183 DIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFE 257 (271)
Q Consensus 183 Dikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~ 257 (271)
||||+||+++.++.+||+|||+++...... .....+++.|+|||++.+..++.++|+||||+++|++++ |..||.
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999987654321 122335678999999988889999999999999999998 899999
Q ss_pred CCCHHHHHHhh
Q psy4396 258 SKDQDTTLERI 268 (271)
Q Consensus 258 ~~~~~~~~~~I 268 (271)
+.+..++.+.+
T Consensus 242 ~~~~~~~~~~~ 252 (304)
T cd05101 242 GIPVEELFKLL 252 (304)
T ss_pred cCCHHHHHHHH
Confidence 88888776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=217.43 Aligned_cols=181 Identities=24% Similarity=0.371 Sum_probs=134.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++.+.||+|+||.||+|++... ..+|+|.+......... +.++ ........||++....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~~~~~~----~~~e----~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDE----FIEE----AKVMMKLSHEKLVQLYGVCTKQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCcccHHH----HHHH----HHHHhcCCCCCeeeEEEEEccCCC
Confidence 46799999999999999999987654 45999988653221111 1111 0111111222221111
Q ss_pred ---------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 151 ---------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 151 ---------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
+ ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 1 124688899999999999999999999999999999999999999999999988654332
Q ss_pred Ccc---cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 212 HRK---TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 ~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
... ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+...++
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 211 1234568999999988889999999999999999998 99999888877666555
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=220.55 Aligned_cols=191 Identities=24% Similarity=0.360 Sum_probs=133.8
Q ss_pred cccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHH--------HhhhhhhceeeeEEe-cCcCCCc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINE--------RMTHQVHRERCCQVH-LSSSRRH 143 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~~~ 143 (271)
..++|.+.+.||+|++|.||+|.+.. ++..||+|.+........ .....+......... .......
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34679999999999999999999987 678899998753211100 001111111000000 0000011
Q ss_pred ceeee--ccCc----------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC---CEEEeec
Q psy4396 144 PLLSS--EEGY----------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE---DVKISDF 202 (271)
Q Consensus 144 ~~l~~--~~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~---~~kl~Df 202 (271)
..++. ..+. ..+++..+..++.|++.||+|||+++++||||||+||+++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 11111 1110 1367888899999999999999999999999999999998665 5899999
Q ss_pred cccccCCCCCc----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 203 GWSVHAPSLHR----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 203 g~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
|+++....... .....+..|+|||++.+..++.++|||||||++|||++ |+.||.+.+.++..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~ 234 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99876532211 12223568999999998889999999999999999997 99999988877766544
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-33 Score=220.68 Aligned_cols=192 Identities=24% Similarity=0.414 Sum_probs=137.7
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchh---------HHHHHHhhhhhhceee-eEEecCcC------
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKV---------EIINERMTHQVHRERC-CQVHLSSS------ 140 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~~~~~~~~-~~~~~~~~------ 140 (271)
...+.|+-...||+|.||.||+|+.+++++.||+|..--. .+..-.....+..+.. ..+.+...
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 3457788889999999999999999999999999864210 0000011111111100 00000000
Q ss_pred ------------CCcceeeeccC-cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 141 ------------RRHPLLSSEEG-YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 141 ------------~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..|++.-.+.. ...++..++++++.+++.||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 11111000000 13378999999999999999999999999999999999999999999999999954
Q ss_pred CCCCC------cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 208 APSLH------RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 208 ~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
..... .+..+-|+.|++||.+.+ ..|+++.|+|+.|||+.||++|.+-|++.++++++..|
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 32221 223445999999998876 56899999999999999999999999999999988765
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=223.44 Aligned_cols=177 Identities=26% Similarity=0.410 Sum_probs=130.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|...+.||+|+||.||++.+..+++.+|+|.+........ ...+..+... +.....||+++...
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~e~~~---l~~~~~~~~iv~~~~~~~~~~~ 77 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE--QKRLLMDLDV---VMRSSDCPYIVKFYGALFREGD 77 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHH--HHHHHHHHHH---HHHhcCCCCEeeeeeEEecCCc
Confidence 4567778899999999999999999999999999864321100 0000011000 00000122211111
Q ss_pred ----------------------CcccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 151 ----------------------GYSLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 151 ----------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 113477888999999999999999985 999999999999999999999999999865
Q ss_pred CCC-CCcccccccccccCcceeccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 208 APS-LHRKTMCGTLDYLPPEMVTSQ---HYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 208 ~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
... .......+++.|+|||++.+. .++.++|+||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 432 222334678899999998766 68999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=217.00 Aligned_cols=191 Identities=21% Similarity=0.346 Sum_probs=135.4
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH------HhhhhhhceeeeEEecCcCCCcceeeec-
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE------RMTHQVHRERCCQVHLSSSRRHPLLSSE- 149 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~~- 149 (271)
+..++|++.+.||+|++|.||+|.+..++ .+|+|.+........ .....+..................++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEF 81 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEc
Confidence 34567999999999999999999987765 499998754322111 1111111111000000000111112111
Q ss_pred -cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc---c
Q psy4396 150 -EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR---K 214 (271)
Q Consensus 150 -~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 214 (271)
.+ ...+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++........ .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 11 12257788899999999999999999999999999999999999999999999865432211 1
Q ss_pred cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
...++..|+|||...+..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 2335678999999988889999999999999999999 99999988777765554
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=226.14 Aligned_cols=183 Identities=28% Similarity=0.433 Sum_probs=135.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec---------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE--------- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--------- 149 (271)
.++|++++.||+|+||.||+|.+..++..||||++...... ......+.+| +.......||+++..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-ELFAKRAYRE----LRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHH----HHHHHhcCCCCccceeeeecCCcc
Confidence 46799999999999999999999999999999988532110 0000011111 011111122221111
Q ss_pred ---------------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 150 ---------------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 150 ---------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.....+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 89 ~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 89 LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ccccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 01135789999999999999999999999999999999999999999999999998755
Q ss_pred CCCCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 209 PSLHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||.+.+....+..
T Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 227 (343)
T cd07880 169 DSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227 (343)
T ss_pred ccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 432 223457889999998876 4578999999999999999999999988776554443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=225.59 Aligned_cols=187 Identities=29% Similarity=0.445 Sum_probs=134.2
Q ss_pred CeEEecccccCCceEEEEEEEcCC--CeEEEEEEcchhH--------HHHH-HhhhhhhceeeeEEecC-------cCCC
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTT--QIMIALKVLYKVE--------IINE-RMTHQVHRERCCQVHLS-------SSRR 142 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~--------~~~~-~~~~~~~~~~~~~~~~~-------~~~~ 142 (271)
+|++.+.||+|+||.||++++..+ +..||+|.+.... ...+ .....+... ...+.+. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH-KNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCC-CChheeeeeeeeccccCC
Confidence 488999999999999999999888 8899999875321 0001 111111000 0000100 0001
Q ss_pred cceeeec----------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 143 HPLLSSE----------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 143 ~~~l~~~----------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
+.++... .....+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 1111111 12244788999999999999999999999999999999999999999999999998654321
Q ss_pred -----CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 -----HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 -----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
......||+.|+|||.+.+ ..++.++|+||||+++|++++|..||...+....+..+
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~ 222 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI 222 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHH
Confidence 1223468899999998765 56899999999999999999999999887765555443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=216.93 Aligned_cols=177 Identities=37% Similarity=0.607 Sum_probs=133.8
Q ss_pred cccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----------------
Q psy4396 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----------------- 150 (271)
Q Consensus 88 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----------------- 150 (271)
||.|++|.||+|++..+++.+|+|++.+...........+.++ ........||++....
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSE----KEILEECNHPFIVKLYRTFKDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHH----HHHHHhCCCCCEeeeeeeEEcCCccEEEEecCC
Confidence 6999999999999998899999999865432221111122222 1111222233322211
Q ss_pred ---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-Ccccccccc
Q psy4396 151 ---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-HRKTMCGTL 220 (271)
Q Consensus 151 ---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~gt~ 220 (271)
....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...... ......+++
T Consensus 77 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 77 GGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCc
Confidence 1134688889999999999999999999999999999999999999999999998765443 223356789
Q ss_pred cccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHhh
Q psy4396 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD--QDTTLERI 268 (271)
Q Consensus 221 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~I 268 (271)
.|+|||.+.+..++.++|+||||+++|++++|..||...+ ..+.+.++
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 206 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence 9999999988889999999999999999999999998777 55555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=220.18 Aligned_cols=194 Identities=20% Similarity=0.342 Sum_probs=134.8
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHHH--------hhhhhhceeee-EEecCcC
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINER--------MTHQVHRERCC-QVHLSSS 140 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~~ 140 (271)
|++..++|++.+.||+|+||.||+|..+. .+..||+|.+......... ....+...... .......
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45566889999999999999999997652 3457999987533211110 00111111000 0011111
Q ss_pred CCcceeeeccC---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEE
Q psy4396 141 RRHPLLSSEEG---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKI 199 (271)
Q Consensus 141 ~~~~~l~~~~~---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl 199 (271)
....+++.... ....+...+..++.|++.||.|||+++++||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 11222222110 112345667889999999999999999999999999999999999999
Q ss_pred eeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 200 SDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 200 ~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+|||+++...... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+..+.+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999986543211 122234678999999998889999999999999999998 89999988877766654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=222.64 Aligned_cols=189 Identities=23% Similarity=0.359 Sum_probs=131.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCe--EEEEEEcchhHH-------HHH-Hhhhhh-hceeeeEE-ecCcCCCcceee
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQI--MIALKVLYKVEI-------INE-RMTHQV-HRERCCQV-HLSSSRRHPLLS 147 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~-------~~~-~~~~~~-~~~~~~~~-~~~~~~~~~~l~ 147 (271)
++|++.+.||+|+||.||+|....++. .+++|.++.... ..+ .....+ ........ ..........++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999877653 468888753110 000 000011 00000000 000000000011
Q ss_pred ec--c-------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEe
Q psy4396 148 SE--E-------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKIS 200 (271)
Q Consensus 148 ~~--~-------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~ 200 (271)
.. . ....+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 00 0 01236778899999999999999999999999999999999999999999
Q ss_pred eccccccCCCCC-cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 201 DFGWSVHAPSLH-RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 201 Dfg~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
|||++....... ......+..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+..+++
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred CcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999986433211 111223557999999998889999999999999999997 99999988887766654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=219.07 Aligned_cols=180 Identities=31% Similarity=0.508 Sum_probs=134.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|++.+.||+|+||.||+|.+..+++.||+|.++..... ......+.+| ........|+++....+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e----~~~l~~l~~~~i~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALRE----VKVLRQLRHENIVNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHH----HHHHHhcCCCCeeehhheEEECCEE
Confidence 4699999999999999999999999999999988643211 0000111111 01111112222211111
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 1236788999999999999999999999999999999999999999999999986544322
Q ss_pred --cccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 213 --RKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 213 --~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
.....++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+.+..+.
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~ 210 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ 210 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2234578899999999887 789999999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=216.43 Aligned_cols=187 Identities=26% Similarity=0.446 Sum_probs=137.0
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH---------HhhhhhhceeeeEE---ecCcCCCcceeee
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---------RMTHQVHRERCCQV---HLSSSRRHPLLSS 148 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 148 (271)
+|++.+.||.|+||.||+|.+..+++.+|+|++........ .....+........ ..........+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58889999999999999999999999999999854321111 00111111111100 0000111111111
Q ss_pred cc--C-------------cccCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 149 EE--G-------------YSLYTEKDAAKYIYQVADAIHYCH-----QKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 149 ~~--~-------------~~~~~~~~~~~~~~qi~~~L~~LH-----~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.. + ...+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 11 1 134678889999999999999999 889999999999999999999999999998765
Q ss_pred CCCC--cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 209 PSLH--RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 209 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
.... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 221 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK 221 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH
Confidence 5433 2345688999999999988899999999999999999999999998876655444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=225.80 Aligned_cols=182 Identities=26% Similarity=0.436 Sum_probs=130.0
Q ss_pred CeEEecccccCCceEEEEEEEcC--CCeEEEEEEcchhH-----H----HHH-HhhhhhhceeeeE-EecCcCC--Ccce
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKT--TQIMIALKVLYKVE-----I----INE-RMTHQVHRERCCQ-VHLSSSR--RHPL 145 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~----~~~-~~~~~~~~~~~~~-~~~~~~~--~~~~ 145 (271)
+|.+.+.||+|+||.||+|.+.. +++.||+|.+.... . ..+ .....+....... ....... .+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47889999999999999999988 78999999987622 0 000 0111111110000 0000000 1111
Q ss_pred eeeccC---------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC----CCCEEEeeccccc
Q psy4396 146 LSSEEG---------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM----HEDVKISDFGWSV 206 (271)
Q Consensus 146 l~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~----~~~~kl~Dfg~a~ 206 (271)
++.... ...+++..+..++.|++.||.|||+.+++||||||+||+++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 111110 124678889999999999999999999999999999999999 8999999999986
Q ss_pred cCCCCC-----cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 207 HAPSLH-----RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 207 ~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
...... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 543221 223457889999998766 45789999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=221.23 Aligned_cols=182 Identities=32% Similarity=0.471 Sum_probs=135.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++.+.||.|+||.||+|.+..++..+|+|++........ ..+..| +.+.....||++....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL---EDFMVE----IDILSECKHPNIVGLYEAYFYENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHH---HHHHHH----HHHHHhCCCCceeEEEEEEecCCe
Confidence 4679999999999999999999998899999999853321110 011111 0111111233222211
Q ss_pred ---------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 151 ---------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 151 ---------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
+ ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 1 124788999999999999999999999999999999999999999999999987554322
Q ss_pred --CcccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 212 --HRKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 212 --~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...+..+.+.+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~ 219 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK 219 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH
Confidence 223456889999999874 34567899999999999999999999988776665443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=219.58 Aligned_cols=185 Identities=22% Similarity=0.338 Sum_probs=135.6
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCe----EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQI----MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--- 150 (271)
...+|++.+.||+|+||.||+|.++.++. .+|+|.+....... ....+.++ ........||++....
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e----~~~l~~l~h~~i~~~~~~~ 78 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK--ANKEILDE----AYVMASVDHPHVVRLLGIC 78 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHH--HHHHHHHH----HHHHHhCCCCCcceEEEEE
Confidence 34789999999999999999999876553 68999875432110 00111111 1111111233222111
Q ss_pred -------------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 151 -------------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 151 -------------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 79 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 79 LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred ecCceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 1 12367889999999999999999999999999999999999999999999999875
Q ss_pred CCCCCc----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 208 APSLHR----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 208 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
...... ....++..|+|||.+....++.++|+||||+++||+++ |+.||.+....++...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 224 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 443211 11223568999999988889999999999999999998 99999988877765544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=218.37 Aligned_cols=184 Identities=23% Similarity=0.420 Sum_probs=138.0
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee----------
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL---------- 146 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---------- 146 (271)
....+|++++.||.|+||.||+|.+.. +..+|+|++......... .+..+. .......||++
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~---~~~~e~----~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQ---DFQKEV----QALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHH---HHHHHH----HHHhcCCCcchhheeeeEecC
Confidence 345679999999999999999999988 778999998654321110 111110 01111122221
Q ss_pred -----eec--c-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 147 -----SSE--E-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 147 -----~~~--~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
+.. . ....++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence 111 0 1123678889999999999999999999999999999999999999999999998655
Q ss_pred CCCC--cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 209 PSLH--RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.... .....++..|+|||.+....++.++|+||||+++|+|++ |+.||...+..+++..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 4321 122335678999999988889999999999999999998 89999988887776654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=230.58 Aligned_cols=109 Identities=28% Similarity=0.494 Sum_probs=93.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceecc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTS 230 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~ 230 (271)
+++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++...... .....+++.|+|||.+.+
T Consensus 234 l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 313 (400)
T cd05105 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD 313 (400)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence 5667778899999999999999999999999999999999999999999986543221 122345678999999998
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 231 QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 231 ~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
..++.++|||||||++|||++ |..||......+
T Consensus 314 ~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 314 NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 889999999999999999997 999998765443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=215.18 Aligned_cols=175 Identities=32% Similarity=0.519 Sum_probs=136.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|++.+.||+|+||.||+|.+..+++.+|+|.+...... . .+.+|. .......||++....+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~----~~~~e~----~~~~~l~~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-Q----EIIKEI----SILKQCDSPYIVKYYGSYFKNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHH-H----HHHHHH----HHHHhCCCCcEeeeeeeeecCCcE
Confidence 6799999999999999999999988899999998654321 1 111110 1111113332222111
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
...+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 1346889999999999999999999999999999999999999999999999987654332
Q ss_pred --cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 213 --RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
.....++..|+|||++.+..++.++|+||||+++|+|++|+.||...++.+
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 233457889999999998899999999999999999999999998765544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=220.04 Aligned_cols=191 Identities=17% Similarity=0.270 Sum_probs=135.3
Q ss_pred ccccCeEEecccccCCceEEEEEEEcC----CCeEEEEEEcchhHHHH--HHh------hhhhhceeeeEE-e-cCcCCC
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKT----TQIMIALKVLYKVEIIN--ERM------THQVHRERCCQV-H-LSSSRR 142 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~--~~~------~~~~~~~~~~~~-~-~~~~~~ 142 (271)
+..++|++.+.||+|+||.||+|.+.. ++..||+|.+....... ... ...+........ . ......
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345789999999999999999999876 35789999875321110 000 000111100000 0 000001
Q ss_pred cceeeecc-------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 143 HPLLSSEE-------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 143 ~~~l~~~~-------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
.+++.... ....+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 11111110 00336788899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCc----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 204 WSVHAPSLHR----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 204 ~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
+++....... ....++..|+|||++.+..++.++||||||+++||+++ |+.||...+..++...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 231 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY 231 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 9875432211 12335678999999988889999999999999999998 9999988877666544
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=216.06 Aligned_cols=177 Identities=25% Similarity=0.377 Sum_probs=127.9
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+| ..+.....||++....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP--DLKAKFLQE----ARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH--HHHHHHHHH----HHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence 3699999999999999989999999987532110 000111111 0111111233222111
Q ss_pred --C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcc----
Q psy4396 151 --G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK---- 214 (271)
Q Consensus 151 --~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---- 214 (271)
+ ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 1 123678889999999999999999999999999999999999999999999998654322111
Q ss_pred cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
....+..|+|||.+.+..++.++|+||||+++||+++ |..||......+....+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~ 209 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence 1123457999999998889999999999999999997 99999877776654443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=247.90 Aligned_cols=98 Identities=31% Similarity=0.647 Sum_probs=84.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC--------------------CCCCcccc
Q psy4396 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA--------------------PSLHRKTM 216 (271)
Q Consensus 157 ~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~--------------------~~~~~~~~ 216 (271)
...++.++.+|+.||.|+|++|||||||||.||++++++.|||+|||+|... +....+..
T Consensus 696 ~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~ 775 (1351)
T KOG1035|consen 696 RDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQ 775 (1351)
T ss_pred hHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccc
Confidence 5668899999999999999999999999999999999999999999998651 01133456
Q ss_pred cccccccCcceeccC---CCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 217 CGTLDYLPPEMVTSQ---HYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
+||.-|+|||++.+. .|+.|+|+||||++++||+ .||.
T Consensus 776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~ 816 (1351)
T KOG1035|consen 776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFG 816 (1351)
T ss_pred cceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCC
Confidence 799999999999765 4999999999999999999 4564
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=217.74 Aligned_cols=188 Identities=27% Similarity=0.343 Sum_probs=134.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH--HHhh------hhhhceeeeE-EecCcCCCcceeeec-
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN--ERMT------HQVHRERCCQ-VHLSSSRRHPLLSSE- 149 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~------~~~~~~~~~~-~~~~~~~~~~~l~~~- 149 (271)
++|++.+.||.|+||+||+|....++..+|+|++....... .... ..+....... ...........++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999998889999999985432111 0000 0011110000 000000111111111
Q ss_pred -cC------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----
Q psy4396 150 -EG------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH---- 212 (271)
Q Consensus 150 -~~------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 212 (271)
.+ ...+++..+..++.|++.||++||+.|++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 11 1236788899999999999999999999999999999999999999999999885443321
Q ss_pred --cccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 213 --RKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 213 --~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
.....++..|+|||.+... .++.++|+||||+++|+|++|+.||...+..+.+.+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 218 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML 218 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH
Confidence 1234578899999988766 789999999999999999999999987776555443
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=219.85 Aligned_cols=184 Identities=29% Similarity=0.464 Sum_probs=133.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
++|++.+.||+|++|.||+|.+..+++.||+|.+....... .....+.++ +.......||++....+.
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIRE----ISLLKEMQHGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHH----HHHHHhccCCCEeeEEEEEecCCeE
Confidence 67999999999999999999999999999999875432110 000011111 111111123322221111
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCEEEeeccccccCCCC
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM-HEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~-~~~~kl~Dfg~a~~~~~~ 211 (271)
..+++..+..++.|++.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 12467788899999999999999999999999999999985 456899999998654322
Q ss_pred C--cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 H--RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 ~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
. .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+.+.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1 223456889999998865 45789999999999999999999999887776655443
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=217.48 Aligned_cols=191 Identities=26% Similarity=0.406 Sum_probs=137.2
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhh-hceeeeEEe-cC---c--CCCc
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQV-HRERCCQVH-LS---S--SRRH 143 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~-~~~~~~~~~-~~---~--~~~~ 143 (271)
-..++|.+.+.||+|+||.||+|.+..+++.+|+|++......... ....+ ......... .. . ....
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 3468899999999999999999999999999999998643211111 11111 001000000 00 0 0011
Q ss_pred ceeeecc---------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 144 PLLSSEE---------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 144 ~~l~~~~---------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
++++... ....+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 2222211 1234688899999999999999999999999999999999999999999999998654
Q ss_pred CCC--CcccccccccccCcceeccC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 209 PSL--HRKTMCGTLDYLPPEMVTSQ-----HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
... ......++..|+|||.+... .++.++|+|||||++|+|++|+.||...+..+.+.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~ 244 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence 322 22335678899999987543 368899999999999999999999988776554443
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=221.59 Aligned_cols=196 Identities=23% Similarity=0.421 Sum_probs=138.4
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCC-----CeEEEEEEcchhHHHH-------H-Hhhhhh-hceeeeE-Eec
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT-----QIMIALKVLYKVEIIN-------E-RMTHQV-HRERCCQ-VHL 137 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~-------~-~~~~~~-~~~~~~~-~~~ 137 (271)
..+.+..++|++.+.||+|+||.||++.+... ...+|+|.+....... + .....+ ....... ...
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45667778999999999999999999998643 3789999886421110 0 000011 0010000 000
Q ss_pred CcCCCcceeeec---------------------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q psy4396 138 SSSRRHPLLSSE---------------------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLL 190 (271)
Q Consensus 138 ~~~~~~~~l~~~---------------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nil 190 (271)
........+... .....+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 000011111110 11234678888999999999999999999999999999999
Q ss_pred eCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy4396 191 LTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTL 265 (271)
Q Consensus 191 i~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 265 (271)
++.++.++|+|||+++...... .....++..|+|||++.+..++.++|+|||||++||+++ |..||.+....+.+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999999987543321 112234568999999988889999999999999999997 99999988877665
Q ss_pred Hhh
Q psy4396 266 ERI 268 (271)
Q Consensus 266 ~~I 268 (271)
+.+
T Consensus 245 ~~~ 247 (293)
T cd05053 245 KLL 247 (293)
T ss_pred HHH
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=214.61 Aligned_cols=184 Identities=26% Similarity=0.428 Sum_probs=139.6
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC---------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG--------- 151 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--------- 151 (271)
+|+.++.||.|+||.||.++...+++.+++|.+......... ...+.+| ........|+++....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~e----~~~l~~~~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNE----IVILSLLQHPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH-HHHHHHH----HHHHHhCCCCCeeEEEeEEecCCeEE
Confidence 588999999999999999999999999999987543211110 1111111 11111112332221111
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 1236788899999999999999999999999999999999999999999999986543322
Q ss_pred --cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 213 --RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~ 214 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV 214 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 234568899999999988888999999999999999999999999888877766553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=215.89 Aligned_cols=183 Identities=22% Similarity=0.303 Sum_probs=128.8
Q ss_pred cccccCCceEEEEEEEcCCC---eEEEEEEcchhHHHH--HH------hhhhhhceeeeEEecCcCCCcceeeecc--C-
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQ---IMIALKVLYKVEIIN--ER------MTHQVHRERCCQVHLSSSRRHPLLSSEE--G- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~--~~------~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~- 151 (271)
+.||+|+||.||+|.+..++ ..+|+|.+....... .. ....+.........-.....+..++... +
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 46999999999999876654 789999986543310 00 1111111110000000011111222111 1
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcc-----cccc
Q psy4396 152 --------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK-----TMCG 218 (271)
Q Consensus 152 --------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-----~~~g 218 (271)
...+++..+..++.|++.||+|||+.+++||||||+|||++.++.++|+|||+++........ ...+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW 160 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccc
Confidence 123688999999999999999999999999999999999999999999999998654322211 1123
Q ss_pred cccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 219 TLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 219 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05060 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211 (257)
T ss_pred cccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 467999999998889999999999999999998 99999888877665544
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=220.49 Aligned_cols=178 Identities=28% Similarity=0.447 Sum_probs=130.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCC----eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQ----IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---- 150 (271)
...|+..+.||+|.||.||+|...+++ +++|||.++......- .....-+| ..+.....||+++.+.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcRE----iaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACRE----IALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHH----HHHHHHhcCCcchhHHHHHh
Confidence 456899999999999999999765543 3789998865411000 00000000 1111122333222211
Q ss_pred ---------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC----CCEEE
Q psy4396 151 ---------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH----EDVKI 199 (271)
Q Consensus 151 ---------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~----~~~kl 199 (271)
....++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.+||
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 11347889999999999999999999999999999999999877 89999
Q ss_pred eeccccccCCCC-----CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 200 SDFGWSVHAPSL-----HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 200 ~Dfg~a~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
+|||+++..... .....+-|.+|+|||++.+ ..||.+.|+||.|||+.||++-.+.|.+...
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 999999865543 2234567999999998876 5699999999999999999999998875543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=225.91 Aligned_cols=181 Identities=25% Similarity=0.405 Sum_probs=135.0
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec----------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE---------- 149 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---------- 149 (271)
++|++.+.||+|+||.||+|.+..+++.||+|++....... .......++ +.......||+++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-TLAKRTLRE----LKILRHFKHDNIIAIRDILRPPGAD 79 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-cchHHHHHH----HHHHHhcCCCCccCHHHhccccCCC
Confidence 67999999999999999999999999999999986431100 000111111 111111123322211
Q ss_pred -------------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 150 -------------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 150 -------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
.....+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 80 FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred CceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 1123478999999999999999999999999999999999999999999999999865432
Q ss_pred CC------cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 211 LH------RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 211 ~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~ 221 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL 221 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH
Confidence 11 123467889999998765 45889999999999999999999999877655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=225.07 Aligned_cols=107 Identities=29% Similarity=0.521 Sum_probs=91.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceecc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTS 230 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~ 230 (271)
++...+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++....... .....+++.|+|||.+.+
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 255 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 255 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC
Confidence 5677788899999999999999999999999999999999999999999986543221 112234678999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q psy4396 231 QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQ 261 (271)
Q Consensus 231 ~~~~~~~DiwslG~il~el~~-g~~pf~~~~~ 261 (271)
..++.++|+||||+++|++++ |..||.....
T Consensus 256 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 287 (343)
T cd05103 256 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287 (343)
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence 889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=220.69 Aligned_cols=191 Identities=21% Similarity=0.312 Sum_probs=134.3
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCC----------------eEEEEEEcchhHHHH--H------Hhhhhhhceeee
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQ----------------IMIALKVLYKVEIIN--E------RMTHQVHRERCC 133 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~~~--~------~~~~~~~~~~~~ 133 (271)
..++|++.+.||+|+||.||+|.+...+ ..||+|.+....... . .....+......
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3468999999999999999999876533 568999986432110 0 001111111110
Q ss_pred EE-ecCcCCCcceeeecc--C--------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q psy4396 134 QV-HLSSSRRHPLLSSEE--G--------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLL 190 (271)
Q Consensus 134 ~~-~~~~~~~~~~l~~~~--~--------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nil 190 (271)
.. .......+..++... + ...+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 00 000000111111110 0 014688899999999999999999999999999999999
Q ss_pred eCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHH
Q psy4396 191 LTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV--GKPPFESKDQDTT 264 (271)
Q Consensus 191 i~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~~ 264 (271)
++.++.++|+|||+++...... .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||...+..++
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 9999999999999986543221 223345778999999988889999999999999999998 7899988777766
Q ss_pred HHhh
Q psy4396 265 LERI 268 (271)
Q Consensus 265 ~~~I 268 (271)
+..+
T Consensus 243 ~~~~ 246 (296)
T cd05051 243 IENA 246 (296)
T ss_pred HHHH
Confidence 5543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=215.77 Aligned_cols=175 Identities=26% Similarity=0.409 Sum_probs=125.3
Q ss_pred ccccCCceEEEEEEEc--CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceee--------------ec-
Q psy4396 87 PLGTGKFGHVYLAKEK--TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS--------------SE- 149 (271)
Q Consensus 87 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--------------~~- 149 (271)
.||+|+||.||+|.+. .++..||+|++...... .....+.+| ..+.....||+++ ..
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E----~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK--SVRDEMMRE----AEIMHQLDNPYIVRMIGVCEAEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh--HHHHHHHHH----HHHHHhcCCCCeEEEEEEEcCCCeEEEEEe
Confidence 4899999999999875 44567999998543211 000111111 0011111222221 11
Q ss_pred -cC----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc-----
Q psy4396 150 -EG----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR----- 213 (271)
Q Consensus 150 -~~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~----- 213 (271)
.+ ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 11 12468899999999999999999999999999999999999999999999999864432211
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
....+++.|+|||.+....++.++|+||||+++|++++ |..||.+....++...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 210 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF 210 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 11223578999999988889999999999999999996 9999988877665543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=217.94 Aligned_cols=185 Identities=35% Similarity=0.582 Sum_probs=139.6
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCC-cceeeecc--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRR-HPLLSSEE-------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~-------- 150 (271)
++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+..+.. ...... ||++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~----~~~~l~~~~~i~~~~~~~~~~~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE----VLTRLNGHPGIIKLYYTFQDEEN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHH----HHHhcccCCCchhHHHHhcCCce
Confidence 47899999999999999999999999999999986533221111111111110 111111 33322111
Q ss_pred ------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 151 ------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 151 ------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 11247899999999999999999999999999999999999999999999999886543221
Q ss_pred ----------------------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 213 ----------------------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 ----------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.....++..|+|||.+....++.++|+||||++++++++|+.||...+....++++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 12345688999999998888999999999999999999999999988776665544
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=221.53 Aligned_cols=193 Identities=26% Similarity=0.404 Sum_probs=134.9
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEc-----CCCeEEEEEEcchhHHHH-------H-Hhhhhh-hceeeeEE-ec
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYKVEIIN-------E-RMTHQV-HRERCCQV-HL 137 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~-------~-~~~~~~-~~~~~~~~-~~ 137 (271)
..+....++|.+.+.||+|+||.||+|.+. .++..+|+|.++...... + .....+ ........ ..
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 345566778999999999999999999863 345679999886432111 0 001111 00000000 00
Q ss_pred CcCCCcceeeec--cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 138 SSSRRHPLLSSE--EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 138 ~~~~~~~~l~~~--~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
.......+++.. .+ ...+++..+..++.|++.||+|||+++++|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 000111111111 11 12268889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCc----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy4396 205 SVHAPSLHR----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTL 265 (271)
Q Consensus 205 a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 265 (271)
+........ ....++..|+|||.+.+..++.++|+|||||++|++++ |..||...+..+.+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~ 253 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence 865433211 12335678999999998889999999999999999998 99999877765543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=216.46 Aligned_cols=185 Identities=20% Similarity=0.324 Sum_probs=134.3
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCe---EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcce---------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQI---MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL--------- 145 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 145 (271)
..++|+..+.||+|+||.||+|+...++. .+|+|.+....... ....+..+ +.+.....||+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e----~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSE----ASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH--HHHHHHHH----HHHHhcCCCCCeeEEEEEEc
Confidence 34678999999999999999999875543 79999875431110 00111111 11111112332
Q ss_pred ------eeecc--C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 146 ------LSSEE--G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 146 ------l~~~~--~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
++... + ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 22111 0 12367888999999999999999999999999999999999999999999999865
Q ss_pred CCCCCccc-----ccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 208 APSLHRKT-----MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 208 ~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
........ ...++.|+|||++.+..++.++|+|||||++||+++ |+.||...+..++...|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i 223 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 43322111 123457999999988889999999999999999997 99999888777766554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=214.62 Aligned_cols=188 Identities=20% Similarity=0.377 Sum_probs=135.8
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhceeeeE-EecCcCCCcceeeec
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRERCCQ-VHLSSSRRHPLLSSE 149 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~l~~~ 149 (271)
+..++|++.+.||.|+||.||+|... ++.||+|.+......... ....+....... ...........++..
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 44678999999999999999999876 567999998655331111 111111111000 001010111111111
Q ss_pred --cCc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcccc
Q psy4396 150 --EGY-----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM 216 (271)
Q Consensus 150 --~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 216 (271)
.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-~~ 159 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SG 159 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-cC
Confidence 110 1468889999999999999999999999999999999999999999999999876643222 23
Q ss_pred cccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
..+..|+|||.+....++.++|+||||+++|++++ |+.||...+..++...
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 211 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH 211 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 34668999999988889999999999999999997 9999988877665543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=217.51 Aligned_cols=185 Identities=21% Similarity=0.352 Sum_probs=133.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCe---EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQI---MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---- 150 (271)
..++|++.+.||+|+||.||+|.+..+++ .||||.++..... .....+..+ ........||++....
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e----~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSE----ASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH--HHHHHHHHH----HHHHHhCCCcCcceEEEEEC
Confidence 34678999999999999999999876654 6999998643110 001111111 1111111222222111
Q ss_pred -------------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 151 -------------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 151 -------------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 76 KSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred CCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 1 12367888999999999999999999999999999999999999999999998865
Q ss_pred CCCCCcc----ccc---ccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 208 APSLHRK----TMC---GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 208 ~~~~~~~----~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
....... ... .+..|+|||.+.+..++.++|+|||||++||+++ |..||...+..+..+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i 224 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 4321111 111 1357999999998899999999999999999886 99999888777665544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=224.68 Aligned_cols=181 Identities=28% Similarity=0.434 Sum_probs=134.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee-------------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL------------- 146 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------------- 146 (271)
++|.+.+.||+|+||+||+|++..+++.||||.+......... ......| +.+.....||++
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E----~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTLRE----IKLLRHLDHENVIAIKDIMPPPHRE 79 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch-hHHHHHH----HHHHHhcCCCCccchHHheeccccc
Confidence 5799999999999999999999999999999987542110000 0000011 001111122222
Q ss_pred -------eecc----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 147 -------SSEE----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 147 -------~~~~----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
+... ....+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 80 AFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred ccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 1111 12347899999999999999999999999999999999999999999999999987554
Q ss_pred CC--CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 210 SL--HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.. ......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||.+.+..+.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 218 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL 218 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 32 2233457889999998764 46889999999999999999999999877654443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=219.45 Aligned_cols=182 Identities=24% Similarity=0.407 Sum_probs=132.6
Q ss_pred CeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC----
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG---- 151 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---- 151 (271)
+|++.+.||+|+||.||+|.+.. ....+|+|.+........ ...+.+| ........||+++...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~E----~~~l~~l~h~~iv~~~~~~~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSE----FNLLKQVNHPHVIKLYGACSQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHH--HHHHHHH----HHHHhhCCCCCEeeEEEEEec
Confidence 47888999999999999998753 235699998754221100 0111111 11111123333322111
Q ss_pred ----------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q psy4396 152 ----------------------------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIK 185 (271)
Q Consensus 152 ----------------------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDik 185 (271)
...+++..+..++.|++.||+|||+.+++|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 1235677888999999999999999999999999
Q ss_pred CCceEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy4396 186 PENLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKD 260 (271)
Q Consensus 186 p~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~ 260 (271)
|+|||+++++.++|+|||+++..... ......++..|+|||.+.+..++.++|+||||+++|||++ |..||.+..
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999998654321 1222345678999999988889999999999999999998 999999888
Q ss_pred HHHHHHhh
Q psy4396 261 QDTTLERI 268 (271)
Q Consensus 261 ~~~~~~~I 268 (271)
.+++.+.+
T Consensus 235 ~~~~~~~~ 242 (290)
T cd05045 235 PERLFNLL 242 (290)
T ss_pred HHHHHHHH
Confidence 77766543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-33 Score=224.84 Aligned_cols=175 Identities=26% Similarity=0.442 Sum_probs=141.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
+-|.++..||+|+||.||+|.++.+|..+|||.+......++.. .| ..++..+..|+++.++|.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEII-----KE----ISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEII-----KE----ISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHH-----HH----HHHHHHcCCchhhhhhhhhccCCce
Confidence 34788999999999999999999999999999875433322211 11 122222333333333221
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-- 210 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-- 210 (271)
..+++.++..++...++||+|||...-||||||..|||++.+|..||+|||.|...++
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 3378999999999999999999999999999999999999999999999999876654
Q ss_pred CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
..+++..|||-|||||++..-.|+.++||||||++..||..|++||.+--+..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 45677889999999999999999999999999999999999999998765543
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=218.92 Aligned_cols=188 Identities=26% Similarity=0.382 Sum_probs=133.4
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH--------HHH-Hhhhhhhc-eeee-EEecCcCCCc-----
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI--------INE-RMTHQVHR-ERCC-QVHLSSSRRH----- 143 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~-~~~~~~~~-~~~~-~~~~~~~~~~----- 143 (271)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ..+ .....+.. .... ..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468999999999999999999999999999998754211 011 01111111 0000 0000000000
Q ss_pred ceeeecc--C-------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCEEEeecccccc
Q psy4396 144 PLLSSEE--G-------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM-HEDVKISDFGWSVH 207 (271)
Q Consensus 144 ~~l~~~~--~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~-~~~~kl~Dfg~a~~ 207 (271)
.+++... + ...+++..+..++.|++.||.|||++|++||||+|+||+++. ++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 1111110 0 124688999999999999999999999999999999999998 88999999999865
Q ss_pred CCCC--CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 208 APSL--HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
.... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~ 223 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 4322 1122346889999998765 4578999999999999999999999988776665443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=223.10 Aligned_cols=188 Identities=29% Similarity=0.418 Sum_probs=138.3
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceee--------eEEecCcC--------CCcc
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERC--------CQVHLSSS--------RRHP 144 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~--------~~~~ 144 (271)
+|++.+.||+|++|.||+|++..+++.||+|.+...... ......+..+.. ..+.+... ..+.
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 588999999999999999999988999999988643210 000001111100 00000000 0011
Q ss_pred eeeec----------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--
Q psy4396 145 LLSSE----------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-- 212 (271)
Q Consensus 145 ~l~~~----------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 212 (271)
+++.. .....+++..+..++.|++.||++||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 80 YIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 11111 111257888899999999999999999999999999999999999999999999986554332
Q ss_pred ---cccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 213 ---RKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 213 ---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV 220 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 2334578899999999887 78999999999999999999999999988877766654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=221.49 Aligned_cols=181 Identities=29% Similarity=0.484 Sum_probs=134.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
+.|.....||+|+||.||++.+..++..||||.+........ ..+.+|. .......||++....
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~----~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEV----VIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHH---HHHHHHH----HHHHhCCCCcHHHHHHheecCCeE
Confidence 345556779999999999999998899999998754221111 0111110 011111222211111
Q ss_pred --------C--------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--C
Q psy4396 151 --------G--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--H 212 (271)
Q Consensus 151 --------~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~ 212 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 95 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 95 WVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 1 123678899999999999999999999999999999999999999999999998654322 2
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
.....++..|+|||.+.+..++.++|+||||+++||+++|+.||...+..+.+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 229 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 2334578999999999888899999999999999999999999988776655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=233.21 Aligned_cols=189 Identities=24% Similarity=0.349 Sum_probs=153.2
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
..-+..++..+.++||+|.||.|++|.|... -..||||++....... ....+.+| +..+....||.+++++
T Consensus 104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrE----as~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLRE----ASHMLKLQHPHLIRLY 177 (1039)
T ss_pred ceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHH----HHHHHhccCcceeEEe
Confidence 3445667788899999999999999999743 3579999997654332 23344444 4555666888888877
Q ss_pred Cccc---------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 151 GYSL---------------------------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 151 ~~~~---------------------------~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
|..+ |....+..++.||+.||.||.++++|||||..+|+|+-....+||+|||
T Consensus 178 GvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 178 GVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred eeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccc
Confidence 6522 4556677899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccc-----ccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 204 WSVHAPSLHRKT-----MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 204 ~a~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+.+-.+...... ..-...|+|||.+....++.++|+|++||++|||++ |..||.+....+++++|
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i 328 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI 328 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence 997665433221 223568999999999999999999999999999998 99999999999999886
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=223.46 Aligned_cols=176 Identities=24% Similarity=0.346 Sum_probs=128.1
Q ss_pred EecccccC--CceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC----------
Q psy4396 84 VGCPLGTG--KFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG---------- 151 (271)
Q Consensus 84 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---------- 151 (271)
++++||+| +||+||++.++.+++.||+|.++.....+. ....+.+| ..+.....||+++...+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e----~~~l~~l~hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE-MVTFLQGE----LHVSKLFNHPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH-HHHHHHHH----HHHHHhcCCCCeeeEEEEEEECCEEEE
Confidence 46789999 789999999999999999999865322111 11111111 11222224444332211
Q ss_pred ------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 152 ------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 152 ------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.++++||+.+......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 123678889999999999999999999999999999999999999999999864322110
Q ss_pred -------CcccccccccccCcceecc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 212 -------HRKTMCGTLDYLPPEMVTS--QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 212 -------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
......++..|+|||++.+ ..++.++|+|||||++|||++|+.||......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 0112346778999999876 4589999999999999999999999987655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=223.41 Aligned_cols=196 Identities=23% Similarity=0.413 Sum_probs=135.5
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCC-------CeEEEEEEcchhHHH-------HH-Hhhhhh-hceeeeEEe
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT-------QIMIALKVLYKVEII-------NE-RMTHQV-HRERCCQVH 136 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~-------~~-~~~~~~-~~~~~~~~~ 136 (271)
..|++...+|++++.||+|+||.||+|.+... +..||+|.++..... .+ .....+ .........
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 45666677899999999999999999986432 236899987632110 00 111111 010000000
Q ss_pred -cCcCCCcceeeec--cC-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q psy4396 137 -LSSSRRHPLLSSE--EG-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188 (271)
Q Consensus 137 -~~~~~~~~~l~~~--~~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~N 188 (271)
........+++.. .+ ...++...+..++.|++.||+|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 0000000111110 00 0124567778899999999999999999999999999
Q ss_pred eEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 189 LLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 189 ili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
||++.++.+||+|||+++...... .....++..|+|||++.+..++.++|+||||+++|||++ |..||.+.+.++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987544321 111223567999999999999999999999999999998 899999888877
Q ss_pred HHHhh
Q psy4396 264 TLERI 268 (271)
Q Consensus 264 ~~~~I 268 (271)
....+
T Consensus 245 ~~~~~ 249 (334)
T cd05100 245 LFKLL 249 (334)
T ss_pred HHHHH
Confidence 76654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=217.31 Aligned_cols=187 Identities=29% Similarity=0.513 Sum_probs=135.7
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhH--------HHHH-HhhhhhhceeeeEEe-cCcCC--Ccceeeec
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVE--------IINE-RMTHQVHRERCCQVH-LSSSR--RHPLLSSE 149 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~-~~~~~~~~~~~~~~~-~~~~~--~~~~l~~~ 149 (271)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... ...+ .....+......... ..... ....++..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999999999999999986542 0000 011111111110000 00000 11222111
Q ss_pred c-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC---ccc
Q psy4396 150 E-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH---RKT 215 (271)
Q Consensus 150 ~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~---~~~ 215 (271)
. ....+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 1 01357889999999999999999999999999999999999999999999999986554432 223
Q ss_pred ccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 216 MCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 216 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
..++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+....+..+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~ 214 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 456788999998765 45789999999999999999999999988876665544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=218.46 Aligned_cols=182 Identities=27% Similarity=0.460 Sum_probs=135.5
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH--HhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE--RMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
...+.+..++|++.+.||+|+||.||+|.+..+++.||||.++....... ....+.. .+.....||++...
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~-------~~~~~~~~~~i~~~ 79 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD-------VVLKSHDCPYIVKC 79 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHH-------HHHhccCCCchHhh
Confidence 34566778999999999999999999999998899999999864321111 0000000 00011123322222
Q ss_pred cC--------------------------cccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeec
Q psy4396 150 EG--------------------------YSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 150 ~~--------------------------~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
.+ ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+||
T Consensus 80 ~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 80 YGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred heeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcc
Confidence 11 1236788888999999999999997 59999999999999999999999999
Q ss_pred cccccCCCC-CcccccccccccCcceeccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 203 GWSVHAPSL-HRKTMCGTLDYLPPEMVTSQH----YGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 203 g~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
|++...... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 222 (296)
T cd06618 160 GISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222 (296)
T ss_pred ccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence 998654332 222345778999999987553 7889999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=217.44 Aligned_cols=186 Identities=28% Similarity=0.377 Sum_probs=134.2
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh------hhhhhceeeeEEecCcC---------CC
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM------THQVHRERCCQVHLSSS---------RR 142 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~---------~~ 142 (271)
..+.|++.+.||.|+||.||+|.+..+++.+|+|++.......... ...+.. ....+..... ..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~-h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH-HRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcC-CCcEEEEeeehhcccccCCCC
Confidence 4578999999999999999999999999999999975432111111 011100 0111111100 11
Q ss_pred cceeeeccC-------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 143 HPLLSSEEG-------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 143 ~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
+.+++.... ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 122222111 1236778888999999999999999999999999999999999999999999986543
Q ss_pred C--CCcccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 210 S--LHRKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 210 ~--~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
. .......+++.|+|||.+. ...++.++|+|||||++|+|++|+.||....+.+.
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 2 2233456889999999875 34678899999999999999999999976655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=218.64 Aligned_cols=191 Identities=24% Similarity=0.378 Sum_probs=133.2
Q ss_pred cccCeEEecccccCCceEEEEEEEc-----CCCeEEEEEEcchhHHHHH-------HhhhhhhceeeeE-EecCcCCCcc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYKVEIINE-------RMTHQVHRERCCQ-VHLSSSRRHP 144 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~ 144 (271)
...+|...+.||+|+||.||++... .++..+|+|.+........ .....+....... ..........
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 3467889999999999999999753 3466899998754221110 0001111110000 0000000111
Q ss_pred eeeecc--C------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEE
Q psy4396 145 LLSSEE--G------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVK 198 (271)
Q Consensus 145 ~l~~~~--~------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~k 198 (271)
.++... + ...+++..+..++.|++.||+|||+.|++||||||+|||+++++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 111110 0 02367888999999999999999999999999999999999999999
Q ss_pred EeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 199 ISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 199 l~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
|+|||++....... .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||......+....+
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999986543221 112234678999999999999999999999999999998 99999887776665544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=221.43 Aligned_cols=195 Identities=23% Similarity=0.413 Sum_probs=135.8
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcC-------CCeEEEEEEcchhHHH-------HH-Hhhhhhh-ceeeeE-Ee
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKT-------TQIMIALKVLYKVEII-------NE-RMTHQVH-RERCCQ-VH 136 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~-------~~-~~~~~~~-~~~~~~-~~ 136 (271)
.+....++|.+.+.||+|+||.||+|++.. ....+|+|.++..... .+ .....+. ...... ..
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 455666889999999999999999998642 3457999987642111 00 0000110 000000 00
Q ss_pred cCcCCCcceeeec--cC-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q psy4396 137 LSSSRRHPLLSSE--EG-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENL 189 (271)
Q Consensus 137 ~~~~~~~~~l~~~--~~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Ni 189 (271)
.........++.. .+ ...++...+..++.|++.||+|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 0000011111111 00 12367788889999999999999999999999999999
Q ss_pred EeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy4396 190 LLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTT 264 (271)
Q Consensus 190 li~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~ 264 (271)
|++.++.+||+|||+++...... .....++..|+|||++.+..++.++|+||||+++|++++ |..||.+.+..+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999987554321 112224467999999988889999999999999999999 9999998887776
Q ss_pred HHhh
Q psy4396 265 LERI 268 (271)
Q Consensus 265 ~~~I 268 (271)
++.+
T Consensus 246 ~~~~ 249 (314)
T cd05099 246 FKLL 249 (314)
T ss_pred HHHH
Confidence 6554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=230.31 Aligned_cols=179 Identities=27% Similarity=0.421 Sum_probs=140.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCcc-----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYS----- 153 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~----- 153 (271)
.+.|++...+|.|+|+.|-.+.+..+++..|+|++.+.... ..++. -.......||+++...+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~---~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEI---PISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------ccccc---chhhhhcCCCcceeecceecCCce
Confidence 56788888999999999999999999999999999754111 11110 0111222455444332210
Q ss_pred --------------------cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe-CCCCCEEEeeccccccCCCCC
Q psy4396 154 --------------------LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL-TMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 154 --------------------~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili-~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
......+..|+.+|+.|+.|||++|++|||+||+|||+ ++.|+++|+|||.++..+..
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 01225677899999999999999999999999999999 68999999999998776655
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHhh
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD-TTLERI 268 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~I 268 (271)
..+.+-|..|.|||++...+||.+||+||||++||+|++|+.||...+.+ +++.+|
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i 526 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI 526 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence 44567799999999999999999999999999999999999999887777 666665
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=216.63 Aligned_cols=184 Identities=21% Similarity=0.333 Sum_probs=133.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCC---eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQ---IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----- 150 (271)
.++|++.+.||+|+||.||+|.+..++ ..+|+|.++...... ....+.+| +.......||++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSE----ASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH--HHHHHHHH----HHHHHhCCCCCcceEEEEEec
Confidence 467999999999999999999886443 479999885422110 00111111 1111112333322211
Q ss_pred ------------Cc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 151 ------------GY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 151 ------------~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
+. ..++...+..++.|++.||++||++|++||||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 10 23678888999999999999999999999999999999999999999999998654
Q ss_pred CCCCc-----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 209 PSLHR-----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~ 222 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH
Confidence 43221 11223568999999998889999999999999999886 99999887776665544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=214.81 Aligned_cols=177 Identities=36% Similarity=0.635 Sum_probs=133.2
Q ss_pred cccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec-----------------c
Q psy4396 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE-----------------E 150 (271)
Q Consensus 88 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-----------------~ 150 (271)
||.|+||.||++++..+++.+|+|++.............+.++. .......||++... .
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~----~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTER----DILSQAQSPYVVKLYYSFQGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHH----HHHHhCCCcchhHHHHheecCcEEEEEEecCC
Confidence 68999999999999988999999998654332111111111110 11111123322111 1
Q ss_pred C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC----------
Q psy4396 151 G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL---------- 211 (271)
Q Consensus 151 ~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~---------- 211 (271)
+ ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 77 GGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 1 134788899999999999999999999999999999999999999999999988654322
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
......++..|+|||.+....++.++|+||||+++|++++|..||...+..+....+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 213 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI 213 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 223345788999999998888999999999999999999999999988887766554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=217.54 Aligned_cols=188 Identities=25% Similarity=0.471 Sum_probs=134.9
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH-------HH-HhhhhhhceeeeE-EecCcCCCcceeeecc-
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII-------NE-RMTHQVHRERCCQ-VHLSSSRRHPLLSSEE- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~-~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~- 150 (271)
+|++.+.||.|++|.||+|++..+++.||||+++..... .+ .....+....... ........+..++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588999999999999999999999999999987543110 00 0111111100000 0000001111111110
Q ss_pred ------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Ccccc
Q psy4396 151 ------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTM 216 (271)
Q Consensus 151 ------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~ 216 (271)
....+++..+..++.|++.||+|||+.|++||||+|+||++++++.++|+|||++...... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE 160 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccc
Confidence 0123788999999999999999999999999999999999999999999999998644322 12234
Q ss_pred cccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 217 CGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.+++.|+|||++.+. .++.++|+||||+++|++++|+.||.+.+..+.+.++
T Consensus 161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 213 (284)
T cd07836 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213 (284)
T ss_pred cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 568899999988654 5688999999999999999999999988877766554
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=215.59 Aligned_cols=186 Identities=25% Similarity=0.367 Sum_probs=132.4
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH--------Hhhhhhh-ceeee-EEe--cCcCCCcceeeec
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE--------RMTHQVH-RERCC-QVH--LSSSRRHPLLSSE 149 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~-~~~~~-~~~--~~~~~~~~~l~~~ 149 (271)
|++.+.||+|+||.||+|.+..+++.||+|.++....... .....+. ..... ... .........++..
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 5778899999999999999999999999999864311100 0000110 00000 000 0000012222211
Q ss_pred cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-ccccc
Q psy4396 150 EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-RKTMC 217 (271)
Q Consensus 150 ~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 217 (271)
.. ...+++..+..++.|++.||+|||+.|++||||+|+||+++. +.+||+|||++....... .....
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~ 159 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYI 159 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCC
Confidence 11 134788999999999999999999999999999999999998 999999999986543322 22345
Q ss_pred ccccccCcceec-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 218 GTLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 218 gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
++..|+|||.+. +..++.++|+|||||++|||++|..||.+.+..+.+..+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred CCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 788999999764 455788999999999999999999999988776654443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=213.86 Aligned_cols=183 Identities=25% Similarity=0.396 Sum_probs=133.5
Q ss_pred cccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHH--HH------hhhhhhceeeeEE-ecCcCCCcceeeec----
Q psy4396 86 CPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIIN--ER------MTHQVHRERCCQV-HLSSSRRHPLLSSE---- 149 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~--~~------~~~~~~~~~~~~~-~~~~~~~~~~l~~~---- 149 (271)
+.||+|+||.||+|.+... +..||+|++....... .. ....+........ ..........++..
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999866 8889999986543221 00 0011110000000 00000011111111
Q ss_pred -------cC---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 150 -------EG---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 150 -------~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
.. ...+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 11 2457899999999999999999999999999999999999999999999999987655422
Q ss_pred ---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 213 ---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.....+++.|+|||.+....++.++|+||||+++|+|++ |..||...+..+..+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 220 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 334557889999999988889999999999999999999 69999988887776655
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=217.16 Aligned_cols=182 Identities=23% Similarity=0.349 Sum_probs=130.8
Q ss_pred eEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
|.+.+.||+|+||.||+|.+. .+++.||||++......... .+.+.+|. .......||++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~----~~l~~l~h~~i~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREA----ACMKEFDHPNVIKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH-HHHHHHHH----HHHhcCCCCCcceEEEEEccCCC
Confidence 567889999999999999865 35688999988543211100 00111110 011111122111100
Q ss_pred ------------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEe
Q psy4396 151 ------------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKIS 200 (271)
Q Consensus 151 ------------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~ 200 (271)
....++...+..++.|++.||+|||++|++||||||+||+++.++.++|+
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEEC
Confidence 00135778889999999999999999999999999999999999999999
Q ss_pred eccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 201 DFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 201 Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
|||+++...... .....+++.|++||.+....++.++|+||||+++|+|++ |+.||.+.+..+....+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 999987543211 122335678999999988889999999999999999999 99999888877665544
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=220.51 Aligned_cols=179 Identities=31% Similarity=0.510 Sum_probs=134.5
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC----------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG---------- 151 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---------- 151 (271)
|.....||+|+||.||+|.+..+++.||+|++........ ..+.++ +.......||++....+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~e----~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNE----VVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchH---HHHHHH----HHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 4445579999999999999998899999999854221111 111111 11112223443322211
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Ccc
Q psy4396 152 ---------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRK 214 (271)
Q Consensus 152 ---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~ 214 (271)
...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... ...
T Consensus 96 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 96 LMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred EEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 123678899999999999999999999999999999999999999999999998644322 223
Q ss_pred cccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
...++..|+|||++.+..++.++|+|||||++|||++|+.||...+..+.+..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 228 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 228 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 45688999999999988899999999999999999999999987776655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=220.22 Aligned_cols=178 Identities=29% Similarity=0.417 Sum_probs=135.2
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
..++|++++.||+|+||+||++.+..+++.||+|++...... .....+.+| +.+.....||++....+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E----~~~l~~l~h~~i~~~~~~~~~~~ 76 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS--SVRKQILRE----LQIMHECRSPYIVSFYGAFLNEN 76 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc--hHHHHHHHH----HHHHHHcCCCCcceEeeeEecCC
Confidence 357899999999999999999999999999999987532110 001111111 11111122332221111
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 1236788899999999999999997 5899999999999999999999999999865443
Q ss_pred CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.......++..|+|||++.+..++.++|+|||||++|++++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 333456789999999999888899999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=214.27 Aligned_cols=175 Identities=28% Similarity=0.515 Sum_probs=131.6
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC---------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG--------- 151 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--------- 151 (271)
+|.+.+.||+|+||.||+|.+..+++.||+|.++..... ......+..|. .......|+++....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~----~~~~~l~~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEM----KVLELLKHPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHH----HHHHhCCCCChhheeeeEecCCEEE
Confidence 588899999999999999999988999999998654321 11111111221 1111112332211111
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc-
Q psy4396 152 -----------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR- 213 (271)
Q Consensus 152 -----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 213 (271)
...+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 12367888999999999999999999999999999999999999999999999865443211
Q ss_pred -----ccccccccccCcceeccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 214 -----KTMCGTLDYLPPEMVTSQH---YGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 214 -----~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
....+++.|+|||++.+.. ++.++|+||||+++|++++|+.||...+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 1245788999999998766 8899999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=216.95 Aligned_cols=181 Identities=29% Similarity=0.483 Sum_probs=135.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
..|+..+.||.|+||.||+|.+..++..||+|++....... ....+.++ +.......||++....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQE----ITVLSQCDSPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH--HHHHHHHH----HHHHHhCCCCCEeeEEEEEEECCEE
Confidence 45778899999999999999999989999999986432111 01111111 1111112233222211
Q ss_pred --------C--------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--
Q psy4396 151 --------G--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-- 212 (271)
Q Consensus 151 --------~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 212 (271)
+ ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 1 1236788888999999999999999999999999999999999999999999986544322
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
.....++..|+|||.+.+..++.++|+||||+++|||++|..||...+..+...
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence 223457889999999988889999999999999999999999998776655443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=212.47 Aligned_cols=188 Identities=24% Similarity=0.401 Sum_probs=138.1
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceee-----------eEEecCcCCCcceeeec
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERC-----------CQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~~ 149 (271)
+|++.+.||+|+||.||++.+..+++.||+|.+........ ....+.++.. ..........+..++..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58899999999999999999999999999999864321111 0011111100 00001111112222221
Q ss_pred c--C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--cc
Q psy4396 150 E--G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH--RK 214 (271)
Q Consensus 150 ~--~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 214 (271)
. + ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 1 1 1235788889999999999999999999999999999999999999999999986544322 12
Q ss_pred cccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
...+++.|+|||++.+..++.++|+||||++++++++|+.||...+..+....++
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~ 214 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII 214 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh
Confidence 3457889999999988889999999999999999999999998888777665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=214.35 Aligned_cols=179 Identities=31% Similarity=0.496 Sum_probs=130.6
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH---HHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI---INERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
+|.+.+.||+|+||.||+|... +++.+|+|.+..... ...+....+.+| ........|+++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e----~~~l~~l~~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEE----VDLLKSLKHVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHH----HHHHHhcCCCCEeeEeeEeecCC
Confidence 4778899999999999999864 577899998753211 011111111111 1111111222222111
Q ss_pred ----------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-
Q psy4396 151 ----------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS- 210 (271)
Q Consensus 151 ----------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~- 210 (271)
+ ...+++..+..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||++.....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 1 13468888999999999999999999999999999999999999999999998864321
Q ss_pred -------CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 211 -------LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 211 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
.......++..|+|||.+.+..++.++|+||||+++|++++|+.||...+..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 216 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH
Confidence 111234578899999999988899999999999999999999999987665443
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=216.67 Aligned_cols=170 Identities=31% Similarity=0.483 Sum_probs=126.7
Q ss_pred cccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----------------
Q psy4396 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----------------- 150 (271)
Q Consensus 88 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----------------- 150 (271)
||+|+||+||+|.+..+++.||+|++.............+..+ +.+.....||++....
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e----~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNE----KKILEKVSSRFIVSLAYAFETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHH----HHHHHhCCCCCEeeeeeEEecCCeEEEEEecCC
Confidence 6999999999999999999999999865332111111111111 1111111233222111
Q ss_pred -----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-CCcccccc
Q psy4396 151 -----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-LHRKTMCG 218 (271)
Q Consensus 151 -----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-~~~~~~~g 218 (271)
....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .......+
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence 012478889999999999999999999999999999999999999999999998865432 22233457
Q ss_pred cccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 219 TLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 219 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
+..|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 8899999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=212.79 Aligned_cols=192 Identities=19% Similarity=0.356 Sum_probs=135.5
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhceeeeEEecCcCCCcceeee
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRERCCQVHLSSSRRHPLLSS 148 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~ 148 (271)
|++..++|++.+.||+|+||.||+|.+.. +..+|+|.+......... ....+................+++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~ 79 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT 79 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEE
Confidence 45667899999999999999999998665 445999988643221111 11111111111110000001222221
Q ss_pred cc--C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc--
Q psy4396 149 EE--G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR-- 213 (271)
Q Consensus 149 ~~--~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 213 (271)
.. + ...++...+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 11 1 12356778888999999999999999999999999999999999999999998865432211
Q ss_pred -ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 214 -KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 214 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
....++..|+|||++....++.++|+||||+++|++++ |+.||.+.+.......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 215 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 215 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 12234567999999988889999999999999999998 9999998777665544
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=223.71 Aligned_cols=181 Identities=25% Similarity=0.391 Sum_probs=131.8
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec----------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE---------- 149 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---------- 149 (271)
++|.+.+.||.|+||.||+|.+..+++.||+|.+........ ....+| +.......||++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~---~~~~~E----i~~l~~l~h~~i~~~~~~~~~~~~~ 77 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV---KHALRE----IKIIRRLDHDNIVKVYEVLGPSGSD 77 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchH---HHHHHH----HHHHHhcCCCcchhhHhhhcccccc
Confidence 689999999999999999999999999999998754221100 000000 000111112211111
Q ss_pred -------------------c---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCEEEe
Q psy4396 150 -------------------E---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM-HEDVKIS 200 (271)
Q Consensus 150 -------------------~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~-~~~~kl~ 200 (271)
. ....+++..++.++.|++.||.|||+.|++||||||+||+++. ++.++|+
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 0 1134788999999999999999999999999999999999974 4578999
Q ss_pred eccccccCCCCC-----cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 201 DFGWSVHAPSLH-----RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 201 Dfg~a~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
|||++....... .....++..|+|||.+.. ..++.++|+|||||++|+|++|+.||.+.+..+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 230 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999986543211 122356889999997654 5678899999999999999999999987776555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=215.27 Aligned_cols=176 Identities=28% Similarity=0.570 Sum_probs=130.7
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH---HHHHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI---INERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
+|+..+.||+|++|.||+|.+..+++.+|+|++..... ........+..| +.......||+++...+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKE----IRLMARLNHPHIIRMLGATCEDS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHH----HHHHHHcCCCceehhhceeccCC
Confidence 47788999999999999999999999999999864221 001111111221 11111223333222111
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CEEEeeccccccCCC
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPS 210 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 13467888999999999999999999999999999999998776 589999999865443
Q ss_pred CC------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 211 LH------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 211 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
.. .....++..|+|||.+.+..++.++|+||||+++|++++|..||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 21 123457889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=217.01 Aligned_cols=191 Identities=23% Similarity=0.376 Sum_probs=135.1
Q ss_pred cccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHHHh-------hhhhhceeeeE-EecCcCCCcc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINERM-------THQVHRERCCQ-VHLSSSRRHP 144 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~ 144 (271)
..++|.+.+.||+|+||.||+|.+.. ++..+++|.+.......... ...+....... .........+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 45679999999999999999998643 45679999986433211100 01111100000 0000011111
Q ss_pred eeeecc--C-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCE
Q psy4396 145 LLSSEE--G-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV 197 (271)
Q Consensus 145 ~l~~~~--~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~ 197 (271)
.++... + ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 111110 0 0126778899999999999999999999999999999999999999
Q ss_pred EEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 198 KISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 198 kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|||++ |+.||...+..+.++.+
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999986544322 122345788999999999999999999999999999998 99999888877665543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=220.01 Aligned_cols=183 Identities=28% Similarity=0.434 Sum_probs=134.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee-------------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL------------- 146 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------------- 146 (271)
..|...+.||+|+||.||+|++..++..+|+|.+.............+..+ ........||++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE----VKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHH----HHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 347788899999999999999998999999999854321111111111111 011111122222
Q ss_pred --eecc-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 147 --SSEE-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 147 --~~~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
+... ....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .
T Consensus 101 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~ 178 (317)
T cd06635 101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--A 178 (317)
T ss_pred EEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--c
Confidence 1111 113367888999999999999999999999999999999999999999999998865433 2
Q ss_pred ccccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 214 KTMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
....+++.|+|||.+. ...++.++|+|||||++|+|++|+.||...+..+....+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 236 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 3346788999999873 456889999999999999999999999877766555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=215.86 Aligned_cols=188 Identities=27% Similarity=0.382 Sum_probs=136.1
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH------HhhhhhhceeeeEEecC--------cCC
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE------RMTHQVHRERCCQVHLS--------SSR 141 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~~~~~~~~~~~--------~~~ 141 (271)
....++|++.+.||+|+||.||+|.+..+++.+|+|++........ .....+.. ....+.+. ...
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD-HPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhc-CCCeeeeeeeeeecccCCC
Confidence 3356889999999999999999999999999999998754221111 11111110 00111111 011
Q ss_pred Ccceeeecc--C-------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 142 RHPLLSSEE--G-------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 142 ~~~~l~~~~--~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
.+++++... + ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 122332211 1 1236777888999999999999999999999999999999999999999999986
Q ss_pred cCCCC--CcccccccccccCcceecc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 207 HAPSL--HRKTMCGTLDYLPPEMVTS-----QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 207 ~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
..... ......|++.|+|||++.. ..++.++|+|||||++|+|++|+.||......+.
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 54332 2234568999999998753 4578899999999999999999999987765443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=218.33 Aligned_cols=180 Identities=30% Similarity=0.515 Sum_probs=133.7
Q ss_pred EEecccccCCceEEEEEEEc----CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 83 EVGCPLGTGKFGHVYLAKEK----TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 83 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.+.+.||.|+||.||+|.+. ..+..|+||.++...... ....+.++ ........||+++...+.
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~--~~~~~~~e----~~~l~~l~h~ni~~~~g~~~~~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE--EEEEFLNE----IQILRKLRHPNIVKLYGFCIENEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH--HHHHHHHH----HHHHHTHSBTTBE-EEEEEESSSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc--cceeeeec----cccccccccccccccccccccccc
Confidence 46788999999999999998 446789999995421110 01111111 111112233333322221
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2478899999999999999999999999999999999999999999999999876632
Q ss_pred CC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 211 LH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.. .........|+|||.+....++.++||||||+++||+++ |+.||...+..++..++
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~ 218 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL 218 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11 122346779999999988889999999999999999999 78999999888877765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=229.52 Aligned_cols=180 Identities=28% Similarity=0.478 Sum_probs=144.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhh-hhhhceeeeEEecC---cCCCcceeeeccCc--
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT-HQVHRERCCQVHLS---SSRRHPLLSSEEGY-- 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~l~~~~~~-- 152 (271)
..+|..++.+|.|+||.|+.|.++....+|+||.+.+.++...... +.-.-....+..++ ....|+||..+...
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4679999999999999999999999999999999988765433211 11111111112222 23346665543221
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..++|.+++.++.|++.|+++||++||||||||-+|+.++.+|-+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 3378999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 208 APSLHRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
..+..-..++||..|+|||++.+..| ...-|||+||++||.++....||.+
T Consensus 720 ~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 76666677899999999999999998 5678999999999999999999864
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=219.77 Aligned_cols=183 Identities=29% Similarity=0.460 Sum_probs=131.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--------HH-HhhhhhhceeeeEEe--cCcCCCcceee
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--------NE-RMTHQVHRERCCQVH--LSSSRRHPLLS 147 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~-~~~~~~~~~~~~~~~--~~~~~~~~~l~ 147 (271)
.++|++.+.||.|+||.||+|.+..+++.||+|.+.+.... .+ .....+......... .........++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 46799999999999999999999999999999987432110 00 111111111110000 00001111121
Q ss_pred ecc-C--------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcccccc
Q psy4396 148 SEE-G--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG 218 (271)
Q Consensus 148 ~~~-~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~g 218 (271)
... + ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... .....+
T Consensus 89 ~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-~~~~~~ 167 (328)
T cd07856 89 TELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-MTGYVS 167 (328)
T ss_pred eehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-cCCCcc
Confidence 111 1 134677888899999999999999999999999999999999999999999998654332 223456
Q ss_pred cccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 219 TLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 219 t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...+..
T Consensus 168 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred cccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 889999998765 56899999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=222.78 Aligned_cols=185 Identities=30% Similarity=0.501 Sum_probs=134.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCC-CcceeeeccC------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR-RHPLLSSEEG------ 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~------ 151 (271)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+......... ......+ +...... .||++....+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~-~~~~~~E----~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD-AQRTFRE----IMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh-hhhhhHH----HHHHHHhcCCCCccceeeeeccCC
Confidence 46799999999999999999999988999999987432100000 0000011 1111111 2222221111
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred CceEEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 114677888889999999999999999999999999999999999999999998654322
Q ss_pred -------CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 -------HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 -------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....+...++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 1123457889999998755 55788999999999999999999999887766655544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=214.18 Aligned_cols=186 Identities=25% Similarity=0.425 Sum_probs=134.2
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-- 151 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-- 151 (271)
+...+|.+.+.||+|+||.||+|.+... ...||+|......... ..+.+.+| +.......||+++...+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~e----~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS--VREKFLQE----AYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHH--HHHHHHHH----HHHHHhCCCCchhceeEEE
Confidence 4456799999999999999999987644 4569999875432110 00011111 01111112222211111
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 152 ------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 152 ------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 77 TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred cCCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeee
Confidence 12368888999999999999999999999999999999999999999999999865
Q ss_pred CCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 208 APSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 208 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..... .....++..|+|||.+....++.++|+||||+++||+++ |..||.+.+..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~ 221 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 43321 112234568999999988889999999999999999986 99999888877665543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=218.81 Aligned_cols=184 Identities=20% Similarity=0.332 Sum_probs=131.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcCC--------------CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTT--------------QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRH 143 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (271)
..++|++.+.||+|+||.||++++..+ ...||+|.+....... ....+.+| ........|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e----i~~l~~l~h 76 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT--ARNDFLKE----IKIMSRLKN 76 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHH--HHHHHHHH----HHHHHhCCC
Confidence 456899999999999999999987543 2358999986421110 00111111 111111123
Q ss_pred ceeeecc-----------------Cc---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q psy4396 144 PLLSSEE-----------------GY---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIK 185 (271)
Q Consensus 144 ~~l~~~~-----------------~~---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDik 185 (271)
|++.... +. ..+++..+..++.|++.||+|||+.|++|||||
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk 156 (295)
T cd05097 77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156 (295)
T ss_pred CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence 3221111 00 124667788899999999999999999999999
Q ss_pred CCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q psy4396 186 PENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV--GKPPFESK 259 (271)
Q Consensus 186 p~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~ 259 (271)
|+||+++.++.+||+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999999999986543221 122334678999999988889999999999999999988 77899887
Q ss_pred CHHHHHHh
Q psy4396 260 DQDTTLER 267 (271)
Q Consensus 260 ~~~~~~~~ 267 (271)
+.++....
T Consensus 237 ~~~~~~~~ 244 (295)
T cd05097 237 SDEQVIEN 244 (295)
T ss_pred ChHHHHHH
Confidence 76665543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=217.93 Aligned_cols=172 Identities=24% Similarity=0.333 Sum_probs=125.3
Q ss_pred eEEecccccCCceEEEEEEE----cCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKE----KTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
|++++.||+|+||+||++.. ..++..||+|++....... ....+.+| ........||++....+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E----~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ--NTSGWKKE----INILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH--HHHHHHHH----HHHHHhCCCCCEeeEEEEEecCC
Confidence 48899999999999988653 3467789999986432100 00011111 11111112222221111
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 ---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 ---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||+++....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 12368899999999999999999999999999999999999999999999999875543
Q ss_pred CCc-----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 211 LHR-----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 211 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
... ....++..|+|||.+.+..++.++|+||||+++|||++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 221 1223466799999998888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=217.34 Aligned_cols=179 Identities=28% Similarity=0.472 Sum_probs=135.0
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
+.|+..+.||+|+||.||+|.+..++..||+|.+....... ....+.++ +.......||+++...+.
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQE----ITVLSQCDSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH--HHHHHHHH----HHHHHcCCCCccHhhhcccccCCce
Confidence 34677888999999999999999889999999876322111 11111121 111122234433222211
Q ss_pred ------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--
Q psy4396 153 ------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-- 212 (271)
Q Consensus 153 ------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 212 (271)
..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 78 WIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 236788899999999999999999999999999999999999999999999986544322
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||......+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 209 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV 209 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH
Confidence 2234578899999999988899999999999999999999999976655443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=213.06 Aligned_cols=181 Identities=29% Similarity=0.485 Sum_probs=131.5
Q ss_pred cCeEEeccc--ccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH-HhhhhhhceeeeEEecCc---CCCcceeeec--cC
Q psy4396 80 SDFEVGCPL--GTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE-RMTHQVHRERCCQVHLSS---SRRHPLLSSE--EG 151 (271)
Q Consensus 80 ~~~~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~l~~~--~~ 151 (271)
++|++.+.+ |+|+||.||++..+.++..+|+|++........ .............+.+.. .....+++.. .+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~ 93 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKD 93 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCC
Confidence 345555555 999999999999999999999999865432211 111111000001111110 0111111111 11
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CEEEeeccccccCCCCCccccccccc
Q psy4396 152 ---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPSLHRKTMCGTLD 221 (271)
Q Consensus 152 ---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~gt~~ 221 (271)
...+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++...... ....++..
T Consensus 94 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 171 (267)
T PHA03390 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDGTLD 171 (267)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCCCCc
Confidence 12578999999999999999999999999999999999999888 9999999998665432 23457899
Q ss_pred ccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 222 YLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 222 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
|+|||++.+..++.++|+||||+++|+|++|+.||.....+
T Consensus 172 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 212 (267)
T PHA03390 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212 (267)
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 99999999989999999999999999999999999865443
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=217.20 Aligned_cols=178 Identities=30% Similarity=0.507 Sum_probs=135.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|.+.+.||+|+||.||++.+..++..||+|.+........ +.+.++ ........||++....+.
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~e----~~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINE----ILVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHH---HHHHHH----HHHHhhcCCCCeeehhheeeeCCc
Confidence 4789999999999999999999988888999999753221111 111111 111222234433332211
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 23678888999999999999999999999999999999999999999999987644332
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
......+++.|+|||.+....++.++|+||||+++|++++|+.||...+..+
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~ 222 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 2233457889999999988889999999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=213.06 Aligned_cols=189 Identities=20% Similarity=0.352 Sum_probs=132.8
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH----H-HhhhhhhceeeeEEecCcCCCcceeeec--
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN----E-RMTHQVHRERCCQVHLSSSRRHPLLSSE-- 149 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~-- 149 (271)
+..++|++.+.||+|+||.||++.. +++.||+|.+....... + .....+..................++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~ 80 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELM 80 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECC
Confidence 3457899999999999999999975 45679999875432111 0 0011111110000000000011111111
Q ss_pred cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcccccc
Q psy4396 150 EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG 218 (271)
Q Consensus 150 ~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~g 218 (271)
.+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 159 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-DNSKL 159 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-CCCCC
Confidence 11 1236788889999999999999999999999999999999999999999999986543321 22334
Q ss_pred cccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 219 TLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 219 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+
T Consensus 160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 210 (254)
T cd05083 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210 (254)
T ss_pred CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 578999999988889999999999999999997 99999988877655543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=211.36 Aligned_cols=183 Identities=30% Similarity=0.476 Sum_probs=136.5
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee------------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS------------ 148 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~------------ 148 (271)
+|++.+.||+|+||.||+|.+..+++.+|+|.+......... ...+.++ +.......||++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~e----~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNE----CQVLKLLSHPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH-HHHHHHH----HHHHhhCCCCchhheeeeEecCCEEE
Confidence 588999999999999999999999999999998643221110 1111111 11111112222111
Q ss_pred -----ccC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CEEEeeccccccCCCC
Q psy4396 149 -----EEG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPSL 211 (271)
Q Consensus 149 -----~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~~~~~ 211 (271)
..+ ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 111 12368889999999999999999999999999999999998654 5799999998765433
Q ss_pred C-cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 H-RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+......++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 213 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI 213 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH
Confidence 2 22345788999999999888999999999999999999999999888776665544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=222.34 Aligned_cols=185 Identities=26% Similarity=0.414 Sum_probs=134.9
Q ss_pred cCeE-EecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH-----------hhhhhhceeeeEEecCcCCCcceee
Q psy4396 80 SDFE-VGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER-----------MTHQVHRERCCQVHLSSSRRHPLLS 147 (271)
Q Consensus 80 ~~~~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~ 147 (271)
++|. +.+.||+|+||+||+|.+..+++.||+|.+......... ....+.+| +.......||+++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~iv 83 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRE----LKIMNEIKHENIM 83 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHH----HHHHHhCCCccee
Confidence 4564 457799999999999999999999999998543221100 00001111 1112222333322
Q ss_pred eccC-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeec
Q psy4396 148 SEEG-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 148 ~~~~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
...+ ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeeEEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 2111 123688889999999999999999999999999999999999999999999
Q ss_pred cccccCCC----------------CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 203 GWSVHAPS----------------LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 203 g~a~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
|++..... .......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 98865431 111223467889999988764 4689999999999999999999999988887766
Q ss_pred Hhh
Q psy4396 266 ERI 268 (271)
Q Consensus 266 ~~I 268 (271)
..|
T Consensus 244 ~~i 246 (335)
T PTZ00024 244 GRI 246 (335)
T ss_pred HHH
Confidence 554
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=212.87 Aligned_cols=181 Identities=28% Similarity=0.488 Sum_probs=132.9
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--HHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--NERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
+|+..+.||+|++|.||+|.+..++..|++|.+...... .......+..+ +.......||++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e----~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQE----IALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHH----HHHHHhcCCCCchheeeeEecCCe
Confidence 467788899999999999999988899999987543210 00001111111 1111111222221111
Q ss_pred ---------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 151 ---------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 151 ---------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
+ ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 1 1236788888999999999999999999999999999999999999999999886544322
Q ss_pred -cccccccccccCcceeccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 213 -RKTMCGTLDYLPPEMVTSQH-YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 213 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.....+++.|+|||.+.... ++.++|+||||+++|++++|+.||......+..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~ 211 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV 211 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH
Confidence 33456789999999987766 899999999999999999999999776654443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=222.95 Aligned_cols=185 Identities=27% Similarity=0.443 Sum_probs=137.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee------------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL------------ 146 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------------ 146 (271)
.++|++.+.||+|++|.||+|++..+++.||+|++........ ......++ ........||++
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI-HAKRTYRE----LRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh-HHHHHHHH----HHHHHhccCCCHHHHHHHhhcccc
Confidence 4679999999999999999999999999999999754211000 00001011 000111112211
Q ss_pred ---------eec---------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 147 ---------SSE---------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 147 ---------~~~---------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
+.. .....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...
T Consensus 89 ~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 89 LEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccccccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 111 11134788999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 209 PSLHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
... .....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||.+.+..+.+..|+
T Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~ 229 (343)
T cd07851 169 DDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM 229 (343)
T ss_pred ccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 432 233457889999998865 467899999999999999999999999888777666543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=215.76 Aligned_cols=188 Identities=26% Similarity=0.429 Sum_probs=136.4
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--------HH-Hhhhhhh---ceeee-EEecCcCCC-----c
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--------NE-RMTHQVH---RERCC-QVHLSSSRR-----H 143 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~-~~~~~~~---~~~~~-~~~~~~~~~-----~ 143 (271)
|++.+.||+|+||.||+|+++.+++.||+|.+...... .+ .....+. ..... ......... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999999988899999998532110 00 0000110 00000 000000000 0
Q ss_pred ceeeecc------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 144 PLLSSEE------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 144 ~~l~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
..+.... ....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 1111100 1123788999999999999999999999999999999999999999999999998665432
Q ss_pred -CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 212 -HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
......++..|+|||.+.+..++.++|+|||||++|+|++|++||......+.+.+++
T Consensus 161 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07838 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF 219 (287)
T ss_pred cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHH
Confidence 2223447889999999998889999999999999999999999999888877766653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=214.38 Aligned_cols=174 Identities=30% Similarity=0.432 Sum_probs=133.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|+..+.||.|++|.||++.+..+++.+|+|.+...... .....+.++ +.......||+++...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRE----LEINKSCKSPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHH----HHHHHhCCCCCeeeeeeEEEccCCC
Confidence 4688999999999999999999999999999998643211 001111111 11111122333222111
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 152 ------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 152 ------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 12256777889999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 208 APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
..........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 5443333456788999999999889999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=216.21 Aligned_cols=174 Identities=27% Similarity=0.421 Sum_probs=132.6
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++.+.||+|++|.||+|.++.+++.+|+|.+....... ....+.++. .......||++....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~----~~l~~~~~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA--IQKQILREL----DILHKCNSPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChH--HHHHHHHHH----HHHHHCCCCchhhhheeeecCCEE
Confidence 36788899999999999999999999999999886532110 111111110 111111222221111
Q ss_pred ------C------------cccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 151 ------G------------YSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 151 ------~------------~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
. ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 0 0446788889999999999999999 99999999999999999999999999998655433
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
......++..|+|||.+.+..++.++|+||||+++|++++|+.||...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 333366889999999999889999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=212.76 Aligned_cols=180 Identities=29% Similarity=0.501 Sum_probs=132.4
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH-------hhhhhhceeeeEEecCcCCCcceeeecc---
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER-------MTHQVHRERCCQVHLSSSRRHPLLSSEE--- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~~--- 150 (271)
+|.+.+.||+|+||.||+|.+..+++.+|+|.+......... ..+.+..| ........||++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE----IETLKDLDHLNIVQYLGFE 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHH----HHHHHhcCCCCcceEEEEe
Confidence 477889999999999999999988999999987532111100 01111122 1111122233221111
Q ss_pred -----------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 151 -----------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 151 -----------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
....+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++..
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 113477888999999999999999999999999999999999999999999999865
Q ss_pred CCCC----CcccccccccccCcceeccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 208 APSL----HRKTMCGTLDYLPPEMVTSQH--YGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 208 ~~~~----~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
.... ......++..|+|||.+.... ++.++|+||||+++|++++|..||...+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 220 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH
Confidence 4322 122345788999999987654 78999999999999999999999976655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=212.19 Aligned_cols=177 Identities=25% Similarity=0.416 Sum_probs=129.7
Q ss_pred cccccCCceEEEEEEEcC-CC--eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc------------
Q psy4396 86 CPLGTGKFGHVYLAKEKT-TQ--IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------------ 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------------ 150 (271)
+.||+|++|.||+|.+.. .+ ..||+|.+...... .....+..| ........||+++...
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKE----AAIMHSLDHENLIRLYGVVLTHPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHH----HHHHhhcCCCCccceeEEEcCCeEEEEE
Confidence 468999999999999865 22 36999998764431 111111111 1111111222221111
Q ss_pred ----Cc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC---
Q psy4396 151 ----GY-----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH--- 212 (271)
Q Consensus 151 ----~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 212 (271)
+. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 10 236788899999999999999999999999999999999999999999999986554311
Q ss_pred --cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 213 --RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 112346788999999998889999999999999999998 99999887777765544
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=209.72 Aligned_cols=182 Identities=30% Similarity=0.451 Sum_probs=138.4
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceee-------------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS------------- 147 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~------------- 147 (271)
+|++.+.||.|+||.||++.+..+++.+|+|.+.......... ..+..+ ........||++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~-~~~~~e----~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER-EDAVNE----IRILASVNHPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHH-HHHHHH----HHHHHhCCCCCchhhhhhhccCCEEE
Confidence 5889999999999999999999999999999986533211110 011111 1111111222221
Q ss_pred --ecc--C-------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 148 --SEE--G-------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 148 --~~~--~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
... + ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 111 1 12367788899999999999999999999999999999999999999999999876554
Q ss_pred CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
.......+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+..+....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08530 156 NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212 (256)
T ss_pred CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 444445678999999999988899999999999999999999999998887665444
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=214.13 Aligned_cols=113 Identities=23% Similarity=0.453 Sum_probs=92.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceecc-
Q psy4396 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTS- 230 (271)
Q Consensus 156 ~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~- 230 (271)
++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ......+++.|+|||++..
T Consensus 98 ~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05042 98 QKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177 (269)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhc
Confidence 45677889999999999999999999999999999999999999999998643221 1122345678999998743
Q ss_pred ------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 231 ------QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 231 ------~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..++.++|+|||||++|||++ |..||....+.+.+..+
T Consensus 178 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 222 (269)
T cd05042 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222 (269)
T ss_pred cccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 456889999999999999998 89999888776665543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=210.91 Aligned_cols=189 Identities=23% Similarity=0.412 Sum_probs=133.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH------HhhhhhhceeeeEE-ecCcCCCcceeeec--
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE------RMTHQVHRERCCQV-HLSSSRRHPLLSSE-- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~l~~~-- 149 (271)
..+|++.+.||+|+||.||+|.+.. +..+|+|.+........ .....+........ ..........++..
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4679999999999999999998864 55799998864322111 11111111100000 00000111111111
Q ss_pred cC----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcc---cc
Q psy4396 150 EG----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK---TM 216 (271)
Q Consensus 150 ~~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~---~~ 216 (271)
.+ ...++++.+..++.|++.||++||+.+++||||||+||+++.++.++|+|||++......... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 11 123678889999999999999999999999999999999999999999999998654332221 22
Q ss_pred cccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.++..|+|||.+.+..++.++|+||||+++||+++ |+.||......+..+.+
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 34568999999998889999999999999999998 99999887776665543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=216.77 Aligned_cols=191 Identities=27% Similarity=0.472 Sum_probs=135.6
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--------HH-HhhhhhhceeeeEEec-CcC------
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--------NE-RMTHQVHRERCCQVHL-SSS------ 140 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~-~~~~~~~~~~~~~~~~-~~~------ 140 (271)
...++|++.+.||+|+||.||+|.++.+++.||+|.++..... .+ .....+.......... ...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3467899999999999999999999999999999998542110 00 0111111110000000 000
Q ss_pred ----CCcceeeeccC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 141 ----RRHPLLSSEEG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 141 ----~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
..+..++.... ...+++..+..++.|++.||+|||+.||+||||+|+||++++++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 00111111110 124788999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC---cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 206 VHAPSLH---RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 206 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
....... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+..+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~ 229 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 6543322 122345778999998865 4578999999999999999999999987776655443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=216.11 Aligned_cols=185 Identities=26% Similarity=0.407 Sum_probs=133.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcce-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL------- 145 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 145 (271)
+.++|++.+.||+|+||.||+|.+.. ++..||+|.+....... ....+.++ +.+.....||+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e----i~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQRE----AALMAEFDHPNIVKLLGV 76 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHH--HHHHHHHH----HHHHHhcCCCchheEEEE
Confidence 45789999999999999999999753 56789999985432110 00011111 00111111221
Q ss_pred --------eeecc---------------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q psy4396 146 --------LSSEE---------------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDI 184 (271)
Q Consensus 146 --------l~~~~---------------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDi 184 (271)
++... ....+++..+..++.|++.||+|||+++++||||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 156 (288)
T cd05050 77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156 (288)
T ss_pred EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 11110 0113567778899999999999999999999999
Q ss_pred CCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy4396 185 KPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESK 259 (271)
Q Consensus 185 kp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~ 259 (271)
||+||+++.++.++|+|||++....... ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986533221 112234667999999988899999999999999999997 88999887
Q ss_pred CHHHHHHhh
Q psy4396 260 DQDTTLERI 268 (271)
Q Consensus 260 ~~~~~~~~I 268 (271)
+..++...+
T Consensus 237 ~~~~~~~~~ 245 (288)
T cd05050 237 AHEEVIYYV 245 (288)
T ss_pred CHHHHHHHH
Confidence 777765544
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=225.44 Aligned_cols=110 Identities=26% Similarity=0.487 Sum_probs=93.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceecc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTS 230 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~ 230 (271)
++...+..++.|++.||+|||+.+++||||||+|||++.++.++|+|||+++..... ......+++.|+|||.+.+
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 315 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence 456677889999999999999999999999999999999999999999998654321 1223346788999999988
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy4396 231 QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTT 264 (271)
Q Consensus 231 ~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~ 264 (271)
..++.++|+||||+++|||++ |..||......+.
T Consensus 316 ~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 316 NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 889999999999999999998 8999987655443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=211.74 Aligned_cols=181 Identities=29% Similarity=0.406 Sum_probs=134.0
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--HHHh------hhhhhceeeeEE-ecCcCCCcceeeec-
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--NERM------THQVHRERCCQV-HLSSSRRHPLLSSE- 149 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~------~~~~~~~~~~~~-~~~~~~~~~~l~~~- 149 (271)
++|++.+.||+|++|.||+|.+..+++.||+|++...... .... ...+........ ........+.++..
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 3688999999999999999999999999999997654210 0110 011111111100 01111111222211
Q ss_pred -c---------CcccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc--ccc
Q psy4396 150 -E---------GYSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR--KTM 216 (271)
Q Consensus 150 -~---------~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 216 (271)
. ....+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 160 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence 1 11447889999999999999999999 9999999999999999999999999998865543222 245
Q ss_pred cccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 57889999999998889999999999999999999999998774
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=217.63 Aligned_cols=112 Identities=21% Similarity=0.361 Sum_probs=94.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceecc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTS 230 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~ 230 (271)
+++..+..++.|++.||+|||+.|++||||||+|||++.++.++|+|||++....... .....+++.|+|||...+
T Consensus 127 ~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL 206 (296)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc
Confidence 4567889999999999999999999999999999999999999999999986543221 112234678999998888
Q ss_pred CCCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHH
Q psy4396 231 QHYGKEVDNWCIGILAYEFLV--GKPPFESKDQDTTLE 266 (271)
Q Consensus 231 ~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~~~~ 266 (271)
..++.++|+|||||++|||++ |..||...+..+.+.
T Consensus 207 ~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 207 GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 889999999999999999998 789998777666543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=214.50 Aligned_cols=179 Identities=28% Similarity=0.457 Sum_probs=130.2
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----------- 150 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----------- 150 (271)
|++.+.||.|++|.||+|.+..++..||+|++....... .....+.+| +.......||++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E----~~~l~~l~~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIRE----ISLLKELNHPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHH----HHHHHhcCCCCccCHhheeccCCeEEE
Confidence 567889999999999999999999999999885322100 000000011 0011111122211110
Q ss_pred --------------Cc--ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--
Q psy4396 151 --------------GY--SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-- 212 (271)
Q Consensus 151 --------------~~--~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 212 (271)
.. ..+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 11 247889999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 213 RKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.....+++.|+|||++.+. .++.++|+||||+++|+|++|+.||...+....+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 209 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL 209 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1223468899999988664 5688999999999999999999999877765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=211.21 Aligned_cols=177 Identities=26% Similarity=0.391 Sum_probs=123.6
Q ss_pred cccccCCceEEEEEEEcC---CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-----------
Q psy4396 86 CPLGTGKFGHVYLAKEKT---TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG----------- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----------- 151 (271)
+.||+|+||.||+|.+.. .+..+|+|.+....... ....+..+ ........||++....+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKE----GIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHH--HHHHHHHH----HHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 368999999999998753 34679999874321100 00111111 01111122332222111
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--
Q psy4396 152 -----------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-- 212 (271)
Q Consensus 152 -----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 212 (271)
....+...+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++......
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 0123566778889999999999999999999999999999999999999999986543211
Q ss_pred ----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 213 ----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.....++..|+|||.+.+..++.++|+||||+++|||++ |.+||...+..+....+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 112345678999999988889999999999999999999 67788877666555443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-31 Score=237.03 Aligned_cols=187 Identities=22% Similarity=0.357 Sum_probs=154.5
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCC---eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQ---IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
++.+...+.+.||.|.||.|++|+.+..+ ..||||.++..- .+..++++..+..++..+.|||+.+++|-
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy------tekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY------TEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc------cHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 34566788999999999999999987544 689999996532 22334455555788899999999888765
Q ss_pred --------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 153 --------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 153 --------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
+.|+.-++.-+++.|+.|++||-+.++|||||..+|||++.+-.+|++|||+++
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence 225667788899999999999999999999999999999999999999999998
Q ss_pred cCCCCC--ccccc---ccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 207 HAPSLH--RKTMC---GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 207 ~~~~~~--~~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
...+.. ..+.. -+.+|.|||.+....+|.++||||+|+++||+++ |..||.++.++++++.|-
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe 848 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 848 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH
Confidence 654322 11111 2469999999999999999999999999999876 999999999999998773
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=213.23 Aligned_cols=181 Identities=29% Similarity=0.492 Sum_probs=135.2
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---------- 150 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---------- 150 (271)
-|++.+.||+|+||.||+|.+..++..+|+|++........ ...+.++ ........||+++...
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQE----ITVLSQCDSPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHH--HHHHHHH----HHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence 36778889999999999999998899999998753321110 0111111 1111112233322111
Q ss_pred -------C--------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Cc
Q psy4396 151 -------G--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HR 213 (271)
Q Consensus 151 -------~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~ 213 (271)
+ ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 79 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 1 133678889999999999999999999999999999999999999999999988654332 22
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
....++..|+|||.+.+..++.++|+|||||++|++++|..||...........
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 212 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH
Confidence 334578899999999888889999999999999999999999987666554443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=209.44 Aligned_cols=182 Identities=25% Similarity=0.364 Sum_probs=128.0
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH--H------HhhhhhhceeeeE-EecCcCCCcceeeecc--C---
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN--E------RMTHQVHRERCCQ-VHLSSSRRHPLLSSEE--G--- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~------~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~--~--- 151 (271)
+.||.|+||.||+|.+.. ++.||+|.+....... . .....+....... ........+++++... +
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999887 8889999876432210 0 0111111111110 0111111122222111 1
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc----ccccccc
Q psy4396 152 -------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR----KTMCGTL 220 (271)
Q Consensus 152 -------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~ 220 (271)
...+++..+..++.+++.||.|||+++++||||+|+||+++.++.++|+|||++........ .....+.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 12357788899999999999999999999999999999999999999999999865442111 1122356
Q ss_pred cccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 221 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.|+|||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~ 208 (251)
T cd05041 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208 (251)
T ss_pred ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH
Confidence 7999999988889999999999999999998 89999887766655443
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=214.18 Aligned_cols=171 Identities=23% Similarity=0.366 Sum_probs=124.5
Q ss_pred cCeEEecccccCCceEEEEEEE----cCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKE----KTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----- 150 (271)
.+|++.+.||+|+||.||++.. ..++..||+|.+........ ..+.+| +.......||+++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~e----~~~l~~l~h~~iv~~~~~~~~ 76 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL---RDFERE----IEILKSLQHDNIVKYKGVCYS 76 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHH---HHHHHH----HHHHHhCCCCCeeEEEEEEcc
Confidence 5789999999999999999984 45678899999854321110 011111 0111111222221111
Q ss_pred --------------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 151 --------------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 151 --------------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 77 AGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 1 1236788889999999999999999999999999999999999999999999987
Q ss_pred cCCCCCc-----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 207 HAPSLHR-----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 207 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
....... ....++..|+|||++.+..++.++|+||||+++|||++|..|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 6543221 11223456999999988889999999999999999999877764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=215.89 Aligned_cols=180 Identities=28% Similarity=0.436 Sum_probs=131.4
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee---------------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL--------------- 146 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--------------- 146 (271)
|...+.||+|+||+||+|++..+++.||+|.+.............+..+ ........||++
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKE----VKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHH----HHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 5667779999999999999999999999999853221111110111111 011111122221
Q ss_pred eecc-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCccc
Q psy4396 147 SSEE-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT 215 (271)
Q Consensus 147 ~~~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 215 (271)
+... ....+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ...
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--~~~ 176 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--ANS 176 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--CCC
Confidence 1111 113467888999999999999999999999999999999999999999999998865432 234
Q ss_pred ccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 216 MCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 216 ~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
..++..|+|||.+. ...++.++|+||||+++|+|++|..||...+.......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~ 231 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 231 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 56888999999884 45688899999999999999999999987766554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=211.44 Aligned_cols=190 Identities=31% Similarity=0.450 Sum_probs=135.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh------hhhhh-ceeee-EEecCc------CCCc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM------THQVH-RERCC-QVHLSS------SRRH 143 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~------~~~~~-~~~~~-~~~~~~------~~~~ 143 (271)
..++|++.+.||+|++|.||+|.+..+++.+++|++.......... ...+. ..... ...... ...+
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 3578999999999999999999999889999999986432211111 11110 00000 000000 0011
Q ss_pred ceeeec--cC-------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 144 PLLSSE--EG-------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 144 ~~l~~~--~~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..++.. .+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 112111 11 134788889999999999999999999999999999999999999999999988654
Q ss_pred CCC--CcccccccccccCcceecc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 209 PSL--HRKTMCGTLDYLPPEMVTS-----QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
... ......++..|+|||++.. ..++.++|+||||+++|++++|+.||..........+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 229 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH
Confidence 332 2234557889999998753 3467899999999999999999999987665544443
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-31 Score=246.22 Aligned_cols=177 Identities=29% Similarity=0.489 Sum_probs=139.5
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCccc------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSL------ 154 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~------ 154 (271)
+++-...||.|.||.||-|.+..+|+..|+|-++-.... ........+| .......+||+++..+|...
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eE----m~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEE----MKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHH----HHHHHhccCccccccCceeecHHHHH
Confidence 355567799999999999999999999999977432111 1122222232 45556679999998877522
Q ss_pred --------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--
Q psy4396 155 --------------------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-- 212 (271)
Q Consensus 155 --------------------~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 212 (271)
.++...+.+..|++.|++|||+.|||||||||+||+++.+|.+|++|||.|+......
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 3555667788999999999999999999999999999999999999999997654321
Q ss_pred ----cccccccccccCcceecc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 213 ----RKTMCGTLDYLPPEMVTS---QHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 213 ----~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
.....||+-|||||++.+ ++...++|||||||++.||+||+.||...+.+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 234569999999999965 44677999999999999999999999877654
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=208.26 Aligned_cols=175 Identities=28% Similarity=0.469 Sum_probs=127.0
Q ss_pred ecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH-HHhhh-------------------hhhceeeeEEecCcCCCcc
Q psy4396 85 GCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-ERMTH-------------------QVHRERCCQVHLSSSRRHP 144 (271)
Q Consensus 85 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~-------------------~~~~~~~~~~~~~~~~~~~ 144 (271)
.+.||+|+|+.|--+....++.+||||++.+..--. .+..+ -+..+.............|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 457999999999999999999999999986531100 01110 0111111112222222334
Q ss_pred eeeeccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC---CEEEeeccccccC---------CCCC
Q psy4396 145 LLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE---DVKISDFGWSVHA---------PSLH 212 (271)
Q Consensus 145 ~l~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~---~~kl~Dfg~a~~~---------~~~~ 212 (271)
++..+.....|++.++..+..+|+.||.+||.+||.|||+||+|||-.... -+||+||.+.... ....
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 444444445589999999999999999999999999999999999986554 3799999876321 1122
Q ss_pred cccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 213 RKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
-.+.+|+..|||||+.. ..-|+.++|.||||||||-|++|.+||.+.
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 24567889999999763 345899999999999999999999999764
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=208.20 Aligned_cols=176 Identities=25% Similarity=0.357 Sum_probs=126.3
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------------- 150 (271)
+.||+|+||.||+|... ++..+|+|.+........ ...+.+| ........||++....
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~--~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQEL--KIKFLSE----ARILKQYDHPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHH--HHHHHHH----HHHHHhCCCCCcCeEEEEEecCCccEEEEEC
Confidence 36899999999999865 567899998754321100 0011111 0111111222221111
Q ss_pred --C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc---cc
Q psy4396 151 --G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR---KT 215 (271)
Q Consensus 151 --~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~~ 215 (271)
+ ...+++..+..++.|++.+|.|||++|++||||+|+||+++.++.++|+|||++........ ..
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 1 12357888899999999999999999999999999999999999999999999865332111 11
Q ss_pred ccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 216 MCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..++..|+|||++.+..++.++|+||||+++|++++ |..||...........+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~ 207 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 234567999999988889999999999999999998 99999888777665543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=234.45 Aligned_cols=128 Identities=38% Similarity=0.653 Sum_probs=90.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceee----------eE-EecCcCCCcceee
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERC----------CQ-VHLSSSRRHPLLS 147 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~----------~~-~~~~~~~~~~~l~ 147 (271)
+++|.+++.||+|+||.||+|.+..+++.||||++.............+..+.. .. ........+.+++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999986543221111111111100 00 0000001111222
Q ss_pred ecc--C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 148 SEE--G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 148 ~~~--~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
... + ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 211 1 1236788899999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=211.58 Aligned_cols=115 Identities=23% Similarity=0.402 Sum_probs=97.4
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-cccccccccccCcceeccCC
Q psy4396 154 LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-RKTMCGTLDYLPPEMVTSQH 232 (271)
Q Consensus 154 ~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~ 232 (271)
.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++....... ......+..|+|||.+....
T Consensus 108 ~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 187 (270)
T cd05047 108 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV 187 (270)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCC
Confidence 36788899999999999999999999999999999999999999999999985432211 11223356799999998888
Q ss_pred CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 233 YGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 233 ~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
++.++|+||||+++|||++ |..||.+.+..+.++.+
T Consensus 188 ~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~ 224 (270)
T cd05047 188 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224 (270)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH
Confidence 9999999999999999997 99999888777766544
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=228.39 Aligned_cols=182 Identities=21% Similarity=0.239 Sum_probs=121.1
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCC----CeEEEEEEcchhHHHHHHhhhhhhc-----------eeeeEEecCc
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTT----QIMIALKVLYKVEIINERMTHQVHR-----------ERCCQVHLSS 139 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~ 139 (271)
..+..++|.+.+.||+|+||.||+|++..+ +..||+|.+.............+.. .+..... ..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~-~~ 205 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVS-SK 205 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccc-cc
Confidence 345678999999999999999999999988 8899999875321111000000000 0000000 00
Q ss_pred CCCcceeeeccC-------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q psy4396 140 SRRHPLLSSEEG-------------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188 (271)
Q Consensus 140 ~~~~~~l~~~~~-------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~N 188 (271)
.....+++..+. ........+..++.|++.||+|||+++|+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 000011111000 0011234466899999999999999999999999999
Q ss_pred eEeCC-CCCEEEeeccccccCCC---CCcccccccccccCcceeccC----------------------CCCCchhHHHH
Q psy4396 189 LLLTM-HEDVKISDFGWSVHAPS---LHRKTMCGTLDYLPPEMVTSQ----------------------HYGKEVDNWCI 242 (271)
Q Consensus 189 ili~~-~~~~kl~Dfg~a~~~~~---~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Diwsl 242 (271)
||++. ++.+||+|||+|+.... .......+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 57899999999965432 223446789999999965322 23456799999
Q ss_pred HHHHHHHHhCCCCCC
Q psy4396 243 GILAYEFLVGKPPFE 257 (271)
Q Consensus 243 G~il~el~~g~~pf~ 257 (271)
||++|||+++..|+.
T Consensus 366 GviL~el~~~~~~~~ 380 (566)
T PLN03225 366 GLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHhCcCCCc
Confidence 999999998776653
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=212.96 Aligned_cols=187 Identities=28% Similarity=0.462 Sum_probs=133.0
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH-------HhhhhhhceeeeEE-ecCcCCCcceeeecc--C
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE-------RMTHQVHRERCCQV-HLSSSRRHPLLSSEE--G 151 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~--~ 151 (271)
|...+.||+|++|.||++.+..+++.+|+|.+........ .....+........ .......+..++... +
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 4445679999999999999998899999998743211110 00011111000000 000001111111111 1
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Cccccccccc
Q psy4396 152 --------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTMCGTLD 221 (271)
Q Consensus 152 --------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~gt~~ 221 (271)
...+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+...... ......+++.
T Consensus 101 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 180 (285)
T cd06648 101 GALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 180 (285)
T ss_pred CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCcc
Confidence 123678888999999999999999999999999999999999999999999987543321 2223458899
Q ss_pred ccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 222 YLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 222 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+...++
T Consensus 181 y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~ 227 (285)
T cd06648 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227 (285)
T ss_pred ccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 99999998888999999999999999999999999887776655544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=206.22 Aligned_cols=184 Identities=30% Similarity=0.465 Sum_probs=134.9
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH-HHHhh------hhhhceeeeEE-ecCcCCCcceeeecc-C
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII-NERMT------HQVHRERCCQV-HLSSSRRHPLLSSEE-G 151 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~------~~~~~~~~~~~-~~~~~~~~~~l~~~~-~ 151 (271)
+|+..+.||+|++|.||++.+..+++.+++|++...... ..... ..+........ ..........+.... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 478889999999999999999988999999998654320 00000 11111100000 000000111111110 0
Q ss_pred ----------c-ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-ccccccc
Q psy4396 152 ----------Y-SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-RKTMCGT 219 (271)
Q Consensus 152 ----------~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~gt 219 (271)
. ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+....... .....++
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 160 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGT 160 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecC
Confidence 0 357888999999999999999999999999999999999999999999999987655433 3445688
Q ss_pred ccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 220 LDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 220 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+.
T Consensus 161 ~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 205 (253)
T cd05122 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA 205 (253)
T ss_pred CcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 999999999888899999999999999999999999987754443
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=206.81 Aligned_cols=184 Identities=28% Similarity=0.472 Sum_probs=135.6
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeE-----------EecCcCCCcceeeec
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQ-----------VHLSSSRRHPLLSSE 149 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~~ 149 (271)
+|++.+.||+|++|.||+|.+..+++.||+|.+........ ....+.++.... ...........++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHH-HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 57889999999999999999998899999999865432101 111111110000 000000011111111
Q ss_pred --c---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc--ccc
Q psy4396 150 --E---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR--KTM 216 (271)
Q Consensus 150 --~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 216 (271)
. ....+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 1 113478899999999999999999999999999999999999999999999999876544332 345
Q ss_pred cccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.++..|+|||.+.+..++.++|+||||+++|++++|+.||...+.....
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~ 208 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL 208 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 6788999999998888899999999999999999999999876654443
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=211.96 Aligned_cols=175 Identities=32% Similarity=0.558 Sum_probs=126.2
Q ss_pred CeEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHH-HhhhhhhceeeeEEecCcCC-Ccceee--------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINE-RMTHQVHRERCCQVHLSSSR-RHPLLS-------- 147 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~l~-------- 147 (271)
+|++.+.||.|+||.||+|++. .+++.||+|++........ .......++.. +.... .|+++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~----~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQ----VLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHH----HHHhcccCCChhceeeEeec
Confidence 4788999999999999999875 3678899999865322111 00001111100 00000 111111
Q ss_pred -------e--cc---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 148 -------S--EE---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 148 -------~--~~---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
. .. ....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++....
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 1 11 11336788899999999999999999999999999999999999999999999986543
Q ss_pred CC---CcccccccccccCcceeccC--CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 210 SL---HRKTMCGTLDYLPPEMVTSQ--HYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 32 12234578999999998653 4678999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=211.81 Aligned_cols=187 Identities=26% Similarity=0.447 Sum_probs=133.8
Q ss_pred CeEEecccccCCceEEEEEEEcC-CCeEEEEEEcchhHHHH-------HHhhhhhhce-----------e-eeEEecCcC
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKT-TQIMIALKVLYKVEIIN-------ERMTHQVHRE-----------R-CCQVHLSSS 140 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~-------~~~~~~~~~~-----------~-~~~~~~~~~ 140 (271)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+....... .........+ . .........
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 67889999875321100 0000000000 0 000001111
Q ss_pred CCcceeeecc---------------CcccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 141 RRHPLLSSEE---------------GYSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 141 ~~~~~l~~~~---------------~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
..+.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 1222222211 11236788899999999999999996 6899999999999999999999999999
Q ss_pred cccCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 205 SVHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 205 a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
+...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~ 224 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK 224 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH
Confidence 8665443 22345578899999999988899999999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=211.46 Aligned_cols=185 Identities=26% Similarity=0.420 Sum_probs=133.9
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH---HHH------hhhhhhceeeeEEecC---cCCCcceeeec
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII---NER------MTHQVHRERCCQVHLS---SSRRHPLLSSE 149 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~------~~~~~~~~~~~~~~~~---~~~~~~~l~~~ 149 (271)
|.+.+.||+|++|.||+|.+..+++.+|+|.+...... ... ....+.... .+... ....+..++..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN--IIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCC--cchHHHhhccCCCEEEEEe
Confidence 56678899999999999999988999999997543221 000 001111000 00000 00011111111
Q ss_pred cC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--cccc
Q psy4396 150 EG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH--RKTM 216 (271)
Q Consensus 150 ~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~ 216 (271)
.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 10 1357888999999999999999999999999999999999999999999999886554432 2224
Q ss_pred cccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 217 CGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.++..|+|||.+.+. .++.++|+||||+++|++++|+.||...+..+.+.++
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 467889999998776 7899999999999999999999999888876655443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=212.34 Aligned_cols=185 Identities=29% Similarity=0.424 Sum_probs=132.5
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--HHH------hhhhhh---ceeee-EEecCcCCCcceeee
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--NER------MTHQVH---RERCC-QVHLSSSRRHPLLSS 148 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~------~~~~~~---~~~~~-~~~~~~~~~~~~l~~ 148 (271)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ... ....+. ..... .........++.++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999999999999999987532110 000 001111 01000 000000111111221
Q ss_pred c--cC--------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Ccccc
Q psy4396 149 E--EG--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTM 216 (271)
Q Consensus 149 ~--~~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~ 216 (271)
. .+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF 161 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccc
Confidence 1 11 134688999999999999999999999999999999999999999999999998655432 22334
Q ss_pred cccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 217 CGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 217 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.....
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred cCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 68889999998865 45688999999999999999999999877665543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=210.84 Aligned_cols=182 Identities=30% Similarity=0.484 Sum_probs=133.9
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee---------------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL--------------- 146 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--------------- 146 (271)
|+..+.||+|++|.||+|+...+++.+|+|++...... .........+ +.......|+++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e----~~~l~~~~~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALRE----ISLLKELKHPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHH----HHHHHhcCCCCHHHHHhhhhcCCceEE
Confidence 56778899999999999999999999999998653210 0000000011 000111112221
Q ss_pred eecc----------C-cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC--c
Q psy4396 147 SSEE----------G-YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH--R 213 (271)
Q Consensus 147 ~~~~----------~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 213 (271)
+... . ...+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||++....... .
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 1110 0 0257889999999999999999999999999999999999999999999999986554322 2
Q ss_pred ccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 214 KTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
....++..|+|||.+.+. .++.++|+||||+++||+++|+.||.+.+..+.+.++
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 233457789999988766 7899999999999999999999999888776655543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=216.20 Aligned_cols=179 Identities=27% Similarity=0.418 Sum_probs=130.6
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcc---------------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP--------------- 144 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 144 (271)
..|...+.||+|+||.||+|++..++..+|+|.+.............+.++ ........|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE----VRFLQKLRHPNTIQYRGCYLREHTA 90 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHH----HHHHHhCCCCCcccEEEEEEcCCee
Confidence 447778899999999999999999999999998753211100000011111 0001111111
Q ss_pred eeeecc-----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 145 LLSSEE-----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 145 ~l~~~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
+++... ....+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 111111 1133688889999999999999999999999999999999999999999999988654432
Q ss_pred ccccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 214 KTMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
....+++.|+|||.+. ...++.++|+|||||++|+|++|+.||...+..+.
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 222 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH
Confidence 2345788999999874 35678899999999999999999999987665544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=208.38 Aligned_cols=168 Identities=23% Similarity=0.326 Sum_probs=123.6
Q ss_pred cccccCCceEEEEEEEcCCC----------eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc---
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQ----------IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY--- 152 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--- 152 (271)
+.||+|+||.||+|.+..++ ..+++|++....... ..+.++ +.......||++....+.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~----~~~~~e----~~~l~~l~h~~i~~~~~~~~~ 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS----LAFFET----ASLMSQLSHKHLVKLYGVCVR 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhH----HHHHHH----HHHHHcCCCcchhheeeEEec
Confidence 36899999999999998766 458888775433211 111111 111122233333222111
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-------CEEEeec
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-------DVKISDF 202 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-------~~kl~Df 202 (271)
..++...+..++.|++.||+|||++|++||||||+|||++.++ .++|+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 1367888899999999999999999999999999999999887 7999999
Q ss_pred cccccCCCCCcccccccccccCcceeccC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 203 GWSVHAPSLHRKTMCGTLDYLPPEMVTSQ--HYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 203 g~a~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
|++..... .....++..|+|||++.+. .++.++|+||||+++|++++ |..||...+..+
T Consensus 153 g~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~ 214 (259)
T cd05037 153 GIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214 (259)
T ss_pred Cccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence 99876543 2234567789999999876 78999999999999999999 688887765443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=207.95 Aligned_cols=181 Identities=27% Similarity=0.426 Sum_probs=132.4
Q ss_pred eEEecccccCCceEEEEEEEcCCC----eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec--------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQ----IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE-------- 149 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-------- 149 (271)
+++.+.||.|+||.||++.+...+ ..||+|.+....... ....+..+. .......|+++...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~----~~l~~l~~~~i~~~~~~~~~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREA----RIMRKLDHPNIVKLLGVCTEEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHH----HHHHhcCCCchheEEEEEcCCC
Confidence 356788999999999999998766 889999986433210 000111110 00001112211111
Q ss_pred ---------cC---------ccc--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 150 ---------EG---------YSL--YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 150 ---------~~---------~~~--~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
.+ ... +++..+..++.|++.||++||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 01 011 7888899999999999999999999999999999999999999999999986554
Q ss_pred CCCcc---cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 210 SLHRK---TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..... ...+++.|+|||.+.+..++.++|+||||+++++|++ |+.||...+.....+.+
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~ 217 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL 217 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 32111 1236789999999988889999999999999999998 89999887777766544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=219.85 Aligned_cols=182 Identities=25% Similarity=0.417 Sum_probs=125.6
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH--------HHH-HhhhhhhceeeeEEecCc-CCCcc-
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI--------INE-RMTHQVHRERCCQVHLSS-SRRHP- 144 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~-~~~~~~~~~~~~~~~~~~-~~~~~- 144 (271)
.+.-..|+++++||+||.+.||++.....+ .||+|.+..... .++ .....+.....+ +.+.. .....
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~I-IqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKI-IQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceE-EEEeeeeccCce
Confidence 344567999999999999999999876554 477765432111 111 111111111111 11110 00011
Q ss_pred -eeeeccCc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--
Q psy4396 145 -LLSSEEGY-----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-- 210 (271)
Q Consensus 145 -~l~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-- 210 (271)
+++...|. ...+.-.++.+..||+.++.++|..||||.||||.|+|+- +|.+||+|||+|.....
T Consensus 435 lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 435 LYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 12222222 1134347889999999999999999999999999999998 78999999999965543
Q ss_pred --CCcccccccccccCcceeccCC-----------CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 211 --LHRKTMCGTLDYLPPEMVTSQH-----------YGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
..+...+||+-||+||.+.... .++++||||||||||+|+.|++||..-.
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 3345678999999999885432 4578999999999999999999997544
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=208.76 Aligned_cols=174 Identities=24% Similarity=0.359 Sum_probs=121.3
Q ss_pred cccccCCceEEEEEEEcC--CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC------------
Q psy4396 86 CPLGTGKFGHVYLAKEKT--TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------------ 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------------ 151 (271)
+.||+|+||.||+|.... ++..+|+|.+........ ...+.+| +.......||+++...+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE--QMKFLEE----AQPYRSLQHSNLLQCLGQCTEVTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH--HHHHHHH----HHHHHhCCCCCEeeEEEEEcCCCCcEEEE
Confidence 368999999999998653 456799998754321111 0011111 11111223333322211
Q ss_pred -----c--------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 152 -----Y--------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 152 -----~--------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
. ...++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 1 012445667889999999999999999999999999999999999999999986433221
Q ss_pred ----cccccccccccCcceeccC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy4396 213 ----RKTMCGTLDYLPPEMVTSQ-------HYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTL 265 (271)
Q Consensus 213 ----~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 265 (271)
.....+++.|+|||++.+. .++.++|+||||+++|||++ |+.||......+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 219 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence 1234467889999988542 35789999999999999996 99999877766653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=206.85 Aligned_cols=182 Identities=26% Similarity=0.460 Sum_probs=134.9
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC---------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG--------- 151 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--------- 151 (271)
+|.+.+.||+|+||.||++.++.++..+|+|.+........ ....+.+|. .......|+++....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~----~~l~~~~h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEV----ILLAKMKHPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-hhHHHHHHH----HHHHhCCCCChhhhhheeccCCeEE
Confidence 58899999999999999999999999999999865321110 111111111 1111112222211111
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-EEEeeccccccCCCC
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED-VKISDFGWSVHAPSL 211 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~-~kl~Dfg~a~~~~~~ 211 (271)
...+++..+..++.|++.||.|||+.+++|+||+|+||++++++. ++|+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 123678889999999999999999999999999999999998864 699999988654432
Q ss_pred C--cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 212 H--RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 212 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
. .....|++.|+|||.+.+..++.++|+||||+++|++++|+.||...+..+....
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 213 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 2 1223578899999999888899999999999999999999999987776665544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=221.75 Aligned_cols=189 Identities=22% Similarity=0.362 Sum_probs=155.0
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
...|+.+..+..+...||-|.||.||.|.|+.-.-.||||.++.....- +++..| ..++...+||+++++.|
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMev----eEFLkE----AAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKE----AAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhH----HHHHHH----HHHHHhhcCccHHHHhh
Confidence 3567777778889999999999999999999988889999987543321 222222 34555567887777666
Q ss_pred ccc----------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 152 YSL----------------------------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 152 ~~~----------------------------~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
.|. ++.-.+..++.||..|++||..+++|||||..+|+|+.++..+|++|||
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccc
Confidence 543 3445577889999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccc---ccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 204 WSVHAPSLHRKTMC---GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 204 ~a~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+++...+...+... ....|.|||.+..+.++.|+|||+|||+|||+.| |-.||++-+--+++..+
T Consensus 411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL 479 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL 479 (1157)
T ss_pred hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH
Confidence 99887765544443 4678999999999999999999999999999998 99999999988887654
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=207.97 Aligned_cols=169 Identities=22% Similarity=0.310 Sum_probs=120.4
Q ss_pred cccccCCceEEEEEEEcC------------CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--
Q psy4396 86 CPLGTGKFGHVYLAKEKT------------TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-- 151 (271)
+.||+|+||.||+|+... ....+|+|++....... ...+.++ ........||+++...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~---~~~~~~~----~~~l~~l~hp~iv~~~~~~ 73 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDI---SLAFFET----ASMMRQVSHKHIVLLYGVC 73 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhH---HHHHHHH----HHHHHhCCCCCEeeEEEEE
Confidence 368999999999998542 23358999875432211 1111111 11111223333332221
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-------EEE
Q psy4396 152 -------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED-------VKI 199 (271)
Q Consensus 152 -------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~-------~kl 199 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++. +++
T Consensus 74 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 74 VRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 123688889999999999999999999999999999999987664 899
Q ss_pred eeccccccCCCCCcccccccccccCcceec-cCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHH
Q psy4396 200 SDFGWSVHAPSLHRKTMCGTLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFL-VGKPPFESKDQDT 263 (271)
Q Consensus 200 ~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~ 263 (271)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+
T Consensus 154 ~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 154 SDPGIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred CCCCCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 999988654322 2345788999999886 566899999999999999997 5999998765443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=207.58 Aligned_cols=176 Identities=32% Similarity=0.534 Sum_probs=126.1
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
+.+++..-..||+|+||.||+|++..++..||+|.+........ ..+.+| +.......|++++...+.
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~---~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV---QPLHEE----IALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHH---HHHHHH----HHHHHhcCCCCeeeeeeeeccCC
Confidence 34455555679999999999999999999999998754321111 011111 111111223322222111
Q ss_pred ----------------------ccC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCEEEeecccccc
Q psy4396 153 ----------------------SLY--TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM-HEDVKISDFGWSVH 207 (271)
Q Consensus 153 ----------------------~~~--~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~-~~~~kl~Dfg~a~~ 207 (271)
..+ ++..+..++.|++.||+|||++|++||||||+||+++. ++.++|+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 123 66777888999999999999999999999999999976 67899999998865
Q ss_pred CCCC--CcccccccccccCcceeccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 208 APSL--HRKTMCGTLDYLPPEMVTSQH--YGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
.... ......+++.|+|||.+.... ++.++|+||||+++|++++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 4322 222345789999999986543 7889999999999999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=219.05 Aligned_cols=187 Identities=29% Similarity=0.487 Sum_probs=141.7
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc---
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY--- 152 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--- 152 (271)
+.-.++|.++.+||+|||+.||+|.+...++.||+|+-...........++.....+.+..+.....||-|+..+.+
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 33457899999999999999999999999999999985432222222222333333333444555566665554433
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCC---CCEEEeecc
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTMH---EDVKISDFG 203 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~~---~~~kl~Dfg 203 (271)
..+++++++.|+.||+.||.||.+.. |||-||||.|||+-.. |.+||.|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 33789999999999999999999874 9999999999999533 679999999
Q ss_pred ccccCCCCC---------cccccccccccCcceecc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 204 WSVHAPSLH---------RKTMCGTLDYLPPEMVTS----QHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 204 ~a~~~~~~~---------~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
+++...+.. +....||.+|++||.+.- ...+.++||||.|||+|.++.|+.||.....+
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 997654322 234679999999997742 24688999999999999999999999765443
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=204.34 Aligned_cols=177 Identities=40% Similarity=0.690 Sum_probs=133.3
Q ss_pred cccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcce---------------eeecc--
Q psy4396 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL---------------LSSEE-- 150 (271)
Q Consensus 88 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------l~~~~-- 150 (271)
||.|+||.||++.+..+++.+|+|++.+..............+. .......||+ ++...
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~----~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTER----NILSRINHPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHH----HHHHHcCCCcHHHHHHHeecCCeeEEEEecCC
Confidence 69999999999999988999999998654332111111111111 0111111222 11111
Q ss_pred ---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Cccccccc
Q psy4396 151 ---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTMCGT 219 (271)
Q Consensus 151 ---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~gt 219 (271)
....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ......++
T Consensus 77 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 77 GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCC
Confidence 1124688999999999999999999999999999999999999999999999988655432 23445678
Q ss_pred ccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 220 LDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 220 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
..|+|||...+...+.++|+||||+++|++++|+.||...+..+..+++
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 205 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 8999999998888899999999999999999999999888776666554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=209.83 Aligned_cols=189 Identities=25% Similarity=0.414 Sum_probs=136.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhceeeeE-EecCcCCCcceeeec--
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRERCCQ-VHLSSSRRHPLLSSE-- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~l~~~-- 149 (271)
.+.|+..+.||+|++|.||+|.+..++..+|+|++......... ....+....... ...........++..
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 97 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence 35688899999999999999999988889999998643221110 011111110000 000000011111111
Q ss_pred c---------Ccc-cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Cccccc
Q psy4396 150 E---------GYS-LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTMC 217 (271)
Q Consensus 150 ~---------~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~ 217 (271)
. ... .++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...... ......
T Consensus 98 ~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 177 (286)
T cd06614 98 DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177 (286)
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcccc
Confidence 1 011 5788899999999999999999999999999999999999999999999987544322 222345
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....
T Consensus 178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~ 227 (286)
T cd06614 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL 227 (286)
T ss_pred CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 78899999999888899999999999999999999999987776554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=211.99 Aligned_cols=171 Identities=23% Similarity=0.320 Sum_probs=123.6
Q ss_pred cCeEEecccccCCceEEEEEEE----cCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKE----KTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL--------- 146 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--------- 146 (271)
.-|++++.||+|+||.||+++. ..++..||+|.++...... ....+.++. .......||++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~e~----~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEI----EILRNLYHENIVKYKGICTE 77 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHH--HHHHHHHHH----HHHHhCCCCCeeeeeeEEec
Confidence 4478899999999999999985 3567889999986332110 001111110 00111112211
Q ss_pred --------eec--cCc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 147 --------SSE--EGY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 147 --------~~~--~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
+.. .+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 111 111 236788899999999999999999999999999999999999999999999986
Q ss_pred cCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy4396 207 HAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256 (271)
Q Consensus 207 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 256 (271)
...... .....++..|+|||.+.+..++.++|+||||+++|++++++.|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 543221 12234567899999998888999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=208.46 Aligned_cols=190 Identities=24% Similarity=0.394 Sum_probs=133.4
Q ss_pred ccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHH-------HH-HhhhhhhceeeeEE-ecCcCCCcc
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEII-------NE-RMTHQVHRERCCQV-HLSSSRRHP 144 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-------~~-~~~~~~~~~~~~~~-~~~~~~~~~ 144 (271)
.++|++.+.||+|+||.||+|+.+. +.+.+|+|.+...... .+ .....+........ .........
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 4679999999999999999999754 3467999988542211 00 11111111110000 000000111
Q ss_pred eeeec--cC---------cc---------cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 145 LLSSE--EG---------YS---------LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 145 ~l~~~--~~---------~~---------~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
.++.. .+ .. .+++..+..++.|++.||+|||+.+++||||||+||+++.++.++++|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 11111 00 01 478899999999999999999999999999999999999999999999998
Q ss_pred cccCCCC---CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSL---HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+...... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||........+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~ 231 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence 8643321 1223345778999999988888999999999999999998 89999877766655544
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=204.69 Aligned_cols=187 Identities=29% Similarity=0.477 Sum_probs=136.9
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH---HHHh------hhhhhceeee-EEecCcCCCcceeeec-
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII---NERM------THQVHRERCC-QVHLSSSRRHPLLSSE- 149 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~------~~~~~~~~~~-~~~~~~~~~~~~l~~~- 149 (271)
+|.+.+.||+|+||.||++.+..++..+|+|++...... .... ...+...... ............++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 588899999999999999999988999999998643211 0000 0011100000 0000000011111111
Q ss_pred -cC-------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Cc
Q psy4396 150 -EG-------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HR 213 (271)
Q Consensus 150 -~~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~ 213 (271)
.+ ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 11 144788899999999999999999999999999999999999999999999998654433 22
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
....+++.|+|||.+.+..++.++|+||+|+++++|++|+.||...+..++...
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 214 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK 214 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH
Confidence 335678899999999888899999999999999999999999988876665554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=211.65 Aligned_cols=191 Identities=20% Similarity=0.307 Sum_probs=138.3
Q ss_pred cccHHHHHHHHhhhhccccCCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhce
Q psy4396 51 KENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE 130 (271)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~ 130 (271)
.+.+++.+..++..-+....|....+.-..+..+.+.||+|.||+||+|++++.. ||||++...+.. ...+|
T Consensus 182 ~stl~Dll~~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~--VAVKiF~srdE~------SWfrE 253 (513)
T KOG2052|consen 182 DSTLKDLLDDLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGED--VAVKIFSSRDER------SWFRE 253 (513)
T ss_pred CccHHHHHHhhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccccCCc--eEEEEecccchh------hhhhH
Confidence 4457777777776666666666555666788999999999999999999999765 999999643211 00111
Q ss_pred eeeEEecCcCCCcceeeeccCc-----------------------------ccCCHHHHHHHHHHHHHHHHHHHHC----
Q psy4396 131 RCCQVHLSSSRRHPLLSSEEGY-----------------------------SLYTEKDAAKYIYQVADAIHYCHQK---- 177 (271)
Q Consensus 131 ~~~~~~~~~~~~~~~l~~~~~~-----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~---- 177 (271)
..+ .-....+|+||..+.+. ..++.+....++..++.||+|||..
T Consensus 254 tEI--YqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GT 331 (513)
T KOG2052|consen 254 TEI--YQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGT 331 (513)
T ss_pred HHH--HHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcC
Confidence 000 00001134433222111 3367888999999999999999963
Q ss_pred ----CceeccCCCCceEeCCCCCEEEeeccccccCCC------CCcccccccccccCcceeccC------CCCCchhHHH
Q psy4396 178 ----KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS------LHRKTMCGTLDYLPPEMVTSQ------HYGKEVDNWC 241 (271)
Q Consensus 178 ----~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~------~~~~~~~gt~~y~aPE~~~~~------~~~~~~Diws 241 (271)
.|.|||||+.|||+..+|.+.|+|+|||....+ ...+..+||.+|||||++... ..-..+||||
T Consensus 332 qgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa 411 (513)
T KOG2052|consen 332 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA 411 (513)
T ss_pred CCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence 399999999999999999999999999965433 334567899999999998542 2234689999
Q ss_pred HHHHHHHHHh
Q psy4396 242 IGILAYEFLV 251 (271)
Q Consensus 242 lG~il~el~~ 251 (271)
||.++||++.
T Consensus 412 fgLVlWEiar 421 (513)
T KOG2052|consen 412 FGLVLWEIAR 421 (513)
T ss_pred HHHHHHHHHH
Confidence 9999999875
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=210.79 Aligned_cols=185 Identities=28% Similarity=0.444 Sum_probs=131.4
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH-HHh------hhhhhceeee-EEecCcCCCcceeeecc--C
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-ERM------THQVHRERCC-QVHLSSSRRHPLLSSEE--G 151 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~------~~~~~~~~~~-~~~~~~~~~~~~l~~~~--~ 151 (271)
|+....||+|+||.||++....+++.||+|.+....... ... ...+...... .........+..++... +
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 334567999999999999999999999999874321110 000 0011100000 00000001122222211 1
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Cccccccccc
Q psy4396 152 --------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HRKTMCGTLD 221 (271)
Q Consensus 152 --------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~gt~~ 221 (271)
...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... ......+++.
T Consensus 102 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 181 (292)
T cd06657 102 GALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCcc
Confidence 124688889999999999999999999999999999999999999999999987654332 1233457889
Q ss_pred ccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 222 YLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 222 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+..+...
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~ 226 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 226 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999988889999999999999999999999998776655433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=204.89 Aligned_cols=186 Identities=24% Similarity=0.331 Sum_probs=151.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCccc----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSL---- 154 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~---- 154 (271)
..+|.-++.+|.|.- .|..|.+.-.++.||+|.+... ..+........+| ..++....|++++.....-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~re----l~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRE----LKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhh----hhhhhhhcccceeeeeeccCcccc
Confidence 467888999999998 8889999989999999987554 2222122222233 44455557887776554311
Q ss_pred -------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 155 -------------------------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 155 -------------------------~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
+..+.+..+++|+++|++|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 4567788999999999999999999999999999999999999999999998766
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhcc
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~~ 270 (271)
.. ..+....|.-|.|||++.+..+...+||||+||++.||++|+..|++.+..+.+.+|..
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~ 231 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIE 231 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHH
Confidence 54 44556678899999999998899999999999999999999999999999999888764
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=206.98 Aligned_cols=184 Identities=30% Similarity=0.414 Sum_probs=131.8
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH-----Hh---hhhhhceeeeEEec---CcCCCcceeeecc
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE-----RM---THQVHRERCCQVHL---SSSRRHPLLSSEE 150 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~---~~~~~~~~~~~~~~---~~~~~~~~l~~~~ 150 (271)
|++.+.||+|++|.||+|+...+++.||||.+........ .. ...+.. ......+ .....+.+++...
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE-HPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccC-CCCchhHHHHhhcCCcEEEEEec
Confidence 6788899999999999999998899999998754321000 00 000000 0000000 0001111111110
Q ss_pred -C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-ccccc
Q psy4396 151 -G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-RKTMC 217 (271)
Q Consensus 151 -~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 217 (271)
+ ...+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (283)
T cd07830 80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV 159 (283)
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCC
Confidence 0 1246889999999999999999999999999999999999999999999999986554322 23345
Q ss_pred ccccccCcceec-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 218 GTLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 218 gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
++..|+|||++. ...++.++|+||||+++++|++|+.||......+.+.
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 788999999875 4557899999999999999999999998777655544
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=221.91 Aligned_cols=190 Identities=23% Similarity=0.402 Sum_probs=150.4
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcC----CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceee
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKT----TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 147 (271)
..++++..+...+.+.||.|-||.||+|.... ..-.||||..+....... .+.+..| ..++..+.||.|+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqE----a~iMrnfdHphIi 454 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQE----ASIMRNFDHPHII 454 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHH----HHHHHhCCCcchh
Confidence 34566666777788899999999999998743 346799999876432221 2233333 3566777899888
Q ss_pred eccCccc--------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEee
Q psy4396 148 SEEGYSL--------------------------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISD 201 (271)
Q Consensus 148 ~~~~~~~--------------------------~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~D 201 (271)
.+.|.+. ++...+..+++||+.||+|||+.++|||||..+|||+.+...+||+|
T Consensus 455 kLIGv~~e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 455 KLIGVCVEQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred heeeeeeccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecc
Confidence 7766532 56777888999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCc---ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 202 FGWSVHAPSLHR---KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 202 fg~a~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
||+++...+... +...-+..|||||.+.-..+|.++|||-|||++||+++ |..||.+-.+.+++..
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~ 604 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH 604 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE
Confidence 999987665322 22334678999999999999999999999999999987 9999998877665443
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=211.65 Aligned_cols=169 Identities=19% Similarity=0.307 Sum_probs=124.8
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
.....++.++||+|+||.||+|...+ +.||||++.......-...+++... -...|++|..+.+.
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~~kqs~~~Ek~Iy~l--------p~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQEKQSFQNEKNIYSL--------PGMKHENILQFIGAEKRGT 277 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccC--ceeEEEecCHHHHHHHHhHHHHHhc--------cCccchhHHHhhchhccCC
Confidence 35677889999999999999998775 6799999864332211111111111 02244444433222
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCceEeCCCCCEEE
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQK---------KVIHRDIKPENLLLTMHEDVKI 199 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~---------~iiHrDikp~Nili~~~~~~kl 199 (271)
...++..+.+++..+++||+|||+. .|+|||||.+|||+.+|+++.|
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 3368899999999999999999973 5999999999999999999999
Q ss_pred eeccccccCCC----CCcccccccccccCcceeccCC-C-----CCchhHHHHHHHHHHHHhCCCCC
Q psy4396 200 SDFGWSVHAPS----LHRKTMCGTLDYLPPEMVTSQH-Y-----GKEVDNWCIGILAYEFLVGKPPF 256 (271)
Q Consensus 200 ~Dfg~a~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DiwslG~il~el~~g~~pf 256 (271)
+|||+|..... ......+||.+|||||++.+.- + -...||||+|.+||||+++..-+
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99999965442 1223467999999999997632 1 24689999999999999876554
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=217.88 Aligned_cols=189 Identities=23% Similarity=0.361 Sum_probs=145.0
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhh----hceeeeEEecCcCCCcce----
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQV----HRERCCQVHLSSSRRHPL---- 145 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~----~~~~~~~~~~~~~~~~~~---- 145 (271)
++|.+....|+|-||+|.+|.+...+..||||++.+....... ....+ ......++.+...+.|.+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 5788999999999999999999999999999998654332211 00000 001111122222222221
Q ss_pred ------------eeeccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CEEEeeccccccCCCCC
Q psy4396 146 ------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPSLH 212 (271)
Q Consensus 146 ------------l~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~~~~~~ 212 (271)
+..+...-.+....+..++.|++.||..|-..||+|.||||.|||+++.. .+||||||.|.......
T Consensus 512 VFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene 591 (752)
T KOG0670|consen 512 VFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE 591 (752)
T ss_pred EehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc
Confidence 11112223367788999999999999999999999999999999998764 57999999998888777
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.+...-+..|.|||++.+.+|+...|+||.||+|||+.||+..|++.++...+...
T Consensus 592 itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 592 ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 66666678899999999999999999999999999999999999999998877654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=207.52 Aligned_cols=176 Identities=28% Similarity=0.437 Sum_probs=125.7
Q ss_pred cccccCCceEEEEEEEcCCC------eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQ------IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
+.||+|+||.||+|++.... +.+|+|.+........ ...+.++ ........||++....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKE----AHLMSNFNHPNIVKLLGVCLLNEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhh--HHHHHHH----HHHHHhcCCCCeeeEeeeecCCCCe
Confidence 35899999999999986533 6799998754321000 0011111 11111222332222111
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-----CEEEee
Q psy4396 152 -------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-----DVKISD 201 (271)
Q Consensus 152 -------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-----~~kl~D 201 (271)
...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 11246677888999999999999999999999999999999877 899999
Q ss_pred ccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 202 FGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 202 fg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~ 225 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH
Confidence 99986543221 112335678999999998899999999999999999998 9999988777665544
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=212.06 Aligned_cols=176 Identities=23% Similarity=0.369 Sum_probs=124.4
Q ss_pred cccccC--CceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----------
Q psy4396 86 CPLGTG--KFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----------- 152 (271)
Q Consensus 86 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----------- 152 (271)
..||+| +||+||+|++..+++.||+|++........ ..+.+.++ ..+.....||+++...+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e----~~~~~~l~h~niv~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE-HLKALQNE----VVLSHFFRHPNIMTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH-HHHHHHHH----HHHHHhCCCCCcceEeeeEecCCceEEEE
Confidence 456776 999999999999999999999864321111 11112222 111122234443322111
Q ss_pred -----------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--CC-
Q psy4396 153 -----------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LH- 212 (271)
Q Consensus 153 -----------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~~- 212 (271)
..+++..+..++.|++.||+|||++|++||||||+|||++.++.++++||+.+..... ..
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 1267788889999999999999999999999999999999999999999985422111 00
Q ss_pred ------cccccccccccCcceeccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 213 ------RKTMCGTLDYLPPEMVTSQ--HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 213 ------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
.....++..|+|||++.+. .++.++|+|||||++|+|++|+.||......+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 220 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH
Confidence 0112245679999998763 47899999999999999999999998877655543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=206.32 Aligned_cols=109 Identities=23% Similarity=0.352 Sum_probs=90.2
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-------CEEEeeccccccCCCCCcccccccccccCcc
Q psy4396 154 LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-------DVKISDFGWSVHAPSLHRKTMCGTLDYLPPE 226 (271)
Q Consensus 154 ~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-------~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE 226 (271)
.+++..+..++.|++.||+|||++|++||||||+|||++..+ .++++|||++...... ....++..|+|||
T Consensus 113 ~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe 190 (274)
T cd05076 113 RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPE 190 (274)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--cccccCCcccCch
Confidence 367888999999999999999999999999999999997654 3799999987544322 2235678899999
Q ss_pred eecc-CCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHH
Q psy4396 227 MVTS-QHYGKEVDNWCIGILAYEFL-VGKPPFESKDQDTT 264 (271)
Q Consensus 227 ~~~~-~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~ 264 (271)
.+.+ ..++.++|+||||+++||++ +|+.||......+.
T Consensus 191 ~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 191 CVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred hhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 8865 56899999999999999985 69999987665543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=201.68 Aligned_cols=180 Identities=27% Similarity=0.473 Sum_probs=133.5
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH---HHH------hhhhhhceeeeEE-ecCcCC--Ccceeee
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII---NER------MTHQVHRERCCQV-HLSSSR--RHPLLSS 148 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~------~~~~~~~~~~~~~-~~~~~~--~~~~l~~ 148 (271)
+|.+.+.||+|++|.||+|.+..+++.|++|++...... ... ....+........ ...... ....++.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 477889999999999999999988999999998654310 010 0111111111110 000000 1111211
Q ss_pred cc--C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----c
Q psy4396 149 EE--G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----R 213 (271)
Q Consensus 149 ~~--~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~ 213 (271)
.. + ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 11 1 1246888999999999999999999999999999999999999999999999986655433 3
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
....++..|+|||.+.+...+.++|+||||++++++++|..||...+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 44568899999999988889999999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=192.89 Aligned_cols=182 Identities=24% Similarity=0.459 Sum_probs=137.1
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
..++|++.+.+|+|.|++||.|....+++.++||++++.........-.+. .....+|+++.+..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL---------~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKIL---------QNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHH---------HhccCCCCeeehhhhhcCcc
Confidence 357899999999999999999999988999999999876543211110110 01112444333221
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCEEEeeccccccCCC-
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGWSVHAPS- 210 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-~~~kl~Dfg~a~~~~~- 210 (271)
+..++..+++.++.+++.||.|+|++||.|||+||.|++|+.. -.++|+|+|+|...-.
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred ccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 2347888899999999999999999999999999999999865 4689999999976543
Q ss_pred CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHhh
Q psy4396 211 LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPF-ESKDQDTTLERI 268 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~I 268 (271)
..-+..+.+..|--||++.. ..|+.+.|+|||||++..|+..+.|| .+.++.+++-+|
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI 246 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI 246 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence 34445566778899998865 45789999999999999999877776 555555555444
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=218.01 Aligned_cols=184 Identities=21% Similarity=0.350 Sum_probs=147.1
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCccc--
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSL-- 154 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-- 154 (271)
++.+.+.+.+.||+|-||.|.++.-.+ +..||+|.++...-.+. ...+.+| ...+..++||+++.+.|.|.
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~--r~~F~kE----IkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNA--RNDFLKE----IKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhH--HHHHHHH----HHHHhccCCCCeeEEEeeeecC
Confidence 445678899999999999999998776 56799999976543322 2233444 55666669999988877643
Q ss_pred --------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 155 --------------------------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 155 --------------------------~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
........++.||+.||+||.+.++||||+.++|+|++.++++||+|||.++..
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence 122335568999999999999999999999999999999999999999999854
Q ss_pred CCCCcc----cccccccccCcceeccCCCCCchhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHh
Q psy4396 209 PSLHRK----TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFL--VGKPPFESKDQDTTLER 267 (271)
Q Consensus 209 ~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~ 267 (271)
-+.... ..+-+.+|||||.+..+++|+++|+|+||+++||++ +...||....++++.+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven 752 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN 752 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence 332222 234578999999999999999999999999999976 48999999999887764
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=208.57 Aligned_cols=180 Identities=23% Similarity=0.337 Sum_probs=127.4
Q ss_pred cCeEEecccccCCceEEEEEEEc----CCCeEEEEEEcchhHHH--HHHh------hhhhhceeeeE-Eec--CcCCCcc
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEK----TTQIMIALKVLYKVEII--NERM------THQVHRERCCQ-VHL--SSSRRHP 144 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~--~~~~------~~~~~~~~~~~-~~~--~~~~~~~ 144 (271)
+.|++.+.||+|+||.||+|+.. .+++.+|+|++...... .... ...+....... ... .....+.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 56788899999999999999865 34788999998654321 1100 01111100000 000 0001112
Q ss_pred eeeec--cCc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 145 LLSSE--EGY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 145 ~l~~~--~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
.++.. .+. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 22211 111 126788889999999999999999999999999999999999999999999987654221
Q ss_pred c-----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 213 R-----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 213 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
. ....++..|+|||.+.+..++.++|+||||+++|||++|..||...
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 1 1223456799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=206.27 Aligned_cols=169 Identities=24% Similarity=0.365 Sum_probs=118.9
Q ss_pred cccccCCceEEEEEEEcCCCe-------EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQI-------MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
+.||+|+||.||+|.+...+. .+|+|.+....... ...+..+ ..+.....||+++...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e----~~~l~~~~h~~iv~~~~~~~~~~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNY---SESFFEA----ASMMSQLSHKHLVLNYGVCVCGDE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHH---HHHHHHH----HHHHHhCCCCChhheeeEEEeCCC
Confidence 369999999999999865443 48888875432111 0011111 0111112233222111
Q ss_pred ---------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC--------EEEeecc
Q psy4396 151 ---------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED--------VKISDFG 203 (271)
Q Consensus 151 ---------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~--------~kl~Dfg 203 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+||+++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 1 123678888899999999999999999999999999999987765 6999999
Q ss_pred ccccCCCCCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHH
Q psy4396 204 WSVHAPSLHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVG-KPPFESKDQDT 263 (271)
Q Consensus 204 ~a~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~ 263 (271)
++..... .....+++.|+|||++.+ ..++.++|+||||+++|++++| ..||...+...
T Consensus 154 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 154 ISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred cccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 8865433 223457889999999976 4578999999999999999998 57777665544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=203.66 Aligned_cols=113 Identities=20% Similarity=0.397 Sum_probs=92.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC----CCcccccccccccCcceecc-
Q psy4396 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS----LHRKTMCGTLDYLPPEMVTS- 230 (271)
Q Consensus 156 ~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~~gt~~y~aPE~~~~- 230 (271)
++..+..++.|++.||+|||+.+++||||||+|||++.++.++|+|||++..... .......++..|+|||++..
T Consensus 97 ~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 176 (268)
T cd05086 97 QLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176 (268)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccc
Confidence 4556778899999999999999999999999999999999999999998754221 11223457889999998743
Q ss_pred ------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 231 ------QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 231 ------~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..++.++|+||||+++|||++ |..||...++.+.+..+
T Consensus 177 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 221 (268)
T cd05086 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221 (268)
T ss_pred cCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 345789999999999999997 68899888877766554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=204.67 Aligned_cols=176 Identities=34% Similarity=0.606 Sum_probs=126.1
Q ss_pred CeEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHH-HhhhhhhceeeeEEecCcCCCcce-----------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINE-RMTHQVHRERCCQVHLSSSRRHPL----------- 145 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----------- 145 (271)
+|++.+.||+|++|.||++++. .+++.||||++++...... .....+.+|......+ ..||+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~---~~~~~i~~~~~~~~~~ 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV---RRCPFLVTLHYAFQTD 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhc---cCCcchhhhheeeecC
Confidence 4788999999999999999864 3567899999865432211 1111111110000000 01111
Q ss_pred ----eeec--cC---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 146 ----LSSE--EG---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 146 ----l~~~--~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
++.. .+ ...+++..+..++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++.....
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 78 TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 1111 11 13467888999999999999999999999999999999999999999999998865432
Q ss_pred CC---cccccccccccCcceeccCC--CCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 211 LH---RKTMCGTLDYLPPEMVTSQH--YGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 211 ~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.. .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 21 22345788999999987654 688999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=200.99 Aligned_cols=183 Identities=31% Similarity=0.488 Sum_probs=131.3
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH--HhhhhhhceeeeEEecCcCCCcceeeec---------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE--RMTHQVHRERCCQVHLSSSRRHPLLSSE--------- 149 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~--------- 149 (271)
+|.+.+.||+|+||.||++.+..++..+++|+++....... ........+ ........||++...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHH----HHHHHhCCCCcHHHHHHHHhcCCc
Confidence 58889999999999999999988777777777653221100 000000011 011111123322111
Q ss_pred --------c-------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 150 --------E-------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 150 --------~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~~~~l~d~g~~~~~ 155 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLL 155 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cCCEeecccCceeec
Confidence 0 113467888999999999999999999999999999999997 467999999988654
Q ss_pred CCC--CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 209 PSL--HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
... ......+++.|+|||.+.+..++.++|+||||+++|++++|..||......+...++
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~ 217 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 322 223345788999999998888899999999999999999999999876665554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=204.95 Aligned_cols=109 Identities=29% Similarity=0.463 Sum_probs=92.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC---------CcccccccccccCc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL---------HRKTMCGTLDYLPP 225 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~---------~~~~~~gt~~y~aP 225 (271)
+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||.+...... ......++..|+||
T Consensus 98 ~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (314)
T cd08216 98 LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177 (314)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCH
Confidence 678889999999999999999999999999999999999999999999987543221 11233467789999
Q ss_pred ceecc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 226 EMVTS--QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 226 E~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
|++.+ ..++.++|+|||||++|||++|+.||...+...
T Consensus 178 E~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~ 217 (314)
T cd08216 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217 (314)
T ss_pred HHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99866 358899999999999999999999998765443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=193.91 Aligned_cols=168 Identities=21% Similarity=0.279 Sum_probs=121.2
Q ss_pred CCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecC---cCCCcceeeec--cC---------cccCC
Q psy4396 91 GKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS---SSRRHPLLSSE--EG---------YSLYT 156 (271)
Q Consensus 91 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~~--~~---------~~~~~ 156 (271)
|.+|.||++++..+++.||+|.+.....................+.+. ....+.+++.. .+ ...++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 83 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCC
Confidence 899999999999999999999987643222111100000000001110 01111122111 11 12378
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcccccccccccCcceeccCCCCCc
Q psy4396 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKE 236 (271)
Q Consensus 157 ~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 236 (271)
+..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+...... .....++..|+|||.+.+..++.+
T Consensus 84 ~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 162 (237)
T cd05576 84 EECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPEVGGISEETEA 162 (237)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCcccCCCCCCch
Confidence 8899999999999999999999999999999999999999999999987554432 223445778999999988889999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 237 VDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 237 ~DiwslG~il~el~~g~~pf~~~ 259 (271)
+|+||+|+++|||++|+.||...
T Consensus 163 ~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 163 CDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred hhHHHHHHHHHHHHHCcchhhcC
Confidence 99999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=217.35 Aligned_cols=189 Identities=25% Similarity=0.415 Sum_probs=137.3
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcC-------CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKT-------TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL 146 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 146 (271)
.|++..+++.+.+.||+|.||.|++|.... ....||||.++......+ ...+..|.. .+.....||++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~--~~~~~~El~---~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSE--KKDLMSELN---VLKELGKHPNI 364 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHH--HHHHHHHHH---HHHHhcCCcch
Confidence 677777788888899999999999997541 146799999864332211 111111100 01111123322
Q ss_pred eeccCc-------------------------c-----------------cCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q psy4396 147 SSEEGY-------------------------S-----------------LYTEKDAAKYIYQVADAIHYCHQKKVIHRDI 184 (271)
Q Consensus 147 ~~~~~~-------------------------~-----------------~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDi 184 (271)
+.+.|. + .++..++..++.||+.|++||++.++|||||
T Consensus 365 v~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL 444 (609)
T KOG0200|consen 365 VNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL 444 (609)
T ss_pred hhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence 222211 1 2788899999999999999999999999999
Q ss_pred CCCceEeCCCCCEEEeeccccccCCCCCccc---cc--ccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy4396 185 KPENLLLTMHEDVKISDFGWSVHAPSLHRKT---MC--GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFES 258 (271)
Q Consensus 185 kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~---~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~ 258 (271)
..+|||+..+..+||+|||+|+......... .. -...|||||.+....|+.++||||+|++|||+++ |..||.+
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999998644432222 12 2446999999999999999999999999999998 9999998
Q ss_pred CC-HHHHHHh
Q psy4396 259 KD-QDTTLER 267 (271)
Q Consensus 259 ~~-~~~~~~~ 267 (271)
.. ..++++.
T Consensus 525 ~~~~~~l~~~ 534 (609)
T KOG0200|consen 525 IPPTEELLEF 534 (609)
T ss_pred CCcHHHHHHH
Confidence 65 5555543
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-28 Score=216.05 Aligned_cols=182 Identities=23% Similarity=0.430 Sum_probs=142.1
Q ss_pred CeEEecccccCCceEEEEEEEcCCC----eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCccc--
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQ----IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSL-- 154 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-- 154 (271)
.....++||+|+||+||+|.+...+ .+||||++...... .....+..+ ...+....||++.++.+.++
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~Lde----Al~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDE----ALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHH----HHHHhcCCCchHHHHhhhcccc
Confidence 4556788999999999999986554 57899987543221 111122222 23444558888888777654
Q ss_pred ------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 155 ------------------------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 155 ------------------------~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
+.......|.+||++||.|||.++++||||..+|+|+.+-..+|+.|||+++....
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 34566778899999999999999999999999999999999999999999976554
Q ss_pred CCcc----cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 211 LHRK----TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.... ...-.+.|||-|.+....|+.++|||||||++||++| |..||.+...+++-+.+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll 913 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL 913 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH
Confidence 3222 2233568999999999999999999999999999998 99999999999886543
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=211.77 Aligned_cols=188 Identities=30% Similarity=0.433 Sum_probs=146.1
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
......+-|++...||.|.+|.||+++.+.+++..|+|++.......++...... .+.....||++...++.
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eyn-------il~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYN-------MLKKYSHHPNVATFYGAF 85 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHH-------HHHhccCCCCcceEEEEE
Confidence 3344457799999999999999999999999999999998654332222211110 11112234443333322
Q ss_pred --------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEe
Q psy4396 153 --------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKIS 200 (271)
Q Consensus 153 --------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~ 200 (271)
..+.|+.+..++..++.||.|||...++|||||-.|||++.+|.+||+
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEe
Confidence 236889999999999999999999999999999999999999999999
Q ss_pred eccccccCCC--CCcccccccccccCcceeccC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 201 DFGWSVHAPS--LHRKTMCGTLDYLPPEMVTSQ-----HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 201 Dfg~a~~~~~--~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
|||.+...++ ..+++..|||.|||||++... .|+..+|+||||++..||..|.+|+.++=+...+-+|
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I 240 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 240 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence 9999976655 356678899999999999653 4678999999999999999999999888776665444
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=186.80 Aligned_cols=188 Identities=34% Similarity=0.536 Sum_probs=132.8
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--HHHhh------hhhhceeee-EEecCcCCCcceeeec--c
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--NERMT------HQVHRERCC-QVHLSSSRRHPLLSSE--E 150 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~------~~~~~~~~~-~~~~~~~~~~~~l~~~--~ 150 (271)
|.+.+.||+|++|.||++....+++.+|+|.+...... ..... ..+...... ............+... .
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56778899999999999999988889999998654211 00000 011000000 0000000001111110 0
Q ss_pred ---------Cccc-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC---Cccccc
Q psy4396 151 ---------GYSL-YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL---HRKTMC 217 (271)
Q Consensus 151 ---------~~~~-~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~---~~~~~~ 217 (271)
.... +++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+...... ......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 1122 678888999999999999999999999999999999999999999999988665443 223456
Q ss_pred ccccccCccee-ccCCCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMV-TSQHYGKEVDNWCIGILAYEFLVGKPPFES--KDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~--~~~~~~~~~I~ 269 (271)
++..|++||.+ ....++.++|+||||+++++|++|+.||.. .+..++.+.|.
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 78899999998 667788899999999999999999999977 34445565553
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=195.76 Aligned_cols=113 Identities=30% Similarity=0.443 Sum_probs=83.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhh------hceeeeEEecCcCCCcc--e
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQV------HRERCCQVHLSSSRRHP--L 145 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~------~~~~~~~~~~~~~~~~~--~ 145 (271)
++|-+.++||-|.|++||+|.+..+.+.||+|+.+....-.+. +..++ .....+++.+...++|. +
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 7999999999999999999999999999999998765432221 11111 12233444544443332 1
Q ss_pred -----------------eeeccCcccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeC
Q psy4396 146 -----------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLT 192 (271)
Q Consensus 146 -----------------l~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~ 192 (271)
+.....+..++...++.|++|++.||.|||.+ ||||.||||+|||+.
T Consensus 158 G~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 11123456689999999999999999999975 999999999999994
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=226.35 Aligned_cols=164 Identities=18% Similarity=0.288 Sum_probs=125.4
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
..+...+.||+|+||.||+|++..++..||+|.+.......... +.......||+++...+.
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-----------~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE-----------IADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHH-----------HHHHhhCCCCCcceEEEEEEcCCCC
Confidence 34566778999999999999998889999999885432111110 112223356655544332
Q ss_pred ----------------ccCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 153 ----------------SLYTEKDAAKYIYQVADAIHYCH---QKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 153 ----------------~~~~~~~~~~~~~qi~~~L~~LH---~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
..+++..+..++.|++.||+||| +.+++||||||+||+++.++..++. ||.+..... .
T Consensus 759 ~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--~ 835 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--D 835 (968)
T ss_pred EEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--C
Confidence 12578889999999999999999 6699999999999999988888775 665433221 1
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 22357899999999999999999999999999999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=203.69 Aligned_cols=104 Identities=30% Similarity=0.403 Sum_probs=83.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-Ccc--cccccccccCcceeccC
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-HRK--TMCGTLDYLPPEMVTSQ 231 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~--~~~gt~~y~aPE~~~~~ 231 (271)
+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++...... ... ...+|+.|+|||.+...
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 356678889999999999999999999999999999999999999999998654321 111 22347899999987532
Q ss_pred C--------------------C--CCchhHHHHHHHHHHHHhCCC-CCCC
Q psy4396 232 H--------------------Y--GKEVDNWCIGILAYEFLVGKP-PFES 258 (271)
Q Consensus 232 ~--------------------~--~~~~DiwslG~il~el~~g~~-pf~~ 258 (271)
. + ..+.|+||+||++++|++|.. ||.+
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 2 1 234799999999999999875 7754
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-27 Score=187.69 Aligned_cols=173 Identities=27% Similarity=0.420 Sum_probs=129.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceee-----------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS----------- 147 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~----------- 147 (271)
.+.|.+.+.||+|.||.+-++++++++..+++|.+.+......+. .+|+.....+. .|.+|+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF----~rEfhY~~~Ls---~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADF----VREFHYSFFLS---PHQHIIDTYEVAFQTSD 95 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHH----HHHhccceeec---cchhhhHHHHHHhhcCc
Confidence 367999999999999999999999999999999987655443333 33332222221 222221
Q ss_pred ---ec------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC--CCCCEEEeeccccccCCC
Q psy4396 148 ---SE------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT--MHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 148 ---~~------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~--~~~~~kl~Dfg~a~~~~~ 210 (271)
.. .+...+.|...+.++.|++.||+|+|++++||||||.+||||- +...+||+|||+++..+.
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 11 1123367888999999999999999999999999999999993 235799999998876554
Q ss_pred CCcccccccccccCcceecc---C--CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 211 LHRKTMCGTLDYLPPEMVTS---Q--HYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.. ....-+..|.+||++.. + ...+.+|+|.||+++|.+++|++||+..
T Consensus 176 tV-~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 176 TV-KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred ee-hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 32 22334678999997743 2 3478899999999999999999999844
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-26 Score=207.67 Aligned_cols=170 Identities=27% Similarity=0.358 Sum_probs=122.5
Q ss_pred eEEecccccCCce-EEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCccc------
Q psy4396 82 FEVGCPLGTGKFG-HVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSL------ 154 (271)
Q Consensus 82 ~~~~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~------ 154 (271)
|.-.+.+|.|+.| .||+|... +++||||.+-..... ...+|. ..+...-.||++++..+...
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~------~A~rEi---~lL~eSD~H~NviRyyc~E~d~qF~Y 579 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFD------FAQREI---QLLQESDEHPNVIRYYCSEQDRQFLY 579 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHH------HHHHHH---HHHHhccCCCceEEEEeeccCCceEE
Confidence 3445678999997 68999987 457999987443221 111110 11222235666555543310
Q ss_pred -------C----------------CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CC--CEEEeeccccc
Q psy4396 155 -------Y----------------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM---HE--DVKISDFGWSV 206 (271)
Q Consensus 155 -------~----------------~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~---~~--~~kl~Dfg~a~ 206 (271)
. ..-.....+.|++.||+|||+.+||||||||+||||+. ++ .++|+|||+++
T Consensus 580 IalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 580 IALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 0 11234677899999999999999999999999999976 34 57899999998
Q ss_pred cCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy4396 207 HAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQD 262 (271)
Q Consensus 207 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~ 262 (271)
..+... .....||.+|+|||++....-+.++|||||||++|+.++ |..||.+.-..
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 765422 234569999999999998888889999999999999888 69999765444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=178.80 Aligned_cols=168 Identities=36% Similarity=0.643 Sum_probs=123.2
Q ss_pred CceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec-----------------c----
Q psy4396 92 KFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE-----------------E---- 150 (271)
Q Consensus 92 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-----------------~---- 150 (271)
+||.||+|.+..+++.+|+|++........ ...+..+. .......|+++... .
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~----~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREI----SILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHH----HHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 589999999998889999999864322110 00111110 00000012211110 0
Q ss_pred -----CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-CcccccccccccC
Q psy4396 151 -----GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-HRKTMCGTLDYLP 224 (271)
Q Consensus 151 -----~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~gt~~y~a 224 (271)
....++...+..++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+...... ......++..|+|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence 1112678889999999999999999999999999999999999999999999998765543 3344567889999
Q ss_pred cceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHH
Q psy4396 225 PEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES-KDQDTTL 265 (271)
Q Consensus 225 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~ 265 (271)
||.+.+..++.++|+||||++++++++|..||.. .+.....
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~ 196 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF 196 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999888889999999999999999999999987 4444333
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-25 Score=173.49 Aligned_cols=192 Identities=21% Similarity=0.320 Sum_probs=136.4
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhH----HHH-HHhhhhhhce--eeeEEecCcCCCcceee--
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVE----IIN-ERMTHQVHRE--RCCQVHLSSSRRHPLLS-- 147 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~l~-- 147 (271)
+..++|.+++.||+|+||.+|.|....+|..||||+=++.. +.- ......+..- +...........+..++
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34688999999999999999999999999999999753211 110 0111111000 00000111111111111
Q ss_pred -------ecc--CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC---CCEEEeeccccccCCCCC---
Q psy4396 148 -------SEE--GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH---EDVKISDFGWSVHAPSLH--- 212 (271)
Q Consensus 148 -------~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~---~~~kl~Dfg~a~~~~~~~--- 212 (271)
.+. +...|+.+++.-++.|++.-++|+|.+++|||||||+|+|..-+ ..+.|+|||+|+...+..
T Consensus 92 LLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 92 LLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred ccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence 111 12347889999999999999999999999999999999999644 457899999997654322
Q ss_pred ------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHhh
Q psy4396 213 ------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT---TLERI 268 (271)
Q Consensus 213 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~I 268 (271)
.....||.+|++-..+.+...+...|+-|+|.+|..+.-|..||++..... -+++|
T Consensus 172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 234569999999999999999999999999999999999999998765543 34444
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=180.11 Aligned_cols=181 Identities=23% Similarity=0.311 Sum_probs=131.4
Q ss_pred CeEEecccccCCceEEEEEEEcCCC-eEEEEEEcchhHH------HHH-Hhhhhhh-----ceeeeEEecC-cCCCccee
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQ-IMIALKVLYKVEI------INE-RMTHQVH-----RERCCQVHLS-SSRRHPLL 146 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~------~~~-~~~~~~~-----~~~~~~~~~~-~~~~~~~l 146 (271)
+|.+.+.||+|+||.||.+.+..++ ..+|+|+-..... ..+ .....+. ..+......- ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999998774 6799998654211 111 1111111 0111111111 01112222
Q ss_pred ee------------ccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-----CCEEEeeccccc--c
Q psy4396 147 SS------------EEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-----EDVKISDFGWSV--H 207 (271)
Q Consensus 147 ~~------------~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-----~~~kl~Dfg~a~--~ 207 (271)
+. ......++..++..++.|++.+|++||+.|++||||||+|++++.. ..+.|.|||+++ .
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~ 178 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK 178 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence 21 1112458999999999999999999999999999999999999865 358999999998 3
Q ss_pred CCC---------CC-cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 208 APS---------LH-RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 208 ~~~---------~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
... .. .....||..|++++++.+...+.+.|+||+++++.++..|..||.+...
T Consensus 179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 111 11 2235599999999999999999999999999999999999999977664
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-25 Score=185.28 Aligned_cols=180 Identities=23% Similarity=0.397 Sum_probs=124.2
Q ss_pred cCeEEecccccCCceEEEEEEEcC---CCeEEEEEEcchhHHH----HH-HhhhhhhceeeeEEecCcCC--Ccceeeec
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKT---TQIMIALKVLYKVEII----NE-RMTHQVHRERCCQVHLSSSR--RHPLLSSE 149 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~~~--~~~~l~~~ 149 (271)
+.|..++.||.|.|++||+|.+.. .++.||+|.+...... ++ ++...+.-...+ +.+.... .......+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni-~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNI-IKLNGCFRNNDQVAIVL 114 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhh-hcchhhhccCCeeEEEe
Confidence 568889999999999999999887 7889999998543221 11 111111111000 0000000 00000000
Q ss_pred ---------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCEEEeeccccccC-----------
Q psy4396 150 ---------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGWSVHA----------- 208 (271)
Q Consensus 150 ---------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-~~~kl~Dfg~a~~~----------- 208 (271)
.-+..++...++.++..++.||+++|.+|||||||||+|+|.+.. +.-.|+|||+|...
T Consensus 115 p~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~ 194 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRS 194 (418)
T ss_pred cccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhh
Confidence 011336788999999999999999999999999999999999755 56789999997510
Q ss_pred ------CC-----------------------------CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhC
Q psy4396 209 ------PS-----------------------------LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVG 252 (271)
Q Consensus 209 ------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g 252 (271)
.. .......||++|+|||++.. ...++++|+||.|+|+..++++
T Consensus 195 ~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~ 274 (418)
T KOG1167|consen 195 YSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSR 274 (418)
T ss_pred hhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcc
Confidence 00 00012458999999998865 4578999999999999999999
Q ss_pred CCCCCCCC
Q psy4396 253 KPPFESKD 260 (271)
Q Consensus 253 ~~pf~~~~ 260 (271)
+.||-...
T Consensus 275 ~~PFf~a~ 282 (418)
T KOG1167|consen 275 RYPFFKAK 282 (418)
T ss_pred ccccccCc
Confidence 99986443
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-24 Score=173.77 Aligned_cols=184 Identities=24% Similarity=0.352 Sum_probs=137.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee-----------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS----------- 148 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~----------- 148 (271)
-.|.+++.||.|+||+++.|++.-++++||||.=... - ...+++.|......+......|.+-+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-S----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-C----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 4699999999999999999999999999999963211 0 11112222111111111111221111
Q ss_pred ------------ccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-----CEEEeeccccccCCCC
Q psy4396 149 ------------EEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-----DVKISDFGWSVHAPSL 211 (271)
Q Consensus 149 ------------~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-----~~kl~Dfg~a~~~~~~ 211 (271)
..+...|+.+++..++.|++.-++++|++.+|.|||||+|+||+.-+ .+.++|||+|+...+.
T Consensus 103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 11224589999999999999999999999999999999999997554 4789999999876543
Q ss_pred Cc---------ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHhh
Q psy4396 212 HR---------KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK---DQDTTLERI 268 (271)
Q Consensus 212 ~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~I 268 (271)
.+ .+..||.+||+-..+.+.+.+...|+-|||-++...+-|..||++. +..+-+++|
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 33 3456999999999999999999999999999999999999999864 445556655
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=191.80 Aligned_cols=181 Identities=30% Similarity=0.446 Sum_probs=145.3
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
+.++|+++..+|+|.||.||+|+++.+++..|+|+++-..- ....-+..| ..+....+||+|+.+.+.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqe----i~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQE----IGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccc----eeeeecCCCcChHHHHhhhhhhc
Confidence 45789999999999999999999999999999999863211 111122233 334455588887665432
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS- 210 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~- 210 (271)
..+++.++....+..+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+...+.
T Consensus 86 klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 3478999999999999999999999999999999999999999999999998865543
Q ss_pred -CCcccccccccccCccee---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 211 -LHRKTMCGTLDYLPPEMV---TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 211 -~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
..+..+.||+.|||||+. ..+.|...||+|++|+...|+..-++|-...-+++.+
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l 224 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL 224 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH
Confidence 455678899999999976 4667999999999999999999988887665555443
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-24 Score=178.06 Aligned_cols=186 Identities=23% Similarity=0.311 Sum_probs=132.9
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCC-----eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQ-----IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 152 (271)
...+++....+-+|.||+||+|.+...+ +.|-+|.++...- +.....+..| ..+.....||++....+-
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--~iQv~~~L~e----s~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--QIQVNLLLQE----SMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--HHHHHHHHHH----HHHHhcCcCCCccceeEE
Confidence 3456788888999999999999776432 3345555432110 0000111111 111222234443222111
Q ss_pred -----------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCE
Q psy4396 153 -----------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV 197 (271)
Q Consensus 153 -----------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~ 197 (271)
..++..+...++.|++.|++|||+.|+||.||..+|.+|++.-.+
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 224566777889999999999999999999999999999999999
Q ss_pred EEeeccccccCCCCCcc----cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 198 KISDFGWSVHAPSLHRK----TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 198 kl~Dfg~a~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
||+|=.+++...+..-. ..-.+..||+||.+....|+.++|+|||||++|||+| |+.||..-++.|...-+.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 99999998765443222 2234678999999999999999999999999999998 999999999998766543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=199.88 Aligned_cols=106 Identities=14% Similarity=0.233 Sum_probs=86.7
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-------------------CCEEEeeccccccCCCC--
Q psy4396 153 SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-------------------EDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 153 ~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-------------------~~~kl~Dfg~a~~~~~~-- 211 (271)
..+++.+++.++.||+.||+|||++||+||||||+|||++.. +.+|++|||+++.....
T Consensus 75 ~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~ 154 (793)
T PLN00181 75 RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSE 154 (793)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccc
Confidence 448899999999999999999999999999999999999653 44566666666432110
Q ss_pred ----------------CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 212 ----------------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 212 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
......||+.|+|||++.+..++.++|||||||+||||++|..|+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 155 RRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred cchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 00113478889999999999999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=159.68 Aligned_cols=97 Identities=23% Similarity=0.316 Sum_probs=87.1
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcccccccccccCcceeccCCC
Q psy4396 154 LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHY 233 (271)
Q Consensus 154 ~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 233 (271)
.+++..+..++.|++.||+|||+++ ||+|||++.++.+++ ||++....... ..||+.|+|||++.+..+
T Consensus 13 ~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---~~g~~~y~aPE~~~~~~~ 81 (176)
T smart00750 13 PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---SRVDPYFMAPEVIQGQSY 81 (176)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc---CCCcccccChHHhcCCCC
Confidence 4799999999999999999999998 999999999999999 99987654422 358999999999999999
Q ss_pred CCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 234 GKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 234 ~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
+.++|||||||++|||++|+.||.....
T Consensus 82 ~~~~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 82 TEKADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred cchhhHHHHHHHHHHHHhCCCCccccch
Confidence 9999999999999999999999976543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=193.33 Aligned_cols=173 Identities=33% Similarity=0.603 Sum_probs=131.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCcccCCHH
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEK 158 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 158 (271)
..+|+.+++|-.|+||.||.++++.+.+.+|+|+-+. .++-+. +...-..|+++ |.|.-..+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~lilRn--------------ilt~a~npfvv---gDc~tllk 143 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLILRN--------------ILTFAGNPFVV---GDCATLLK 143 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-chhhhc--------------cccccCCccee---chhhhhcc
Confidence 4689999999999999999999999999999975433 222111 11111233332 11111111
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-----------------CCccccccccc
Q psy4396 159 DAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-----------------LHRKTMCGTLD 221 (271)
Q Consensus 159 ~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-----------------~~~~~~~gt~~ 221 (271)
.+...-.+++.+++|||+-||+|||+||+|.+|+.-|.+|+.|||+++.... ......+|||.
T Consensus 144 ~~g~lPvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPe 223 (1205)
T KOG0606|consen 144 NIGPLPVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPE 223 (1205)
T ss_pred cCCCCcchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCcc
Confidence 1111223348899999999999999999999999999999999999754321 11134589999
Q ss_pred ccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 222 YLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 222 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
|.|||++....|...+|+|++|+|+||.+-|+.||.++++++++..++
T Consensus 224 yiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 224 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred ccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 999999999999999999999999999999999999999999988765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=166.86 Aligned_cols=101 Identities=29% Similarity=0.447 Sum_probs=76.0
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcccccccccccCcceecc--------C
Q psy4396 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTS--------Q 231 (271)
Q Consensus 160 ~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~--------~ 231 (271)
...+..|+++.+++||+.|++|+||+|+|++++.+|.+.|+||+.....+..... ...+..|.+||.... .
T Consensus 147 rl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~ 225 (288)
T PF14531_consen 147 RLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNA 225 (288)
T ss_dssp HHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEE
T ss_pred HHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccc
Confidence 3455589999999999999999999999999999999999999987666553332 344678999997744 2
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 232 HYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 232 ~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.++.+.|.|+||+++|.|.+|..||.....
T Consensus 226 ~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~ 255 (288)
T PF14531_consen 226 PYTFATDAWQLGITLYSLWCGRLPFGLSSP 255 (288)
T ss_dssp EE-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred eeeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence 478899999999999999999999986544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.8e-21 Score=151.23 Aligned_cols=160 Identities=34% Similarity=0.590 Sum_probs=115.8
Q ss_pred cccCCceEEEEEEEcCCCeEEEEEEcchhHHH-------HH-HhhhhhhceeeeEEecCcCC---CcceeeeccC-----
Q psy4396 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEII-------NE-RMTHQVHRERCCQVHLSSSR---RHPLLSSEEG----- 151 (271)
Q Consensus 88 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~~---~~~~l~~~~~----- 151 (271)
||+|++|.||++....+++.+++|++...... .+ .....+.... ........ ....++....
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPN--IVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCC--eeeEeeeeecCCeEEEEEecCCCCcH
Confidence 68999999999999988889999998765431 11 1111111110 01111000 0111111111
Q ss_pred -----c--ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCEEEeeccccccCCCCC--ccccccccc
Q psy4396 152 -----Y--SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM-HEDVKISDFGWSVHAPSLH--RKTMCGTLD 221 (271)
Q Consensus 152 -----~--~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~-~~~~kl~Dfg~a~~~~~~~--~~~~~gt~~ 221 (271)
. ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+....... .....+...
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 1 24678889999999999999999999999999999999998 8999999999987655443 334557889
Q ss_pred ccCcceeccC-CCCCchhHHHHHHHHHHH
Q psy4396 222 YLPPEMVTSQ-HYGKEVDNWCIGILAYEF 249 (271)
Q Consensus 222 y~aPE~~~~~-~~~~~~DiwslG~il~el 249 (271)
|++||.+... .++.+.|+|++|++++++
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 9999999877 788999999999999988
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=165.40 Aligned_cols=160 Identities=16% Similarity=0.142 Sum_probs=101.2
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcC-CCeEEEEEEcchhHH--HHHHhhhhhhceeeeEEe---------cC
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKT-TQIMIALKVLYKVEI--INERMTHQVHRERCCQVH---------LS 138 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~---------~~ 138 (271)
|....+.-.++|.+.+.||+|+||+||+|.+.. +++.+|||++..... ........+.+|...... +.
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 334445556889999999999999999999876 677789998642100 000001111111111000 00
Q ss_pred cCCCcceeeec--cCcccC--CHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 139 SSRRHPLLSSE--EGYSLY--TEKDAAKYIYQVADAIHYCHQKKVIHRDI-KPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 139 ~~~~~~~l~~~--~~~~~~--~~~~~~~~~~qi~~~L~~LH~~~iiHrDi-kp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
.. ...+++.. .+..+. .......++.|++.+|+|||++||+|||| ||+|||++.++.++|+|||+|+.......
T Consensus 89 ~~-~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 89 AT-GKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA 167 (365)
T ss_pred Ec-CCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence 11 12222221 111110 11112578899999999999999999999 99999999899999999999975432211
Q ss_pred ----------ccccccccccCcceeccC
Q psy4396 214 ----------KTMCGTLDYLPPEMVTSQ 231 (271)
Q Consensus 214 ----------~~~~gt~~y~aPE~~~~~ 231 (271)
....+++.|+|||.+...
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCChh
Confidence 234578889999998654
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-22 Score=174.71 Aligned_cols=171 Identities=33% Similarity=0.546 Sum_probs=124.9
Q ss_pred ccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceee----------------
Q psy4396 87 PLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS---------------- 147 (271)
Q Consensus 87 ~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---------------- 147 (271)
.+|+|+||.|++++.. ..+..+|+|++++......... ....++. .+.....+|+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~---il~~~~~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERI---ILAFVHNTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHH---HHhhccCCCceeeeeeeeccccchhHhh
Confidence 3799999999987543 3467799999876543322111 0000000 000011122222
Q ss_pred ----------eccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCccccc
Q psy4396 148 ----------SEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMC 217 (271)
Q Consensus 148 ----------~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 217 (271)
.......+.+.....+...++.+++++|+.+|+|||+|++||+++.+|.+++.|||+++..-..... |
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--c 154 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--C 154 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--c
Confidence 1222244678888899999999999999999999999999999999999999999999876554433 8
Q ss_pred ccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||..|||||++. ....++|.||||++.+||++|..||.+ ++..+|+
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il 200 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL 200 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh
Confidence 999999999998 567899999999999999999999998 4544443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=153.98 Aligned_cols=177 Identities=34% Similarity=0.528 Sum_probs=126.8
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH----Hhh------hhhhce--eeeEEecCcCCCcceeeec
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE----RMT------HQVHRE--RCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~------~~~~~~--~~~~~~~~~~~~~~~l~~~ 149 (271)
|.+.+.||.|+||.||++.+. ..+|+|.+........ ... ..+... ...............++..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 678889999999999999988 5689999865432211 000 011100 0000000000000011110
Q ss_pred -c----------Cc---ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CEEEeeccccccCCCC---
Q psy4396 150 -E----------GY---SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPSL--- 211 (271)
Q Consensus 150 -~----------~~---~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~~~~~--- 211 (271)
. .. ..+++.....++.|++.++.++|+.+++|||+||+||+++..+ .++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 0 01 1578889999999999999999999999999999999999888 6999999998644332
Q ss_pred -----CcccccccccccCcceecc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 212 -----HRKTMCGTLDYLPPEMVTS---QHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 212 -----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
......||..|+|||.+.+ ..++...|+||+|++++++++|..||.....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2355678999999999987 5788999999999999999999999887763
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.9e-20 Score=171.72 Aligned_cols=182 Identities=24% Similarity=0.330 Sum_probs=129.0
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH----HHHHhhhhhh-ceeeeEEecCcCC---C
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI----INERMTHQVH-RERCCQVHLSSSR---R 142 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~---~ 142 (271)
+....++.-..|.|.+.||+|+||.||+|.... ++.||+|+=++... +..+...++. ........+.... .
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 344555566789999999999999999999888 88999998544321 1112222221 0000001100000 0
Q ss_pred --------cc---eeeeccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-------CCCEEEeeccc
Q psy4396 143 --------HP---LLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM-------HEDVKISDFGW 204 (271)
Q Consensus 143 --------~~---~l~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~-------~~~~kl~Dfg~ 204 (271)
++ ++........+++..+..+..|++..+++||..+|||+||||+|+||.. ...++|+|||-
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 00 1112223355788999999999999999999999999999999999942 23589999998
Q ss_pred cccCC---CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCC
Q psy4396 205 SVHAP---SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGK 253 (271)
Q Consensus 205 a~~~~---~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 253 (271)
|.... +. .-...++|-.+-++|+..+.+++..+|.|.++.+++-|+.|+
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 75432 22 223456789999999999999999999999999999999885
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.3e-20 Score=144.65 Aligned_cols=55 Identities=24% Similarity=0.300 Sum_probs=49.5
Q ss_pred cCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 154 LYTEKDAAKYIYQVADAIHYC-HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 154 ~~~~~~~~~~~~qi~~~L~~L-H~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
.++...+..++.|++.+|.++ |+.||+||||||+|||++ ++.++|+|||+|....
T Consensus 113 ~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 113 PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 467888999999999999999 799999999999999998 5889999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-19 Score=139.87 Aligned_cols=176 Identities=18% Similarity=0.199 Sum_probs=111.1
Q ss_pred EecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh-hhhhhceeeeEEecCcCCCcceeee----------ccCc
Q psy4396 84 VGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM-THQVHRERCCQVHLSSSRRHPLLSS----------EEGY 152 (271)
Q Consensus 84 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~----------~~~~ 152 (271)
+...|++|+||+|+.+.. .+..++.+.+.......... ...+.+|......+.....+|.+.. ..|.
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~ 83 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA 83 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence 466799999999998875 34557766665443321111 0012222222222211112222211 1121
Q ss_pred ccC--CHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEeCCCCCEEEeeccccccCCCCCc---------------c
Q psy4396 153 SLY--TEKDAAKYIYQVADAIHYCHQKKVIHRDI-KPENLLLTMHEDVKISDFGWSVHAPSLHR---------------K 214 (271)
Q Consensus 153 ~~~--~~~~~~~~~~qi~~~L~~LH~~~iiHrDi-kp~Nili~~~~~~kl~Dfg~a~~~~~~~~---------------~ 214 (271)
.+. .......++.|++.+|+++|++||+|||| ||+|||++.++.++|+|||+|........ .
T Consensus 84 ~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~ 163 (218)
T PRK12274 84 AMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKH 163 (218)
T ss_pred cHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHH
Confidence 111 11123467889999999999999999999 79999999999999999999975443221 0
Q ss_pred cccccccccCcceec--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 215 TMCGTLDYLPPEMVT--SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
-...++.|++|+... ...--...+.++.|+-+|.++||+.|+.++++
T Consensus 164 ~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 164 KRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 122577888887432 22223678899999999999999999876654
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-19 Score=144.97 Aligned_cols=180 Identities=16% Similarity=0.263 Sum_probs=130.5
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCccc--
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSL-- 154 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-- 154 (271)
++.+++.++.+|.....|+.|+|++.++. ++.|+++.... ..+..+.+..|+..... ..||++....+.|.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~-t~risrdfneefp~lri----fshpnilpvlgacnsp 259 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREV-TARISRDFNEEFPALRI----FSHPNILPVLGACNSP 259 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhc-chhhcchhhhhCcceee----ecCCchhhhhhhccCC
Confidence 45667778888999999999999999865 77788754332 34455556666544333 35555443333211
Q ss_pred --------------------------CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCCEEEe--eccc
Q psy4396 155 --------------------------YTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTMHEDVKIS--DFGW 204 (271)
Q Consensus 155 --------------------------~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~~~~~kl~--Dfg~ 204 (271)
....++.+++.++++|++|||+.. |.---|++..++||++.+.+|+ |--+
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence 345778899999999999999975 4444788999999999887764 3222
Q ss_pred cccCCCCCcccccccccccCcceeccCCCC---CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLHRKTMCGTLDYLPPEMVTSQHYG---KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
+-.. ......|.|++||.+..++-+ .++|+|||++++||+.|+..||....+.|+-.+|
T Consensus 340 sfqe-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 340 SFQE-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred eeec-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 2111 123357899999999776543 4899999999999999999999999999987665
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=136.44 Aligned_cols=55 Identities=22% Similarity=0.265 Sum_probs=50.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
++...+..++.|++.++.++|+ .||+||||||+|||++ ++.++|+|||++.....
T Consensus 114 ~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 114 LEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 5677889999999999999999 9999999999999999 89999999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-19 Score=163.53 Aligned_cols=176 Identities=27% Similarity=0.425 Sum_probs=125.3
Q ss_pred EEecccccCCceEEEEEEEcCCCeEEEEEEcch---hHHHHHHhhhhhhceeeeEEecCcCCCcceeee-----------
Q psy4396 83 EVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK---VEIINERMTHQVHRERCCQVHLSSSRRHPLLSS----------- 148 (271)
Q Consensus 83 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~----------- 148 (271)
.....+|.|++|.|+.+......+.++.|.+.. ...........+..|++.. ..+.||++..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~----~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIG----SSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeec----ccccCCchhhhHHHHhhcccc
Confidence 356789999999888887776655566554421 1111111111133343333 3334443210
Q ss_pred --------------ccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC---C-
Q psy4396 149 --------------EEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP---S- 210 (271)
Q Consensus 149 --------------~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~---~- 210 (271)
......++..++..++.|++.|++|+|+.|+.|||+||+|+++..+|.+||+|||.+.... +
T Consensus 397 ~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 397 LQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 1111246778889999999999999999999999999999999999999999999874321 1
Q ss_pred --CCcccccccccccCcceeccCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 211 --LHRKTMCGTLDYLPPEMVTSQHYGK-EVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
......+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 2223467899999999999999976 689999999999999999999765544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.9e-19 Score=143.32 Aligned_cols=157 Identities=16% Similarity=0.138 Sum_probs=95.3
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh----------------hhhhhceeeeEE------ec
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM----------------THQVHRERCCQV------HL 137 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----------------~~~~~~~~~~~~------~~ 137 (271)
++|...+.||.|+||.||++... +..+|+|++.+.....+.. ...+........ ..
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 78999999999999999998663 4469999986432111111 111111100000 00
Q ss_pred CcC---CCccee--eeccCcccCCH-HHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 138 SSS---RRHPLL--SSEEGYSLYTE-KDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 138 ~~~---~~~~~l--~~~~~~~~~~~-~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
... .....+ ....|..+-.. ........+++.+|..+|+.|++|||++|+||+++.+| ++|+|||.+......
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~ 187 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQR 187 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccch
Confidence 000 001111 12222211000 00023466999999999999999999999999999888 999999977544321
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHH
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEF 249 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 249 (271)
... ........++.++|+||||+++...
T Consensus 188 ~a~----------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 188 KAK----------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred hhH----------HHHHHHhHhcccccccceeEeehHH
Confidence 111 1133455677899999999987644
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.2e-18 Score=142.32 Aligned_cols=106 Identities=26% Similarity=0.482 Sum_probs=80.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC--CCC--CEEEeeccccccCCC--------CCcccccccccc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT--MHE--DVKISDFGWSVHAPS--------LHRKTMCGTLDY 222 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~--~~~--~~kl~Dfg~a~~~~~--------~~~~~~~gt~~y 222 (271)
.+.....-++.|++.|+.|||.+|+.|||+|++|||+. +|+ .+.|+|||.+.-... +..-..-|.-.-
T Consensus 338 ~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~l 417 (598)
T KOG4158|consen 338 RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKL 417 (598)
T ss_pred CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCccee
Confidence 35666778899999999999999999999999999993 343 468899996532111 111122356778
Q ss_pred cCcceeccCC------CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 223 LPPEMVTSQH------YGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 223 ~aPE~~~~~~------~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
||||+....+ --.++|.|+.|.+.||++....||.+..
T Consensus 418 mAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 418 MAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG 461 (598)
T ss_pred cchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc
Confidence 9999885432 1248999999999999999999998743
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.1e-18 Score=156.83 Aligned_cols=173 Identities=23% Similarity=0.324 Sum_probs=115.3
Q ss_pred CeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhH--HHHHHhhhhhhceeeeEEecCcC------------------
Q psy4396 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVE--IINERMTHQVHRERCCQVHLSSS------------------ 140 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~------------------ 140 (271)
++...+.||++.|=.|.+|++...- |+||++-+.. +.-+...+.+.... .......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~--vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL--VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce--EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHH
Confidence 5777888999999999999987643 9999985432 10011111111110 0001000
Q ss_pred ---CCcceeeeccCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC--CCCCc--
Q psy4396 141 ---RRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA--PSLHR-- 213 (271)
Q Consensus 141 ---~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~--~~~~~-- 213 (271)
..|-+..++.-...+..-+.+-++.|++.||..+|..||+|||||.+||||++=..+.|+||..-+.. +....
T Consensus 100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 11112222222233566778889999999999999999999999999999999999999999754321 11111
Q ss_pred -----ccccccccccCcceecc----------CC-CCCchhHHHHHHHHHHHHh-CCCCCC
Q psy4396 214 -----KTMCGTLDYLPPEMVTS----------QH-YGKEVDNWCIGILAYEFLV-GKPPFE 257 (271)
Q Consensus 214 -----~~~~gt~~y~aPE~~~~----------~~-~~~~~DiwslG~il~el~~-g~~pf~ 257 (271)
.+...-.+|.|||.+.. .+ .+++.||||+||++.|+++ |++||.
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 11223458999997743 12 5789999999999999987 899994
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-18 Score=148.85 Aligned_cols=92 Identities=33% Similarity=0.596 Sum_probs=80.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--------CcccccccccccCccee
Q psy4396 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--------HRKTMCGTLDYLPPEMV 228 (271)
Q Consensus 157 ~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--------~~~~~~gt~~y~aPE~~ 228 (271)
....+.++.|++.|++| +|.+|||+||.||+...+..+||.|||+....... ..+...||..||+||.+
T Consensus 358 ~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi 434 (516)
T KOG1033|consen 358 LSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQI 434 (516)
T ss_pred hhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHH
Confidence 44566788899999999 99999999999999999999999999997544332 23456799999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHh
Q psy4396 229 TSQHYGKEVDNWCIGILAYEFLV 251 (271)
Q Consensus 229 ~~~~~~~~~DiwslG~il~el~~ 251 (271)
.+..|+.++||||||++|+|++.
T Consensus 435 ~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 435 RGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhhhcchhhHHHHHHHHHH
Confidence 99999999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=130.76 Aligned_cols=127 Identities=20% Similarity=0.166 Sum_probs=82.4
Q ss_pred CeEEecccccCCceEEEEEE-EcCCCeEEEEEEcchhHHH------------------------------HH-Hhhhhhh
Q psy4396 81 DFEVGCPLGTGKFGHVYLAK-EKTTQIMIALKVLYKVEII------------------------------NE-RMTHQVH 128 (271)
Q Consensus 81 ~~~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~------------------------------~~-~~~~~~~ 128 (271)
-|.+.+.||+|++|.||+|. +..+++.||+|++...... .+ .....+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37788899999999999998 6678899999998643210 00 0000011
Q ss_pred ceeeeEEecCcCCCcceeee--ccC---------cccCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEeCCCCC
Q psy4396 129 RERCCQVHLSSSRRHPLLSS--EEG---------YSLYTEKDAAKYIYQVADAIHYCHQKK-VIHRDIKPENLLLTMHED 196 (271)
Q Consensus 129 ~~~~~~~~~~~~~~~~~l~~--~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~-iiHrDikp~Nili~~~~~ 196 (271)
..............+ +++. ..+ ...+....+..++.|++.+|.+||+.| ++||||||+||+++ ++.
T Consensus 109 ~~~i~~p~~~~~~~~-~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~ 186 (237)
T smart00090 109 EAGVPVPKPIAWRRN-VLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGK 186 (237)
T ss_pred hcCCCCCeeeEecCc-eEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCC
Confidence 000000000000011 1111 111 112345557789999999999999999 99999999999999 889
Q ss_pred EEEeeccccccCC
Q psy4396 197 VKISDFGWSVHAP 209 (271)
Q Consensus 197 ~kl~Dfg~a~~~~ 209 (271)
++|+|||.+....
T Consensus 187 i~LiDFg~a~~~~ 199 (237)
T smart00090 187 VVIIDVSQSVELD 199 (237)
T ss_pred EEEEEChhhhccC
Confidence 9999999876543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=120.30 Aligned_cols=127 Identities=21% Similarity=0.218 Sum_probs=80.0
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH----------------------------HH-Hhhhhhhceee
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII----------------------------NE-RMTHQVHRERC 132 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~-~~~~~~~~~~~ 132 (271)
|.+.+.||+|+||.||++... +++.||||++...... .+ .....+.....
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 667788999999999999875 6888999986432100 00 00000000000
Q ss_pred eEEecCcCCCcceeee--ccCcc--cCCH-HHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 133 CQVHLSSSRRHPLLSS--EEGYS--LYTE-KDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 133 ~~~~~~~~~~~~~l~~--~~~~~--~~~~-~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..........+ .++. ..+.. .+.. .....++.+++.++.++|+.|++||||+|+||+++.++.++|+|||.+..
T Consensus 96 ~v~~~~~~~~~-~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 96 PVPKPIDWNRH-AVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CCCceeecCCc-eEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence 00000000111 1111 11111 1112 45667889999999999999999999999999999999999999998855
Q ss_pred CCC
Q psy4396 208 APS 210 (271)
Q Consensus 208 ~~~ 210 (271)
...
T Consensus 175 ~~~ 177 (198)
T cd05144 175 TDH 177 (198)
T ss_pred CCC
Confidence 544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.3e-16 Score=122.90 Aligned_cols=52 Identities=19% Similarity=0.266 Sum_probs=47.2
Q ss_pred HHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 158 KDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 158 ~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..+..++.+++.++.++|. .|++||||||+||+++ ++.++|+|||.+.....
T Consensus 114 ~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 114 EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccccC
Confidence 5678899999999999999 9999999999999999 89999999998865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.4e-14 Score=112.72 Aligned_cols=50 Identities=18% Similarity=0.389 Sum_probs=45.3
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 159 DAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 159 ~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+....
T Consensus 96 ~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 96 EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 4568899999999999999999999999999999 8899999999886543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.1e-14 Score=113.60 Aligned_cols=44 Identities=16% Similarity=0.223 Sum_probs=36.6
Q ss_pred HHHHHHHHHH-HHHHHCCceeccCCCCceEeCCC----CCEEEeecccc
Q psy4396 162 KYIYQVADAI-HYCHQKKVIHRDIKPENLLLTMH----EDVKISDFGWS 205 (271)
Q Consensus 162 ~~~~qi~~~L-~~LH~~~iiHrDikp~Nili~~~----~~~kl~Dfg~a 205 (271)
.++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 108 ~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 108 AQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 5577888777 99999999999999999999743 37999995433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.7e-13 Score=108.46 Aligned_cols=47 Identities=15% Similarity=0.420 Sum_probs=43.6
Q ss_pred HHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 162 ~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
.++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++....
T Consensus 94 ~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 94 ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 7899999999999999999999999999999 8999999999886643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.46 E-value=7.3e-15 Score=134.85 Aligned_cols=179 Identities=28% Similarity=0.425 Sum_probs=127.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcC-CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKT-TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
...|.+.+.||+|+|+.|-.+.... ....+|+|.+.... .......+...+......+.. |.+++...+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~---h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSK---HSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccc---cccccccCCccCCCc
Confidence 4678889999999999999887643 34456777654332 111111222222222222211 3333322211
Q ss_pred ----------------------c-cCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeCCCC-CEEEeecccccc
Q psy4396 153 ----------------------S-LYTEKDAAKYIYQVADAIHYCH-QKKVIHRDIKPENLLLTMHE-DVKISDFGWSVH 207 (271)
Q Consensus 153 ----------------------~-~~~~~~~~~~~~qi~~~L~~LH-~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~ 207 (271)
. ..+...+..++.|+..++.|+| ..++.|||+||+|.+++..+ .++++|||+|..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 1 3566778899999999999999 99999999999999999999 999999999854
Q ss_pred CCC-----CCcccccc-cccccCcceeccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 208 APS-----LHRKTMCG-TLDYLPPEMVTSQH-YGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 208 ~~~-----~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
... ......+| ++.|+|||...+.. .....|+||.|+++.-+++|..|+.....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 333 23344678 99999999998854 46789999999999999999999975443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.8e-13 Score=121.62 Aligned_cols=50 Identities=16% Similarity=0.389 Sum_probs=45.2
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 160 ~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++....
T Consensus 430 ~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~~ 479 (535)
T PRK09605 430 NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSDL 479 (535)
T ss_pred HHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCCc
Confidence 56788999999999999999999999999999 578999999999976543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=5e-12 Score=103.91 Aligned_cols=47 Identities=21% Similarity=0.266 Sum_probs=42.6
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 163 ~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
.+.+++.+|.+||+.||+||||||.|||++.++.++|+|||.+....
T Consensus 147 ~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 147 QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGELRT 193 (239)
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence 36789999999999999999999999999988999999999876543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.29 E-value=4e-11 Score=90.77 Aligned_cols=123 Identities=23% Similarity=0.191 Sum_probs=78.1
Q ss_pred EecccccCCceEEEEEEEcCCCeEEEEEEcchhHH----HHH-Hhhhhhhce---eeeEEecCcCCCcceeee--ccCcc
Q psy4396 84 VGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI----INE-RMTHQVHRE---RCCQVHLSSSRRHPLLSS--EEGYS 153 (271)
Q Consensus 84 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~-~~~~~~~~~---~~~~~~~~~~~~~~~l~~--~~~~~ 153 (271)
+++.||+|.++.||++...+ ..+++|....... ..+ .....+... ...............+.. ..+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 35679999999999999865 4699999865421 111 111122111 000011111101122221 11111
Q ss_pred c--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 154 L--YTEKDAAKYIYQVADAIHYCHQK---KVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 154 ~--~~~~~~~~~~~qi~~~L~~LH~~---~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
. ++......++.+++.+|+.+|.. +++|+|++|+||+++..+.++++|||.+...
T Consensus 80 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 1 13466778899999999999985 6999999999999998899999999987543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.23 E-value=7e-12 Score=117.26 Aligned_cols=191 Identities=23% Similarity=0.375 Sum_probs=137.7
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec-----
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE----- 149 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~----- 149 (271)
++...+.+.+.+.+-+|+++.++.++-..++-..++|+......+.....+....+..... ...+|+.+..
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i----~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI----TPRSPAVVRSFPSFP 874 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccc----cCCCCceecccCCCC
Confidence 5667788999999999999999999988888777777665443332211111111111111 0122222211
Q ss_pred -----------cCc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 150 -----------EGY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 150 -----------~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.+. .....+-++.....+..++++||+..+.|||++|.|.|+..+|..+++|||+....
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccc
Confidence 100 11344556677788999999999999999999999999999999999999842110
Q ss_pred C------C---------------------------CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCC
Q psy4396 209 P------S---------------------------LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPP 255 (271)
Q Consensus 209 ~------~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 255 (271)
+ + .......+|+.|.+||.+.+......+|+|+.|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 0 0 001234589999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhhc
Q psy4396 256 FESKDQDTTLERIF 269 (271)
Q Consensus 256 f~~~~~~~~~~~I~ 269 (271)
|.....+++++.|+
T Consensus 1035 ~na~tpq~~f~ni~ 1048 (1205)
T KOG0606|consen 1035 FNAETPQQIFENIL 1048 (1205)
T ss_pred CCCcchhhhhhccc
Confidence 99999999988775
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.6e-10 Score=90.18 Aligned_cols=53 Identities=21% Similarity=0.310 Sum_probs=46.0
Q ss_pred CHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 156 TEKDAAKYIYQVADAIHYC-HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 156 ~~~~~~~~~~qi~~~L~~L-H~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
+++.+..+..+++.+|..| |+.|++|+||++.|||+. ++.+.|+|||.+....
T Consensus 122 ~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 122 NDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 4456677889999999999 899999999999999997 6789999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.3e-10 Score=99.25 Aligned_cols=50 Identities=16% Similarity=0.260 Sum_probs=42.1
Q ss_pred HHHHHHHHH-HHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 161 AKYIYQVAD-AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 161 ~~~~~qi~~-~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..++.+++. .+..+|..|++|+|++|.||+++.++.++++|||++...+.
T Consensus 259 ~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 259 KALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 345666665 47889999999999999999999999999999999866543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.9e-11 Score=107.02 Aligned_cols=103 Identities=21% Similarity=0.372 Sum_probs=82.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCceEeCCCCCEEEeeccccccCCC----CCcccccccccccCcceecc
Q psy4396 156 TEKDAAKYIYQVADAIHYCHQKKV-IHRDIKPENLLLTMHEDVKISDFGWSVHAPS----LHRKTMCGTLDYLPPEMVTS 230 (271)
Q Consensus 156 ~~~~~~~~~~qi~~~L~~LH~~~i-iHrDikp~Nili~~~~~~kl~Dfg~a~~~~~----~~~~~~~gt~~y~aPE~~~~ 230 (271)
...-...++++++.||+|||...| .|+.++++|.+++..-.+||+|||+...... .......-..-|.|||.+..
T Consensus 46 d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 46 DYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred cHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 444456778899999999999876 9999999999999999999999998755432 11112223567999999866
Q ss_pred CC-------CCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 231 QH-------YGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 231 ~~-------~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
.. .+.+.|+||+|++++|+++.+.||..
T Consensus 126 ~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 126 ALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred cccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 31 46789999999999999999999976
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.4e-10 Score=86.79 Aligned_cols=120 Identities=16% Similarity=0.156 Sum_probs=71.0
Q ss_pred ecccccCCceEEEEEEEcCCCeEEEEEEcchhHH-----HHH-Hhhhhhhce--eeeEEecCcCCCcceeeeccCcccCC
Q psy4396 85 GCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI-----INE-RMTHQVHRE--RCCQVHLSSSRRHPLLSSEEGYSLYT 156 (271)
Q Consensus 85 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~-~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~ 156 (271)
++.|+.|.++.||+++.. +..|++|+...... ..+ .....+... .............-......+.....
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT 80 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence 456899999999999865 55799999754320 011 011111110 00011111100111122222222211
Q ss_pred -HHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 157 -EKDAAKYIYQVADAIHYCHQKKV-----IHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 157 -~~~~~~~~~qi~~~L~~LH~~~i-----iHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
.......+.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 EDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 11223567889999999999985 9999999999999 67899999997653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=98.72 Aligned_cols=64 Identities=19% Similarity=0.279 Sum_probs=43.3
Q ss_pred cccHHHHHHHHhhhhccccCC----------CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcch
Q psy4396 51 KENVEEYLKKMQTHYDAREAP----------NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK 115 (271)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~ 115 (271)
.+.+.+.+++.++...+.+.. ...+.--..+|+. +.||+|++|+||+|+.+.+|+.||||+..+
T Consensus 81 P~~~~~eL~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP 154 (537)
T PRK04750 81 PPDIADELALLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRP 154 (537)
T ss_pred CHHHHHHHHHHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCc
Confidence 344555566666655443321 0112222456776 789999999999999988889999999864
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.1e-10 Score=100.81 Aligned_cols=183 Identities=16% Similarity=0.189 Sum_probs=120.8
Q ss_pred cccccCeEEeccccc--CCceEEEEEEE--cCCCeEEEEEEcchhHH--------HHHHhhhhhhceeeeEEe---cCcC
Q psy4396 76 RWQMSDFEVGCPLGT--GKFGHVYLAKE--KTTQIMIALKVLYKVEI--------INERMTHQVHRERCCQVH---LSSS 140 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~~~~~~~~---~~~~ 140 (271)
.+....+.+.+.+|. |.+|.||.+.. ..+...+|+|.-+...- ..+-............+. ....
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 334456778889999 99999999998 77888899987321100 000000000000000000 0000
Q ss_pred CCcceeeeccC----------c-ccCCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCceEeCCC-CCEEEeeccc
Q psy4396 141 RRHPLLSSEEG----------Y-SLYTEKDAAKYIYQVAD----AIHYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGW 204 (271)
Q Consensus 141 ~~~~~l~~~~~----------~-~~~~~~~~~~~~~qi~~----~L~~LH~~~iiHrDikp~Nili~~~-~~~kl~Dfg~ 204 (271)
..+-++..... - ..+++..++..+.+... ||.++|+.+++|-|+||.||++..+ ..+++.|||+
T Consensus 190 ~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 190 SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 01111111110 1 22678888888899988 9999999999999999999999999 8899999998
Q ss_pred cccCCCCCc--c-----cccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 205 SVHAPSLHR--K-----TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 205 a~~~~~~~~--~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.....+..- . ...|...|++||...+- ++.+.|++|||.+..+..++..+....
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCC
Confidence 765543221 1 12467889999988654 788999999999999988876665433
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.5e-09 Score=91.01 Aligned_cols=106 Identities=18% Similarity=0.294 Sum_probs=87.9
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc-cccCCCCCcccccccccccCcceec---
Q psy4396 154 LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW-SVHAPSLHRKTMCGTLDYLPPEMVT--- 229 (271)
Q Consensus 154 ~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~-a~~~~~~~~~~~~gt~~y~aPE~~~--- 229 (271)
.+.+.-+.+.+..++.+.+.||..|-+-+|++++|+|+++++.+.|.|=.. .....+....+.+|.+.|++||...
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~s 192 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPS 192 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhcccc
Confidence 356777889999999999999999999999999999999999999987532 2234444455677999999999764
Q ss_pred --cCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy4396 230 --SQHYGKEVDNWCIGILAYEFLV-GKPPFESK 259 (271)
Q Consensus 230 --~~~~~~~~DiwslG~il~el~~-g~~pf~~~ 259 (271)
+...+...|.|.||+++++++. |+.||.+-
T Consensus 193 f~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 193 FVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 4556788999999999999887 59999864
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.1e-10 Score=100.06 Aligned_cols=178 Identities=19% Similarity=0.219 Sum_probs=113.8
Q ss_pred cccccCeEEecccccCCceEEEEEEEc-CCCeEEEEEEcchhHHHHHHhhhhh---hceeeeEEecCcCC--------Cc
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEK-TTQIMIALKVLYKVEIINERMTHQV---HRERCCQVHLSSSR--------RH 143 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~--------~~ 143 (271)
.....+|..+..||.|.|+.|+....+ .++..|++|.+.+...........+ ..+........... ++
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344678999999999999999998766 5677899887754332211111000 00000001110000 01
Q ss_pred ceeeeccC--c---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCEEEeeccccccCCCC
Q psy4396 144 PLLSSEEG--Y---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGWSVHAPSL 211 (271)
Q Consensus 144 ~~l~~~~~--~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-~~~kl~Dfg~a~~~~~~ 211 (271)
-++..... . ..+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.|||......-.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 01100000 0 125677788889999999999999999999999999999876 67789999987543222
Q ss_pred Ccccccccccc-cCcceeccCCCCCchhHHHHHHHHHHHHhCC
Q psy4396 212 HRKTMCGTLDY-LPPEMVTSQHYGKEVDNWCIGILAYEFLVGK 253 (271)
Q Consensus 212 ~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 253 (271)
.......+..| .+|.......+..++|++|||.-+.+.+++.
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~ 463 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS 463 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCc
Confidence 22222223334 3566667778889999999999888887764
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.6e-09 Score=92.72 Aligned_cols=95 Identities=15% Similarity=0.356 Sum_probs=71.9
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc--ccccccccccCcceeccCC
Q psy4396 156 TEKDAAKYIYQVADAIHYCH-QKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR--KTMCGTLDYLPPEMVTSQH 232 (271)
Q Consensus 156 ~~~~~~~~~~qi~~~L~~LH-~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~gt~~y~aPE~~~~~~ 232 (271)
....+...+.||++||.+|| +.+++|++|.-+.|+++..|..||++|.++........ ....-.-.|..|+.+....
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence 34556677899999999998 56799999999999999999999999998765544321 1111223466666554332
Q ss_pred CCCchhHHHHHHHHHHHHhC
Q psy4396 233 YGKEVDNWCIGILAYEFLVG 252 (271)
Q Consensus 233 ~~~~~DiwslG~il~el~~g 252 (271)
-..|.|.|||+++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 457999999999999998
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.2e-10 Score=100.18 Aligned_cols=98 Identities=26% Similarity=0.489 Sum_probs=78.6
Q ss_pred HHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeeccccccCCCCCcc-----------cccccccccCcceeccC
Q psy4396 164 IYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK-----------TMCGTLDYLPPEMVTSQ 231 (271)
Q Consensus 164 ~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-----------~~~gt~~y~aPE~~~~~ 231 (271)
+.+...|+.++|.. ++||++|.|++|.++..|.+||+.|+.+....+.... .......|.|||.+.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44556999999976 8999999999999999999999999988655441111 11235689999999998
Q ss_pred CCCCchhHHHHHHHHHHHH-hCCCCCCCCCH
Q psy4396 232 HYGKEVDNWCIGILAYEFL-VGKPPFESKDQ 261 (271)
Q Consensus 232 ~~~~~~DiwslG~il~el~-~g~~pf~~~~~ 261 (271)
..+.++|+||+|+++|.+. .|+.-+...+.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~ 215 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG 215 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCC
Confidence 8899999999999999998 57776665543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.8e-08 Score=75.42 Aligned_cols=49 Identities=18% Similarity=0.379 Sum_probs=41.4
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 161 AKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 161 ~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..++..+-.-+.-||..||+|+||.++||++..+ .+.++|||++.....
T Consensus 95 ~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s~~ 143 (204)
T COG3642 95 PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSDE 143 (204)
T ss_pred hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccccccc
Confidence 3567778888999999999999999999999844 599999999865443
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.77 E-value=6e-08 Score=74.77 Aligned_cols=49 Identities=27% Similarity=0.432 Sum_probs=42.1
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---EEEeeccccccC
Q psy4396 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHA 208 (271)
Q Consensus 160 ~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~---~kl~Dfg~a~~~ 208 (271)
...++.++-..+.-||..+|+|+||..+||++.+++. +.++|||++...
T Consensus 115 ~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 115 LAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred HHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 3678889999999999999999999999999976654 579999997443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.4e-06 Score=71.42 Aligned_cols=52 Identities=15% Similarity=0.335 Sum_probs=44.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 157 ~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.+....++..|+.-+..+-..|+||+|+++-||+++++|.+.++||-.+...
T Consensus 201 ~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 201 VENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccccC
Confidence 6667777888888888878999999999999999999999999999866443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.8e-06 Score=68.12 Aligned_cols=54 Identities=17% Similarity=0.208 Sum_probs=46.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 156 TEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 156 ~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..+++..+..++++.+.-|-. .++||+||+.-|||+. ++.+.++|||.|.....
T Consensus 164 e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 164 ELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 344688888999999999887 8999999999999999 89999999998865543
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.5e-06 Score=72.73 Aligned_cols=100 Identities=17% Similarity=0.237 Sum_probs=76.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCCEEEeecccccc------CCCCCcccccccccccCcc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTMHEDVKISDFGWSVH------APSLHRKTMCGTLDYLPPE 226 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~~~~~kl~Dfg~a~~------~~~~~~~~~~gt~~y~aPE 226 (271)
+.....++|+.||+.||.|||+.. |+|+++..+.|++..+|-+|+.--.-... .....+....+-++|.+||
T Consensus 173 ~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~ 252 (458)
T KOG1266|consen 173 LFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPE 252 (458)
T ss_pred hhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCC
Confidence 567778899999999999999985 99999999999999888888743211111 1111222334678999999
Q ss_pred eeccCCCCCchhHHHHHHHHHHHHhCCC
Q psy4396 227 MVTSQHYGKEVDNWCIGILAYEFLVGKP 254 (271)
Q Consensus 227 ~~~~~~~~~~~DiwslG~il~el~~g~~ 254 (271)
.=.....+.++|||+||....||..+..
T Consensus 253 sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 253 SGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCcccccccchhhhhhhHHHHHHHHhee
Confidence 7666667789999999999999887643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.4e-06 Score=69.99 Aligned_cols=54 Identities=19% Similarity=0.329 Sum_probs=47.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC---CEEEeeccccccCC
Q psy4396 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE---DVKISDFGWSVHAP 209 (271)
Q Consensus 156 ~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~---~~kl~Dfg~a~~~~ 209 (271)
+......++.+++..++-||+.|++|+|++|.|||++.++ .+.++||+-++...
T Consensus 116 ~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 116 DPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred chhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 4556778999999999999999999999999999999887 78999999765443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.6e-06 Score=72.29 Aligned_cols=51 Identities=20% Similarity=0.208 Sum_probs=44.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-------CCCEEEeecccccc
Q psy4396 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM-------HEDVKISDFGWSVH 207 (271)
Q Consensus 157 ~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~-------~~~~kl~Dfg~a~~ 207 (271)
......++.+++..+..||..||+|+|+++.|||++. ++.+.|+||+.+..
T Consensus 137 ~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 137 PRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 4466788999999999999999999999999999975 46789999998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.6e-05 Score=62.90 Aligned_cols=30 Identities=20% Similarity=0.327 Sum_probs=25.3
Q ss_pred ceeccCCCCceEeCC--CCCEEEeeccccccC
Q psy4396 179 VIHRDIKPENLLLTM--HEDVKISDFGWSVHA 208 (271)
Q Consensus 179 iiHrDikp~Nili~~--~~~~kl~Dfg~a~~~ 208 (271)
++|+|+.|.||+++. ++.+.|+||+.+...
T Consensus 176 l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 176 LVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred EEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 589999999999998 566899999976543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.7e-06 Score=66.35 Aligned_cols=52 Identities=23% Similarity=0.418 Sum_probs=39.8
Q ss_pred HHHHHHHHHHHHHHHH-HHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 158 KDAAKYIYQVADAIHY-CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 158 ~~~~~~~~qi~~~L~~-LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
+....++.+++..+.. +|+.|++|+|+.+.|||++++ .+.++|||.+.....
T Consensus 106 ~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~~ 158 (188)
T PF01163_consen 106 EEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSSH 158 (188)
T ss_dssp STHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETTS
T ss_pred hhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecCC
Confidence 4466788888885555 579999999999999999966 999999998866543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.2e-05 Score=67.95 Aligned_cols=95 Identities=18% Similarity=0.183 Sum_probs=70.2
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcccccccccccCcceeccCCC
Q psy4396 154 LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHY 233 (271)
Q Consensus 154 ~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 233 (271)
..+++.++.++.|+..||.++|+.|+..+-|.|.+||++.+..++|+.-|......... . +.+..
T Consensus 389 ~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~----------~--~~le~--- 453 (655)
T KOG3741|consen 389 KAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP----------T--EPLES--- 453 (655)
T ss_pred CchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC----------C--cchhH---
Confidence 36789999999999999999999999999999999999988888888777553322211 0 11111
Q ss_pred CCchhHHHHHHHHHHHHhCCCC-CCCCCHHH
Q psy4396 234 GKEVDNWCIGILAYEFLVGKPP-FESKDQDT 263 (271)
Q Consensus 234 ~~~~DiwslG~il~el~~g~~p-f~~~~~~~ 263 (271)
-.+-|.=.||.++..|.||..- +.....++
T Consensus 454 ~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~ 484 (655)
T KOG3741|consen 454 QQQNDLRDLGLLLLALATGTENSNRTDSTQS 484 (655)
T ss_pred HhhhhHHHHHHHHHHHhhcccccccccchHH
Confidence 1357888999999999998433 34344333
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=6.2e-05 Score=68.26 Aligned_cols=40 Identities=20% Similarity=0.324 Sum_probs=33.9
Q ss_pred HHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 171 IHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 171 L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
+..+=..|+.|.|..|.||+++.+|.+.+.|||+....++
T Consensus 278 ~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 4445568999999999999999999999999998765544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00022 Score=57.25 Aligned_cols=44 Identities=23% Similarity=0.351 Sum_probs=37.2
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 163 ~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
+...+..++.-||+.|+.|+|..|.|++++ ++.++++||+..+.
T Consensus 140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~-~~~i~iID~~~k~~ 183 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVS-NNGIRIIDTQGKRM 183 (229)
T ss_pred HHHHHHHHHHHHHHcCCccCCCCcCcEEEE-CCcEEEEECccccc
Confidence 445677889999999999999999999999 45599999985543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=3.1e-05 Score=61.81 Aligned_cols=52 Identities=13% Similarity=0.063 Sum_probs=45.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC--EEEeecccccc
Q psy4396 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED--VKISDFGWSVH 207 (271)
Q Consensus 156 ~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~--~kl~Dfg~a~~ 207 (271)
+......++.+++..++-||+.|+.|+|+.+.||+++.+|. ++++||.-++.
T Consensus 126 ~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 126 SDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred chHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 45555789999999999999999999999999999987777 89999986644
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00027 Score=56.03 Aligned_cols=41 Identities=29% Similarity=0.416 Sum_probs=33.6
Q ss_pred HHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 160 ~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
...-+.+|.+-|..+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 166 ~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QIRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred chhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 3344667888899999999999999999987 3389999854
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0032 Score=48.79 Aligned_cols=122 Identities=20% Similarity=0.189 Sum_probs=66.7
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH-----Hhhhhhhceeee-EEecCcCCCcceeeeccCcccC
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE-----RMTHQVHRERCC-QVHLSSSRRHPLLSSEEGYSLY 155 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~ 155 (271)
....+.||+|.+|.||++.+.+. .+|+|+-..+..... ...+.+.-+... .+..... ..-......|..+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~--~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~-~~i~me~i~G~~L~ 100 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGG--EVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE-DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCc--eEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech-hhhhhhhhcCcchh
Confidence 34577899999999999998864 699998643321111 001111000000 0000000 00002222332222
Q ss_pred CHHHH--HHHHHHHHHHHHHHHHCCceeccCC-CCceEeCCCCCEEEeeccccc
Q psy4396 156 TEKDA--AKYIYQVADAIHYCHQKKVIHRDIK-PENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 156 ~~~~~--~~~~~qi~~~L~~LH~~~iiHrDik-p~Nili~~~~~~kl~Dfg~a~ 206 (271)
..... .+....++..-.-|-..||-|+.|. |...++..++.+.|+||..|.
T Consensus 101 ~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 101 KLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 22221 4455556666666777899999997 544444446699999999876
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.012 Score=48.08 Aligned_cols=30 Identities=20% Similarity=0.151 Sum_probs=25.7
Q ss_pred CceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.++|+|+.|.||++++++ +.++||+.+...
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 368999999999999877 999999977544
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0072 Score=52.31 Aligned_cols=55 Identities=20% Similarity=0.227 Sum_probs=46.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 155 YTEKDAAKYIYQVADAIHYCH-QKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH-~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
++...+..+-.+++.-+.-|- ..++||.||+--|+|+- +|.+.++|-+.+.....
T Consensus 261 ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 261 LSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred CChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEEEEccccccCCC
Confidence 567788888888888888885 56899999999999998 88999999998765443
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0094 Score=54.36 Aligned_cols=37 Identities=22% Similarity=0.362 Sum_probs=30.3
Q ss_pred HHHCCceeccCCCCceEeCC----CCCEEEeeccccccCCC
Q psy4396 174 CHQKKVIHRDIKPENLLLTM----HEDVKISDFGWSVHAPS 210 (271)
Q Consensus 174 LH~~~iiHrDikp~Nili~~----~~~~kl~Dfg~a~~~~~ 210 (271)
+=..|++|+|-.|.||++.. ++.+.+.|||+......
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 34578999999999999984 56799999999765544
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.00072 Score=61.85 Aligned_cols=91 Identities=25% Similarity=0.346 Sum_probs=71.1
Q ss_pred HHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-CcccccccccccCcceeccCCCCCchhH
Q psy4396 161 AKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDN 239 (271)
Q Consensus 161 ~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di 239 (271)
......-++++++||+..-+||| ||+.. .+..+..||+.....+.. ...+..+++.++|||+.....+....|.
T Consensus 339 ~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~ 413 (829)
T KOG0576|consen 339 AYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDS 413 (829)
T ss_pred hhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCc
Confidence 34445567789999998778998 77776 478899999987555443 3455678999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCC
Q psy4396 240 WCIGILAYEFLVGKPPF 256 (271)
Q Consensus 240 wslG~il~el~~g~~pf 256 (271)
||+|+-..++.-|-+|=
T Consensus 414 ~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 414 GSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCcchhhcCCCCCCC
Confidence 99998666666666654
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.004 Score=52.97 Aligned_cols=49 Identities=18% Similarity=0.267 Sum_probs=41.8
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 158 KDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 158 ~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
..+..+...+..-+.-|-..|+||+|.+-=||++++++.++++||-...
T Consensus 202 ~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 202 EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhh
Confidence 3455666777888888999999999999999999999999999997543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.014 Score=46.16 Aligned_cols=51 Identities=16% Similarity=0.137 Sum_probs=46.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQ---KKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~---~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
.++..+..++.+++..+++|+. ..+.-.|++|+|+-++++|.+|++|....
T Consensus 56 ~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 56 SPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhc
Confidence 4789999999999999999998 34777999999999999999999999865
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.017 Score=49.39 Aligned_cols=32 Identities=28% Similarity=0.470 Sum_probs=27.6
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.+++|+|+.+.|++++.++...|+||+.+...
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~ 218 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACTD 218 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccCc
Confidence 57999999999999998877789999987443
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.026 Score=48.08 Aligned_cols=30 Identities=27% Similarity=0.453 Sum_probs=25.8
Q ss_pred CCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999986 6789999996543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.013 Score=47.80 Aligned_cols=31 Identities=19% Similarity=0.334 Sum_probs=26.6
Q ss_pred CCceeccCCCCceEeCC-CCCEEEeecccccc
Q psy4396 177 KKVIHRDIKPENLLLTM-HEDVKISDFGWSVH 207 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~-~~~~kl~Dfg~a~~ 207 (271)
.+++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 36999999999999997 57899999987643
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.013 Score=47.91 Aligned_cols=32 Identities=28% Similarity=0.323 Sum_probs=25.8
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.+++|+|+.|.|+|++.++..-|+||+.+...
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 35899999999999986655679999976443
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.029 Score=48.09 Aligned_cols=32 Identities=25% Similarity=0.372 Sum_probs=26.5
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.+++|+|+.|.|||++.+...-|+||+.+...
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 47999999999999986555689999987543
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.0028 Score=63.65 Aligned_cols=79 Identities=13% Similarity=0.038 Sum_probs=66.2
Q ss_pred ceeccCCCCceEeCCCCCEEEeeccccccCCC--CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy4396 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256 (271)
Q Consensus 179 iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 256 (271)
-+|+++|+-|.+|..+..+++.++|+.+.... .......+++.|++|++...-.++.++|+|..|+.+|+...|..||
T Consensus 1361 ~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred chhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 57999999999999999999999999983332 2233456788899999998888888899999999999998888887
Q ss_pred C
Q psy4396 257 E 257 (271)
Q Consensus 257 ~ 257 (271)
.
T Consensus 1441 i 1441 (2724)
T KOG1826|consen 1441 I 1441 (2724)
T ss_pred H
Confidence 4
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.025 Score=47.88 Aligned_cols=32 Identities=28% Similarity=0.413 Sum_probs=27.3
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.+++|+|+.|.|+|++.++.+.|+||+.+...
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 46999999999999998777789999976543
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.034 Score=47.29 Aligned_cols=31 Identities=23% Similarity=0.396 Sum_probs=26.9
Q ss_pred CceeccCCCCceEeCCC----CCEEEeeccccccC
Q psy4396 178 KVIHRDIKPENLLLTMH----EDVKISDFGWSVHA 208 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~----~~~kl~Dfg~a~~~ 208 (271)
.++|+|+.|.|||++.+ +.+.++||+.|...
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 58999999999999975 88999999987543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.042 Score=46.04 Aligned_cols=49 Identities=22% Similarity=0.308 Sum_probs=36.2
Q ss_pred HHHHHHHHHHHHHHHHHC--CceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 160 AAKYIYQVADAIHYCHQK--KVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 160 ~~~~~~qi~~~L~~LH~~--~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
....+..+-.++.-.+.. -++|+|+.|.|+|.++.+.++|+||..|...
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 333444455555555544 4899999999999998899999999877543
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.022 Score=44.82 Aligned_cols=30 Identities=17% Similarity=0.399 Sum_probs=25.4
Q ss_pred ceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 179 iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
.+|+|+.|.|++++++| ++|+||+.+....
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD 108 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDGD 108 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence 58999999999998766 8999999875443
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.091 Score=51.81 Aligned_cols=101 Identities=18% Similarity=0.189 Sum_probs=75.2
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC---ceEeCCCCCEEEe--eccccccCCCCCc-ccccccccccCcce
Q psy4396 154 LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPE---NLLLTMHEDVKIS--DFGWSVHAPSLHR-KTMCGTLDYLPPEM 227 (271)
Q Consensus 154 ~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~---Nili~~~~~~kl~--Dfg~a~~~~~~~~-~~~~gt~~y~aPE~ 227 (271)
..+.+.++.+..++.+||+++|+....|.-+..+ +...+.++....+ ||+.+...+.... .....+..+.+||.
T Consensus 282 ~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~ 361 (1351)
T KOG1035|consen 282 SIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADED 361 (1351)
T ss_pred ccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccc
Confidence 3678889999999999999999997777766655 5555666677766 8888776655332 23344667888998
Q ss_pred eccCCCCCc--hhHHHHHHHHHHHHhCCC
Q psy4396 228 VTSQHYGKE--VDNWCIGILAYEFLVGKP 254 (271)
Q Consensus 228 ~~~~~~~~~--~DiwslG~il~el~~g~~ 254 (271)
.....++.+ .|+|.+|.++..+..|..
T Consensus 362 ~~~~~~~~~r~~dL~~lgll~~~~~~~~~ 390 (1351)
T KOG1035|consen 362 LKENTAKKSRLTDLWCLGLLLLQLSQGED 390 (1351)
T ss_pred cccccchhhhhhHHHHHHHHHhhhhhcCc
Confidence 877766554 799999999988877543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.024 Score=46.61 Aligned_cols=32 Identities=22% Similarity=0.108 Sum_probs=27.2
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..++|+|+.|.|||++.++...|+||+.+...
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 35899999999999998777889999976543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.015 Score=46.96 Aligned_cols=31 Identities=29% Similarity=0.438 Sum_probs=21.0
Q ss_pred CCceeccCCCCceEeC-CCCCEEEeecccccc
Q psy4396 177 KKVIHRDIKPENLLLT-MHEDVKISDFGWSVH 207 (271)
Q Consensus 177 ~~iiHrDikp~Nili~-~~~~~kl~Dfg~a~~ 207 (271)
..++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 3599999999999999 556668999986643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.079 Score=42.10 Aligned_cols=33 Identities=24% Similarity=0.408 Sum_probs=26.5
Q ss_pred CCceeccCCCCceEeCCCC-----CEEEeeccccccCC
Q psy4396 177 KKVIHRDIKPENLLLTMHE-----DVKISDFGWSVHAP 209 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~-----~~kl~Dfg~a~~~~ 209 (271)
..++|||+.+.|+++..++ .+.++||..+....
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g~ 157 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYGS 157 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCcCC
Confidence 4589999999999997553 58999999775443
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.069 Score=45.65 Aligned_cols=32 Identities=13% Similarity=0.173 Sum_probs=28.4
Q ss_pred CceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
+++|+|+.+.|+|++.++.+.++||..+....
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d~ 228 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFAS 228 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccCC
Confidence 69999999999999989999999999775544
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.034 Score=44.90 Aligned_cols=37 Identities=19% Similarity=0.308 Sum_probs=31.9
Q ss_pred HHHHHHHHHC--CceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 168 ADAIHYCHQK--KVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 168 ~~~L~~LH~~--~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
+.+|.-.|+. +.+|+|..|+||+-|..|.+||.|-+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 4567777853 699999999999999999999999874
|
The function of this family is unknown. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.03 Score=46.47 Aligned_cols=30 Identities=23% Similarity=0.461 Sum_probs=25.8
Q ss_pred CceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.++|+|+.|.||+++.++ +.|+||+.|...
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence 489999999999999776 789999977543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.28 Score=39.13 Aligned_cols=37 Identities=16% Similarity=0.427 Sum_probs=27.7
Q ss_pred HHHHHHHHHHHHCCceeccCCCCceEeCCCC----CEEEee
Q psy4396 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMHE----DVKISD 201 (271)
Q Consensus 165 ~qi~~~L~~LH~~~iiHrDikp~Nili~~~~----~~kl~D 201 (271)
..+-.-.++|-+.+|+.+|++|.||++...+ .+.|+|
T Consensus 125 ~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 125 QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 3344456778889999999999999995442 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.033 Score=44.72 Aligned_cols=29 Identities=31% Similarity=0.620 Sum_probs=20.6
Q ss_pred CceeccCCCCceEe-CCCCCEEEeeccccc
Q psy4396 178 KVIHRDIKPENLLL-TMHEDVKISDFGWSV 206 (271)
Q Consensus 178 ~iiHrDikp~Nili-~~~~~~kl~Dfg~a~ 206 (271)
-++|.|+.|.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48899999999999 788999999999764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.059 Score=46.31 Aligned_cols=50 Identities=24% Similarity=0.297 Sum_probs=32.5
Q ss_pred HHHHHHHHHHHHHHH---H-HCCceeccCCCCceEeCCCC------------------CEEEeeccccccCC
Q psy4396 160 AAKYIYQVADAIHYC---H-QKKVIHRDIKPENLLLTMHE------------------DVKISDFGWSVHAP 209 (271)
Q Consensus 160 ~~~~~~qi~~~L~~L---H-~~~iiHrDikp~Nili~~~~------------------~~kl~Dfg~a~~~~ 209 (271)
++.++.||+.-.--. - ....+|-||||+|||+-+.. .++|.||.+|+..+
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 455666665543212 1 23689999999999994222 36788888875544
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.16 Score=44.21 Aligned_cols=51 Identities=18% Similarity=0.387 Sum_probs=43.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 156 TEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 156 ~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..++.+.+..+.-+... ..-|||+.-.||||+ +|++.|+||-+++-
T Consensus 319 ~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 319 RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4677778888877777777665 588999999999999 99999999999874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.48 E-value=0.1 Score=45.39 Aligned_cols=31 Identities=16% Similarity=0.382 Sum_probs=26.3
Q ss_pred CceeccCCCCceEeCC-CCCEEEeeccccccC
Q psy4396 178 KVIHRDIKPENLLLTM-HEDVKISDFGWSVHA 208 (271)
Q Consensus 178 ~iiHrDikp~Nili~~-~~~~kl~Dfg~a~~~ 208 (271)
.++|+|+++.|||+++ ++.+.++||..+...
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 5899999999999986 467999999987543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.30 E-value=0.14 Score=44.22 Aligned_cols=29 Identities=31% Similarity=0.500 Sum_probs=25.5
Q ss_pred ceeccCCCCceEeCCCCC-EEEeecccccc
Q psy4396 179 VIHRDIKPENLLLTMHED-VKISDFGWSVH 207 (271)
Q Consensus 179 iiHrDikp~Nili~~~~~-~kl~Dfg~a~~ 207 (271)
+||+|+.|.||+++.+.. +.++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999997774 88999997654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.88 E-value=0.086 Score=44.36 Aligned_cols=32 Identities=16% Similarity=0.335 Sum_probs=26.0
Q ss_pred CceeccCCCCceEeCCCCC-EEEeeccccccCC
Q psy4396 178 KVIHRDIKPENLLLTMHED-VKISDFGWSVHAP 209 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~~~-~kl~Dfg~a~~~~ 209 (271)
.++|+|+.|.|||++.++. .-|+||+.+....
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 4899999999999997565 4699999775543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.20 E-value=0.21 Score=49.88 Aligned_cols=32 Identities=38% Similarity=0.634 Sum_probs=26.3
Q ss_pred CCceeccCCCCceEeCCCC--CEE-EeeccccccC
Q psy4396 177 KKVIHRDIKPENLLLTMHE--DVK-ISDFGWSVHA 208 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~--~~k-l~Dfg~a~~~ 208 (271)
.++||+|+++.|||++.++ .+. |+|||-+...
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 4799999999999999775 554 9999976543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.16 E-value=0.24 Score=42.75 Aligned_cols=30 Identities=20% Similarity=0.241 Sum_probs=24.8
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.+++|+|+.+.|||++ + .+.++||+-+...
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~g 225 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARMG 225 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCCC
Confidence 3689999999999995 4 5789999977543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.53 E-value=0.14 Score=43.79 Aligned_cols=33 Identities=18% Similarity=0.376 Sum_probs=28.6
Q ss_pred CceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
.++|+|+++.|++++.++-+-+.||+++.....
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 489999999999999888899999998865543
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.93 E-value=0.28 Score=48.77 Aligned_cols=32 Identities=25% Similarity=0.337 Sum_probs=25.4
Q ss_pred HCCceeccCCCCceEeCCCC--C---EEEeecccccc
Q psy4396 176 QKKVIHRDIKPENLLLTMHE--D---VKISDFGWSVH 207 (271)
Q Consensus 176 ~~~iiHrDikp~Nili~~~~--~---~kl~Dfg~a~~ 207 (271)
..++||+|+++.|||++.+. . .-|+|||-+..
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 35899999999999998653 3 36999997643
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=90.75 E-value=0.42 Score=40.37 Aligned_cols=31 Identities=26% Similarity=0.428 Sum_probs=25.4
Q ss_pred ceeccCCCCceEeCCCC-----CEEEeeccccccCC
Q psy4396 179 VIHRDIKPENLLLTMHE-----DVKISDFGWSVHAP 209 (271)
Q Consensus 179 iiHrDikp~Nili~~~~-----~~kl~Dfg~a~~~~ 209 (271)
++|||+++.|||+..++ .+++.||..++...
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g~ 252 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYGS 252 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccCCC
Confidence 89999999999996653 58999998765543
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=90.66 E-value=0.071 Score=38.73 Aligned_cols=30 Identities=27% Similarity=0.216 Sum_probs=25.6
Q ss_pred cccccCCceEEEEEEEcCCCeEEEEEEcchh
Q psy4396 86 CPLGTGKFGHVYLAKEKTTQIMIALKVLYKV 116 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~ 116 (271)
+.||+|+.|+||+|+.+. |+.||||+.++.
T Consensus 17 ~PlasASiaQVh~a~l~~-g~~VaVKV~rP~ 46 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKD-GEEVAVKVQRPG 46 (119)
T ss_pred chhhheehhhheeeeecc-cchhhhhhcchH
Confidence 459999999999999776 778999998654
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=90.19 E-value=0.26 Score=43.72 Aligned_cols=32 Identities=19% Similarity=0.461 Sum_probs=26.6
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..++|||+.|.|||+..+ .++++||..+..++
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~~G~ 254 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAFYGP 254 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccccCC
Confidence 358999999999999855 68999999776544
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=90.04 E-value=0.24 Score=42.81 Aligned_cols=29 Identities=24% Similarity=0.402 Sum_probs=25.1
Q ss_pred ceeccCCCCceEeCC-CCCEEEeecccccc
Q psy4396 179 VIHRDIKPENLLLTM-HEDVKISDFGWSVH 207 (271)
Q Consensus 179 iiHrDikp~Nili~~-~~~~kl~Dfg~a~~ 207 (271)
.+|.|+.+.|||+++ ++.++++||+.|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 789999999999974 47899999998743
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.74 E-value=0.79 Score=39.49 Aligned_cols=51 Identities=24% Similarity=0.305 Sum_probs=34.6
Q ss_pred HHHHHHHHHHHHHHHHHH----CCceeccCCCCceEeCCCC------------------CEEEeeccccccCC
Q psy4396 159 DAAKYIYQVADAIHYCHQ----KKVIHRDIKPENLLLTMHE------------------DVKISDFGWSVHAP 209 (271)
Q Consensus 159 ~~~~~~~qi~~~L~~LH~----~~iiHrDikp~Nili~~~~------------------~~kl~Dfg~a~~~~ 209 (271)
-++.++.||+.-.-.+-. ...+|-||||+|||+-+.. .++|.||.+|+..+
T Consensus 280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 352 (444)
T PHA03111 280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVAN 352 (444)
T ss_pred HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHcc
Confidence 356677888766544433 3599999999999994322 25678888775443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=88.86 E-value=0.28 Score=42.78 Aligned_cols=32 Identities=19% Similarity=0.517 Sum_probs=25.9
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..++|||+.+.||+++++ .++++|+..+...+
T Consensus 192 ~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~G~ 223 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEH-ETKVIDPEFAFYGP 223 (370)
T ss_pred ceeeeccCCcccEEEcCC-CCEEEcCcccccCc
Confidence 468999999999999855 57899998765443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=88.01 E-value=0.72 Score=40.85 Aligned_cols=33 Identities=18% Similarity=0.390 Sum_probs=27.0
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+|||+.|.|||++++ ..|++|...|-.++.
T Consensus 227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfyGP~ 259 (409)
T PRK12396 227 QALIHGDLHTGSVFVKND-STKVIDPEFAFYGPM 259 (409)
T ss_pred hhhccCcCCCCCEEecCC-ceEEEcccccccCCc
Confidence 459999999999999954 689999888765543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 271 | ||||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-52 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-52 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-51 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-51 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-51 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-51 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-51 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-51 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-51 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-51 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-51 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-51 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-51 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-51 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-51 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-51 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-51 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-51 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-51 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-51 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-51 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-51 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-51 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-50 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-50 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-50 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-50 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-50 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-50 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-50 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-50 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-50 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-50 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-50 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-50 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-49 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-25 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-25 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-25 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-25 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-25 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-24 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-24 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-24 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-24 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-24 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-24 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-24 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-24 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-24 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-24 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-24 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-24 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-24 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-24 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-24 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-24 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-24 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-24 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-24 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-23 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-23 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-23 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-23 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-23 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-23 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-23 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-23 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-23 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-23 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-23 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-23 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-23 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-23 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-23 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-23 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-23 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-23 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-23 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-23 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-23 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-23 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-23 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-23 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-23 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-23 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-23 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-23 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-23 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-23 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-22 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-22 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-22 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-22 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-22 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-22 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-21 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-21 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-21 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-20 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-20 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-20 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-20 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-20 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-19 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-19 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-19 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-19 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-19 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-19 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-19 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-19 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-19 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-19 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-18 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-17 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-17 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-16 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-16 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-16 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-16 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-16 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-16 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-16 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-16 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-16 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-16 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-16 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-16 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-16 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-16 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-15 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-15 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-09 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-08 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-08 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-08 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-08 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-08 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-08 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-08 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-08 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-08 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-08 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 8e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 4e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-07 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 4e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-07 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 5e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-07 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-04 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-04 |
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 1e-91
Identities = 102/224 (45%), Positives = 137/224 (61%), Gaps = 30/224 (13%)
Query: 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER 131
+K +W + DFE+G PLG GKFG+VYLA+EK ++ ++ALKVL+K ++ + HQ+ RE
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 132 CCQVHLSSSRRHP--------------------LLSSEEGYSL------YTEKDAAKYIY 165
Q HL RHP Y + E+ A YI
Sbjct: 61 EIQSHL----RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 116
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPP 225
++A+A+ YCH K+VIHRDIKPENLLL ++KI+DFGWSVHAPS R +CGTLDYLPP
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPP 176
Query: 226 EMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
EM+ + + ++VD W +G+L YEFLVGKPPFE+ T +RI
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 4e-91
Identities = 105/226 (46%), Positives = 142/226 (62%), Gaps = 30/226 (13%)
Query: 70 APNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHR 129
A ++ + DF++G PLG GKFG+VYLA+EK + ++ALKVL+K ++ E + HQ+ R
Sbjct: 4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63
Query: 130 ERCCQVHLSSSRRHP-----------------LLSSEEGYSLY---------TEKDAAKY 163
E Q HL RHP +L LY E+ +A +
Sbjct: 64 EIEIQSHL----RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF 119
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYL 223
+ ++ADA+HYCH++KVIHRDIKPENLL+ ++KI+DFGWSVHAPSL R+TMCGTLDYL
Sbjct: 120 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL 179
Query: 224 PPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
PPEM+ + + ++VD WC G+L YEFLVG PPF+S T RI
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-85
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 33/224 (14%)
Query: 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCC 133
++ DF+VG LG G F VY A+ T + +A+K++ K + M +V E
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 134 QVHLSSSRRHP-----------------LLSSEEGYSLY----------TEKDAAKYIYQ 166
L +HP +L + +E +A +++Q
Sbjct: 65 HCQL----KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLP 224
+ + Y H ++HRD+ NLLLT + ++KI+DFG + P T+CGT +Y+
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180
Query: 225 PEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
PE+ T +G E D W +G + Y L+G+PPF++ TL ++
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-74
Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV 135
+ G LG G F + + T+ + A K++ K ++ ++ E +
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----I 92
Query: 136 HLSSSRRHP-----------------LLSSEEGYSLY---------TEKDAAKYIYQVAD 169
+ S H +L SL TE +A Y+ Q+
Sbjct: 93 SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 152
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEM 227
Y H+ +VIHRD+K NL L +VKI DFG + V +K +CGT +Y+ PE+
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 212
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
++ + + EVD W IG + Y LVGKPPFE+ T RI
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 5e-74
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 33/231 (14%)
Query: 67 AREAPNKSYR-WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH 125
A+E P + G LG G F + + T+ + A K++ K ++
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 126 QVHRERCCQVHLSSSRRHP-----------------LLSSEEGYSLY---------TEKD 159
++ E + + S H +L SL TE +
Sbjct: 61 KMSME----ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 116
Query: 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMC 217
A Y+ Q+ Y H+ +VIHRD+K NL L +VKI DFG + V +K +C
Sbjct: 117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC 176
Query: 218 GTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
GT +Y+ PE+++ + + EVD W IG + Y LVGKPPFE+ T RI
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 227
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-68
Identities = 49/252 (19%), Positives = 83/252 (32%), Gaps = 58/252 (23%)
Query: 69 EAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------ 122
K ++D+ + L GKF + L ++ ALK K + +R
Sbjct: 20 NKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSN 77
Query: 123 --------MTHQVHRERCCQVHLSSSRRHP------------------------------ 144
E + ++
Sbjct: 78 NDKISIKSKYDDFKNELQIITDI----KNEYCLTCEGIITNYDEVYIIYEYMENDSILKF 133
Query: 145 ----LLSSEEGYSLYTEKDAAKYIYQVADAIHYCH-QKKVIHRDIKPENLLLTMHEDVKI 199
+ + + I V ++ Y H +K + HRD+KP N+L+ + VK+
Sbjct: 134 DEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKL 193
Query: 200 SDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQ--HYGKEVDNWCIGILAYEFLVGKPPFE 257
SDFG S + K GT +++PPE +++ + G +VD W +GI Y PF
Sbjct: 194 SDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
Query: 258 SK-DQDTTLERI 268
K I
Sbjct: 254 LKISLVELFNNI 265
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-52
Identities = 65/237 (27%), Positives = 102/237 (43%), Gaps = 34/237 (14%)
Query: 62 QTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE 121
+ P + + + DF+ G LG G F V LA+E T A+K+L K II E
Sbjct: 12 AGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE 71
Query: 122 RMTHQVHRERCCQVHLSSSRRHPLL-----SSEEGYSLY--------------------- 155
V RER + S HP + ++ LY
Sbjct: 72 NKVPYVTRER----DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 127
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR-- 213
E Y ++ A+ Y H K +IHRD+KPEN+LL ++I+DFG + +
Sbjct: 128 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 214 --KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ GT Y+ PE++T + K D W +G + Y+ + G PPF + ++ ++I
Sbjct: 188 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 244
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-51
Identities = 69/248 (27%), Positives = 114/248 (45%), Gaps = 31/248 (12%)
Query: 47 EGTNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQI 106
+G+ +E+V+E+L K + + + Q+ F+ LGTG FG V L K K +
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN 67
Query: 107 MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL-----SSEEGYSLY------ 155
A+K+L K +++ + E+ + + P L S ++ +LY
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEK----RILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 156 ---------------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKIS 200
+E A Y Q+ Y H +I+RD+KPENLL+ ++++
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 201 DFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
DFG++ T+CGT + L PE++ S+ Y K VD W +G+L YE G PPF +
Sbjct: 184 DFGFAKRVKG-RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 261 QDTTLERI 268
E+I
Sbjct: 243 PIQIYEKI 250
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-50
Identities = 69/220 (31%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV--HL 137
F LG+G F V+L K++ T + ALK + K + + E V +
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENE--IAVLKKI 63
Query: 138 SSSRRHP-------LLSSEEGYSL-------------------YTEKDAAKYIYQVADAI 171
H + S Y L YTEKDA+ I QV A+
Sbjct: 64 K----HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119
Query: 172 HYCHQKKVIHRDIKPENLLL-TMHED--VKISDFGWSVHAPSLHRKTMCGTLDYLPPEMV 228
Y H+ ++HRD+KPENLL T E+ + I+DFG S + T CGT Y+ PE++
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVL 179
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ Y K VD W IG++ Y L G PPF + + E+I
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-48
Identities = 46/244 (18%), Positives = 85/244 (34%), Gaps = 50/244 (20%)
Query: 68 REAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQV 127
+S + + + +G+G V+ + QI A+K + E + +
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY-AIKYVNL-EEADNQTLDSY 73
Query: 128 HRERCCQVHLSSSRRHP------LLSSEE------------GYSLY---------TEKDA 160
E + + + L E L +
Sbjct: 74 RNE----IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWER 129
Query: 161 AKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS----VHAPSLHRKTM 216
Y + +A+H HQ ++H D+KP N L+ +K+ DFG + S+ + +
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 217 CGTLDYLPPEMVTSQH-----------YGKEVDNWCIGILAYEFLVGKPPFES-KDQDTT 264
GT++Y+PPE + + D W +G + Y GK PF+ +Q +
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 265 LERI 268
L I
Sbjct: 249 LHAI 252
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-48
Identities = 46/230 (20%), Positives = 84/230 (36%), Gaps = 42/230 (18%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE---------- 130
+ + LG G +V+ + K T + A+KV + R RE
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHK 67
Query: 131 ---RCCQVHLSSSRRHPLL--------------SSEEGYSLYTEKDAAKYIYQVADAIHY 173
+ + ++ RH +L E + + V +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 174 CHQKKVIHRDIKPENLLLTMHED----VKISDFGWS-VHAPSLHRKTMCGTLDYLPPEMV 228
+ ++HR+IKP N++ + ED K++DFG + ++ GT +YL P+M
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 229 T--------SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270
+ YG VD W IG+ Y G PF + + + +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 70/251 (27%), Positives = 111/251 (44%), Gaps = 40/251 (15%)
Query: 50 NKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIA 109
+N++ +L + Y + R + D+EV +G G FG V L + K+T+ + A
Sbjct: 43 KNKNIDNFLSR----YKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 98
Query: 110 LKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL-----SSEEGYSLY--------- 155
+K+L K E+I + ER + + P + + ++ LY
Sbjct: 99 MKLLSKFEMIKRSDSAFFWEER----DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154
Query: 156 -----------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204
EK A Y +V A+ H IHRD+KP+N+LL +K++DFG
Sbjct: 155 DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 205 SVHAPSLHR---KTMCGTLDYLPPEMVTSQ----HYGKEVDNWCIGILAYEFLVGKPPFE 257
+ T GT DY+ PE++ SQ +YG+E D W +G+ YE LVG PF
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274
Query: 258 SKDQDTTLERI 268
+ T +I
Sbjct: 275 ADSLVGTYSKI 285
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-47
Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 31/219 (14%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV 135
++ + DF++ LGTG FG V+L + + A+KVL K ++ + + ER
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER---- 57
Query: 136 HLSSSRRHPLL-----SSEEGYSLY---------------------TEKDAAKYIYQVAD 169
+ S HP + + ++ ++ A Y +V
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVT 229
A+ Y H K +I+RD+KPEN+LL + +KI+DFG++ + P + T+CGT DY+ PE+V+
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVS 176
Query: 230 SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
++ Y K +D W GIL YE L G PF + T E+I
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-47
Identities = 57/221 (25%), Positives = 87/221 (39%), Gaps = 42/221 (19%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
+ + +G G +G V +A +K T+I A K + K + + +E L
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLD- 64
Query: 140 SRRHP--------------------LLS--------SEEGYSLYTEKDAAKYIYQVADAI 171
HP L + + + E DAA+ + V A+
Sbjct: 65 ---HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAV 119
Query: 172 HYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHAPSLHR-KTMCGTLDYLPPEM 227
YCH+ V HRD+KPEN L +K+ DFG + +T GT Y+ P+
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ- 178
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
V YG E D W G++ Y L G PPF + + +I
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI 219
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-47
Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 39/221 (17%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV--HL 137
++ LG G FG V L K+K T A+KV+ K ++ + + RE Q+ L
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE--VQLLKQL 83
Query: 138 SSSRRHP--------------------------LLSSEEGYSLYTEKDAAKYIYQVADAI 171
HP L ++E DAA+ I QV I
Sbjct: 84 D----HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 172 HYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVH-APSLHRKTMCGTLDYLPPEM 227
Y H+ K++HRD+KPENLLL ++I DFG S H S K GT Y+ PE
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE- 198
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
V Y ++ D W G++ Y L G PPF ++ L+++
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 7e-47
Identities = 67/256 (26%), Positives = 108/256 (42%), Gaps = 47/256 (18%)
Query: 50 NKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIA 109
++N+ EYL+ + K R DFE+ +G G FG V + K K + A
Sbjct: 48 REKNILEYLEW----AKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFA 103
Query: 110 LKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP------------------------- 144
+K+L K E++ T ER + +
Sbjct: 104 MKILNKWEMLKRAETACFREER----DVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG 159
Query: 145 ----LLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKIS 200
LLS E E+ A Y+ ++ AI HQ +HRDIKP+N+L+ M+ ++++
Sbjct: 160 DLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLA 217
Query: 201 DFGWS---VHAPSLHRKTMCGTLDYLPPEMVTSQH-----YGKEVDNWCIGILAYEFLVG 252
DFG + ++ GT DY+ PE++ + YG E D W +G+ YE L G
Sbjct: 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
Query: 253 KPPFESKDQDTTLERI 268
+ PF ++ T +I
Sbjct: 278 ETPFYAESLVETYGKI 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 159 bits (402), Expect = 1e-46
Identities = 36/255 (14%), Positives = 66/255 (25%), Gaps = 68/255 (26%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKV-------------EIINERMTHQV 127
G LG A ++ T + V Y E++ R+ +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 128 HRERCCQVHLS--------SSRRHP----------------------------------L 145
++ +VHL + L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 146 LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205
LS + + QV + H ++H ++P +++L V ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 206 VHAPSLHRKTMCGTLDYLPPEMVTSQ-----------HYGKEVDNWCIGILAYEFLVGKP 254
V R + + PPE+ + D W +G++ Y
Sbjct: 254 V--RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 255 PFESKDQDTTLERIF 269
P E IF
Sbjct: 312 PITKDAALGGSEWIF 326
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-46
Identities = 67/221 (30%), Positives = 98/221 (44%), Gaps = 40/221 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
+ + C LG G FG V K++ TQ A+KV+ K N+ + RE L
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLD- 79
Query: 140 SRRHP--------------------LLS--------SEEGYSLYTEKDAAKYIYQVADAI 171
HP L + + ++E DAA+ I QV I
Sbjct: 80 ---HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGI 134
Query: 172 HYCHQKKVIHRDIKPENLLL-TMHED--VKISDFGWSVHAPSLHR-KTMCGTLDYLPPEM 227
Y H+ ++HRD+KPEN+LL + +D +KI DFG S + K GT Y+ PE
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE- 193
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
V Y ++ D W G++ Y L G PPF K++ L+R+
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-46
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE-RCCQVHLSSS 140
++V LG G F V KTT + A K++ ++ ++ RE R C+ L
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICR-KLQ-- 86
Query: 141 RRHP-------LLSSEEGYSL-------------------YTEKDAAKYIYQVADAIHYC 174
HP + E + L Y+E DA+ I Q+ ++I YC
Sbjct: 87 --HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 175 HQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHAPSLHR-KTMCGTLDYLPPEMVTS 230
H ++HR++KPENLLL VK++DFG ++ GT YL PE++
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y K VD W G++ Y LVG PPF +DQ +I
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-46
Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE-RCCQVHLS 138
+++V LG G F V KTT + A K++ ++ ++ RE R C+ L
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICR-KLQ 63
Query: 139 SSRRHP-------LLSSEEGYSL-------------------YTEKDAAKYIYQVADAIH 172
HP + E + L Y+E DA+ I Q+ ++I
Sbjct: 64 ----HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 173 YCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHAPSLHR-KTMCGTLDYLPPEMV 228
YCH ++HR++KPENLLL VK++DFG ++ GT YL PE++
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y K VD W G++ Y LVG PPF +DQ +I
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-46
Identities = 61/258 (23%), Positives = 100/258 (38%), Gaps = 49/258 (18%)
Query: 50 NKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIA 109
+ V ++L+ + K R Q DFE+ +G G F V + K K T + A
Sbjct: 35 QDKYVADFLQW----AEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYA 90
Query: 110 LKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP------------------------- 144
+K++ K +++ ER + +
Sbjct: 91 MKIMNKWDMLKRGEVSCFREER----DVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG 146
Query: 145 ----LLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKIS 200
LLS + A Y+ ++ AI H+ +HRDIKP+N+LL ++++
Sbjct: 147 DLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLA 204
Query: 201 DFGWS---VHAPSLHRKTMCGTLDYLPPEMVTSQ-------HYGKEVDNWCIGILAYEFL 250
DFG ++ GT DYL PE++ + YG E D W +G+ AYE
Sbjct: 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 251 VGKPPFESKDQDTTLERI 268
G+ PF + T +I
Sbjct: 265 YGQTPFYADSTAETYGKI 282
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-46
Identities = 47/230 (20%), Positives = 85/230 (36%), Gaps = 42/230 (18%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE---------- 130
+ + LG G +V+ + K T + A+KV + R RE
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHK 67
Query: 131 ---RCCQVHLSSSRRHPLLSSE--------------EGYSLYTEKDAAKYIYQVADAIHY 173
+ + ++ RH +L E E + + V +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 174 CHQKKVIHRDIKPENLLLTMHED----VKISDFGWS-VHAPSLHRKTMCGTLDYLPPEMV 228
+ ++HR+IKP N++ + ED K++DFG + ++ GT +YL P+M
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 229 T--------SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270
+ YG VD W IG+ Y G PF + + + +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-46
Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 41/223 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
F LG+G FG V+L +E+++ + +K + K Q+ E + +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAE----IEVLK 75
Query: 140 SRRHP------------------------------LLSSEEGYSLYTEKDAAKYIYQVAD 169
S HP ++S++ +E A+ + Q+ +
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHA-PSLHRKTMCGTLDYLPP 225
A+ Y H + V+H+D+KPEN+L +KI DFG + H GT Y+ P
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 226 EMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
E V + + D W G++ Y L G PF + ++
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA 237
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-46
Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 42/223 (18%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH---QVHRERCCQVHLS 138
+E+G LG+G+F V ++K T A K + K + + R ++ RE V++
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE----VNIL 62
Query: 139 SSRRHP--------------------LLS--------SEEGYSLYTEKDAAKYIYQVADA 170
RHP L+S +E+ TE +A +++ Q+ D
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDG 120
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHE----DVKISDFGWSVH-APSLHRKTMCGTLDYLPP 225
+HY H K++ H D+KPEN++L +K+ DFG + K + GT +++ P
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 226 EMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
E+V + G E D W IG++ Y L G PF + + TL I
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-46
Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 44/225 (19%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER--MTHQVHRE-RCCQVHLS 138
+E+ +G G F V + T A+K++ + + T + RE C L
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH-MLK 84
Query: 139 SSRRHP------------------------------LLSSEEGYSLYTEKDAAKYIYQVA 168
HP ++ + +Y+E A+ Y+ Q+
Sbjct: 85 ----HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVH--APSLHRKTMCGTLDYL 223
+A+ YCH +IHRD+KP +LL E+ VK+ FG ++ L GT ++
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 224 PPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
PE+V + YGK VD W G++ + L G PF + E I
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGI 244
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-46
Identities = 45/231 (19%), Positives = 82/231 (35%), Gaps = 50/231 (21%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
+ + +G+G V+ + QI A+K + E + + E + +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIY-AIKYVNL-EEADNQTLDSYRNE----IAYLNK 63
Query: 141 RRHP------LLSSEE------------GYSLY---------TEKDAAKYIYQVADAIHY 173
+ L E L + Y + +A+H
Sbjct: 64 LQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWS----VHAPSLHRKTMCGTLDYLPPEMVT 229
HQ ++H D+KP N L+ +K+ DFG + S+ + + GT++Y+PPE +
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 230 SQH-----------YGKEVDNWCIGILAYEFLVGKPPF-ESKDQDTTLERI 268
+ D W +G + Y GK PF + +Q + L I
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-46
Identities = 58/253 (22%), Positives = 101/253 (39%), Gaps = 40/253 (15%)
Query: 47 EGTNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQI 106
+G + +++ + + Y + K +++ LG+G FG V+ EK T
Sbjct: 19 DGPKINDYDKFYEDIWKKYVPQPVEVKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGR 77
Query: 107 MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP--------------------LL 146
+ K + +++ V E + + + HP L
Sbjct: 78 VFVAKFINTPYPLDKYT---VKNE----ISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130
Query: 147 S--------SEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED-- 196
S + E Y +E + Y+ Q + + + H+ ++H DIKPEN++ +
Sbjct: 131 SGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 189
Query: 197 VKISDFGWSVHA-PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPP 255
VKI DFG + P K T ++ PE+V + G D W IG+L Y L G P
Sbjct: 190 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
Query: 256 FESKDQDTTLERI 268
F +D TL+ +
Sbjct: 250 FAGEDDLETLQNV 262
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-46
Identities = 31/239 (12%), Positives = 61/239 (25%), Gaps = 57/239 (23%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKV--------------EIINERMTHQ 126
++ PL G V+L ++ ALKV R+ +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 127 VHRERCCQVHLSSS------RRHP----LLSSEEGYSLY--------------------- 155
E + L + P L ++ Y++
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 156 --------TEKDAAKYI-YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206
A + Q+ K ++H P+NL + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 207 HAPSLHRKTMCGTLDYLPPEMVTSQH--YGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263
+ + Y P E + + + ++ W +G+ Y PF
Sbjct: 243 KVGTR-GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-45
Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 24/212 (11%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK-----VEIINE-RMTHQVHRERCC 133
+ + LG G+FG V+ E +++ K + V + E + +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 134 QVHLS-SSRRHPLLSSE-------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKV 179
+H S S ++ E + E++ Y++QV +A+ + H +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHNI 123
Query: 180 IHRDIKPENLLLTMHED--VKISDFGWSVH-APSLHRKTMCGTLDYLPPEMVTSQHYGKE 236
H DI+PEN++ +KI +FG + P + + + +Y PE+
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
D W +G L Y L G PF ++ +E I
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-45
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE-RCCQVHLS 138
++++ LG G F V + A ++ ++ ++ RE R C+ L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICR-LLK 68
Query: 139 SSRRHP-------LLSSEEGYSL-------------------YTEKDAAKYIYQVADAIH 172
HP +S E + L Y+E DA+ I Q+ +A+
Sbjct: 69 ----HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 124
Query: 173 YCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVH--APSLHRKTMCGTLDYLPPEM 227
+CHQ V+HR++KPENLLL VK++DFG ++ GT YL PE+
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ YGK VD W G++ Y LVG PPF +DQ ++I
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI 225
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-45
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 42/225 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT---HQVHRERCCQVH 136
+++G LG+G+F V +EK+T + A K + K + R ++ RE V
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VS 67
Query: 137 LSSSRRHP--------------------LLS--------SEEGYSLYTEKDAAKYIYQVA 168
+ H L+S +++ +E++A +I Q+
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQIL 125
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHE----DVKISDFGWSVH-APSLHRKTMCGTLDYL 223
D ++Y H KK+ H D+KPEN++L +K+ DFG + + K + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 224 PPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
PE+V + G E D W IG++ Y L G PF + TL I
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-45
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYK-------VEIINERMTHQ--VH-RERCCQVH 136
LG G G V + T ALK+LY V+ + V + +H
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH 95
Query: 137 LSSSRRH---------PLLS--SEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIK 185
L S E G +TE++AA+ + + AI + H + HRD+K
Sbjct: 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVK 155
Query: 186 PENLLLTMHED---VKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCI 242
PENLL T E +K++DFG++ +T C T Y+ PE++ + Y K D W +
Sbjct: 156 PENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215
Query: 243 GILAYEFLVGKPPFESKDQDTTLERIF 269
G++ Y L G PPF S +
Sbjct: 216 GVIMYILLCGFPPFYSNTGQAISPGMK 242
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 42/225 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH---QVHRERCCQVH 136
+++G LG+G+F V +EK+T + A K + K + R ++ RE V
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE----VS 67
Query: 137 LSSSRRHP--------------------LLS--------SEEGYSLYTEKDAAKYIYQVA 168
+ HP L+S +++ +E++A +I Q+
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQIL 125
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHE----DVKISDFGWSVH-APSLHRKTMCGTLDYL 223
D ++Y H KK+ H D+KPEN++L +K+ DFG + + K + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 224 PPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
PE+V + G E D W IG++ Y L G PF + TL I
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-45
Identities = 72/214 (33%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
FEV LG G VY K+K TQ ALKVL K V E + LS
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLS--- 106
Query: 142 RHP-------LLSSEEGYSL-------------------YTEKDAAKYIYQVADAIHYCH 175
HP + + SL Y+E+DAA + Q+ +A+ Y H
Sbjct: 107 -HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH 165
Query: 176 QKKVIHRDIKPENLLLTMHED---VKISDFGWSVH-APSLHRKTMCGTLDYLPPEMVTSQ 231
+ ++HRD+KPENLL +KI+DFG S + KT+CGT Y PE++
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 232 HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265
YG EVD W +GI+ Y L G PF + D +
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-45
Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK-----VEIINERMTHQVHRERCCQV 135
++ + LG+G G V LA E+ T +A+K++ K V E +
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE----I 66
Query: 136 HLSSSRRHP----LLSSEEGYSLY---------------------TEKDAAKYIYQVADA 170
+ HP + + + Y E Y YQ+ A
Sbjct: 67 EILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHAPSLHR-KTMCGTLDYLPPE 226
+ Y H+ +IHRD+KPEN+LL+ E+ +KI+DFG S +T+CGT YL PE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 227 MVTS---QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265
++ S Y + VD W +G++ + L G PPF +L
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-45
Identities = 41/230 (17%), Positives = 69/230 (30%), Gaps = 55/230 (23%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
+ LG G F +V L + ALK ++ ++ + RE +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALK---RILCHEQQDREEAQRE----ADMHRL 82
Query: 141 RRHP---------LLSSEEGYSLY-------------------------TEKDAAKYIYQ 166
HP L + + TE +
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK-----------T 215
+ + H K HRD+KP N+LL + D G A
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 216 MCGTLDYLPPEMVTSQHY---GKEVDNWCIGILAYEFLVGKPPFESKDQD 262
T+ Y PE+ + Q + + D W +G + Y + G+ P++ Q
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-45
Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 44/223 (19%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV--HL 137
+ + C LG G FG V K++ TQ A+KV+ K N+ + RE ++ L
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILRE--VELLKKL 78
Query: 138 SSSRRHP--------------------LLS--------SEEGYSLYTEKDAAKYIYQVAD 169
HP L + + ++E DAA+ I QV
Sbjct: 79 D----HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFS 132
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVH-APSLHRKTMCGTLDYLPP 225
I Y H+ ++HRD+KPEN+LL E +KI DFG S + K GT Y+ P
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 226 EMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
E V Y ++ D W G++ Y L G PPF K++ L+R+
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-45
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQ----VHL------ 137
LG G G V K TQ ALK+L R ++H R Q V +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKA--RREVELHW-RASQCPHIVRIVDVYEN 126
Query: 138 -SSSRRH-----------PLLS--SEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRD 183
+ R+ L S + G +TE++A++ + + +AI Y H + HRD
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 184 IKPENLLLTMHED---VKISDFGWSVHAPSLHR-KTMCGTLDYLPPEMVTSQHYGKEVDN 239
+KPENLL T +K++DFG++ S + T C T Y+ PE++ + Y K D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 246
Query: 240 WCIGILAYEFLVGKPPFESKDQDTTLERIF 269
W +G++ Y L G PPF S +
Sbjct: 247 WSLGVIMYILLCGYPPFYSNHGLAISPGMK 276
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-45
Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 46/225 (20%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH---QVHRERCCQV--H 136
++ G LG+G+F V +EK+T + A K + K + R + RE +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE--VSILKE 70
Query: 137 LSSSRRHP--------------------LLS--------SEEGYSLYTEKDAAKYIYQVA 168
+ HP L++ +E+ TE++A +++ Q+
Sbjct: 71 IQ----HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQIL 124
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHE----DVKISDFGWSVH-APSLHRKTMCGTLDYL 223
+ ++Y H ++ H D+KPEN++L +KI DFG + K + GT +++
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 224 PPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
PE+V + G E D W IG++ Y L G PF + TL +
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-45
Identities = 56/228 (24%), Positives = 84/228 (36%), Gaps = 57/228 (25%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
DF+ +G+G FG V+ AK + +K + + RE V
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK-----RVKYNNE--KAERE----VKAL 58
Query: 139 SSRRHP---------------------LLSSEEGYSLY---------------------- 155
+ H S + L+
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 156 -TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHR 213
+ A + Q+ + Y H KK+I+RD+KP N+ L + VKI DFG R
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFL-VGKPPFESKD 260
GTL Y+ PE ++SQ YGKEVD + +G++ E L V FE+
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-44
Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 35/228 (15%)
Query: 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE 130
Y M + +G G FG L K +K + + ++ + + RE
Sbjct: 15 TENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKEREESRRE 73
Query: 131 RCCQVHLSSSRRHP-----LLSSEEGYSLY-----------------------TEKDAAK 162
V + ++ +HP S EE SLY E
Sbjct: 74 ----VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL 220
+ Q+ A+ + H +K++HRDIK +N+ LT V++ DFG + +++ + GT
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTP 189
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
YL PE+ ++ Y + D W +G + YE K FE+ + +I
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-44
Identities = 61/221 (27%), Positives = 91/221 (41%), Gaps = 40/221 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV--HL 137
++ LG+G +G V L ++K T + A+K++ K + ++ E V L
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEE--VAVLKLL 93
Query: 138 SSSRRHP--------------------------LLSSEEGYSLYTEKDAAKYIYQVADAI 171
HP L + E DAA I QV +
Sbjct: 94 D----HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 172 HYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVH-APSLHRKTMCGTLDYLPPEM 227
Y H+ ++HRD+KPENLLL E +KI DFG S K GT Y+ PE
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE- 208
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
V + Y ++ D W IG++ + L G PPF + L ++
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-44
Identities = 52/253 (20%), Positives = 95/253 (37%), Gaps = 68/253 (26%)
Query: 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCC 133
S R+ SDFE LG G FG V A+ A+K + E + E
Sbjct: 1 SLRYA-SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSE--- 52
Query: 134 QVHLSSSRRHP------------------LLSSEEGYSLY-------------------- 155
V L +S H + + ++ +L+
Sbjct: 53 -VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111
Query: 156 --TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-------- 205
+ + Q+ +A+ Y H + +IHRD+KP N+ + +VKI DFG +
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 206 --------VHAPSLHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPF 256
+ S + + GT Y+ E++ HY +++D + +GI+ +E + P
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFS 229
Query: 257 ESKDQDTTLERIF 269
++ L+++
Sbjct: 230 TGMERVNILKKLR 242
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 70/228 (30%), Positives = 106/228 (46%), Gaps = 33/228 (14%)
Query: 70 APNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHR 129
P+ + + SDF +G G FG V LA+ K ++ A+KVL K I+ ++ +
Sbjct: 28 GPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS 87
Query: 130 ERCCQVHLSSSRRHPLLSSEEGYS------LY---------------------TEKDAAK 162
ER V L + +HP L +S LY E A
Sbjct: 88 ER--NV-LLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF 143
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL 220
Y ++A A+ Y H +++RD+KPEN+LL + ++DFG + T CGT
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTP 203
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+YL PE++ Q Y + VD WC+G + YE L G PPF S++ + I
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-44
Identities = 57/230 (24%), Positives = 90/230 (39%), Gaps = 46/230 (20%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK------VEIINERMTHQVHRERCC 133
++E LG G V K T A+K++ + + +E
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE--V 74
Query: 134 QV--HLSSSRRHP-------LLSSEEGYSL-------------------YTEKDAAKYIY 165
+ +S HP + + L +EK+ K +
Sbjct: 75 DILRKVS---GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR-KTMCGTLDYLP 224
+ + I H+ ++HRD+KPEN+LL ++K++DFG+S + + +CGT YL
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 191
Query: 225 PE------MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
PE YGKEVD W G++ Y L G PPF + Q L I
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-44
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 42/226 (18%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK-----VEIINERMTHQVHRERCCQV 135
++ + LG+G G V LA E+ T +A++++ K V E +
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE----I 191
Query: 136 HLSSSRRHP----LLSSEEGYSLY---------------------TEKDAAKYIYQVADA 170
+ HP + + + Y E Y YQ+ A
Sbjct: 192 EILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHAPSLHR-KTMCGTLDYLPPE 226
+ Y H+ +IHRD+KPEN+LL+ E+ +KI+DFG S +T+CGT YL PE
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311
Query: 227 MVTSQH---YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL-ERI 268
++ S Y + VD W +G++ + L G PPF +L ++I
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-44
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 37/214 (17%)
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE----RCCQVH------ 136
PLG G F K + A+K II++RM +E + C+ H
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVK------IISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 137 --LSSSRRHPLLSSE--EGYSL---------YTEKDAAKYIYQVADAIHYCHQKKVIHRD 183
+ + H L E G L ++E +A+ + ++ A+ + H V+HRD
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 184 IKPENLLLTMHED---VKISDFGWSVHAPSLHR--KTMCGTLDYLPPEMVTSQHYGKEVD 238
+KPENLL T D +KI DFG++ P ++ KT C TL Y PE++ Y + D
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCD 191
Query: 239 NWCIGILAYEFLVGKPPFESKDQD---TTLERIF 269
W +G++ Y L G+ PF+S D+ T+ I
Sbjct: 192 LWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-44
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 36/216 (16%)
Query: 85 GCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP 144
LG GKF V K+T A K L K + ++ E V L ++ P
Sbjct: 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR-AEILHE--IAV-LELAKSCP 89
Query: 145 --------------------LLS--------SEEGYSLYTEKDAAKYIYQVADAIHYCHQ 176
+ E + +E D + I Q+ + ++Y HQ
Sbjct: 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 177 KKVIHRDIKPENLLL-TMHED--VKISDFGWSVH-APSLHRKTMCGTLDYLPPEMVTSQH 232
++H D+KP+N+LL +++ +KI DFG S + + + GT +YL PE++
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDP 209
Query: 233 YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
D W IGI+AY L PF +D T I
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-44
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 25/212 (11%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK------VEIINE-RMTHQVHRERCC 133
LG G+FG V+ +E T + +A K++ E+ NE + +Q+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 134 QVHLS-SSRRHPLLSSE-------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKV 179
Q++ + S+ +L E E Y+ TE D ++ Q+ + I + HQ +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMHQMYI 208
Query: 180 IHRDIKPENLLLTMHED--VKISDFGWSVH-APSLHRKTMCGTLDYLPPEMVTSQHYGKE 236
+H D+KPEN+L + +KI DFG + P K GT ++L PE+V
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFP 268
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
D W +G++AY L G PF + TL I
Sbjct: 269 TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-44
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
FE+ +G G FG V + ++ T+ M A+K + K + + V +E +
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL----QIM 69
Query: 139 SSRRHPLLSSEEGYS------LY---------------------TEKDAAKYIYQVADAI 171
HP L + YS ++ E+ +I ++ A+
Sbjct: 70 QGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL 128
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR-KTMCGTLDYLPPEMVTS 230
Y +++IHRD+KP+N+LL H V I+DF + P + TM GT Y+ PEM +S
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 231 QH---YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266
+ Y VD W +G+ AYE L G+ P+ + ++ E
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-44
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 31/229 (13%)
Query: 68 REAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQV 127
+E P+ + ++ DF + LG G FG V+LA+ K T A+K L K ++ +
Sbjct: 5 KERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 128 HRERCCQVHLSSSRRHPLL-----SSEEGYSLY---------------------TEKDAA 161
E+ LS + HP L + + +L+ A
Sbjct: 65 MVEKRV---LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 121
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK--TMCGT 219
Y ++ + + H K +++RD+K +N+LL +KI+DFG K T CGT
Sbjct: 122 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT 181
Query: 220 LDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
DY+ PE++ Q Y VD W G+L YE L+G+ PF +D++ I
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-44
Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 41/225 (18%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK-----VEIINERMTHQVHRERCCQVH 136
++ +G G V + T A+K++ E + RE +
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE--THI- 152
Query: 137 LSSSRRHP-------LLSSEEGYSL-------------------YTEKDAAKYIYQVADA 170
L HP S L +EK+ + + +A
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR-KTMCGTLDYLPPE--- 226
+ + H ++HRD+KPEN+LL + +++SDFG+S H + + +CGT YL PE
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 227 ---MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
T YGKEVD W G++ + L G PPF + Q L I
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-44
Identities = 51/225 (22%), Positives = 93/225 (41%), Gaps = 49/225 (21%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK--------VEIINERMTHQ------ 126
+EV +G G + K T + A+K++ K +EI+ H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 127 -VHRERCCQVHLS-------------SSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIH 172
V+ + V++ ++ ++E++A+ ++ + +
Sbjct: 83 DVYDDGKY-VYVVTELMKGGELLDKILRQKF-----------FSEREASAVLFTITKTVE 130
Query: 173 YCHQKKVIHRDIKPENLLLTMHED----VKISDFGWSVHAPSLHR--KTMCGTLDYLPPE 226
Y H + V+HRD+KP N+L ++I DFG++ + + T C T +++ PE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT---LERI 268
++ Q Y D W +G+L Y L G PF + DT L RI
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 57/228 (25%), Positives = 87/228 (38%), Gaps = 43/228 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
+ LG+G +G V L KEK A+KV+ K + R + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGR---YSDDNKNIEKFHEE 92
Query: 140 SRR---------HP--------------------------LLSSEEGYSLYTEKDAAKYI 164
HP L + E DAA +
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVH-APSLHRKTMCGTL 220
Q+ I Y H+ ++HRDIKPEN+LL +KI DFG S + + GT
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y+ PE V + Y ++ D W G++ Y L G PPF ++ ++++
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 3e-43
Identities = 52/227 (22%), Positives = 83/227 (36%), Gaps = 45/227 (19%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
+E+ LGTG FG+V + T +A+K + ++ + + E + +
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLE----IQIMKK 68
Query: 141 RRHP-----------------------------------LLSSEEGYSLYTEKDAAKYIY 165
HP L+ E E +
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHAPSLHR-KTMCGTLD 221
++ A+ Y H+ ++IHRD+KPEN++L KI D G++ GTL
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188
Query: 222 YLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
YL PE++ + Y VD W G LA+E + G PF Q
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 27/214 (12%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK------VEIINE-RMTHQVHRERC 132
+++ LGTG FG V+ E+ T A K + + E + +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 133 CQVHLS--SSRRHPL-------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQK 177
+H + + ++ E +E +A +Y+ QV + + H+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 274
Query: 178 KVIHRDIKPENLLLTMHED--VKISDFGWSVH-APSLHRKTMCGTLDYLPPEMVTSQHYG 234
+H D+KPEN++ T +K+ DFG + H P K GT ++ PE+ + G
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
D W +G+L+Y L G PF ++ D TL +
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-43
Identities = 71/232 (30%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 66 DAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH 125
N S R + +FE LG G FG V LA+ K T + A+KVL K I+ +
Sbjct: 9 GNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVE 68
Query: 126 QVHRERCCQVHLSSSRRHPLLSSEEGYS------LY---------------------TEK 158
E+ ++ LS +R HP L+ L+ E
Sbjct: 69 CTMTEK--RI-LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA 124
Query: 159 DAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTM 216
A Y ++ A+ + H K +I+RD+K +N+LL K++DFG + T
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184
Query: 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
CGT DY+ PE++ YG VD W +G+L YE L G PFE++++D E I
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-43
Identities = 57/237 (24%), Positives = 87/237 (36%), Gaps = 34/237 (14%)
Query: 67 AREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQ 126
K +++ +G LG G FG V+ T ++ +A+KV+ + ++
Sbjct: 18 TPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSD 77
Query: 127 ---VHRERCCQVHLSSSRRHP----LLS--------------SEEGYSLY---------T 156
E + + HP LL L+
Sbjct: 78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG 137
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPSLHRKT 215
E + + QV AI +CH + V+HRDIK EN+L+ + K+ DFG
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
Query: 216 MCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFWF 271
GT Y PPE ++ Y W +GIL Y+ + G PFE LE F
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE--RDQEILEAELHF 252
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-43
Identities = 61/273 (22%), Positives = 104/273 (38%), Gaps = 33/273 (12%)
Query: 27 QTTEKNYTITNMKEYFEGLTEGTNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGC 86
Q E+ +E E + +YL + + + + + F
Sbjct: 131 QRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR 190
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL 146
LG G FG V + + T M A K L K I + E+ + +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK----QILEKVNSRFV 246
Query: 147 SS----------------------------EEGYSLYTEKDAAKYIYQVADAIHYCHQKK 178
S G + + E A Y ++ + H+++
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR-KTMCGTLDYLPPEMVTSQHYGKEV 237
+++RD+KPEN+LL H ++ISD G +VH P K GT+ Y+ PE+V ++ Y
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 238 DNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270
D W +G L YE + G+ PF+ + + E +
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-43
Identities = 45/241 (18%), Positives = 84/241 (34%), Gaps = 50/241 (20%)
Query: 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE 130
N+ + + + +G+G V+ + QI A+K + E + + E
Sbjct: 47 ANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY-AIKYVNL-EEADNQTLDSYRNE 104
Query: 131 RCCQVHLSSSRRHP------LLSSEE------------GYSLY---------TEKDAAKY 163
+ + + L E L + Y
Sbjct: 105 ----IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSY 160
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS----VHAPSLHRKTMCGT 219
+ +A+H HQ ++H D+KP N L+ +K+ DFG + S+ + + G
Sbjct: 161 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
Query: 220 LDYLPPEMVTSQ-----------HYGKEVDNWCIGILAYEFLVGKPPFES-KDQDTTLER 267
++Y+PPE + + D W +G + Y GK PF+ +Q + L
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
Query: 268 I 268
I
Sbjct: 280 I 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-43
Identities = 53/280 (18%), Positives = 101/280 (36%), Gaps = 36/280 (12%)
Query: 22 DEVIVQTTEKNYTITNMKEYFEGLTEGTNKENVEEYLKKMQTHYDAREAPNKSYRWQMSD 81
D V + + + +E+L + + ++
Sbjct: 127 DAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDW 186
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
F LG G FG V+ + K T + A K L K + + E+ + +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK----KILAKV 242
Query: 142 RHP------------------------------LLSSEEGYSLYTEKDAAKYIYQVADAI 171
+ + +E + E A Y Q+ +
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR--KTMCGTLDYLPPEMVT 229
+ HQ+ +I+RD+KPEN+LL +V+ISD G +V + K GT ++ PE++
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 230 SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+ Y VD + +G+ YE + + PF ++ + + +
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-43
Identities = 60/239 (25%), Positives = 94/239 (39%), Gaps = 40/239 (16%)
Query: 67 AREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---RM 123
+ AP K S ++VG LG+G FG VY + + +A+K + K I +
Sbjct: 30 TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 89
Query: 124 THQVHRERCCQVHLSSSRRHPL---------LSSEEGYSL-------------Y------ 155
+V E V L + + L +
Sbjct: 90 GTRVPME----VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 145
Query: 156 -TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL-TMHEDVKISDFGWSVHAPSLHR 213
E+ A + +QV +A+ +CH V+HRDIK EN+L+ ++K+ DFG
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 205
Query: 214 KTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFWF 271
GT Y PPE + Y G+ W +GIL Y+ + G PFE + + +F
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--HDEEIIRGQVFF 262
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-42
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 31/228 (13%)
Query: 69 EAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVH 128
+ R +++DF LG G FG V L++ K T + A+K+L K +I +
Sbjct: 9 DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM 68
Query: 129 RERCCQVHLSSSRRHPLL-----SSEEGYSLY---------------------TEKDAAK 162
E+ L+ + P L + LY E A
Sbjct: 69 VEKRV---LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTL 220
Y ++A + + K +I+RD+K +N++L +KI+DFG + KT CGT
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
DY+ PE++ Q YGK VD W G+L YE L G+ PFE +D+D + I
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-42
Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 70 APNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHR 129
R ++ + +G LG G FG V + + + T +A+K+L + +I + + ++ R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 130 ERCCQVHLSSSRRHP-------LLSSE----------EGYSLY---------TEKDAAKY 163
E + RHP ++S+ G L+ E +A +
Sbjct: 61 E----IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL 116
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHRKTMCGTLDY 222
Q+ A+ YCH+ V+HRD+KPEN+LL H + KI+DFG S + + +T CG+ +Y
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNY 176
Query: 223 LPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
PE+++ + Y G EVD W G++ Y L G PF+ + T ++I
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-42
Identities = 60/280 (21%), Positives = 108/280 (38%), Gaps = 34/280 (12%)
Query: 21 ADEVIVQTTEKNYTITNMKEYFEGLTEGTNKENVEEYLKKMQ-THYDAREAPNKSYRWQM 79
+ V +K + Y E + + + +++++ + T + + + M
Sbjct: 129 IEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTM 188
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV-HLS 138
+DF V +G G FG VY ++ T M A+K L K I ++ ER + L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER--IMLSLV 246
Query: 139 SSRRHPLLSS-----EEGYSLY---------------------TEKDAAKYIYQVADAIH 172
S+ P + L +E D Y ++ +
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQH 232
+ H + V++RD+KP N+LL H V+ISD G + GT Y+ PE++
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 233 -YGKEVDNWCIGILAYEFLVGKPPF---ESKDQDTTLERI 268
Y D + +G + ++ L G PF ++KD+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-41
Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
M+DF+ LG G FG V L +EK T A+K+L K II + E +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES----RVL 59
Query: 139 SSRRHPLL-----SSEEGYSLY---------------------TEKDAAKYIYQVADAIH 172
+ RHP L + + L TE+ A Y ++ A+
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPEMVTS 230
Y H + V++RDIK ENL+L +KI+DFG + KT CGT +YL PE++
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
YG+ VD W +G++ YE + G+ PF ++D + E I
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-41
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 10/164 (6%)
Query: 115 KVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYC 174
+ C + + + E + EK + + Q+ A+HY
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184
Query: 175 HQKKVIHRDIKPENLLLTMHED--VKISDFGWSVHAPSLHR------KTMCGTLDYLPPE 226
H + + HRDIKPEN L + ++ +K+ DFG S L+ T GT ++ PE
Sbjct: 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
Query: 227 MV--TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
++ T++ YG + D W G+L + L+G PF + T+ ++
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV 288
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 4e-06
Identities = 16/67 (23%), Positives = 30/67 (44%), Gaps = 6/67 (8%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK--VEIINERMTHQVHRERCCQVHL 137
+ + +G G +G V +A E T+ + A+K++ K + IN + ++ E L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 138 SSSRRHP 144
HP
Sbjct: 86 H----HP 88
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 40/257 (15%)
Query: 49 TNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKE---KTTQ 105
+ + E L ++ + + + +FE+ LGTG +G V+L ++ T
Sbjct: 23 ADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTG 82
Query: 106 IMIALKVLYKVEII-NERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYS------LY--- 155
+ A+KVL K I+ + T ER QV L R+ P L + Y+ L+
Sbjct: 83 KLYAMKVLKKATIVQKAKTTEHTRTER--QV-LEHIRQSPFLVTLH-YAFQTETKLHLIL 138
Query: 156 ------------------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV 197
TE + Y+ ++ A+ + H+ +I+RDIK EN+LL + V
Sbjct: 139 DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV 198
Query: 198 KISDFGWS---VHAPSLHRKTMCGTLDYLPPEMVTSQHYG--KEVDNWCIGILAYEFLVG 252
++DFG S V + CGT++Y+ P++V G K VD W +G+L YE L G
Sbjct: 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 253 KPPFESKDQDTTLERIF 269
PF + + I
Sbjct: 259 ASPFTVDGEKNSQAEIS 275
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-41
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 36/217 (16%)
Query: 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHL 137
+++F + +G G+F VY A + +ALK + ++++ + +E + L
Sbjct: 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKE----IDL 85
Query: 138 SSSRRHP-----LLSSEEGYSLY-------------------------TEKDAAKYIYQV 167
HP S E L E+ KY Q+
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPP 225
A+ + H ++V+HRDIKP N+ +T VK+ D G + + ++ GT Y+ P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 226 EMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262
E + Y + D W +G L YE + PF +
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 242
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-41
Identities = 58/256 (22%), Positives = 113/256 (44%), Gaps = 40/256 (15%)
Query: 50 NKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIA 109
+ + +++ + + RE+ S + DF++ +G G + V L + K T + A
Sbjct: 22 FQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYA 81
Query: 110 LKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL-----SSEEGYSLY--------- 155
++V+ K + ++ V E+ V + HP L + L+
Sbjct: 82 MRVVKKELVNDDEDIDWVQTEK--HV-FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 138
Query: 156 ------------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203
E+ A Y +++ A++Y H++ +I+RD+K +N+LL +K++D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 204 WSVH--APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF----- 256
P T CGT +Y+ PE++ + YG VD W +G+L +E + G+ PF
Sbjct: 199 MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258
Query: 257 ----ESKDQDTTLERI 268
+ +D + I
Sbjct: 259 SDNPDQNTEDYLFQVI 274
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-41
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 44/230 (19%)
Query: 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHL 137
+ D+EV +GTG +G + K+ ++ K L + E + E V+L
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSE----VNL 58
Query: 138 SSSRRHP-------LLSSEEGYSLY-------------------------TEKDAAKYIY 165
+HP + +LY E+ + +
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 166 QVADAIHYCHQKK-----VIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCG 218
Q+ A+ CH++ V+HRD+KP N+ L ++VK+ DFG + ++ + KT G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 219 TLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
T Y+ PE + Y ++ D W +G L YE PPF + Q +I
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-41
Identities = 42/205 (20%), Positives = 69/205 (33%), Gaps = 32/205 (15%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
F+ LG G +G V+ + K + A+K + + E
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEV---GSHE 111
Query: 139 SSRRHP----LLSS-EEGYSLY---------------------TEKDAAKYIYQVADAIH 172
+HP L + EEG LY E Y+ A+
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH-APSLHRKTMCGTLDYLPPEMVTSQ 231
+ H + ++H D+KP N+ L K+ DFG V + + G Y+ PE++
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS 231
Query: 232 HYGKEVDNWCIGILAYEFLVGKPPF 256
YG D + +G+ E
Sbjct: 232 -YGTAADVFSLGLTILEVACNMELP 255
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-41
Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 40/227 (17%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
+ DF++ +G G + V L + K T + A+KV+ K + ++ V E+ V
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK--HV-FE 64
Query: 139 SSRRHPLL-----SSEEGYSLY---------------------TEKDAAKYIYQVADAIH 172
+ HP L + L+ E+ A Y +++ A++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPEMVTS 230
Y H++ +I+RD+K +N+LL +K++D+G P T CGT +Y+ PE++
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 184
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPF---------ESKDQDTTLERI 268
+ YG VD W +G+L +E + G+ PF + +D + I
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 68/246 (27%), Positives = 107/246 (43%), Gaps = 31/246 (12%)
Query: 51 KENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIAL 110
+ + +K + R +++DF LG G FG V L++ K T + A+
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAV 371
Query: 111 KVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL-----SSEEGYSLY---------- 155
K+L K +I + E+ L+ + P L + LY
Sbjct: 372 KILKKDVVIQDDDVECTMVEKRV---LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 428
Query: 156 -----------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204
E A Y ++A + + K +I+RD+K +N++L +KI+DFG
Sbjct: 429 LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488
Query: 205 SVH--APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262
+ KT CGT DY+ PE++ Q YGK VD W G+L YE L G+ PFE +D+D
Sbjct: 489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548
Query: 263 TTLERI 268
+ I
Sbjct: 549 ELFQSI 554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-40
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 33/227 (14%)
Query: 70 APNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHR 129
A + + ++ + +G G F V LA+ T +A+K++ K +N ++ R
Sbjct: 5 ASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFR 63
Query: 130 ERCCQVHLSSSRRHP-------LLSSE----------EGYSLY---------TEKDAAKY 163
E V + HP ++ +E G ++ EK+A
Sbjct: 64 E----VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHRKTMCGTLDY 222
Q+ A+ YCHQK+++HRD+K ENLLL ++KI+DFG+S CG Y
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPY 179
Query: 223 LPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
PE+ + Y G EVD W +G++ Y + G PF+ ++ ER+
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-40
Identities = 57/227 (25%), Positives = 87/227 (38%), Gaps = 40/227 (17%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-ERMTHQVHRERCCQVHL 137
+ + +G LG G +G V + T A+K+L K ++ V +E + L
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQL 59
Query: 138 SSSRRHP-------LLSSEEGYSLY----------------------TEKDAAKYIYQVA 168
RH +L +EE +Y A Y Q+
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR----KTMCGTLDYLP 224
D + Y H + ++H+DIKP NLLLT +KIS G + +T G+ + P
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 225 PEMVT-SQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
PE+ + G +VD W G+ Y G PFE + E I
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 38/217 (17%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI-----INERMTHQVHRERCC 133
+ PLG+G FG V+ A +K + +K + K ++ I + +V E
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE--- 79
Query: 134 QVHLSSSRRHP------------------LLSSEEGYSLY---------TEKDAAKYIYQ 166
+ + S H + G L+ E A+ Q
Sbjct: 80 -IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR-KTMCGTLDYLPP 225
+ A+ Y K +IHRDIK EN+++ +K+ DFG + + T CGT++Y P
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198
Query: 226 EMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQ 261
E++ Y G E++ W +G+ Y + + PF ++
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
+ + LG G FG V LA TQ +ALK + + + M +V RE +
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLL 66
Query: 142 RHP-------LLSSEEGYSLY--------------------TEKDAAKYIYQVADAIHYC 174
RHP ++++ + TE + ++ Q+ AI YC
Sbjct: 67 RHPHIIKLYDVITTPT--DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
H+ K++HRD+KPENLLL + +VKI+DFG S + KT CG+ +Y PE++ + Y
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 234 -GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
G EVD W GI+ Y LVG+ PF+ + +++
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-40
Identities = 69/253 (27%), Positives = 115/253 (45%), Gaps = 53/253 (20%)
Query: 54 VEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKE---KTTQIMIAL 110
+E +K++ + +E K S FE+ LG G FG V+L K+ + + A+
Sbjct: 1 MEGSIKEIAITHHVKEGHEK---ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAM 57
Query: 111 KVLYK--------VEIINER-----MTH----QVH-----RERCCQV-----------HL 137
KVL K V ER + H ++H + + L
Sbjct: 58 KVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL 117
Query: 138 SSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV 197
S +TE+D Y+ ++A A+ + H +I+RD+KPEN+LL +
Sbjct: 118 SKEVM------------FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 165
Query: 198 KISDFGWSVHAPSLHRK--TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPP 255
K++DFG S + +K + CGT++Y+ PE+V + + + D W G+L +E L G P
Sbjct: 166 KLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
Query: 256 FESKDQDTTLERI 268
F+ KD+ T+ I
Sbjct: 226 FQGKDRKETMTMI 238
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 7e-40
Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 36/229 (15%)
Query: 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKE---KTTQIMIALKVLYKVEII-NERMTHQV 127
+ + FE+ LG G +G V+ ++ T + A+KVL K I+ N + T
Sbjct: 9 RGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT 68
Query: 128 HRERCCQVHLSSSRRHPLL-----SSEEGYSLY---------------------TEKDAA 161
ER ++ +HP + + + G LY E A
Sbjct: 69 KAER----NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTAC 124
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK--TMCGT 219
Y+ +++ A+ + HQK +I+RD+KPEN++L VK++DFG + T CGT
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGT 184
Query: 220 LDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
++Y+ PE++ + + VD W +G L Y+ L G PPF +++ T+++I
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-40
Identities = 53/206 (25%), Positives = 77/206 (37%), Gaps = 44/206 (21%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN---ERMTHQVHRERCCQVH-----LSS 139
LG G G V K TQ ALK+L E ++ L +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 85
Query: 140 SRRHPLLSSE-------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKP 186
R+ L+ E G +TE++A++ + + +AI Y H + HRD+KP
Sbjct: 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 145
Query: 187 ENLLLTMHED---VKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIG 243
ENLL T +K++DFG E T + Y K D W +G
Sbjct: 146 ENLLYTSKRPNAILKLTDFG-------------------FAKE-TTGEKYDKSCDMWSLG 185
Query: 244 ILAYEFLVGKPPFESKDQDTTLERIF 269
++ Y L G PPF S +
Sbjct: 186 VIMYILLCGYPPFYSNHGLAISPGMK 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-39
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
+ D+++ LG G +G V LA + T+ +A+K++ ++ + +E + ++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKE----ICIN 59
Query: 139 SSRRHP-------LLSSE----------EGYSLY---------TEKDAAKYIYQVADAIH 172
H G L+ E DA ++ +Q+ +
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR----KTMCGTLDYLPPEMV 228
Y H + HRDIKPENLLL +++KISDFG + +R MCGTL Y+ PE++
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 229 TSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267
+ + + VD W GI+ L G+ P++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 68 REAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQV 127
E R ++ + +G LG G FG V + K + T +A+K+L + +I + + ++
Sbjct: 4 AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI 63
Query: 128 HRERCCQVHLSSSRRHP-------LLSSE----------EGYSLY---------TEKDAA 161
RE + RHP ++S+ G L+ EK++
Sbjct: 64 RRE----IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESR 119
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHRKTMCGTL 220
+ Q+ + YCH+ V+HRD+KPEN+LL H + KI+DFG S + + +T CG+
Sbjct: 120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSP 179
Query: 221 DYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+Y PE+++ + Y G EVD W G++ Y L G PF+ T ++I
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC 229
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-39
Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 37/230 (16%)
Query: 70 APNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHR 129
+R M++FE LG G FG V L KEK T A+K+L K I+ +
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 197
Query: 130 ERCCQVHLSSSRRHPLLS----------------------------SEEGYSLYTEKDAA 161
E + + RHP L+ S E +++E A
Sbjct: 198 EN----RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRAR 251
Query: 162 KYIYQVADAIHYCHQKK-VIHRDIKPENLLLTMHEDVKISDFGWSVHA--PSLHRKTMCG 218
Y ++ A+ Y H +K V++RD+K ENL+L +KI+DFG KT CG
Sbjct: 252 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 311
Query: 219 TLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
T +YL PE++ YG+ VD W +G++ YE + G+ PF ++D + E I
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 7e-39
Identities = 37/241 (15%), Positives = 71/241 (29%), Gaps = 44/241 (18%)
Query: 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINERMTH 125
P ++ V LG G F VY A + + LKV +
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115
Query: 126 QVHRE----------RCCQVHLSSSRRHPLLSSEEGYSLY--------------TEKDAA 161
Q+ + HL + + +L +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLT-----------MHEDVKISDFGWSVHAPS 210
+ ++ I H ++IH DIKP+N +L + + + D G S+
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 211 LHR----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266
+ C T + EM++++ + ++D + + Y L G +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295
Query: 267 R 267
Sbjct: 296 E 296
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-38
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
+ D+++ LG G +G V LA + T+ +A+K++ ++ + +E + ++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKE----ICIN 59
Query: 139 SSRRHP-------LLSSE----------EGYSLY---------TEKDAAKYIYQVADAIH 172
H G L+ E DA ++ +Q+ +
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS----VHAPSLHRKTMCGTLDYLPPEMV 228
Y H + HRDIKPENLLL +++KISDFG + + MCGTL Y+ PE++
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 229 TSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267
+ + + VD W GI+ L G+ P++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-38
Identities = 57/243 (23%), Positives = 90/243 (37%), Gaps = 51/243 (20%)
Query: 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHL 137
Q++ + + +G G +G V LA + A+KVL K ++I + + R +
Sbjct: 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 138 SSSR-------------------RHP-------LLSSEEGYSLY---------------- 155
HP +L LY
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130
Query: 156 ----TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAP 209
+E A Y + I Y H +K+IHRDIKP NLL+ +KI+DFG S
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 210 SLHRKTMCGTLDYLPPEMVTSQH--Y-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266
GT ++ PE ++ + GK +D W +G+ Y F+ G+ PF +
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 267 RIF 269
+I
Sbjct: 251 KIK 253
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-38
Identities = 54/215 (25%), Positives = 81/215 (37%), Gaps = 47/215 (21%)
Query: 87 PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE-----RCCQ----VHL 137
LG G V T A+K++ K V RE +C + L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR---VFREVEMLYQCQGHRNVLEL 76
Query: 138 -----SSSRRH---------PLLS--SEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIH 181
R + +LS + + + E +A+ + VA A+ + H K + H
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAH 134
Query: 182 RDIKPENLLLTMHED---VKISDFGWSVHAPSLHR---------KTMCGTLDYLPPEMVT 229
RD+KPEN+L VKI DF T CG+ +Y+ PE+V
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 230 SQH-----YGKEVDNWCIGILAYEFLVGKPPFESK 259
+ Y K D W +G++ Y L G PPF +
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 61 MQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN 120
M + ++ +G+G FG L ++K T+ ++A+K + + I+
Sbjct: 1 MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID 60
Query: 121 ERMTHQVHRERCCQVHLSSSRRHP--------LLSSEEGY---------SLY-------- 155
E V RE + S RHP +L+ LY
Sbjct: 61 E----NVQRE----IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR 112
Query: 156 -TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE--DVKISDFGWSVHAPSLH 212
+E +A + Q+ + YCH ++ HRD+K EN LL +KI DFG+S +
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
Query: 213 R-KTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFE 257
+ K+ GT Y+ PE++ Q Y GK D W G+ Y LVG PFE
Sbjct: 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-37
Identities = 53/245 (21%), Positives = 83/245 (33%), Gaps = 63/245 (25%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
++DFE LG G FG V+ AK K A+K + E +V RE V
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMRE----VKAL 57
Query: 139 SSRRHP-----------------------------------------LLSSEEGYSLYTE 157
+ HP ++
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 158 KDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS------------ 205
Q+A+A+ + H K ++HRD+KP N+ TM + VK+ DFG
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 206 --VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263
GT Y+ PE + Y +VD + +G++ +E L P ++
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVR 235
Query: 264 TLERI 268
TL +
Sbjct: 236 TLTDV 240
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 32/252 (12%), Positives = 62/252 (24%), Gaps = 65/252 (25%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKV-------------EIINERMTHQVH 128
G LG A ++ T + V Y E++ R+ +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 129 RERCCQVHLSSSRRHPLLSSEEGYSLY--------------------------------- 155
++ +VHL L+ + +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 156 ---------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206
+ QV + H ++H ++P +++L V ++ F V
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 207 HAPSLHRKTMCGTL----DYLPPEMVTSQ-----HYGKEVDNWCIGILAYEFLVGKPPFE 257
+ + G + M+ D W +G+ Y P
Sbjct: 260 RDGA-SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 258 SKDQDTTLERIF 269
E IF
Sbjct: 319 DDAALGGSEWIF 330
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 45/228 (19%), Positives = 74/228 (32%), Gaps = 50/228 (21%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
F LG G G + + V+ I RE Q+ L S
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNR-------DVAVKRILPECFSFADRE--VQL-LRES 74
Query: 141 RRHP----LLSSEE------------GYSL----------YTEKDAAKYIYQVADAIHYC 174
HP +E+ +L + + + Q + +
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 175 HQKKVIHRDIKPENLLLTMHED-----VKISDFGWSVHAPS-----LHRKTMCGTLDYLP 224
H ++HRD+KP N+L++M ISDFG R + GT ++
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 225 PEMVTS---QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
PEM++ ++ VD + G + Y + G PF Q +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 48/241 (19%), Positives = 77/241 (31%), Gaps = 71/241 (29%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVH-LSSS 140
LG G G V + +A+K + E + L+ S
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGR-PVAVK------RMLIDFCDIALME----IKLLTES 65
Query: 141 RRHP-------------------------LL-------SSEEGYSLYTEKDAAKYIYQVA 168
HP L S+E L E + + Q+A
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHED-------------VKISDFGWSVH------AP 209
+ + H K+IHRD+KP+N+L++ + ISDFG +
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 210 SLHRKTMCGTLDYLPPEM-------VTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQ 261
+ GT + PE+ T + + +D + +G + Y L GK PF K
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 262 D 262
Sbjct: 246 R 246
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-33
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 66 DAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH 125
D E + LG G +G VY ++ + Q+ IA+K ++ + R +
Sbjct: 13 DLLEYDYEYDENGDRVV-----LGKGTYGIVYAGRDLSNQVRIAIK---EIPERDSRYSQ 64
Query: 126 QVHRERCCQVHLSSSRRHP-----------------------------LLSSEEGYSLYT 156
+H E + L +H LL S+ G
Sbjct: 65 PLHEE----IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWS--VHAPSLHR 213
E+ Y Q+ + + Y H +++HRDIK +N+L+ + +KISDFG S + +
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180
Query: 214 KTMCGTLDYLPPEMV--TSQHYGKEVDNWCIGILAYEFLVGKPPF 256
+T GTL Y+ PE++ + YGK D W +G E GKPPF
Sbjct: 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-33
Identities = 54/228 (23%), Positives = 81/228 (35%), Gaps = 55/228 (24%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQ------- 134
V L G F VY A++ + ALK L E + +E C
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHP 86
Query: 135 --VHLSSSRRHPLLSSEEGYSLY------------------------TEKDAAKYIYQVA 168
V S+ S+ G + + + K YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 169 DAIHYCHQKK--VIHRDIKPENLLLTMHEDVKISDFG------------WSVHAPSL--H 212
A+ + H++K +IHRD+K ENLLL+ +K+ DFG WS +L
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 213 RKTMCGTLDYLPPEMVTS---QHYGKEVDNWCIGILAYEFLVGKPPFE 257
T T Y PE++ G++ D W +G + Y + PFE
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-31
Identities = 37/232 (15%), Positives = 71/232 (30%), Gaps = 56/232 (24%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
++F +G+G+FG V+ ++ + A+K K + RE H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALRE--VYAHAVL 67
Query: 140 SRRHP-----LLSSEEGYSLY-------------------------TEKDAAKYIYQVAD 169
+ H + E + E + + QV
Sbjct: 68 GQ-HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHED-------------------VKISDFGWSVHAPS 210
+ Y H ++H DIKP N+ ++ KI D G S
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 211 LHRKTMCGTLDYLPPEMVTSQH-YGKEVDNWCIGILAYEFLVGKPPFESKDQ 261
+ G +L E++ + + + D + + + +P + DQ
Sbjct: 187 --PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 46/220 (20%), Positives = 81/220 (36%), Gaps = 46/220 (20%)
Query: 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE 130
+ YR ++ +G G FG V+ K+K T A+K KV + R+ E
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV-----EE 100
Query: 131 RCCQVHLSSSRRHP-----LLSSEEGYSLY---------------------TEKDAAKYI 164
+ + P + EG + E A Y+
Sbjct: 101 ----LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYL 156
Query: 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGWSVH-------APSLHRKTM 216
Q + + Y H ++++H D+K +N+LL+ + DFG ++ L +
Sbjct: 157 GQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
GT ++ PE+V + +VD W + L G P+
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-29
Identities = 56/224 (25%), Positives = 88/224 (39%), Gaps = 33/224 (14%)
Query: 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE 130
K + DFE LG G G V+ K + +++A K++ +EI + +Q+ RE
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEI-KPAIRNQIIRE 81
Query: 131 RCCQVHLSSSRRHP--------LLSSEE---------GYSL---------YTEKDAAKYI 164
+ + P S E G SL E+ K
Sbjct: 82 ----LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS 137
Query: 165 YQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYL 223
V + Y +K K++HRD+KP N+L+ ++K+ DFG S + GT Y+
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 197
Query: 224 PPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267
PE + HY + D W +G+ E VG+ P D
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-28
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 46/210 (21%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLY------KVEIINERMTHQVHRERCC 133
+ +G G G VY A + T +A++ + K IINE
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE------------ 67
Query: 134 QVHLSSSRRHP---------LLSSE--------EGYSL--------YTEKDAAKYIYQVA 168
+ + ++P L+ E G SL E A +
Sbjct: 68 -ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPE 226
A+ + H +VIHRDIK +N+LL M VK++DFG+ + R TM GT ++ PE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
+VT + YG +VD W +GI+A E + G+PP+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-28
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 46/208 (22%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLY------KVEIINERMTHQVHRERCCQV 135
+ +G G G V LA+EK + +A+K++ + + NE V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNE-------------V 93
Query: 136 HLSSSRRHP---------LLSSE--------EGYSL--------YTEKDAAKYIYQVADA 170
+ +H L+ E +G +L E+ A V A
Sbjct: 94 VIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQA 153
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMV 228
+ Y H + VIHRDIK +++LLT+ VK+SDFG+ + RK++ GT ++ PE++
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPF 256
+ Y EVD W +GI+ E + G+PP+
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPY 241
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 67/239 (28%), Positives = 112/239 (46%), Gaps = 39/239 (16%)
Query: 62 QTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE 121
H+ + N ++ M ++ +G G +G VY AK+ +I +ALK + +++ +E
Sbjct: 3 HHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRI-RLDAEDE 60
Query: 122 RMTHQVHRERCCQVHLSSSRRHP-------LLSSEEGYSL---YTEKDAAKYI------- 164
+ RE + L HP ++ SE +L + EKD K +
Sbjct: 61 GIPSTAIRE----ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGL 116
Query: 165 ---------YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT 215
YQ+ + +CHQ +++HRD+KP+NLL+ +K++DFG + A + ++
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRS 175
Query: 216 MCG---TLDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
TL Y P+ ++ S+ Y VD W IG I A E + GKP F D L +IF
Sbjct: 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA-EMITGKPLFPGVTDDDQLPKIF 233
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 42/213 (19%), Positives = 85/213 (39%), Gaps = 37/213 (17%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
++ E +G G FG V+ + + ++A+K L + E + +E +V + S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 140 SRRHP-------------LLSSE--EGYSLY----------TEKDAAKYIYQVADAIHYC 174
+ HP + E LY + + +A I Y
Sbjct: 79 NLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 175 HQKK--VIHRDIKPENLLLTMHED-----VKISDFGWS-VHAPSLHRKTMCGTLDYLPPE 226
+ ++HRD++ N+ L ++ K++DFG S S+ + G ++ PE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQWMAPE 196
Query: 227 MVTSQH--YGKEVDNWCIGILAYEFLVGKPPFE 257
+ ++ Y ++ D + ++ Y L G+ PF+
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 55/223 (24%), Positives = 85/223 (38%), Gaps = 45/223 (20%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
+ EV +G G FG V AK + + A+K + +E E +
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDV--AIKQI-----ESESERKAFIVE----LRQL 55
Query: 139 SSRRHP---------------------------LLSSEEGYSLYTEKDAAKYIYQVADAI 171
S HP +L E YT A + Q + +
Sbjct: 56 SRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 172 HYCHQ---KKVIHRDIKPENLLLTMHEDV-KISDFGWSVHAPSLHRKTMCGTLDYLPPEM 227
Y H K +IHRD+KP NLLL V KI DFG + + H G+ ++ PE+
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-HMTNNKGSAAWMAPEV 174
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270
+Y ++ D + GI+ +E + + PF+ + RI W
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMW 215
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 46/211 (21%), Positives = 85/211 (40%), Gaps = 40/211 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
D + +G G FG V+ A+ + + A+K+L + + ++ RE V +
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGSDV--AVKIL-MEQDFHAERVNEFLRE----VAIMK 89
Query: 140 SRRHP-----------------------------LLSSEEGYSLYTEKDAAKYIYQVADA 170
RHP LL E+ Y VA
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 171 IHYCHQKK--VIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPE 226
++Y H + ++HR++K NLL+ VK+ DFG S + L K+ GT +++ PE
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257
++ + ++ D + G++ +E + P+
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-26
Identities = 38/202 (18%), Positives = 73/202 (36%), Gaps = 39/202 (19%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP--- 144
+G G F VY + T + +A L + + + + E + +HP
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEE----AEMLKGLQHPNIV 88
Query: 145 ------LLSSEEGYSLY---------------------TEKDAAKYIYQVADAIHYCHQK 177
+ + + K + Q+ + + H +
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 178 K--VIHRDIKPENLLLTMHE-DVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYG 234
+IHRD+K +N+ +T VKI D G + + K + GT +++ PEM + Y
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYD 207
Query: 235 KEVDNWCIGILAYEFLVGKPPF 256
+ VD + G+ E + P+
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPY 229
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 29/140 (20%), Positives = 55/140 (39%), Gaps = 16/140 (11%)
Query: 143 HPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202
++ Q+A+A+ + H K ++HRD+KP N+ TM + VK+ DF
Sbjct: 149 KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 208
Query: 203 G--------------WSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYE 248
G + GT Y+ PE + +Y +VD + +G++ +E
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
Query: 249 FLVGKPPFESKDQDTTLERI 268
L + + + +
Sbjct: 269 LLYSFSTQMERVR--IITDV 286
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 6e-05
Identities = 28/143 (19%), Positives = 47/143 (32%), Gaps = 12/143 (8%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-ERMTHQVHRERCCQVHL 137
++DFE +G G FG V+ AK K A+K ++ + N E +V RE V
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIK---RIRLPNRELAREKVMRE----VKA 57
Query: 138 SSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV 197
+ HP + L T +Q + + P + +
Sbjct: 58 LAKLEHPGIVRYFNAWLETP----PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIR 113
Query: 198 KISDFGWSVHAPSLHRKTMCGTL 220
++ F L + L
Sbjct: 114 RMDPFSTKNTVGQLQPSSPKVYL 136
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 3e-26
Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 39/222 (17%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
M + +G G +G VY A+ + ALK + ++E +E + RE + +
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKI-RLEKEDEGIPSTTIRE----ISIL 54
Query: 139 SSRRHP-------LLSSEEGYSL---YTEKDAAKYI----------------YQVADAIH 172
+H ++ +++ L + ++D K + Q+ + I
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MV 228
YCH ++V+HRD+KP+NLL+ ++KI+DFG + A + + TL Y P+ ++
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLA-RAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 229 TSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
S+ Y +D W +G I A E + G P F + L RIF
Sbjct: 174 GSKKYSTTIDIWSVGCIFA-EMVNGTPLFPGVSEADQLMRIF 214
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 54/198 (27%), Positives = 87/198 (43%), Gaps = 21/198 (10%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLY-------KVEIINE-RMTHQVHRER 131
F +G G FG V+ + TQ ++A+K++ +I E + Q
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 132 CCQVHLSSSRRHPL-LSSE--EGYSLY--------TEKDAAKYIYQVADAIHYCHQKKVI 180
+ + S + L + E G S E A + ++ + Y H +K I
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 141
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPEMVTSQHYGKEVD 238
HRDIK N+LL+ H +VK++DFG + + R T GT ++ PE++ Y + D
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 201
Query: 239 NWCIGILAYEFLVGKPPF 256
W +GI A E G+PP
Sbjct: 202 IWSLGITAIELARGEPPH 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---------------- 122
M +E +G G +G V+ + + T ++A+K K +
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQ 58
Query: 123 MTHQ--------VHRERCCQVHL-----SSSRRHPLLSSEEGYSLYTEKDAAKYIYQVAD 169
+ H R+R ++HL + H L + G + K +Q
Sbjct: 59 LKHPNLVNLLEVFRRKR--RLHLVFEYCDHTVLHELDRYQRGVPEHLVK---SITWQTLQ 113
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW--SVHAPSLHRKTM---CGTLDYLP 224
A+++CH+ IHRD+KPEN+L+T H +K+ DFG+ + PS T Y
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS---DYYDDEVATRWYRS 170
Query: 225 PEM-VTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
PE+ V YG VD W IG + A E L G P + K L I
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFA-ELLSGVPLWPGKSDVDQLYLIR 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 58/196 (29%), Positives = 85/196 (43%), Gaps = 22/196 (11%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVE-----IINE-RMTHQVHRERCCQV 135
F+V LG G +G VY A K T ++A+K + VE II E + Q +
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 136 HLSSSRRHPL-LSSE--EGYSL----------YTEKDAAKYIYQVADAIHYCHQKKVIHR 182
+ S + L + E S+ TE + A + + Y H + IHR
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 183 DIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNW 240
DIK N+LL K++DFG + R T+ GT ++ PE++ Y D W
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 241 CIGILAYEFLVGKPPF 256
+GI A E GKPP+
Sbjct: 210 SLGITAIEMAEGKPPY 225
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
M +E +G G +G V+ AK + T ++ALK + +++ +E + RE + L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALRE----ICLL 55
Query: 139 SSRRHP-------LLSSEEGYSL---YTEKDAAKYI----------------YQVADAIH 172
+H +L S++ +L + ++D KY +Q+ +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE-MV 228
+CH + V+HRD+KP+NLL+ + ++K+++FG + A + + TL Y PP+ +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 229 TSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
++ Y +D W G I A G+P F D D L+RIF
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 49/226 (21%), Positives = 85/226 (37%), Gaps = 36/226 (15%)
Query: 67 AREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-------YKVEII 119
+ ++ + D+E+ +G+G V A + +A+K + E++
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL 61
Query: 120 NE-----RMTHQ-VHRERCCQVH---------------LSSSRRHPLLSSEEGYSLYTEK 158
E + H + V + +H + E + E
Sbjct: 62 KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121
Query: 159 DAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-------VHAPSL 211
A + +V + + Y H+ IHRD+K N+LL V+I+DFG S +
Sbjct: 122 TIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 212 HRKTMCGTLDYLPPEMVTSQH-YGKEVDNWCIGILAYEFLVGKPPF 256
RKT GT ++ PE++ Y + D W GI A E G P+
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 56/239 (23%), Positives = 90/239 (37%), Gaps = 62/239 (25%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
S +E +G G +G VY A++ + +ALK V + N + +S
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK---SVRVPNGG-------GGGGGLPIS 57
Query: 139 SSR-----------RHP----LL------SSEEGYSL-----YTEKDAAKYI-------- 164
+ R HP L+ ++ + + ++D Y+
Sbjct: 58 TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 117
Query: 165 ---------YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSL 211
Q + + H ++HRD+KPEN+L+T VK++DFG +S
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT 177
Query: 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
TL Y PE++ Y VD W +G I A E KP F + L +IF
Sbjct: 178 PV---VVTLWYRAPEVLLQSTYATPVDMWSVGCIFA-EMFRRKPLFCGNSEADQLGKIF 232
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 44/239 (18%)
Query: 67 AREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQ 126
+ + + LG G +G VY A + T +A+K + ++E E +
Sbjct: 21 SMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGT 79
Query: 127 VHRERCCQVHLSSSRRHP-------LLSSEEGYSL---YTEKDAAKYI------------ 164
RE V L +H ++ L Y E D KY+
Sbjct: 80 AIRE----VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIK 135
Query: 165 ---YQVADAIHYCHQKKVIHRDIKPENLLLTMHED-----VKISDFG----WSVHAPSLH 212
YQ+ + +++CH ++ +HRD+KP+NLLL++ + +KI DFG + +
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 213 RKTMCGTLDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
+ + TL Y PPE ++ S+HY VD W I I A E L+ P F + L +IF
Sbjct: 196 HEII--TLWYRPPEILLGSRHYSTSVDIWSIACIWA-EMLMKTPLFPGDSEIDQLFKIF 251
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 46/226 (20%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---------------- 122
M +E +G G +G V + K T ++A+K K ++
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 123 MTHQ--------VHRERCCQVHL-----SSSRRHPLLSSEEGYSLYTEKDAAKYIYQVAD 169
+ H+ +++ + +L + L G + KY++Q+ +
Sbjct: 81 LRHENLVNLLEVCKKKK--RWYLVFEFVDHTILDDLELFPNGLDYQVVQ---KYLFQIIN 135
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSLHRKTMCGTLDYLPP 225
I +CH +IHRDIKPEN+L++ VK+ DFG + + T Y P
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAP 193
Query: 226 EM-VTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
E+ V YGK VD W IG ++ E +G+P F L I
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVT-EMFMGEPLFPGDSDIDQLYHIM 238
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-25
Identities = 47/210 (22%), Positives = 79/210 (37%), Gaps = 43/210 (20%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-----ERMTHQVHRERCCQVH 136
+ + +G G G VY A++ + ++ALK++ + + RM RE
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRM----QRE----AR 86
Query: 137 LSSSRRHPLLSS-----EEGYSLY---------------------TEKDAAKYIYQVADA 170
+ + P + E LY A + Q+ A
Sbjct: 87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG--WSVHAPSL-HRKTMCGTLDYLPPEM 227
+ H HRD+KPEN+L++ + + DFG + L GTL Y+ PE
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 228 VTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257
+ H D + + + YE L G PP++
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-25
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 29/202 (14%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKV------EIINE-RMTHQVHRERCCQ 134
+E+ LG G FG VY AK K T + A KV+ + I E + +
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 135 VHLSSSRRHPL--------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVI 180
+ + L + E L TE Q+ +A+++ H K++I
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL-TEPQIQVVCRQMLEALNFLHSKRII 139
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPEMVTSQH-----Y 233
HRD+K N+L+T+ D++++DFG S R + GT ++ PE+V + Y
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 234 GKEVDNWCIGILAYEFLVGKPP 255
+ D W +GI E +PP
Sbjct: 200 DYKADIWSLGITLIEMAQIEPP 221
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-24
Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 46/228 (20%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---------------RM 123
S F+ LG G + VY KTT + +ALK +V++ +E +
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK---EVKLDSEEGTPSTAIREISLMKEL 60
Query: 124 THQ--------VHRERCCQVHL----------SSSRRHPLLSSEEGYSLYTEKDAAKYIY 165
H+ +H E ++ L + ++ G L K + +
Sbjct: 61 KHENIVRLYDVIHTEN--KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK---YFQW 115
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDY 222
Q+ + +CH+ K++HRD+KP+NLL+ +K+ DFG + A + T TL Y
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVNTFSSEVVTLWY 174
Query: 223 LPPE-MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
P+ ++ S+ Y +D W G + E + GKP F + + L+ IF
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-24
Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 60/224 (26%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----YKVEIINERMTHQVHRERCCQ 134
FE+ +G G +G VY + T + A+KV+ + EI E
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE-----------IN 72
Query: 135 VHLSSSRRHP-----------------------------------LLSSEEGYSLYTEKD 159
+ L H L+ + +G +L E+
Sbjct: 73 M-LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL-KEEW 130
Query: 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMC 217
A ++ + + HQ KVIHRDIK +N+LLT + +VK+ DFG S R T
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 190
Query: 218 GTLDYLPPEMVTSQH-----YGKEVDNWCIGILAYEFLVGKPPF 256
GT ++ PE++ Y + D W +GI A E G PP
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 43/224 (19%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---MTHQVHRERCCQV 135
M + LG G + VY K K T ++ALK ++ + +E T RE V
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIRLEHEEGAPCT--AIRE----V 51
Query: 136 HLSSSRRHP-------LLSSEEGYSL---YTEKDAAKYI----------------YQVAD 169
L +H ++ +E+ +L Y +KD +Y+ +Q+
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCG---TLDYLPPE 226
+ YCH++KV+HRD+KP+NLL+ ++K++DFG + A S+ KT TL Y PP+
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYDNEVVTLWYRPPD 170
Query: 227 -MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
++ S Y ++D W +G + YE G+P F + L IF
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-24
Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 41/224 (18%)
Query: 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE 130
P + + + D + +G G +G V K + ++A+K + + + +E+ Q+ +
Sbjct: 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTV-DEKEQKQLLMD 70
Query: 131 RCCQVHLSSSRRHPLL----------------------SSEEGYSLY--------TEKDA 160
V + SS P + S ++ Y E+
Sbjct: 71 --LDVVMRSSD-CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127
Query: 161 AKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVH-APSLHRKTMCG 218
K A+++ + K+IHRDIKP N+LL ++K+ DFG S S+ + G
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAG 187
Query: 219 TLDYLPPE----MVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
Y+ PE + Q Y D W +GI YE G+ P+
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-24
Identities = 60/237 (25%), Positives = 94/237 (39%), Gaps = 63/237 (26%)
Query: 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHL 137
+ +E LG G+F VY A++K T ++A+K K+ ++ H+ E ++
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---KI-----KLGHR--SEAKDGINR 57
Query: 138 SSSR--------RHP-------LLSSEEGYSL---YTEKDAAKYI--------------- 164
++ R HP + SL + E D I
Sbjct: 58 TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY 117
Query: 165 -YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR------KTMC 217
+ Y HQ ++HRD+KP NLLL + +K++DFG L + +
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFG-------LAKSFGSPNRAYT 170
Query: 218 G---TLDYLPPEMVT-SQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
T Y PE++ ++ YG VD W +G ILA E L+ P L RIF
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA-ELLLRVPFLPGDSDLDQLTRIF 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-24
Identities = 46/220 (20%), Positives = 84/220 (38%), Gaps = 40/220 (18%)
Query: 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCC 133
S + D E LG G +G V + + ++A+K + + + N + ++ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATV-NSQEQKRLLMD--L 56
Query: 134 QVHLSSSRRHPLL----------------------SSEEGYSLY-------TEKDAAKYI 164
+ + + P S ++ Y E K
Sbjct: 57 DISMRTVD-CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 165 YQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVH-APSLHRKTMCGTLDY 222
+ A+ + H K VIHRD+KP N+L+ VK+ DFG S + + + G Y
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPY 175
Query: 223 LPPE----MVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
+ PE + + Y + D W +GI E + + P++S
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-24
Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 38/220 (17%)
Query: 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER 131
+ Y+ +++D E +G+G G V+ + + T +IA+K + + N+ ++ +
Sbjct: 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSG-NKEENKRILMD- 73
Query: 132 CCQVHLSSSRRHPLL----------------------SSEEGYSLY----TEKDAAKYIY 165
V L S P + +E+ E+ K
Sbjct: 74 -LDVVLKSHD-CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 166 QVADAIHYCH-QKKVIHRDIKPENLLLTMHEDVKISDFGWSVH-APSLHRKTMCGTLDYL 223
+ A++Y + VIHRD+KP N+LL +K+ DFG S + G Y+
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191
Query: 224 PPE-----MVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
PE T Y D W +GI E G+ P+++
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-24
Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 43/216 (19%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT-HQVHRERCCQVHL 137
++ + +G G FG VY A ++ A+K + T V +E L
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWIGDEV--AVKAARHDPDEDISQTIENVRQE----AKL 59
Query: 138 SSSRRHP----LL---SSEEGYSLYTE------------------KDAAKYIYQVADAIH 172
+ +HP L E L E + Q+A ++
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMN 119
Query: 173 YCHQKK---VIHRDIKPENLLLTMHED--------VKISDFGWSVHAPSLHRKTMCGTLD 221
Y H + +IHRD+K N+L+ + +KI+DFG + + + G
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA 179
Query: 222 YLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257
++ PE++ + + K D W G+L +E L G+ PF
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-24
Identities = 49/202 (24%), Positives = 77/202 (38%), Gaps = 31/202 (15%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL---------YKVEIINE-RMTHQVHRER 131
F +G G FG VY A++ ++A+K + +II E R ++
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 132 CCQVHLSSSRRHPL--------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQK 177
Q R H L + E + A + + Y H
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH 173
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQ---HYG 234
+IHRD+K N+LL+ VK+ DFG + + GT ++ PE++ + Y
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFG--SASIMAPANSFVGTPYWMAPEVILAMDEGQYD 231
Query: 235 KEVDNWCIGILAYEFLVGKPPF 256
+VD W +GI E KPP
Sbjct: 232 GKVDVWSLGITCIELAERKPPL 253
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-24
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 56/238 (23%)
Query: 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER----MTHQVHRERCC 133
++S +E +G G FG V+ A+ + T +ALK KV + NE+ +T RE
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL--RE--- 66
Query: 134 QVHLSSSRRHP-------------LLSSEEGYSLY---------------------TEKD 159
+ + +H + S+Y T +
Sbjct: 67 -IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSLHRK- 214
+ + + + ++Y H+ K++HRD+K N+L+T +K++DFG +S+ S +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 215 -TMCGTLDYLPPEMVT-SQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
TL Y PPE++ + YG +D W G I+A E P + + L I
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA-EMWTRSPIMQGNTEQHQLALIS 242
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-24
Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 41/212 (19%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
VG +G+G FG VY K +A+K+L V + E V +
Sbjct: 23 DGQITVGQRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNE----VGVL 74
Query: 139 SSRRHPLL------SSEEGYSLYTE--------------------KDAAKYIYQVADAIH 172
RH + S+ ++ T+ K Q A +
Sbjct: 75 RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS----VHAPSLHRKTMCGTLDYLPPEMV 228
Y H K +IHRD+K N+ L VKI DFG + + S + + G++ ++ PE++
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 229 TSQ---HYGKEVDNWCIGILAYEFLVGKPPFE 257
Q Y + D + GI+ YE + G+ P+
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 8e-24
Identities = 71/264 (26%), Positives = 102/264 (38%), Gaps = 69/264 (26%)
Query: 65 YDAREAPNKSYRWQMSDFEV-GCPLGTGKFGHVYLA--KEKTTQIMIALKVLYKVEIINE 121
YD + + FE GC +G G +GHVY A K+ ALK ++E
Sbjct: 5 YDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK---QIEGTGI 61
Query: 122 RMTHQVHRERCCQVHLSSSRRHP-------LLSSEEGYSL-----YTEKDAAKYI----- 164
M+ C ++ L +HP + S + Y E D I
Sbjct: 62 SMSA------CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA 115
Query: 165 -------------------YQVADAIHYCHQKKVIHRDIKPENLLLTMHED----VKISD 201
YQ+ D IHY H V+HRD+KP N+L+ VKI+D
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175
Query: 202 FG----WSVHAPSL-HRKTMCGTLDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKP 254
G ++ L + T Y PE ++ ++HY K +D W IG I A E L +P
Sbjct: 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA-ELLTSEP 234
Query: 255 PFESKDQDTT---------LERIF 269
F + +D L+RIF
Sbjct: 235 IFHCRQEDIKTSNPYHHDQLDRIF 258
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 48/238 (20%), Positives = 81/238 (34%), Gaps = 62/238 (26%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
E+G +G G+FG VY + +A++++ +E NE RE V
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLI-DIERDNEDQLKAFKRE----VMAY 83
Query: 139 SSRRHP--------------------LLSSEEGYSLY----------TEKDAAKYIYQVA 168
RH L +G +LY + ++
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLC---KGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG-------WSVHAPSLHRKTMCGTLD 221
+ Y H K ++H+D+K +N+ V I+DFG + G L
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 222 YLPPEMV---------TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270
+L PE++ + K D + +G + YE + PF+ E I W
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK----TQPAEAIIW 253
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-23
Identities = 28/215 (13%), Positives = 61/215 (28%), Gaps = 47/215 (21%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
L G ++ + + I +KVL KV + R + + E
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQGNDI--VVKVL-KVRDWSTRKSRDFNEE----CPRL 61
Query: 139 SSRRHP-------------------------------LLSSEEGYSLYTEKDAAKYIYQV 167
HP +L + + + A K+ +
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDM 120
Query: 168 ADAIHYCHQKK--VIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPP 225
A + + H + + + ++++ +IS S ++ P
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF---SFQSPGRMYAPAWVAP 177
Query: 226 EMVTSQ---HYGKEVDNWCIGILAYEFLVGKPPFE 257
E + + + D W +L +E + + PF
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 4e-23
Identities = 42/236 (17%), Positives = 82/236 (34%), Gaps = 46/236 (19%)
Query: 62 QTHYDAREAPNKSYRWQMSDFEVGCPLGTG--KFGHVYLAKEKTTQIMIALKVLYKVEII 119
+ S+ + +E+ +G G V LA+ K T + ++ + +E
Sbjct: 7 HHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEAC 65
Query: 120 NERMTHQVHRERCCQVHLSSSRRHP-----LLSSEEGYSLY------------------- 155
+ M + E +H+S HP + L+
Sbjct: 66 SNEMVTFLQGE----LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121
Query: 156 ----TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAP 209
E A + V A+ Y H +HR +K ++L+++ V +S + + +
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181
Query: 210 SLHRKTMC-------GTLDYLPPEMVTSQH--YGKEVDNWCIGILAYEFLVGKPPF 256
++ + L +L PE++ Y + D + +GI A E G PF
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-23
Identities = 55/233 (23%), Positives = 91/233 (39%), Gaps = 52/233 (22%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKE-KTTQIMIALKVLYKVEIINER----MTHQVHRERCC 133
+E +G G +G V+ A++ K +ALK +V + ++ RE
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLS--TIREVAV 64
Query: 134 QVHLSSSRRHP----LL------SSEEGYSL-----YTEKDAAKYI-------------- 164
HL + HP L ++ L + ++D Y+
Sbjct: 65 LRHLETFE-HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 165 ---YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSLHRKTMC 217
+Q+ + + H +V+HRD+KP+N+L+T +K++DFG +S
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---V 180
Query: 218 GTLDYLPPEMVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
TL Y PE++ Y VD W +G I A E KP F L +I
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFA-EMFRRKPLFRGSSDVDQLGKIL 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-23
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 5/107 (4%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG-----WSVHAPS 210
T K A + I A+++ HQ +IHRD+KP N++++ VK+ DFG
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257
+ GT YL PE D + +G + YE L G+PPF
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 8e-23
Identities = 28/205 (13%), Positives = 58/205 (28%), Gaps = 45/205 (21%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE----------R 131
+ + G + A + +AL + ++ + + +
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 132 CCQVH-LSSSRRHPLLSSE--EGYSLYTE-------KDAAKYIYQVADAIHYCHQKKVIH 181
+V + +R L+ +E G SL A + + +A A H+ V
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 182 RDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWC 241
P + +++ DV ++ +P + D
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPA------------------TMPDA-------NPQDDIRG 187
Query: 242 IGILAYEFLVGKPPFESKDQDTTLE 266
IG Y LV + P + L
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLA 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 9e-23
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 33/205 (16%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
+++ LG G VYLA++ I +A+K ++ E + RE VH SS
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFERE----VHNSSQL 68
Query: 142 RHPLLSS-----EEGYSLY---------------------TEKDAAKYIYQVADAIHYCH 175
H + S EE Y + A + Q+ D I + H
Sbjct: 69 SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFG--WSVHAPSL-HRKTMCGTLDYLPPEMVTSQH 232
+++HRDIKP+N+L+ ++ +KI DFG ++ SL + GT+ Y PE +
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 233 YGKEVDNWCIGILAYEFLVGKPPFE 257
+ D + IGI+ YE LVG+PPF
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKV-------EI-INERMTHQVHRE 130
D+++ LG GK+ V+ A T + +K+L V EI I E + +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 94
Query: 131 RCCQVHLSSSRRHPLLSSEEG--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHR 182
+ R P L E Y T+ D Y+Y++ A+ YCH ++HR
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 154
Query: 183 DIKPENLLL-TMHEDVKISDFGWS-VHAPSLHRKTMCGTLDYLPPE-MVTSQHYGKEVDN 239
D+KP N+++ H +++ D+G + + P + + PE +V Q Y +D
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 214
Query: 240 WCIG-ILAYEFLVGKPP-FESKDQDTTLERIF 269
W +G +LA + K P F D L RI
Sbjct: 215 WSLGCMLA-SMIFRKEPFFHGHDNYDQLVRIA 245
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-22
Identities = 41/208 (19%), Positives = 72/208 (34%), Gaps = 42/208 (20%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQI-MIALKVLYKVEIINERMTHQVHRER--------- 131
+EV + G G +YLA ++ + LK L + ER
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHP 139
Query: 132 -CCQVH------LSSSRRHPLLSSE--EGYSL-------YTEKDAAKYIYQVADAIHYCH 175
Q+ + E G SL +A Y+ ++ A+ Y H
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH 199
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFG--WSVHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
+++ D+KPEN++LT E +K+ D G +++ + GT + PE+V
Sbjct: 200 SIGLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFG----YLYGTPGFQAPEIVR---- 250
Query: 234 GKEV---DNWCIGILAYEFLVGKPPFES 258
D + +G + P
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNG 278
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-22
Identities = 45/221 (20%), Positives = 78/221 (35%), Gaps = 50/221 (22%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
SD G LG G FG + T ++ +K L + +E +E V +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKE----VKVMR 62
Query: 140 SRRHP-------LLSSEEGYSLYTE-----------KDAAKYI---------YQVADAIH 172
HP +L ++ + TE K +A +
Sbjct: 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS----------------VHAPSLHRKTM 216
Y H +IHRD+ N L+ +++V ++DFG + R T+
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257
G ++ PEM+ + Y ++VD + GI+ E +
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-21
Identities = 59/236 (25%), Positives = 87/236 (36%), Gaps = 57/236 (24%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER-------MTHQVH 128
R Q + +G G FG VY AK + ++A+K KV M H
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQDKRFKNRELQIMRKLDH 106
Query: 129 RERCCQVHLSSSRRHPLLSSEEGYSLY--TE----------KDAAK------------YI 164
C V L +E Y L + + ++ Y+
Sbjct: 107 ---CNIVRLRYFFYSSGEKKDEVY-LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV-KISDFGWSVHAPSLHRKTMCG----- 218
YQ+ ++ Y H + HRDIKP+NLLL V K+ DFG ++ + G
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-------SAKQLVRGEPNVS 215
Query: 219 ---TLDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
+ Y PE + + Y +D W G +LA E L+G+P F L I
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLA-ELLLGQPIFPGDSGVDQLVEII 270
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 66/252 (26%), Positives = 97/252 (38%), Gaps = 53/252 (21%)
Query: 62 QTHYDAREAPNKSYRWQMSDFEVGC------PLGTGKFGHVYLAKEKTTQIMIALKVLYK 115
H+ A A + F+VG +G G +G V A + ++ +A+K K
Sbjct: 3 HHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---K 59
Query: 116 VEIINERMTHQ-VHRERCCQVHLSSSRRHP----LL-----SSEEGYS---LYTE----- 157
+ + Q RE + RH + + E + +
Sbjct: 60 ISPFEHQTYCQRTLREIKILLRF----RHENIIGINDIIRAPTIEQMKDVYIVQDLMETD 115
Query: 158 -----------KDAAKY-IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205
D Y +YQ+ + Y H V+HRD+KP NLLL D+KI DFG +
Sbjct: 116 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 206 VHAPSLHRKTMCGTLDYL------PPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFE 257
A H T T +Y+ PE M+ S+ Y K +D W +G ILA E L +P F
Sbjct: 176 RVADPDHDHTGFLT-EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA-EMLSNRPIFP 233
Query: 258 SKDQDTTLERIF 269
K L I
Sbjct: 234 GKHYLDQLNHIL 245
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 4e-21
Identities = 58/268 (21%), Positives = 103/268 (38%), Gaps = 54/268 (20%)
Query: 43 EGLTEGTNKENVEEYLKKMQTHYDAREAPNKSYRWQMSD--FEVG------CPLGTGKFG 94
+G + + + ++ ++ D N+ Y ++ D F V P+G+G G
Sbjct: 22 QGFDKQVDVSYIAKHYNMSKSKVD-----NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQG 76
Query: 95 HVYLAKEKTTQIMIALKVLYKVEIINERMTH--QVHRERCCQVHLSSSRRH--------- 143
V A + +A+K K+ + TH + +RE + H
Sbjct: 77 IVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV----NHKNIISLLNV 129
Query: 144 --PLLSSEEGYSLYT-----------------EKDAAKY-IYQVADAIHYCHQKKVIHRD 183
P + EE +Y + + Y +YQ+ I + H +IHRD
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
Query: 184 IKPENLLLTMHEDVKISDFGWSVHAPSLHRKT-MCGTLDYLPPEMVTSQHYGKEVDNWCI 242
+KP N+++ +KI DFG + A + T T Y PE++ Y + VD W +
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
Query: 243 G-ILAYEFLVGKPPFESKDQDTTLERIF 269
G I+ E + K F +D ++
Sbjct: 250 GCIMG-EMVRHKILFPGRDYIDQWNKVI 276
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 69/258 (26%), Positives = 104/258 (40%), Gaps = 64/258 (24%)
Query: 61 MQTHYDAREAPNKSYRWQM---SDFEVG------CPLGTGKFGHVYLAKEKTTQIMIALK 111
M H+ ++ Q + +EV P+G+G +G V A + T + +A+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 112 VLYKVEIINERMTH--QVHRERCCQVHLSSSRRH-----------PLLSSEEGYSLYT-- 156
K+ + + H + +RE H+ +H P S EE +Y
Sbjct: 61 ---KLSRPFQSIIHAKRTYRELRLLKHM----KHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 157 ----------------EKDAAKY-IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKI 199
D ++ IYQ+ + Y H +IHRD+KP NL + ++KI
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 173
Query: 200 SDFGWSVHAPSLHRKT---MCG---TLDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLV 251
DFG L R T M G T Y PE M+ HY + VD W +G I+A E L
Sbjct: 174 LDFG-------LARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA-ELLT 225
Query: 252 GKPPFESKDQDTTLERIF 269
G+ F D L+ I
Sbjct: 226 GRTLFPGTDHIDQLKLIL 243
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-20
Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 41/224 (18%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH--QVHRERCCQVH 136
+ ++ P+G+G G V A + + +A+K K+ + TH + +RE
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 80
Query: 137 LSSSRRH-----------PLLSSEEGYSLYT-----EKDAAKYI-------------YQV 167
+ H P S EE +Y + + + I YQ+
Sbjct: 81 V----NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM-CGTLDYLPPE 226
I + H +IHRD+KP N+++ +KI DFG + A + T T Y PE
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 227 MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
++ Y + VD W +G I+ E + G F D ++
Sbjct: 197 VILGMGYKENVDIWSVGCIMG-EMIKGGVLFPGTDHIDQWNKVI 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 57/236 (24%), Positives = 91/236 (38%), Gaps = 61/236 (25%)
Query: 80 SDFEVG------CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH--QVHRER 131
+ +EV P+G+G +G V A + T +A+K K+ + + +RE
Sbjct: 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYREL 75
Query: 132 CCQVHLSSSRRH-----------PLLSSEEGYSLYT-----EKDAAKYI----------- 164
H+ RH P + ++ Y D K +
Sbjct: 76 RLLKHM----RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 131
Query: 165 ---YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLD 221
YQ+ + Y H +IHRD+KP NL + ++KI DFG L R+
Sbjct: 132 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG-------LARQADSEMTG 184
Query: 222 YL------PPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
Y+ PE ++ Y + VD W +G I+A E + GK F+ D L+ I
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA-EMITGKTLFKGSDHLDQLKEIM 239
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 63/232 (27%), Positives = 92/232 (39%), Gaps = 52/232 (22%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQ-VHRERCCQVHLSSS 140
F++ LG G +G V A K T ++A+K K+E ++ + RE H
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHF--- 66
Query: 141 RRHP----LL-----SSEEGYS---LYTE----------------KDAAKY-IYQVADAI 171
+H + S E ++ + E D +Y IYQ A+
Sbjct: 67 -KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLD---------- 221
H VIHRD+KP NLL+ + D+K+ DFG + T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 222 --YLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
Y PE M+TS Y + +D W G ILA E + +P F +D L IF
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILA-ELFLRRPIFPGRDYRHQLLLIF 236
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 53/232 (22%), Positives = 88/232 (37%), Gaps = 46/232 (19%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHL-- 137
S + PLG G G V+ A + +A+K K+ + + + RE L
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDH 67
Query: 138 ------------SSSRRHPLLSSEEGYS---LYTE----------------KDAAKY-IY 165
S S+ + S + + E ++ A+ +Y
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 166 QVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGW--SVHAPSLHRKTMCG---T 219
Q+ + Y H V+HRD+KP NL + + +KI DFG + H+ + T
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 220 LDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
Y P +++ +Y K +D W G I A E L GK F + ++ I
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFA-EMLTGKTLFAGAHELEQMQLIL 238
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 60/235 (25%)
Query: 80 SDFEVG------CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH--QVHRER 131
+ +E+ +G+G +G V A +K + +A+K K+ + + +RE
Sbjct: 18 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYREL 74
Query: 132 CCQVHLSSSRRH-----------PLLSSEEGYSLYT-----EKDAAKYI----------- 164
H+ +H P S Y Y + D K +
Sbjct: 75 LLLKHM----QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY 130
Query: 165 --YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDY 222
YQ+ + Y H V+HRD+KP NL + ++KI DFG L R Y
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG-------LARHADAEMTGY 183
Query: 223 L------PPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
+ PE +++ HY + VD W +G I+A E L GK F+ KD L +I
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA-EMLTGKTLFKGKDYLDQLTQIL 237
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 53/240 (22%), Positives = 85/240 (35%), Gaps = 56/240 (23%)
Query: 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER-------M 123
K+ + + +G G FG V+ AK + +A+K KV M
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIK---KVLQDKRFKNRELQIM 86
Query: 124 THQVHRERCCQVHLSSSRRHPLLSSEEGY----------SLY-------------TEKDA 160
H V L + +E + ++Y
Sbjct: 87 RIVKH---PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143
Query: 161 AKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV-KISDFGWSVHAPSLHRKTMCG- 218
Y+YQ+ ++ Y H + HRDIKP+NLLL V K+ DFG + + G
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG-------SAKILIAGE 196
Query: 219 -------TLDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
+ Y PE + + +Y +D W G ++A E + G+P F + L I
Sbjct: 197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA-ELMQGQPLFPGESGIDQLVEII 255
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 57/249 (22%), Positives = 93/249 (37%), Gaps = 49/249 (19%)
Query: 62 QTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALK-----VLYKV 116
+A A ++ R +M F+V G G FG V L KEK+T + +A+K ++
Sbjct: 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN 64
Query: 117 EIINE--RMTHQVHRE--RCCQVHLSSSRR------------------HPLLSSEEGYSL 154
+ + H + + R H + +
Sbjct: 65 RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV 124
Query: 155 YTEKDAAK-YIYQVADAIHYCHQK--KVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPS 210
K +++Q+ +I H V HRDIKP N+L+ + +K+ DFG
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG------- 177
Query: 211 LHRKTMCG--------TLDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKD 260
+K + Y PE + +QHY VD W +G I A E ++G+P F +
Sbjct: 178 SAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFA-EMMLGEPIFRGDN 236
Query: 261 QDTTLERIF 269
L I
Sbjct: 237 SAGQLHEIV 245
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-19
Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 4/110 (3%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM-CGTLD 221
++Y + +H H+ V+HRD+ P N+LL + D+ I DF + + KT
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 222 YLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
Y PE ++ + + K VD W G ++A E K F L +I
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMA-EMFNRKALFRGSTFYNQLNKIV 247
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 60/248 (24%), Positives = 90/248 (36%), Gaps = 66/248 (26%)
Query: 81 DFEVG------CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH--QVHRERC 132
D V LG G +G V+ + ++ T ++A+K K+ + T + RE
Sbjct: 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIM 60
Query: 133 CQVHLSSSRRHP-------LLSSEEGYSLYT-----EKDAAKYI--------------YQ 166
L H +L ++ +Y E D I YQ
Sbjct: 61 ILTEL---SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ 117
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG-------------WSVHAPSLHR 213
+ I Y H ++HRD+KP N+LL VK++DFG + + +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 214 KTMCGTLDYL----------PPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQ 261
+ L PE ++ S Y K +D W +G IL E L GKP F
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EILCGKPIFPGSST 236
Query: 262 DTTLERIF 269
LERI
Sbjct: 237 MNQLERII 244
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-18
Identities = 58/294 (19%), Positives = 94/294 (31%), Gaps = 86/294 (29%)
Query: 46 TEGTNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVG------CPLGTGKFGHVYLA 99
GT + Q P S SD+++ +GTG +GHV A
Sbjct: 13 NSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEA 72
Query: 100 KEKTTQIMIALKVLYKVEIINERMTH--QVHRERCCQVHLSSSRRHP----LL------S 147
+K + ++A+K K+ + E + ++ RE L H +L
Sbjct: 73 YDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRL----NHDHVVKVLDIVIPKD 125
Query: 148 SEEGYSLYT-----EKDAAKYI---------------YQVADAIHYCHQKKVIHRDIKPE 187
E+ LY + D K Y + + Y H ++HRD+KP
Sbjct: 126 VEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPA 185
Query: 188 NLLLTMHEDVKISDFG--------------------------WSVHAPSLHRKTMCG--- 218
N L+ VK+ DFG + ++ + G
Sbjct: 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 219 TLDYLPPE-MVTSQHYGKEVDNWCIG-ILA----------YEFLVGKPPFESKD 260
T Y PE ++ ++Y + +D W IG I A P F
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 7e-18
Identities = 54/266 (20%), Positives = 91/266 (34%), Gaps = 72/266 (27%)
Query: 61 MQTHYDAREAPNKSYRWQMSDFEVG------CPLGTGKFGHVYLAKEKTTQIMIALKVLY 114
M H+ Y + + V +G G +G+VYLA +K T+ +A+K
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--- 57
Query: 115 KVEIINERMTH--QVHRERCCQVHLSSSRRHP----LL-----SSEEGYS---LYTE--- 157
KV + E + ++ RE L + L + + E
Sbjct: 58 KVNRMFEDLIDCKRILREITILNRL----KSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113
Query: 158 --------------KDAAKY-IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202
++ K +Y + ++ H+ +IHRD+KP N LL VK+ DF
Sbjct: 114 SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF 173
Query: 203 GWSVHAPSLHRKTMCGTLD------------------------YLPPE-MVTSQHYGKEV 237
G + S + L+ Y PE ++ ++Y K +
Sbjct: 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI 233
Query: 238 DNWCIG-ILAYEFLVGKPPFESKDQD 262
D W G I A E L + +
Sbjct: 234 DIWSTGCIFA-ELLNMLQSHINDPTN 258
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 55/229 (24%), Positives = 92/229 (40%), Gaps = 33/229 (14%)
Query: 72 NKSYRWQMSD-----FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----Y----KVE 117
SY D +EV +G G FG V A + +ALK++ + E
Sbjct: 84 QGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE 143
Query: 118 I-INERMTHQVHRERCCQVHLSSS---RRHPLLSSEE-GYSLY-----------TEKDAA 161
I I E + Q +H+ + R H ++ E +LY +
Sbjct: 144 IRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR 203
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLT--MHEDVKISDFGWSVHAPSLHRKTMCGT 219
K+ + + + H+ ++IH D+KPEN+LL +K+ DFG S + + +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ-S 262
Query: 220 LDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y PE++ YG +D W +G + E L G P +D+ L +
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 19/118 (16%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV-KISDFGWSVHAPSLHRKTMCG--- 218
YIYQ+ A+ + H + HRDIKP+NLL+ ++ K+ DFG +K +
Sbjct: 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG-------SAKKLIPSEPS 198
Query: 219 -----TLDYLPPE-MVTSQHYGKEVDNWCIG-ILAYEFLVGKPPFESKDQDTTLERIF 269
+ Y PE M+ + Y +D W IG + E ++GKP F + L RI
Sbjct: 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG-ELILGKPLFSGETSIDQLVRII 255
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 42/224 (18%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----Y----KVEI-----INER-MTHQ 126
+ + LG G F V+LAK+ +A+K++ Y + EI +N+ T +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 127 VHRERCCQVHL-------SSSRRHPLLSSEE-GYSLY-----------TEKDAAKYIYQV 167
+ L + H ++ E G +L + Q+
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 168 ADAIHYCHQK-KVIHRDIKPENLLLTMHED------VKISDFGWSVHAPSLHRKTMCGTL 220
+ Y H++ +IH DIKPEN+L+ + + +KI+D G + H T
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-DEHYTNSIQTR 199
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264
+Y PE++ +G D W L +E + G FE + +
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-16
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 47/238 (19%)
Query: 71 PNKSYRWQMSD-----FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--NERM 123
N Y + + +E+ +G G FG V A ++ Q +A+K II +
Sbjct: 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK------IIKNKKAF 93
Query: 124 THQVHRE--------------RCCQVHLSSS---RRHPLLSSEE-GYSLY---------- 155
+Q E + VHL R H L E Y+LY
Sbjct: 94 LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG 153
Query: 156 -TEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLT--MHEDVKISDFGWSVHAPS 210
+ K+ Q+ A+ + + +IH D+KPEN+LL +KI DFG S
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213
Query: 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ + + Y PE++ Y +D W +G + E G+P F ++ + +I
Sbjct: 214 RIYQYIQ-SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 8e-16
Identities = 46/262 (17%), Positives = 93/262 (35%), Gaps = 59/262 (22%)
Query: 49 TNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMI 108
E++ + +++ Q+ P R ++ +G G++G V++ K + ++
Sbjct: 6 PPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKV-- 63
Query: 109 ALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP-------------------LLSSE 149
A+KV + E + RE +++ + RH L ++
Sbjct: 64 AVKVFFTTEEASWF------RET--EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115
Query: 150 --EGYSLY--------TEKDAAKYIYQVADAIHYCHQK--------KVIHRDIKPENLLL 191
E SLY K K Y + + H + + HRD+K +N+L+
Sbjct: 116 YHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 192 TMHEDVKISDFGWSV------HAPSLHRKTMCGTLDYLPPEM------VTSQHYGKEVDN 239
+ I+D G +V + + T GT Y+PPE+ D
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 240 WCIGILAYEFLVGKPPFESKDQ 261
+ G++ +E ++
Sbjct: 236 YSFGLILWEVARRCVSGGIVEE 257
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-15
Identities = 41/229 (17%), Positives = 78/229 (34%), Gaps = 59/229 (25%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
D + +G G++G V+ + + A+K+ + R RE +++ +
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENV--AVKIF------SSRDEKSWFRET--ELYNTVM 58
Query: 141 RRHP-------------------LLSSE--EGYSLY--------TEKDAAKYIYQVADAI 171
RH L + E SLY + + +A +
Sbjct: 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGL 118
Query: 172 HYCH--------QKKVIHRDIKPENLLLTMHEDVKISDFGWSV------HAPSLHRKTMC 217
+ H + + HRD+K +N+L+ + I+D G +V + +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 218 GTLDYLPPEM------VTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260
GT Y+ PE+ V K VD W G++ +E +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 5e-15
Identities = 45/253 (17%), Positives = 86/253 (33%), Gaps = 43/253 (16%)
Query: 49 TNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMI 108
+ +++ + M T P R + +G G+FG V+ K + ++
Sbjct: 11 SEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEV-- 68
Query: 109 ALKVLYKVEI---INERMTHQVHRER--------CCQVHLSSSRRHPLLSSE--EGYSLY 155
A+K+ E E +Q R + + L S+ E SL+
Sbjct: 69 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 128
Query: 156 --------TEKDAAKYIYQVADAIHYCHQK--------KVIHRDIKPENLLLTMHEDVKI 199
T + K A + + H + + HRD+K +N+L+ + I
Sbjct: 129 DYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188
Query: 200 SDFGWSVHAPS------LHRKTMCGTLDYLPPEM------VTSQHYGKEVDNWCIGILAY 247
+D G +V S + GT Y+ PE+ + K D + +G++ +
Sbjct: 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248
Query: 248 EFLVGKPPFESKD 260
E +
Sbjct: 249 EIARRCSIGGIHE 261
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 7e-15
Identities = 44/228 (19%), Positives = 81/228 (35%), Gaps = 50/228 (21%)
Query: 69 EAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLY---KVEIINERMTH 125
EA + + ++ +G G++G VY +A+KV + INE+ +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANRQNFINEKNIY 59
Query: 126 QVHRER---------CCQVHLSSSRRHPLLSSE--EGYSL--------YTEKDAAKYIYQ 166
+V + + R LL E SL + + +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHS 119
Query: 167 VADAIHYCH---------QKKVIHRDIKPENLLLTMHEDVKISDFGWSV----------H 207
V + Y H + + HRD+ N+L+ ISDFG S+
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 208 APSLHRKTMCGTLDYLPPEMVTS-------QHYGKEVDNWCIGILAYE 248
+ GT+ Y+ PE++ + K+VD + +G++ +E
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-14
Identities = 37/223 (16%), Positives = 77/223 (34%), Gaps = 50/223 (22%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI---INERMTHQVHRERCCQVH 136
++ G+FG V+ A+ + A+K+ + NE + + + H
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLLNEYV--AVKIFPIQDKQSWQNEYEVYSLPGMK----H 77
Query: 137 ------LSSSRRHPLLSSE--------EGYSLY--------TEKDAAKYIYQVADAIHYC 174
+ + +R + + E SL + + +A + Y
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYL 137
Query: 175 HQK----------KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS----LHRKTMCGTL 220
H+ + HRDIK +N+LL + I+DFG ++ + GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 221 DYLPPE-----MVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258
Y+ PE + + +D + +G++ +E +
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 58/273 (21%), Positives = 98/273 (35%), Gaps = 36/273 (13%)
Query: 31 KNYTITNMKEYF--EGLTEGTNKENVEEY------LKKMQTHYDAREAPNKSYRWQMSDF 82
+++ I ++ + EG + ++ L K R P + D
Sbjct: 57 RHFIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDL 116
Query: 83 EVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-------YKVEIINE-RMTHQVHRERCCQ 134
+G +G G FG V+ + + ++A+K K + + E R+ Q +
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 135 VHLSSSRRHP------------LLS--SEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVI 180
+ +++ P L+ EG L K + + A + Y K I
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARL-RVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 181 HRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDY--LPPEMVTSQHYGKE 236
HRD+ N L+T +KISDFG S + PE + Y E
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 237 VDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
D W GIL +E F +G P+ + T E +
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-14
Identities = 43/214 (20%), Positives = 77/214 (35%), Gaps = 26/214 (12%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----YKVEIINE-RMTHQVHRERCC 133
+D + LG G++G VY K + +A+K L E + E + ++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 134 QVHLSSSRRHPL---------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKK 178
Q+ +R P L + + Q++ A+ Y +K
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 338
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHRKTMCGTLDY--LPPEMVTSQHYGK 235
IHR++ N L+ + VK++DFG S + + PE + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 236 EVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ D W G+L +E G P+ D E +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 52/252 (20%), Positives = 87/252 (34%), Gaps = 57/252 (22%)
Query: 72 NKSYRWQMSD-----FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----Y----KVE 117
+ W+ F V +G G FG V L + + A+KV+ Y K+E
Sbjct: 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE 81
Query: 118 I-INERMTHQVHRERCCQVHLSSS---RRHPLLSSEE-GYSLY-----------TEKDAA 161
I +++ + V H L E G SLY +D
Sbjct: 82 ADILKKIQNDDINNNNI-VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK 140
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-------------------------D 196
Y ++ A++Y + + H D+KPEN+LL
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 197 VKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPF 256
+K+ DFG + S + ++ T Y PE++ + + D W G + E G F
Sbjct: 201 IKLIDFGCATFK-SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259
Query: 257 ESKDQDTTLERI 268
+ + L +
Sbjct: 260 RTHEHMEHLAMM 271
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-13
Identities = 49/253 (19%), Positives = 88/253 (34%), Gaps = 63/253 (24%)
Query: 72 NKSYRWQMSD-----FEVGCPLGTGKFGHVYLAKE-KTTQIMIALKVLYKVEII--NERM 123
++ D +E+ LG G FG V + + +ALK II +
Sbjct: 6 EGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALK------IIRNVGKY 59
Query: 124 THQVHRE--------------RCCQVHLSSS---RRHPLLSSEE-GYSLY---------- 155
E + V +S H ++ E G + +
Sbjct: 60 REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP 119
Query: 156 -TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE------------------- 195
YQ+ A+ + H+ ++ H D+KPEN+L E
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 196 DVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPP 255
++++DFG + H T+ T Y PPE++ + + D W IG + +E+ G
Sbjct: 180 SIRVADFGSATFDHEHH-TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238
Query: 256 FESKDQDTTLERI 268
F++ + L +
Sbjct: 239 FQTHENREHLVMM 251
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 53/216 (24%), Positives = 79/216 (36%), Gaps = 56/216 (25%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
+F+ +G G FG VY + +ALK + Q E ++ S
Sbjct: 40 NFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRR-------TPESSQGIEEFETEIETLSF 91
Query: 141 RRHPLLSSEEGYS---------------------LYTEK----------------DAAKY 163
RHP L S G+ LY AA+
Sbjct: 92 CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR- 150
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL---HRKTMC-GT 219
+HY H + +IHRD+K N+LL + KI+DFG S L H T+ GT
Sbjct: 151 ------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 220 LDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPP 255
L Y+ PE ++ D + G++ +E L +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 57/231 (24%), Positives = 85/231 (36%), Gaps = 53/231 (22%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
F VG +G G FG + L K T +A+K+ E + R Q+H E L S
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRA-PQLHLEYRFYKQLGSGD 65
Query: 142 RHPLL---SSEEGY----------SL----------YTEKDAAKYIYQVADAIHYCHQKK 178
P + Y SL ++ K Q+ + Y H K
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 179 VIHRDIKPENLLL-----TMHEDVKISDFGWS---------VHAPSLHRKTMCGTLDYLP 224
+I+RD+KPEN L+ + + I DF + H P K++ GT Y
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY-- 183
Query: 225 PEMVTSQHYGKEV----DNWCIGILAYEFLVGKPP---FESKDQDTTLERI 268
M + H GKE D +G + FL G P ++ ++I
Sbjct: 184 --MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 54/247 (21%), Positives = 90/247 (36%), Gaps = 51/247 (20%)
Query: 72 NKSYRWQMSD-----FEVGCPLGTGKFGHVYLAK-EKTTQIMIALKVL-----Y----KV 116
+ Q D +E+ LG G FG V K +A+K++ Y +
Sbjct: 1 SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS 60
Query: 117 EI-INERMTHQVHRERCCQVHLSSS---RRHPLLSSEE-GYSLY-----------TEKDA 160
EI + E + V + H + E G S Y
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHI 120
Query: 161 AKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-------------------DVKISD 201
K YQ+ ++++ H K+ H D+KPEN+L + D+K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 202 FGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261
FG + + H T+ T Y PE++ + + + D W IG + E+ +G F + D
Sbjct: 181 FGSATYDDEHH-STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 262 DTTLERI 268
L +
Sbjct: 240 KEHLAMM 246
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-12
Identities = 50/281 (17%), Positives = 90/281 (32%), Gaps = 46/281 (16%)
Query: 25 IVQTTEKNYTITNMKEYFEGLTE-----GTNKENVEEYLKKMQTHYDAREAPNKSYRWQM 79
I + + IT+ + F L + + + + L + + W++
Sbjct: 123 IRKLDSGGFYITS-RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEI 181
Query: 80 --SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----YKVEIINE--RMTHQVHRE 130
+ LG G FG V++ +A+K L + E M H +
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 131 --RCCQVHLSSSRRHPL---------------LSSEEGYSLYTEKDAAKYIYQVADAIHY 173
+ V P+ L E G L Q+A + Y
Sbjct: 241 LVQLYAVVS----EEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAY 295
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLP-----PEMV 228
+ +HRD++ N+L+ + K++DFG + G P PE
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAPEAA 353
Query: 229 TSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ + D W GIL E G+ P+ L+++
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 6e-12
Identities = 54/266 (20%), Positives = 81/266 (30%), Gaps = 90/266 (33%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS- 140
+ V LG G F V+L+ + + +A+KV+ E T E + +S
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLKSVRNSD 94
Query: 141 RRHP-------LLSSEE----------------GYSLYTEKDAAKY-----------IYQ 166
P LL + G+ L + Y I Q
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 167 VADAIHYCHQK-KVIHRDIKPENLLLTMHE------------------------------ 195
V + Y H K ++IH DIKPEN+LL+++E
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 196 -------------------DVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKE 236
VKI+D G + H T Y E++ Y
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-HFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 237 VDNWCIGILAYEFLVGKPPFESKDQD 262
D W +A+E G FE +
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGE 299
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-12
Identities = 50/231 (21%), Positives = 81/231 (35%), Gaps = 53/231 (22%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
++VG +G G FG ++ +A+K E Q+ E L+
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDA-PQLRDEYRTYKLLAGCT 66
Query: 142 RHPLL---SSEEGY----------SL----------YTEKDAAKYIYQVADAIHYCHQKK 178
P + E + SL ++ K A Q+ + H+K
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 179 VIHRDIKPENLLLTMHED-----VKISDFGWS---------VHAPSLHRKTMCGTLDYLP 224
+++RDIKP+N L+ + + DFG H P +K + GT Y
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY-- 184
Query: 225 PEMVTSQHYGKEV----DNWCIGILAYEFLVGKPP---FESKDQDTTLERI 268
M + H G+E D +G + FL G P ++ ERI
Sbjct: 185 --MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 54/229 (23%), Positives = 83/229 (36%), Gaps = 51/229 (22%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
F +G +G+G FG +YL T +A+K+ E + + Q+ E L
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKH-PQLLYESKIYRILQGGT 63
Query: 142 RHPLL---SSEEGY----------SL----------YTEKDAAKYIYQVADAIHYCHQKK 178
P + E Y SL + K Q+ + + + H K
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 179 VIHRDIKPENLLLTMHED---VKISDFGWS---------VHAPSLHRKTMCGTLDYLPPE 226
+HRDIKP+N L+ + V I DFG + H P K + GT Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY---- 179
Query: 227 MVTSQHYGKEV----DNWCIGILAYEFLVGKPP---FESKDQDTTLERI 268
+ H G E D +G + FL G P ++ + E+I
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 50/281 (17%), Positives = 90/281 (32%), Gaps = 46/281 (16%)
Query: 25 IVQTTEKNYTITNMKEYFEGLTE-----GTNKENVEEYLKKMQTHYDAREAPNKSYRWQM 79
I + + IT+ + F L + + + + L + + W++
Sbjct: 206 IRKLDSGGFYITS-RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEI 264
Query: 80 --SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----YKVEIINE--RMTHQVHRE 130
+ LG G FG V++ +A+K L + E M H +
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 131 --RCCQVHLSSSRRHPL---------------LSSEEGYSLYTEKDAAKYIYQVADAIHY 173
+ V P+ L E G L Q+A + Y
Sbjct: 324 LVQLYAVVS----EEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAY 378
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLP-----PEMV 228
+ +HRD++ N+L+ + K++DFG + G P PE
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAPEAA 436
Query: 229 TSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ + D W GIL E G+ P+ L+++
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 3e-11
Identities = 48/212 (22%), Positives = 80/212 (37%), Gaps = 41/212 (19%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147
+G G FG VY K +A+K L + I T ++ ++ ++ + + +H L
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDIT---TEELKQQFDQEIKVMAKCQHENLV 93
Query: 148 SEEGYS---------------------LYTEKDAA--------KYIYQVADAIHYCHQKK 178
G+S L K A+ I++ H+
Sbjct: 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL---HRKT--MCGTLDYLPPEMVTSQHY 233
IHRDIK N+LL KISDFG + + + + GT Y+ PE + +
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV-GTTAYMAPEALRGEIT 212
Query: 234 GKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265
K D + G++ E + G P + + L
Sbjct: 213 PK-SDIYSFGVVLLEIITGLPAVDEHREPQLL 243
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 5e-11
Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 5/105 (4%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHR 213
T + Y +QVA + + +K IHRD+ N+LL+ VKI DFG + ++ +
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250
Query: 214 KTMCGTLDY--LPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPP 255
+ L + PE + + Y + D W G+L +E F +G P
Sbjct: 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-11
Identities = 54/233 (23%), Positives = 83/233 (35%), Gaps = 59/233 (25%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER---------- 131
+ +G +G+G FG +YL + +A+K+ E + + Q+H E
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKH-PQLHIESKIYKMMQGGV 65
Query: 132 -CCQVHLSSSRRH------PLLSSEEGYSL----------YTEKDAAKYIYQVADAIHYC 174
+ + LL G SL ++ K Q+ I Y
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL----GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 175 HQKKVIHRDIKPENLLL---TMHEDVKISDFGWS---------VHAPSLHRKTMCGTLDY 222
H K IHRD+KP+N L+ V I DFG + H P K + GT Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 223 LPPEMVTSQHYGKEV----DNWCIGILAYEFLVGKPP---FESKDQDTTLERI 268
+ H G E D +G + F +G P ++ + ERI
Sbjct: 182 ----ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-10
Identities = 47/230 (20%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 69 EAPNKSYRWQM--SDFEVGCPLGTGKFGHVYLA----KEKTTQIMIALKVLYKVEIINER 122
EAPN++ + ++F+ LG+G FG VY + + +I +A+K L E
Sbjct: 2 EAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL------REA 55
Query: 123 MTHQVHRERCCQVHLSSSRRHP-------------------------LLS--SEEGYSLY 155
+ + ++E + ++ +S +P LL E ++
Sbjct: 56 TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI- 114
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHR 213
+ + Q+A ++Y ++++HRD+ N+L+ + VKI+DFG + + A
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 214 KTMCGTL--DYLPPEMVTSQHYGK---EVDNWCIGILAYE-FLVGKPPFE 257
G + ++ E S + + D W G+ +E G P++
Sbjct: 175 HAEGGKVPIKWMALE---SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 2e-10
Identities = 48/229 (20%), Positives = 83/229 (36%), Gaps = 55/229 (24%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
+F LG G FG VY + + +A+K L E T + +V + S
Sbjct: 31 NFSNKNILGRGGFGKVYKGRLADGTL-VAVKRL------KEERTQGGELQFQTEVEMISM 83
Query: 141 RRHPLLSSEEGYSLYTEKDAAKYIYQ------VADAIH---------------------- 172
H L G+ +Y VA +
Sbjct: 84 AVHRNLLRLRGF--CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 173 ----YCHQK---KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT-----MCGTL 220
Y H K+IHRD+K N+LL + + DFG + ++ T + GT+
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--YKDTHVTTAVRGTI 199
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE----SKDQDTTL 265
++ PE +++ ++ D + G++ E + G+ F+ + D D L
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-10
Identities = 48/226 (21%), Positives = 80/226 (35%), Gaps = 40/226 (17%)
Query: 76 RWQM--SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----YKVEIINE-----RM 123
+W+M +D + LG G++G VY K + +A+K L E + E +
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 124 THQ--VHRERCCQVHLSSSRRHPL---------------LSSEEGYSLYTEKDAAKYIYQ 166
H V C +R P L + + Q
Sbjct: 67 KHPNLVQLLGVC------TREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQ 119
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHRKTMCGTLDY--L 223
++ A+ Y +K IHRD+ N L+ + VK++DFG S + +
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 224 PPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
PE + + + D W G+L +E G P+ D E +
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 52/226 (23%), Positives = 83/226 (36%), Gaps = 61/226 (26%)
Query: 80 SDFEVGCPLGTGKFGHVYLA-------------------KEKTT-----------QIMIA 109
+ E G LG+G FG V A KEK ++M
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 110 LKV----------------LYKVEIINERMTH-------QVHRERCCQVHLSSSRRHPLL 146
L +Y +I E + + RE+ + + + L
Sbjct: 105 LGSHENIVNLLGACTLSGPIY---LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 147 SSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS- 205
E+ L T +D + YQVA + + K +HRD+ N+L+T + VKI DFG +
Sbjct: 162 EEEDLNVL-TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 206 -VHAPSLHRKTMCGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYE 248
+ + S + L ++ PE + Y + D W GIL +E
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 266
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 57/292 (19%), Positives = 99/292 (33%), Gaps = 70/292 (23%)
Query: 25 IVQTTEKNYTITNMKEYFEGLTE-----GTNKENVEEYLKKMQTHYDAREAPNKSYR--W 77
+ +I + YFE L + T+ + + L K + A ++ YR W
Sbjct: 130 RIMYHASKLSIDE-EVYFENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGW 188
Query: 78 QM--SDFEVGCPLGTGKFGHVYLAKEKTT--------------------QIMIALK---- 111
+ + ++ +G G+FG V L + +M L+
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNL 248
Query: 112 -VLY--------KVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAK 162
L + I+ E M +L S R L K
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAK-----GSLVDYLRSRGRSVL----------GGDCLLK 293
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDY 222
+ V +A+ Y +HRD+ N+L++ K+SDFG + A S
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------ 347
Query: 223 LP-----PEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
LP PE + + + + D W GIL +E + G+ P+ + R+
Sbjct: 348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 46/244 (18%), Positives = 88/244 (36%), Gaps = 66/244 (27%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIM-----IALKV-------------LYKV-----EI 118
++VG P+G G FG +YLA +++ + +KV Y+ +I
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 119 INERMTHQVH-----RERCCQVHLSSSRRH-----PLLSSEEGYSL----------YTEK 158
T ++ + +H + + + G L ++ K
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF----GSDLQKIYEANAKRFSRK 152
Query: 159 DAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL-TMHED-VKISDFGWS---------VH 207
+ ++ D + Y H+ + +H DIK NLLL + D V + D+G +
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 208 APSLHRKTMCGTLDYLPPEMVTSQHYGKEV----DNWCIGILAYEFLVGKPPFESKDQDT 263
+ ++ GT+++ H G D +G ++L G P+E +D
Sbjct: 213 YAADPKRCHDGTIEF----TSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268
Query: 264 TLER 267
R
Sbjct: 269 KYVR 272
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 44/222 (19%), Positives = 78/222 (35%), Gaps = 53/222 (23%)
Query: 80 SDFEVGCPLGTGKFGHVYLA-------------------KEKTT-----------QIMIA 109
+ +G LG G+FG V A KE + ++
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 110 LK----V-LYKV-------EIINERMTH-------QVHRERCCQVHLSSSRRHPLLSSEE 150
+ + LY +I E + + R+ S R+
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 151 GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHA 208
T D + +Q++ + Y + K++HRD+ N+L+ +KISDFG S V+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 209 PSLHRKTMCGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYE 248
+ K G + ++ E + Y + D W G+L +E
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-09
Identities = 52/226 (23%), Positives = 77/226 (34%), Gaps = 51/226 (22%)
Query: 80 SDFEVGCPLGTGKFGHVYLA-------------------KEKTTQIMIA-----LKVLYK 115
+ G LG G FG V A K LKVL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 116 VE-------------------IINERMTHQVHRE--RCCQVHLSSSRRHPLLSSEEGYSL 154
+ +I E + R + S+ P + ++ +L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLH 212
+D + YQVA + + K IHRD+ N+LLT KI DFG + + S +
Sbjct: 143 -DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 213 RKTMCGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPP 255
L ++ PE + + Y E D W GI +E F +G P
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 44/228 (19%), Positives = 76/228 (33%), Gaps = 65/228 (28%)
Query: 80 SDFEVGCPLGTGKFGHVYLA-------------------KEKTT-----------QIMIA 109
++ E +G G FG V+ A KE+ + +M
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 110 LK---------VLYKVE---IINERMTH-------QVHRERCCQVHLSSSRRHPLLSSEE 150
V + ++ E M + + S S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 151 GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHA 208
G + + QVA + Y ++K +HRD+ N L+ + VKI+DFG S +++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 209 PSLHRKTMCGTLDYLP-----PEMVTSQHYGK---EVDNWCIGILAYE 248
++ D +P PE S Y + E D W G++ +E
Sbjct: 227 ADYYKA---DGNDAIPIRWMPPE---SIFYNRYTTESDVWAYGVVLWE 268
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 44/237 (18%), Positives = 77/237 (32%), Gaps = 63/237 (26%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKV--------------------LYKVEIINE 121
+ +G +G+G FG +YLA A V + K + I +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 122 RMTHQVHRE------RCCQVHLSSSRRH-----PLLSSEEGYSL---------YTEKDAA 161
+ + + R + L G L + +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL----GIDLQKISGQNGTFKKSTVL 154
Query: 162 KYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKI--SDFGWS---------VHAPS 210
+ ++ D + Y H+ + +H DIK NLLL ++ +D+G S
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 211 LHRKTMCGTLDYLPPEMVTSQHYGKEV----DNWCIGILAYEFLVGKPPFESKDQDT 263
RK GT+++ H G + D +G +L GK P+E +D
Sbjct: 215 NPRKGHNGTIEF----TSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 41/215 (19%), Positives = 79/215 (36%), Gaps = 30/215 (13%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----YKVEIINE-RMTHQVHRERCC 133
++ LG G+FG V++A +A+K + + E + + ++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 134 QVHLSSSRRHPL--------------LSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKV 179
++H ++ L S+EG + Q+A+ + + Q+
Sbjct: 247 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 180 IHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLP-----PEMVTSQHYG 234
IHRD++ N+L++ KI+DFG + G P PE + +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK--FPIKWTAPEAINFGSFT 363
Query: 235 KEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
+ D W GIL E G+ P+ + +
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-09
Identities = 45/235 (19%), Positives = 86/235 (36%), Gaps = 52/235 (22%)
Query: 72 NKSYRWQMSDFEV-------GCPLGTGKFGHVYLAK---EKTTQIMIALKVLYKVEIINE 121
+ + ++ D + G LG G+FG V A+ E + + +A+K+L K +II
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIAS 66
Query: 122 RMTHQVHRER-----------------CCQVHLSSSRRHPLL------------------ 146
+ RE + P++
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 147 SSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS- 205
E ++L + +++ +A + Y + IHRD+ N +L V ++DFG S
Sbjct: 127 IGENPFNL-PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 206 -VHAPSLHRKTMCGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
+++ +R+ L +L E + Y D W G+ +E G+ P+
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 34/187 (18%), Positives = 67/187 (35%), Gaps = 41/187 (21%)
Query: 58 LKKMQTHYDAREAPNKSYRWQM--SDFEVGCPLGTGKFGHVYLA--KEKTTQIMIALKVL 113
+KK H+ + P+ + + +D + +G G FG V A K+ ++ A+K +
Sbjct: 1 MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60
Query: 114 YK-------------VEIINERMTHQ--VHRERCC----------------------QVH 136
+ +E++ + H ++ C +
Sbjct: 61 KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 120
Query: 137 LSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED 196
+ S + + + VA + Y QK+ IHRD+ N+L+ +
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180
Query: 197 VKISDFG 203
KI+DFG
Sbjct: 181 AKIADFG 187
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 47/220 (21%), Positives = 92/220 (41%), Gaps = 31/220 (14%)
Query: 69 EAPNKSYRWQM--SDFEVGCPLGTGKFGHVYLA----KEKTTQIMIALKVL-------YK 115
EAPN++ + ++F+ LG+G FG VY + + +I +A+K L
Sbjct: 2 EAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 61
Query: 116 VEIINE-RMTHQVHRERCCQVHLSSSRRHPLLSSE--EGYSL----------YTEKDAAK 162
EI++E + V C++ L ++ L +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL 220
+ Q+A ++Y ++++HRD+ N+L+ + VKI+DFG + + A G +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 221 --DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFE 257
++ E + + Y + D W G+ +E G P++
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 49/257 (19%), Positives = 78/257 (30%), Gaps = 73/257 (28%)
Query: 51 KENVEEYLKKMQTHYDAREAPNKSYRWQM--SDFEVGCPLGTGKFGHVYLA--------- 99
+ +E Y T D + P +W+ ++ + G LG G FG V A
Sbjct: 16 WKIIESYEGNSYTFIDPTQLPYNE-KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKED 74
Query: 100 ----------KEKTT-----------QIMIALKV----------------LYKVEIINER 122
K +IM L + +I E
Sbjct: 75 AVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL---VITEY 131
Query: 123 MTH-------QVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCH 175
+ + + + +D + QVA + +
Sbjct: 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTA----------STRDLLHFSSQVAQGMAFLA 181
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL--DYLPPEMVTSQ 231
K IHRD+ N+LLT KI DFG + + S + L ++ PE +
Sbjct: 182 SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC 241
Query: 232 HYGKEVDNWCIGILAYE 248
Y + D W GIL +E
Sbjct: 242 VYTVQSDVWSYGILLWE 258
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 51/237 (21%), Positives = 89/237 (37%), Gaps = 33/237 (13%)
Query: 63 THYDAREAPNKSYRWQMSDFEVG-CPLGTGKFGHVYLA--KEKTTQIMIALKVL------ 113
D E +K + + + LG G FG V + + QI +A+KVL
Sbjct: 318 PFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK 377
Query: 114 -YKVEIINE-RMTHQVHRERCCQVHLSSSRRHPLLSSE--EGYSL----------YTEKD 159
E++ E ++ HQ+ ++ +L E G L +
Sbjct: 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSN 437
Query: 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMC 217
A+ ++QV+ + Y +K +HR++ N+LL KISDFG S + A +
Sbjct: 438 VAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497
Query: 218 GTLDYLP-----PEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
P PE + + + D W G+ +E G+ P++ + I
Sbjct: 498 AGK--WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 41/218 (18%), Positives = 80/218 (36%), Gaps = 42/218 (19%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK---EKTTQIMIALKVLYKVEIINERMTHQVHRER----- 131
+ +G LG G+FG V E T + +A+K + K++ ++R + E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92
Query: 132 -----------CCQVHLSSSRRHPLL-----------------SSEEGYSLYTEKDAAKY 163
C S P++ E G + K+
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 164 IYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL- 220
+ +A + Y + +HRD+ N +L V ++DFG S +++ +R+ +
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 221 -DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
++ E + + Y + D W G+ +E G P+
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-08
Identities = 44/230 (19%), Positives = 76/230 (33%), Gaps = 64/230 (27%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTT--------------------QIMIALK-----VLY 114
+ ++ +G G+FG V L + +M L+ L
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 115 --------KVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQ 166
+ I+ E M +L S R L K+
Sbjct: 81 GVIVEEKGGLYIVTEYMAKG-----SLVDYLRSRGRSVL----------GGDCLLKFSLD 125
Query: 167 VADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLP 224
V +A+ Y +HRD+ N+L++ K+SDFG + + K LP
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--------LP 177
Query: 225 -----PEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
PE + + + + D W GIL +E + G+ P+ + R+
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 32/245 (13%), Positives = 74/245 (30%), Gaps = 68/245 (27%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
+++ G +Y A +T + K + + ++ E Q +
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNE---QNFFQRAA 100
Query: 142 RHPLLSSEE-------------------------------GYSL-----------YTEKD 159
+ ++ + G SL +E+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS 160
Query: 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLL--TMHEDVKISDFGWS---------VHA 208
+ ++ DA+ + H+ + +H ++ EN+ + V ++ +G++ V
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 209 PSLHRKTMCGTLDYLPPEMVTS--QHYGKEV----DNWCIGILAYEFLVGKPPFESKDQD 262
R G L++ S H G D +G ++L G P+ + +
Sbjct: 221 VEGSRSPHEGDLEF------ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274
Query: 263 TTLER 267
T
Sbjct: 275 TEDIM 279
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-08
Identities = 37/224 (16%), Positives = 75/224 (33%), Gaps = 43/224 (19%)
Query: 71 PNKSYRWQM--SDFEVGCPLGTGKFGHVYLAK----EKTTQIMIALKVLYKVEIINERMT 124
K ++ LG+G FG V+ ++ +I + +KV+ ++
Sbjct: 2 AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI------EDKSG 55
Query: 125 HQVHRERCCQVHLSSSRRHP----LL--SSEEGYSLYTE--------------------K 158
Q + + S H LL L T+ +
Sbjct: 56 RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 159 DAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTM 216
+ Q+A ++Y + ++HR++ N+LL V+++DFG + +
Sbjct: 116 LLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 217 CGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFE 257
++ E + Y + D W G+ +E G P+
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 33/155 (21%), Positives = 47/155 (30%), Gaps = 37/155 (23%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK----EKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV 135
+ LG G FG V L T M+A+K L Q ++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL------KADAGPQHRSGWKQEI 84
Query: 136 HLSSSRRHP----LL---SSEEGYSLY--TE------------------KDAAKYIYQVA 168
+ + H SL E + Q+
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC 144
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203
+ + Y H + IHRD+ N+LL VKI DFG
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 30/128 (23%), Positives = 53/128 (41%), Gaps = 18/128 (14%)
Query: 140 SRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKI 199
S R + ++ + + ++AD + Y + K +HRD+ N ++ VKI
Sbjct: 121 SLRPAMANNPVLAPP-SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179
Query: 200 SDFGWS--VHAPSLHRKTMCGTLDYLP-----PEMVTSQHYGK---EVDNWCIGILAYE- 248
DFG + ++ +RK G LP PE S G D W G++ +E
Sbjct: 180 GDFGMTRDIYETDYYRK---GGKGLLPVRWMSPE---SLKDGVFTTYSDVWSFGVVLWEI 233
Query: 249 FLVGKPPF 256
+ + P+
Sbjct: 234 ATLAEQPY 241
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 49/233 (21%), Positives = 81/233 (34%), Gaps = 64/233 (27%)
Query: 80 SDFEVGCPLGTGKFGHVYLA-------------------KEKTT-----------QIMIA 109
++G PLG G FG V A KE T +I+I
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 110 LKV------LYKV--------EIINERMTH-------QVHRERCCQVHLSSSRRHPLLSS 148
+ L +I E + R ++ +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK---- 142
Query: 149 EEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--V 206
T + Y +QVA + + +K IHRD+ N+LL+ VKI DFG + +
Sbjct: 143 ----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 207 HAPSLHRKTMCGTL--DYLPPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
+ + + L ++ PE + + Y + D W G+L +E F +G P+
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 33/178 (18%), Positives = 53/178 (29%), Gaps = 46/178 (25%)
Query: 59 KKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAK----EKTTQIMIALKVLY 114
KK T D + LG G FG V L + T +A+K L
Sbjct: 7 KKPATEVDPTHFEK-------RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL- 58
Query: 115 KVEIINERMTHQVHRERCCQVHLSSSRRHP----LL---SSEEGYSLY------------ 155
+ ++ + + H + + G +
Sbjct: 59 -----KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113
Query: 156 ----------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203
K KY Q+ + Y ++ +HRD+ N+L+ VKI DFG
Sbjct: 114 EYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 57/249 (22%), Positives = 79/249 (31%), Gaps = 61/249 (24%)
Query: 67 AREAPNKSYRW--QMSDFEVGCPLGTGKFGHVYLAK---EKTTQIMIALKVLYKVEIINE 121
A E P +S D + LG G FG V + + +A+K L +
Sbjct: 3 AGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62
Query: 122 RMTHQVHRERCCQVHLSSSRRHPLL------SSEEGYSLYTE------------------ 157
RE V+ S H L + TE
Sbjct: 63 EAMDDFIRE----VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHF 118
Query: 158 --KDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT 215
++Y QVA+ + Y K+ IHRD+ NLLL + VKI DFG L R
Sbjct: 119 LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG-------LMRAL 171
Query: 216 MCGTLDY------------LPPEMVTSQHYGK---EVDNWCIGILAYE-FLVGKPPFESK 259
Y PE S D W G+ +E F G+ P+
Sbjct: 172 PQNDDHYVMQEHRKVPFAWCAPE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228
Query: 260 DQDTTLERI 268
+ L +I
Sbjct: 229 NGSQILHKI 237
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 48/219 (21%)
Query: 88 LGTGKFGHVYLA--KEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL 145
LG+G FG V + K +A+K+L K E + + ++ E ++ +P
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAE----ANVMQQLDNPY 79
Query: 146 L------SSEEGYSLYTE-------------------KDAAKYIYQVADAIHYCHQKKVI 180
+ E + L E K+ + ++QV+ + Y + +
Sbjct: 80 IVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 181 HRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLP-----PEMVTSQHY 233
HRD+ N+LL KISDFG S + A + K P PE +Y
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK--WPVKWYAPE---CINY 194
Query: 234 GK---EVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
K + D W G+L +E F G+ P+ +
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-07
Identities = 48/227 (21%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 76 RWQM--SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER--------MTH 125
+W + S+ +G+G+FG V+L + +A+K + + ++E M
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMM- 58
Query: 126 QVHRERCCQVHLSSSRRHPL---------------LSSEEGYSLYTEKDAAKYIYQVADA 170
++ + Q++ + P+ L ++ G L+ + V +
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEG 116
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLP-----P 225
+ Y + VIHRD+ N L+ ++ +K+SDFG + + GT P P
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVKWASP 174
Query: 226 EMVTSQHYGK---EVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
E + + + D W G+L +E F GK P+E++ +E I
Sbjct: 175 E---VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-07
Identities = 45/234 (19%), Positives = 79/234 (33%), Gaps = 58/234 (24%)
Query: 76 RWQM--SDFEVGCPLGTGKFGHVYLA-------------KEKTT---------QIMIALK 111
W++ ++ LG G+FG V++ K+ + +M L+
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 66
Query: 112 -----VLYKV------EIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEKDA 160
LY V II E M + L + L T
Sbjct: 67 HQRLVRLYAVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKL----------TINKL 111
Query: 161 AKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTL 220
Q+A+ + + ++ IHRD++ N+L++ KI+DFG + G
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 221 DYLP-----PEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
P PE + + + D W GIL E G+ P+ ++ +
Sbjct: 172 --FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 41/246 (16%), Positives = 85/246 (34%), Gaps = 52/246 (21%)
Query: 65 YDAREAPNKSYRWQM--SDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVL------ 113
Y+ +S+ ++ S + +G+G G V + + + +A+K L
Sbjct: 32 YEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91
Query: 114 -YKVEIINE-----RMTHQ--VHRERCCQVHLSSSRRHPL---------------LSSEE 150
+ + ++E + H + E +R L + +
Sbjct: 92 RQRRDFLSEASIMGQFDHPNIIRLEGVV------TRGRLAMIVTEYMENGSLDTFLRTHD 145
Query: 151 GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHA 208
G +T + V + Y +HRD+ N+L+ + K+SDFG S +
Sbjct: 146 G--QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203
Query: 209 PSLHRKTMCGTLDYLP-----PEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQD 262
T G +P PE + + + D W G++ +E G+ P+ +
Sbjct: 204 DPDAAYTTTGGK--IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR 261
Query: 263 TTLERI 268
+ +
Sbjct: 262 DVISSV 267
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-07
Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 38/223 (17%)
Query: 77 WQM--SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----YKVEIINE-RMTHQVH 128
++ + + LG+G+FG V L K K Q +A+K++ + E E + ++
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSEDEFFQEAQTMMKLS 61
Query: 129 RERCCQVHLSSSRRHP------------LLS--SEEGYSLYTEKDAAKYIYQVADAIHYC 174
+ + + S+ +P LL+ G L + Y V + + +
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL-EPSQLLEMCYDVCEGMAFL 120
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLP-----PEMVT 229
+ IHRD+ N L+ VK+SDFG + + + GT P PE
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK--FPVKWSAPE--- 175
Query: 230 SQHYGK---EVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
HY K + D W GIL +E F +GK P++ + ++
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-07
Identities = 57/237 (24%), Positives = 84/237 (35%), Gaps = 66/237 (27%)
Query: 77 WQM--SDFEVGCPLGTGKFGHVYLA-------------KEKTT---------QIMIALK- 111
W++ D LGTG+FG V KE + ++M+ L
Sbjct: 19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH 78
Query: 112 ----VLYKV-------EIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYSLYTEKDA 160
LY V II E M + C +L R +
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANG-----CLLNYLREMRHRF-----------QTQQL 122
Query: 161 AKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTL 220
+ V +A+ Y K+ +HRD+ N L+ VK+SDFG S + + G+
Sbjct: 123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 182
Query: 221 DYLP-----PEMVTSQHYGK---EVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
P PE Y K + D W G+L +E + +GK P+E T E I
Sbjct: 183 --FPVRWSPPE---VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 59/291 (20%), Positives = 98/291 (33%), Gaps = 78/291 (26%)
Query: 31 KNYTITNMKEYFEGLTEGTNKENVEEYLKKMQT----------HYDAREAPNKSYRWQM- 79
+Y I + + G+ ++ E L K++T + A + + S ++
Sbjct: 10 HDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVP 69
Query: 80 -SDFEVGCPLGTGKFGHVYLAK-----EKTTQIMIALKVL-------YKVEIINE----- 121
+ + LG G FG VY + + + +A+K L +++ + E
Sbjct: 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 129
Query: 122 RMTHQ--VHRERCCQVHLSSSRRHPLL--------------------SSEEGYSLYTEKD 159
+ HQ V + P + SL D
Sbjct: 130 KFNHQNIVRCIGVS------LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL-AMLD 182
Query: 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWS--VHAPSLHRK 214
+A Y + IHRDI N LLT KI DFG + ++ +RK
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 215 TMCGTLDYLP-----PEMVTSQHYGK---EVDNWCIGILAYE-FLVGKPPF 256
G LP PE + G + D W G+L +E F +G P+
Sbjct: 243 ---GGCAMLPVKWMPPE---AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 52/258 (20%), Positives = 93/258 (36%), Gaps = 54/258 (20%)
Query: 40 EYFEGLTEGTNKENVEEYLKKMQTHYDAREAPN-KSYRWQMSDFEVGCPLGTGKFGHVY- 97
+G+ T + + ++ D P+ + Y Q E+G +G G+FG V+
Sbjct: 349 NEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQ 408
Query: 98 --LAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP----LL--SSE 149
+ + +A+K + V + + HP L+ +E
Sbjct: 409 GIYMSPENPAMAVAIKTC------KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462
Query: 150 EGYSLYTE--------------------KDAAKYIYQVADAIHYCHQKKVIHRDIKPENL 189
+ E Y YQ++ A+ Y K+ +HRDI N+
Sbjct: 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 522
Query: 190 LLTMHEDVKISDFGWSVHAPSLHR--------KTMCGTL--DYLPPEMVTSQHYGKEVDN 239
L++ ++ VK+ DFG L R K G L ++ PE + + + D
Sbjct: 523 LVSSNDCVKLGDFG-------LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 575
Query: 240 WCIGILAYE-FLVGKPPF 256
W G+ +E + G PF
Sbjct: 576 WMFGVCMWEILMHGVKPF 593
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 43/243 (17%), Positives = 83/243 (34%), Gaps = 53/243 (21%)
Query: 64 HYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVL------- 113
H A+E ++ + +G G+FG V + K +I +A+K L
Sbjct: 36 HEFAKELDA-------TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88
Query: 114 YKVEIINE-----RMTHQ--VHRERCCQVHLSSSRRHPL---------------LSSEEG 151
+ + + E + H + E ++ P+ L +
Sbjct: 89 QRRDFLGEASIMGQFDHPNIIRLEGVV------TKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 152 YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS---VHA 208
+T + +A + Y +HRD+ N+L+ + K+SDFG
Sbjct: 143 --QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
Query: 209 PSLHRKTMCGTLDYL--PPEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTL 265
P T G + PE + + + D W GI+ +E G+ P+ +
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 266 ERI 268
+ +
Sbjct: 261 KAV 263
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 51/230 (22%), Positives = 77/230 (33%), Gaps = 66/230 (28%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK-----EKTTQIMIALKVL-------YKVEIINE-----R 122
+ + LG G FG VY + + + +A+K L +++ + E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 123 MTHQ--VHRERCCQVHLSSSRRHPLL--------------------SSEEGYSLYTEKDA 160
HQ V + P + SL D
Sbjct: 90 FNHQNIVRCIGVS------LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL-AMLDL 142
Query: 161 AKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWS--VHAPSLHRKT 215
+A Y + IHRDI N LLT KI DFG + ++ S +RK
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK- 201
Query: 216 MCGTLDYLP-----PEMVTSQHYGK---EVDNWCIGILAYE-FLVGKPPF 256
G LP PE + G + D W G+L +E F +G P+
Sbjct: 202 --GGCAMLPVKWMPPE---AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 51/228 (22%), Positives = 80/228 (35%), Gaps = 57/228 (25%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK-----EKTTQIMIALKVL------YKVEIINE-----RM 123
D + LG G FG V+LA+ ++++A+K L + + E +
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 124 THQ--VHRERCC----------------------QVHLSSSRRHPLLSSEEGYSLYTEKD 159
H+ V C + H + +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 160 AAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMC 217
Q+A + Y + +HRD+ N L+ + VKI DFG S V++ +R
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV--- 191
Query: 218 GTLDYLP-----PEMVTSQHYGK---EVDNWCIGILAYE-FLVGKPPF 256
G LP PE S Y K E D W G++ +E F GK P+
Sbjct: 192 GGHTMLPIRWMPPE---SIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 49/220 (22%), Positives = 84/220 (38%), Gaps = 54/220 (24%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK-------EKTTQIMIALKVLYKVEIINER---------M 123
+G PLG G FG V +A+ + + +A+K+L + M
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 124 THQVHRER------CC------------------QVHLSSSRRHPLLSSEEGYSLY---- 155
+ C + +L + R + S + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHR 213
T KD YQ+A + Y +K IHRD+ N+L+T + +KI+DFG + ++ ++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 214 KTMCGTLDYLP-----PEMVTSQHYGKEVDNWCIGILAYE 248
K T LP PE + + Y + D W G+L +E
Sbjct: 215 K---TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 251
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 54/227 (23%), Positives = 79/227 (34%), Gaps = 56/227 (24%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK-----EKTTQIMIALKVL------YKVEIINE-----RM 123
D + LG G FG V+LA+ + ++++A+K L + + E +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 124 THQ--VHRERCC------------------QVHLSSSRRHPLLSSEEGYSLY---TEKDA 160
HQ V C L S L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 161 AKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCG 218
QVA + Y +HRD+ N L+ VKI DFG S +++ +R G
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV---G 217
Query: 219 TLDYLP-----PEMVTSQHYGK---EVDNWCIGILAYE-FLVGKPPF 256
LP PE S Y K E D W G++ +E F GK P+
Sbjct: 218 GRTMLPIRWMPPE---SILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 21/48 (43%), Positives = 28/48 (58%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203
+ KD YQVA + Y KK IHRD+ N+L+T +KI+DFG
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 20/48 (41%), Positives = 29/48 (60%)
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203
T KD YQ+A + Y +K IHRD+ N+L+T + +KI+DFG
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 248
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 3e-06
Identities = 50/258 (19%), Positives = 78/258 (30%), Gaps = 59/258 (22%)
Query: 49 TNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEV---------GCPLGTGKFGHVYLA 99
+ Y + T + A N + + +G G FG VY
Sbjct: 49 KKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG 108
Query: 100 KEKT---TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP----LL--SSEE 150
+I A+K L N + + + HP LL
Sbjct: 109 TLLDNDGKKIHCAVKSL------NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 151 GYSLY----------------------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188
S T KD + QVA + + KK +HRD+ N
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222
Query: 189 LLLTMHEDVKISDFGWS--VHA--PSLHRKTMCGTL--DYLPPEMVTSQHYGK---EVDN 239
+L VK++DFG + ++ L ++ E S K + D
Sbjct: 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE---SLQTQKFTTKSDV 279
Query: 240 WCIGILAYE-FLVGKPPF 256
W G+L +E G PP+
Sbjct: 280 WSFGVLLWELMTRGAPPY 297
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 52/244 (21%), Positives = 81/244 (33%), Gaps = 71/244 (29%)
Query: 69 EAPNKSYRWQMSDFEV---------GCPLGTGKFGHVYLAK---EKTTQIMIALKVLYKV 116
+ + ++ D + +G G FG VY + + +I A+K L
Sbjct: 1 RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-S- 58
Query: 117 EIINERMTHQVHRERCCQVHLSSSRRHP----LL---SSEEGYSL--------------- 154
I + RE L HP L+ EG
Sbjct: 59 RITEMQQVEAFLRE----GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
Query: 155 ------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--V 206
T KD + QVA + Y ++K +HRD+ N +L VK++DFG + +
Sbjct: 115 RSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174
Query: 207 H-----APSLHRKTMCGTLDYLP-----PEMVTSQHYGK---EVDNWCIGILAYE-FLVG 252
+ HR LP E S + + D W G+L +E G
Sbjct: 175 LDREYYSVQQHRHAR------LPVKWTALE---SLQTYRFTTKSDVWSFGVLLWELLTRG 225
Query: 253 KPPF 256
PP+
Sbjct: 226 APPY 229
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 47/240 (19%), Positives = 91/240 (37%), Gaps = 44/240 (18%)
Query: 69 EAPNK---SYRWQM--SDFEVGCPLGTGKFGHVYLAKEKTT----QIMIALKVL------ 113
PN+ + ++ S +G G+FG VY KT+ ++ +A+K L
Sbjct: 28 SDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE 87
Query: 114 -YKVEIINE-RMTHQVHRERCCQVHLSSSRRHPL---------------LSSEEGYSLYT 156
+V+ + E + Q ++ S+ P+ L ++G ++
Sbjct: 88 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFS 145
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRK 214
+ +A + Y +HRD+ N+L+ + K+SDFG S +
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 215 TMCGTLDYLP-----PEMVTSQHYGKEVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
T G +P PE ++ + + D W GI+ +E G+ P+ ++ I
Sbjct: 206 TTSGGK--IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 30/156 (19%), Positives = 50/156 (32%), Gaps = 38/156 (24%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK----EKTTQIMIALKVL------YKVEIINE-RMTHQVH 128
+ LG G FG V L + T ++A+K L + + E ++ +H
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 129 RER------CCQVHLSSSRRHPL---------------LSSEEGYSLYTEKDAAKYIYQV 167
+ R L L Y Q+
Sbjct: 83 SDFIVKYRGVS----YGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQI 136
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203
+ Y ++ +HRD+ N+L+ VKI+DFG
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-06
Identities = 32/156 (20%), Positives = 53/156 (33%), Gaps = 38/156 (24%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK----EKTTQIMIALKVL------YKVEIINE-RMTHQVH 128
+ LG G FG V + + + T ++A+K L + + E + +
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 129 RER------CCQVHLSSSRRHPL---------------LSSEEGYSLYTEKDAAKYIYQV 167
+ C S+ R L L + +Y Q+
Sbjct: 70 HDNIVKYKGVC----YSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQI 123
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203
+ Y K+ IHRD+ N+L+ VKI DFG
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 5e-06
Identities = 48/209 (22%), Positives = 72/209 (34%), Gaps = 46/209 (22%)
Query: 87 PLGTGKFGHVYLAK---EKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRH 143
+G G FG VY +I A+K L N + + + H
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------NRITDIGEVSQFLTEGIIMKDFSH 85
Query: 144 P----LL--SSEEGYSLY----------------------TEKDAAKYIYQVADAIHYCH 175
P LL S T KD + QVA + Y
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLP-----PEMV 228
KK +HRD+ N +L VK++DFG + ++ + T LP E +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH-NKTGAKLPVKWMALESL 204
Query: 229 TSQHYGKEVDNWCIGILAYE-FLVGKPPF 256
+Q + + D W G+L +E G PP+
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 6e-06
Identities = 32/147 (21%), Positives = 50/147 (34%), Gaps = 23/147 (15%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK---EKTTQIMIALKVL-------YKVEIINE-RMTHQVH 128
D + LG G FG VY K +I +A+K K + ++E + +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 129 RERCCQVHLSSSRRHPLLSSE--EGYSL----------YTEKDAAKYIYQVADAIHYCHQ 176
++ + E L Y Q+ A+ Y
Sbjct: 72 HPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFG 203
+HRDI N+L+ E VK+ DFG
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFG 158
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 41/237 (17%), Positives = 70/237 (29%), Gaps = 61/237 (25%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTT-------QIMIALKVL------YKVEIINE-RMTH 125
D LG G F ++ + + + LKVL Y M
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 126 QVHRERCCQVHLSSSRRHP------------LLS--SEEGYSLYTEKDAAKYIYQVADAI 171
++ + + L + + + + Q+A A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCI-NILWKLEVAKQLAAAM 126
Query: 172 HYCHQKKVIHRDIKPENLLLTMHED--------VKISDFGWSVHAPSLHRKTMCGTLDYL 223
H+ + +IH ++ +N+LL ED +K+SD G + + D L
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG-------ISITVLPK--DIL 177
Query: 224 -------PPEMVTSQHYGK----EVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
PPE K D W G +E G P + D L+
Sbjct: 178 QERIPWVPPE---CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 6e-06
Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 16/117 (13%)
Query: 163 YIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTL 220
++QV+ + Y +K +HRD+ N+LL KISDFG S + A +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 221 DYLP-----PEMVTSQHYGK---EVDNWCIGILAYE-FLVGKPPFESKDQDTTLERI 268
P PE ++ K D W G+ +E G+ P++ + I
Sbjct: 175 --WPLKWYAPE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 32/156 (20%), Positives = 53/156 (33%), Gaps = 38/156 (24%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK----EKTTQIMIALKVL------YKVEIINE-RMTHQVH 128
+ LG G FG V + + + T ++A+K L + + E + +
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 129 RER------CCQVHLSSSRRHPL---------------LSSEEGYSLYTEKDAAKYIYQV 167
+ C S+ R L L + +Y Q+
Sbjct: 101 HDNIVKYKGVC----YSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQI 154
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203
+ Y K+ IHRD+ N+L+ VKI DFG
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 34/154 (22%), Positives = 56/154 (36%), Gaps = 37/154 (24%)
Query: 80 SDFEVGCPLGTGKFGHVY---LAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVH 136
E+G +G G+FG V+ + + +A+K + V + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC------KNCTSDSVREKFLQEAL 68
Query: 137 LSSSRRHP-------------------------LLS--SEEGYSLYTEKDAAKYIYQVAD 169
HP L S YSL Y YQ++
Sbjct: 69 TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSL-DLASLILYAYQLST 127
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203
A+ Y K+ +HRDI N+L++ ++ VK+ DFG
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 161
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 44/217 (20%), Positives = 70/217 (32%), Gaps = 51/217 (23%)
Query: 80 SDFEVGCPLGTGKFGHVYLAK-----EKTTQIMIALKVL-------YKVEIINE-----R 122
S LG +FG VY +A+K L + E +E R
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 123 MTHQ--VHRERCC----------------------QVHLSSSRRHPLLSSEEGYSLYTEK 158
+ H V + S S
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 159 DAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTM 216
D + Q+A + Y V+H+D+ N+L+ +VKISD G V+A ++
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 217 CGTL--DYLPPEMVTSQHYGK---EVDNWCIGILAYE 248
L ++ PE + YGK + D W G++ +E
Sbjct: 189 NSLLPIRWMAPE---AIMYGKFSIDSDIWSYGVVLWE 222
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 2e-04
Identities = 10/52 (19%), Positives = 20/52 (38%), Gaps = 1/52 (1%)
Query: 153 SLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFG 203
L + A ++Q+ ++ + HRD+ N+LL K+
Sbjct: 156 KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTL 207
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 271 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.98 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.61 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.5 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.34 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.83 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.05 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.89 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.86 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.82 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.62 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.12 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.67 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.44 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.23 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 93.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.44 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 93.08 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 91.04 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.54 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 84.64 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=338.32 Aligned_cols=188 Identities=32% Similarity=0.546 Sum_probs=161.4
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
..++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+| +.++....||+++.+.+.
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E----~~il~~l~HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPFFVKLYFTFQDDE 105 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHTTCCCTTBCCEEEEEECSS
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHH----HHHHHhCCCCCCCeEEEEEEeCC
Confidence 35789999999999999999999999999999999987655444444445555 445556678887664432
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS- 210 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~- 210 (271)
..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 3489999999999999999999999999999999999999999999999999976532
Q ss_pred ---CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 ---LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 247 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII 247 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 23456789999999999999999999999999999999999999999999999998875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=323.70 Aligned_cols=187 Identities=35% Similarity=0.631 Sum_probs=140.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|++..+++.||||++++...........+.+| +.++....||+++...+.
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E----i~il~~l~HpnIv~~~~~~~~~~~ 87 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIERE----ISYLRLLRHPHIIKLYDVIKSKDE 87 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHH----HHHHHHCCCTTBCCEEEEEECSSE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHH----HHHHHHCCCCCCCeEEEEEEECCE
Confidence 5799999999999999999999999999999999976544333333334444 333444467766554322
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-C
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-H 212 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-~ 212 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 34899999999999999999999999999999999999999999999999999765443 3
Q ss_pred cccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
..+.+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.+.+..+++++|.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~ 225 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS 225 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 445789999999999998886 579999999999999999999999999988887764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=334.73 Aligned_cols=186 Identities=26% Similarity=0.443 Sum_probs=149.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|+++.+++.||||++.+...... ....+.+| +.++....||+|+.+.+.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E----~~il~~l~HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRRE----VAVLANMKHPNIVQYRESFEENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH-HHHHHHHH----HHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH-HHHHHHHH----HHHHHHCCCCCCCcEEEEEEECCE
Confidence 5799999999999999999999999999999999965433221 22233344 344444567766554322
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 2368899999999999999999999999999999999999999999999999987654
Q ss_pred C--CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 L--HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|+
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 238 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 3 2345679999999999999999999999999999999999999999999999988875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=328.81 Aligned_cols=184 Identities=28% Similarity=0.443 Sum_probs=155.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.+.|++++.||+|+||+||+|+++.+++.||||+++..... ..+.+.+| +.++....||+|+.+.+.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~E----i~il~~l~HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNE----VVIMRDYQHENVVEMYNSYLVGDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHH----HHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHH----HHHHHhCCCCCCCcEEEEEEECCE
Confidence 36799999999999999999999999999999998643221 12223333 344455578877665432
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--C
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--L 211 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~ 211 (271)
..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .
T Consensus 146 ~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 3389999999999999999999999999999999999999999999999999976543 3
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 283 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 283 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999998887764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=323.93 Aligned_cols=187 Identities=32% Similarity=0.545 Sum_probs=153.5
Q ss_pred cccCeEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-- 152 (271)
+.++|++++.||+|+||+||+|++. .+++.||||++++...... .... ...+..++....||+++.+.+.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~----~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVR----TKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC----------CCCCCCCCTTEECEEEEEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHH----HHHHHHHHHHCCCCCCCeEEEEEE
Confidence 3478999999999999999999984 4678999999965432111 1112 2233566677789988775432
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 34799999999999999999999999999999999999999999999999999764
Q ss_pred C--CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 209 P--SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 209 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. .....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|+
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 239 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence 3 233456789999999999999999999999999999999999999999999999988875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=323.01 Aligned_cols=183 Identities=23% Similarity=0.329 Sum_probs=150.1
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-- 152 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-- 152 (271)
+....+.|++.+.||+|+||+||+|+++.+++.||||+++..... .+| +.++....||+|+.+.+.
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E----~~il~~l~HpnIV~l~~~~~ 120 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEE----LVACAGLSSPRIVPLYGAVR 120 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THH----HHTTTTCCCTTBCCEEEEEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHH----HHHHHhCCCCCCCcEEEEEE
Confidence 334567899999999999999999999999999999999653221 112 344555677776654432
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CEEEeecccccc
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVH 207 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~ 207 (271)
..+++..+..++.|++.||+|||++|||||||||+|||++.+| .+||+|||+|+.
T Consensus 121 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred ECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 3489999999999999999999999999999999999999988 599999999976
Q ss_pred CCCC-------CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 208 APSL-------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 208 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~ 269 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 269 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence 4321 1234579999999999999999999999999999999999999999888777666653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=329.46 Aligned_cols=184 Identities=28% Similarity=0.443 Sum_probs=154.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.+.|++++.||+|+||.||+|+++.+++.||||++...... ..+.+.+| +.++....||+|+.+.+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~E----i~il~~l~HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNE----VVIMRDYQHENVVEMYNSYLVGDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHH----HHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHH----HHHHHhCCCCCCCceEEEEEECCE
Confidence 36799999999999999999999999999999998643211 11223333 344445567776654432
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--C
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--L 211 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~ 211 (271)
..+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.... .
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 3379999999999999999999999999999999999999999999999999976543 3
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 360 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 360 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 4456789999999999999999999999999999999999999999999998887764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=313.93 Aligned_cols=183 Identities=22% Similarity=0.407 Sum_probs=147.8
Q ss_pred cCe-EEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 80 SDF-EVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 80 ~~~-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
++| ++.+.||+|+||+||+|.+..+++.||+|++........ ....+.+| +.++....||+|+.+.+.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E----~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEE----AEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHH----HHHHHTCCCTTBCCEEEEEEEEET
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHH----HHHHHhCCCCCCCcEEEEEeeccC
Confidence 344 778889999999999999999999999999865433221 22233444 445555678877655431
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCC-CCCEEEeecccc
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTM-HEDVKISDFGWS 205 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~-~~~~kl~Dfg~a 205 (271)
..+++..+..++.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 23789999999999999999999998 999999999999974 789999999999
Q ss_pred ccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHhh
Q psy4396 206 VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ-DTTLERI 268 (271)
Q Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~I 268 (271)
+........+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+. .+++..|
T Consensus 180 ~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i 242 (290)
T 3fpq_A 180 TLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred EeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH
Confidence 8776666677899999999998865 699999999999999999999999976554 4444443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=315.59 Aligned_cols=188 Identities=24% Similarity=0.414 Sum_probs=146.7
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
...|+++.+++.+.+.||+|+||+||+|++.+ .||||+++..... ....+.+.+| +.++....|||++.+.+
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~-~~~~~~f~~E----~~il~~l~HpNIV~l~g 99 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPT-PEQFQAFRNE----VAVLRKTRHVNILLFMG 99 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCC-HHHHHHHHHH----HHHHTTCCCTTBCCEEE
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCC-HHHHHHHHHH----HHHHHhCCCCCEeeEEE
Confidence 34578888999999999999999999998654 4999998643221 1222334444 45556667887766554
Q ss_pred c--------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 152 Y--------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 152 ~--------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
+ ..+++..+..++.|++.||+|||+++||||||||+|||+++++.+||+|||+|
T Consensus 100 ~~~~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 100 YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp EECSSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EEECCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence 3 23789999999999999999999999999999999999999999999999999
Q ss_pred ccCCC----CCcccccccccccCcceecc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 206 VHAPS----LHRKTMCGTLDYLPPEMVTS---QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 206 ~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
+.... ......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+..+.+..
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~ 248 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF 248 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 75432 22345689999999999864 4689999999999999999999999998776655443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=336.13 Aligned_cols=193 Identities=27% Similarity=0.438 Sum_probs=155.7
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-- 152 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-- 152 (271)
..+.+++|++++.||+|+||+||+|+++.+++.||||++++.............++.. +..+.....||+|+.+.+.
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~-~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI-MLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHHHSSSCCTTBCCEEEEEE
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHH-HHHHHhhCCCCCEeEEEEEEE
Confidence 3456789999999999999999999999999999999998765543322222222211 1234445567776554321
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 34899999999999999999999999999999999999999999999999999887
Q ss_pred CCCCcccccccccccCcceec-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHhh
Q psy4396 209 PSLHRKTMCGTLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKD---QDTTLERI 268 (271)
Q Consensus 209 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~I 268 (271)
......+.+||+.|||||++. +..|+.++|+|||||++|||++|++||.+.+ ..++...|
T Consensus 343 ~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i 406 (689)
T 3v5w_A 343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406 (689)
T ss_dssp SSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH
T ss_pred CCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Confidence 776777789999999999996 4579999999999999999999999997643 33444444
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=311.75 Aligned_cols=186 Identities=26% Similarity=0.429 Sum_probs=150.8
Q ss_pred ccccCeEEecccccCCceEEEEEEEc-----CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
+..++|.+.+.||+|+||+||+|++. .++..||||+++.... ...+.+.+| +.++....|||++.+.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E----~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHRE----AELLTNLQHEHIVKFYG 82 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH---HHHHHHHHH----HHHHTTCCCTTBCCEEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh---HHHHHHHHH----HHHHHhCCCCCCccEEE
Confidence 45678999999999999999999875 3578899999965321 122234444 55666668888777654
Q ss_pred c---------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC
Q psy4396 152 Y---------------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT 192 (271)
Q Consensus 152 ~---------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~ 192 (271)
. ..+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 83 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~ 162 (299)
T 4asz_A 83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162 (299)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC
Confidence 3 1267889999999999999999999999999999999999
Q ss_pred CCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 193 MHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 193 ~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
+++.+||+|||+|+...... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+++..
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 242 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997544322 223468999999999999999999999999999999998 9999999999998877
Q ss_pred hc
Q psy4396 268 IF 269 (271)
Q Consensus 268 I~ 269 (271)
|.
T Consensus 243 i~ 244 (299)
T 4asz_A 243 IT 244 (299)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=311.78 Aligned_cols=188 Identities=22% Similarity=0.346 Sum_probs=149.9
Q ss_pred cccccCeEEecccccCCceEEEEEEEc-----CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
++..+++++.+.||+|+||+||+|++. .+++.||||+++.... ....+.+.+| +.++....|||++.+.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~--~~~~~~f~~E----~~il~~l~HpNIV~l~ 95 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHE----AMLRARLQHPNVVCLL 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC--C-CHHHHHHH----HHHHHHCCCTTBCCEE
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC--hHHHHHHHHH----HHHHHhCCCCCCCCcc
Confidence 456788999999999999999999864 3568899999864321 1111223333 3444455677766554
Q ss_pred Cc------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q psy4396 151 GY------------------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188 (271)
Q Consensus 151 ~~------------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~N 188 (271)
+. ..+++..+..++.||+.||+|||+++||||||||+|
T Consensus 96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N 175 (308)
T 4gt4_A 96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN 175 (308)
T ss_dssp EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence 43 126788899999999999999999999999999999
Q ss_pred eEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 189 LLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 189 ili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
||+++++.+||+|||+|+..... .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999754322 2334678999999999999999999999999999999998 899999999999
Q ss_pred HHHhhc
Q psy4396 264 TLERIF 269 (271)
Q Consensus 264 ~~~~I~ 269 (271)
+++.|.
T Consensus 256 ~~~~i~ 261 (308)
T 4gt4_A 256 VVEMIR 261 (308)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887763
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=317.98 Aligned_cols=185 Identities=25% Similarity=0.414 Sum_probs=147.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|++++.||+|+||+||+|+++.+++.||||++++...... ....+.+| +.++....||+++.+.+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~-~~~~~~~E----i~il~~l~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVT-NAKRTLRE----LKILKHFKHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHH-HHHHHHHH----HHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchH-HHHHHHHH----HHHHHhcCCCCcceEeeeeeccccc
Confidence 579999999999999999999999999999999864322111 11122222 22233334555443321
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 152 -----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 152 -----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 129 ~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 129 GEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp TTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred ccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 134899999999999999999999999999999999999999999999999999754
Q ss_pred CC------CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 209 PS------LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 209 ~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+..+++.+|+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~ 276 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 276 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 32 233457899999999998775 56999999999999999999999999999999988875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=309.27 Aligned_cols=188 Identities=24% Similarity=0.376 Sum_probs=148.2
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
..+..+++.+.+.||+|+||+||+|++.. +++.||||+++.... ...+.+.+| +.++....||||+.+
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E----~~il~~l~HpnIV~l 108 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQRE----AELLTMLQHQHIVRF 108 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH---HHHHHHHHH----HHHHTTCCCTTBCCE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH---HHHHHHHHH----HHHHHhCCCCCCCcE
Confidence 34566889999999999999999999753 578999999965322 122234444 555666688887765
Q ss_pred cCc-----------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q psy4396 150 EGY-----------------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188 (271)
Q Consensus 150 ~~~-----------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~N 188 (271)
.+. ..+++..+..++.|++.||+|||+++||||||||+|
T Consensus 109 ~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N 188 (329)
T 4aoj_A 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN 188 (329)
T ss_dssp EEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence 543 126788899999999999999999999999999999
Q ss_pred eEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 189 LLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 189 ili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
||+++++.+||+|||+|+..... .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+
T Consensus 189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp EEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred EEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999999764332 2234678999999999999999999999999999999999 999999999998
Q ss_pred HHHhhc
Q psy4396 264 TLERIF 269 (271)
Q Consensus 264 ~~~~I~ 269 (271)
++..|.
T Consensus 269 ~~~~i~ 274 (329)
T 4aoj_A 269 AIDCIT 274 (329)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=309.67 Aligned_cols=193 Identities=24% Similarity=0.394 Sum_probs=142.4
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCC-----eEEEEEEcchhHHHHH--------HhhhhhhceeeeEEecC-
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ-----IMIALKVLYKVEIINE--------RMTHQVHRERCCQVHLS- 138 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~--------~~~~~~~~~~~~~~~~~- 138 (271)
..|+++.++|++++.||+|+||+||+|++...+ +.||||.++....... .....+.... .++.+.
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhp-nIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL-NVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT-TBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCC-cEEEEEE
Confidence 357788899999999999999999999987643 6899999865321111 0111111100 011111
Q ss_pred ---cCCCcceeeecc--Cc-------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q psy4396 139 ---SSRRHPLLSSEE--GY-------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPEN 188 (271)
Q Consensus 139 ---~~~~~~~l~~~~--~~-------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~N 188 (271)
......+++..+ +. ..+++..+..++.||+.||+|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 111111222211 11 226889999999999999999999999999999999
Q ss_pred eEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 189 LLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 189 ili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
||+++++.+||+|||+|+..... .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999765432 2234578999999999999999999999999999999998 999999877555
Q ss_pred HHH
Q psy4396 264 TLE 266 (271)
Q Consensus 264 ~~~ 266 (271)
.+.
T Consensus 296 ~~~ 298 (353)
T 4ase_A 296 EFC 298 (353)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=300.92 Aligned_cols=172 Identities=30% Similarity=0.485 Sum_probs=129.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|+++.+++.||||+++.... ....+.+.+| +.++....||+|+.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E----~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMRE----VKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHH----HHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHH----HHHHHhCCCCCCCeEEEEEEecCc
Confidence 3679999999999999999999999999999999864321 1111223333 344555577776554321
Q ss_pred -----------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCE
Q psy4396 153 -----------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDV 197 (271)
Q Consensus 153 -----------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~ 197 (271)
...++..+..++.|++.||+|||++||+||||||+|||++.+|.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence 012445688999999999999999999999999999999999999
Q ss_pred EEeeccccccCCCC--------------CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 198 KISDFGWSVHAPSL--------------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 198 kl~Dfg~a~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
||+|||+|+..... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.+.
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 99999999754321 1234579999999999999999999999999999999995 88643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=300.10 Aligned_cols=182 Identities=25% Similarity=0.402 Sum_probs=135.1
Q ss_pred cCeEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------ 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------ 150 (271)
++|++.+.||+|+||+||+|+++ .+++.||||.+.+...... +.+|.. .+.....||+++.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~E~~---~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIR-----IAAELQ---CLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHH-----HHHHHH---HHHHTCSBTTBCCCSEEEEET
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHH-----HHHHHH---HHHHhcCCCCCceEEEEEEEC
Confidence 67999999999999999999875 4578899998854322111 111100 000111344333221
Q ss_pred -----------Cc------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCEEEeeccccccCCCC-
Q psy4396 151 -----------GY------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 151 -----------~~------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-~~~kl~Dfg~a~~~~~~- 211 (271)
+. ..+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred CEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 11 237999999999999999999999999999999999999877 79999999999654321
Q ss_pred -----------------------------CcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCC-CCC
Q psy4396 212 -----------------------------HRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFE-SKD 260 (271)
Q Consensus 212 -----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~-~~~ 260 (271)
.....+||+.|+|||++.+. .|+.++||||+||++|||++|+.||. +.+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 11235799999999999775 58999999999999999999999994 455
Q ss_pred HHHHHHhhc
Q psy4396 261 QDTTLERIF 269 (271)
Q Consensus 261 ~~~~~~~I~ 269 (271)
+.+.+.+|+
T Consensus 253 ~~~~l~~I~ 261 (361)
T 4f9c_A 253 DLTALAQIM 261 (361)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 556665553
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=290.86 Aligned_cols=168 Identities=21% Similarity=0.269 Sum_probs=128.6
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
++|.+.+.||+|+||+||+|++. ++.||||+++......... ..| +.......|||++.+.+.
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~~~~~----e~E----i~~~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFR----EAE----IYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHHHHHH----HHH----HHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhhHHH----HHH----HHHHhcCCCCCCCcEEEEEEecCCC
Confidence 56899999999999999999984 6789999997543221111 111 223334467766554332
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEeCCCCCEEEeec
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQK--------KVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~--------~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
..++++.+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 73 WTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 2268889999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCC------cccccccccccCcceeccC------CCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 203 GWSVHAPSLH------RKTMCGTLDYLPPEMVTSQ------HYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 203 g~a~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
|+|+...... ....+||+.|||||++.+. .++.++|||||||++|||+||++||.
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 9997543321 2235799999999999764 36779999999999999999987664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=311.79 Aligned_cols=184 Identities=29% Similarity=0.529 Sum_probs=151.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
+++|++++.||+|+||+||+|+++.+++.||+|++........ ..+.+| +.++....||+++.+.+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~---~~~~~E----i~il~~l~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKE----IQTMSVLRHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH---HHHHHH----HHHHHHTCCTTBCCEEEEEECSSE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhH---HHHHHH----HHHHHhCCCCCCCeEEEEEEECCE
Confidence 4789999999999999999999999999999999865432211 122222 22333345665543221
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC--CCEEEeeccccccCC
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH--EDVKISDFGWSVHAP 209 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~--~~~kl~Dfg~a~~~~ 209 (271)
...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 1347899999999999999999999999999999999999854 899999999998765
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~ 369 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 43 3455789999999999999999999999999999999999999999999999988875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=286.91 Aligned_cols=189 Identities=36% Similarity=0.615 Sum_probs=152.1
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG----- 151 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----- 151 (271)
+..++|++++.||+|+||.||+|+++.+++.||+|++++.............+| ........||+++...+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE----SRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHHSCCCTTBCCEEEEEECS
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHH----HHHHHhCCCCcCcceEEEEEeC
Confidence 356899999999999999999999999999999999976543322222222222 12222234554433221
Q ss_pred ------------c---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC-
Q psy4396 152 ------------Y---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP- 209 (271)
Q Consensus 152 ------------~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~- 209 (271)
. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 1 237899999999999999999999999999999999999999999999999997533
Q ss_pred -CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 -SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..++++.|+
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 218 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 234456789999999999999999999999999999999999999999999888877764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=290.52 Aligned_cols=191 Identities=36% Similarity=0.607 Sum_probs=145.2
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----- 150 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----- 150 (271)
.+.+++|++++.||+|+||.||+|+++.+++.||||++.+..............|... +.....||+++...
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~i---l~~~~~hp~Iv~l~~~~~~ 95 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI---LSLARNHPFLTQLFCCFQT 95 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHH---HHHTTTCTTBCCEEEEEEC
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHH---HHhccCCCceeeEEEEEEe
Confidence 4567899999999999999999999999999999999976543322222111111110 00011344332221
Q ss_pred ------------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 151 ------------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 ------------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 11 347899999999999999999999999999999999999999999999999997533
Q ss_pred --CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 --SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+++++|+
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 237 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 234455789999999999999999999999999999999999999999999999888775
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=285.46 Aligned_cols=189 Identities=32% Similarity=0.536 Sum_probs=153.1
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC----
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG---- 151 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---- 151 (271)
....++|++++.||+|+||.||+|++..+++.||||++.+...........+.+| ..+.....||+++...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE----KRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHH----HHHHHhCCCCCCCeEEEEEEc
Confidence 3457899999999999999999999999999999999976544322222222222 12223334554433211
Q ss_pred -------------c---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 152 -------------Y---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 -------------~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 1 337899999999999999999999999999999999999999999999999997655
Q ss_pred CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+++++|.
T Consensus 193 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 251 (350)
T 1rdq_E 193 GR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251 (350)
T ss_dssp SC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CC-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH
Confidence 43 345679999999999999999999999999999999999999999999988887764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=285.58 Aligned_cols=193 Identities=32% Similarity=0.563 Sum_probs=148.9
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--- 150 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--- 150 (271)
...+..++|++.+.||+|+||.||+|+++.+++.||||++++..............|... +.....||+++...
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~i---l~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV---LSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHH---HHHHTTCTTBCCEEEEE
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHH---HHhcCCCCCCCcEEEEE
Confidence 345567899999999999999999999999999999999976543221111111111000 00011333332211
Q ss_pred --------------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 151 --------------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 151 --------------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
+. ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 11 3478999999999999999999999999999999999999999999999999975
Q ss_pred CC--CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 208 AP--SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 208 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+++.+|.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 231 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 43 334456789999999999999999999999999999999999999999999988887764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=285.53 Aligned_cols=192 Identities=34% Similarity=0.606 Sum_probs=153.2
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-- 152 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-- 152 (271)
.....++|++++.||+|+||.||+|+++.+++.||||++.+..............+.. .+.....||+++...+.
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~---~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN---VLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------CCBCCCCCTTBCCEEEEEE
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHH---HHHHhCCCCCCCCEEEEEE
Confidence 3456789999999999999999999999999999999997654332222222222211 12344567766543221
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 23788999999999999999999999999999999999999999999999999753
Q ss_pred --CCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 209 --PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 209 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
........+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+++++|+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 252 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 2334456789999999999999999999999999999999999999999999999888775
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=285.83 Aligned_cols=191 Identities=35% Similarity=0.617 Sum_probs=149.9
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----- 150 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----- 150 (271)
.+..++|++++.||+|+||.||+|+++.+++.||||++++..............|... +.....||+++...
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~---l~~~~~hp~iv~l~~~~~~ 92 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV---LALPGKPPFLTQLHSCFQT 92 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHH---HTCTTCCTTBCCEEEEEEC
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHH---HHhcCCCCEEeeEEEEEEc
Confidence 4557899999999999999999999999999999999976543322111111111110 11111344332211
Q ss_pred ------------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 151 ------------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 ------------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 11 347899999999999999999999999999999999999999999999999997532
Q ss_pred --CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 --SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+++++|+
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 234 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 334456789999999999999999999999999999999999999999999998888774
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=292.33 Aligned_cols=191 Identities=34% Similarity=0.509 Sum_probs=153.0
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-- 152 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-- 152 (271)
.+...++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+| ..+.....||+++...+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E----~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE----RDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHH----HHHHHHCCCTTBCCEEEEEE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHH----HHHHHhCCCCCCCeEEEEEE
Confidence 44567899999999999999999999999999999999976544332222222222 122222345544332211
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 237899999999999999999999999999999999999999999999999997655
Q ss_pred CC---CcccccccccccCcceeccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL---HRKTMCGTLDYLPPEMVTSQH----YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. .....+||+.|+|||++.+.. ++.++|+|||||++|||++|+.||.+.+..+++.+|+
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 286 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence 43 234578999999999998765 7899999999999999999999999999999888875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=280.22 Aligned_cols=188 Identities=36% Similarity=0.629 Sum_probs=151.5
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
+..++|++++.||+|+||.||+|++..+++.||+|++++.............+| ..+.....||+++...+.
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE----RLMLSIVTHPFIIRMWGTFQDA 78 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHHSCCBTTBCCEEEEEECS
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHH----HHHHhhCCCCCCceEeEEEEeC
Confidence 346899999999999999999999999999999999976543322222222222 112222345544332211
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 3378999999999999999999999999999999999999999999999999976554
Q ss_pred CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+++.+|+
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 216 (318)
T 1fot_A 159 V-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216 (318)
T ss_dssp C-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred c-cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3 345679999999999999999999999999999999999999999999888887764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=292.65 Aligned_cols=191 Identities=31% Similarity=0.527 Sum_probs=151.0
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---- 150 (271)
..+..++|++++.||+|+||+||+|+++.+++.||+|++.+...........+..|. .+.....||+++.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~----~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER----DVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHH----HHHHHSCTTTBCCEEEEEE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHH----HHHHhCCCCCEEEEEEEEe
Confidence 345568999999999999999999999999999999999765443322222222221 111122344332211
Q ss_pred -------------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 151 -------------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 151 -------------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 1 13478999999999999999999999999999999999999999999999999976
Q ss_pred CCCCC---cccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 208 APSLH---RKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 208 ~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
..... ....+||+.|+|||++. ...++.++|+|||||++|||++|+.||.+.+..+++.+|+
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 294 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence 54322 23467999999999987 4568999999999999999999999999999999888875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=288.47 Aligned_cols=191 Identities=29% Similarity=0.492 Sum_probs=151.5
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---- 150 (271)
..+..++|++++.||+|+||.||+|+++.+++.||||++++...........+.+|.. +.....||+++...
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~----il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD----VLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHH----HHHHSCTTTBCCEEEEEE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHH----HHHhcCCCCeeeEEEEEe
Confidence 3456789999999999999999999999999999999997654433322222222211 11122344332211
Q ss_pred -------------Cc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 151 -------------GY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 151 -------------~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 11 2478999999999999999999999999999999999999999999999999976
Q ss_pred CCCCC---cccccccccccCcceec-------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 208 APSLH---RKTMCGTLDYLPPEMVT-------SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 208 ~~~~~---~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
..... ....+||+.|+|||++. ...++.++|+|||||++|||++|+.||.+.+..+++.+|+
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 54332 23468999999999987 3568999999999999999999999999999999888875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=286.23 Aligned_cols=181 Identities=29% Similarity=0.577 Sum_probs=140.1
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---- 150 (271)
..+..++|++++.||+|+||.||+|+++.+++.||+|++++...........+..|... +.....||+++.+.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~i---l~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV---FEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHH---HHHHTTCTTBCCEEEEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHH---HHhcCCCCCcCeeEEEEE
Confidence 34567899999999999999999999999999999999976433222111111111100 00011334332221
Q ss_pred -------------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 151 -------------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 151 -------------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 11 34789999999999999999999999999999999999999999999999999753
Q ss_pred --CCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 209 --PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 209 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
........+||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 23345567899999999999999999999999999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=278.17 Aligned_cols=179 Identities=29% Similarity=0.570 Sum_probs=139.7
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc------
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------ 150 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------ 150 (271)
+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|... +.....||+++...
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~---l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV---FEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHH---HHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHH---HHhcCCCCccCeEEEEEEeC
Confidence 456899999999999999999999999999999999975432211111111111100 00011344332221
Q ss_pred -----------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC-
Q psy4396 151 -----------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP- 209 (271)
Q Consensus 151 -----------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~- 209 (271)
+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 11 337899999999999999999999999999999999999999999999999997532
Q ss_pred -CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 210 -SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 3344557899999999999999999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=285.58 Aligned_cols=191 Identities=36% Similarity=0.608 Sum_probs=150.5
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-- 152 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-- 152 (271)
..+..++|++++.||+|+||.||+|++..+++.||||++.+...........+..| ..+.....||+++...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE----NRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-----------------CCCCCSCTTSCCEEEEEE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHH----HHHHHhCCCCeEeeEEEEEe
Confidence 34567899999999999999999999999999999999976543222222222232 444555567766543221
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+|+.
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 236899999999999999999998 9999999999999999999999999999975
Q ss_pred CC--CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 208 AP--SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 208 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++..|.
T Consensus 299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 362 (446)
T 4ejn_A 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362 (446)
T ss_dssp TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 33 233445779999999999999999999999999999999999999999999888877664
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=298.63 Aligned_cols=192 Identities=35% Similarity=0.617 Sum_probs=150.3
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee------
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS------ 148 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~------ 148 (271)
..+.+++|++++.||+|+||.||+|+++.+++.||||++++..............|.. .+.....||+++.
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~---~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR---VLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHH---HHTCTTCCTTBCCEEEECB
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHH---HHHhccCCCeEEEEEEEEE
Confidence 3456789999999999999999999999999999999997654332221111111110 0111112332221
Q ss_pred ---------c--cCc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 149 ---------E--EGY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 149 ---------~--~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
. .+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 1 111 34789999999999999999999999999999999999999999999999999753
Q ss_pred C--CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 209 P--SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 209 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+++++|+
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 555 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 2 334556789999999999999999999999999999999999999999999999998876
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=278.10 Aligned_cols=182 Identities=31% Similarity=0.576 Sum_probs=145.7
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
...+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+| ..+.....||+++...+.
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E----~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE----LQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHHTCCCTTBCCEEEEE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHH----HHHHHhCCCCCCCcEEEEE
Confidence 345667899999999999999999999999999999999976544332222223233 222333355654443211
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 2478999999999999999999999999999999999999999999999999976
Q ss_pred CCC-CCcccccccccccCcceecc---CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 208 APS-LHRKTMCGTLDYLPPEMVTS---QHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 208 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
... ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 543 34456789999999999863 45899999999999999999999999743
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=273.81 Aligned_cols=187 Identities=30% Similarity=0.584 Sum_probs=147.8
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
..++|++++.||+|+||.||+|++..+++.||||++.+...... ....+.+| +.+.....||+++...+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E----~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFRE----VRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHH----HHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH-HHHHHHHH----HHHHHhCCCCCEeeEEEEEEECC
Confidence 46899999999999999999999999999999999865432111 11112222 112222234443322211
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS- 210 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~- 210 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 3478999999999999999999999999999999999999999999999999975443
Q ss_pred CCcccccccccccCcceeccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYG-KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++.++|.
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 227 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 334556799999999999888875 79999999999999999999999999888877664
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.66 Aligned_cols=186 Identities=24% Similarity=0.324 Sum_probs=142.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|++++.||+|+||+||+|.+..+++.||||++.+.... ......+.+| +.+.....||+++...+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E----~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRE----LVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS-HHHHHHHHHH----HHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC-hHHHHHHHHH----HHHHHhCCCCCCCcEEEEEccCCc
Confidence 57899999999999999999999999999999998643211 1111111122 112222234443332211
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 136 ~~~~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp TTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred cccCCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 127889999999999999999999999999999999999999999999999997655
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.+|+
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~ 276 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 43 3345679999999999999999999999999999999999999999999888887764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=274.18 Aligned_cols=185 Identities=36% Similarity=0.608 Sum_probs=146.7
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
..+++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+| +.......||+++...+.
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHIIKLYDVITTP 81 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHH----HHHHTTCCCTTBCCEEEEEECS
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHH----HHHHHhCCCCCCCeEEEEEEeC
Confidence 346899999999999999999999999999999999876543322222223333 223333355554433221
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS- 210 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~- 210 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 3378999999999999999999999999999999999999999999999999976543
Q ss_pred CCcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+....++.
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~ 217 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF 217 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 23445679999999999988776 68999999999999999999999876554443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=262.82 Aligned_cols=189 Identities=54% Similarity=1.013 Sum_probs=148.6
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc---
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY--- 152 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--- 152 (271)
.+..++|++.+.||+|+||+||+|.+..+++.||+|++.............+.++ ........||++....+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE----VEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHH----HHHHTTCCCTTBCCEEEEEEC
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHH----HHHHHcCCCCCCcchhheEec
Confidence 4567899999999999999999999999999999999866543332222222222 222233345544332211
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 236889999999999999999999999999999999999999999999999997766
Q ss_pred CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
........||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+...++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 219 (279)
T 3fdn_A 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 66556678999999999999999999999999999999999999999999888777654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=278.14 Aligned_cols=191 Identities=27% Similarity=0.429 Sum_probs=133.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH---------Hhhhhhh-ceeee-E--EecCcCCCcce
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---------RMTHQVH-RERCC-Q--VHLSSSRRHPL 145 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~~-~~~~~-~--~~~~~~~~~~~ 145 (271)
.++|++++.||+|+||.||+|.+..+++.||||++.+...... .....+. ..... . ........+.+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 5789999999999999999999999999999998843211000 0001111 00000 0 00000111112
Q ss_pred eeeccCc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC------
Q psy4396 146 LSSEEGY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS------ 210 (271)
Q Consensus 146 l~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~------ 210 (271)
++..... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 88 lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 167 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167 (388)
T ss_dssp EEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCC
T ss_pred EEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccc
Confidence 2221111 3478889999999999999999999999999999999999999999999999965422
Q ss_pred -----------------CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 -----------------LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 -----------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+.+|+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 11233579999999999876 678999999999999999999999999999998888775
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=265.00 Aligned_cols=185 Identities=30% Similarity=0.491 Sum_probs=139.0
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
-.++|++++.||+|+||.||+|++..+++.||+|++.............+.+| ........||+++...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e----~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFERE----VHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHH----HHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHH----HHHHhcCCCCCCceEEEeeeeCC
Confidence 35789999999999999999999999999999999743221111111122222 1222222344333221
Q ss_pred ----------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 151 ----------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 151 ----------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 11 23789999999999999999999999999999999999999999999999999755432
Q ss_pred ---CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 212 ---HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
......||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~ 222 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 2234568999999999999999999999999999999999999999888766543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=283.87 Aligned_cols=189 Identities=27% Similarity=0.428 Sum_probs=146.0
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec------
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE------ 149 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~------ 149 (271)
.+..++|.+.+.||+|+||.||+|+++.+++.||||++.+...........+..|. .+.....||+++..
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~----~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK----KILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH----HHHHHCCCTTBCCEEEEEEC
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHH----HHHHhcCCCCEeeEEEEEee
Confidence 34568999999999999999999999999999999999765433221111121221 11111133332221
Q ss_pred -----------cC-------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 150 -----------EG-------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 150 -----------~~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence 11 124789999999999999999999999999999999999999999999999999
Q ss_pred ccCCCC--CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHhh
Q psy4396 206 VHAPSL--HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD----QDTTLERI 268 (271)
Q Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~I 268 (271)
+..... .....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+ ..++..+|
T Consensus 337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i 405 (543)
T 3c4z_A 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405 (543)
T ss_dssp EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH
T ss_pred eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH
Confidence 765433 2334589999999999999999999999999999999999999998763 34555544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=265.62 Aligned_cols=186 Identities=27% Similarity=0.443 Sum_probs=140.8
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
-.++|++.+.||+|+||.||+|++..+++.||||++.............+.+| ........||+++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRRE----AQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHH----HTTCCCCCCTTBCCEEEEEEEEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHH----HHHHHcCCCCCcceEEEeeeccC
Confidence 35789999999999999999999999999999999865432222222222233 222233345544332211
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 2378899999999999999999999999999999999999999999999999865
Q ss_pred CCCC-----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 208 APSL-----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 208 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+...+
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~ 230 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 230 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4322 22335689999999999999999999999999999999999999998887766543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=271.65 Aligned_cols=187 Identities=31% Similarity=0.537 Sum_probs=147.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH---hhhhhhceeeeEEecCcCCCcceeeeccC----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---MTHQVHRERCCQVHLSSSRRHPLLSSEEG---- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---- 151 (271)
.++|++++.||+|+||.||+|+++.+++.||+|++++....... ....+.+| +.+.....||+++...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E----~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE----VSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHH----HHHHTTCCCTTBCCEEEEEEC
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHH----HHHHHhCCCcCCCcEEEEEEe
Confidence 36799999999999999999999999999999998653221100 00111122 22222234444333211
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC----CEEEeecccc
Q psy4396 152 ----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE----DVKISDFGWS 205 (271)
Q Consensus 152 ----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~----~~kl~Dfg~a 205 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 13478999999999999999999999999999999999998777 7999999999
Q ss_pred ccCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 206 VHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 206 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
...... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+++..|.
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~ 231 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 765443 3345679999999999999999999999999999999999999999999988887764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=266.57 Aligned_cols=190 Identities=31% Similarity=0.585 Sum_probs=142.3
Q ss_pred cccccCeEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHH-HhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINE-RMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
.+..++|++.+.||+|+||.||+|++. .+++.||+|++++...... .....+.+| ..+.....||+++...+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE----RNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------H----HHHHHHCCCTTBCCEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHH----HHHHHhCCCCCccceeE
Confidence 345689999999999999999999985 6788999999875432111 111111111 11222223444433211
Q ss_pred c--------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 152 Y--------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 152 ~--------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 89 AFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 1 23788999999999999999999999999999999999999999999999998
Q ss_pred ccCCC--CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 206 VHAPS--LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 206 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+.... ......+||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+++.+|+
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 234 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 65332 23345679999999999999999999999999999999999999999999888877664
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=283.40 Aligned_cols=180 Identities=30% Similarity=0.497 Sum_probs=142.9
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc------
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------ 150 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------ 150 (271)
+..++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|. .+.....||+++...
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~----~iL~~l~hp~Iv~l~~~~~~~ 256 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK----QILEKVNSRFVVSLAYAYETK 256 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH----HHHHHCCCTTBCCEEEEEECS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHH----HHHHHcCCCCEeeEEEEEeeC
Confidence 4568899999999999999999999999999999999765433222111222221 111122344332211
Q ss_pred -----------Cc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 151 -----------GY-----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 151 -----------~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 11 22789999999999999999999999999999999999999999999999999766
Q ss_pred CCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 209 PSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
... .....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 543 3345689999999999999899999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.97 Aligned_cols=191 Identities=32% Similarity=0.602 Sum_probs=152.3
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC---
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG--- 151 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--- 151 (271)
..+..++|.+++.||+|+||.||+|++..+++.||||++.+...........+.+| +.......||+++...+
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E----i~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHH----HHHHTTCCCTTBCCEEEEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHH----HHHHHhCCCCCCCcEEEEEE
Confidence 34567899999999999999999999999999999999976543322222222232 22223334554433221
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 152 -----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 152 -----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 134789999999999999999999999999999999999999999999999999765
Q ss_pred CC-CCcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 209 PS-LHRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ......+||+.|+|||++.+..+ +.++|+|||||++|+|++|+.||.+.+..+++.+|.
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 229 (476)
T 2y94_A 167 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC 229 (476)
T ss_dssp CTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH
T ss_pred cccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 43 33345679999999999988776 689999999999999999999999988887777664
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=258.67 Aligned_cols=190 Identities=53% Similarity=1.018 Sum_probs=151.5
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc---
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY--- 152 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--- 152 (271)
.+..++|++.+.||+|+||.||+|++..+++.||+|++.............+.+| ........||++....+.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE----IEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHH----HHHHHTCCCTTBCCEEEEEEC
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHH----HHHHhcCCCCCEeeEEEEEEc
Confidence 4557899999999999999999999999999999999866443222111222222 112222234443322111
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 237889999999999999999999999999999999999999999999999997766
Q ss_pred CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
........|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 225 (284)
T 2vgo_A 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225 (284)
T ss_dssp SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh
Confidence 655566779999999999999999999999999999999999999999888877766553
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=261.41 Aligned_cols=182 Identities=29% Similarity=0.485 Sum_probs=143.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|++.+.||+|+||+||+|.+..+++.||+|++......... .+.+| ........||+++...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~E----~~~l~~l~hp~iv~~~~~~~~~~~ 91 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINE----ILVMRENKNPNIVNYLDSYLVGDE 91 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHH---HHHHH----HHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHH---HHHHH----HHHHhcCCCCCCCeEeEEEEECCE
Confidence 47899999999999999999999999999999998543211110 11111 11112223444333221
Q ss_pred ----------c--------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 152 ----------Y--------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 152 ----------~--------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 1 23788999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 227 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 33456799999999999999999999999999999999999999998887665544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=260.64 Aligned_cols=185 Identities=26% Similarity=0.466 Sum_probs=141.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
+++|++++.||+|+||+||+|++..+++.||+|++....... .......+| ........||+++...+
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~ 75 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALRE----ICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHH----HHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHH----HHHHhcCCCCCEeeEEeEEEeCCE
Confidence 368999999999999999999999999999999986432110 000111111 12222234444333221
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-- 210 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-- 210 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 13478999999999999999999999999999999999999999999999999976542
Q ss_pred CCcccccccccccCcceeccCC-CCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHhh
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQH-YGKEVDNWCIGILAYEFLVGKPP-FESKDQDTTLERI 268 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~I 268 (271)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+.+|
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i 215 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 2334457899999999997765 79999999999999999987666 6777777766665
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=264.82 Aligned_cols=191 Identities=21% Similarity=0.371 Sum_probs=146.1
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhh--hhhhceeeeEEecCcCCCcceeeec
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT--HQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
.....+..++|++++.||+|+||+||+|++..+++.||||++........... ........ .....||+++..
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----~~~~~h~~iv~~ 101 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQ-----NDDINNNNIVKY 101 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTC-----CCSTTGGGBCCE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhc-----ccCCCCCCeecc
Confidence 34444556899999999999999999999999999999999864221111100 00000000 011123333222
Q ss_pred cC---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---------
Q psy4396 150 EG---------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM--------- 193 (271)
Q Consensus 150 ~~---------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~--------- 193 (271)
.+ ...+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred cceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 11 123788999999999999999999999999999999999975
Q ss_pred ----------------CCCEEEeeccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 194 ----------------HEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 194 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC-CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 788999999999765443 334678999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhh
Q psy4396 258 SKDQDTTLERI 268 (271)
Q Consensus 258 ~~~~~~~~~~I 268 (271)
+.+..+.+..+
T Consensus 261 ~~~~~~~~~~~ 271 (360)
T 3llt_A 261 THEHMEHLAMM 271 (360)
T ss_dssp CSSHHHHHHHH
T ss_pred CCcHHHHHHHH
Confidence 98888776654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=274.80 Aligned_cols=186 Identities=31% Similarity=0.532 Sum_probs=145.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|++.+.||+|+||+||+|.+..+++.||+|++........ ....+.+| +.+.....||+++...+.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~-~~~~~~~E----~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR-DHQKLERE----ARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHH-HHHHHHHH----HHHHHHCCBTTBCCEEEEEECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHH-HHHHHHHH----HHHHHhCCCcCCCeEEEEEEECCE
Confidence 4679999999999999999999999999999999865432211 11122222 122222345554433211
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC---CCCCEEEeeccccccCC
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT---MHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~---~~~~~kl~Dfg~a~~~~ 209 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 3378999999999999999999999999999999999998 45789999999997655
Q ss_pred CCC--cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SLH--RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++.+|.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 226 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 432 234679999999999999999999999999999999999999999999888877653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=259.71 Aligned_cols=188 Identities=30% Similarity=0.485 Sum_probs=140.2
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH-----------------------hhhhhhceeee
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER-----------------------MTHQVHRERCC 133 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----------------------~~~~~~~~~~~ 133 (271)
...++|++.+.||+|+||.||+|++..+++.||||++......... ....+.+|
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E--- 86 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE--- 86 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH---
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH---
Confidence 4568999999999999999999999999999999998654321100 00111111
Q ss_pred EEecCcCCCcceeeecc---------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q psy4396 134 QVHLSSSRRHPLLSSEE---------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKP 186 (271)
Q Consensus 134 ~~~~~~~~~~~~l~~~~---------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp 186 (271)
........||+++... ....+++..+..++.|++.||+|||++||+||||||
T Consensus 87 -~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 87 -IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp -HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred -HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 1112222333322211 113478999999999999999999999999999999
Q ss_pred CceEeCCCCCEEEeeccccccCCCC--CcccccccccccCcceeccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 187 ENLLLTMHEDVKISDFGWSVHAPSL--HRKTMCGTLDYLPPEMVTSQH---YGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 187 ~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
+|||++.++.+||+|||++...... ......||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999999999765432 233467899999999997765 37789999999999999999999998877
Q ss_pred HHHHHhh
Q psy4396 262 DTTLERI 268 (271)
Q Consensus 262 ~~~~~~I 268 (271)
......+
T Consensus 246 ~~~~~~~ 252 (298)
T 2zv2_A 246 MCLHSKI 252 (298)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 6665544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=263.08 Aligned_cols=185 Identities=28% Similarity=0.514 Sum_probs=140.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|++..+++.||+|++...... .....+.+| +.......||+++...+.
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~ 74 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIRE----VSLLKDLKHANIVTLHDIIHTEKS 74 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCC----HHHHSCCCCTTBCCEEEEEECSSC
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHH----HHHHHhcCCCCCCeeeeEEeeCCE
Confidence 36899999999999999999999999999999998643211 111111122 233334456654443221
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 75 LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred EEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 23788999999999999999999999999999999999999999999999998754422
Q ss_pred -CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 212 -HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|.
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 214 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF 214 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2334568999999999876 568999999999999999999999999999888776653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=268.23 Aligned_cols=185 Identities=29% Similarity=0.438 Sum_probs=137.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+| +.+.....||+++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E----~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRE----LRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHH----HHHHHHCCBTTBCCCSEEECSCSS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHH----HHHHHhCCCcCCCCceeeEecCCc
Confidence 36899999999999999999999999999999998542110 1111111111 1111111233322211
Q ss_pred --------------C--------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 151 --------------G--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 151 --------------~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 99 LDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccCceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 1 133789999999999999999999999999999999999999999999999999775
Q ss_pred CCCCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 209 PSLHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
... .....+|+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+.+.+|+
T Consensus 179 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 239 (367)
T 1cm8_A 179 DSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239 (367)
T ss_dssp CSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccc-cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 543 344678999999999877 679999999999999999999999999999888777664
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=268.09 Aligned_cols=185 Identities=33% Similarity=0.604 Sum_probs=144.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ ....+.+| +.+.....||+++...+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~E----~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLERE----ARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHH-HHHHHHHH----HHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHH-HHHHHHHH----HHHHHhCCCCCCCeEEEEEEeCCE
Confidence 3679999999999999999999999999999999865332111 11112222 11122223444332211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC---CEEEeeccccccCC
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE---DVKISDFGWSVHAP 209 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~---~~kl~Dfg~a~~~~ 209 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 13378999999999999999999999999999999999998654 59999999997655
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+|
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i 242 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 43 234467999999999999999999999999999999999999999998888877665
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=259.39 Aligned_cols=184 Identities=27% Similarity=0.448 Sum_probs=139.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|++ .+++.||+|++...... ......+.+| ........||+++...+.
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIRE----ISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHH----HHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHH----HHHHHhcCCCCEeeeeeEEccCCe
Confidence 36899999999999999999998 56788999998543211 1011111122 222233345544332211
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-- 210 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-- 210 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 3478899999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.......+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+.+.++
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 213 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 223345689999999998764 5899999999999999999999999998888776665
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=258.81 Aligned_cols=192 Identities=25% Similarity=0.413 Sum_probs=142.7
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhH-----------HHHH-Hhhhhhh---ceeee-EEe--cCc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVE-----------IINE-RMTHQVH---RERCC-QVH--LSS 139 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~-~~~~~~~---~~~~~-~~~--~~~ 139 (271)
..++|++.+.||+|+||+||+|++..+++.||||++.... ...+ .....+. ..... ... ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3578999999999999999999999999999999985311 1111 1111110 00000 000 000
Q ss_pred CC---Ccceeeecc------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 140 SR---RHPLLSSEE------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 140 ~~---~~~~l~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
.. .+..++... ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 00 011111111 112279999999999999999999999999999999999999999999999999
Q ss_pred cccCCC-CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 205 SVHAPS-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 205 a~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
++.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+|+
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 976543 33345678999999999999999999999999999999999999999999988877764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=262.30 Aligned_cols=185 Identities=29% Similarity=0.485 Sum_probs=139.4
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
-.++|++++.||+|+||+||+|++.. ++.||+|++...... ......+.+| ..+.....||+++...+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E----~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAED-EGIPSTAIRE----ISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC-------CHHHHHHHH----HHHHHHCCCTTBCCEEEEECCSS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEeccccc-chhhHHHHHH----HHHHHHcCCCCEeeeeeEEccCC
Confidence 35889999999999999999999864 788999998643211 1111111111 11112223443332211
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS- 210 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~- 210 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 12378999999999999999999999999999999999999999999999999976542
Q ss_pred -CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 -LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.+|
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 232 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 23344578999999999876 56899999999999999999999999988887776665
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=263.81 Aligned_cols=185 Identities=26% Similarity=0.438 Sum_probs=129.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|++++.||+|+||.||+|.+..+++.||+|+++..... .....+.+| +.......||+++...+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E----~~~l~~l~hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIRE----ISLMKELKHENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHH----HHHHTTCCBTTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHH----HHHHHhcCCCCcceEEEEEEECCe
Confidence 46899999999999999999999999999999998543210 000111111 122222234443322211
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 2378889999999999999999999999999999999999999999999999976
Q ss_pred CCC--CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 208 APS--LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 208 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|+
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 222 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 542 22334578999999999976 468999999999999999999999999999888777663
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=267.73 Aligned_cols=184 Identities=28% Similarity=0.446 Sum_probs=128.8
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+| +.+.....||+++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E----~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRE----LRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHH----HHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHH----HHHHHhCCCCCCCcEEEEEecCCcc
Confidence 7899999999999999999999999999999998542110 0000011111 0111111222222111
Q ss_pred ---------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 151 ---------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 ---------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
....+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 104 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GGCCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred ccCCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 11347899999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+.+|+
T Consensus 184 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 243 (367)
T 2fst_X 184 DE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 33 334578999999999877 678999999999999999999999999999888777664
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=267.85 Aligned_cols=188 Identities=18% Similarity=0.238 Sum_probs=135.5
Q ss_pred CCcccccccCeEEecccccCCceEEEEE-----EEcCCCeEEEEEEcchhHHHHH----Hhhhhhh----ceeeeEEecC
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLA-----KEKTTQIMIALKVLYKVEIINE----RMTHQVH----RERCCQVHLS 138 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~----~~~~~~~~~~ 138 (271)
...+.+..++|.+.+.||+|+||+||+| .+..+++.||||++........ .....+. ..........
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3455566788999999999999999999 4667788999999865322111 0111111 0000000110
Q ss_pred cCCCcceeeecc----------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---------
Q psy4396 139 SSRRHPLLSSEE----------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM--------- 193 (271)
Q Consensus 139 ~~~~~~~l~~~~----------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~--------- 193 (271)
....+.+++... ....+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 111122222211 1234889999999999999999999999999999999999998
Q ss_pred --CCCEEEeeccccccCC----CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 194 --HEDVKISDFGWSVHAP----SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 194 --~~~~kl~Dfg~a~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
++.+||+|||+|+... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999996432 22334567999999999999999999999999999999999999998543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=262.48 Aligned_cols=183 Identities=23% Similarity=0.397 Sum_probs=145.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++......... +.+| +.......||+++...+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~----~~~E----~~~l~~l~hpnIv~~~~~~~~~~~ 75 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKE----ISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHH----HHHH----HHHHHHSCCTTBCCEEEEEEETTE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHH----HHHH----HHHHHhCCCCCCCeEeEEEecCCE
Confidence 47899999999999999999999999999999998643221111 1111 11111223443322211
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC--CCCEEEeeccccccCC
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM--HEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~--~~~~kl~Dfg~a~~~~ 209 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 124789999999999999999999999999999999999987 7899999999997654
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+++..|.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 216 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 33 3344668999999999998889999999999999999999999999999888877664
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.65 Aligned_cols=190 Identities=24% Similarity=0.396 Sum_probs=143.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh------hhhhhce-------eeeEEecCcCCCcce
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM------THQVHRE-------RCCQVHLSSSRRHPL 145 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~------~~~~~~~-------~~~~~~~~~~~~~~~ 145 (271)
..+|++++.||+|+||+||+|.+..+++.||||++.......... ...+... ............+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 467999999999999999999999999999999986543211111 1111000 000000000011111
Q ss_pred eeecc------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC--EEEeeccccccCCCC
Q psy4396 146 LSSEE------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED--VKISDFGWSVHAPSL 211 (271)
Q Consensus 146 l~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~--~kl~Dfg~a~~~~~~ 211 (271)
++... ....+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 176 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~ 255 (429)
T 3kvw_A 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255 (429)
T ss_dssp EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred EEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence 11111 1123789999999999999999999999999999999999999887 999999999765433
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..|+
T Consensus 256 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 256 -VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp -CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 334678999999999999999999999999999999999999999999888877654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=266.51 Aligned_cols=186 Identities=23% Similarity=0.329 Sum_probs=136.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+| ..+.....||+++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E----~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRE----LVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHH----HHHHHHCCCTTBCCEEEEECSCCS
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHH----HHHHHhcCCCCccceEEeeccccc
Confidence 57899999999999999999999999999999998642110 0001111111 11111123333322111
Q ss_pred --------------c--------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 152 --------------Y--------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 --------------~--------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp TTTCCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cccccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 0 236889999999999999999999999999999999999999999999999997654
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+|+
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 239 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 33 2344678999999999999999999999999999999999999999999888777664
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=264.82 Aligned_cols=185 Identities=29% Similarity=0.520 Sum_probs=140.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH--hhhhhhceeeeEEecCcCCCcceeeeccC-----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER--MTHQVHRERCCQVHLSSSRRHPLLSSEEG----- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----- 151 (271)
.++|++.+.||+|+||+||+|.+..+++.||||++......... ....+.+| +.+.....||+++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE----ASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHH----HHHHHHCCCTTBCCEEEEEEET
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHH----HHHHHhCCCCCCCcEEEEEEeC
Confidence 36799999999999999999999999999999998654322110 01112222 11222224444433221
Q ss_pred ------------c-------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---EEEeecc
Q psy4396 152 ------------Y-------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFG 203 (271)
Q Consensus 152 ------------~-------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~---~kl~Dfg 203 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 1 12688999999999999999999999999999999999987655 9999999
Q ss_pred ccccCCCCC--cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 204 WSVHAPSLH--RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 204 ~a~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. .+++..|
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i 244 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGI 244 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHH
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHH
Confidence 997655432 344679999999999999999999999999999999999999998753 4444433
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=268.04 Aligned_cols=192 Identities=24% Similarity=0.393 Sum_probs=150.1
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
+...|.+..++|.+.+.||+|+||.||+|++..+++.||||+++.... ......+.+| ...+....||+++...
T Consensus 105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E----~~~l~~l~hpniv~~~ 178 (377)
T 3cbl_A 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQE----ARILKQYSHPNIVRLI 178 (377)
T ss_dssp CCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC--HHHHTTTTHH----HHHHTTCCCTTBCCEE
T ss_pred cccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC--HHHHHHHHHH----HHHHHhCCCCCEEEEE
Confidence 445677788999999999999999999999998899999999864311 1111122222 2233333455544332
Q ss_pred Cc---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 151 GY---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 151 ~~---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
+. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||
T Consensus 179 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred EEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCC
Confidence 21 237888999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcc----cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 204 WSVHAPSLHRK----TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 204 ~a~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+++........ ...+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..++.+.+
T Consensus 259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~ 328 (377)
T 3cbl_A 259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328 (377)
T ss_dssp GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH
T ss_pred CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99765432211 2235778999999998889999999999999999998 99999998887776544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=263.08 Aligned_cols=186 Identities=30% Similarity=0.519 Sum_probs=143.4
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH---hhhhhhceeeeEEecCcCCCcceeeecc-----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---MTHQVHRERCCQVHLSSSRRHPLLSSEE----- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~~----- 150 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++......... ....+.+| +.......||+++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHH----HHHHHHCCCTTBCCEEEEEEC
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHH----HHHHHhCCCCCCCcEEEEEEe
Confidence 36799999999999999999999999999999998643211000 00011111 1111112233322211
Q ss_pred ---------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC----CEEEeecccc
Q psy4396 151 ---------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE----DVKISDFGWS 205 (271)
Q Consensus 151 ---------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~----~~kl~Dfg~a 205 (271)
....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 113478999999999999999999999999999999999998887 7999999999
Q ss_pred ccCCC-CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 206 VHAPS-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 206 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
..... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+.+..+
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 76543 2334567999999999999999999999999999999999999999998888776654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=271.23 Aligned_cols=189 Identities=16% Similarity=0.183 Sum_probs=134.0
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc------
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------ 150 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------ 150 (271)
...++|++.+.||+|+||+||+|++..+++.||||++.............+.+|... ........||+++...
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR-LRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHG-GGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHH-HHhccccCCHHHHHHHhhhhhh
Confidence 345789999999999999999999998899999999863211111111111122100 0222222344432211
Q ss_pred ----------------------------------Cc---------ccCC-------HHHHHHHHHHHHHHHHHHHHCCce
Q psy4396 151 ----------------------------------GY---------SLYT-------EKDAAKYIYQVADAIHYCHQKKVI 180 (271)
Q Consensus 151 ----------------------------------~~---------~~~~-------~~~~~~~~~qi~~~L~~LH~~~ii 180 (271)
+. ..++ +..+..++.|++.||+|||++||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 11 1123 367778999999999999999999
Q ss_pred eccCCCCceEeCCCCCEEEeeccccccCCCCCcccccccccccCcceeccC-----------CCCCchhHHHHHHHHHHH
Q psy4396 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQ-----------HYGKEVDNWCIGILAYEF 249 (271)
Q Consensus 181 HrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~el 249 (271)
||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||++|||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999999986544 3344567 999999999887 899999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHhh
Q psy4396 250 LVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 250 ~~g~~pf~~~~~~~~~~~I 268 (271)
++|+.||.+.+..+....+
T Consensus 307 ltg~~Pf~~~~~~~~~~~~ 325 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWI 325 (377)
T ss_dssp HHSSCCC------CCSGGG
T ss_pred HHCCCCCcccccccchhhh
Confidence 9999999877665544443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=263.27 Aligned_cols=183 Identities=23% Similarity=0.334 Sum_probs=134.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH----HH-Hhhhhh-hceee-eEEecCcCCCcceeeecc-
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII----NE-RMTHQV-HRERC-CQVHLSSSRRHPLLSSEE- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~-~~~~~~-~~~~~-~~~~~~~~~~~~~l~~~~- 150 (271)
-++|++.+.||+|+||.||+|++..+++.||||++...... .+ .....+ ..... ..........+.+++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 36899999999999999999999999999999998543210 00 111111 00000 000000001111111111
Q ss_pred C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-----EEEeeccccccCCCCC---
Q psy4396 151 G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED-----VKISDFGWSVHAPSLH--- 212 (271)
Q Consensus 151 ~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~-----~kl~Dfg~a~~~~~~~--- 212 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~ 167 (330)
T 2izr_A 88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK 167 (330)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCC
T ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCc
Confidence 1 135789999999999999999999999999999999999998887 9999999997543221
Q ss_pred ------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 213 ------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 213 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.....||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+.
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 168 HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 2356799999999999999999999999999999999999999987543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.84 Aligned_cols=190 Identities=24% Similarity=0.429 Sum_probs=135.3
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE- 150 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~- 150 (271)
...+.+..++|++.+.||+|+||+||+|++. ++.||||++......... ...+.+| +.......||+++...
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~-~~~~~~E----~~~l~~l~hp~iv~~~~ 101 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAER-VNEFLRE----VAIMKRLRHPNIVLFMG 101 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHH-HHHHHHH----HHHHHHCCCTTBCCEEE
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHH-HHHHHHH----HHHHHhCCCCCEeeEEE
Confidence 4455667789999999999999999999874 667999998543211110 1111111 1111112333332221
Q ss_pred ----------------Cc------------ccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCCEEEe
Q psy4396 151 ----------------GY------------SLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTMHEDVKIS 200 (271)
Q Consensus 151 ----------------~~------------~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~~~~~kl~ 200 (271)
+. ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp EECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred EEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 11 12788899999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCC--CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 201 DFGWSVHAPSL--HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 201 Dfg~a~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
|||+++..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 182 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp CCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred CCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99998654432 234467899999999999999999999999999999999999999998888776654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=263.72 Aligned_cols=183 Identities=27% Similarity=0.428 Sum_probs=141.5
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
+.|++++.||+|+||+||+|++..+++.||||++.............+.+| +.......||+++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE----VRFLQKLRHPNTIQYRGCYLREHTA 129 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHH----HHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHH----HHHHHhCCCCCEeeEEEEEEECCeE
Confidence 569999999999999999999999999999999854221111111112222 112222234443332211
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 130 ~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 130 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 33788999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 214 KTMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+.+..+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 265 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 265 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 3467899999999984 567899999999999999999999999988877665443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=272.76 Aligned_cols=176 Identities=26% Similarity=0.410 Sum_probs=120.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|++++.||+|+||+||+|++..+++.||||++.+.... ......+.+| +.++....||+++.+.+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E----~~~l~~l~h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKRILRE----IAILNRLNHDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-HHHHHHHHHH----HHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-HHHHHHHHHH----HHHHHhCCCCCCCceEEEEecCCcc
Confidence 7899999999999999999999999999999998542110 0011111111 11111113333322211
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 152 ----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 ----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+...
T Consensus 128 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 128 KFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp TCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred cCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 1337899999999999999999999999999999999999999999999999997643
Q ss_pred CC-----------------------------CcccccccccccCccee-ccCCCCCchhHHHHHHHHHHHHh--------
Q psy4396 210 SL-----------------------------HRKTMCGTLDYLPPEMV-TSQHYGKEVDNWCIGILAYEFLV-------- 251 (271)
Q Consensus 210 ~~-----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~-------- 251 (271)
.. .....+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 21 12335689999999976 56679999999999999999998
Q ss_pred ---CCCCCCCCC
Q psy4396 252 ---GKPPFESKD 260 (271)
Q Consensus 252 ---g~~pf~~~~ 260 (271)
|++||.+.+
T Consensus 288 ~~~~~p~f~g~~ 299 (458)
T 3rp9_A 288 HADRGPLFPGSS 299 (458)
T ss_dssp GGGCCCSCC---
T ss_pred cccccccCCCCc
Confidence 788887755
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=253.79 Aligned_cols=186 Identities=32% Similarity=0.631 Sum_probs=121.9
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
.+++|++.+.||+|+||.||+|++..+++.||+|++.............+.+| ........||++....+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE----VKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHTTBCCTTBCCEEEEEECSS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHH----HHHHHhCCCCCeEeEEEEEccCC
Confidence 35789999999999999999999999999999999975443222111222222 11222223443322211
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 ---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 ---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 13478999999999999999999999999999999999999999999999999876542
Q ss_pred --CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 211 --LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
.......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+.+.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 223 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK 223 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH
Confidence 222345689999999999998899999999999999999999999987766555443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=259.99 Aligned_cols=179 Identities=20% Similarity=0.287 Sum_probs=130.6
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee-------
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS------- 148 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~------- 148 (271)
.+..++|++.+.||+|+||+||+|++..+++.||||++...............+. ..+.....||+++.
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~----~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV----GSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHH----HHHHHHCCCTTBCCEEEEEEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHH----HHHHHhcCCCcEEEEEEEEEe
Confidence 3344789999999999999999999999999999998743211100000000000 00000012222221
Q ss_pred --------ccC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 149 --------EEG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 149 --------~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 129 ~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 129 GGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp TTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred CCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 111 1237899999999999999999999999999999999999999999999999987654
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+.
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 209 TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred cCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 33 2334568999999999876 6899999999999999999997666543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=264.03 Aligned_cols=190 Identities=23% Similarity=0.416 Sum_probs=142.6
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcC-------CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCC-Ccc
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKT-------TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR-RHP 144 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 144 (271)
..+.+..++|++++.||+|+||.||+|++.. ++..||||+++...... ....+.+| ....... .||
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E----~~~l~~l~~hp 147 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSE----MEMMKMIGKHK 147 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHH--HHHHHHHH----HHHHHHSCCCT
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHH--HHHHHHHH----HHHHHHhcCCC
Confidence 4456677899999999999999999999753 45679999986432110 00111111 0111111 233
Q ss_pred eeeecc-----------------Cc-------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy4396 145 LLSSEE-----------------GY-------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHR 182 (271)
Q Consensus 145 ~l~~~~-----------------~~-------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHr 182 (271)
+++... +. ..+++..+..++.|++.||+|||++||+||
T Consensus 148 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 227 (370)
T 2psq_A 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227 (370)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 222211 10 125788899999999999999999999999
Q ss_pred cCCCCceEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy4396 183 DIKPENLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFE 257 (271)
Q Consensus 183 Dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~ 257 (271)
||||+|||++.++.+||+|||+++..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999754432 2233456889999999999999999999999999999999 999999
Q ss_pred CCCHHHHHHhh
Q psy4396 258 SKDQDTTLERI 268 (271)
Q Consensus 258 ~~~~~~~~~~I 268 (271)
+.+..+++..+
T Consensus 308 ~~~~~~~~~~~ 318 (370)
T 2psq_A 308 GIPVEELFKLL 318 (370)
T ss_dssp TCCGGGHHHHH
T ss_pred CCCHHHHHHHH
Confidence 98888776654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=267.92 Aligned_cols=181 Identities=26% Similarity=0.402 Sum_probs=140.2
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
...+|++.+.||+|+||.||+|++..+++.||||++........ +| +.++....||+++.+.
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~E----~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RE----LQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCC-------HH----HHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHH-------HH----HHHHHHcCCCCccceeeEEeccC
Confidence 34579999999999999999999999999999999854321100 00 1111112233322210
Q ss_pred ----------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCEEEee
Q psy4396 151 ----------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-EDVKISD 201 (271)
Q Consensus 151 ----------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-~~~kl~D 201 (271)
....+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus 121 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp TTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEecc
Confidence 11347888899999999999999999999999999999999965 5689999
Q ss_pred ccccccCCC-CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 202 FGWSVHAPS-LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 202 fg~a~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+++.... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+.+|+
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~ 270 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999976433 233446789999999998764 78999999999999999999999999998877776654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=262.61 Aligned_cols=184 Identities=27% Similarity=0.457 Sum_probs=142.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|++++.||+|+||.||+|.+..+++.||||++....... ....+.+| +.......||+++...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E----~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT--YCQRTLRE----IKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHH--HHHHHHHH----HHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcH--HHHHHHHH----HHHHHhcCCCCCccceeEEecCCcc
Confidence 68999999999999999999999999999999986422111 01111111 11111123333322211
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 ---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 ---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ccceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 12378999999999999999999999999999999999999999999999999976543
Q ss_pred CC-----cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 LH-----RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.+|+
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 22 234578999999998754 558999999999999999999999999998888777654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=255.36 Aligned_cols=176 Identities=24% Similarity=0.389 Sum_probs=138.1
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
+..++|.+.+.||+|+||+||+|.+..+++.||+|++...... ....+.+| +.......||+++...+.
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E----~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKE----VKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHH---HHHHHHHH----HHHHTTCCCTTBCCEEEEEEET
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHH---HHHHHHHH----HHHHHhCCCcCcccEEEEEecC
Confidence 4568999999999999999999999999999999987442111 11112222 122223345544332211
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 337889999999999999999999999999999999999999999999999986543
Q ss_pred CCCc----------------ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 210 SLHR----------------KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 210 ~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.... ....||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 3211 1456899999999999999999999999999999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=263.27 Aligned_cols=183 Identities=28% Similarity=0.461 Sum_probs=144.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ ..+.+| +.++....||+++...+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~E----~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNE----ISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH---HHHHHH----HHHHTTCCSTTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhH---HHHHHH----HHHHHhCCCcCCCeEEEEEEeCCE
Confidence 4789999999999999999999999999999999864321111 011111 11222223444332211
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC--CCCEEEeeccccccCC
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM--HEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~--~~~~kl~Dfg~a~~~~ 209 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 124789999999999999999999999999999999999974 4679999999997655
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i 262 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 43 334457999999999999999999999999999999999999999998887776655
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=263.04 Aligned_cols=182 Identities=27% Similarity=0.400 Sum_probs=140.2
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee--------
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS-------- 148 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-------- 148 (271)
...++|++++.||+|+||+||+|.+..+++.||||++........+ | +.+.....||+++.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~-------E----~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-------E----LDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCH-------H----HHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHH-------H----HHHHHHcCCCCccchhheeeec
Confidence 3457899999999999999999999999999999988543211000 0 01111112222211
Q ss_pred ---------------------------------------------cc--------------CcccCCHHHHHHHHHHHHH
Q psy4396 149 ---------------------------------------------EE--------------GYSLYTEKDAAKYIYQVAD 169 (271)
Q Consensus 149 ---------------------------------------------~~--------------~~~~~~~~~~~~~~~qi~~ 169 (271)
.. ....+++..++.++.|++.
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp -------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 11 1134788999999999999
Q ss_pred HHHHHHHCCceeccCCCCceEeC-CCCCEEEeeccccccCCC-CCcccccccccccCcceeccC-CCCCchhHHHHHHHH
Q psy4396 170 AIHYCHQKKVIHRDIKPENLLLT-MHEDVKISDFGWSVHAPS-LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILA 246 (271)
Q Consensus 170 ~L~~LH~~~iiHrDikp~Nili~-~~~~~kl~Dfg~a~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il 246 (271)
||+|||++||+||||||+|||++ .++.+||+|||+|+.... .......+|+.|+|||++.+. .++.++|||||||++
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999999997 678999999999975433 334456789999999998765 489999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 247 YEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 247 ~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
|||++|+.||.+.+..+.+.+|+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~ 255 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRII 255 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHH
T ss_pred HHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999999999888877664
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=262.30 Aligned_cols=186 Identities=28% Similarity=0.390 Sum_probs=138.1
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhce------eeeEEecCc--
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRE------RCCQVHLSS-- 139 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~------~~~~~~~~~-- 139 (271)
....-.++|++.+.||+|+||+||+|++..+++.||||++......... ....+... ....+.+..
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3344458899999999999999999999999999999998653221111 11111100 000000000
Q ss_pred -----CCCcceeeecc------------CcccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCC------
Q psy4396 140 -----SRRHPLLSSEE------------GYSLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHE------ 195 (271)
Q Consensus 140 -----~~~~~~l~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~------ 195 (271)
...+..++... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 111 KISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred eecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 01111222111 113478999999999999999999998 999999999999998775
Q ss_pred -------------------------------------------CEEEeeccccccCCCCCcccccccccccCcceeccCC
Q psy4396 196 -------------------------------------------DVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQH 232 (271)
Q Consensus 196 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~ 232 (271)
.+||+|||++...... .....||+.|+|||++.+..
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTSC
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhcCCC
Confidence 7999999999765433 33457899999999999999
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 233 YGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 233 ~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
++.++|||||||++|||++|+.||.+.+
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999998765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=261.62 Aligned_cols=191 Identities=24% Similarity=0.419 Sum_probs=140.8
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--------HH-HhhhhhhceeeeE-EecCcC-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--------NE-RMTHQVHRERCCQ-VHLSSS------- 140 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~-~~~~~~~~~~~~~-~~~~~~------- 140 (271)
..++|++++.||+|+||.||+|++..+++.||+|++...... .+ .....+....... ......
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 468999999999999999999999999999999987432110 00 0111111100000 000000
Q ss_pred -CCcceeeeccC-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 141 -RRHPLLSSEEG-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 141 -~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..+.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 01111211111 134789999999999999999999999999999999999999999999999998654
Q ss_pred CC------CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 209 PS------LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....|
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 241 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 31 22234568999999999876 45899999999999999999999999999888776655
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=256.44 Aligned_cols=182 Identities=30% Similarity=0.475 Sum_probs=142.4
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
..|...+.||+|+||.||+|++..+++.||||++....... ...+.+| +.......||+++...+
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E----~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNE----VVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHH----HHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHH----HHHHHhCCCCCcceEEEEEEECCEE
Confidence 34777889999999999999999899999999986432110 0111111 12222223444332211
Q ss_pred -----------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--C
Q psy4396 152 -----------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--H 212 (271)
Q Consensus 152 -----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~ 212 (271)
...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...... .
T Consensus 118 ~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 124789999999999999999999999999999999999999999999999998765432 3
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.....||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+...++
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~ 253 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 34567999999999999999999999999999999999999999988887766554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=250.88 Aligned_cols=185 Identities=34% Similarity=0.620 Sum_probs=143.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++......... ...+.+| ........||++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLERE----ARICRKLQHPNIVRLHDSIQEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHH-HHHHHHH----HHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHH-HHHHHHH----HHHHHHcCCCCcCeEEEEEEcCCE
Confidence 37899999999999999999999999999999998654321111 1111111 1111111233322211
Q ss_pred ---------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---EEEeeccccccCC
Q psy4396 151 ---------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHAP 209 (271)
Q Consensus 151 ---------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~---~kl~Dfg~a~~~~ 209 (271)
+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 11 23789999999999999999999999999999999999986655 9999999996655
Q ss_pred CCC-cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SLH-RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
... .....||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 219 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH
Confidence 432 23467899999999999999999999999999999999999999998888776654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=260.80 Aligned_cols=184 Identities=29% Similarity=0.432 Sum_probs=139.4
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|.+.+.||+|+||.||+|.+..+++.||||++....... .....+.+| ........||+++...+
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E----~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE-IFAKRAYRE----LLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH-HHHHHHHHH----HHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch-hHHHHHHHH----HHHHHhcCCCCchhhhhheeccCCc
Confidence 68999999999999999999999999999999986421110 001111111 11111112333222111
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 ---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 ---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 117 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 117 RNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp TTCCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred ccceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 12378999999999999999999999999999999999999999999999999976543
Q ss_pred CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. .....||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+.+|+
T Consensus 197 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 255 (371)
T 4exu_A 197 E-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 255 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred C-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 3 334578999999999877 778999999999999999999999999998888777654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=273.52 Aligned_cols=187 Identities=34% Similarity=0.570 Sum_probs=145.8
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG----- 151 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----- 151 (271)
.-.++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+| +.......||+++...+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E----~~~l~~l~hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE----VQLLKQLDHPNIMKLYEFFEDK 98 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHH----HHHHTTCCCTTBCCEEEEEECS
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHH----HHHHHhCCCCCCCcEEEEEEeC
Confidence 345789999999999999999999999999999999854322111111112222 22222334554433221
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe---CCCCCEEEeecccccc
Q psy4396 152 ---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL---TMHEDVKISDFGWSVH 207 (271)
Q Consensus 152 ---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili---~~~~~~kl~Dfg~a~~ 207 (271)
...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 1347899999999999999999999999999999999999 5678999999999976
Q ss_pred CCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 208 APSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 208 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+++.+|
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 239 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 5433 3345679999999999876 6899999999999999999999999999988887765
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=266.30 Aligned_cols=180 Identities=16% Similarity=0.218 Sum_probs=130.2
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcc-------------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP------------- 144 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 144 (271)
...+|.+.+.||+|+||+||+|++..+++.||||++.............+.+|.... ..... .||
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~-~~l~~-~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA-ARLLG-ESPEEARDRRRLLLPS 137 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHH-HHHHC-----------CBCCCC
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHH-HHhcc-cChhhhhhceeEEeee
Confidence 345699999999999999999999999999999998763221111111111110000 00000 122
Q ss_pred --------------------------eeeeccCc-----------ccCCHHHH------HHHHHHHHHHHHHHHHCCcee
Q psy4396 145 --------------------------LLSSEEGY-----------SLYTEKDA------AKYIYQVADAIHYCHQKKVIH 181 (271)
Q Consensus 145 --------------------------~l~~~~~~-----------~~~~~~~~------~~~~~qi~~~L~~LH~~~iiH 181 (271)
+++..... ..+++..+ ..++.|++.||+|||++||+|
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 22211111 11233334 566799999999999999999
Q ss_pred ccCCCCceEeCCCCCEEEeeccccccCCCCCcccccccccccCcceecc--CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 182 RDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTS--QHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 182 rDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
|||||+|||++.++.+||+|||+|+....... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999999987654332 4456799999999987 77999999999999999999999999876
Q ss_pred C
Q psy4396 260 D 260 (271)
Q Consensus 260 ~ 260 (271)
.
T Consensus 297 ~ 297 (371)
T 3q60_A 297 T 297 (371)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=258.22 Aligned_cols=189 Identities=28% Similarity=0.444 Sum_probs=138.9
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc---
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY--- 152 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--- 152 (271)
....++|++++.||+|+||+||+|.+..+++.||||++....... .....+.+| +.......||+++...+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~ 104 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIRE----VSLLKELQHRNIIELKSVIHH 104 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHH----HHHGGGCCCTTBCCEEEEEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHH----HHHHHHcCCCCcceEEEEEec
Confidence 345689999999999999999999999999999999986432211 111111111 222333345554432221
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC-----CCCCEEEeecccc
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT-----MHEDVKISDFGWS 205 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~-----~~~~~kl~Dfg~a 205 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 105 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 105 NHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp TTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 2378999999999999999999999999999999999994 4455999999999
Q ss_pred ccCCC--CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 206 VHAPS--LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 206 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+.... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.+++
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 251 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHH
Confidence 65432 233445689999999999774 48999999999999999999999999998888776653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=251.96 Aligned_cols=187 Identities=32% Similarity=0.553 Sum_probs=145.9
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+| ........||+++...+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQHVVGFHGFFEDND 88 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHH----HHHHHTCCCTTBCCEEEEEECSS
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHH----HHHHHhCCCCCEeeeeeeeccCC
Confidence 35789999999999999999999999999999999865432211111122222 111222234443332211
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP-- 209 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~-- 209 (271)
..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 237899999999999999999999999999999999999999999999999987643
Q ss_pred CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
........||+.|+|||++.+..++.++|+||||+++|+|++|+.||......+.+.++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 227 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 227 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22334456899999999999999999999999999999999999999988877766554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=261.32 Aligned_cols=188 Identities=28% Similarity=0.425 Sum_probs=138.8
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH--HhhhhhhceeeeEEecCcCCCcceeeeccC----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE--RMTHQVHRERCCQVHLSSSRRHPLLSSEEG---- 151 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---- 151 (271)
..++|++++.||+|+||.||+|++..+++.||||++........ .....+.+| +.......||+++...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE----IKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHH----HHHHHHCCCTTBCCEEEEECC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHH----HHHHhhCCCCCCCeEEEEEee
Confidence 35789999999999999999999999999999999864322110 001111111 11112223443332211
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 152 ----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 ----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 1237888999999999999999999999999999999999999999999999997654
Q ss_pred C--CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 S--LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. .......+|+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+.+|+
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~ 226 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 3 233446789999999998654 58999999999999999999999999999888877664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=254.37 Aligned_cols=185 Identities=29% Similarity=0.476 Sum_probs=136.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
+++|++++.||+|+||+||+|++..+++.||+|++....... .....+.+| ........||+++...+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E----~~~l~~l~h~~i~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP-VIKKIALRE----IRMLKQLKHPNLVNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H-HHHHHHHHH----HHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch-HHHHHHHHH----HHHHHhCCCCCccchhheeecCCe
Confidence 478999999999999999999999999999999874432111 001111111 11111123333322211
Q ss_pred -------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 152 -------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 152 -------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 133789999999999999999999999999999999999999999999999999765432
Q ss_pred -CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 212 -HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
......+|+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 215 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2334578999999999876 66899999999999999999999999998887766544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=261.87 Aligned_cols=183 Identities=19% Similarity=0.283 Sum_probs=133.2
Q ss_pred cccCeEEecccccCCceEEEEEEEcCC-----CeEEEEEEcchhHHHHHH---hhhhhhce-eeeEEecCcCCCcceeee
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTT-----QIMIALKVLYKVEIINER---MTHQVHRE-RCCQVHLSSSRRHPLLSS 148 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~l~~ 148 (271)
..++|++.+.||+|+||.||+|.+..+ ++.||||++......... .......+ ............||+++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999999998765 578999997643211100 00000000 000001111223333221
Q ss_pred cc------------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC--CCCC
Q psy4396 149 EE------------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT--MHED 196 (271)
Q Consensus 149 ~~------------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~--~~~~ 196 (271)
.. ....+++..+..++.|++.||+|||++||+||||||+|||++ .++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 11 113479999999999999999999999999999999999998 8899
Q ss_pred EEEeeccccccCCCC---------CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 197 VKISDFGWSVHAPSL---------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 197 ~kl~Dfg~a~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 999999999654321 1133459999999999999999999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=256.99 Aligned_cols=187 Identities=32% Similarity=0.553 Sum_probs=145.6
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
..++|.+.+.||+|+||.||++.+..+++.||+|++.............+.+| ........||+++...+.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME----ISIHRSLAHQHVVGFHGFFEDND 114 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHH----HHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHH----HHHHHhCCCCCCCeEEEEEecCC
Confidence 35689999999999999999999999999999999865432111111112222 111222234443322111
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC--
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP-- 209 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~-- 209 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 237899999999999999999999999999999999999999999999999997653
Q ss_pred CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
........||+.|+|||++.+..++.++|+||||+++|+|++|+.||......+.+.++
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 253 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 22334467899999999999999999999999999999999999999988877765544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=269.69 Aligned_cols=189 Identities=16% Similarity=0.170 Sum_probs=134.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeee------------------------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCC------------------------ 133 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~------------------------ 133 (271)
...+|...+.||+|+||+||+|++..+++.||||++.............+.+|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568899999999999999999999999999999862111110000000000000
Q ss_pred EEecCcCC-------------Ccce-eeec-----------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy4396 134 QVHLSSSR-------------RHPL-LSSE-----------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHR 182 (271)
Q Consensus 134 ~~~~~~~~-------------~~~~-l~~~-----------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHr 182 (271)
...+.... ...+ +... .....+++..+..++.|++.||+|||++||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 00000000 0000 0000 001235667888889999999999999999999
Q ss_pred cCCCCceEeCCCCCEEEeeccccccCCCCCcccccccccccCccee----------ccCCCCCchhHHHHHHHHHHHHhC
Q psy4396 183 DIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMV----------TSQHYGKEVDNWCIGILAYEFLVG 252 (271)
Q Consensus 183 Dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~il~el~~g 252 (271)
||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|||++|
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999999999999998765543 344567 999999999 555688899999999999999999
Q ss_pred CCCCCCCCHHHHHHhh
Q psy4396 253 KPPFESKDQDTTLERI 268 (271)
Q Consensus 253 ~~pf~~~~~~~~~~~I 268 (271)
+.||...+..+....+
T Consensus 314 ~~Pf~~~~~~~~~~~~ 329 (413)
T 3dzo_A 314 DLPNTDDAALGGSEWI 329 (413)
T ss_dssp SCCCCTTGGGSCSGGG
T ss_pred CCCCCCcchhhhHHHH
Confidence 9999887766655544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=266.01 Aligned_cols=169 Identities=26% Similarity=0.396 Sum_probs=125.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee----------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS---------- 148 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---------- 148 (271)
.++|++++.||+|+||.||+|++..+++.||||++...... ......+.+| +.+.....||+++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E----~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKRILRE----ITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-HHHHHHHHHH----HHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-hHHHHHHHHH----HHHHHHcCCCCcceEEEEEecCCC
Confidence 37899999999999999999999999999999998642110 0000111111 11111112222221
Q ss_pred ----------cc----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 149 ----------EE----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 149 ----------~~----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 100 LKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 11 1133799999999999999999999999999999999999999999999999999765
Q ss_pred CCC------------------------CcccccccccccCccee-ccCCCCCchhHHHHHHHHHHHHhC
Q psy4396 209 PSL------------------------HRKTMCGTLDYLPPEMV-TSQHYGKEVDNWCIGILAYEFLVG 252 (271)
Q Consensus 209 ~~~------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g 252 (271)
... .....+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 432 12456789999999986 566799999999999999999983
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=263.16 Aligned_cols=178 Identities=31% Similarity=0.568 Sum_probs=126.9
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----- 150 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----- 150 (271)
....++|++++.||+|+||+||+|++..+++.||||++.......... .+| +.......||+++...
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~E----~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV----QRE----IINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHH----HHH----HHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHH----HHH----HHHHHhCCCCCCCcEEEEEee
Confidence 344688999999999999999999999999999999986532211111 111 0111111333332221
Q ss_pred ------------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC--EEEeecccccc
Q psy4396 151 ------------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED--VKISDFGWSVH 207 (271)
Q Consensus 151 ------------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~--~kl~Dfg~a~~ 207 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 1 133789999999999999999999999999999999999987765 99999999864
Q ss_pred CC-CCCcccccccccccCcceeccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 208 AP-SLHRKTMCGTLDYLPPEMVTSQHYGKE-VDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 208 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.. ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 33 223345679999999999988887655 8999999999999999999987554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=257.49 Aligned_cols=188 Identities=19% Similarity=0.314 Sum_probs=142.1
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCC---eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ---IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
..+..++|++.+.||+|+||.||+|.+..++ ..||||+++...... ....+.+| +.+.....||+++...+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E----~~~l~~l~h~~iv~~~~ 117 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSE----ASIMGQFDHPNIIRLEG 117 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH--HHHHHHHH----HHHHTTCCCTTBCCEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH--HHHHHHHH----HHHHHhCCCCCCCcEEE
Confidence 3456789999999999999999999998554 459999986431111 11111222 12222223444332211
Q ss_pred c---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 152 Y---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 152 ~---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 1 2478899999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
++...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++...+
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 267 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 97654321 122345778999999998899999999999999999999 99999999888877655
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=259.08 Aligned_cols=177 Identities=30% Similarity=0.538 Sum_probs=134.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec---------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE--------- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--------- 149 (271)
.++|++++.||+|+||+||+|.+..+++.||||++........ ...+.+| ..+.....||+++..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E----~~~l~~l~hpnIv~~~~~~~~~~~ 79 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKE----ICINKMLNHENVVKFYGHRREGNI 79 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHH----HHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccch--HHHHHHH----HHHHHhCCCCCCCeEEEEEecCCe
Confidence 4789999999999999999999999999999999854321110 0111111 111111123322221
Q ss_pred -----------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--
Q psy4396 150 -----------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-- 210 (271)
Q Consensus 150 -----------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-- 210 (271)
.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 1123478999999999999999999999999999999999999999999999999965321
Q ss_pred --CCcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 211 --LHRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 12234678999999999987775 7789999999999999999999986654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=250.98 Aligned_cols=179 Identities=24% Similarity=0.326 Sum_probs=126.6
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---- 150 (271)
+++..++|++.+.||+|+||+||+|++..+++.||+|++.......... ....++ ........||+++...
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~----~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-RLLMDL----DISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHH-HHHHHH----HHHHTTCCCTTBCCEEEEEE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHH-HHHHHH----HHHHHhCCCCeEEEEeeeee
Confidence 4566789999999999999999999999999999999986532211110 000000 0011112233222211
Q ss_pred -------------------------CcccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 151 -------------------------GYSLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 151 -------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
....+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||+
T Consensus 77 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 77 REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp CSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred ccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 113478999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCC-CcccccccccccCccee----ccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 205 SVHAPSL-HRKTMCGTLDYLPPEMV----TSQHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 205 a~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
+...... ......||+.|+|||++ .+..++.++|+||||+++|+|++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 8765433 23345789999999996 566789999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=258.45 Aligned_cols=186 Identities=18% Similarity=0.284 Sum_probs=138.1
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeE----EEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIM----IALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 152 (271)
+..++|++++.||+|+||+||+|.+..+++. ||+|.+...... .....+.++ ........||+++...+.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e----~~~l~~l~h~~iv~~~~~ 83 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDH----MLAIGSLDHAHIVRLLGL 83 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHH----HHHHHTCCCTTBCCEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHH----HHHHhcCCCCCcCeEEEE
Confidence 4567899999999999999999999888765 677765322100 000011111 111122234433322111
Q ss_pred --------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 153 --------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 153 --------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 84 CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp ECBSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EcCCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 247888999999999999999999999999999999999999999999999997
Q ss_pred cCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 207 HAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 207 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+....++...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 230 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence 654322 233457789999999999999999999999999999999 99999988877766544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=257.07 Aligned_cols=182 Identities=38% Similarity=0.581 Sum_probs=131.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
..++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+| +.......||+++...+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~E----~~~l~~l~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-----KIVRTE----IGVLLRLSHPNIIKLKEIFETPT 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhH-----HHHHHH----HHHHHhCCCCCCcceeeeEecCC
Confidence 357799999999999999999999999999999998653211 111111 22222223444332211
Q ss_pred --------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCEEEeeccccccC
Q psy4396 152 --------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM---HEDVKISDFGWSVHA 208 (271)
Q Consensus 152 --------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~---~~~~kl~Dfg~a~~~ 208 (271)
...+++..+..++.|++.||+|||+.||+||||||+|||++. ++.+||+|||+++..
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 123789999999999999999999999999999999999975 789999999998765
Q ss_pred CCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHhh
Q psy4396 209 PSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT-TLERI 268 (271)
Q Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~I 268 (271)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.+|
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i 263 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI 263 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH
T ss_pred CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH
Confidence 432 2344678999999999999999999999999999999999999998766554 44433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=252.33 Aligned_cols=184 Identities=23% Similarity=0.418 Sum_probs=132.8
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
...++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+| ........||+++...+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e----~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQRE----ARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHH----HHHHTTCCCTTBCCEEEEEEET
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHH----HHHHhhcCCCCeeEEEEEEeeC
Confidence 346899999999999999999999999999999999865432222222222222 122223344544332211
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 2378899999999999999999999999999999999999999999999999865543
Q ss_pred CC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 211 LH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 211 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
.. .....+|+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+....
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence 22 2345689999999999999999999999999999999999999987766543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=259.89 Aligned_cols=184 Identities=33% Similarity=0.527 Sum_probs=130.7
Q ss_pred cccCeEEe-cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhh--hh-hceee-eEEe----cCcCCCcceeee
Q psy4396 78 QMSDFEVG-CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH--QV-HRERC-CQVH----LSSSRRHPLLSS 148 (271)
Q Consensus 78 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~--~~-~~~~~-~~~~----~~~~~~~~~l~~ 148 (271)
..++|.+. +.||+|+||+||+|.+..+++.||||++........+... .. ..... .... ......+.+++.
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 35778887 7899999999999999999999999998643322211110 00 00000 0000 000011112221
Q ss_pred cc--C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCEEEeeccccccCCCC-
Q psy4396 149 EE--G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM---HEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 149 ~~--~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~---~~~~kl~Dfg~a~~~~~~- 211 (271)
.. + ...+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 139 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp ECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred EeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 11 1 124789999999999999999999999999999999999997 788999999999765532
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp --------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 33456789999999999999999999999999999999999999976553
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=261.35 Aligned_cols=188 Identities=25% Similarity=0.345 Sum_probs=139.6
Q ss_pred cccccCeEEecccccCCceEEEEEEE-----cCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKE-----KTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
.+..++|++++.||+|+||+||+|++ ..+++.||||++........ ...+.+| ..+.....||+++...
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E----~~~l~~l~hpnIv~~~ 140 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLME----ALIISKFNHQNIVRCI 140 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHH--HHHHHHH----HHHHHHCCCTTBCCEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhh--HHHHHHH----HHHHHhCCCCCCCeEE
Confidence 45568899999999999999999994 45678899999853211110 0011111 1111111333332211
Q ss_pred -----------------Cc----------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC--
Q psy4396 151 -----------------GY----------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-- 195 (271)
Q Consensus 151 -----------------~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-- 195 (271)
+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence 11 2377888999999999999999999999999999999999555
Q ss_pred -CEEEeeccccccC----CCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 196 -DVKISDFGWSVHA----PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 196 -~~kl~Dfg~a~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
.+||+|||+++.. .........+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..++++.+.
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 4999999998642 1223334567899999999999999999999999999999998 999999999888877653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=261.28 Aligned_cols=191 Identities=24% Similarity=0.313 Sum_probs=145.9
Q ss_pred CcccccccCeEEecccccC--CceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 73 KSYRWQMSDFEVGCPLGTG--KFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
..+....++|++++.||+| +||.||+|++..+++.||||++....... .....+.+| +.+.....||+++...
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E----~~~l~~l~h~niv~~~ 92 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGE----LHVSKLFNHPNIVPYR 92 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHH----HHHHHHCCCTTBCCEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHH----HHHHHhCCCCCCCcEe
Confidence 4445567899999999999 99999999999999999999986543211 111122222 1222222444443322
Q ss_pred Cc----------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeec
Q psy4396 151 GY----------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 151 ~~----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCG
T ss_pred EEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccc
Confidence 11 33789999999999999999999999999999999999999999999999
Q ss_pred cccccCCC---------CCcccccccccccCcceecc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 203 GWSVHAPS---------LHRKTMCGTLDYLPPEMVTS--QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 203 g~a~~~~~---------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
|.+..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 98753211 11223468999999999987 67899999999999999999999999987776665443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=269.16 Aligned_cols=186 Identities=36% Similarity=0.588 Sum_probs=142.5
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
-.++|++++.||+|+||+||+|++..+++.||||++.+...... ....+.+| +.+.....||+++...+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E----~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILRE----VELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHH----HHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHH----HHHHHhCCCCCcCeEEEEEEcCC
Confidence 35789999999999999999999999999999999865432111 01111122 112222244444332211
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC---CCCCEEEeeccccccC
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT---MHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~---~~~~~kl~Dfg~a~~~ 208 (271)
..+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 3378999999999999999999999999999999999995 4567999999999754
Q ss_pred CC-CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 209 PS-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+++.+|.
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 235 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 43 23345679999999999876 58999999999999999999999999999888877653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=257.05 Aligned_cols=184 Identities=19% Similarity=0.261 Sum_probs=139.8
Q ss_pred cccCCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee
Q psy4396 67 AREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL 146 (271)
Q Consensus 67 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 146 (271)
....+..++.+..++|++.+.||+|+||+||+|++. ++.||||++........... .| +.......||++
T Consensus 11 ~~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~----~E----~~~l~~l~hpni 80 (322)
T 3soc_A 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNE----YE----VYSLPGMKHENI 80 (322)
T ss_dssp ---CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHH----HH----HHTSTTCCCTTB
T ss_pred ccccCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHH----HH----HHHHhcCCCCCc
Confidence 334556777788899999999999999999999876 67899999865432211111 11 122233345544
Q ss_pred eeccCc-----------------------------ccCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCC
Q psy4396 147 SSEEGY-----------------------------SLYTEKDAAKYIYQVADAIHYCHQK----------KVIHRDIKPE 187 (271)
Q Consensus 147 ~~~~~~-----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~----------~iiHrDikp~ 187 (271)
+...+. ..+++..+..++.|++.||+|||+. ||+||||||+
T Consensus 81 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~ 160 (322)
T 3soc_A 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160 (322)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGG
T ss_pred hhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChH
Confidence 332211 2378899999999999999999999 9999999999
Q ss_pred ceEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccC-----CCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 188 NLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQ-----HYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 188 Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
|||++.++.+||+|||+++..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 161 Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp GEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred hEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999654322 22335789999999999763 456688999999999999999999976
Q ss_pred CC
Q psy4396 259 KD 260 (271)
Q Consensus 259 ~~ 260 (271)
..
T Consensus 241 ~~ 242 (322)
T 3soc_A 241 PV 242 (322)
T ss_dssp CC
T ss_pred Cc
Confidence 43
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=248.60 Aligned_cols=186 Identities=24% Similarity=0.412 Sum_probs=131.9
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH-HHhhhhhhceeeeEEecCcCCCcceeeeccC---
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-ERMTHQVHRERCCQVHLSSSRRHPLLSSEEG--- 151 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--- 151 (271)
++..++|++.+.||+|+||.||+|.+. ++.||||++....... ......+.++ ........||+++...+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQE----AKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHH----HHHHHHCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHH----HHHHHhcCCCCEeeEEEEEe
Confidence 456789999999999999999999976 6779999986532211 0111111111 11111123333322211
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEeCC--------CCCEE
Q psy4396 152 ----------------------YSLYTEKDAAKYIYQVADAIHYCHQKK---VIHRDIKPENLLLTM--------HEDVK 198 (271)
Q Consensus 152 ----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiHrDikp~Nili~~--------~~~~k 198 (271)
...+++..+..++.|++.||+|||++| ++||||||+|||++. ++.+|
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred cCCceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 134789999999999999999999999 899999999999986 67899
Q ss_pred EeeccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 199 ISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 199 l~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
|+|||++............||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+....
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 225 (271)
T 3dtc_A 157 ITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG 225 (271)
T ss_dssp ECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred EccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Confidence 999999977665555566799999999999999999999999999999999999999998887766544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=258.91 Aligned_cols=186 Identities=20% Similarity=0.358 Sum_probs=134.8
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeE----EEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIM----IALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 152 (271)
+..++|++.+.||+|+||+||+|++..+++. ||+|.+..... ......+.+| ........||+++...+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E----~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE----AYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHH----HHHHHHCCBTTBCCEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHH----HHHHHhCCCCCEeEEEEE
Confidence 4467899999999999999999999877654 47777643221 1111111122 112222234443332211
Q ss_pred --------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 153 --------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 153 --------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 86 CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EESSSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EecCCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 237889999999999999999999999999999999999999999999999996
Q ss_pred cCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 207 HAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 207 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 232 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH
Confidence 543221 223446889999999999999999999999999999999 99999988877765543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=255.06 Aligned_cols=192 Identities=22% Similarity=0.336 Sum_probs=132.3
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCCe---EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQI---MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
....+..++|++.+.||+|+||.||+|++..++. .||||++......... ...+.+| ........||+++..
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~E----~~~l~~l~h~~iv~~ 90 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLRE----AACMKEFDHPHVAKL 90 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH-HHHHHHH----HHHHTTCCCTTBCCC
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH-HHHHHHH----HHHHHHCCCCceehh
Confidence 3445667899999999999999999999887764 7999998653221111 1112222 112222234433222
Q ss_pred cC-----------------------c---------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe
Q psy4396 150 EG-----------------------Y---------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL 191 (271)
Q Consensus 150 ~~-----------------------~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili 191 (271)
.+ . ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli 170 (323)
T 3qup_A 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML 170 (323)
T ss_dssp CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE
Confidence 11 0 037889999999999999999999999999999999999
Q ss_pred CCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy4396 192 TMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLE 266 (271)
Q Consensus 192 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~ 266 (271)
+.++.+||+|||+++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++..
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 250 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence 999999999999997543321 223446789999999999999999999999999999999 999999988888776
Q ss_pred hhc
Q psy4396 267 RIF 269 (271)
Q Consensus 267 ~I~ 269 (271)
.+.
T Consensus 251 ~~~ 253 (323)
T 3qup_A 251 YLI 253 (323)
T ss_dssp HHH
T ss_pred HHh
Confidence 553
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.57 Aligned_cols=198 Identities=23% Similarity=0.398 Sum_probs=144.9
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcCC-------CeEEEEEEcchhHHHHH--------Hhhhhh-hceee-e
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT-------QIMIALKVLYKVEIINE--------RMTHQV-HRERC-C 133 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~--------~~~~~~-~~~~~-~ 133 (271)
+...+.+..++|.+.+.||+|+||.||+|++..+ +..||+|+++....... .....+ ..... .
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 3456778889999999999999999999998643 35799999865321110 000111 00000 0
Q ss_pred EEecCcCCCcceeeecc--C-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q psy4396 134 QVHLSSSRRHPLLSSEE--G-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKP 186 (271)
Q Consensus 134 ~~~~~~~~~~~~l~~~~--~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp 186 (271)
............++... + ...+++..+..++.|++.||+|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 00000011111111111 1 02378999999999999999999999999999999
Q ss_pred CceEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q psy4396 187 ENLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQ 261 (271)
Q Consensus 187 ~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~ 261 (271)
+|||++.++.+||+|||+++..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999755432 2233457889999999999999999999999999999999 9999999988
Q ss_pred HHHHHhh
Q psy4396 262 DTTLERI 268 (271)
Q Consensus 262 ~~~~~~I 268 (271)
.++.+.+
T Consensus 300 ~~~~~~~ 306 (382)
T 3tt0_A 300 EELFKLL 306 (382)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8877655
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=247.73 Aligned_cols=186 Identities=23% Similarity=0.387 Sum_probs=143.1
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--- 150 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--- 150 (271)
.|.+..++|++.+.||+|+||.||+|.+.. ++.||+|++......... +.+| ........||+++...
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~----~~~E----~~~l~~l~h~~i~~~~~~~ 74 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEED----FIEE----AEVMMKLSHPKLVQLYGVC 74 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHH----HHHH----HHHHHTCCCTTBCCEEEEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHH----HHHH----HHHHHhCCCCCEeeEEEEE
Confidence 456677899999999999999999999875 567999998653221111 1111 1111111233322211
Q ss_pred --------------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 151 --------------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 151 --------------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 75 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred ecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence 1 1237899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 207 HAPSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 207 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
...... .....+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~ 220 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 654322 223446778999999999999999999999999999999 99999999888877665
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=268.20 Aligned_cols=186 Identities=31% Similarity=0.537 Sum_probs=143.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH----------HhhhhhhceeeeEEecCcCCCcceeee
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE----------RMTHQVHRERCCQVHLSSSRRHPLLSS 148 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~ 148 (271)
.++|.+++.||+|+||+||+|++..+++.||+|++.+...... ...+.+.+| +.+.....||+++.
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE----ISLLKSLDHPNIIK 110 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHH----HHHHHTCCCTTBCC
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHH----HHHHHhCCCCCCCe
Confidence 4789999999999999999999999999999999875432211 111122222 23333335555443
Q ss_pred ccCc--------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC---CEEE
Q psy4396 149 EEGY--------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE---DVKI 199 (271)
Q Consensus 149 ~~~~--------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~---~~kl 199 (271)
..+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 3221 2378999999999999999999999999999999999998776 6999
Q ss_pred eeccccccCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 200 SDFGWSVHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 200 ~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+++.+|.
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999765433 344567999999999987 468999999999999999999999999999988877653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.50 Aligned_cols=183 Identities=30% Similarity=0.436 Sum_probs=137.5
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC--------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-------- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-------- 151 (271)
++|.+.+.||+|+||.||+|.+..+++.||||++...... ......+.+| ........||+++...+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRE----LLLLKHMQHENVIGLLDVFTPASSL 98 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHH----HHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHH----HHHHHhcCCCCcccHhheEeccccc
Confidence 6899999999999999999999999999999998542110 0000111111 01111112222221110
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 ---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 ---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 99 RNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp GGCCCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred ccceeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 12378999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
. .....+|+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..|
T Consensus 179 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i 236 (353)
T 3coi_A 179 E-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH
T ss_pred C-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2 334568999999999876 67899999999999999999999999998887766655
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=260.49 Aligned_cols=180 Identities=25% Similarity=0.386 Sum_probs=138.6
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec--------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE-------- 149 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-------- 149 (271)
...+|++.+.||+|+||+||+|++..+++ +|+|.+........+ | ..+.....||+++..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~-------E----~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR-------E----LQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCH-------H----HHHHHTCCCTTBCCEEEEEEEES
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHH-------H----HHHHHhCCCCCcceEEEEEEecC
Confidence 45679999999999999999999988776 888876432111000 0 111111123322221
Q ss_pred -------------cC--------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC-CCCCEEEee
Q psy4396 150 -------------EG--------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT-MHEDVKISD 201 (271)
Q Consensus 150 -------------~~--------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~-~~~~~kl~D 201 (271)
.. ...+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 10 13478889999999999999999999999999999999998 789999999
Q ss_pred ccccccCCC-CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 202 FGWSVHAPS-LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 202 fg~a~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+|+.... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..|+
T Consensus 186 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~ 255 (394)
T 4e7w_A 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII 255 (394)
T ss_dssp CTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999976532 333456789999999998764 58999999999999999999999999999887776654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=247.01 Aligned_cols=190 Identities=33% Similarity=0.597 Sum_probs=138.2
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC---
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG--- 151 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--- 151 (271)
..+..++|.+.+.||+|+||.||+|.+..+++.||||++.............+.++ ........||++....+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e----~~~l~~l~h~~i~~~~~~~~ 81 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHPHIIKLYQVIS 81 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHHTCCCTTBCCEEEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHH----HHHHhcCCCCCEeEEEEEEe
Confidence 34567899999999999999999999999999999999876433221111122222 11111223443322211
Q ss_pred --------------c---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 152 --------------Y---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 152 --------------~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 1 23688999999999999999999999999999999999999999999999998765
Q ss_pred CCC-CcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 209 PSL-HRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
... ......+|+.|+|||++.+..+ +.++|+||||+++|+|++|+.||...+..+.++.+
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 223 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 432 2334568999999999988765 68999999999999999999999988877766654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=256.20 Aligned_cols=182 Identities=23% Similarity=0.395 Sum_probs=134.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH--------HhhhhhhceeeeE---EecCcCCCcceee
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE--------RMTHQVHRERCCQ---VHLSSSRRHPLLS 147 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~~l~ 147 (271)
.++|++.+.||+|+||+||+|++..+++.||||++........ .....+....... ........+.+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4789999999999999999999999999999999865332110 0001111100000 0000111122222
Q ss_pred ecc--Cc------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe----CCCCCEEEeeccccccCC
Q psy4396 148 SEE--GY------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL----TMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 148 ~~~--~~------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili----~~~~~~kl~Dfg~a~~~~ 209 (271)
... +. ..+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 211 11 117899999999999999999999999999999999999 777889999999997654
Q ss_pred CC-CcccccccccccCcceec--------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVT--------SQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
.. ......||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33 334466899999999886 5778999999999999999999999997544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=252.35 Aligned_cols=183 Identities=36% Similarity=0.622 Sum_probs=142.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|.+.+.||+|+||.||+|++..+++.||+|++........ ..+.+| ........||++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENE----IAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHH----HHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccch---HHHHHH----HHHHHhCCCCCeeehhhhcccCCE
Confidence 3679999999999999999999999999999999864321111 011111 0111111233322211
Q ss_pred ---------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe---CCCCCEEEeeccccccCC
Q psy4396 151 ---------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL---TMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 ---------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili---~~~~~~kl~Dfg~a~~~~ 209 (271)
+ ...+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 1 1236889999999999999999999999999999999999 778899999999997665
Q ss_pred CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
........||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..++.+.|
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 219 (304)
T 2jam_A 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219 (304)
T ss_dssp CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 55455567899999999999999999999999999999999999999988887776654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.05 Aligned_cols=187 Identities=30% Similarity=0.490 Sum_probs=139.4
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG----- 151 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----- 151 (271)
...++|++++.||+|+||.||+|++..+++.||+|++....... .....+.+| ........||+++...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-MVKKIAMRE----IKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-HHHHHHHHH----HHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch-HHHHHHHHH----HHHHhhCCCCCEeeEEEEeecC
Confidence 35789999999999999999999999999999999874322110 000111111 11111112333322211
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 ---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 ---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 13478899999999999999999999999999999999999999999999999865433
Q ss_pred --CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 --LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.......+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+.+..+
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 237 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI 237 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 223345689999999999775 6899999999999999999999999999887776654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=258.60 Aligned_cols=181 Identities=25% Similarity=0.444 Sum_probs=138.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh-hhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM-THQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
.++|++.+.||+|+||.||+|.+..+++.||||++.......... ..........++.......||+++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 367999999999999999999999999999999987543211100 0000011111122333334554433211
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 ---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 ---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 12478999999999999999999999999999999999999999999999999976543
Q ss_pred C-CcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 211 L-HRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 211 ~-~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
. ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 3 3345679999999999988876 78999999999999999999999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=265.59 Aligned_cols=183 Identities=23% Similarity=0.404 Sum_probs=140.3
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--- 150 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--- 150 (271)
.|.+..++|++.+.||+|+||.||+|.+. ++.||||+++...... .+.+| ..++....||+++...
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~-----~~~~E----~~~l~~l~h~niv~~~~~~ 255 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQ-----AFLAE----ASVMTQLRHSNLVQLLGVI 255 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSH-----HHHHH----HHHHHTCCCTTBCCEEEEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHH-----HHHHH----HHHHHhccCCCEEEEEEEE
Confidence 45677889999999999999999999986 5689999986532111 11111 1111122233322211
Q ss_pred ---------------Cc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 151 ---------------GY-----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 151 ---------------~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
+. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 256 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp ECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 11 1268889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
++...... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..++...+
T Consensus 336 a~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 399 (450)
T 1k9a_A 336 TKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399 (450)
T ss_dssp CEECC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH
T ss_pred cccccccc-cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 97654332 23357889999999999999999999999999999998 99999988877776654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=263.75 Aligned_cols=188 Identities=20% Similarity=0.369 Sum_probs=146.0
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
...+.+..++|++.+.||+|+||.||+|.+.. +..||||+++...... +.+.+| ..++....||+++...+
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~----~~~~~E----~~~l~~l~h~~iv~l~~ 250 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSV----EAFLAE----ANVMKTLQHDKLVKLHA 250 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCH----HHHHHH----HHHHTTCCCTTBCCEEE
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccH----HHHHHH----HHHHhhCCCCCEeeEEE
Confidence 34567788899999999999999999999875 5679999987532111 111111 12222234444333221
Q ss_pred c---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 152 Y---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 152 ~---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 251 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred EEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 1 1367788999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
++...... .....+|+.|+|||++....++.++||||||+++|||++ |+.||.+.+..++...+
T Consensus 331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 398 (454)
T 1qcf_A 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398 (454)
T ss_dssp GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 97654321 122346788999999998999999999999999999999 99999999888877654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=255.40 Aligned_cols=186 Identities=31% Similarity=0.531 Sum_probs=142.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH---hhhhhhceeeeEEecCcCCCcceeeec------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---MTHQVHRERCCQVHLSSSRRHPLLSSE------ 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~------ 149 (271)
.++|++.+.||+|+||.||+|++..+++.||+|++......... ....+.+| ........||+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHH----HHHHHHCCCTTBCCEEEEEEC
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHH----HHHHHhCCCCCcceEEEEEec
Confidence 46799999999999999999999999999999998643211000 00011111 111111123322211
Q ss_pred ---------c--C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC----CEEEeecccc
Q psy4396 150 ---------E--G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE----DVKISDFGWS 205 (271)
Q Consensus 150 ---------~--~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~----~~kl~Dfg~a 205 (271)
. + ...+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 1 1 12368899999999999999999999999999999999999888 7999999999
Q ss_pred ccCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 206 VHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 206 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
...... ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 230 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 765443 234456899999999999999999999999999999999999999998888777655
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=255.39 Aligned_cols=184 Identities=27% Similarity=0.443 Sum_probs=138.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+| ........||+++...+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL--FALRTLRE----IKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHH--HHHHHHHH----HHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccch--HHHHHHHH----HHHHHhCcCCCcCCeeeeeccccc
Confidence 478999999999999999999999999999999985321100 00011111 11111112333222111
Q ss_pred ----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 152 ----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 152 ----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 84 ENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TTCCCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CccceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 1337899999999999999999999999999999999999999999999999986543
Q ss_pred CCC------------cccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SLH------------RKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~~------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
... .....||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 211 123468999999998764 67899999999999999999999999998877665544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=258.41 Aligned_cols=180 Identities=29% Similarity=0.458 Sum_probs=136.0
Q ss_pred EEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----------
Q psy4396 83 EVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---------- 152 (271)
Q Consensus 83 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---------- 152 (271)
...+.||+|+||.||+|.+..+++.||+|+++....... ..+.+| +.+.....||+++...+.
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~---~~~~~E----~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNE----ISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHH---HHHHHH----HHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccH---HHHHHH----HHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 336789999999999999999999999999865322111 112222 122222345544332211
Q ss_pred -----------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe--CCCCCEEEeeccccccCCCC-C
Q psy4396 153 -----------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL--TMHEDVKISDFGWSVHAPSL-H 212 (271)
Q Consensus 153 -----------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili--~~~~~~kl~Dfg~a~~~~~~-~ 212 (271)
..+++..+..++.|++.||+|||+.||+||||||+|||+ +.++.+||+|||+++..... .
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 237889999999999999999999999999999999999 56678999999999765443 2
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.+|+
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 301 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 334569999999999998889999999999999999999999999999888877664
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=267.57 Aligned_cols=184 Identities=31% Similarity=0.555 Sum_probs=140.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|++++.||+|+||+||+|++..++..||+|++.+...... ....+.+| +.+.....||+++...+.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E----~~~l~~l~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEE----VAVLKLLDHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHH----HHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHH----HHHHHhCCCCCCCeEEEEEEeCCE
Confidence 3579999999999999999999999999999999865432111 11112222 223333355655443221
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC---CCEEEeeccccccCC
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH---EDVKISDFGWSVHAP 209 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~---~~~kl~Dfg~a~~~~ 209 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.. +.+||+|||++....
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 236889999999999999999999999999999999999764 459999999987654
Q ss_pred C-CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 S-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
. ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+++.+|
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 249 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3 2334567999999999886 46899999999999999999999999999998887765
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=245.87 Aligned_cols=178 Identities=21% Similarity=0.378 Sum_probs=138.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
...|.+.+.||+|+||.||+|.+..++..||+|++........ ....+.+| ........||+++...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~-~~~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEE----AEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHH----HHHHTTCCCTTBCCEEEEEEEESS
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHH-HHHHHHHH----HHHHHhCCCCCeeeeeeeeccccC
Confidence 4568999999999999999999999999999999865432111 11111111 1112222344332221
Q ss_pred -------------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeC-CCCCEEEeecccc
Q psy4396 151 -------------GY---------SLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLT-MHEDVKISDFGWS 205 (271)
Q Consensus 151 -------------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~-~~~~~kl~Dfg~a 205 (271)
+. ..+++..+..++.|++.||+|||++| ++||||||+|||++ .++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 11 33788999999999999999999999 99999999999997 7899999999999
Q ss_pred ccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 206 VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
............||+.|+|||++.+ .++.++|+||||+++|+|++|+.||......
T Consensus 180 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 235 (290)
T 1t4h_A 180 TLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA 235 (290)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred ccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH
Confidence 8766666666779999999998864 5899999999999999999999999875443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=261.20 Aligned_cols=110 Identities=28% Similarity=0.510 Sum_probs=96.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceecc
Q psy4396 155 YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTS 230 (271)
Q Consensus 155 ~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~ 230 (271)
+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ......||+.|+|||++.+
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 269 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC
Confidence 788999999999999999999999999999999999999999999999999754322 2234567889999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy4396 231 QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTT 264 (271)
Q Consensus 231 ~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~ 264 (271)
..++.++||||||+++|||++ |+.||.+....+.
T Consensus 270 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 304 (359)
T 3vhe_A 270 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304 (359)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH
Confidence 999999999999999999998 9999988765443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=255.38 Aligned_cols=173 Identities=28% Similarity=0.428 Sum_probs=130.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|++++.||+|+||.||+|++..+++.||||++..... ......+.+| +.......||+++...+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E----~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMRE----VKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHH----HHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHH----HHHHHhCCCCCEeeEEEEEEEecc
Confidence 4689999999999999999999999999999999863211 0011111222 222222244444332210
Q ss_pred --------------------------------------------------------------------------------
Q psy4396 153 -------------------------------------------------------------------------------- 152 (271)
Q Consensus 153 -------------------------------------------------------------------------------- 152 (271)
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--------------Ccccccc
Q psy4396 153 SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--------------HRKTMCG 218 (271)
Q Consensus 153 ~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--------------~~~~~~g 218 (271)
...++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ......|
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 11345568899999999999999999999999999999999999999999998765432 1233568
Q ss_pred cccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 219 TLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 219 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
|+.|+|||++.+..++.++|+||||+++|+|++|..|+.
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999999887763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=256.90 Aligned_cols=190 Identities=25% Similarity=0.483 Sum_probs=137.4
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh---hhhh-hceee-eEEecCcCCCcceeeecc--C
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM---THQV-HRERC-CQVHLSSSRRHPLLSSEE--G 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~-~~~~~-~~~~~~~~~~~~~l~~~~--~ 151 (271)
.++|++.+.||+|+||.||+|.++.+++.||||++.+........ .... ..... ..........+.+++... +
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999999999999999999999986542111100 0000 00000 000000111111222111 1
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC----CCEEEeeccccccCCC--CCcccc
Q psy4396 152 ---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH----EDVKISDFGWSVHAPS--LHRKTM 216 (271)
Q Consensus 152 ---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~----~~~kl~Dfg~a~~~~~--~~~~~~ 216 (271)
...+++..+..++.|++.||+|||++||+||||||+|||+..+ +.+||+|||+++.... ......
T Consensus 101 g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 180 (342)
T 2qr7_A 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180 (342)
T ss_dssp CBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCS
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceecc
Confidence 1347899999999999999999999999999999999998543 3499999999975433 233456
Q ss_pred cccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHhh
Q psy4396 217 CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES---KDQDTTLERI 268 (271)
Q Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~---~~~~~~~~~I 268 (271)
+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+ .+..+++.+|
T Consensus 181 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i 235 (342)
T 2qr7_A 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235 (342)
T ss_dssp SCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH
T ss_pred CCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH
Confidence 789999999999888899999999999999999999999986 3455555544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=249.76 Aligned_cols=190 Identities=24% Similarity=0.409 Sum_probs=133.9
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
..+.+..++|++.+.||+|+||.||+|.+..+ +..||+|++...... .....+.+| ........||+++..
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e----~~~l~~l~h~~iv~~ 81 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQE----ALTMRQFDHPHIVKL 81 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHH----HHHHHTCCCTTBCCE
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHH----HHHHHhCCCCccceE
Confidence 34567778999999999999999999998654 457999997642111 011111111 111111123332221
Q ss_pred cC--------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 150 EG--------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 150 ~~--------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
.+ ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 82 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp EEEECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEEEccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccc
Confidence 11 1237889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 204 WSVHAPSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 204 ~a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+++...... .....+|+.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+....|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i 230 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH
Confidence 987654322 223446789999999999999999999999999999996 99999988887776655
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=258.12 Aligned_cols=184 Identities=27% Similarity=0.438 Sum_probs=142.7
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc---
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY--- 152 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--- 152 (271)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+| ........||+++...+.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRE----LQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--HHHHHHHHHH----HGGGGGCCCTTBCCEEEEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--HHHHHHHHHH----HHHHHHCCCCCEEEEeEEEEE
Confidence 4456889999999999999999999999999999999864311 1111112222 122222345544332221
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 2378889999999999999999996 9999999999999999999999999998654
Q ss_pred CCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 209 PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 239 (360)
T 3eqc_A 183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239 (360)
T ss_dssp HHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred ccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 433444567899999999999999999999999999999999999999988876653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.56 Aligned_cols=193 Identities=24% Similarity=0.378 Sum_probs=144.3
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH------Hhhhhhhce-------eeeEEecCcCCC
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE------RMTHQVHRE-------RCCQVHLSSSRR 142 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~~~-------~~~~~~~~~~~~ 142 (271)
....++|++.+.||+|+||+||+|.+..+++.||||+++....... .....+... ............
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3446899999999999999999999999999999999864322111 011111000 000000000011
Q ss_pred cceeeecc------------CcccCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEeC--CCCCEEEeeccccc
Q psy4396 143 HPLLSSEE------------GYSLYTEKDAAKYIYQVADAIHYCH--QKKVIHRDIKPENLLLT--MHEDVKISDFGWSV 206 (271)
Q Consensus 143 ~~~l~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH--~~~iiHrDikp~Nili~--~~~~~kl~Dfg~a~ 206 (271)
+..++... ....+++..+..++.|++.||.||| +.||+||||||+|||++ .++.+||+|||+++
T Consensus 130 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 22222111 1134789999999999999999999 57999999999999995 46789999999997
Q ss_pred cCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 207 HAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.+|+
T Consensus 210 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 210 QLGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp ETTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ecccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 66543 334678999999999999999999999999999999999999999999888877664
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=250.75 Aligned_cols=183 Identities=22% Similarity=0.416 Sum_probs=137.9
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh----hhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM----THQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
.+..++|++.+.||+|+||.||+|++..+++.||+|++.......... ...+.+| ........||+++...+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~i~~~~~ 90 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE----VFIMSNLNHPNIVKLYG 90 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHH----HHHHTTCCCTTBCCEEE
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHH----HHHHHhCCCCCchhhhe
Confidence 345689999999999999999999999999999999985322110000 0111111 12222223443332211
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCC-----EEE
Q psy4396 152 -------------------------YSLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTMHED-----VKI 199 (271)
Q Consensus 152 -------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~~~~-----~kl 199 (271)
...+++..+..++.|++.||+|||++| ++||||||+|||++.++. +||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 91 LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EETTTTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred eecCCCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 124788999999999999999999999 999999999999988776 999
Q ss_pred eeccccccCCCCCcccccccccccCcceec--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 200 SDFGWSVHAPSLHRKTMCGTLDYLPPEMVT--SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 200 ~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
+|||+++.... ......||+.|+|||++. ...++.++|+||||+++|+|++|+.||...+..+
T Consensus 171 ~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 171 ADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp CCCTTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred CCCCccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 99999975444 234467899999999984 4557889999999999999999999998765443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=246.76 Aligned_cols=196 Identities=24% Similarity=0.379 Sum_probs=141.7
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhh------hhhhceeee-EEecCcCCCcc
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT------HQVHRERCC-QVHLSSSRRHP 144 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~ 144 (271)
...+.+..++|++++.||+|+||+||+|.+. ++..||+|++........... ..+...... .........+.
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 4567778899999999999999999999877 466799999865322111111 111100000 00000111111
Q ss_pred eeeecc--C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 145 LLSSEE--G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 145 ~l~~~~--~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
+++... + ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 121111 1 1347899999999999999999999999999999999999999999999999997654322
Q ss_pred ---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 213 ---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.....+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+....+
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 234 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH
Confidence 223346788999999998899999999999999999998 99999998888777655
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=249.22 Aligned_cols=183 Identities=21% Similarity=0.298 Sum_probs=135.1
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH----HH-Hhhhhhhc--eeeeEEecCcCCCcceeeecc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII----NE-RMTHQVHR--ERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~-~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~ 150 (271)
..++|++.+.||+|+||.||+|.+..+++.||||++...... .+ .....+.. .............+.+++...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 357899999999999999999999999999999998542211 00 01111100 000001111111111222111
Q ss_pred -C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-----EEEeeccccccCCCC---
Q psy4396 151 -G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED-----VKISDFGWSVHAPSL--- 211 (271)
Q Consensus 151 -~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~-----~kl~Dfg~a~~~~~~--- 211 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (298)
T 1csn_A 88 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167 (298)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred cCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence 1 124789999999999999999999999999999999999987776 999999998654332
Q ss_pred ------CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 212 ------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 212 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 168 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 1234568999999999999999999999999999999999999998743
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=252.43 Aligned_cols=182 Identities=30% Similarity=0.515 Sum_probs=114.0
Q ss_pred cCeEEe---cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh----hhhhh-ce-eeeEEecCcCCCcceeeecc
Q psy4396 80 SDFEVG---CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM----THQVH-RE-RCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 80 ~~~~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----~~~~~-~~-~~~~~~~~~~~~~~~l~~~~ 150 (271)
++|++. +.||+|+||+||+|.+..+++.||||++.+........ ...+. .. ............+.+++...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 456664 78999999999999999999999999986542211110 00010 00 00000000111111222111
Q ss_pred --C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC---CEEEeeccccccCCCC--Ccc
Q psy4396 151 --G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE---DVKISDFGWSVHAPSL--HRK 214 (271)
Q Consensus 151 --~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~---~~kl~Dfg~a~~~~~~--~~~ 214 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++..... ...
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 167 (325)
T 3kn6_A 88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167 (325)
T ss_dssp CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence 1 13478999999999999999999999999999999999998766 7999999999754432 234
Q ss_pred cccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 215 TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
..+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 56789999999999999999999999999999999999999986543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=254.27 Aligned_cols=184 Identities=26% Similarity=0.382 Sum_probs=138.5
Q ss_pred CCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 70 APNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
.+........++|++.+.||+|+||.||+|++. +++.||||++....... ...+.+| ........||+++..
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E----~~~l~~l~h~~iv~~ 100 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQG---IEEFETE----IETLSFCRHPHLVSL 100 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSH---HHHHHHH----HHGGGSCCCTTBCCE
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHH---HHHHHHH----HHHHHhCCCCCEeeE
Confidence 344455556789999999999999999999965 57789999875432110 0111111 111222234433221
Q ss_pred cCc------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEE
Q psy4396 150 EGY------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKI 199 (271)
Q Consensus 150 ~~~------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl 199 (271)
.+. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl 180 (321)
T 2qkw_B 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKI 180 (321)
T ss_dssp EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEE
T ss_pred EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEE
Confidence 111 13788999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 200 SDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 200 ~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
+|||+++..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+
T Consensus 181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 999998754322 22334589999999999988999999999999999999999999976544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=269.22 Aligned_cols=188 Identities=23% Similarity=0.365 Sum_probs=145.7
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG- 151 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~- 151 (271)
..+++..++|++.+.||+|+||.||+|.+..++..||||+++....... .+.+| ..++....||+++...+
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~E----~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKE----AAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHH----HHHHH----HHHHHHCCCTTBCCEEEE
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchH----HHHHH----HHHHHhcCCCCEeeEEEE
Confidence 3566778899999999999999999999999899999999864321111 11111 11111123333322211
Q ss_pred ---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 152 ---------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 152 ---------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence 12367888999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLHR---KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
++....... ....+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..++.+.+
T Consensus 365 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~ 432 (495)
T 1opk_A 365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432 (495)
T ss_dssp EECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred ceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 976543222 22345778999999998889999999999999999999 99999998887776654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=255.55 Aligned_cols=187 Identities=28% Similarity=0.520 Sum_probs=139.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH--HHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN--ERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+.+| +.......||+++...+.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE----VRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHH----HHHHHHCCCTTBCCEEEEEECS
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHH----HHHHHhCCCCCcceeehhhccC
Confidence 478999999999999999999999999999999987543211 1111112222 111122234433322111
Q ss_pred --------------------------------------------------------------ccCCHHHHHHHHHHHHHH
Q psy4396 153 --------------------------------------------------------------SLYTEKDAAKYIYQVADA 170 (271)
Q Consensus 153 --------------------------------------------------------------~~~~~~~~~~~~~qi~~~ 170 (271)
..+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 012567788899999999
Q ss_pred HHHHHHCCceeccCCCCceEeCCCC--CEEEeeccccccCCC------CCcccccccccccCcceecc--CCCCCchhHH
Q psy4396 171 IHYCHQKKVIHRDIKPENLLLTMHE--DVKISDFGWSVHAPS------LHRKTMCGTLDYLPPEMVTS--QHYGKEVDNW 240 (271)
Q Consensus 171 L~~LH~~~iiHrDikp~Nili~~~~--~~kl~Dfg~a~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Diw 240 (271)
|+|||++||+||||||+|||++.++ .+||+|||++..... .......||+.|+|||++.+ ..++.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999999999999999999998776 899999999864322 12234668999999999865 6789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 241 CIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 241 slG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
|||+++|+|++|+.||.+.+..+...+++
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~ 289 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVL 289 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 99999999999999999988888776653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=263.39 Aligned_cols=179 Identities=32% Similarity=0.574 Sum_probs=130.4
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH-----HHhhhhhhceeeeEEecCcCCCcceeeeccC--
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-----ERMTHQVHRERCCQVHLSSSRRHPLLSSEEG-- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-- 151 (271)
.++|.+.+.||+|+||+||+|.+..+++.||||++.+..... ......+.+| +.+.....||+++...+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE----IEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHH----HHHHHHCCCTTBCCCCEEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHH----HHHHHhCCCCCEeeEEEEE
Confidence 478999999999999999999999999999999987543210 0000111111 12222224444333221
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC---CEEEeecccc
Q psy4396 152 -----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE---DVKISDFGWS 205 (271)
Q Consensus 152 -----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~---~~kl~Dfg~a 205 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 210 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 210 DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp ESSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ecCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 23478999999999999999999999999999999999997544 5999999999
Q ss_pred ccCCCC-CcccccccccccCcceecc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 206 VHAPSL-HRKTMCGTLDYLPPEMVTS---QHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 206 ~~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
+..... .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.....
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 765543 2345679999999998853 6678899999999999999999999986543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=245.08 Aligned_cols=182 Identities=31% Similarity=0.560 Sum_probs=141.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++.+.||+|+||.||+|.+..++..+|+|.+........ ..+.+| ........||+++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~---~~~~~E----~~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQE----IEIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCH---HHHHHH----HHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchH---HHHHHH----HHHHHhCCCCCEeeEEEEEecCCe
Confidence 3679999999999999999999999999999999865321110 011111 1111122333332221
Q ss_pred ---------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe---CCCCCEEEeeccccccCC
Q psy4396 151 ---------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL---TMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 ---------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili---~~~~~~kl~Dfg~a~~~~ 209 (271)
+. ..+++..+..++.|++.||+|||++|++||||||+|||+ +.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 11 237899999999999999999999999999999999999 778899999999987544
Q ss_pred C-CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 S-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
. .......||+.|+|||++.+. ++.++|+||||+++|+|++|+.||...+..+....+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 219 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI 219 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 3 333456789999999998665 899999999999999999999999998887776654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=248.44 Aligned_cols=186 Identities=28% Similarity=0.436 Sum_probs=142.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH-HHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-ERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+.+| ........||+++...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHH----HHHHTTCCCTTBCCEEEEEECC-
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHH----HHHHHhcCCCCeeEEEEEEEcCC
Confidence 478999999999999999999999999999999997654321 0111112222 11222223333322211
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 152 -----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 152 -----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 80 KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp --CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 123788999999999999999999999999999999999999999999999998754
Q ss_pred CC----CCcccccccccccCcceeccCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 209 PS----LHRKTMCGTLDYLPPEMVTSQHY--GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~----~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.. .......||+.|+|||++.+... +.++|+||||+++|+|++|+.||.+.+..+..+.|
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i 225 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH
Confidence 32 22234568999999999876543 77999999999999999999999998887776654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=254.59 Aligned_cols=186 Identities=20% Similarity=0.368 Sum_probs=134.8
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEE----EEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMI----ALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 152 (271)
+..++|++++.||+|+||.||+|.+..+++.+ |+|.+..... ......+.+| ........||+++...+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E----~~~l~~l~hp~iv~~~~~ 85 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE----AYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHH----HHHHTTCCBTTBCCCCEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHH----HHHHHhCCCCCeeEEEEE
Confidence 34688999999999999999999998887655 5665532110 0000111111 122222344544332221
Q ss_pred --------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 153 --------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 153 --------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 86 CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EESSSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EecCCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 237889999999999999999999999999999999999999999999999997
Q ss_pred cCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 207 HAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 207 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 232 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 54322 1223446788999999999999999999999999999999 99999988887765544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=250.44 Aligned_cols=191 Identities=22% Similarity=0.390 Sum_probs=145.7
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEc-----CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL 146 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 146 (271)
...+.+..++|.+.+.||+|+||.||+|.+. .+++.||+|++...... .....+.+| ........||++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E----~~~l~~l~hp~i 88 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP--SELRDLLSE----FNVLKQVNHPHV 88 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH--HHHHHHHHH----HHHHTTCCCTTB
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH--HHHHHHHHH----HHHHhhCCCCce
Confidence 4566777899999999999999999999984 34588999998643211 111111222 112222234443
Q ss_pred eeccCc--------------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHH
Q psy4396 147 SSEEGY--------------------------------------------------SLYTEKDAAKYIYQVADAIHYCHQ 176 (271)
Q Consensus 147 ~~~~~~--------------------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~ 176 (271)
+...+. ..+++..+..++.|++.||+|||+
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 322111 126788999999999999999999
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV- 251 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~- 251 (271)
+||+||||||+|||++.++.+||+|||++....... .....+|+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999997654322 223456789999999998889999999999999999999
Q ss_pred CCCCCCCCCHHHHHHhh
Q psy4396 252 GKPPFESKDQDTTLERI 268 (271)
Q Consensus 252 g~~pf~~~~~~~~~~~I 268 (271)
|+.||.+.+..++.+.+
T Consensus 249 g~~p~~~~~~~~~~~~~ 265 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLL 265 (314)
T ss_dssp SCCSSTTCCGGGHHHHH
T ss_pred CCCCCCCCCHHHHHHHh
Confidence 99999998887776554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=244.17 Aligned_cols=193 Identities=21% Similarity=0.324 Sum_probs=141.0
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhh------hhhceeee-EEecCcCCCcceee
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH------QVHRERCC-QVHLSSSRRHPLLS 147 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~~~l~ 147 (271)
+.+..++|++.+.||+|+||.||+|++.. +..||+|++............ .+...... .........+.+++
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 35567899999999999999999998774 567999998654321111110 11100000 00000111111122
Q ss_pred ecc--Cc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcc-
Q psy4396 148 SEE--GY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK- 214 (271)
Q Consensus 148 ~~~--~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~- 214 (271)
... +. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 111 11 23789999999999999999999999999999999999999999999999999765443322
Q ss_pred --cccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 215 --TMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 215 --~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
...+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+....+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 218 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH
Confidence 2345678999999999889999999999999999999 99999988887776554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=247.03 Aligned_cols=197 Identities=20% Similarity=0.322 Sum_probs=146.1
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhh------hhhhceeee-EEecCcCCCcc
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT------HQVHRERCC-QVHLSSSRRHP 144 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~ 144 (271)
...+.+..++|++.+.||+|+||+||+|.+..++..||+|++........... ..+...... .........+.
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 35677788999999999999999999999999999999999865322111111 111100000 00000011111
Q ss_pred eeeecc-------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 145 LLSSEE-------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 145 ~l~~~~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
+++... ....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 111111 1133788999999999999999999999999999999999999999999999999765543
Q ss_pred Cc---ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 212 HR---KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 212 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.. ....+|+.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+..+.+
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~ 225 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 22 23446788999999999999999999999999999999 99999988877766544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=254.40 Aligned_cols=188 Identities=24% Similarity=0.400 Sum_probs=142.0
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
+.+..++|++++.||+|+||.||+|++.. +++.||||+++...... ....+.+| ........||+++..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E----~~~l~~l~hp~iv~~ 115 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQRE----AALMAEFDNPNIVKL 115 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH--HHHHHHHH----HHHHHTCCCTTBCCE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHH--HHHHHHHH----HHHHHhCCCCCEEEE
Confidence 45567899999999999999999999974 45889999986532111 11111111 111111233332221
Q ss_pred cC--------------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy4396 150 EG--------------------------------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKV 179 (271)
Q Consensus 150 ~~--------------------------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i 179 (271)
.+ ...+++..+..++.|++.||+|||++||
T Consensus 116 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i 195 (343)
T 1luf_A 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 195 (343)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 11 0346788899999999999999999999
Q ss_pred eeccCCCCceEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCC
Q psy4396 180 IHRDIKPENLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKP 254 (271)
Q Consensus 180 iHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~ 254 (271)
+||||||+|||++.++.+||+|||+++..... ......+|+.|+|||++.+..++.++|+||||+++|+|++ |..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999998654321 2233557899999999999999999999999999999999 999
Q ss_pred CCCCCCHHHHHHhh
Q psy4396 255 PFESKDQDTTLERI 268 (271)
Q Consensus 255 pf~~~~~~~~~~~I 268 (271)
||.+.+..++...+
T Consensus 276 p~~~~~~~~~~~~~ 289 (343)
T 1luf_A 276 PYYGMAHEEVIYYV 289 (343)
T ss_dssp TTTTSCHHHHHHHH
T ss_pred cCCCCChHHHHHHH
Confidence 99999888877654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=255.80 Aligned_cols=195 Identities=26% Similarity=0.396 Sum_probs=132.6
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh------hhhhhceeee-----EEecCcCCC-
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM------THQVHRERCC-----QVHLSSSRR- 142 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~------~~~~~~~~~~-----~~~~~~~~~- 142 (271)
....+++|++.+.||+|+||.||+|++..+++.||||++.......... ...+...... .........
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 3455789999999999999999999999999999999874421110000 0000000000 000000000
Q ss_pred --cceeeec--------------cCcccCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEeCC-CCCEEEeecc
Q psy4396 143 --HPLLSSE--------------EGYSLYTEKDAAKYIYQVADAIHYCH--QKKVIHRDIKPENLLLTM-HEDVKISDFG 203 (271)
Q Consensus 143 --~~~l~~~--------------~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~iiHrDikp~Nili~~-~~~~kl~Dfg 203 (271)
+..++.. .....+++..+..++.|++.||.||| +.||+||||||+|||++. ++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 0111111 11234678889999999999999999 999999999999999996 8999999999
Q ss_pred ccccCCCC-CcccccccccccCcceeccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 204 WSVHAPSL-HRKTMCGTLDYLPPEMVTSQH-YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 204 ~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..++
T Consensus 178 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 178 SAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp TCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 99765433 334457899999999986654 8999999999999999999999999999888777653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=253.75 Aligned_cols=190 Identities=28% Similarity=0.485 Sum_probs=139.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH-----HHHHhhhhhhceee------------eEEecCcCC
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI-----INERMTHQVHRERC------------CQVHLSSSR 141 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~~~~------------~~~~~~~~~ 141 (271)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ........+.+|.. .........
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 3679999999999999999999998999999999854320 00000111111100 000000011
Q ss_pred Ccceeeecc--Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 142 RHPLLSSEE--GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 142 ~~~~l~~~~--~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
.+.+++... +. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 111222111 11 2478899999999999999999999999999999999999999999999999876543
Q ss_pred -CCcccccccccccCcceecc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 -LHRKTMCGTLDYLPPEMVTS------QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 -~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..|
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 23345679999999998863 35789999999999999999999999988877766554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=249.04 Aligned_cols=193 Identities=19% Similarity=0.292 Sum_probs=137.4
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcC---CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceee
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKT---TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 147 (271)
......+..++|.+.+.||+|+||.||+|.+.. +++.||+|++........ ....+.++ ........||+++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e----~~~l~~l~h~~iv 99 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR-EIEEFLSE----AACMKDFSHPNVI 99 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHH-HHHHHHHH----HHHHHTCCCTTBC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchh-HHHHHHHH----HHHHhcCCCCCee
Confidence 345556677899999999999999999998875 456899999864321111 00111111 1111111233222
Q ss_pred ecc-------------------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q psy4396 148 SEE-------------------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLL 190 (271)
Q Consensus 148 ~~~-------------------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nil 190 (271)
... ....+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIl 179 (313)
T 3brb_A 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179 (313)
T ss_dssp CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEE
T ss_pred eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence 111 1134788999999999999999999999999999999999
Q ss_pred eCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy4396 191 LTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTL 265 (271)
Q Consensus 191 i~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 265 (271)
++.++.+||+|||++...... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+..
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 259 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 999999999999998654332 1223456889999999999999999999999999999999 99999988887776
Q ss_pred Hhh
Q psy4396 266 ERI 268 (271)
Q Consensus 266 ~~I 268 (271)
..+
T Consensus 260 ~~~ 262 (313)
T 3brb_A 260 DYL 262 (313)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=252.08 Aligned_cols=190 Identities=30% Similarity=0.440 Sum_probs=137.3
Q ss_pred ccCeEEe-cccccCCceEEEEEEEcCCCeEEEEEEcchhHH--------HHH-Hhhhhhhc-ee-eeEEecCcCCCccee
Q psy4396 79 MSDFEVG-CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI--------INE-RMTHQVHR-ER-CCQVHLSSSRRHPLL 146 (271)
Q Consensus 79 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~-~~~~~~~~-~~-~~~~~~~~~~~~~~l 146 (271)
.++|.+. +.||+|+||.||+|.+..+++.||+|++..... ..+ .....+.. .. .............++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3567777 899999999999999999999999999864211 111 01111100 00 000000000111111
Q ss_pred eec-------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCEEEeeccccccCCC
Q psy4396 147 SSE-------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM---HEDVKISDFGWSVHAPS 210 (271)
Q Consensus 147 ~~~-------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~---~~~~kl~Dfg~a~~~~~ 210 (271)
+.. .....+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 111 11244789999999999999999999999999999999999987 78999999999976543
Q ss_pred C-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 L-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
. ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 245 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence 3 234467899999999999999999999999999999999999999998888776554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=250.42 Aligned_cols=188 Identities=25% Similarity=0.414 Sum_probs=125.3
Q ss_pred ccCCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceee
Q psy4396 68 REAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLS 147 (271)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 147 (271)
...+...+.+..++|++++.||+|+||.||+|.+..+++.||||++......... .....+. ..+.....||+++
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~---~~~~~~~~h~niv 84 (327)
T 3aln_A 10 KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ--KQLLMDL---DVVMRSSDCPYIV 84 (327)
T ss_dssp ECCCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHH--HHHHHHH---HHHHSSCCCTTBC
T ss_pred CCChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHH--HHHHHHH---HHHHHcCCCCcEe
Confidence 3455677788889999999999999999999999999999999998643211100 0000100 0011222344333
Q ss_pred eccC------------------------------cccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCC
Q psy4396 148 SEEG------------------------------YSLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHED 196 (271)
Q Consensus 148 ~~~~------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~ 196 (271)
...+ ...+++..+..++.|++.||.|||+. |++||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~ 164 (327)
T 3aln_A 85 QFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN 164 (327)
T ss_dssp CEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE
T ss_pred eeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC
Confidence 3221 23468889999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccCCCC-CcccccccccccCccee----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 197 VKISDFGWSVHAPSL-HRKTMCGTLDYLPPEMV----TSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 197 ~kl~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
+||+|||+++..... ......||+.|+|||++ .+..++.++|+||||+++|+|++|+.||...+
T Consensus 165 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 165 IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp EEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred EEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 999999998765433 22334689999999998 46678999999999999999999999998654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=247.66 Aligned_cols=182 Identities=21% Similarity=0.304 Sum_probs=134.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH----HHH-Hhhhhhhcee--eeEEecCcCCCcceeeecc-
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI----INE-RMTHQVHRER--CCQVHLSSSRRHPLLSSEE- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~-~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~- 150 (271)
.++|++.+.||+|+||.||+|++..+++.||||++..... ..+ .....+.... ...........+..++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 3789999999999999999999999999999998753211 111 1111111000 0000000011111122111
Q ss_pred ----------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe---CCCCCEEEeeccccccCCCCC-----
Q psy4396 151 ----------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL---TMHEDVKISDFGWSVHAPSLH----- 212 (271)
Q Consensus 151 ----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili---~~~~~~kl~Dfg~a~~~~~~~----- 212 (271)
....+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccc
Confidence 12347899999999999999999999999999999999999 478999999999986544322
Q ss_pred ----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 213 ----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 213 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 234578999999999999999999999999999999999999998643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=247.53 Aligned_cols=180 Identities=23% Similarity=0.455 Sum_probs=133.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH---HH-Hhhhhhh-cee---eeEEecCcCCCcceeeecc
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII---NE-RMTHQVH-RER---CCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~-~~~~~~~-~~~---~~~~~~~~~~~~~~l~~~~ 150 (271)
.++|++++.||+|+||+||+|.+..+++.||||+++..... .+ .....+. ... ...........+..++...
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 47899999999999999999999999999999998643211 11 1111111 000 0001111011222222221
Q ss_pred C--c------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CEEEeeccccccCCC-CCcccccccc
Q psy4396 151 G--Y------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPS-LHRKTMCGTL 220 (271)
Q Consensus 151 ~--~------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~~~~-~~~~~~~gt~ 220 (271)
. . ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+|+
T Consensus 115 ~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 194 (330)
T 3nsz_A 115 VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 194 (330)
T ss_dssp CCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCG
T ss_pred cCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccc
Confidence 1 1 2378999999999999999999999999999999999999777 899999999975443 3334567899
Q ss_pred cccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 221 DYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 221 ~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 195 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp GGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999877 6789999999999999999999999943
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=253.73 Aligned_cols=183 Identities=21% Similarity=0.374 Sum_probs=128.0
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH--------H-Hhhhhhhc--e-eeeEEecCcCCCc
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN--------E-RMTHQVHR--E-RCCQVHLSSSRRH 143 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~-~~~~~~~~--~-~~~~~~~~~~~~~ 143 (271)
.+.-++|++++.||+|+||.||+|.+. +++.||||++....... + .....+.. . ............+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 445678999999999999999999875 47789999985321110 0 00111111 0 0000111111112
Q ss_pred ceeeeccC----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC-
Q psy4396 144 PLLSSEEG----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH- 212 (271)
Q Consensus 144 ~~l~~~~~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~- 212 (271)
.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 84 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 84 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 22222211 13478999999999999999999999999999999999997 7889999999997654322
Q ss_pred ---cccccccccccCcceecc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 213 ---RKTMCGTLDYLPPEMVTS-----------QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 213 ---~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 234579999999999865 678899999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=245.92 Aligned_cols=185 Identities=32% Similarity=0.580 Sum_probs=138.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH---hhhhhhceeeeEEecCcCCCcceeeecc------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---MTHQVHRERCCQVHLSSSRRHPLLSSEE------ 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~~------ 150 (271)
++|++.+.||+|+||.||+|++..+++.||+|+++........ ....+.+| ........||++....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE----VNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHH----HHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHH----HHHHHhCCCCCeeehhheecCC
Confidence 5799999999999999999999999999999998643211000 00011111 1111111233322211
Q ss_pred -----------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC----CEEEeeccccc
Q psy4396 151 -----------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE----DVKISDFGWSV 206 (271)
Q Consensus 151 -----------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~----~~kl~Dfg~a~ 206 (271)
+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 11 2378999999999999999999999999999999999998877 79999999987
Q ss_pred cCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 207 HAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 207 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
..... ......+|+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 223 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh
Confidence 65432 233456899999999999999999999999999999999999999998887776654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=244.34 Aligned_cols=186 Identities=23% Similarity=0.404 Sum_probs=135.5
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee--
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS-- 148 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-- 148 (271)
....+.+..++|++.+.||+|+||.||+|++. ++.||+|+++...... .+.+| ........||+++.
T Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~-----~~~~E----~~~l~~l~h~~iv~~~ 80 (278)
T 1byg_A 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQ-----AFLAE----ASVMTQLRHSNLVQLL 80 (278)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--H-----HHHHT----HHHHTTCCCTTBCCEE
T ss_pred hhccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHH-----HHHHH----HHHHHhCCCCCEeeEE
Confidence 34456777899999999999999999999875 6789999986532111 11111 11111112332222
Q ss_pred --------------cc--Cc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEee
Q psy4396 149 --------------EE--GY-----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISD 201 (271)
Q Consensus 149 --------------~~--~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~D 201 (271)
.. +. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp EEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEee
Confidence 11 11 1167888999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 202 FGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 202 fg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
||++....... ....+++.|+|||++.+..++.++|+||||+++|+|++ |+.||...+..++...+
T Consensus 161 fg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 227 (278)
T 1byg_A 161 FGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227 (278)
T ss_dssp CCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred ccccccccccc-cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99987554432 23457889999999999999999999999999999998 99999988877766554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=257.91 Aligned_cols=182 Identities=21% Similarity=0.370 Sum_probs=128.0
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH--------H-Hhhhhhhc--e-eeeEEecCcCCCcc
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN--------E-RMTHQVHR--E-RCCQVHLSSSRRHP 144 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~-~~~~~~~~--~-~~~~~~~~~~~~~~ 144 (271)
+.-.+|++++.||+|+||.||+|.+.. ++.||||++....... + .....+.. . ..............
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 344669999999999999999999876 7889999985432110 0 00111110 0 00000000011111
Q ss_pred eeeeccC----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC---
Q psy4396 145 LLSSEEG----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--- 211 (271)
Q Consensus 145 ~l~~~~~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--- 211 (271)
+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 132 ~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 2222211 12468889999999999999999999999999999999996 689999999999765432
Q ss_pred -CcccccccccccCcceecc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 212 -HRKTMCGTLDYLPPEMVTS-----------QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 2234679999999999865 468899999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=262.12 Aligned_cols=188 Identities=21% Similarity=0.341 Sum_probs=140.1
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE- 150 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~- 150 (271)
...|.+..++|++.+.||+|+||.||+|.+..+ ..||||+++....... .+.+| ..++....||+++...
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~----~~~~E----~~~l~~l~hp~iv~~~~ 246 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPE----AFLQE----AQVMKKLRHEKLVQLYA 246 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHH----HHHHH----HHHHHHCCCTTBCCEEE
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCCHH----HHHHH----HHHHHhCCCCCEeeEEE
Confidence 345677788999999999999999999998864 5699999875321111 11111 1111111233222211
Q ss_pred ---------------Cc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 151 ---------------GY-----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 151 ---------------~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 247 ~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp EECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence 11 2378889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
++...... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..++...+
T Consensus 327 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 394 (452)
T 1fmk_A 327 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394 (452)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 97654322 223446789999999999999999999999999999999 99999999888877655
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=257.91 Aligned_cols=187 Identities=20% Similarity=0.357 Sum_probs=132.5
Q ss_pred cccccCeEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY 152 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 152 (271)
.+..++|++.+.||+|+||.||+|++. .++..||||+++..... .....+.+| +.......||+++...+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E----~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGE----ASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH--HHHHHHHHH----HHHHTTCCCTTBCCEEEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH--HHHHHHHHH----HHHHHhCCCCCCCeEEEE
Confidence 445678999999999999999999987 45677999998643211 111112222 122222344443332211
Q ss_pred ---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 153 ---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 153 ---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 24788999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 206 VHAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 206 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+...... .....+++.|+|||++.+..++.++||||||+++||+++ |+.||...+..++...+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i 263 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7654321 112235678999999999999999999999999999998 99999998888776654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=256.37 Aligned_cols=186 Identities=30% Similarity=0.504 Sum_probs=132.4
Q ss_pred cccccccCeEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHH----------H-Hhhhhhh-ceeee-EEec
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIIN----------E-RMTHQVH-RERCC-QVHL 137 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~----------~-~~~~~~~-~~~~~-~~~~ 137 (271)
...+..++|++.+.||+|+||.||+|++. .+++.||||++++..... + .....+. ..... ....
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 48 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 34456789999999999999999999984 478899999986422100 0 0011110 00000 0000
Q ss_pred CcCCCcceeeecc--C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 138 SSSRRHPLLSSEE--G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 138 ~~~~~~~~l~~~~--~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
.......+++... + ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 0000111121111 1 1347899999999999999999999999999999999999999999999999997
Q ss_pred cCCCC---CcccccccccccCcceecc--CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 207 HAPSL---HRKTMCGTLDYLPPEMVTS--QHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 207 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 54322 2234579999999999985 34789999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=243.71 Aligned_cols=191 Identities=24% Similarity=0.432 Sum_probs=141.3
Q ss_pred ccccCeEEecccccCCceEEEEEEE-cCCCeEEEEEEcchhHHHHHH------hhhhhhce-------eeeEEecCcCCC
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKE-KTTQIMIALKVLYKVEIINER------MTHQVHRE-------RCCQVHLSSSRR 142 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~~ 142 (271)
.-.++|++.+.||+|+||.||+|.+ ..+++.||||+++........ ....+... ............
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 3457899999999999999999998 567899999998643211110 01111100 000000001111
Q ss_pred cceeeecc------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-----------------
Q psy4396 143 HPLLSSEE------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM----------------- 193 (271)
Q Consensus 143 ~~~l~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~----------------- 193 (271)
+..++... +...+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 91 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 91 HICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 22222211 1124789999999999999999999999999999999999987
Q ss_pred --CCCEEEeeccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 194 --HEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 194 --~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
++.+||+|||++...... .....||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+....+
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH-HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC-CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred ccCCCceEeeCcccccCccc-cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 668999999999765433 33467899999999999999999999999999999999999999998887765543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=247.76 Aligned_cols=184 Identities=26% Similarity=0.458 Sum_probs=128.9
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG- 151 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~- 151 (271)
...++..++|++.+.||+|+||+||+|++.. .||+|+++..... ......+.+| +.......||+++...+
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~-~~~~~~~~~E----~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPT-PQQLQAFKNE----VGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCC-HHHHHHHHHH----HHHHTTCCCTTBCCEEEE
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCC-HHHHHHHHHH----HHHHHhCCCCcEEEEEee
Confidence 3456677899999999999999999998654 3999998532211 1111111122 12222223443332211
Q ss_pred -------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 152 -------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 152 -------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 89 STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp ECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred ccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecc
Confidence 1237889999999999999999999999999999999999999999999999986
Q ss_pred cCCC----CCcccccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 207 HAPS----LHRKTMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 207 ~~~~----~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
.... .......||+.|+|||++. +..++.++||||||+++|+|++|+.||.+.+..+.
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 233 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH
Confidence 5432 2223456899999999886 56788899999999999999999999987665443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=248.12 Aligned_cols=181 Identities=22% Similarity=0.307 Sum_probs=132.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH----HH-Hhhhhhhcee--eeEEecCcCCCcceeeeccC-
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII----NE-RMTHQVHRER--CCQVHLSSSRRHPLLSSEEG- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~-~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~- 151 (271)
++|++.+.||+|+||.||+|++..+++.||||++...... .+ .....+.... ...........+..++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 88 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 88 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccC
Confidence 6899999999999999999999999999999986432211 00 1111111100 00000000111112221111
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe---CCCCCEEEeeccccccCCCC-------
Q psy4396 152 ----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL---TMHEDVKISDFGWSVHAPSL------- 211 (271)
Q Consensus 152 ----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili---~~~~~~kl~Dfg~a~~~~~~------- 211 (271)
...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 89 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 168 (296)
T 4hgt_A 89 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168 (296)
T ss_dssp CBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCC
T ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCC
Confidence 2347899999999999999999999999999999999999 78899999999998654332
Q ss_pred --CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 212 --HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 169 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 1234578999999999999999999999999999999999999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=253.01 Aligned_cols=186 Identities=23% Similarity=0.402 Sum_probs=134.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--------HHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--------NERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
.++|++.+.||+|+||.||+|.+.. ++.||||++...... .......+.+| +.......||+++...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE----IRLLNHFHHPNILGLR 95 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHH----HHHHHHCCCTTBCCCS
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHH----HHHHHhCCCcCcccee
Confidence 4789999999999999999999866 788999988432110 00000111111 1111122333332221
Q ss_pred C-------------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEE
Q psy4396 151 G-------------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKI 199 (271)
Q Consensus 151 ~-------------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl 199 (271)
+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 1 124789999999999999999999999999999999999999999999
Q ss_pred eeccccccCCC-CCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 200 SDFGWSVHAPS-LHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 200 ~Dfg~a~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+|||++..... .......+|+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+.+++
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999975433 23344578999999999876 678999999999999999999999999998888777653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=249.68 Aligned_cols=192 Identities=23% Similarity=0.403 Sum_probs=141.7
Q ss_pred cccCeEEecccccCCceEEEEEEEc-CCCeEEEEEEcchhHH--------HHH-Hhhhhh---hceeeeE-EecC-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEK-TTQIMIALKVLYKVEI--------INE-RMTHQV---HRERCCQ-VHLS----- 138 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--------~~~-~~~~~~---~~~~~~~-~~~~----- 138 (271)
..++|++.+.||+|+||.||+|++. .+++.||+|++..... ..+ .....+ ....... ....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3578999999999999999999995 6788999999853211 000 000111 0000000 0000
Q ss_pred cCCCcceeeecc------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 139 SSRRHPLLSSEE------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 139 ~~~~~~~l~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
....+..++... ....+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 000111111111 11237899999999999999999999999999999999999999999999999987
Q ss_pred cCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 207 HAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 207 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
..... ......+|+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+.+.+|+
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 65432 2334568999999999999999999999999999999999999999998888776654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=245.67 Aligned_cols=192 Identities=23% Similarity=0.464 Sum_probs=141.8
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCC-eEEEEEEcchhHHHHHH------hhhhhhce-------eeeEEecCcCC
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ-IMIALKVLYKVEIINER------MTHQVHRE-------RCCQVHLSSSR 141 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~ 141 (271)
.+-.++|++.+.||+|+||+||+|.+..++ +.||+|+++........ ....+... ...........
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 344589999999999999999999998776 78999998643211110 11111100 00000000011
Q ss_pred Ccceeeecc------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe------------------
Q psy4396 142 RHPLLSSEE------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL------------------ 191 (271)
Q Consensus 142 ~~~~l~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili------------------ 191 (271)
.+..++... ....+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 122222111 11347899999999999999999999999999999999999
Q ss_pred -CCCCCEEEeeccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 192 -TMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 192 -~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+.+..+
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH-HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccCCCcEEEeecCcccccccc-ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56789999999999765433 33467899999999999999999999999999999999999999998887765443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=250.90 Aligned_cols=194 Identities=25% Similarity=0.354 Sum_probs=121.7
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH-------Hhhhhhh-ceeeeEE-ecC----
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE-------RMTHQVH-RERCCQV-HLS---- 138 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~-~~~~~~~-~~~---- 138 (271)
...+.+...+|++.+.||+|+||.||+|++..+++.||||++........ .....+. ....... ...
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 34455566789999999999999999999999999999998743221110 0001110 0000000 000
Q ss_pred ----cCCCcceeeecc-------------CcccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCCEEE
Q psy4396 139 ----SSRRHPLLSSEE-------------GYSLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTMHEDVKI 199 (271)
Q Consensus 139 ----~~~~~~~l~~~~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~~~~~kl 199 (271)
....+.+++... ....+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 000001111111 1234789999999999999999999999 999999999999999999999
Q ss_pred eeccccccCCCCCc--------------ccccccccccCccee---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 200 SDFGWSVHAPSLHR--------------KTMCGTLDYLPPEMV---TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 200 ~Dfg~a~~~~~~~~--------------~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
+|||++........ ....+|+.|+|||++ .+..++.++||||||+++|+|++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 99999876543211 134589999999998 5677899999999999999999999999876655
Q ss_pred HHH
Q psy4396 263 TTL 265 (271)
Q Consensus 263 ~~~ 265 (271)
++.
T Consensus 260 ~~~ 262 (337)
T 3ll6_A 260 RIV 262 (337)
T ss_dssp ---
T ss_pred Hhh
Confidence 443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=245.47 Aligned_cols=183 Identities=28% Similarity=0.458 Sum_probs=135.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|.+.+.||+|+||.||+|++..+++.+|+|++....... ....+.+| ........||+++...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E----~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAE----IEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHH----HHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHH----HHHHHhCCCchHHhHHHheecCCe
Confidence 378999999999999999999999999999999986542110 00111111 1111122333332211
Q ss_pred ---------Cc-------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe---CCCCCEEEeecccc
Q psy4396 151 ---------GY-------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL---TMHEDVKISDFGWS 205 (271)
Q Consensus 151 ---------~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili---~~~~~~kl~Dfg~a 205 (271)
+. ..+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 11 337889999999999999999999999999999999999 45578999999999
Q ss_pred ccCCC-CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 206 VHAPS-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 206 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
..... .......||+.|+|||++. ..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~ 237 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA 237 (285)
T ss_dssp CC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh
Confidence 65443 2334567899999999885 56899999999999999999999999998887766554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=258.12 Aligned_cols=173 Identities=34% Similarity=0.557 Sum_probs=119.4
Q ss_pred cCeEE-ecccccCCceEEEEEEEc--CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 80 SDFEV-GCPLGTGKFGHVYLAKEK--TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 80 ~~~~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
+.|++ ++.||+|+||+||+|+++ .+++.||||++........ +.+| +.+.....||+++...+.
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~E----~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS-----ACRE----IALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHH-----HHHH----HHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHH-----HHHH----HHHHHhcCCCCeeeEeeEEecC
Confidence 44666 558999999999999976 4678899999864321110 1111 111111123332221110
Q ss_pred --------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe----CCCCC
Q psy4396 153 --------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL----TMHED 196 (271)
Q Consensus 153 --------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili----~~~~~ 196 (271)
..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 127889999999999999999999999999999999999 67789
Q ss_pred EEEeeccccccCCC-----CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 197 VKISDFGWSVHAPS-----LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 197 ~kl~Dfg~a~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
+||+|||+|+.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999976543 223346789999999999874 589999999999999999999999987665
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=247.67 Aligned_cols=183 Identities=26% Similarity=0.385 Sum_probs=133.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+| +.......||+++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e----~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS---VKHALRE----IKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHH---HHHHHHH----HHHHHTCCCTTBCCEEEEECTTSC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHH---HHHHHHH----HHHHHhcCCCCeeEEEEecccccc
Confidence 478999999999999999999999999999999885432111 1111111 1111112233332221
Q ss_pred ------------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC-CCCCEEE
Q psy4396 151 ------------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT-MHEDVKI 199 (271)
Q Consensus 151 ------------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~-~~~~~kl 199 (271)
....+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 113478899999999999999999999999999999999997 5678999
Q ss_pred eeccccccCCCC-----CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 200 SDFGWSVHAPSL-----HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 200 ~Dfg~a~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
+|||+++..... ......+|+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999998764321 2233457899999998865 67899999999999999999999999999887776655
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=240.95 Aligned_cols=185 Identities=23% Similarity=0.384 Sum_probs=142.1
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc----
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE---- 150 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---- 150 (271)
|.++.++|++.+.||+|+||.||+|.+. +++.||+|++......... +.+| ........||++....
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~----~~~e----~~~l~~l~h~~i~~~~~~~~ 73 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED----FIEE----AEVMMKLSHPKLVQLYGVCL 73 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHH----HHHH----HHHHHTCCCTTBCCEEEEEC
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHH----HHHH----HHHHHhCCCCCEeeEEEEEc
Confidence 4566789999999999999999999987 4667999998654321111 1111 1111111233322211
Q ss_pred -------------Cc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 151 -------------GY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 151 -------------~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred cCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 11 2368899999999999999999999999999999999999999999999999876
Q ss_pred CCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 208 APSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 208 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..... .....+++.|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+....+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i 218 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 54321 223456788999999998899999999999999999999 99999998888776654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=246.83 Aligned_cols=172 Identities=21% Similarity=0.336 Sum_probs=129.2
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
..++|++.+.||+|+||+||+|++ +++.||||++................. ....||+++...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~--------~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNT--------VMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHH--------TCCCCTTBCCEEEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHH--------hhccCcCeeeEEEeecccc
Confidence 357899999999999999999987 477899999865432211111111000 001233222211
Q ss_pred ----------------------CcccCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEeCCCCCEEEe
Q psy4396 151 ----------------------GYSLYTEKDAAKYIYQVADAIHYCH--------QKKVIHRDIKPENLLLTMHEDVKIS 200 (271)
Q Consensus 151 ----------------------~~~~~~~~~~~~~~~qi~~~L~~LH--------~~~iiHrDikp~Nili~~~~~~kl~ 200 (271)
....+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 1134789999999999999999999 9999999999999999999999999
Q ss_pred eccccccCCCCC------cccccccccccCcceeccC------CCCCchhHHHHHHHHHHHHhC----------CCCCCC
Q psy4396 201 DFGWSVHAPSLH------RKTMCGTLDYLPPEMVTSQ------HYGKEVDNWCIGILAYEFLVG----------KPPFES 258 (271)
Q Consensus 201 Dfg~a~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------~~pf~~ 258 (271)
|||+++...... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999986533221 2234789999999999876 455799999999999999999 899965
Q ss_pred C
Q psy4396 259 K 259 (271)
Q Consensus 259 ~ 259 (271)
.
T Consensus 236 ~ 236 (301)
T 3q4u_A 236 V 236 (301)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=245.49 Aligned_cols=183 Identities=28% Similarity=0.459 Sum_probs=141.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.+.|++++.||+|+||.||+|.+..+++.||+|++....... ....+.++ ........||++....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQE----ITVLSQCDSPYVTKYYGSYLKDTK 94 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHH----HHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHH----HHHHHhCCCCCEeEEEEEEecCCe
Confidence 467999999999999999999999999999999986432110 00011111 0111111233222111
Q ss_pred -----------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--
Q psy4396 151 -----------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL-- 211 (271)
Q Consensus 151 -----------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~-- 211 (271)
....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 95 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 1134789999999999999999999999999999999999999999999999998665432
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
......||+.|+|||++.+..++.++|+||||+++|+|++|+.||......+....
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 230 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 230 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH
Confidence 23445789999999999999999999999999999999999999998877766544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=252.84 Aligned_cols=194 Identities=27% Similarity=0.377 Sum_probs=137.7
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEc-----CCCeEEEEEEcchhHHHH-------H-Hhhhhh-hcee-eeEEec
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYKVEIIN-------E-RMTHQV-HRER-CCQVHL 137 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~-------~-~~~~~~-~~~~-~~~~~~ 137 (271)
..+++..++|.+.+.||+|+||.||+|++. .++..||+|++....... + .....+ .... ......
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 356677899999999999999999999973 456789999986432110 0 001111 0000 000000
Q ss_pred CcCCCcceeeecc--Cc--------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q psy4396 138 SSSRRHPLLSSEE--GY--------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRD 183 (271)
Q Consensus 138 ~~~~~~~~l~~~~--~~--------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrD 183 (271)
.......+++... +. ..+++..+..++.|++.||+|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 0111111121111 10 1268888999999999999999999999999
Q ss_pred CCCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy4396 184 IKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFES 258 (271)
Q Consensus 184 ikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~ 258 (271)
|||+|||++.++.+||+|||++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999986543221 223456889999999999999999999999999999998 9999988
Q ss_pred CCHHHHHH
Q psy4396 259 KDQDTTLE 266 (271)
Q Consensus 259 ~~~~~~~~ 266 (271)
.+..+.+.
T Consensus 278 ~~~~~~~~ 285 (344)
T 1rjb_A 278 IPVDANFY 285 (344)
T ss_dssp CCCSHHHH
T ss_pred CCcHHHHH
Confidence 77655443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=247.11 Aligned_cols=177 Identities=23% Similarity=0.392 Sum_probs=132.2
Q ss_pred cccccCeEEecccccCCceEEEEEE----EcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAK----EKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
.+..++|++++.||+|+||+||+|+ +..+++.||||++....... ...+.+| ........||+++...+
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E----~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFERE----IEILKSLQHDNIVKYKG 78 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHH---HHHHHHH----HHHHHTCCCTTBCCEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHH---HHHHHHH----HHHHHhCCCCCEeeEEE
Confidence 3456889999999999999999999 56688999999986432111 1111111 11112223443332211
Q ss_pred -------------------c----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeec
Q psy4396 152 -------------------Y----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 152 -------------------~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 1 22788999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 203 GWSVHAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 203 g~a~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
|++....... .....+++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 9997654321 22344677899999999999999999999999999999999998643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=247.57 Aligned_cols=192 Identities=18% Similarity=0.308 Sum_probs=144.9
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEc-----CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcce
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPL 145 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (271)
....+.+..++|++.+.||+|+||.||+|.+. .+++.||+|++........ ...+.+| ........||+
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E----~~~l~~l~h~~ 89 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNE----ASVMKEFNCHH 89 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH--HHHHHHH----HHHGGGCCCTT
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHH--HHHHHHH----HHHHHhcCCCC
Confidence 34567777899999999999999999999887 3567899999864321111 0111111 11112223333
Q ss_pred eeeccC-----------------c-------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q psy4396 146 LSSEEG-----------------Y-------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENL 189 (271)
Q Consensus 146 l~~~~~-----------------~-------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Ni 189 (271)
+....+ . ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 90 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NI 169 (322)
T 1p4o_A 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 169 (322)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred EeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceE
Confidence 222111 1 1247788899999999999999999999999999999
Q ss_pred EeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy4396 190 LLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTT 264 (271)
Q Consensus 190 li~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~ 264 (271)
|++.++.+||+|||+++...... .....+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+..+.
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 249 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence 99999999999999986543321 223456889999999999999999999999999999999 9999999888877
Q ss_pred HHhh
Q psy4396 265 LERI 268 (271)
Q Consensus 265 ~~~I 268 (271)
...+
T Consensus 250 ~~~~ 253 (322)
T 1p4o_A 250 LRFV 253 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=242.41 Aligned_cols=195 Identities=18% Similarity=0.338 Sum_probs=142.5
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhceeeeEEecCcCCCccee
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRERCCQVHLSSSRRHPLL 146 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l 146 (271)
..|.+..++|++.+.||+|+||.||+|.+.. +..||+|++......... ....+.........-.....+.++
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI 84 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEE
Confidence 4567778999999999999999999999764 567999998653211111 011111110000000000111112
Q ss_pred eecc--Cc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 147 SSEE--GY-----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 147 ~~~~--~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
+... +. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 2111 11 1478899999999999999999999999999999999999999999999999976543322
Q ss_pred ---ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 214 ---KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
....+++.|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+..++...+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 223 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 23346788999999998889999999999999999999 99999998887776554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=249.74 Aligned_cols=197 Identities=22% Similarity=0.417 Sum_probs=141.8
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEc-------CCCeEEEEEEcchhHHHHH--------Hhhhhh-hcee-eeE
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEK-------TTQIMIALKVLYKVEIINE--------RMTHQV-HRER-CCQ 134 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~--------~~~~~~-~~~~-~~~ 134 (271)
...+.+..++|++.+.||+|+||.||+|++. .++..||+|++........ .....+ .... ...
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 4566777899999999999999999999986 3567899999864321100 000111 0000 000
Q ss_pred EecCcCCCcceeeecc--Cc-------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q psy4396 135 VHLSSSRRHPLLSSEE--GY-------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPE 187 (271)
Q Consensus 135 ~~~~~~~~~~~l~~~~--~~-------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~ 187 (271)
........+.+++... +. ..+++..+..++.|++.||+|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 0000111111111111 10 12688899999999999999999999999999999
Q ss_pred ceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy4396 188 NLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQD 262 (271)
Q Consensus 188 Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~ 262 (271)
|||++.++.+||+|||+++...... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999999997654322 223456789999999988889999999999999999999 99999998888
Q ss_pred HHHHhh
Q psy4396 263 TTLERI 268 (271)
Q Consensus 263 ~~~~~I 268 (271)
++...+
T Consensus 267 ~~~~~~ 272 (334)
T 2pvf_A 267 ELFKLL 272 (334)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776554
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=242.47 Aligned_cols=191 Identities=28% Similarity=0.436 Sum_probs=140.6
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhH------HHHHHhhhhhhceeee------------EEecCc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVE------IINERMTHQVHRERCC------------QVHLSS 139 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~~~~~------------~~~~~~ 139 (271)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .........+.+|... ......
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3588999999999999999999999999999999985421 0000001111111000 000001
Q ss_pred CCCcceeeecc--Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 140 SRRHPLLSSEE--GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 140 ~~~~~~l~~~~--~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
...+.+++... +. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 11111222111 11 24789999999999999999999999999999999999999999999999998765
Q ss_pred CC-CCcccccccccccCcceec------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 209 PS-LHRKTMCGTLDYLPPEMVT------SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.. .......+|+.|+|||++. ...++.++|+||||+++|+|++|+.||...+..+....+
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 241 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH
Confidence 43 2334467899999999885 456889999999999999999999999988877766554
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=261.73 Aligned_cols=183 Identities=22% Similarity=0.318 Sum_probs=136.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH----HHH-Hhhhhhhce--eeeEEecCcCCCcceeeeccC
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI----INE-RMTHQVHRE--RCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~-~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~ 151 (271)
.++|++++.||+|+||.||+|++..+++.||||++..... ..+ .....+... ............+.+++....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4789999999999999999999999999999998753211 111 111111110 000000000111112222111
Q ss_pred -----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe---CCCCCEEEeeccccccCCCCC-----
Q psy4396 152 -----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL---TMHEDVKISDFGWSVHAPSLH----- 212 (271)
Q Consensus 152 -----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili---~~~~~~kl~Dfg~a~~~~~~~----- 212 (271)
...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccc
Confidence 2347899999999999999999999999999999999999 578999999999997544322
Q ss_pred ----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 213 ----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 213 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 166 PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 1256789999999999999999999999999999999999999987544
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=249.04 Aligned_cols=186 Identities=31% Similarity=0.541 Sum_probs=115.8
Q ss_pred cccCeEEec-ccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhh---ce-eeeEEecC----cCCCcceeee
Q psy4396 78 QMSDFEVGC-PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVH---RE-RCCQVHLS----SSRRHPLLSS 148 (271)
Q Consensus 78 ~~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~---~~-~~~~~~~~----~~~~~~~l~~ 148 (271)
-.++|.+.+ .||+|+||.||+|.+..+++.||||++............... .. ........ ....+.+++.
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 457899965 699999999999999999999999998654322221111000 00 00000000 0011112211
Q ss_pred cc--C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCEEEeeccccccCCCCC
Q psy4396 149 EE--G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM---HEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 149 ~~--~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~---~~~~kl~Dfg~a~~~~~~~ 212 (271)
.. + ...+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~ 185 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc
Confidence 11 1 124899999999999999999999999999999999999976 4559999999998776655
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
.....+|+.|+|||++.+..++.++|+||||+++|+|++|+.||.......
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (336)
T 3fhr_A 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA 236 (336)
T ss_dssp ------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence 566778999999999988889999999999999999999999997766544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=245.80 Aligned_cols=186 Identities=26% Similarity=0.400 Sum_probs=129.9
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
.+.+..++|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+| ........||+++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e----~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKE----IQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------------CCCCCCCTTBCCEEEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHH----HHHHhhcCCCCEeeEEEEE
Confidence 4556678999999999999999999999888999999998643221 111122222 344444466665443221
Q ss_pred ---------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEE
Q psy4396 153 ---------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKI 199 (271)
Q Consensus 153 ---------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl 199 (271)
..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 22688999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCC-------CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 200 SDFGWSVHAPSL-------HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 200 ~Dfg~a~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
+|||++...... ......||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||...+..+..
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 236 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH
Confidence 999998654321 1234568999999999875 56899999999999999999999999887665544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=243.83 Aligned_cols=189 Identities=23% Similarity=0.329 Sum_probs=138.4
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
..+.+..++|.+.+.||+|+||+||+|.+... +..||+|++........ ...+.+|. .......||++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~----~~l~~l~h~~i~~~ 78 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN--KEKFMSEA----VIMKNLDHPHIVKL 78 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHH--HHHHHHHH----HHHHHHCCTTBCCE
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchH--HHHHHHHH----HHHHhCCCCCcceE
Confidence 34566778999999999999999999997643 45699999865311100 01111110 00111122222211
Q ss_pred --------------c--Cc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 150 --------------E--GY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 150 --------------~--~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
. +. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 79 IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EEEECSSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEEEcCCCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence 1 11 237889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 204 WSVHAPSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 204 ~a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
++....... .....+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~ 226 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH
Confidence 987654322 233456889999999998999999999999999999998 9999987777665544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=251.03 Aligned_cols=187 Identities=29% Similarity=0.466 Sum_probs=136.8
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH-------------HHhhhhhhc--e-eeeEEe
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-------------ERMTHQVHR--E-RCCQVH 136 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~~~--~-~~~~~~ 136 (271)
.......++|++.+.||+|+||.||+|.+..+++.||||++....... ......+.. . ......
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 333445688999999999999999999999999999999986543211 000111110 0 000000
Q ss_pred cCcCCCcceeeeccC------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC-CCCCEEEeecc
Q psy4396 137 LSSSRRHPLLSSEEG------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT-MHEDVKISDFG 203 (271)
Q Consensus 137 ~~~~~~~~~l~~~~~------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~-~~~~~kl~Dfg 203 (271)
........+++.... ...+++..+..++.|++.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 000011111111111 13478899999999999999999999999999999999998 77899999999
Q ss_pred ccccCCCCCcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 204 WSVHAPSLHRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 204 ~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
++............||+.|+|||++.+..+ +.++|+||||+++|||++|+.||...
T Consensus 196 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 196 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 998776655566779999999999987765 67899999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=243.74 Aligned_cols=185 Identities=28% Similarity=0.461 Sum_probs=139.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++.+.||+|+||.||+|++..+++.||+|++........ ....+.+|. .......||+++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~----~~l~~l~h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEV----NLLRELKHPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHH-HHHHHHHHH----HHHHHCCCTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHH-HHHHHHHHH----HHHHhcCCCCCCeEEEEEecCCC
Confidence 5789999999999999999999999999999999864321110 011111111 111111233222211
Q ss_pred -----------Cc-------------ccCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEeCCCCCEEEee
Q psy4396 151 -----------GY-------------SLYTEKDAAKYIYQVADAIHYCHQKK-----VIHRDIKPENLLLTMHEDVKISD 201 (271)
Q Consensus 151 -----------~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~~-----iiHrDikp~Nili~~~~~~kl~D 201 (271)
+. ..+++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 11 12788999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCC--cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 202 FGWSVHAPSLH--RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 202 fg~a~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
||++....... .....||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..++...|
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i 228 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH
Confidence 99987654332 22356899999999999989999999999999999999999999998887766554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=246.92 Aligned_cols=192 Identities=24% Similarity=0.377 Sum_probs=140.4
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEE-----cCCCeEEEEEEcchhHHHHHHhhhhhhceee------------eE
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKE-----KTTQIMIALKVLYKVEIINERMTHQVHRERC------------CQ 134 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~------------~~ 134 (271)
...+.+..++|++.+.||+|+||.||+|++ ..+++.||+|++........ ...+.+|.. ..
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHH--HHHHHHHHHHHhhcccCCCeeeE
Confidence 445677788999999999999999999996 34678999999864321110 011111100 00
Q ss_pred EecCcCCCcceeeecc--Cc---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q psy4396 135 VHLSSSRRHPLLSSEE--GY---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIK 185 (271)
Q Consensus 135 ~~~~~~~~~~~l~~~~--~~---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDik 185 (271)
...........++... +. ..+++..+..++.|++.||.|||++|++|||||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 172 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 0000111111221111 10 137889999999999999999999999999999
Q ss_pred CCceEeCCCCCEEEeeccccccCCCCCc----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy4396 186 PENLLLTMHEDVKISDFGWSVHAPSLHR----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKD 260 (271)
Q Consensus 186 p~Nili~~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~ 260 (271)
|+|||++.++.+||+|||++........ ....+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||.+..
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999976544322 23446789999999999999999999999999999998 999998876
Q ss_pred HHHHH
Q psy4396 261 QDTTL 265 (271)
Q Consensus 261 ~~~~~ 265 (271)
..+..
T Consensus 253 ~~~~~ 257 (313)
T 1t46_A 253 VDSKF 257 (313)
T ss_dssp SSHHH
T ss_pred chhHH
Confidence 55443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=243.60 Aligned_cols=189 Identities=24% Similarity=0.362 Sum_probs=140.4
Q ss_pred cccccccCeEEec-ccccCCceEEEEEEEc--CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 74 SYRWQMSDFEVGC-PLGTGKFGHVYLAKEK--TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 74 ~~~~~~~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
.+.+..++|.+.+ .||+|+||.||+|.+. .++..||+|+++...... ....+.+|. .......||+++...
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~----~~l~~l~h~~i~~~~ 76 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREA----QIMHQLDNPYIVRLI 76 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH--HHHHHHHHH----HHHHHCCCTTBCCEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchh--HHHHHHHHH----HHHHhCCCCCEeEEE
Confidence 3455668888887 9999999999999864 467889999986531110 011111110 111111223222111
Q ss_pred --------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 151 --------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 151 --------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 77 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp EEEESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEecCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence 113378999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+....... .....+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||...+..++...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i 226 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 97654322 123346889999999988889999999999999999998 99999988887766554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=251.16 Aligned_cols=181 Identities=22% Similarity=0.315 Sum_probs=127.4
Q ss_pred cccCeEEecccccCCceEEEEEEEcC---CCeEEEEEEcchhHHH--HH-Hhhhhhhc-eeeeEEecCcCCCcceeeecc
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKT---TQIMIALKVLYKVEII--NE-RMTHQVHR-ERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~-~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~ 150 (271)
..++|++.+.||+|+||.||+|.+.. ++..+|+|++...... .+ ........ .............||+++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45789999999999999999999987 7788999998643211 00 00000000 000001111112233222111
Q ss_pred -----------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC--CEEE
Q psy4396 151 -----------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE--DVKI 199 (271)
Q Consensus 151 -----------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~--~~kl 199 (271)
....+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred cccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 112579999999999999999999999999999999999998887 9999
Q ss_pred eeccccccCCC---------CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 200 SDFGWSVHAPS---------LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 200 ~Dfg~a~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
+|||+++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999965422 112345789999999999999999999999999999999999999965
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=258.52 Aligned_cols=180 Identities=23% Similarity=0.400 Sum_probs=132.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH--------HhhhhhhceeeeE---EecCcCCCcceee
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE--------RMTHQVHRERCCQ---VHLSSSRRHPLLS 147 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~~l~ 147 (271)
.++|.+.+.||+|+||+||+|++..+++.||||++........ .....+....... ........+.+++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4689999999999999999999999999999999865332110 0011111110000 0001111122222
Q ss_pred eccC--c------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe----CCCCCEEEeeccccccCC
Q psy4396 148 SEEG--Y------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL----TMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 148 ~~~~--~------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili----~~~~~~kl~Dfg~a~~~~ 209 (271)
.... . ..+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 2111 1 117899999999999999999999999999999999999 777789999999997654
Q ss_pred CC-CcccccccccccCcceecc--------CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTS--------QHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 43 2334668999999999865 5678899999999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=244.77 Aligned_cols=191 Identities=25% Similarity=0.402 Sum_probs=127.8
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
...+....++|++++.||+|+||.||+|.+..+++.||||++.......... ..+..+ ..+.....||+++...+
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~----~~~~~~~~h~~i~~~~~ 91 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK-RILMDL----DVVLKSHDCPYIVQCFG 91 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHH-HHHHHH----HHHHHTTTCTTBCCEEE
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHH-HHHHHH----HHHHHhcCCCceeeEEE
Confidence 4556677899999999999999999999999999999999986432111100 000000 00111122333222111
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 152 --------------------------YSLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 152 --------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
...+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 13478999999999999999999996 999999999999999999999999999
Q ss_pred cccCCC-CCcccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHh
Q psy4396 205 SVHAPS-LHRKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESK-DQDTTLER 267 (271)
Q Consensus 205 a~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~ 267 (271)
+..... .......+|+.|+|||++. ...++.++||||||+++|+|++|+.||... ...+.+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 241 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK 241 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence 865433 2233456899999999984 556889999999999999999999999874 34444443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=238.04 Aligned_cols=185 Identities=14% Similarity=0.197 Sum_probs=140.4
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
...+..++|++.+.||+|+||.||+|++. ++.||+|++........ ....+.+| ........||+++...+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~-~~~~~~~E----~~~l~~l~h~~iv~~~~~~ 76 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTR-KSRDFNEE----CPRLRIFSHPNVLPVLGAC 76 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHH-HHHHHHHH----GGGGCCCSCTTEECEEEEE
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHH-HHHHHHHH----HHHHHhcCCCchhheEEEE
Confidence 34567789999999999999999999986 67799999865321111 11112222 122222344444332211
Q ss_pred -----------------------------ccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeCCCCCEEEee
Q psy4396 153 -----------------------------SLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLTMHEDVKISD 201 (271)
Q Consensus 153 -----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~~~~~~kl~D 201 (271)
..+++..+..++.|++.||+|||++| ++||||||+|||++.++.++|+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp CTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred ccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEe
Confidence 13789999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccCcceeccCCCCC---chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 202 FGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGK---EVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 202 fg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
||++..... ....+|+.|+|||++.+..++. ++||||||+++|+|++|+.||.+.+..+....+
T Consensus 157 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 223 (271)
T 3kmu_A 157 ADVKFSFQS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223 (271)
T ss_dssp GGSCCTTSC---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred ccceeeecc---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence 987644322 3356899999999998765544 799999999999999999999988887765544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=248.26 Aligned_cols=188 Identities=26% Similarity=0.407 Sum_probs=143.2
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhh--------------hhhhceeeeEEecCcC
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT--------------HQVHRERCCQVHLSSS 140 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~ 140 (271)
.....++|++.+.||+|+||.||+|.+ +++.||||++........... ..+.+| ......
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E----~~~l~~ 99 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE----LQIITD 99 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHH----HHHHTT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHH----HHHHHh
Confidence 344578999999999999999999998 788999999865432210000 111111 111111
Q ss_pred CCcceeee--------------------------------ccC--cccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCC
Q psy4396 141 RRHPLLSS--------------------------------EEG--YSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIK 185 (271)
Q Consensus 141 ~~~~~l~~--------------------------------~~~--~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDik 185 (271)
..||+++. ... ...+++..+..++.|++.||+|||+ .|++|||||
T Consensus 100 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~ 179 (348)
T 2pml_X 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179 (348)
T ss_dssp CCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred CCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence 12222211 111 3457899999999999999999999 999999999
Q ss_pred CCceEeCCCCCEEEeeccccccCCCCCcccccccccccCcceeccC-CCCC-chhHHHHHHHHHHHHhCCCCCCCCCH-H
Q psy4396 186 PENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQ-HYGK-EVDNWCIGILAYEFLVGKPPFESKDQ-D 262 (271)
Q Consensus 186 p~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~el~~g~~pf~~~~~-~ 262 (271)
|+||+++.++.++|+|||++............||+.|+|||++.+. .++. ++|+||||+++|+|++|+.||...+. .
T Consensus 180 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 180 PSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp GGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred hHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999999999999999977655555567789999999999877 6666 99999999999999999999988776 5
Q ss_pred HHHHhh
Q psy4396 263 TTLERI 268 (271)
Q Consensus 263 ~~~~~I 268 (271)
++...+
T Consensus 260 ~~~~~i 265 (348)
T 2pml_X 260 ELFNNI 265 (348)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 555544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=244.75 Aligned_cols=196 Identities=20% Similarity=0.341 Sum_probs=137.5
Q ss_pred HHHHHHHHhhhhccccCCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeee
Q psy4396 54 VEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCC 133 (271)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~ 133 (271)
..+..+...........+........++|++.+.||+|+||.||+|++. ++.||||++.................
T Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~--- 85 (337)
T 3mdy_A 11 LRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQT--- 85 (337)
T ss_dssp HHHHHHHHHHHCSCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTS---
T ss_pred HHHHhcccccCCCCCCCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHH---
Confidence 3333333333333333333333444578999999999999999999986 77899999865432211111111000
Q ss_pred EEecCcCCCccee-------------------eecc--Cc--------ccCCHHHHHHHHHHHHHHHHHHHHC-------
Q psy4396 134 QVHLSSSRRHPLL-------------------SSEE--GY--------SLYTEKDAAKYIYQVADAIHYCHQK------- 177 (271)
Q Consensus 134 ~~~~~~~~~~~~l-------------------~~~~--~~--------~~~~~~~~~~~~~qi~~~L~~LH~~------- 177 (271)
....||++ +... +. ..+++..+..++.|++.||+|||++
T Consensus 86 -----~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~ 160 (337)
T 3mdy_A 86 -----VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160 (337)
T ss_dssp -----TTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB
T ss_pred -----HhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence 00122222 2111 11 2378899999999999999999999
Q ss_pred -CceeccCCCCceEeCCCCCEEEeeccccccCCCCCc------ccccccccccCcceeccCCCCCc------hhHHHHHH
Q psy4396 178 -KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR------KTMCGTLDYLPPEMVTSQHYGKE------VDNWCIGI 244 (271)
Q Consensus 178 -~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~ 244 (271)
||+||||||+|||++.++.+||+|||+++....... ....||+.|+|||++.+..++.. +|||||||
T Consensus 161 ~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 240 (337)
T 3mdy_A 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240 (337)
T ss_dssp CCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHH
T ss_pred CCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHH
Confidence 999999999999999999999999999965443221 24578999999999988776665 99999999
Q ss_pred HHHHHHhC----------CCCCCCC
Q psy4396 245 LAYEFLVG----------KPPFESK 259 (271)
Q Consensus 245 il~el~~g----------~~pf~~~ 259 (271)
++|||++| +.||...
T Consensus 241 il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 241 ILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred HHHHHHhccCcccccccccccHhhh
Confidence 99999999 7777643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=247.20 Aligned_cols=187 Identities=21% Similarity=0.316 Sum_probs=135.7
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCC----eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ----IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
++..++|.+.+.||+|+||.||+|.+..++ ..||+|++....... ....+.+| ........||+++...+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E----~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGE----AGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHH----HHHHHTCCCTTBCCEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHH--HHHHHHHH----HHHHHhCCCCCCCcEEE
Confidence 455688999999999999999999987553 469999986432111 11111111 11112223443322211
Q ss_pred c---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 152 Y---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 152 ~---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 1 2378899999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
++...... .....+|+.|+|||++.+..++.++|+||||+++|||++ |+.||.+.+..++...+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 263 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 87654321 122345788999999999999999999999999999998 99999988888776654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=245.90 Aligned_cols=190 Identities=25% Similarity=0.381 Sum_probs=133.0
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcC-CC--eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKT-TQ--IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
..+..++|++.+.||+|+||+||+|++.. ++ ..||+|+++............+.+|. .......||+++...+
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~----~~l~~l~h~~i~~~~~ 88 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV----NAMHSLDHRNLIRLYG 88 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHH----HHHHHCCCTTBCCEEE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHH----HHHHhCCCCCcccEEE
Confidence 34456789999999999999999998753 22 36999998654322111111222221 1111113333322211
Q ss_pred ----------------c----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 152 ----------------Y----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 152 ----------------~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 89 VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EECSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred EEccCCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 1 23788999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 206 VHAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 206 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
....... .....+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+..++...+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 237 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence 7654322 123456788999999998889999999999999999999 99999999888877665
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=247.82 Aligned_cols=174 Identities=20% Similarity=0.307 Sum_probs=127.9
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec----
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE---- 149 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---- 149 (271)
...+..++|++++.||+|+||.||+|++ +++.||||++.............+.. .....||++...
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~--------~~~~~h~~i~~~~~~~ 76 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYR--------VPLMEHDNIARFIVGD 76 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHT--------STTCCCTTBCCEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHH--------HHhccCcchhhheecc
Confidence 3456789999999999999999999976 46789999986543221111111100 111122222211
Q ss_pred ----------------c--Cc--------ccCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCceEeCCC
Q psy4396 150 ----------------E--GY--------SLYTEKDAAKYIYQVADAIHYCHQK---------KVIHRDIKPENLLLTMH 194 (271)
Q Consensus 150 ----------------~--~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---------~iiHrDikp~Nili~~~ 194 (271)
. +. ...++..+..++.|++.||+|||+. ||+||||||+|||++.+
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EEECTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred cccccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 1 11 2257788899999999999999999 99999999999999999
Q ss_pred CCEEEeeccccccCCCC----------CcccccccccccCcceecc-------CCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 195 EDVKISDFGWSVHAPSL----------HRKTMCGTLDYLPPEMVTS-------QHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 195 ~~~kl~Dfg~a~~~~~~----------~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
+.+||+|||+++..... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 99999999999654321 1224468999999999976 456778999999999999999976664
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=248.21 Aligned_cols=179 Identities=33% Similarity=0.600 Sum_probs=133.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH-----HHhhhhhhceeeeEEecCcCCCcceeeecc---
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-----ERMTHQVHRERCCQVHLSSSRRHPLLSSEE--- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--- 150 (271)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ......+.+| +.......||+++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE----IEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHH----HHHHHHCCCTTBCCEEEEE
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHH----HHHHHhCCCCCCceEeeEE
Confidence 367999999999999999999999999999999986532210 0000111111 1111122333322211
Q ss_pred ----------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---EEEeecccc
Q psy4396 151 ----------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWS 205 (271)
Q Consensus 151 ----------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~---~kl~Dfg~a 205 (271)
....+++..+..++.|++.||+|||++|++||||||+|||++.++. +||+|||++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 85 DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp ESSSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred cCCceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 1134789999999999999999999999999999999999987664 999999999
Q ss_pred ccCCCCC-cccccccccccCcceec---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 206 VHAPSLH-RKTMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 206 ~~~~~~~-~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
....... .....||+.|+|||++. ...++.++|+|||||++|+|++|+.||.....
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 7665432 23456899999999874 56789999999999999999999999976543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=242.28 Aligned_cols=179 Identities=28% Similarity=0.458 Sum_probs=134.2
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.++ ........||++....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~e----~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIKE----ISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCH-----HHHHH----HHHHHTCCCTTBCCEEEEEEETT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHH-----HHHHH----HHHHHhCCCCCCccEEEEEEeCC
Confidence 3578999999999999999999999999999999986432111 01111 11111112332222111
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 ---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 ---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 13478999999999999999999999999999999999999999999999999865443
Q ss_pred C--CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 211 L--HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
. ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+..
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 234 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 2 234456899999999999999999999999999999999999999887765543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=243.99 Aligned_cols=191 Identities=21% Similarity=0.340 Sum_probs=140.1
Q ss_pred CcccccccCeEEec-ccccCCceEEEEEEE--cCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 73 KSYRWQMSDFEVGC-PLGTGKFGHVYLAKE--KTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 73 ~~~~~~~~~~~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
....+..++|.+.+ .||+|+||.||+|.+ ..+++.||||++...... ......+.+| ........||++...
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e----~~~l~~l~h~~i~~~ 83 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAE----ANVMQQLDNPYIVRM 83 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHH----HHHHHTCCCTTBCCE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHH----HHHHHhCCCCCEEEE
Confidence 44556678899998 999999999999955 456789999998654211 1111111111 111112233333222
Q ss_pred cC-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 150 EG-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 150 ~~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
.+ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 84 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp EEEEESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEECCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 11 12378999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCc-----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLHR-----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+........ ....+++.|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+..++...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 233 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 876543221 22345788999999988889999999999999999999 99999998887776554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=240.95 Aligned_cols=177 Identities=30% Similarity=0.538 Sum_probs=134.4
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec---------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE--------- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--------- 149 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ ...+.+| ........||++...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKE----ICINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTH--HHHHHHH----HHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhh--hHHHHHH----HHHHHhcCCCCceeeeeEEEcCCE
Confidence 4689999999999999999999999999999999864321100 0011111 011111123322111
Q ss_pred -----------------cCcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--
Q psy4396 150 -----------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-- 210 (271)
Q Consensus 150 -----------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-- 210 (271)
.....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 1123478999999999999999999999999999999999999999999999999865422
Q ss_pred --CCcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 211 --LHRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.......||+.|+|||++.+..+ +.++|+||||+++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 12234568999999999987765 7789999999999999999999987654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=267.42 Aligned_cols=188 Identities=20% Similarity=0.343 Sum_probs=137.6
Q ss_pred cccccCeEEe-cccccCCceEEEEEEEc--CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc
Q psy4396 76 RWQMSDFEVG-CPLGTGKFGHVYLAKEK--TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY 152 (271)
Q Consensus 76 ~~~~~~~~~~-~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 152 (271)
.+....+.+. +.||+|+||.||+|.+. .+++.||||+++..... ......+.+| +.++....||+++.+.+.
T Consensus 364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E----~~il~~l~hpnIv~l~~~ 438 (635)
T 4fl3_A 364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAE----ANVMQQLDNPYIVRMIGI 438 (635)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHH----HHHHHHCCCTTBCCEEEE
T ss_pred cccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHH----HHHHHhCCCCCEeeEEEE
Confidence 3344455553 47999999999999654 56688999998653221 1111112222 122222234443332211
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 439 ~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 439 CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp EESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred EecCCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 2378999999999999999999999999999999999999999999999999975
Q ss_pred CCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 208 APSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 208 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++.+.|
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i 585 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 585 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 54321 223346788999999999999999999999999999998 99999999988877665
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=245.06 Aligned_cols=178 Identities=28% Similarity=0.486 Sum_probs=125.1
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+| ........||+++...
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHH----HHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHH----HHHHHhCCCCCEeeEEEEEEcCC
Confidence 46789999999999999999999999999999999864221111111111111 1111122333332221
Q ss_pred ----------C-------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 151 ----------G-------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 151 ----------~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 1 12368889999999999999999999999999999999999999999999999865
Q ss_pred CCCC--CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 208 APSL--HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 4432 223456899999999999999999999999999999999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=248.45 Aligned_cols=193 Identities=23% Similarity=0.366 Sum_probs=138.7
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCCe-----EEEEEEcchhHHHH-------H-Hhhhhh-hceee-eEEec
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQI-----MIALKVLYKVEIIN-------E-RMTHQV-HRERC-CQVHL 137 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~-------~-~~~~~~-~~~~~-~~~~~ 137 (271)
..+++..++|++.+.||+|+||.||+|.+..+++ .||+|++....... + .....+ ..... .....
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4567778999999999999999999999977654 79999986532110 0 001111 00000 00000
Q ss_pred CcCCCcceeeecc--C-----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC
Q psy4396 138 SSSRRHPLLSSEE--G-----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT 192 (271)
Q Consensus 138 ~~~~~~~~l~~~~--~-----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~ 192 (271)
.....+.+++... + ...+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 0111111222111 1 11357888999999999999999999999999999999999
Q ss_pred CCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy4396 193 MHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTL 265 (271)
Q Consensus 193 ~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 265 (271)
.++.+||+|||++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+.+
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999986543221 223456789999999999999999999999999999998 99999887655443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=262.14 Aligned_cols=188 Identities=21% Similarity=0.340 Sum_probs=144.1
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec--
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE-- 149 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-- 149 (271)
...|++..++|++.+.||+|+||.||+|.+..+ ..||||+++........ +.+| ..++....||+++..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~----~~~E----~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA----FLQE----AQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSCHHH----HHHH----HHHHHHCCCTTBCCEEE
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCCHHH----HHHH----HHHHHhCCCCCEeeEEE
Confidence 345677888999999999999999999998864 56999998653211111 1111 111111123322221
Q ss_pred ------------c--Cc-----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 150 ------------E--GY-----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 150 ------------~--~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
. +. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 330 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp EECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred EEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 1 11 2378889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
++...... .....++..|+|||++....++.++||||||+++|||++ |+.||.+....++++.+
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i 477 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH
T ss_pred ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 97654321 122346789999999999999999999999999999999 99999999888877665
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=240.29 Aligned_cols=183 Identities=24% Similarity=0.357 Sum_probs=134.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCe---EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-----
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQI---MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG----- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~----- 151 (271)
-.|.+.+.||+|+||+||+|.+..++. .||+|++....... ....+.+| ........||+++...+
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLRE----GLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHH--HHHHHHHH----HHHHHTCCCTTBCCCCEEECCS
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHH--HHHHHHHH----HHHHHhCCCCCeeeEEEEEecC
Confidence 357788999999999999999765543 79999986422111 01111111 11111112333222111
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 152 -----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 152 -----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 123678899999999999999999999999999999999999999999999998654
Q ss_pred CC------CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 209 PS------LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.. .......+|+.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+....+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~ 241 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh
Confidence 32 22233557889999999999999999999999999999999 66777777766655443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=265.95 Aligned_cols=188 Identities=24% Similarity=0.374 Sum_probs=138.9
Q ss_pred ccccccCeEEec-ccccCCceEEEEEEEc--CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 75 YRWQMSDFEVGC-PLGTGKFGHVYLAKEK--TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 75 ~~~~~~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
+.+..+++.+.+ .||+|+||.||+|.+. .++..||||+++..... .....+.+| +.++....||+++...+
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E----~~il~~l~hpniv~l~~ 403 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMRE----AQIMHQLDNPYIVRLIG 403 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHH----HHHHTTCCCTTBCCEEE
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHH----HHHHHhCCCCCEeeEEE
Confidence 334456677666 8999999999999876 35667999998653110 011111122 22222334444333221
Q ss_pred c--------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 152 Y--------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 152 ~--------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 404 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 404 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp EEESSSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred EeccCCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 1 23788999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 206 VHAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 206 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...|
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i 552 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 7653221 112335689999999999999999999999999999998 99999999888877665
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=246.91 Aligned_cols=186 Identities=22% Similarity=0.346 Sum_probs=139.5
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEE--EEEEcchhHHHHHHhhhhhhceeeeEEecCcCC-Ccceeeecc---
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMI--ALKVLYKVEIINERMTHQVHRERCCQVHLSSSR-RHPLLSSEE--- 150 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~--- 150 (271)
+..++|++.+.||+|+||.||+|++..++..+ |+|.+...... .....+.+| ....... .||+++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E----~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGE----LEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHH----HHHHTTCCCCTTBCCEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--HHHHHHHHH----HHHHHhccCCCchhhhceee
Confidence 45689999999999999999999999888755 99988642111 011111111 1111111 333332211
Q ss_pred --------------C-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEe
Q psy4396 151 --------------G-------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLL 191 (271)
Q Consensus 151 --------------~-------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili 191 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE
Confidence 1 0247889999999999999999999999999999999999
Q ss_pred CCCCCEEEeeccccccCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 192 TMHEDVKISDFGWSVHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 192 ~~~~~~kl~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
+.++.+||+|||+++..... ......+++.|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+..++.+.+
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 99999999999998754322 2233456889999999998889999999999999999998 99999999888877665
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=248.80 Aligned_cols=180 Identities=23% Similarity=0.376 Sum_probs=136.8
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
.........++|++.+.||+|+||.||+|++. +++.||||++........ ...+.+| +.......||+++...
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e----~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTE----VEMISMAVHRNLLRLR 93 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHH----HHGGGTCCCTTBCCCC
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHH----HHHHHhccCCCccceE
Confidence 33444556789999999999999999999854 577899999865432110 0011111 1222333455443322
Q ss_pred Cc------------------------------ccCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEeCCCCCE
Q psy4396 151 GY------------------------------SLYTEKDAAKYIYQVADAIHYCHQK---KVIHRDIKPENLLLTMHEDV 197 (271)
Q Consensus 151 ~~------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiHrDikp~Nili~~~~~~ 197 (271)
+. ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 21 1278899999999999999999999 99999999999999999999
Q ss_pred EEeeccccccCCCC---CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 198 KISDFGWSVHAPSL---HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 198 kl~Dfg~a~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
||+|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999999765422 2233558999999999988889999999999999999999999995
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=243.33 Aligned_cols=194 Identities=29% Similarity=0.390 Sum_probs=135.0
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH-----HHH-Hhhhhh-hceee---eEEecCc----
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI-----INE-RMTHQV-HRERC---CQVHLSS---- 139 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~-~~~~~~-~~~~~---~~~~~~~---- 139 (271)
......++|++.+.||+|+||.||+|++..+++.||||++..... ..+ .....+ ..... .......
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 444456899999999999999999999999999999999853211 111 011111 00000 0000000
Q ss_pred CCCcceeeecc--C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 140 SRRHPLLSSEE--G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 140 ~~~~~~l~~~~--~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
...+.+++... + ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 01112222211 1 1347899999999999999999999999999999999999999999999999987
Q ss_pred cCCCC--CcccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Q psy4396 207 HAPSL--HRKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267 (271)
Q Consensus 207 ~~~~~--~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 267 (271)
..... ......||+.|+|||++. +..++.++|+||||+++|+|++|+.||.+.+..+....
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 54432 233456899999999986 56689999999999999999999999988877665544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=246.07 Aligned_cols=175 Identities=30% Similarity=0.451 Sum_probs=126.7
Q ss_pred cCeEEe-cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 80 SDFEVG-CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 80 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
++|++. +.||+|+||.||+|.+..+++.||||++....... ...+.+|... +.....||+++...
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~---l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEM---LYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHH---HHHTCCCTTBCCEEEEEEETTE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHH---HHHhcCCCCeeeEEEEEeeCCE
Confidence 678885 78999999999999999999999999985431100 0001111000 00001233322211
Q ss_pred ---------Cc---------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---EEEeeccccccCC
Q psy4396 151 ---------GY---------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKISDFGWSVHAP 209 (271)
Q Consensus 151 ---------~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~---~kl~Dfg~a~~~~ 209 (271)
+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 11 33789999999999999999999999999999999999988776 9999999986432
Q ss_pred C---------CCcccccccccccCcceecc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 210 S---------LHRKTMCGTLDYLPPEMVTS-----QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 210 ~---------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 1 11223458999999999875 557899999999999999999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=246.40 Aligned_cols=184 Identities=23% Similarity=0.369 Sum_probs=132.6
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH------hhhhhhce---------eeeEEecCcC
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER------MTHQVHRE---------RCCQVHLSSS 140 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~~~---------~~~~~~~~~~ 140 (271)
.+..++|++.+.||+|+||+||+|++..+++.||||++......... ....+... ....+.+...
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 34567899999999999999999999999999999998643221110 00111100 0000000000
Q ss_pred -------CCcceeeecc------------CcccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCC------C
Q psy4396 141 -------RRHPLLSSEE------------GYSLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTM------H 194 (271)
Q Consensus 141 -------~~~~~l~~~~------------~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~------~ 194 (271)
..+..++... ....+++..+..++.|++.||+|||++ ||+||||||+|||++. .
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 0011222111 113378999999999999999999998 9999999999999943 3
Q ss_pred CCEEEeeccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 195 EDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 195 ~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 175 ~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 47999999999765443 334578999999999999999999999999999999999999998665
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=245.78 Aligned_cols=182 Identities=14% Similarity=0.234 Sum_probs=132.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcC--------CCeEEEEEEcchhHHHHH--Hhhhhhhceeee---------------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKT--------TQIMIALKVLYKVEIINE--RMTHQVHRERCC--------------- 133 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~--------------- 133 (271)
.++|++.+.||+|+||.||+|++.. .++.||+|++........ .....+......
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 4789999999999999999999987 378899999865321111 011111000000
Q ss_pred -EE-ecCcCCCcceeeecc-C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC--CE
Q psy4396 134 -QV-HLSSSRRHPLLSSEE-G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE--DV 197 (271)
Q Consensus 134 -~~-~~~~~~~~~~l~~~~-~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~--~~ 197 (271)
.. .........+++... + ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~ 200 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV 200 (352)
T ss_dssp CCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEE
T ss_pred chhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceE
Confidence 00 000001111221111 1 14589999999999999999999999999999999999999988 89
Q ss_pred EEeeccccccCCCC---------CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 198 KISDFGWSVHAPSL---------HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 198 kl~Dfg~a~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
||+|||+++..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 201 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 201 TLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp EECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred EEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 99999999654321 1133478999999999999999999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=240.93 Aligned_cols=181 Identities=23% Similarity=0.370 Sum_probs=135.7
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCC-------eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ-------IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS 148 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 148 (271)
++..++|.+.+.||+|+||.||+|.+..++ ..||+|++........ ..+.+| ........||+++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~---~~~~~E----~~~l~~l~h~~iv~ 76 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEA----ASMMSKLSHKHLVL 76 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGH---HHHHHH----HHHHHTSCCTTBCC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHH---HHHHHH----HHHHHhCCCCCEeE
Confidence 345688999999999999999999998776 5799999865322111 111111 11222223443332
Q ss_pred ccCc---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC-----
Q psy4396 149 EEGY---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED----- 196 (271)
Q Consensus 149 ~~~~---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~----- 196 (271)
..+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp EEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred EEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccc
Confidence 2111 12788999999999999999999999999999999999998887
Q ss_pred ---EEEeeccccccCCCCCcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy4396 197 ---VKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTL 265 (271)
Q Consensus 197 ---~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~ 265 (271)
+||+|||++...... ....+|+.|+|||++.+ ..++.++||||||+++|+|++ |.+||...+.....
T Consensus 157 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~ 228 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228 (289)
T ss_dssp CCEEEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred cceeeeccCcccccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence 999999998655432 33457899999999987 678999999999999999999 56677666555443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=243.68 Aligned_cols=184 Identities=29% Similarity=0.463 Sum_probs=136.0
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------ 151 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 151 (271)
..++|++++.||+|+||.||+|++..+++.||+|++....... ...+.++ ........||+++...+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVE----IEILATCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHH----HHHHHHCCCTTBCCEEEEEECC-
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHH----HHHHhcCCCCCEeeeeeeeeeCC
Confidence 3578999999999999999999999999999999985432110 0111111 11111113333322111
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 152 ---------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 152 ---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 13378999999999999999999999999999999999999999999999998743211
Q ss_pred --CCcccccccccccCccee-----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 --LHRKTMCGTLDYLPPEMV-----TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.......||+.|+|||++ .+..++.++|+||||+++|+|++|+.||...+..+....+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 234 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 234 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 122335689999999988 3667899999999999999999999999988877665543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=246.29 Aligned_cols=191 Identities=24% Similarity=0.388 Sum_probs=137.6
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEc-----CCCeEEEEEEcchhHHHHH--------Hhhhhhhc-ee-eeEEec
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYKVEIINE--------RMTHQVHR-ER-CCQVHL 137 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~--------~~~~~~~~-~~-~~~~~~ 137 (271)
..+.+..++|++.+.||+|+||.||+|++. .+++.||||++........ .....+.. .. ......
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 455666789999999999999999999864 4668999999865321110 00111100 00 000000
Q ss_pred -CcCCCcceeeecc--Cc-------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q psy4396 138 -SSSRRHPLLSSEE--GY-------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENL 189 (271)
Q Consensus 138 -~~~~~~~~l~~~~--~~-------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Ni 189 (271)
.......+++... +. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 1111111221111 10 1168899999999999999999999999999999999
Q ss_pred EeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 190 LLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 190 li~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
+++.++.+||+|||+++...... .....+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||.+....+
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 99999999999999997543322 223457889999999999999999999999999999998 999998776444
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=250.44 Aligned_cols=182 Identities=24% Similarity=0.343 Sum_probs=128.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
..|.+.+.||+|+||.||+|++..+ +..||+|.++.... ......+.+| ..+.....||+++...+.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E----~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTE----GIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--SHHHHHHHHH----HTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--HHHHHHHHHH----HHHHHhCCCCCcceEEEEEEcC
Confidence 4588899999999999999997643 34689999854211 0111112222 223333345544433221
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 22578889999999999999999999999999999999999999999999999754
Q ss_pred CCCC------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 209 PSLH------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 209 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
.... .....+|+.|+|||++.+..++.++||||||+++|||++ |.+||...+..++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~ 308 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH
Confidence 3221 123456789999999999999999999999999999999 8899987766555443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=245.95 Aligned_cols=182 Identities=28% Similarity=0.455 Sum_probs=132.8
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH---hhhhhhceeeeEEecCcCCCcceeee-----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---MTHQVHRERCCQVHLSSSRRHPLLSS----- 148 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~----- 148 (271)
.-.++|++.+.||+|+||.||+|++..+++.||||++......... ......++......+.....||++..
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999999999999999998653221100 00001111000001111112332222
Q ss_pred ----------cc---C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC-CCCCEEEeecccc
Q psy4396 149 ----------EE---G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT-MHEDVKISDFGWS 205 (271)
Q Consensus 149 ----------~~---~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~-~~~~~kl~Dfg~a 205 (271)
.. + ...+++..+..++.|++.||+|||++|++||||||+||+++ .++.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 11 0 12378999999999999999999999999999999999998 7899999999999
Q ss_pred ccCCCCCcccccccccccCcceeccCCCC-CchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 206 VHAPSLHRKTMCGTLDYLPPEMVTSQHYG-KEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~ 258 (271)
............||+.|+|||++.+..+. .++|+||||+++|+|++|+.||..
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 87766555667799999999999877664 589999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=241.37 Aligned_cols=190 Identities=21% Similarity=0.359 Sum_probs=141.5
Q ss_pred CCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 70 APNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
.....+.+..++|++.+.||+|+||.||+|++..+ +|+|+++..... ......+.+| ........||+++..
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~---~avk~~~~~~~~-~~~~~~~~~e----~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDN-EDQLKAFKRE----VMAYRQTRHENVVLF 94 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESSS---EEEEECCCCSCC-CCCCCCCCTT----GGGGTTCCCTTBCCC
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcCe---EEEEEeecCCCC-HHHHHHHHHH----HHHHhcCCCCCEeEE
Confidence 44567788889999999999999999999998653 999998643211 1111112222 333344456655433
Q ss_pred cCc---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeec
Q psy4396 150 EGY---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 150 ~~~---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
.+. ..+++..+..++.|++.||+|||++|++||||||+|||++ ++.++|+||
T Consensus 95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp CEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCC
T ss_pred EEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeec
Confidence 221 2378899999999999999999999999999999999998 789999999
Q ss_pred cccccCCC-------CCcccccccccccCcceecc---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 203 GWSVHAPS-------LHRKTMCGTLDYLPPEMVTS---------QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 203 g~a~~~~~-------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
|++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+...
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 253 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 98754321 12233458999999999864 457889999999999999999999999888877665
Q ss_pred hh
Q psy4396 267 RI 268 (271)
Q Consensus 267 ~I 268 (271)
.+
T Consensus 254 ~~ 255 (319)
T 2y4i_B 254 QM 255 (319)
T ss_dssp HH
T ss_pred Hh
Confidence 54
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=243.62 Aligned_cols=178 Identities=21% Similarity=0.291 Sum_probs=132.2
Q ss_pred cccccccCeEEecccccCCceEEEEEE----EcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAK----EKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
...+..++|++++.||+|+||.||+|+ +..+++.||+|++....... ....+.+| ........||++...
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E----~~~l~~l~h~~i~~~ 88 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKE----IEILRNLYHENIVKY 88 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHH----HHHHHTCCCTTBCCE
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHH----HHHHHhCCCCCeeee
Confidence 334556789999999999999999999 46688999999986432110 00111111 111111122222211
Q ss_pred -------------------cCc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEe
Q psy4396 150 -------------------EGY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKIS 200 (271)
Q Consensus 150 -------------------~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~ 200 (271)
.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+
T Consensus 89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp EEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred eeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEEC
Confidence 111 237889999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 201 DFGWSVHAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 201 Dfg~a~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
|||++....... .....+|+.|+|||++.+..++.++|+||||+++|+|++|..|+.
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 999997654322 233457888999999999889999999999999999999998864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=239.19 Aligned_cols=177 Identities=21% Similarity=0.280 Sum_probs=129.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++.+.||+|+||+||+|.+..+++.||+|++.......... ....++.. .+.....||+++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~e~~---~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVY---AHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHH-HHHHHHHH---HHHHSCSCTTBCCEEEEEEETTE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHH-HHHHHHHH---HHHHhCCCCCeeeeeeeeecCCe
Confidence 467999999999999999999999999999999986421110000 00001100 000000233222211
Q ss_pred ---------Cc-------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC--------------
Q psy4396 151 ---------GY-------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-------------- 194 (271)
Q Consensus 151 ---------~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-------------- 194 (271)
+. ..+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 11 236889999999999999999999999999999999999844
Q ss_pred -----CCEEEeeccccccCCCCCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 195 -----EDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 195 -----~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|.+|+...+.
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ--VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC--CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred ccCCceEEEEcccccccccCCcc--ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 479999999987665433 34589999999999765 566899999999999999999988765443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=240.41 Aligned_cols=183 Identities=25% Similarity=0.357 Sum_probs=132.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC----
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG---- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---- 151 (271)
..+|++.+.||+|+||+||+|++..+ ...+|+|.+....... ....+.+| ........||+++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~E----~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTE----GIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHH--HHHHHHHH----HHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHH--HHHHHHHH----HHHHHhCCCCCEeeeeeEEEc
Confidence 35699999999999999999997543 3468999976422111 00111111 11111112332222111
Q ss_pred ------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 152 ------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 152 ------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 12368899999999999999999999999999999999999999999999999975
Q ss_pred CCCCC------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHh
Q psy4396 208 APSLH------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLER 267 (271)
Q Consensus 208 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~ 267 (271)
..... .....+|+.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 43321 223456789999999999999999999999999999999 7888887776665444
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=238.38 Aligned_cols=184 Identities=37% Similarity=0.615 Sum_probs=138.4
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-------- 150 (271)
.++|++.+.||+|+||.||+|++..+++.||+|++........ ....+.+| ........||++....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e----~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILRE----VELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-CHHHHHHH----HHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-HHHHHHHH----HHHHHhccCCCccEEEEEEeCCCe
Confidence 3679999999999999999999999999999999864321100 00011111 1111111233322211
Q ss_pred ---------C---------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC---CCEEEeeccccccCC
Q psy4396 151 ---------G---------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH---EDVKISDFGWSVHAP 209 (271)
Q Consensus 151 ---------~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~---~~~kl~Dfg~a~~~~ 209 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 1 1347899999999999999999999999999999999999754 469999999987554
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
.. ......+|+.|+|||++.+. ++.++|+||||+++|+|++|+.||.+.+..++..++
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 32 23345689999999988764 899999999999999999999999998887776654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=242.71 Aligned_cols=179 Identities=22% Similarity=0.313 Sum_probs=132.1
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc--
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE-- 150 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-- 150 (271)
..+.+..++|++.+.||+|+||.||+|++..+++.||||++........ ..+.+| ........||+++...
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E----~~~l~~l~h~~iv~~~~~ 94 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQRE----ADMHRLFNHPNILRLVAY 94 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHH---HHHHHH----HHHHHTCCCTTBCCCCEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHH---HHHHHH----HHHHhhcCCCCeeeEEEE
Confidence 3445566889999999999999999999999999999998743211111 111111 1111111233322211
Q ss_pred -------------------C-------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEE
Q psy4396 151 -------------------G-------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVK 198 (271)
Q Consensus 151 -------------------~-------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~k 198 (271)
+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~k 174 (317)
T 2buj_A 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV 174 (317)
T ss_dssp EEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred EEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEE
Confidence 1 13378999999999999999999999999999999999999999999
Q ss_pred EeeccccccCCCCCc-----------ccccccccccCcceeccCC---CCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 199 ISDFGWSVHAPSLHR-----------KTMCGTLDYLPPEMVTSQH---YGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 199 l~Dfg~a~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
|+|||++........ ....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 999998865432111 1234699999999987554 68999999999999999999999953
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=238.91 Aligned_cols=172 Identities=28% Similarity=0.446 Sum_probs=126.3
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
++.++|++.+.||+|+||.||+|++. ++.||+|.+....... .+.+| +.......||+++...+.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~-----~~~~E----~~~l~~l~hp~iv~~~~~~~~~ 73 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERK-----AFIVE----LRQLSRVNHPNIVKLYGACLNP 73 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHH-----HHHHH----HHHHHHCCCTTBCCEEEBCTTT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHH-----HHHHH----HHHHhcCCCCCcCeEEEEEcCC
Confidence 45688999999999999999999886 5679999986432211 11111 111111233333222111
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCceEeCCCCC-EEEeecccc
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQ---KKVIHRDIKPENLLLTMHED-VKISDFGWS 205 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~---~~iiHrDikp~Nili~~~~~-~kl~Dfg~a 205 (271)
..++...+..++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 125788899999999999999999 89999999999999998887 799999998
Q ss_pred ccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 206 VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 154 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 154 CDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred cccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 654432 233468999999999999999999999999999999999999997543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=242.68 Aligned_cols=187 Identities=25% Similarity=0.361 Sum_probs=133.4
Q ss_pred cccccCeEEecccccCCceEEEEEE-----EcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec-
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAK-----EKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE- 149 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~- 149 (271)
.+..++|++.+.||+|+||.||+|+ +..+++.||||++........ ...+.+| ........||+++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E----~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLME----ALIISKFNHQNIVRCI 99 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHH--HHHHHHH----HHHHHHCCCTTBCCEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhh--HHHHHHH----HHHHhhCCCCCCCeEE
Confidence 4556899999999999999999999 556778899999853211100 0011111 011111123322221
Q ss_pred --------------c--Cc----------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC---
Q psy4396 150 --------------E--GY----------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH--- 194 (271)
Q Consensus 150 --------------~--~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~--- 194 (271)
. +. ..+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 1 11 226788899999999999999999999999999999999844
Q ss_pred CCEEEeeccccccCCC----CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 195 EDVKISDFGWSVHAPS----LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 195 ~~~kl~Dfg~a~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
..+||+|||++..... .......+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||...+..++.+.+
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 4699999999864321 12234557889999999999999999999999999999998 99999998888776654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=260.50 Aligned_cols=189 Identities=24% Similarity=0.401 Sum_probs=140.3
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
.+.+..++|++.+.||+|+||.||+|.+..+ +..||+|.+...... .....+.+| ........||+++...
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E----~~~l~~l~HpnIv~l~ 457 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQE----ALTMRQFDHPHIVKLI 457 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH--HHHHHHHHH----HHHHHHCCCTTBCCEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH--HHHHHHHHH----HHHHHhCCCCCCCeEE
Confidence 4556678899999999999999999998653 467999997542111 001111111 1111112333332221
Q ss_pred C----------------c----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 151 G----------------Y----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 151 ~----------------~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
+ . ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 458 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp EEECSSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred EEEecCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCC
Confidence 1 1 1368888999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
++...... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+++..|
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i 605 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 97654322 223446789999999999999999999999999999997 99999998888877655
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=237.73 Aligned_cols=182 Identities=30% Similarity=0.528 Sum_probs=134.0
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
...+....++|.....||+|+||.||+|.+..+++.||+|++....... ...+.++ ........||+++...+
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e----~~~l~~l~h~~iv~~~~ 86 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEE----IALHKHLKHKNIVQYLG 86 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHH----HHHHHTCCCTTBCCEEE
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH---HHHHHHH----HHHHHhCCCCCEeeEee
Confidence 3444555666776778999999999999999999999999985432110 0111111 11111223333322211
Q ss_pred c-----------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-CCCEEEee
Q psy4396 152 Y-----------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM-HEDVKISD 201 (271)
Q Consensus 152 ~-----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~-~~~~kl~D 201 (271)
. ..+++..+..++.|++.||+|||++|++||||||+||+++. ++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~D 166 (295)
T 2clq_A 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISD 166 (295)
T ss_dssp EEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECC
T ss_pred EEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEee
Confidence 1 12468888899999999999999999999999999999987 89999999
Q ss_pred ccccccCCCC--CcccccccccccCcceeccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 202 FGWSVHAPSL--HRKTMCGTLDYLPPEMVTSQH--YGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 202 fg~a~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
||++...... ......||+.|+|||++.+.. ++.++|+||||+++|+|++|+.||...+
T Consensus 167 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 167 FGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp TTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred cccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 9998765432 233456899999999987643 7899999999999999999999997543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=242.11 Aligned_cols=185 Identities=22% Similarity=0.370 Sum_probs=134.6
Q ss_pred ccccCeEEecccccCCceEEEEEE----EcCCCeEEEEEEcchhHHHHHH-------hhhhhhceeeeE---EecCcCCC
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAK----EKTTQIMIALKVLYKVEIINER-------MTHQVHRERCCQ---VHLSSSRR 142 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~~~~~~~---~~~~~~~~ 142 (271)
+..++|++.+.||+|+||.||+|+ +..+++.||||++......... ....+....... ........
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 456889999999999999999999 4677899999998643211110 001111100000 00000111
Q ss_pred cceeeecc--Cc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 143 HPLLSSEE--GY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 143 ~~~l~~~~--~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..+++... +. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 11122111 11 2378999999999999999999999999999999999999999999999999976543
Q ss_pred CC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 211 LH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 211 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.. .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 22 2234578889999999998899999999999999999999999965443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=232.30 Aligned_cols=179 Identities=28% Similarity=0.378 Sum_probs=132.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH--HH-HhhhhhhceeeeEE-ecC----------------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--NE-RMTHQVHRERCCQV-HLS---------------- 138 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~-~~~~~~~~~~~~~~-~~~---------------- 138 (271)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... .+ .....+........ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 36799999999999999999999989999999998643211 11 00111110000000 000
Q ss_pred cCCCcceeeecc--C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 139 SSRRHPLLSSEE--G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 139 ~~~~~~~l~~~~--~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
......+++... + ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 169 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhh
Confidence 000001111111 1 134788999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 206 VHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 206 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
...... ......+|+.|+|||++.+..++.++|+||||+++|+|++|..||.
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 170 TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred eeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 765432 3344568999999999999999999999999999999999998885
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=241.79 Aligned_cols=178 Identities=24% Similarity=0.293 Sum_probs=130.2
Q ss_pred cccccCeEEecccccCCceEEEEEEE----cCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee---
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKE----KTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS--- 148 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--- 148 (271)
.+..+.|++++.||+|+||+||++.+ ..+++.||||+++...... ....+.+|. .......||+++.
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~----~~l~~l~h~~iv~~~~ 100 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEI----DILRTLYHEHIIKYKG 100 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHH--HHHHHHHHH----HHHHHCCCTTBCCEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChH--HHHHHHHHH----HHHHhCCCcchhhEEE
Confidence 34445569999999999999988765 4578899999986532110 011111110 1111112222211
Q ss_pred --------------cc--C--------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 149 --------------EE--G--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 149 --------------~~--~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
.. + ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence 11 1 12378999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 205 SVHAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 205 a~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
+....... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 97655432 22345788899999999988999999999999999999999999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-33 Score=239.04 Aligned_cols=173 Identities=26% Similarity=0.400 Sum_probs=125.7
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH-HHHhhhhhhceeeeEEecCcCCCcceeeecc----------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII-NERMTHQVHRERCCQVHLSSSRRHPLLSSEE---------- 150 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---------- 150 (271)
|...+.||+|+||.||+|.+ +++.||+|++...... .......+.+| ........||+++...
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E----~~~l~~l~h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQE----IKVMAKCQHENLVELLGFSSDGDDLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHH----HHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHH----HHHHHhcCCCCeEEEEEEEecCCceE
Confidence 34467899999999999986 4667999998542110 00011111111 1111111233222111
Q ss_pred -------C------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 151 -------G------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 151 -------~------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 1 123788999999999999999999999999999999999999999999999998755432
Q ss_pred C----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 212 H----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 212 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
. .....||+.|+|||++.+ .++.++|+||||+++|+|++|+.||.....
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 1 233568999999998865 478999999999999999999999987554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.1e-33 Score=237.52 Aligned_cols=179 Identities=21% Similarity=0.285 Sum_probs=127.9
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhh------hceeee---EEecCcC--CCcceee
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQV------HRERCC---QVHLSSS--RRHPLLS 147 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------~~~~~~---~~~~~~~--~~~~~l~ 147 (271)
.++|++.+.||+|+||.||+|++. ++.||||++.............+ ...... ....... ..+.+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 478999999999999999999984 77899999865432111000000 000000 0000000 0011222
Q ss_pred ecc--Cc--------ccCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 148 SEE--GY--------SLYTEKDAAKYIYQVADAIHYCH--------QKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 148 ~~~--~~--------~~~~~~~~~~~~~qi~~~L~~LH--------~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
... +. ..+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 198 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198 (342)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEE
T ss_pred EeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecc
Confidence 111 11 23788999999999999999999 8999999999999999999999999999986544
Q ss_pred CCC------cccccccccccCcceeccCC------CCCchhHHHHHHHHHHHHhC----------CCCCCCC
Q psy4396 210 SLH------RKTMCGTLDYLPPEMVTSQH------YGKEVDNWCIGILAYEFLVG----------KPPFESK 259 (271)
Q Consensus 210 ~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~el~~g----------~~pf~~~ 259 (271)
... .....||+.|+|||++.+.. ++.++||||||+++|||++| ..||...
T Consensus 199 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp TTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred ccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 322 23456899999999987652 33689999999999999999 8899765
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=231.85 Aligned_cols=167 Identities=29% Similarity=0.467 Sum_probs=122.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++++.||+|+||.||+|++..+++.||||++........ .+.+| ........||++....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~E----~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSE----VMLLASLNHQYVVRYYAAWLERRNF 77 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHH----HHHHH----HHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHH----HHHHH----HHHHHhcCchHHHHHHHHHHhhcch
Confidence 679999999999999999999999999999999864321111 11111 1111112233322211
Q ss_pred ---------------------C----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEE
Q psy4396 151 ---------------------G----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKI 199 (271)
Q Consensus 151 ---------------------~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl 199 (271)
+ ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 1 123577889999999999999999999999999999999999999999
Q ss_pred eeccccccCCC----------------CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 200 SDFGWSVHAPS----------------LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 200 ~Dfg~a~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
+|||++..... .......||+.|+|||++.+. .++.++|+||||+++|+|++ ||.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 99999865432 122345689999999999764 68999999999999999997 554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=236.30 Aligned_cols=187 Identities=21% Similarity=0.369 Sum_probs=129.5
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH--------HHH-Hhhhhhhc--e-eeeEEecCc
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI--------INE-RMTHQVHR--E-RCCQVHLSS 139 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~-~~~~~~~~--~-~~~~~~~~~ 139 (271)
.....+.-++|++++.||+|+||.||+|.+.. ++.||+|++..... ..+ .....+.. . .........
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 44555667789999999999999999999865 77899999853211 000 01111111 0 000011111
Q ss_pred CCCcceeeeccC----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 140 SRRHPLLSSEEG----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 140 ~~~~~~l~~~~~----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
...+.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||++ ++.+||+|||++....
T Consensus 99 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 99 TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp CSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred cCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 111222222211 13478889999999999999999999999999999999996 5899999999987544
Q ss_pred CCC----cccccccccccCcceecc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 210 SLH----RKTMCGTLDYLPPEMVTS-----------QHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 210 ~~~----~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 322 234568999999999865 468889999999999999999999997654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-33 Score=238.53 Aligned_cols=176 Identities=23% Similarity=0.352 Sum_probs=132.3
Q ss_pred cccccCeEEecccccCCceEEEEEEE----cCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee-----
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKE----KTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL----- 146 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l----- 146 (271)
.+..++|++++.||+|+||.||+|++ ..+++.||+|++....... ...+.+|. .......||++
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~----~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREI----EILKSLQHDNIVKYKG 109 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHH---HHHHHHHH----HHHHTCCCTTBCCEEE
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHH---HHHHHHHH----HHHHhCCCCCeeeEEE
Confidence 34567899999999999999999994 5678999999986432111 00111110 11111122222
Q ss_pred ------------eecc--Cc----------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeec
Q psy4396 147 ------------SSEE--GY----------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 147 ------------~~~~--~~----------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
+... +. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+||
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence 2111 11 23788999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCc-----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 203 GWSVHAPSLHR-----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 203 g~a~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
|++........ ....+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 99976543321 233467789999999988899999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=242.22 Aligned_cols=178 Identities=24% Similarity=0.286 Sum_probs=122.6
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCC-CcceeeeccCc-
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR-RHPLLSSEEGY- 152 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~- 152 (271)
..+...+|.+.+.||+|+||+|+.. ...+++.||||++....... ..+| +.+.... .||+++...+.
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~------~~~E----~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSF------ADRE----VQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEE------CHHH----HHHHHHSCCCTTBCCEEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHH------HHHH----HHHHHhccCCCCcCeEEEEE
Confidence 3444557999999999999997643 34567789999985432110 0011 0111111 34444332211
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-----CCEEEeec
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-----EDVKISDF 202 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-----~~~kl~Df 202 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.+ ..+||+||
T Consensus 88 ~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 88 KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp EETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred ecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 113444567899999999999999999999999999999532 35789999
Q ss_pred cccccCCCC-----CcccccccccccCcceec---cCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy4396 203 GWSVHAPSL-----HRKTMCGTLDYLPPEMVT---SQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDT 263 (271)
Q Consensus 203 g~a~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 263 (271)
|+|+..... .....+||+.|+|||++. ...++.++|||||||++|||++ |..||.......
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~ 237 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence 999765432 233467999999999997 4667889999999999999999 999997654443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=253.62 Aligned_cols=172 Identities=22% Similarity=0.323 Sum_probs=130.6
Q ss_pred ccccCeEEecccccCCceEEEEEEEcC-CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKT-TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE----- 150 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----- 150 (271)
...++|++.+.||+|+||.||+|.+.. +++.||||++....... ....+..| ........||+++...
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E----~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE--AQAMAMAE----RQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHH--HHHHHHHH----HGGGGGCCCTTBCCEEEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHH--HHHHHHHH----HHHHHhcCCCCcCeEeeeEee
Confidence 334899999999999999999999986 78999999985421110 00011111 1111112233322211
Q ss_pred -----------------C-------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 151 -----------------G-------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 151 -----------------~-------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
+ ...+++..+..++.|++.||.|||++||+||||||+|||++.+ .+||+|||+++
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 1 0247899999999999999999999999999999999999964 99999999997
Q ss_pred cCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 207 HAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+
T Consensus 230 ~~~~~--~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 230 RINSF--GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ETTCC--SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hcccC--CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 76543 446799999999998765 48899999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=240.66 Aligned_cols=171 Identities=26% Similarity=0.308 Sum_probs=117.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCc-CCCcceeeeccCc------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS-SRRHPLLSSEEGY------ 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~------ 152 (271)
+.|.+.+.||+|+||+||.+. ..+++.||||++........ .+|. .... ...||+++...+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~------~~E~----~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIA------LMEI----KLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHH------HHHH----HHHHHHTTSTTBCCEEEEEECSSE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHH------HHHH----HHHHhccCCCCcCeEEEEEecCCe
Confidence 345667889999999998754 45688999999864321110 0000 0000 0123333222111
Q ss_pred ---------cc-----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC------------
Q psy4396 153 ---------SL-----------------YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH------------ 194 (271)
Q Consensus 153 ---------~~-----------------~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~------------ 194 (271)
+. .++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 84 ~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 84 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 00 1222346799999999999999999999999999999754
Q ss_pred -CCEEEeeccccccCCCCC------cccccccccccCcceecc-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy4396 195 -EDVKISDFGWSVHAPSLH------RKTMCGTLDYLPPEMVTS-------QHYGKEVDNWCIGILAYEFLV-GKPPFESK 259 (271)
Q Consensus 195 -~~~kl~Dfg~a~~~~~~~------~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~-g~~pf~~~ 259 (271)
+.+||+|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 479999999997654322 224579999999999865 668999999999999999998 99999765
Q ss_pred CH
Q psy4396 260 DQ 261 (271)
Q Consensus 260 ~~ 261 (271)
..
T Consensus 244 ~~ 245 (434)
T 2rio_A 244 YS 245 (434)
T ss_dssp TT
T ss_pred hh
Confidence 43
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=252.47 Aligned_cols=178 Identities=29% Similarity=0.447 Sum_probs=131.9
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee-----------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL----------- 146 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l----------- 146 (271)
..++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+| ........||++
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~--~~~~~~~E----i~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLE----IQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHH--HHHHHHHH----HHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHH--HHHHHHHH----HHHHHhCCCCCCCceeeeecccc
Confidence 3588999999999999999999999999999999985421100 00111111 011111122222
Q ss_pred ----------eecc--Cc------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCC---EEE
Q psy4396 147 ----------SSEE--GY------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED---VKI 199 (271)
Q Consensus 147 ----------~~~~--~~------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~---~kl 199 (271)
+... +. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++. +||
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 2111 11 14788899999999999999999999999999999999997765 899
Q ss_pred eeccccccCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 200 SDFGWSVHAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 200 ~Dfg~a~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
+|||++...... ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+...
T Consensus 166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred cccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999765433 23446789999999999999999999999999999999999999976544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=232.86 Aligned_cols=101 Identities=16% Similarity=0.128 Sum_probs=89.8
Q ss_pred cCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeCCCC--------------------CEEEeeccccccCCCCC
Q psy4396 154 LYTEKDAAKYIYQVADAIHYCH-QKKVIHRDIKPENLLLTMHE--------------------DVKISDFGWSVHAPSLH 212 (271)
Q Consensus 154 ~~~~~~~~~~~~qi~~~L~~LH-~~~iiHrDikp~Nili~~~~--------------------~~kl~Dfg~a~~~~~~~ 212 (271)
.+++..++.++.|++.||+||| ++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 157 ~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~- 235 (336)
T 2vuw_A 157 LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG- 235 (336)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-
Confidence 4689999999999999999999 99999999999999999887 8999999999765432
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHH-HHHHHhCCCCCCC
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGIL-AYEFLVGKPPFES 258 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~el~~g~~pf~~ 258 (271)
..+||+.|+|||++.+.. +.++||||||++ .+++++|..||.+
T Consensus 236 --~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 236 --IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp --EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred --cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 357999999999998776 889999998777 6778899999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=220.71 Aligned_cols=156 Identities=14% Similarity=0.110 Sum_probs=115.8
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
-.++|++.+.||+|+||.||+|++..+++.||||++.............+.++. .......||+++...+.
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~----~~l~~l~hp~iv~~~~~~~~~~ 104 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRT----LRLSRIDKPGVARVLDVVHTRA 104 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHH----HHHHTCCCTTBCCEEEEEEETT
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHH----HHHhcCCCCCcceeeEEEEECC
Confidence 347899999999999999999999999999999998654221111111111111 11122234433322111
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
......++..++.|++.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred cEEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 113566788999999999999999999999999999999999999998544
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
|++| ++.++|||||||++|||++|+.||.+.+..
T Consensus 175 --------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 --------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp --------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred --------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 3333 688999999999999999999999876653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=217.61 Aligned_cols=166 Identities=31% Similarity=0.516 Sum_probs=116.8
Q ss_pred cccCeEEe-cccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhh--hh-hcee-----eeEEecCcCCCcceeee
Q psy4396 78 QMSDFEVG-CPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH--QV-HRER-----CCQVHLSSSRRHPLLSS 148 (271)
Q Consensus 78 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~--~~-~~~~-----~~~~~~~~~~~~~~l~~ 148 (271)
..++|.+. +.||+|+||.||+|.+..+++.||+|++........+... .. .... ...........+.+++.
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 45788887 7899999999999999999999999998653322211110 00 0000 00000000011112221
Q ss_pred cc--C-----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCEEEeeccccccCCCCC
Q psy4396 149 EE--G-----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM---HEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 149 ~~--~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~---~~~~kl~Dfg~a~~~~~~~ 212 (271)
.. + ...+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 11 1 124789999999999999999999999999999999999998 7889999999885433
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
+..++.++|+|||||++|+|++|+.||.+.+..+
T Consensus 172 -----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 205 (299)
T 3m2w_A 172 -----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205 (299)
T ss_dssp -----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----
T ss_pred -----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh
Confidence 2346789999999999999999999997765443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-27 Score=214.69 Aligned_cols=162 Identities=10% Similarity=0.016 Sum_probs=90.9
Q ss_pred ecccccCCceEEEEEEEcCCCeEEEEEEcchhHH-------HHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 85 GCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI-------INERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 85 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
....+.|+.|.+..++..-.++.+|+|++.+... ..+...+.+.+|......+ ..|+++..+..+
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~---~~~~~i~~~~~~~ed~~ 315 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQP---PAGFDAPAVLAHGENAQ 315 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSC---CTTCCCCCEEEEEECSS
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhc---CCCCCeeEEEEEEEECC
Confidence 3346778888777777776788899999864311 1112222333332111111 134433322111
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS- 210 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~- 210 (271)
..+++. .++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 234443 5889999999999999999999999999999999999999999976543
Q ss_pred -CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCC
Q psy4396 211 -LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGK 253 (271)
Q Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 253 (271)
....+.+||+.|+|||++.+. +..++|+||+|++++++.++.
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 334557899999999999764 577899999999877765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7e-24 Score=192.77 Aligned_cols=164 Identities=15% Similarity=0.145 Sum_probs=109.5
Q ss_pred EecccccCCceEEEEEEEcCCCeEEEEEEcchhHH-----HHHHhhhhhhceeeeEEecCcCCCcceee-----------
Q psy4396 84 VGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI-----INERMTHQVHRERCCQVHLSSSRRHPLLS----------- 147 (271)
Q Consensus 84 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~----------- 147 (271)
..+.||+|+||.||+|... ++.+|+|....... ......+.+.+| ........||+++
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E----~~il~~l~h~nIv~~~~~~~~~~~ 413 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTARE----ARYLALVKDFGIPAPYIFDVDLDN 413 (540)
T ss_dssp --------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHH----HHHHHHGGGGTCCCCCEEEEETTT
T ss_pred CCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHH----HHHHHhcCCCCcCceEEEEEeCCc
Confidence 4568999999999999544 55689998533211 111111122222 2222222444444
Q ss_pred ----eccC--ccc---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc-----
Q psy4396 148 ----SEEG--YSL---YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR----- 213 (271)
Q Consensus 148 ----~~~~--~~~---~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~----- 213 (271)
.... ..+ +.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+|+.......
T Consensus 414 ~~lVmE~~~ggsL~~~l~~--~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~ 489 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED--NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDL 489 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT--CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHH
T ss_pred cEEEEECCCCCCHHHHHHH--HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccch
Confidence 1111 110 111 5689999999999999999999999999999997 999999999987765321
Q ss_pred ----ccccccccccCcceecc--CCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy4396 214 ----KTMCGTLDYLPPEMVTS--QHYGKEVDNWCIGILAYEFLVGKPPFE 257 (271)
Q Consensus 214 ----~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~ 257 (271)
...+||+.|+|||++.. ..|+..+|+||...-..+-+.++.+|.
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 35679999999999987 668888999999988888888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.5e-22 Score=165.74 Aligned_cols=130 Identities=17% Similarity=0.161 Sum_probs=86.3
Q ss_pred EecccccCCceEEEEEEEcCCCeEEEEEEcchhHH------------------------HHH-HhhhhhhceeeeEEecC
Q psy4396 84 VGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI------------------------INE-RMTHQVHRERCCQVHLS 138 (271)
Q Consensus 84 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------~~~-~~~~~~~~~~~~~~~~~ 138 (271)
+++.||+|+||.||+|.+ .+++.||||++..... ..+ .....+.+ ... ....
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-~~v-~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-LAV-PKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-SSS-CCEE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-CCc-CeEE
Confidence 349999999999999999 7889999999853211 000 00111110 000 0000
Q ss_pred cCCCcceeeecc--Cccc--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCcc
Q psy4396 139 SSRRHPLLSSEE--GYSL--YTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK 214 (271)
Q Consensus 139 ~~~~~~~l~~~~--~~~~--~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 214 (271)
. ..+.+++... +..+ +.......++.|++.||+|||+.||+||||||+|||++ ++.+||+|||+|+.
T Consensus 171 ~-~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~------- 241 (282)
T 1zar_A 171 A-WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------- 241 (282)
T ss_dssp E-EETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE-------
T ss_pred e-ccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE-------
Confidence 0 1122222221 2111 23345668999999999999999999999999999999 99999999998853
Q ss_pred cccccccccCcceec
Q psy4396 215 TMCGTLDYLPPEMVT 229 (271)
Q Consensus 215 ~~~gt~~y~aPE~~~ 229 (271)
+..++|||.+.
T Consensus 242 ----~~~~~a~e~l~ 252 (282)
T 1zar_A 242 ----VGEEGWREILE 252 (282)
T ss_dssp ----TTSTTHHHHHH
T ss_pred ----CCCCCHHHHHH
Confidence 44568888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=5.5e-19 Score=146.04 Aligned_cols=125 Identities=17% Similarity=0.130 Sum_probs=79.8
Q ss_pred eEEecccccCCceEEEEEEEcCCCeE--EEEEEcchhHHHHH---------------------HhhhhhhceeeeEEecC
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIM--IALKVLYKVEIINE---------------------RMTHQVHRERCCQVHLS 138 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~ 138 (271)
|.+.+.||+|+||.||+|.+..+++. ||||+++....... .....+.+|......+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999778888 99998643210000 00000011100000000
Q ss_pred cC---------CCcceeeeccCc--c----c-------CCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEeCCCC
Q psy4396 139 SS---------RRHPLLSSEEGY--S----L-------YTEKDAAKYIYQVADAIHYCH-QKKVIHRDIKPENLLLTMHE 195 (271)
Q Consensus 139 ~~---------~~~~~l~~~~~~--~----~-------~~~~~~~~~~~qi~~~L~~LH-~~~iiHrDikp~Nili~~~~ 195 (271)
.. .....++..... + . .++..+..++.|++.||.||| +.||+||||||+|||++.
T Consensus 129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~-- 206 (258)
T 1zth_A 129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID-- 206 (258)
T ss_dssp HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--
T ss_pred hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--
Confidence 00 011112211110 0 1 123467889999999999999 999999999999999997
Q ss_pred CEEEeeccccccC
Q psy4396 196 DVKISDFGWSVHA 208 (271)
Q Consensus 196 ~~kl~Dfg~a~~~ 208 (271)
.++|+|||+|...
T Consensus 207 ~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEECCCTTCEET
T ss_pred cEEEEECcccccC
Confidence 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.4e-16 Score=135.31 Aligned_cols=127 Identities=19% Similarity=0.225 Sum_probs=79.1
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH-----------------HH-Hhhh-hhhceeeeEEecC----
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII-----------------NE-RMTH-QVHRERCCQVHLS---- 138 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------~~-~~~~-~~~~~~~~~~~~~---- 138 (271)
|.+++.||+|++|.||+|.+. +|+.||||+++..... +. .... ....|......+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999975 5788999987432100 00 0000 0000000000000
Q ss_pred ------cCCCccee-eeccCc---ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC----------CEE
Q psy4396 139 ------SSRRHPLL-SSEEGY---SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE----------DVK 198 (271)
Q Consensus 139 ------~~~~~~~l-~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~----------~~k 198 (271)
....|-++ ....+. .....+.+..++.|++.+|.+||+.|||||||||.|||++++| .+.
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~ 255 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPI 255 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceE
Confidence 00011111 111111 1123345667889999999999999999999999999998776 389
Q ss_pred EeeccccccCC
Q psy4396 199 ISDFGWSVHAP 209 (271)
Q Consensus 199 l~Dfg~a~~~~ 209 (271)
|+||+.+....
T Consensus 256 iID~~Q~V~~~ 266 (397)
T 4gyi_A 256 IIXFPQMVSMD 266 (397)
T ss_dssp ECCCTTCEETT
T ss_pred EEEeCCcccCC
Confidence 99999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=7.9e-08 Score=78.76 Aligned_cols=127 Identities=17% Similarity=0.122 Sum_probs=75.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhH------HHHH-Hhhhhhhcee--eeEEecCcCCCccee--e
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVE------IINE-RMTHQVHRER--CCQVHLSSSRRHPLL--S 147 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~l--~ 147 (271)
+..|.+...++.|+.+.||++... +..+++|+..... ...+ .....+.... ............+++ .
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 456888888998999999999754 4579999975421 1111 1111111100 000110011111122 2
Q ss_pred eccCccc----CCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q psy4396 148 SEEGYSL----YTEKDAAKYIYQVADAIHYCHQ----------------------------------------------- 176 (271)
Q Consensus 148 ~~~~~~~----~~~~~~~~~~~qi~~~L~~LH~----------------------------------------------- 176 (271)
...|... .+......++.++..+|+.||+
T Consensus 91 ~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 91 EADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp CCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred ecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 2222211 0122345788899999999999
Q ss_pred ------------CCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 177 ------------KKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 177 ------------~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998655567999997643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.50 E-value=5.2e-07 Score=73.44 Aligned_cols=30 Identities=23% Similarity=0.119 Sum_probs=25.3
Q ss_pred ceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 179 iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
++|+|++|.|||++.++.+.|+|||.+...
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999986656679999976443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.34 E-value=1.4e-06 Score=74.79 Aligned_cols=122 Identities=12% Similarity=0.154 Sum_probs=72.8
Q ss_pred ecccccCCceEEEEEEEcCCCeEEEEEEcc--hhHHH-------HH-Hhhhhhhce---eeeEEecCcCC---Cccee--
Q psy4396 85 GCPLGTGKFGHVYLAKEKTTQIMIALKVLY--KVEII-------NE-RMTHQVHRE---RCCQVHLSSSR---RHPLL-- 146 (271)
Q Consensus 85 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~-------~~-~~~~~~~~~---~~~~~~~~~~~---~~~~l-- 146 (271)
++.|+.|.++.||++...+ ..+++|+.. ..... .+ .....+... ........... ..+++
T Consensus 43 ~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 5668999999999998653 468899875 32110 01 111111110 00011111111 11222
Q ss_pred eeccCcc-------cCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q psy4396 147 SSEEGYS-------LYTEKDAAKYIYQVADAIHYCHQ------------------------------------------- 176 (271)
Q Consensus 147 ~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~------------------------------------------- 176 (271)
....|.. .++......++.+++..|..||+
T Consensus 121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 2222221 24577888899999999999997
Q ss_pred ---------------CCceeccCCCCceEeCCCCC--EEEeeccccccC
Q psy4396 177 ---------------KKVIHRDIKPENLLLTMHED--VKISDFGWSVHA 208 (271)
Q Consensus 177 ---------------~~iiHrDikp~Nili~~~~~--~kl~Dfg~a~~~ 208 (271)
..++|+|++|.|||++.++. +.|+||+.+...
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 689999987644
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.34 E-value=1.3e-07 Score=79.41 Aligned_cols=79 Identities=18% Similarity=0.256 Sum_probs=49.3
Q ss_pred ceeccCCCCceEeCC--CCCEEEeeccccccCCCCCcccccccccc---cCccee----ccCC----------CCCchhH
Q psy4396 179 VIHRDIKPENLLLTM--HEDVKISDFGWSVHAPSLHRKTMCGTLDY---LPPEMV----TSQH----------YGKEVDN 239 (271)
Q Consensus 179 iiHrDikp~Nili~~--~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y---~aPE~~----~~~~----------~~~~~Di 239 (271)
++|+|++|.||+++. .+.+.|+||+.+........-.. .... ..|+.. ...+ .....+.
T Consensus 193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~--~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~ 270 (304)
T 3sg8_A 193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS--LMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKY 270 (304)
T ss_dssp EECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT--TCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHH
T ss_pred eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH--HHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHH
Confidence 699999999999997 45578999998765432110000 0000 122211 0000 0123689
Q ss_pred HHHHHHHHHHHhCCCCCCCC
Q psy4396 240 WCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 240 wslG~il~el~~g~~pf~~~ 259 (271)
|+++.++|.+.+|..+|...
T Consensus 271 ~~l~~~~~~~~~g~~~~~~~ 290 (304)
T 3sg8_A 271 WSFEKIIYGKEYGYMDWYEE 290 (304)
T ss_dssp HHHHHHHHHHHTTCHHHHHH
T ss_pred HHHHHHHHHHHcCCHHHHHH
Confidence 99999999999999888543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0017 Score=56.16 Aligned_cols=32 Identities=22% Similarity=0.496 Sum_probs=26.4
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..++|+|+.|.|||++.+ .++++||..+...+
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G~ 258 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYGP 258 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEEEC
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccccCC
Confidence 468999999999999865 58999998775543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0094 Score=49.62 Aligned_cols=31 Identities=29% Similarity=0.578 Sum_probs=25.2
Q ss_pred ceeccCCCCceEeCC---CCCE-EEeeccccccCC
Q psy4396 179 VIHRDIKPENLLLTM---HEDV-KISDFGWSVHAP 209 (271)
Q Consensus 179 iiHrDikp~Nili~~---~~~~-kl~Dfg~a~~~~ 209 (271)
++|+|++|.|||++. ++.+ .|+||+.+....
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 489999999999987 4554 899999875543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0017 Score=54.65 Aligned_cols=32 Identities=22% Similarity=0.267 Sum_probs=28.1
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
.+++|+|++|.|||++.++.+.|+||+.+...
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 57999999999999987889999999977544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0085 Score=49.64 Aligned_cols=30 Identities=30% Similarity=0.265 Sum_probs=24.8
Q ss_pred ceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 179 iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
++|+|+.|.||+ ..++.+.++||+.+....
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 699999999999 557788999999775443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0035 Score=50.92 Aligned_cols=30 Identities=27% Similarity=0.282 Sum_probs=25.2
Q ss_pred ceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 179 iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
++|+|+.|.|||++.++.+-|+||+.+...
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 589999999999997766779999976543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.0045 Score=54.00 Aligned_cols=33 Identities=21% Similarity=0.437 Sum_probs=28.3
Q ss_pred HCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 176 QKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 176 ~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
...++|+|++|.|||++.++ +.++||+.+....
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 45799999999999998776 9999999876554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.67 E-value=0.052 Score=42.74 Aligned_cols=92 Identities=12% Similarity=0.086 Sum_probs=57.9
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCceecc-CCCCceEeCCCCCEEEeeccccccCCCCCcccccccccccCcceeccC
Q psy4396 153 SLYTEKDAAKYIYQVADAIHYCHQKKVIHRD-IKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQ 231 (271)
Q Consensus 153 ~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrD-ikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~ 231 (271)
.++++++++.++.|.+.+|.-+-.+.--|.. +.|..|++..+|.+-+.+ +.+. .....+.|||... .
T Consensus 44 ~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------~~~~~~~~pe~~~-~ 111 (229)
T 2yle_A 44 QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------AGEPPPVAGKLGY-S 111 (229)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------------CCSS-S
T ss_pred CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc----------ccccCCCChhhcc-c
Confidence 4589999999999999998776321111233 346889999999988764 2111 1133456787663 3
Q ss_pred CCCCchhHHHHHHHHHHHHh-CCCCC
Q psy4396 232 HYGKEVDNWCIGILAYEFLV-GKPPF 256 (271)
Q Consensus 232 ~~~~~~DiwslG~il~el~~-g~~pf 256 (271)
..+.+.=|||||+++|..+- |-.+=
T Consensus 112 ~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 112 QCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp SSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 44667889999999998874 55443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.44 E-value=0.013 Score=48.86 Aligned_cols=31 Identities=26% Similarity=0.381 Sum_probs=25.8
Q ss_pred CCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
.+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3689999999999998765568999997643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.23 E-value=0.03 Score=46.73 Aligned_cols=31 Identities=19% Similarity=0.246 Sum_probs=25.9
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..++|+|+++.|||++ + .+.|+||+.+....
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~ 225 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARNGP 225 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence 3589999999999999 4 89999998775443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.23 E-value=0.017 Score=48.45 Aligned_cols=34 Identities=26% Similarity=0.319 Sum_probs=28.3
Q ss_pred CCceeccCCCCceEeCCC----CCEEEeeccccccCCC
Q psy4396 177 KKVIHRDIKPENLLLTMH----EDVKISDFGWSVHAPS 210 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~----~~~kl~Dfg~a~~~~~ 210 (271)
..++|||+.+.|||++.+ +.+.|+||+.+.....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 469999999999999864 6789999998765543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=93.92 E-value=0.018 Score=48.74 Aligned_cols=32 Identities=16% Similarity=0.210 Sum_probs=26.2
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..++|+|+.|.|||+++++.+.|+||+.+...
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~g 253 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVALG 253 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccccC
Confidence 46999999999999995445789999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.44 E-value=0.041 Score=46.44 Aligned_cols=33 Identities=30% Similarity=0.420 Sum_probs=28.1
Q ss_pred CCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..++|+|+.+.||+++.++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 358999999999999988889999998765443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=93.08 E-value=0.13 Score=42.13 Aligned_cols=32 Identities=16% Similarity=0.094 Sum_probs=25.9
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcc
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLY 114 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 114 (271)
..-++.+|.|..+.||+.+.. +|+.|.+|+..
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~ 48 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALP 48 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TSCEEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeC
Confidence 455778999999999999865 46779999853
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.90 E-value=0.093 Score=44.63 Aligned_cols=28 Identities=25% Similarity=0.436 Sum_probs=23.5
Q ss_pred CceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 178 KVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
.++|+|+.|.|||++.+ .+.|+||+.+.
T Consensus 213 ~l~HgDl~~~Nil~~~~-~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK-CLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC--CEEECCCTTCE
T ss_pred EEEeCCCCcccEEecCC-cEEEEEecCCC
Confidence 58999999999999854 48999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=91.04 E-value=0.15 Score=44.95 Aligned_cols=30 Identities=10% Similarity=-0.003 Sum_probs=21.5
Q ss_pred ecccccCCceEEEEEEEcCCCeEEEEEEcc
Q psy4396 85 GCPLGTGKFGHVYLAKEKTTQIMIALKVLY 114 (271)
Q Consensus 85 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~ 114 (271)
++.|+.|-...+|++.....+..+.+|+..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g 142 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYG 142 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECC
Confidence 456788888999999876545678999863
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.36 E-value=0.084 Score=46.11 Aligned_cols=77 Identities=12% Similarity=0.214 Sum_probs=37.8
Q ss_pred cccccchHHHhhhhccCCCc---ccHHHHHHHHhhhhccccCCCCccc-ccccCeEEecccccCCceEEEEEEEcC----
Q psy4396 32 NYTITNMKEYFEGLTEGTNK---ENVEEYLKKMQTHYDAREAPNKSYR-WQMSDFEVGCPLGTGKFGHVYLAKEKT---- 103 (271)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~lg~G~~g~V~~~~~~~---- 103 (271)
.....+|++.|......... ..+.+...++-..+... .|. +..+.. -++.|+.|....+|++....
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~l~~~~l~~-----~w~~~~~~~~-~v~~l~gG~tN~~y~v~~~~~~~~ 100 (429)
T 1nw1_A 27 EGHFRGMKELLSTMDLDTDANTIPELKERAHMLCARFLGG-----AWKTVPLEHL-RISRIKGGMSNMLFLCRLSEVYPP 100 (429)
T ss_dssp -----CHHHHHTTCCTTCCGGGCHHHHHHHHHHHHHHHCT-----HHHHCCGGGE-EEEEECCCTTEEEEEEEECTTSCC
T ss_pred hhhHHHHHHHhccCCCcccccccHHHHHHHHHHHHHhccC-----CcCCCCccce-EEEEeCCCcccceEEEEeCCCccc
Confidence 45678888888877543321 12222222222221100 000 011222 24567888889999998653
Q ss_pred ---CCeEEEEEEcc
Q psy4396 104 ---TQIMIALKVLY 114 (271)
Q Consensus 104 ---~~~~vaiK~~~ 114 (271)
++..+.+|+..
T Consensus 101 ~~~~~~~~vlRi~~ 114 (429)
T 1nw1_A 101 IRNEPNKVLLRVYF 114 (429)
T ss_dssp SSSCCSEEEEEEEC
T ss_pred cCCCCceEEEEEeC
Confidence 24679999884
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.73 E-value=0.13 Score=44.14 Aligned_cols=29 Identities=31% Similarity=0.534 Sum_probs=25.7
Q ss_pred CceeccCCCCceEeCCC----CCEEEeeccccc
Q psy4396 178 KVIHRDIKPENLLLTMH----EDVKISDFGWSV 206 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~----~~~kl~Dfg~a~ 206 (271)
.++|+|+.+.|||++.+ +.+.++||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 48999999999999876 789999999764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.77 E-value=0.23 Score=42.83 Aligned_cols=28 Identities=29% Similarity=0.520 Sum_probs=24.1
Q ss_pred ceeccCCCCceEe------CCCCCEEEeeccccc
Q psy4396 179 VIHRDIKPENLLL------TMHEDVKISDFGWSV 206 (271)
Q Consensus 179 iiHrDikp~Nili------~~~~~~kl~Dfg~a~ 206 (271)
++|+|+.+.|||+ ++++.+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 456779999999874
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=84.64 E-value=0.34 Score=42.17 Aligned_cols=28 Identities=25% Similarity=0.604 Sum_probs=24.9
Q ss_pred CceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 178 KVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
.++|+|+.+.||+ +.++.+.++||..|.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 4899999999999 778899999999774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 271 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-57 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-24 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-24 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-23 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-17 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 6e-57
Identities = 101/215 (46%), Positives = 136/215 (63%), Gaps = 22/215 (10%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQV 135
+W + DFE+G PLG GKFG+VYLA+EK ++ ++ALKVL+K ++ + HQ+ RE Q
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 136 HLS-----------SSRRHPLLSSE--EGYSLY---------TEKDAAKYIYQVADAIHY 173
HL L E ++Y E+ A YI ++A+A+ Y
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
CH K+VIHRDIKPENLLL ++KI+DFGWSVHAPS R T+CGTLDYLPPEM+ + +
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 181
Query: 234 GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
++VD W +G+L YEFLVGKPPFE+ T +RI
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (382), Expect = 2e-44
Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 23/246 (9%)
Query: 47 EGTNKENVEEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQI 106
+G+ +E+V+E+L K + + + Q+ F+ LGTG FG V L K K +
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN 67
Query: 107 MIALKVLYKVEIINERMTHQVHRERCCQVHLSSS----------------------RRHP 144
A+K+L K +++ + E+ ++
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 145 LLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204
+ S ++E A Y Q+ Y H +I+RD+KPENLL+ ++++DFG+
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 205 SVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264
+ T+CGT + L PE++ S+ Y K VD W +G+L YE G PPF +
Sbjct: 188 AKRVKG-RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 265 LERIFW 270
E+I
Sbjct: 247 YEKIVS 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (380), Expect = 2e-44
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVH 136
+ + DF++ LGTG FG V+L + + A+KVL K ++ + + ER
Sbjct: 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 137 LSSS----------------------RRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYC 174
++ L S + A Y +V A+ Y
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYG 234
H K +I+RD+KPEN+LL + +KI+DFG++ + P + T+CGT DY+ PE+V+++ Y
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYN 179
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
K +D W GIL YE L G PF + T E+I
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 4e-44
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 25/205 (12%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS- 139
DFE LG G G V+ K + +++A K+++ I + +Q+ RE +S
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 140 ----------SRRHPLLSSE--EGYSLY---------TEKDAAKYIYQVADAIHYCHQK- 177
S + E +G SL E+ K V + Y +K
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEV 237
K++HRD+KP N+L+ ++K+ DFG S + GT Y+ PE + HY +
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 238 DNWCIGILAYEFLVGKPPFESKDQD 262
D W +G+ E VG+ P D
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAK 209
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-43
Identities = 62/215 (28%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS- 139
DF+ G LG G F V LA+E T A+K+L K II E V RER L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 140 ----------SRRHPLLSSE--EGYSLY---------TEKDAAKYIYQVADAIHYCHQKK 178
+ L E Y ++ A+ Y H K
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 179 VIHRDIKPENLLLTMHEDVKISDFG----WSVHAPSLHRKTMCGTLDYLPPEMVTSQHYG 234
+IHRD+KPEN+LL ++I+DFG S + + GT Y+ PE++T +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
K D W +G + Y+ + G PPF + ++ ++I
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 5e-41
Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 42/241 (17%)
Query: 55 EEYLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLY 114
EE L+K+++ + P K Y +G G G VY A + T +A++ +
Sbjct: 3 EEILEKLRSIVSVGD-PKKKY-------TRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 54
Query: 115 KVEIINERMTHQVHRERCCQVHLSSSRRHP-------------------------LLSSE 149
+ + + E + + ++P L+
Sbjct: 55 LQQQPKKE---LIINE----ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 150 EGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS--VH 207
+ E A + A+ + H +VIHRDIK +N+LL M VK++DFG+ +
Sbjct: 108 VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 208 APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLER 267
R TM GT ++ PE+VT + YG +VD W +GI+A E + G+PP+ +++ L
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 268 I 268
I
Sbjct: 228 I 228
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 9e-41
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 33/218 (15%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS- 139
+E+ LG G FG VY A+ K T ++ A KV+ +E E
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69
Query: 140 ----------SRRHPLLSSE--EGYSL----------YTEKDAAKYIYQVADAIHYCHQK 177
+ + E G ++ TE Q DA++Y H
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 178 KVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMV-----TS 230
K+IHRD+K N+L T+ D+K++DFG S R + GT ++ PE+V
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ Y + D W +GI E +PP + L +I
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 227
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE----- 130
+ M+DF+ LG G FG V L +EK T A+K+L K II + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 131 --------RCCQVHLSSSRRHPLLSSEEGYSLY---------TEKDAAKYIYQVADAIHY 173
+ R ++ G L+ TE+ A Y ++ A+ Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM--CGTLDYLPPEMVTSQ 231
H + V++RDIK ENL+L +KI+DFG S CGT +YL PE++
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 232 HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
YG+ VD W +G++ YE + G+ PF ++D + E I
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-40
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 36/223 (16%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE---------- 130
D+EV +GTG +G + K+ ++ K L + E + E
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 131 ---RCCQVHLSSSRRHPLLSSE--EGYSLY-------------TEKDAAKYIYQVADAIH 172
R + + + E EG L E+ + + Q+ A+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 173 YCHQK-----KVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPP 225
CH++ V+HRD+KP N+ L ++VK+ DFG + ++ + K GT Y+ P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 226 EMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
E + Y ++ D W +G L YE PPF + Q +I
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 226
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 141 bits (357), Expect = 1e-40
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
+ +++ LGTG FG V+ E+ T A K + +E V +E L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR 81
Query: 139 S-----------SRRHPLLSSE--EGYSLY----------TEKDAAKYIYQVADAIHYCH 175
++ E G L+ +E +A +Y+ QV + + H
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 176 QKKVIHRDIKPENLLLTMHED--VKISDFGWSVHA-PSLHRKTMCGTLDYLPPEMVTSQH 232
+ +H D+KPEN++ T +K+ DFG + H P K GT ++ PE+ +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201
Query: 233 YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
G D W +G+L+Y L G PF ++ D TL +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-40
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
+ DF + LG G FG V+LA+ K T A+K L K ++ + E+ LS
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV---LS 57
Query: 139 SSRRHPLL-----SSEEGYSLY---------------------TEKDAAKYIYQVADAIH 172
+ HP L + + +L+ A Y ++ +
Sbjct: 58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH--APSLHRKTMCGTLDYLPPEMVTS 230
+ H K +++RD+K +N+LL +KI+DFG T CGT DY+ PE++
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177
Query: 231 QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Q Y VD W G+L YE L+G+ PF +D++ I
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 215
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (347), Expect = 1e-39
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 35/216 (16%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
F +G G FG VY A++ ++A+K + + + +E V
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE----VRFLQKL 72
Query: 142 RHPLL-----SSEEGYSLY---------------------TEKDAAKYIYQVADAIHYCH 175
RHP ++ + E + A + + Y H
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQ---H 232
+IHRD+K N+LL+ VK+ DFG + + + GT ++ PE++ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--SFVGTPYWMAPEVILAMDEGQ 190
Query: 233 YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
Y +VD W +GI E KPP + + + L I
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-38
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
D+++ LG G +G V LA + T+ +A+K++ ++ + +E C L
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML--- 60
Query: 141 RRHPLL-----SSEEGYSLY---------------------TEKDAAKYIYQVADAIHYC 174
H + EG Y E DA ++ +Q+ + Y
Sbjct: 61 -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR----KTMCGTLDYLPPEMVTS 230
H + HRDIKPENLLL +++KISDFG + +R MCGTL Y+ PE++
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 231 QHY-GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+ + + VD W GI+ L G+ P++ +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (341), Expect = 2e-38
Identities = 57/245 (23%), Positives = 100/245 (40%), Gaps = 32/245 (13%)
Query: 52 ENVEEYLKKMQTHYDAREAPNKSYRWQMSD-FEVGCPLGTGKFGHVYLAKEKTTQIMIAL 110
+ +++ + + Y + K + + D +++ LG+G FG V+ EK T +
Sbjct: 2 NDYDKFYEDIWKKYVPQPVEVK--QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 59
Query: 111 KVLYKVEIINERMTHQVHRERCCQVHLSS-----------SRRHPLLSSE--EGYSLY-- 155
K + +++ V E L + +L E G L+
Sbjct: 60 KFINTPYPLDKY---TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 116
Query: 156 --------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHED--VKISDFGWS 205
+E + Y+ Q + + + H+ ++H DIKPEN++ + VKI DFG +
Sbjct: 117 IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
Query: 206 VH-APSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264
P K T ++ PE+V + G D W IG+L Y L G PF +D T
Sbjct: 177 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236
Query: 265 LERIF 269
L+ +
Sbjct: 237 LQNVK 241
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 133 bits (336), Expect = 2e-38
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN------ERMTHQVHRERCCQ 134
++E LG G V K T A+K++ + + + +E
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 135 VHLSS------------SRRHPLLSSE--EGYSLY---------TEKDAAKYIYQVADAI 171
+S + L + + L+ +EK+ K + + + I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA-PSLHRKTMCGTLDYLPPEMVTS 230
H+ ++HRD+KPEN+LL ++K++DFG+S P + +CGT YL PE++
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 183
Query: 231 ------QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
YGKEVD W G++ Y L G PPF + Q L I
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-38
Identities = 48/224 (21%), Positives = 79/224 (35%), Gaps = 41/224 (18%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
VG +G+G FG VY K +A+K+L V + E V +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNE----VGVLR 59
Query: 140 SRRHP----LLSSEEGYSLY----------------------TEKDAAKYIYQVADAIHY 173
RH + L Q A + Y
Sbjct: 60 KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVT 229
H K +IHRD+K N+ L VKI DFG + + + G++ ++ PE++
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 230 SQ---HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270
Q Y + D + GI+ YE + G+ P+ + + + +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 135 bits (340), Expect = 4e-38
Identities = 54/220 (24%), Positives = 85/220 (38%), Gaps = 28/220 (12%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
M+DF V +G G FG VY ++ T M A+K L K I ++ ER + L
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI-MLSLV 61
Query: 139 SSRRHPLL-----SSEEGYSLY---------------------TEKDAAKYIYQVADAIH 172
S+ P + + L +E D Y ++ +
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMV-TSQ 231
+ H + V++RD+KP N+LL H V+ISD G + GT Y+ PE++
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181
Query: 232 HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFWF 271
Y D + +G + ++ L G PF E
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-37
Identities = 40/215 (18%), Positives = 78/215 (36%), Gaps = 29/215 (13%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---------RMTHQVHRERC 132
+ +G G F VY + T + +A L ++ M +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 133 CQVH-----LSSSRRHPLLSSE--EGYSLY---------TEKDAAKYIYQVADAIHYCHQ 176
+ + ++ +L +E +L K + Q+ + + H
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 177 KK--VIHRDIKPENLLLTMHE-DVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
+ +IHRD+K +N+ +T VKI D G + + K + GT +++ PEM + Y
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMY-EEKY 189
Query: 234 GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ VD + G+ E + P+ + R
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 224
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-36
Identities = 45/211 (21%), Positives = 84/211 (39%), Gaps = 22/211 (10%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVL-----YKVEIINE-RMTHQVHRERCCQ 134
+ + LG G+FG V+ E +++ K + +V + E + +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 135 VHLSSSRRHPLLSSEE---GYSLY----------TEKDAAKYIYQVADAIHYCHQKKVIH 181
+H S L+ E G ++ E++ Y++QV +A+ + H + H
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125
Query: 182 RDIKPENLLLTMHED--VKISDFGWSVHAP-SLHRKTMCGTLDYLPPEMVTSQHYGKEVD 238
DI+PEN++ +KI +FG + + + + +Y PE+ D
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 239 NWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
W +G L Y L G PF ++ +E I
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQIIENIM 216
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 128 bits (323), Expect = 2e-36
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 39/224 (17%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS 140
+E+G LG G V+LA++ +A+KVL + + RE +++
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRRE----AQNAAA 63
Query: 141 RRHP---------LLSSEEGYSLY---------------------TEKDAAKYIYQVADA 170
HP + G Y T K A + I A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 171 IHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-----LHRKTMCGTLDYLPP 225
+++ HQ +IHRD+KP N++++ VK+ DFG + + GT YL P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 226 EMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
E D + +G + YE L G+PPF + +
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (323), Expect = 4e-36
Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS- 139
++ LGTG F V LA++K TQ ++A+K + K + + + E +
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHP 67
Query: 140 ----------SRRHPLLSSE--EGYSLY---------TEKDAAKYIYQVADAIHYCHQKK 178
S H L + G L+ TE+DA++ I+QV DA+ Y H
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 179 VIHRDIKPENLLLTMHED---VKISDFGWS-VHAPSLHRKTMCGTLDYLPPEMVTSQHYG 234
++HRD+KPENLL ++ + ISDFG S + P T CGT Y+ PE++ + Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 235 KEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
K VD W IG++AY L G PPF ++ E+I
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-36
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 79 MSDFEV-GCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN---ERMTHQVHRERCCQ 134
+ D++V LG G G V K TQ ALK+L E +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVR 69
Query: 135 VH-----LSSSRRHPLLSSE--EGYSLY-----------TEKDAAKYIYQVADAIHYCHQ 176
+ L + R+ L+ E +G L+ TE++A++ + + +AI Y H
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 177 KKVIHRDIKPENLLLTMHED---VKISDFGWSVHAPSLHR-KTMCGTLDYLPPEMVTSQH 232
+ HRD+KPENLL T +K++DFG++ S + T C T Y+ PE++ +
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 189
Query: 233 YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
Y K D W +G++ Y L G PPF S +
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 226
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-36
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH---QVHRERCCQVH 136
S ++VG LG+G FG VY + + +A+K + K I + +V E
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 137 LSS-------------SRRHPLLSSEEGYSL------------YTEKDAAKYIYQVADAI 171
+SS +L E + E+ A + +QV +A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 172 HYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMV-T 229
+CH V+HRDIK EN+L+ ++ ++K+ DFG GT Y PPE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 230 SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+++G+ W +GIL Y+ + G PFE ++ + F
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 223
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-35
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 36/223 (16%)
Query: 81 DFEVGCPLGTGKFGHVYLAKE-KTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
+E +G G +G V+ A++ K +ALK + +V+ E M RE HL +
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 66
Query: 140 SRRHP----------LLSSEEGYSLY----------------------TEKDAAKYIYQV 167
HP + ++ L + ++Q+
Sbjct: 67 FE-HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHRKTMCGTLDYLPPE 226
+ + H +V+HRD+KP+N+L+T +K++DFG + +++ + ++ TL Y PE
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
++ Y VD W +G + E KP F L +I
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 8e-34
Identities = 42/211 (19%), Positives = 82/211 (38%), Gaps = 24/211 (11%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE-----RMTHQVHRERCC 133
M + ++ +G G+FG V L + ++ A+K + + Q+
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 134 QVH--LSSSRRHPLLSSE-------------EGYSLYTEKDAAKYIYQVADAIHYCHQKK 178
Q+ + + + +E G S+ K+ V +A+ Y
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 179 VIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVD 238
+HRD+ N+L++ K+SDFG + A S + T + + PE + + + + D
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-TQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 239 NWCIGILAYEFL-VGKPPFESKDQDTTLERI 268
W GIL +E G+ P+ + R+
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-33
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 27/209 (12%)
Query: 88 LGTGKFGHVYLAKEKTTQIMIALKVLYKVEII--NERMTHQVHRERCCQVHLSSS----- 140
LG G+F VY A++K T ++A+K + + + RE LS
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 141 -----------------RRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRD 183
+ ++ + T Y+ + Y HQ ++HRD
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125
Query: 184 IKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMV-TSQHYGKEVDNW 240
+KP NLLL + +K++DFG + +P+ T Y PE++ ++ YG VD W
Sbjct: 126 LKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMW 185
Query: 241 CIGILAYEFLVGKPPFESKDQDTTLERIF 269
+G + E L+ P L RIF
Sbjct: 186 AVGCILAELLLRVPFLPGDSDLDQLTRIF 214
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 1e-33
Identities = 44/212 (20%), Positives = 76/212 (35%), Gaps = 24/212 (11%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQ----- 134
D LGTG+FG V K + +A+K++ + + + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 135 ----VHLSSSRRHPLLSSEEGYSLY----------TEKDAAKYIYQVADAIHYCHQKKVI 180
V + L + + V +A+ Y K+ +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM---CGTLDYLPPEMVTSQHYGKEV 237
HRD+ N L+ VK+SDFG S + + + + PPE++ + +
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 238 DNWCIGILAYEFL-VGKPPFESKDQDTTLERI 268
D W G+L +E +GK P+E T E I
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-33
Identities = 50/229 (21%), Positives = 87/229 (37%), Gaps = 38/229 (16%)
Query: 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHL 137
++S +E +G G FG V+ A+ + T +ALK + E E RE L
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLL 66
Query: 138 SSSRRHPLLSS---------EEGYSLY---------------------TEKDAAKYIYQV 167
L+ S+Y T + + + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 168 ADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS------VHAPSLHRKTMCGTLD 221
+ ++Y H+ K++HRD+K N+L+T +K++DFG + ++ TL
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 222 YLPPEMV-TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
Y PPE++ + YG +D W G + E P + + L I
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 2e-33
Identities = 40/212 (18%), Positives = 77/212 (36%), Gaps = 24/212 (11%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE------RMTHQVHRERCC 133
+ LG G FG V++ T +A+K L + E ++ ++ E+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 134 QVHLSSSRRHPLLSSE-------------EGYSLYTEKDAAKYIYQVADAIHYCHQKKVI 180
Q++ S + +E E Q+A + Y + +
Sbjct: 76 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 135
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPS---LHRKTMCGTLDYLPPEMVTSQHYGKEV 237
HRD++ N+L+ + K++DFG + R+ + + PE + +
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195
Query: 238 DNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
D W GIL E G+ P+ L+++
Sbjct: 196 DVWSFGILLTELTTKGRVPYPGMVNREVLDQV 227
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-33
Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 27/217 (12%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE-------- 130
M +F+ +G G +G VY A+ K T ++ALK + +++ E + RE
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 131 ---------------RCCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCH 175
+ V + + Y++Q+ + +CH
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 176 QKKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
+V+HRD+KP+NLL+ +K++DFG + P TL Y PE++ Y
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 234 -GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
VD W +G + E + + F + L RIF
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-33
Identities = 42/212 (19%), Positives = 77/212 (36%), Gaps = 24/212 (11%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQ----- 134
S+ +G+G+FG V+L +A+K + + + E +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 135 ----VHLSSSRRHPLLSSEEGYSLY----------TEKDAAKYIYQVADAIHYCHQKKVI 180
V L + + E L + V + + Y + VI
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPS---LHRKTMCGTLDYLPPEMVTSQHYGKEV 237
HRD+ N L+ ++ +K+SDFG + + + PE+ + Y +
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 238 DNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
D W G+L +E GK P+E++ +E I
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 8e-33
Identities = 47/223 (21%), Positives = 76/223 (34%), Gaps = 39/223 (17%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHL 137
D + LG G FG V + + +A+K L + RE V+
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE----VNA 64
Query: 138 SSSRRHP----LLSSEEGYSLY----------------------TEKDAAKYIYQVADAI 171
S H L + ++Y QVA+ +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-----LHRKTMCGTLDYLPPE 226
Y K+ IHRD+ NLLL + VKI DFG P + ++ + PE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
+ ++ + D W G+ +E G+ P+ + L +I
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-32
Identities = 39/220 (17%), Positives = 84/220 (38%), Gaps = 33/220 (15%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
++F+ LG+G FG VY + + V K + E + + ++E + ++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 66
Query: 140 SRRHP--------------------------LLSSEEGYSLYTEKDAAKYIYQVADAIHY 173
S +P L E + + Q+A ++Y
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS----LHRKTMCGTLDYLPPEMVT 229
++++HRD+ N+L+ + VKI+DFG + + H + + ++ E +
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 230 SQHYGKEVDNWCIGILAYEFL-VGKPPFESKDQDTTLERI 268
+ Y + D W G+ +E + G P++ +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-32
Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
M +E +G G +G V+ AK + T ++ALK + +++ +E + RE C L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 139 S----------------------SRRHPLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQ 176
+ + + +++Q+ + +CH
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMV-TSQHY 233
+ V+HRD+KP+NLL+ + ++K+++FG + P TL Y PP+++ ++ Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 234 GKEVDNWCIGILAYEFLVGK-PPFESKDQDTTLERIFW 270
+D W G + E P F D D L+RIF
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-32
Identities = 41/212 (19%), Positives = 85/212 (40%), Gaps = 24/212 (11%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKV-----EIINE-RMTHQVHRERCC 133
++ LG G+FG V++ +A+K L + + E + Q+ +R
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 134 QVHLSSSRRHPLLSSE--EGYSLY-----------TEKDAAKYIYQVADAIHYCHQKKVI 180
+++ ++ + +E E SL T Q+A+ + + ++ I
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPS---LHRKTMCGTLDYLPPEMVTSQHYGKEV 237
HRD++ N+L++ KI+DFG + R+ + + PE + + +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 238 DNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
D W GIL E + G+ P+ ++ +
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (293), Expect = 6e-32
Identities = 42/226 (18%), Positives = 76/226 (33%), Gaps = 42/226 (18%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
++VG +G G FG ++ +A+K + Q+ E L+
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 142 RHPLL--SSEEGYSLY---------------------TEKDAAKYIYQVADAIHYCHQKK 178
P + +EG + K A Q+ + H+K
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 179 VIHRDIKPENLLLT-----MHEDVKISDFGWS---------VHAPSLHRKTMCGTLDYLP 224
+++RDIKP+N L+ + + DFG H P +K + GT Y+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 225 PEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270
+ + D +G + FL G P++ T ++
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 8e-32
Identities = 45/222 (20%), Positives = 79/222 (35%), Gaps = 27/222 (12%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---MTHQVHRERC 132
R Q + +G G FG VY AK + ++A+K + + + R + ++
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNI 75
Query: 133 CQVH---------------------LSSSRRHPLLSSEEGYSLYTEKDAAKYIYQVADAI 171
++ + + Y+YQ+ ++
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 172 HYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPEMV 228
Y H + HRDIKP+NLLL +K+ DFG + + + +C P +
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 229 TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270
+ Y +D W G + E L+G+P F L I
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (291), Expect = 1e-31
Identities = 45/213 (21%), Positives = 78/213 (36%), Gaps = 24/213 (11%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKV-----EIINE-RMTHQVHRERCC 133
+D + LG G++G VY K + +A+K L + E + E + ++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 134 QVHLSSSRRHPLLSSEE--------------GYSLYTEKDAAKYIYQVADAIHYCHQKKV 179
Q+ +R P E + Q++ A+ Y +K
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136
Query: 180 IHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGT---LDYLPPEMVTSQHYGKE 236
IHRD+ N L+ + VK++DFG S G + + PE + + +
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196
Query: 237 VDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
D W G+L +E G P+ D E +
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-31
Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 41/223 (18%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
+ +G G +G V A + ++ +A+K + E ++ + RE + +
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLRE----IKILLRF 63
Query: 142 RHP----------LLSSEEGYSLY-------------------TEKDAAKYIYQVADAIH 172
RH + E+ +Y + ++YQ+ +
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 173 YCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRK-----TMCGTLDYLPPE- 226
Y H V+HRD+KP NLLL D+KI DFG + A H T Y PE
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
M+ S+ Y K +D W +G + E L +P F K L I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 115 bits (289), Expect = 2e-31
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRE-------- 130
M + +G G +G VY A+ + ALK + ++E +E + RE
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 131 -----RCCQVHLSSSRRHPLLSSEEGYSLY---------TEKDAAKYIYQVADAIHYCHQ 176
+ V + R + + A ++ Q+ + I YCH
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGWS--VHAPSLHRKTMCGTLDYLPPE-MVTSQHY 233
++V+HRD+KP+NLL+ ++KI+DFG + P TL Y P+ ++ S+ Y
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 234 GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+D W +G + E + G P F + L RIF
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (289), Expect = 3e-31
Identities = 46/241 (19%), Positives = 80/241 (33%), Gaps = 37/241 (15%)
Query: 63 THYDAREAPNK-SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEI 118
T D EA + + +S ++ +G G+FG V K +I +A+K L
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS--G 65
Query: 119 INERMTHQVHRE-------------RCCQVHLSSSRRHPLLSSEEGYSL----------Y 155
E+ E V S+ + E SL +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 156 TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV-------HA 208
T + +A + Y +HRD+ N+L+ + K+SDFG S
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 209 PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFL-VGKPPFESKDQDTTLER 267
+ + PE + + + D W GI+ +E + G+ P+ +
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 268 I 268
I
Sbjct: 246 I 246
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-31
Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 28/209 (13%)
Query: 88 LGTGKFGHVYLA--KEKTTQIMIALKVLYKV-------EIINE-RMTHQVHRERCCQVHL 137
LG G FG V + + QI +A+KVL + E++ E ++ HQ+ ++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 138 SSSRRHPLLSSE--EGYSLY----------TEKDAAKYIYQVADAIHYCHQKKVIHRDIK 185
+L E G L+ + A+ ++QV+ + Y +K +HRD+
Sbjct: 77 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 136
Query: 186 PENLLLTMHEDVKISDFGWSVHAPS-----LHRKTMCGTLDYLPPEMVTSQHYGKEVDNW 240
N+LL KISDFG S + R L + PE + + + D W
Sbjct: 137 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196
Query: 241 CIGILAYEFL-VGKPPFESKDQDTTLERI 268
G+ +E L G+ P++ + I
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFI 225
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 4e-31
Identities = 42/214 (19%), Positives = 79/214 (36%), Gaps = 38/214 (17%)
Query: 88 LGTGKFGHVYLA--KEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP- 144
LG+G FG V + K +A+K+L K E + + ++ E ++ +P
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAE----ANVMQQLDNPY 69
Query: 145 ---LLSSEEGYSLY---------------------TEKDAAKYIYQVADAIHYCHQKKVI 180
++ E S +K+ + ++QV+ + Y + +
Sbjct: 70 IVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 181 HRDIKPENLLLTMHEDVKISDFGWSVHAPSLH-----RKTMCGTLDYLPPEMVTSQHYGK 235
HRD+ N+LL KISDFG S + + + + PE + +
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 236 EVDNWCIGILAYEFL-VGKPPFESKDQDTTLERI 268
+ D W G+L +E G+ P+ +
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 7e-31
Identities = 44/234 (18%), Positives = 75/234 (32%), Gaps = 47/234 (20%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
+D + +G G FG V A+ K + + + E ++ E L
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV---LC 65
Query: 139 SSRRHP------------------------------------------LLSSEEGYSLYT 156
HP + S +
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 157 EKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM 216
+ + VA + Y QK+ IHRD+ N+L+ + KI+DFG S +KTM
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185
Query: 217 -CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
+ ++ E + Y D W G+L +E + G P+ E++
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-30
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 38/223 (17%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---MTHQVHRERCCQVHL 137
++ G LG+G+F V +EK+T + A K + K + R + RE V +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSI 66
Query: 138 SSSRRHP--------------------------LLSSEEGYSLYTEKDAAKYIYQVADAI 171
+HP L TE++A +++ Q+ + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 172 HYCHQKKVIHRDIKPENLLLTMHED----VKISDFGWSVHAPSLHRKTM-CGTLDYLPPE 226
+Y H ++ H D+KPEN++L +KI DFG + + GT +++ PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
+V + G E D W IG++ Y L G PF + TL +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-30
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 76 RWQMSDFEVGCPLGTGKFGHVYLAKE---KTTQIMIALKVLYKVEII-NERMTHQVHRER 131
+ + +FE+ LGTG +G V+L ++ T + A+KVL K I+ + T ER
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 132 CCQVHLSSS--------------RRHPLLSSEEGYSLY---------TEKDAAKYIYQVA 168
H+ S + H +L G L+ TE + Y+ ++
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 169 DAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM---CGTLDYLPP 225
A+ + H+ +I+RDIK EN+LL + V ++DFG S + + CGT++Y+ P
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 226 EMV--TSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
++V + K VD W +G+L YE L G PF + + I
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 4e-30
Identities = 58/267 (21%), Positives = 102/267 (38%), Gaps = 60/267 (22%)
Query: 57 YLKKMQTHYDAREAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ-----IMIALK 111
Y+ + YD + + + + E G LG+G FG V A I +A+K
Sbjct: 20 YVDFREYEYDLK------WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 73
Query: 112 VLYK-------------VEIINERMTHQ--VHRERCCQV------------------HLS 138
+L + ++++ + +H+ V+ C + +L
Sbjct: 74 MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133
Query: 139 SSRRH-----------PLLSSEEGYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPE 187
S R L EE ++ T +D + YQVA + + K +HRD+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193
Query: 188 NLLLTMHEDVKISDFGWSVHAPS----LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIG 243
N+L+T + VKI DFG + S + R + ++ PE + Y + D W G
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253
Query: 244 ILAYEFL-VGKPPFESKDQDTTLERIF 269
IL +E +G P+ D ++
Sbjct: 254 ILLWEIFSLGVNPYPGIPVDANFYKLI 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (278), Expect = 1e-29
Identities = 46/225 (20%), Positives = 74/225 (32%), Gaps = 40/225 (17%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR 141
+ +G +G+G FG +YL + +A+K+ + Q+H E +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGV 63
Query: 142 RHPLL--SSEEGYSLY---------------------TEKDAAKYIYQVADAIHYCHQKK 178
P + EG + K Q+ I Y H K
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 179 VIHRDIKPENLLLT---MHEDVKISDFGWS---------VHAPSLHRKTMCGTLDYLPPE 226
IHRD+KP+N L+ V I DFG + H P K + GT Y
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 227 MVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFWF 271
+ D +G + F +G P++ T ++
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (278), Expect = 2e-29
Identities = 47/211 (22%), Positives = 86/211 (40%), Gaps = 20/211 (9%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKV---EIINERMTHQVHRERCCQV 135
D+++ LG GK+ V+ A T + +K+L V +I E + R +
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 93
Query: 136 HLSSSRRHP-------LLSSEEGYSLY------TEKDAAKYIYQVADAIHYCHQKKVIHR 182
L+ + P + T+ D Y+Y++ A+ YCH ++HR
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 183 DIKPENLLLTM-HEDVKISDFGWSVHAPSLHRKTM-CGTLDYLPPEMVTS-QHYGKEVDN 239
D+KP N+++ H +++ D+G + + + + PE++ Q Y +D
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 213
Query: 240 WCIGILAYEFLVGKPPF-ESKDQDTTLERIF 269
W +G + + K PF D L RI
Sbjct: 214 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (277), Expect = 2e-29
Identities = 45/243 (18%), Positives = 82/243 (33%), Gaps = 54/243 (22%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYK-------VEIINER--MTH 125
++ E +G G FG V+ A+ M+A+K+L + + E M
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 126 QVHRERCCQVHLSSSRRHPLLSSE--EGYSLY---------------------------- 155
+ + + + + L E L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 156 -----TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210
+ + QVA + Y ++K +HRD+ N L+ + VKI+DFG S + S
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 211 ----LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTL 265
+ ++PPE + Y E D W G++ +E G P+ + +
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 252
Query: 266 ERI 268
+
Sbjct: 253 YYV 255
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-29
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 27/217 (12%)
Query: 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLS 138
+ ++ P+G+G G V A + +A+K L + N+ + +RE ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 139 SSRRHPLL-------SSEEGYSLY------------------TEKDAAKYIYQVADAIHY 173
LL + EE +Y + + +YQ+ I +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 134
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWS-VHAPSLHRKTMCGTLDYLPPEMVTSQH 232
H +IHRD+KP N+++ +KI DFG + S T Y PE++
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 233 YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
Y + VD W +G + E + K F +D ++
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 7e-29
Identities = 45/221 (20%), Positives = 84/221 (38%), Gaps = 27/221 (12%)
Query: 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ---IMIALKVLYKV-------EIINE-RM 123
Y Q E+G +G G+FG V+ + + + +A+K + + E
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 124 THQVHRERCCQVHLSSSRRHPLLSSE--EGYSLY----------TEKDAAKYIYQVADAI 171
Q ++ + + E L Y YQ++ A+
Sbjct: 62 MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 172 HYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP---SLHRKTMCGTLDYLPPEMV 228
Y K+ +HRDI N+L++ ++ VK+ DFG S + + ++ PE +
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 229 TSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
+ + D W G+ +E L+ G PF+ + + RI
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-28
Identities = 49/220 (22%), Positives = 83/220 (37%), Gaps = 28/220 (12%)
Query: 77 WQMSD-FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER---- 131
W++ + ++ P+G+G +G V A + T + +A+K L + + + +RE
Sbjct: 14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLK 72
Query: 132 ------------CCQVHLSSSRRHPLLSSEEGYSL----------YTEKDAAKYIYQVAD 169
S + + T+ IYQ+
Sbjct: 73 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 170 AIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVT 229
+ Y H +IHRD+KP NL + ++KI DFG + H + P M+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN 192
Query: 230 SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269
HY + VD W +G + E L G+ F D L+ I
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-28
Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 27/217 (12%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSS 139
+ + P+G+G +G V A + T +A+K LY+ +E + +RE H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 140 SRRHPLL-------SSEEGYSLY-------------------TEKDAAKYIYQVADAIHY 173
LL + ++ Y E +YQ+ + Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 174 CHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHY 233
H +IHRD+KP NL + ++KI DFG + A S + P ++ Y
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRY 196
Query: 234 GKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIFW 270
+ VD W +G + E + GK F+ D L+ I
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 6e-27
Identities = 40/219 (18%), Positives = 78/219 (35%), Gaps = 30/219 (13%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKTT----QIMIALKVLYK-------VEIINER--MTHQ 126
S +G G+FG VY KT+ ++ +A+K L V+ + E M
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 127 VHRERCCQVHLSSSRRHPLLSSE------------EGYSLYTEKDAAKYIYQVADAIHYC 174
H + S + ++ +E E ++ + +A + Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 175 HQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKTM-----CGTLDYLPPEMVT 229
+HRD+ N+L+ + K+SDFG S T + + PE ++
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 230 SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+ + D W GI+ +E + + + + +
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 225
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-26
Identities = 50/249 (20%), Positives = 85/249 (34%), Gaps = 52/249 (20%)
Query: 71 PNKSYRWQM--SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVH 128
P + +W+ ++G PLG G FG V A + V+++ E TH H
Sbjct: 2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEH 60
Query: 129 RERCCQVHLSSSRRHP-------------------LLSSEEGYSLY-------------- 155
R ++ + H ++ + +L
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 156 -----------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204
T + Y +QVA + + +K IHRD+ N+LL+ VKI DFG
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 205 SVHAPS----LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVG-KPPFESK 259
+ + + L ++ PE + + Y + D W G+L +E P+
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 260 DQDTTLERI 268
D R
Sbjct: 241 KIDEEFCRR 249
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-26
Identities = 49/247 (19%), Positives = 88/247 (35%), Gaps = 49/247 (19%)
Query: 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ-------IMIALKVLYK-------V 116
+ + +G PLG G FG V LA+ +A+K+L
Sbjct: 4 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63
Query: 117 EIINERMTHQV---HRERCCQVHLSSSRRHPLLSSE--EGYSLY---------------- 155
++I+E ++ H+ + + + E +L
Sbjct: 64 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123
Query: 156 ---------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206
+ KD YQVA + Y KK IHRD+ N+L+T +KI+DFG +
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 207 HAPSLHR----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFL-VGKPPFESKDQ 261
+ + ++ PE + + Y + D W G+L +E +G P+
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 262 DTTLERI 268
+ + +
Sbjct: 244 EELFKLL 250
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 7e-25
Identities = 51/258 (19%), Positives = 88/258 (34%), Gaps = 54/258 (20%)
Query: 63 THYDAREAP-NKSYRWQMSDFEVGCPLGTGKFGHVYLAK-----EKTTQIMIALKVLYKV 116
+ D + P + + + + G LG G FG V A + + +A+K+L
Sbjct: 5 VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 64
Query: 117 EIINERMTHQVHRERCCQVHLSS------------SRRHPLLSSE--EGYSLY------- 155
+ ER + E +L + L+ +E L
Sbjct: 65 AHLTER--EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 156 --------------------TEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE 195
+D + YQVA + + K IHRD+ N+LLT
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182
Query: 196 DVKISDFGWSVHAPSLHRKTM----CGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFL- 250
KI DFG + + + + ++ PE + + Y E D W GI +E
Sbjct: 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 251 VGKPPFESKDQDTTLERI 268
+G P+ D+ ++
Sbjct: 243 LGSSPYPGMPVDSKFYKM 260
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 98.2 bits (243), Expect = 2e-24
Identities = 42/228 (18%), Positives = 79/228 (34%), Gaps = 42/228 (18%)
Query: 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRER---------- 131
+ + LG G F V+LAK+ +A+K++ ++ E ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 132 ------------------------CCQVHLSSSRRHPLLSSEEGYSLYTEKDAAKYIYQV 167
V L + + + Q+
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 168 ADAIHYCHQK-KVIHRDIKPENLLLTMHE------DVKISDFGWSVHAPSLHRKTMCGTL 220
+ Y H++ +IH DIKPEN+L+ + + +KI+D G + H T
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTR 193
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268
+Y PE++ +G D W L +E + G FE + + +
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 8e-24
Identities = 46/219 (21%), Positives = 78/219 (35%), Gaps = 44/219 (20%)
Query: 88 LGTGKFGHVYLAK---EKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP 144
+G G FG VY +I A+K L ++ I E Q E + HP
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV--SQFLTE----GIIMKDFSHP 88
Query: 145 LLSSEEGYSLYTEK----------------------------DAAKYIYQVADAIHYCHQ 176
+ S G L +E D + QVA + +
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS------LHRKTMCGTLDYLPPEMVTS 230
KK +HRD+ N +L VK++DFG + ++ + ++ E + +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 231 QHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268
Q + + D W G+L +E + G PP+ + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 2e-23
Identities = 38/223 (17%), Positives = 76/223 (34%), Gaps = 43/223 (19%)
Query: 81 DFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYK---------VEIINERMTHQVH--- 128
+ +G G+FG V+ K + ++ A+K+ EI M +
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEEV--AVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 129 -RERCCQVHLSSSRRHPLLSSEEGYSLY--------TEKDAAKYIYQVADAIHYCHQ--- 176
+ + + ++ + E SL+ T + K A + + H
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 177 -----KKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS------LHRKTMCGTLDYLPP 225
+ HRD+K +N+L+ + I+D G +V S + GT Y+ P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 226 EMVTSQ------HYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262
E++ K D + +G++ +E +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 4e-23
Identities = 40/229 (17%), Positives = 77/229 (33%), Gaps = 40/229 (17%)
Query: 80 SDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYK-------VEIINER--MTH 125
+ LG G FG VY K + +A+K + + +E +NE M
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 126 QVHRERCCQVHLSSSRRHPLLSSE--EGYSLY-------------------TEKDAAKYI 164
+ + S + L+ E L + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 165 YQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS----LHRKTMCGTL 220
++AD + Y + K +HRD+ N ++ VKI DFG + +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 221 DYLPPEMVTSQHYGKEVDNWCIGILAYEFL-VGKPPFESKDQDTTLERI 268
++ PE + + D W G++ +E + + P++ + L +
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 75.2 bits (184), Expect = 4e-17
Identities = 23/189 (12%), Positives = 55/189 (29%), Gaps = 39/189 (20%)
Query: 83 EVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVH---RERCCQVHLSS 139
+G +G GK V+ + +K +++ + S+
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 140 SRRHPLLSS-----------------------EEGYSLYTEKDAAKYIYQVADAIHYCHQ 176
L + ++ + + + + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSV-----HAPSLHRKTMCGTLDYLPPEMVTSQ 231
+ ++H D+ N+L++ E + I DF SV + + + + Y S+
Sbjct: 122 RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF------SR 174
Query: 232 HYGKEVDNW 240
Y E D
Sbjct: 175 TYRTEKDIN 183
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 271 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.73 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.46 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 93.64 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 83.78 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=323.66 Aligned_cols=189 Identities=54% Similarity=1.009 Sum_probs=161.8
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
|.+++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+| +.+.....||+++...+.
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E----~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE----VEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHHTCCCTTBCCEEEEEECS
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHH----HHHHHhcCCCCCCeEEEEEEEC
Confidence 457899999999999999999999999999999999976554433333334444 344445567776654432
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred CEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 3379999999999999999999999999999999999999999999999999988777
Q ss_pred CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 217 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 217 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 66677889999999999999999999999999999999999999999999999888764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-47 Score=328.18 Aligned_cols=188 Identities=32% Similarity=0.543 Sum_probs=159.1
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
..+++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+| +.++....||+++...+.
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E----~~il~~l~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE----KRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHTTCCCTTBCCEEEEEECS
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHH----HHHHHHcCCCcEeecccccccc
Confidence 346899999999999999999999999999999999976554433333333344 344555578877654332
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 3379999999999999999999999999999999999999999999999999987654
Q ss_pred CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 194 ~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~ 251 (350)
T d1rdqe_ 194 R-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251 (350)
T ss_dssp C-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred c-cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh
Confidence 3 345679999999999999999999999999999999999999999999988888774
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=323.99 Aligned_cols=189 Identities=37% Similarity=0.621 Sum_probs=160.4
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
+.+++|++++.||+|+||.||+|+++.+++.||||++++...........+.+| +.++....||+++...+.
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E----~~il~~l~hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE----SRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHHSCCCTTBCCEEEEEECS
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHH----HHHHHhCCCCCEEEEEeeeccc
Confidence 457899999999999999999999999999999999987655443333344444 334455578876654332
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..++++.++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 3479999999999999999999999999999999999999999999999999986543
Q ss_pred --CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 --LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
......+||+.|+|||++.+..|+.++|+|||||++|||++|+.||.+.+..+++++|.
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~ 218 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh
Confidence 34456789999999999999999999999999999999999999999999999888764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.6e-47 Score=320.16 Aligned_cols=187 Identities=36% Similarity=0.625 Sum_probs=158.6
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
.+++|++++.||+|+||+||+|+++.+++.||||++++.........+.+.+| ..++....||+++.+.+.
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E----~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE----RLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHHSCCBTTBCCEEEEEECSS
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHH----HHHHHhccCcChhheeeeEeeCC
Confidence 46789999999999999999999999999999999976554433333334444 344455578877654432
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 23688899999999999999999999999999999999999999999999999876553
Q ss_pred CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 212 HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|+
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~ 214 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 214 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH
Confidence 345789999999999999999999999999999999999999999999999888875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=316.36 Aligned_cols=186 Identities=33% Similarity=0.551 Sum_probs=153.3
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+| ..++....||+++.+.+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E----~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----HHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHH----HHHHHHcCCCCeeEEEEEEEECCEE
Confidence 689999999999999999999999999999999976554433333333344 233344467766554332
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC---
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--- 210 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--- 210 (271)
..+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 3479999999999999999999999999999999999999999999999999976542
Q ss_pred -CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 -LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++++|+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 223 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH
Confidence 22345679999999999999999999999999999999999999999999999988875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=310.04 Aligned_cols=182 Identities=29% Similarity=0.498 Sum_probs=150.3
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
++|++++.||+|+||+||+|+++.+++.||||+++...... .+.+.+| +.++....||+++...+.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E----~~il~~l~HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINE----ILVMRENKNPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHH----HHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHH----HHHHHhCCCCCEeeEeEEEEECCEE
Confidence 57999999999999999999999999999999986543211 1122233 233444467766554432
Q ss_pred ------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--CC
Q psy4396 153 ------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS--LH 212 (271)
Q Consensus 153 ------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~--~~ 212 (271)
..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 93 ~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 3378999999999999999999999999999999999999999999999999976543 33
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 228 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 45667999999999999999999999999999999999999999998887776654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=306.78 Aligned_cols=186 Identities=27% Similarity=0.452 Sum_probs=144.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|++++.||+|+||+||+|+++.+++.||||++........ ....+.+| +.++....||+++...+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~E----~~il~~l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSE----VNLLRELKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH-HHHHHHHH----HHHTTSCCCTTBCCEEEEEEC---
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH-HHHHHHHH----HHHHHHCCCCCEeeEEEEEEeCCC
Confidence 4789999999999999999999999999999999865433211 12233333 345555577766554321
Q ss_pred --------------------------ccCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEeCCCCCEEEee
Q psy4396 153 --------------------------SLYTEKDAAKYIYQVADAIHYCHQKK-----VIHRDIKPENLLLTMHEDVKISD 201 (271)
Q Consensus 153 --------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~-----iiHrDikp~Nili~~~~~~kl~D 201 (271)
..+++..++.++.|++.||+|||++| |+||||||+|||++.++.+||+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 23788999999999999999999976 99999999999999999999999
Q ss_pred ccccccCCCC--CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 202 FGWSVHAPSL--HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 202 fg~a~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
||+|+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~ 227 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 9999765432 3345779999999999999999999999999999999999999999999998887764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=315.38 Aligned_cols=181 Identities=27% Similarity=0.452 Sum_probs=148.2
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
+..++|++++.||+|+||+||+|++..+++.||+|+++.... ......+.+| +.++....||+++.+.+.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E----i~il~~l~HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRE----LQVLHECNSPYIVGFYGAFYSD 76 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHH----GGGGGGCCCTTBCCEEEEEECS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHH----HHHHHhCCCCCCCcEEEEEEEC
Confidence 445789999999999999999999999999999999864321 1112233333 444555578877665432
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQK-KVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~-~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..+++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+|+...
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 3479999999999999999999974 99999999999999999999999999998665
Q ss_pred CCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDT 263 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 263 (271)
.......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+
T Consensus 157 ~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 555556789999999999999999999999999999999999999998776544
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=306.84 Aligned_cols=178 Identities=30% Similarity=0.544 Sum_probs=142.4
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|+++.+++.||||++....... ..+.+.+| +.++....||+++...+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~E----i~~l~~l~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKE----ICINKMLNHENVVKFYGHRREGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHH----HHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHH----HHHHHhCCCCCEeeEeeeeccCce
Confidence 478999999999999999999999999999999986543211 11223333 334444567766554322
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-- 210 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-- 210 (271)
..+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+....
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 3479999999999999999999999999999999999999999999999999975432
Q ss_pred --CCcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 211 --LHRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 22345679999999999988876 57899999999999999999999765543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-45 Score=309.74 Aligned_cols=184 Identities=27% Similarity=0.424 Sum_probs=152.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
+.|+.++.||+|+||+||+|++..+++.||||++.............+.+| +.++....||+++.+.+.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E----i~il~~l~HpnIv~~~~~~~~~~~~ 90 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE----VRFLQKLRHPNTIQYRGCYLREHTA 90 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHH----HHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHH----HHHHHHCCCCCEeeEEEEEEECCEE
Confidence 459999999999999999999999999999999865433222223334444 344555578877665443
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR 213 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 213 (271)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.... .
T Consensus 91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~ 168 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--A 168 (309)
T ss_dssp EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--B
T ss_pred EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--C
Confidence 3379999999999999999999999999999999999999999999999999976544 3
Q ss_pred ccccccccccCcceecc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 214 KTMCGTLDYLPPEMVTS---QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+.+|.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~ 227 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 34679999999999864 458999999999999999999999999998888776653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.5e-45 Score=314.30 Aligned_cols=184 Identities=28% Similarity=0.469 Sum_probs=148.2
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
.+++|++++.||+|+||.||+|++..+++.||||++.+.............++. ....+.....||+++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~-~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-IMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHH-HHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHH-HHHHHHhcCCCCcEEEEEEEEEECC
Confidence 468999999999999999999999999999999999765443322211111111 11233344456665543221
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 23789999999999999999999999999999999999999999999999999887776
Q ss_pred CcccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Q psy4396 212 HRKTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQD 262 (271)
Q Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 262 (271)
.....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||.+.+..
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 6677889999999999864 56899999999999999999999999876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=306.44 Aligned_cols=183 Identities=31% Similarity=0.470 Sum_probs=149.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
+.|++++.||+|+||+||+|+++.+++.||||+++.... ...+.+.+| +.++....||+++.+.+.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E----~~il~~l~HpnIv~l~~~~~~~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVE----IDILASCDHPNIVKLLDAFYYENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHH----HHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHH----HHHHHhCCCCCCCeEEEEEeeCCeE
Confidence 569999999999999999999999999999999864321 112233333 334444567776655432
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 23799999999999999999999999999999999999999999999999998654332
Q ss_pred -CcccccccccccCcceec-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 212 -HRKTMCGTLDYLPPEMVT-----SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~ 228 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 233567999999999984 4568999999999999999999999999999888877664
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=305.89 Aligned_cols=188 Identities=32% Similarity=0.553 Sum_probs=152.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|+++.+++.||||++++..............+. ..+.....||+++...+.
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~---~~l~~~~~hp~Iv~~~~~~~~~~~ 77 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK---RVLSLAWEHPFLTHMFCTFQTKEN 77 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHH---HHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHH---HHHHHhCCCCcEEEEEEEEccCCc
Confidence 47899999999999999999999999999999999765433222111111211 111223456665543322
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-- 210 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-- 210 (271)
..+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+....
T Consensus 78 ~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred eeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 3378999999999999999999999999999999999999999999999999975443
Q ss_pred CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 216 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 216 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 33445679999999999999999999999999999999999999999999999888764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=295.30 Aligned_cols=181 Identities=22% Similarity=0.404 Sum_probs=145.2
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc---------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY--------- 152 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--------- 152 (271)
|++.+.||+|+||+||+|++..+++.||+|.+........ ....+.+| +.++....||+++.+.+.
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~-~~~~~~~E----~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEE----AEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHH----HHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHH----HHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 4677889999999999999999999999999865432211 12233333 344555567776654321
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEeC-CCCCEEEeeccccccC
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKK--VIHRDIKPENLLLT-MHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~--iiHrDikp~Nili~-~~~~~kl~Dfg~a~~~ 208 (271)
..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 23789999999999999999999998 99999999999996 4789999999999877
Q ss_pred CCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHhh
Q psy4396 209 PSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ-DTTLERI 268 (271)
Q Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~I 268 (271)
........+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+... .+++++|
T Consensus 166 ~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i 225 (270)
T d1t4ha_ 166 RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 225 (270)
T ss_dssp CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred cCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH
Confidence 6666667889999999999865 599999999999999999999999976554 4444444
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-44 Score=301.39 Aligned_cols=192 Identities=22% Similarity=0.336 Sum_probs=153.1
Q ss_pred cCCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeee
Q psy4396 69 EAPNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSS 148 (271)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 148 (271)
.+....|+++.++|++.+.||+|+||+||+|+++.+++.||||+++...... +++.+| +.++....||+++.
T Consensus 6 ~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----~~~~~E----~~il~~l~HpnIv~ 77 (287)
T d1opja_ 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKE----AAVMKEIKHPNLVQ 77 (287)
T ss_dssp STTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH----HHHHHH----HHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchH----HHHHHH----HHHHHhCCCCCEec
Confidence 3344568888999999999999999999999999999999999986532211 122333 33444456777665
Q ss_pred ccCc----------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEe
Q psy4396 149 EEGY----------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKIS 200 (271)
Q Consensus 149 ~~~~----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~ 200 (271)
..+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 78 ~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 5433 236889999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCc---ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHhh
Q psy4396 201 DFGWSVHAPSLHR---KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVG-KPPFESKDQDTTLERI 268 (271)
Q Consensus 201 Dfg~a~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~I 268 (271)
|||+|+....... ....||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+..++.+.+
T Consensus 158 DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i 229 (287)
T d1opja_ 158 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229 (287)
T ss_dssp CCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred cccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH
Confidence 9999987654332 224578899999999999999999999999999999995 5556666766665543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-44 Score=303.89 Aligned_cols=184 Identities=36% Similarity=0.651 Sum_probs=138.0
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
+.|++.+.||+|+||+||+|+++.+++.||||++.+...... ...+.+| +.++....||+++...+.
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~E----i~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENE----IAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHH----HHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHH----HHHHHhCCCCCCCcEEEEEEECCEE
Confidence 569999999999999999999999999999999875433211 1122223 344445567776554322
Q ss_pred -------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC---CCCCEEEeeccccccCCC
Q psy4396 153 -------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT---MHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 153 -------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~---~~~~~kl~Dfg~a~~~~~ 210 (271)
..+++..+..++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 3489999999999999999999999999999999999995 478999999999976543
Q ss_pred C-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 L-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++..+|+
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 222 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 3 3345679999999999999999999999999999999999999999999988887765
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.2e-44 Score=307.04 Aligned_cols=184 Identities=29% Similarity=0.528 Sum_probs=150.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|+++.+++.||||++........ +.+.+| +.++....||+++.+.+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~---~~~~~E----~~il~~l~HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKE----IQTMSVLRHPTLVNLHDAFEDDNE 97 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHH---HHHHHH----HHHHHHTCCTTBCCEEEEEEETTE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhH---HHHHHH----HHHHHhCCCCCCCcEEEEEEECCE
Confidence 5789999999999999999999999999999999865432211 122223 223333356655443221
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC--CCCEEEeeccccccCC
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM--HEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~--~~~~kl~Dfg~a~~~~ 209 (271)
..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 34899999999999999999999999999999999999964 5789999999998765
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+|.
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 43 3445779999999999999999999999999999999999999999999999888764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6e-44 Score=297.41 Aligned_cols=186 Identities=27% Similarity=0.443 Sum_probs=143.8
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
++|++.+.||+|+||+||+|++..+++.||||++++...........+.+| +.......||+++...+.
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E----~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRRE----AQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHH----HHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHH----HHHHHhcCCCCCCcccceeeeccCC
Confidence 679999999999999999999999999999999865433222222233333 223333455554432211
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..+++.++..++.|++.||+|||++||+||||||+|||++.++..+++|||.+....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 347899999999999999999999999999999999999999999999999876443
Q ss_pred C-----CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 S-----LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++.+++
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~ 227 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence 2 22344679999999999999999999999999999999999999999999888776654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=299.12 Aligned_cols=185 Identities=25% Similarity=0.449 Sum_probs=142.2
Q ss_pred cccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 74 SYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 74 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
.|+++.++|++++.||+|+||+||+|+.++ .||||+++...... .....+.+| +.++....||+++...++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~-~~~~~~~~E----~~~l~~l~HpnIv~~~~~~ 73 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTP-QQLQAFKNE----VGVLRKTRHVNILLFMGYS 73 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCT-THHHHHHHH----HHHHTTCCCTTBCCEEEEE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCH-HHHHHHHHH----HHHHHhCCCCCEeeeeEEE
Confidence 467778899999999999999999998653 49999986432111 112223333 344445567776655443
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 74 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 74 TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp CSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred eccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 2378999999999999999999999999999999999999999999999999965
Q ss_pred CCC----CCcccccccccccCcceecc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 208 APS----LHRKTMCGTLDYLPPEMVTS---QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 208 ~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
... .......||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+.+....+.
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~ 219 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH
Confidence 442 22344679999999999864 358999999999999999999999999877655443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-43 Score=304.13 Aligned_cols=184 Identities=28% Similarity=0.453 Sum_probs=152.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|++++.||+|+||+||+|++..+++.||||+++....... ..+.+| +.++....||+++.+.+.
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~E----i~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNE----ISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH---HHHHHH----HHHHTTCCSTTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHH---HHHHHH----HHHHHhCCCCCCCcEEEEEEECCE
Confidence 4689999999999999999999999999999999865432221 122223 334444467765543322
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeC--CCCCEEEeeccccccCC
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLT--MHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~--~~~~~kl~Dfg~a~~~~ 209 (271)
..+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 2379999999999999999999999999999999999997 56899999999998765
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+|.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 241 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 43 3445679999999999999999999999999999999999999999999998887764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=293.81 Aligned_cols=190 Identities=20% Similarity=0.334 Sum_probs=150.7
Q ss_pred CCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc
Q psy4396 71 PNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE 150 (271)
Q Consensus 71 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 150 (271)
....|+++.++|++++.||+|+||+||+|+++ ++..||||+++....... .+.+| +.++....||+++.+.
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~----~~~~E----~~~l~~l~HpnIv~~~ 74 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPD----AFLAE----ANLMKQLQHQRLVRLY 74 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHH----HHHHH----HHHHHHCCCTTBCCEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHH----HHHHH----HHHHHhCCCCCEeEEE
Confidence 35677888899999999999999999999976 467899999865332111 12222 2333333556555443
Q ss_pred Cc---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 151 GY---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 151 ~~---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
+. ..+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||
T Consensus 75 g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 75 AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp EEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeeccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeecccc
Confidence 32 127889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 204 WSVHAPSLH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 204 ~a~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
+|+...... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+++..|.
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~ 224 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 997655432 234568899999999998899999999999999999999 677788888887776653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=296.61 Aligned_cols=186 Identities=30% Similarity=0.519 Sum_probs=150.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHH---hhhhhhceeeeEEecCcCCCcceeeeccCc----
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINER---MTHQVHRERCCQVHLSSSRRHPLLSSEEGY---- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 152 (271)
++|++++.||+|+||+||+|+++.+++.||||++++....... ..+.+.+| +.++....||+++...+.
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E----~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHH----HHHHHHCCCTTBCCEEEEEECS
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHH----HHHHHhCCCCCCCcEEEEEEEC
Confidence 5699999999999999999999999999999998653221110 01122222 233333456665544322
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC----CEEEeeccccc
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE----DVKISDFGWSV 206 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~----~~kl~Dfg~a~ 206 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 3479999999999999999999999999999999999998776 49999999997
Q ss_pred cCCCC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 207 HAPSL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 207 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++.+|.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 229 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 76543 3445678999999999999999999999999999999999999999999999887764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=294.24 Aligned_cols=186 Identities=28% Similarity=0.459 Sum_probs=149.7
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|++..+++.||||+++.... .......+.+| +.+.....||+++...+.
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E----i~il~~l~Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIRE----ISLLKELNHPNIVKLLDVIHTENK 75 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHH----HHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHH----HHHHHhCCCCcEEEeccccccccc
Confidence 3689999999999999999999999999999999865432 12222333333 344455578876654432
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC-
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS- 210 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~- 210 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 3379999999999999999999999999999999999999999999999999976543
Q ss_pred -CCcccccccccccCcceeccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 -LHRKTMCGTLDYLPPEMVTSQH-YGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.......||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+..+.+.+|+
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~ 216 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHH
Confidence 3344467999999999887666 4789999999999999999999999998888776653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-43 Score=294.87 Aligned_cols=187 Identities=21% Similarity=0.329 Sum_probs=140.9
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCCCe---EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTTQI---MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
++.++|++.+.||+|+||+||+|+++.+++ .||||.+...... ...+.+.+| +.++....||+++.+.+.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E----~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSE----ASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHH----HHHHTTCCCTTBCCEEEEE
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH--HHHHHHHHH----HHHHHhCCCCCCccEEEEE
Confidence 345789999999999999999999876653 6899987543211 111233333 445556678887766543
Q ss_pred --------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 153 --------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 153 --------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 237899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCc-------ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 207 HAPSLHR-------KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 207 ~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
....... ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+++..|.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 5443211 12347899999999999999999999999999999998 899999999988877663
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=296.16 Aligned_cols=189 Identities=24% Similarity=0.400 Sum_probs=143.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCC-CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTT-QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
.++|++++.||+|+||+||+|++..+ ++.||||+++....... ......+|... ........||+++.+.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~-l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAV-LRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHH-HHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHH-HHHHhhcCCCCcceeeeeecccc
Confidence 47899999999999999999999755 67899999853211000 00000000000 0001111233322211
Q ss_pred -------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 151 -------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 151 -------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 1133789999999999999999999999999999999999999999999999998
Q ss_pred ccCCC-CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 206 VHAPS-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 206 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+.... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|+
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 228 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred hhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 75543 33455779999999999999999999999999999999999999999999988887764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=288.52 Aligned_cols=182 Identities=24% Similarity=0.412 Sum_probs=138.7
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----- 152 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----- 152 (271)
+.++|++++.||+|+||+||+|++.+ ++.||||+++....... .+.+| +.......||+++.+.+.
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~----~~~~E----~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE----DFIEE----AEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCHH----HHHHH----HHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcHH----HHHHH----HHHHHhcCCCCcccccceeccCC
Confidence 34789999999999999999999874 56799999865332221 22222 333344467766655443
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
..++++.+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 2368899999999999999999999999999999999999999999999999976543
Q ss_pred CC---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 211 LH---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.. .....||+.|+|||++.+..++.++|||||||++|||+| |++||...+..++++.|
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i 215 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 22 223568999999999999999999999999999999998 68888888888887765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=294.43 Aligned_cols=182 Identities=29% Similarity=0.424 Sum_probs=141.8
Q ss_pred EecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH--HhhhhhhceeeeEEecCcCCCcceeeeccCc---------
Q psy4396 84 VGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE--RMTHQVHRERCCQVHLSSSRRHPLLSSEEGY--------- 152 (271)
Q Consensus 84 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--------- 152 (271)
.++.||+|+||+||+|+++.+++.||||+++....... .....+.+| +.++....||+++...+.
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~E----i~il~~l~hpnIv~~~~~~~~~~~~~i 77 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE----IKLLQELSHPNIIGLLDAFGHKSNISL 77 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHH----HHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHH----HHHHHhCCCCCEeEEEeeeccCCceee
Confidence 46789999999999999999999999999865432211 111222233 233334456665544322
Q ss_pred -----------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC--Cc
Q psy4396 153 -----------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL--HR 213 (271)
Q Consensus 153 -----------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~--~~ 213 (271)
..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 78 vmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 33788999999999999999999999999999999999999999999999999765442 33
Q ss_pred ccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 214 KTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
...+||+.|+|||++.. ..|+.++|||||||++|||++|+.||.+.+..+++.+|+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~ 214 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH
Confidence 45679999999998865 457999999999999999999999999999988887764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=297.93 Aligned_cols=190 Identities=25% Similarity=0.384 Sum_probs=142.4
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCCCe-----EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcC-CCccee
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQI-----MIALKVLYKVEIINERMTHQVHRERCCQVHLSSS-RRHPLL 146 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l 146 (271)
..|+++.++|++++.||+|+||+||+|++..+++ .||+|.+....... ....+.+|. ..+.. ..||++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~----~~l~~l~~HpnI 103 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSEL----KMMTQLGSHENI 103 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHH----HHHHHHCCCTTB
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH--HHHHHHHHH----HHHHHhcCCCcE
Confidence 3466777899999999999999999999876543 69999885432111 011111111 11111 134443
Q ss_pred eeccCc-------------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHC
Q psy4396 147 SSEEGY-------------------------------------------------SLYTEKDAAKYIYQVADAIHYCHQK 177 (271)
Q Consensus 147 ~~~~~~-------------------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~ 177 (271)
+.+.+. ..+++..+..++.|++.||+|||++
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~ 183 (325)
T d1rjba_ 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183 (325)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 332211 2368889999999999999999999
Q ss_pred CceeccCCCCceEeCCCCCEEEeeccccccCCCCCc----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-C
Q psy4396 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-G 252 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g 252 (271)
||+||||||+|||++.++.+||+|||+|+....... ....||+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 999999999999999999999999999976543322 24557999999999999999999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHhh
Q psy4396 253 KPPFESKDQDTTLERI 268 (271)
Q Consensus 253 ~~pf~~~~~~~~~~~I 268 (271)
+.||.+.+..+.+.++
T Consensus 264 ~~Pf~~~~~~~~~~~~ 279 (325)
T d1rjba_ 264 VNPYPGIPVDANFYKL 279 (325)
T ss_dssp CCSSTTCCCSHHHHHH
T ss_pred CCCCCCCCHHHHHHHH
Confidence 9999988776665554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=291.85 Aligned_cols=176 Identities=31% Similarity=0.521 Sum_probs=136.8
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHh---hhhhhceeeeEEecCcC--CCcceeeeccCc--
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERM---THQVHRERCCQVHLSSS--RRHPLLSSEEGY-- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~-- 152 (271)
++|++.+.||+|+||+||+|++..+++.||||++.+........ ...+.+| ..++.. ..||+++...+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E----~~il~~l~~~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME----VVLLKKVSSGFSGVIRLLDWFE 79 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHH----HHHHHHHCSSSCSBCCEEEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHH----HHHHHHhccCCCCccEEEEEEe
Confidence 67999999999999999999999999999999986543211100 0001111 111111 124443332211
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC-CCEEEeeccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH-EDVKISDFGWSV 206 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~-~~~kl~Dfg~a~ 206 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 347899999999999999999999999999999999999854 789999999998
Q ss_pred cCCCCCcccccccccccCcceeccCCC-CCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 207 HAPSLHRKTMCGTLDYLPPEMVTSQHY-GKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
...........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.
T Consensus 160 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 160 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 777666667889999999999987765 56799999999999999999999753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=284.56 Aligned_cols=182 Identities=26% Similarity=0.388 Sum_probs=149.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
-++|++++.||+|+||+||+|+++ +++.||||++++...... .+.+| +.......||+++.+.+.
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~----~~~~E----v~~~~~l~HpnIv~~~g~~~~~~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSED----EFIEE----AKVMMNLSHEKLVQLYGVCTKQRP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHH----HHHHH----HHHHHTCCCTTBCCEEEEECCSSS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHH----HHHHH----HHHHHhcCCCceeeEEEEEeeCCc
Confidence 478999999999999999999985 577899999875433221 22233 344445567776665543
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL 211 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~ 211 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 22678899999999999999999999999999999999999999999999999754432
Q ss_pred C---cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 212 H---RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 212 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
. .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++..+|.
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~ 215 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH
Confidence 2 223568999999999999999999999999999999998 899999999999888764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=288.31 Aligned_cols=187 Identities=21% Similarity=0.317 Sum_probs=141.6
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCC----eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ----IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
++..+.|++.+.||+|+||+||+|.++.++ ..||||+++...... ....+.+| +.+.....||+++.+.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E----~~il~~l~H~nIv~~~g 76 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGE----AGIMGQFSHHNIIRLEG 76 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHH----HHHHHTCCCTTBCCEEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH--HHHHHHHH----HHHHHhcCCCCEeeeeE
Confidence 344578999999999999999999987654 479999986432211 11223333 34445557887776654
Q ss_pred c---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccc
Q psy4396 152 Y---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGW 204 (271)
Q Consensus 152 ~---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~ 204 (271)
. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 77 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence 3 2378899999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 205 SVHAPSL-----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 205 a~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
|+..... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..++++.|
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i 226 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 226 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH
Confidence 9764332 1223457999999999999999999999999999999998 56677777777776655
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=295.69 Aligned_cols=184 Identities=20% Similarity=0.359 Sum_probs=142.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCe----EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc--
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQI----MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY-- 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-- 152 (271)
.++|++++.||+|+||+||+|++..+++ .||+|.++.... ....+.+.+| +.+.....||+++.+.+.
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E----~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE----AYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHH----HHHHHHCCCTTBCCEEEEEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHH----HHHHHhCCCCCEeeEEEEEe
Confidence 3679999999999999999999987775 578887754321 1112223333 334444567777665443
Q ss_pred ------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 153 ------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 153 ------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 82 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 82 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred cCCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 23789999999999999999999999999999999999999999999999999765
Q ss_pred CCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 209 PSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
.... .....||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..++...|
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 4322 233458999999999999999999999999999999998 89999998888876654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=289.72 Aligned_cols=188 Identities=25% Similarity=0.367 Sum_probs=147.0
Q ss_pred cccccCeEEecc-cccCCceEEEEEEEcC--CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc
Q psy4396 76 RWQMSDFEVGCP-LGTGKFGHVYLAKEKT--TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY 152 (271)
Q Consensus 76 ~~~~~~~~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 152 (271)
-+..++|.+.+. ||+|+||+||+|.++. ++..||||+++..... .....+.+| +.++....||+++.+.+.
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~E----~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMRE----AQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHH----HHHHHHCCCTTBCCEEEE
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH--HHHHHHHHH----HHHHHhCCCCCEeeEeee
Confidence 345577888885 9999999999998754 4568999998643211 111223333 233334456665554332
Q ss_pred --------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccc
Q psy4396 153 --------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSV 206 (271)
Q Consensus 153 --------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~ 206 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 78 ~~~~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 78 CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred eccCeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhh
Confidence 237899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCC-----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 207 HAPSLH-----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 207 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+++..|.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~ 226 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 226 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 654322 223468899999999999999999999999999999998 999999998888877653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=287.94 Aligned_cols=189 Identities=24% Similarity=0.402 Sum_probs=142.7
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG 151 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 151 (271)
|+++.++|++++.||+|+||+||+|++..+ +..||||.++..... .....+.+| ..++....||+++.+.+
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~E----~~~l~~l~HpnIv~l~~ 75 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQE----ALTMRQFDHPHIVKLIG 75 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHH----HHHHHTCCCTTBCCEEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH--HHHHHHHHH----HHHHHhCCCCCEeeEEE
Confidence 567778999999999999999999998754 357899988543221 111223333 33344456777665544
Q ss_pred c--------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 152 Y--------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 152 ~--------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+|
T Consensus 76 ~~~~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 76 VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp EECSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEecCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhh
Confidence 3 23789999999999999999999999999999999999999999999999999
Q ss_pred ccCCCC---CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 206 VHAPSL---HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 206 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
+..... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+++.+|.
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~ 223 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 764422 2334567899999999999999999999999999999998 999999999998887764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=291.49 Aligned_cols=183 Identities=23% Similarity=0.400 Sum_probs=149.6
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|++++.||+|+||+||+|.++.+++.||||+++....... .+.+| +.++....||+++.+.+.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~----~~~~E----i~il~~l~HpnIv~~~~~~~~~~~ 75 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKE----ISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHH----HHHHH----HHHHHHSCCTTBCCEEEEEEETTE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHH----HHHHH----HHHHHhCCCCCCCeEEEEEEECCE
Confidence 4789999999999999999999999999999999875432211 12222 223333456655443221
Q ss_pred ---------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCC--CCEEEeeccccccCC
Q psy4396 153 ---------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMH--EDVKISDFGWSVHAP 209 (271)
Q Consensus 153 ---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~--~~~kl~Dfg~a~~~~ 209 (271)
..+++.+++.++.||+.||+|||++||+||||||+|||++.+ ..+||+|||+++...
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 247999999999999999999999999999999999999854 479999999997655
Q ss_pred CC-CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SL-HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. ......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+++.+|+
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~ 216 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 43 3445678999999999999999999999999999999999999999999999888775
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.7e-42 Score=284.12 Aligned_cols=187 Identities=30% Similarity=0.501 Sum_probs=145.5
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH------HHhhhhhhceeeeEEecCcCC-CcceeeeccC
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN------ERMTHQVHRERCCQVHLSSSR-RHPLLSSEEG 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~ 151 (271)
.++|++.+.||+|+||+||+|++..+++.||||++.+..... ....+.+.+| ....... .||+++...+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E----~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE----VDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHH----HHHHHHHTTCTTBCCEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHH----HHHHHHhcCCCCeEEEEe
Confidence 368999999999999999999999999999999986532110 1111112222 1111111 1443332211
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 152 --------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 152 --------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence 134799999999999999999999999999999999999999999999999999
Q ss_pred ccCCC-CCcccccccccccCcceecc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 206 VHAPS-LHRKTMCGTLDYLPPEMVTS------QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 206 ~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+.... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..++.++|+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~ 228 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence 76543 33445679999999998853 346889999999999999999999999999988887765
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.4e-42 Score=286.37 Aligned_cols=185 Identities=27% Similarity=0.469 Sum_probs=146.3
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|+++ +++.||||+++.... .......+.+| +.++....||+++...+.
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E----~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIRE----ISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHH----HHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHH----HHHHHhCCCCcEEeeeeecccCCc
Confidence 368999999999999999999986 678899999865432 11122233333 344555578877665432
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC--
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS-- 210 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~-- 210 (271)
..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 3479999999999999999999999999999999999999999999999999865443
Q ss_pred CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 211 LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 211 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.......+++.|+|||.+.+. .++.++|+|||||++|||++|+.||.+.+..+++.+|.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~ 214 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 233445689999999998754 56899999999999999999999999998888877664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=291.91 Aligned_cols=187 Identities=31% Similarity=0.519 Sum_probs=138.0
Q ss_pred ccCeEEec-ccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhh--hh-hceeeeEE-ec----CcCCCcceeeec
Q psy4396 79 MSDFEVGC-PLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTH--QV-HRERCCQV-HL----SSSRRHPLLSSE 149 (271)
Q Consensus 79 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~--~~-~~~~~~~~-~~----~~~~~~~~l~~~ 149 (271)
+++|.++. .||+|+||+||+|++..+++.||||++++......+... .. .....+.+ .. .....+.+++..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 57899875 699999999999999999999999999754433222111 11 00000000 00 000011122211
Q ss_pred c-------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCEEEeeccccccCCC-CC
Q psy4396 150 E-------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM---HEDVKISDFGWSVHAPS-LH 212 (271)
Q Consensus 150 ~-------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~---~~~~kl~Dfg~a~~~~~-~~ 212 (271)
+ +...+++..++.++.|++.||+|||++||+||||||+|||++. .+.+||+|||+|+.... ..
T Consensus 90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~ 169 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169 (335)
T ss_dssp CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCc
Confidence 1 1134899999999999999999999999999999999999975 46799999999976543 34
Q ss_pred cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy4396 213 RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTL 265 (271)
Q Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 265 (271)
....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++.
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~ 222 (335)
T d2ozaa1 170 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 222 (335)
T ss_dssp CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---
T ss_pred cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH
Confidence 45577999999999999999999999999999999999999999877655443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=285.80 Aligned_cols=191 Identities=20% Similarity=0.333 Sum_probs=147.0
Q ss_pred CCCCcccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 70 APNKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
.....|+++.++|++.+.||+|+||+||+|+++.+ +.||||+++......+ .+.+| +.++....||+++.+
T Consensus 7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~----~~~~E----~~~l~~l~h~nIv~~ 77 (285)
T d1fmka3 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPE----AFLQE----AQVMKKLRHEKLVQL 77 (285)
T ss_dssp SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHH----HHHHH----HHHHHHCCCTTBCCE
T ss_pred CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHH----HHHHH----HHHHHhcccCCEeEE
Confidence 34567888889999999999999999999998776 4699999965432211 12222 233333455555444
Q ss_pred cCc---------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeec
Q psy4396 150 EGY---------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 150 ~~~---------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 78 ~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~Df 157 (285)
T d1fmka3 78 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 157 (285)
T ss_dssp EEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEccc
Confidence 322 23789999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC---CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 203 GWSVHAPSL---HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 203 g~a~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
|+|+..... ......||+.|+|||.+....++.++|||||||++|||++ |++||......+++..|.
T Consensus 158 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~ 228 (285)
T d1fmka3 158 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228 (285)
T ss_dssp CTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred chhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999754322 2234568999999999999999999999999999999999 577778888887877664
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=286.95 Aligned_cols=189 Identities=25% Similarity=0.391 Sum_probs=142.3
Q ss_pred ccccCeEEecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY- 152 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~- 152 (271)
+..++|++++.||+|+||+||+|++... ...||||++++.........+.+.+| +.++....||+++...+.
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~E----i~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE----VNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHH----HHHHHHCCCTTBCCEEEEE
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHH----HHHHHhCCCCCEEEEEEEE
Confidence 3457899999999999999999987643 24799999876544333333344444 344445567776665442
Q ss_pred -------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 153 -------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 153 -------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 81 LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp CSSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eecchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 2378999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCc-----ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 208 APSLHR-----KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 208 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
...... ....||..|+|||++.+..++.++||||||+++|||+| |+.||.+.+..+++.+|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~ 228 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH
Confidence 543322 23457889999999999999999999999999999998 899999999999887764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=285.42 Aligned_cols=178 Identities=21% Similarity=0.378 Sum_probs=139.6
Q ss_pred cccccCCceEEEEEEEcC--CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-----------
Q psy4396 86 CPLGTGKFGHVYLAKEKT--TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY----------- 152 (271)
Q Consensus 86 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----------- 152 (271)
+.||+|+||+||+|.+.. +++.||||+++.... .....+.+.+| +.++....||+++...+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E----~~il~~l~HpnIv~~~g~~~~~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAE----ANVMQQLDNPYIVRMIGICEAESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHH----HHHHHTCCCTTBCCEEEEEESSSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHH----HHHHHhCCCCCCceEEEEeccCCEEEEEE
Confidence 469999999999998754 457899999864322 12222233333 344445567776655433
Q ss_pred --------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCc-----
Q psy4396 153 --------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHR----- 213 (271)
Q Consensus 153 --------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~----- 213 (271)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 2378999999999999999999999999999999999999999999999999976543221
Q ss_pred ccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhh
Q psy4396 214 KTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERI 268 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I 268 (271)
....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...|
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i 223 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence 23468999999999999999999999999999999998 99999999988877665
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-42 Score=287.43 Aligned_cols=195 Identities=23% Similarity=0.365 Sum_probs=133.5
Q ss_pred CcccccccCeEEecccccCCceEEEEEEEcCC-----CeEEEEEEcchhHHHHHH--------hhhhhhce-ee--eEEe
Q psy4396 73 KSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTT-----QIMIALKVLYKVEIINER--------MTHQVHRE-RC--CQVH 136 (271)
Q Consensus 73 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~--------~~~~~~~~-~~--~~~~ 136 (271)
..|+++.++|++++.||+|+||.||+|++... ++.||||+++........ ........ .. ....
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 34566778999999999999999999998653 468999998643211110 00011000 00 0001
Q ss_pred cCcCCCcceeeec--cCc-------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q psy4396 137 LSSSRRHPLLSSE--EGY-------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENL 189 (271)
Q Consensus 137 ~~~~~~~~~l~~~--~~~-------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Ni 189 (271)
......+.+++.. .+. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 1111111122211 111 1368899999999999999999999999999999999
Q ss_pred EeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHH
Q psy4396 190 LLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVG-KPPFESKDQDTT 264 (271)
Q Consensus 190 li~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~ 264 (271)
|++.++.+||+|||+|+..... ......||+.|+|||++.+..++.++|||||||++|||++| .+||.+.+..+.
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999754332 23345789999999999999999999999999999999985 678988776555
Q ss_pred HHh
Q psy4396 265 LER 267 (271)
Q Consensus 265 ~~~ 267 (271)
+.+
T Consensus 246 ~~~ 248 (299)
T d1ywna1 246 FCR 248 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=287.56 Aligned_cols=187 Identities=24% Similarity=0.398 Sum_probs=142.6
Q ss_pred cccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc-------
Q psy4396 78 QMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE------- 150 (271)
Q Consensus 78 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------- 150 (271)
++++|++++.||+|+||+||+|++..+++.||||++....... .....+.+| +.++....||++....
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E----~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALRE----IKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHH----HHHHHHCCCTTBCCEEEEEEC--
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHH----HHHHHHhcCCCccceEeeeeccc
Confidence 4799999999999999999999999999999999985432211 011111111 1111222333322211
Q ss_pred ---------------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecc
Q psy4396 151 ---------------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFG 203 (271)
Q Consensus 151 ---------------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg 203 (271)
....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence 11347899999999999999999999999999999999999999999999999
Q ss_pred ccccCCC------CCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 204 WSVHAPS------LHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 204 ~a~~~~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
+++.... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...+|.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 9965432 122345689999999998754 68999999999999999999999999998888776653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-41 Score=286.37 Aligned_cols=189 Identities=24% Similarity=0.373 Sum_probs=146.8
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeec
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSE 149 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 149 (271)
++++.++|++++.||+|+||+||+|++++ +++.||||+++..... .....+.+| +.......||+++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E----~~il~~l~h~niv~~ 81 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQRE----AALMAEFDNPNIVKL 81 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHH----HHHHHTCCCTTBCCE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHH----HHHHHhcCCCCcccc
Confidence 45567889999999999999999999864 4578999998643211 111223333 233333455554443
Q ss_pred cCc--------------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy4396 150 EGY--------------------------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKV 179 (271)
Q Consensus 150 ~~~--------------------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i 179 (271)
.+. ..+++..+..++.|++.||+|||++++
T Consensus 82 ~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i 161 (301)
T d1lufa_ 82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 161 (301)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCe
Confidence 322 126788899999999999999999999
Q ss_pred eeccCCCCceEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhC-CC
Q psy4396 180 IHRDIKPENLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVG-KP 254 (271)
Q Consensus 180 iHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~ 254 (271)
+||||||+|||++.++.+||+|||+|+...+. ......+|+.|+|||.+.+..++.++|||||||++|||++| .+
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999654322 22345688999999999999999999999999999999997 57
Q ss_pred CCCCCCHHHHHHhhc
Q psy4396 255 PFESKDQDTTLERIF 269 (271)
Q Consensus 255 pf~~~~~~~~~~~I~ 269 (271)
||.+.+..+++..|.
T Consensus 242 p~~~~~~~e~~~~v~ 256 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVR 256 (301)
T ss_dssp TTTTSCHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHH
Confidence 899999999887763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=288.30 Aligned_cols=183 Identities=28% Similarity=0.461 Sum_probs=138.0
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++++.||+|+||+||+|+++.+++.||||++.+..... ....+.+| +.++....||+++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~E----i~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLRE----IKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHH--HHHHHHHH----HHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChH--HHHHHHHH----HHHHHHcCCCCCCcEEEEEeecccc
Confidence 56999999999999999999999999999999986432111 11111122 1111222333322111
Q ss_pred ------------C--------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCC
Q psy4396 151 ------------G--------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPS 210 (271)
Q Consensus 151 ------------~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~ 210 (271)
+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 1 13489999999999999999999999999999999999999999999999999865433
Q ss_pred C-----CcccccccccccCcceec-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 211 L-----HRKTMCGTLDYLPPEMVT-SQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 211 ~-----~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
. .....+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..+....+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~ 225 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence 2 223456899999999984 456789999999999999999999999998887766554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-41 Score=288.65 Aligned_cols=184 Identities=29% Similarity=0.427 Sum_probs=140.2
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccC-------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEG------- 151 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------- 151 (271)
.++|++++.||+|+||+||+|.++.+++.||||++++... .......+.+| +.++....||+++.+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E----i~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRE----LRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHH----HHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHH----HHHHHhcCCCCeeEEEEEeccCcc
Confidence 4789999999999999999999999999999999864321 11111222222 22222234444433221
Q ss_pred -----------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccC
Q psy4396 152 -----------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHA 208 (271)
Q Consensus 152 -----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~ 208 (271)
...+++..++.++.|++.||+|||++||+||||||+|||++.++.+|++|||+|+..
T Consensus 92 ~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccccceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 134899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Q psy4396 209 PSLHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERI 268 (271)
Q Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I 268 (271)
... .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+.++
T Consensus 172 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~ 231 (346)
T d1cm8a_ 172 DSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231 (346)
T ss_dssp CSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCc-cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHH
Confidence 553 3456789999999998764 5689999999999999999999999999887776654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-41 Score=276.53 Aligned_cols=183 Identities=23% Similarity=0.409 Sum_probs=145.2
Q ss_pred ccccccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCcc-
Q psy4396 75 YRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYS- 153 (271)
Q Consensus 75 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~- 153 (271)
|++..++|++++.||+|+||.||+|+++ +..||||++++.... +.+.+| +......+||+++...+.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~-----~~~~~E----~~~l~~l~HpnIv~~~g~~~ 70 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA-----QAFLAE----ASVMTQLRHSNLVQLLGVIV 70 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHT----HHHHTTCCCTTBCCEEEEEC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHH-----HHHHHH----HHHHHhCCCCCEeeEEEEEE
Confidence 6788899999999999999999999985 567999999754322 223333 3444555677776655431
Q ss_pred ----------------------------cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 154 ----------------------------LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 154 ----------------------------~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
.+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred ecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccc
Confidence 1688999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHhhc
Q psy4396 206 VHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFESKDQDTTLERIF 269 (271)
Q Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~I~ 269 (271)
+..... .....+|+.|+|||.+.+..++.++||||||+++|||+| |++||...+..+++..|.
T Consensus 151 ~~~~~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~ 214 (262)
T d1byga_ 151 KEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 214 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT
T ss_pred eecCCC-CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 765443 234567899999999999999999999999999999998 899999999988887763
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=283.81 Aligned_cols=190 Identities=23% Similarity=0.350 Sum_probs=141.0
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH---HhhhhhhceeeeE----Eec-C--cCCCcceeeec
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---RMTHQVHRERCCQ----VHL-S--SSRRHPLLSSE 149 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~~~~~~----~~~-~--~~~~~~~l~~~ 149 (271)
-+|+.++.||+|+||+||+|++..+++.||||++.+...... .....+....... ... . ....+-+++..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 369999999999999999999999999999999865321110 0111111100000 000 0 00011112211
Q ss_pred cC--------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CEEEeeccccccCCC-CCc
Q psy4396 150 EG--------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPS-LHR 213 (271)
Q Consensus 150 ~~--------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~~~~-~~~ 213 (271)
.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~ 179 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCC
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCccc
Confidence 11 12478999999999999999999999999999999999999775 899999999976543 334
Q ss_pred ccccccccccCcceecc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 214 KTMCGTLDYLPPEMVTS-QHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+.+.+|+
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence 45679999999998765 568999999999999999999999999999888877764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-40 Score=279.21 Aligned_cols=182 Identities=20% Similarity=0.279 Sum_probs=134.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHH----HHH-Hhhhhhhc--eeeeEEecCcCCCcceeeeccC-
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEI----INE-RMTHQVHR--ERCCQVHLSSSRRHPLLSSEEG- 151 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~-~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~- 151 (271)
++|++++.||+|+||+||+|++..+++.||||++..... ..+ +....+.. .............+.+++....
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~ 84 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 84 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecC
Confidence 689999999999999999999999999999999754221 100 00011100 0000011111111122221111
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC-----CCCEEEeeccccccCCC------
Q psy4396 152 ----------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM-----HEDVKISDFGWSVHAPS------ 210 (271)
Q Consensus 152 ----------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~-----~~~~kl~Dfg~a~~~~~------ 210 (271)
...++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (293)
T d1csna_ 85 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164 (293)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB
T ss_pred CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccc
Confidence 134789999999999999999999999999999999999974 57899999999975432
Q ss_pred ---CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 211 ---LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 165 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 123345799999999999999999999999999999999999999975543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=278.73 Aligned_cols=192 Identities=24% Similarity=0.421 Sum_probs=142.4
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcCCC-------eEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcc
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKTTQ-------IMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHP 144 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (271)
...|.+..++|++++.||+|+||.||+|+...++ ..||||++++...... ...+.+|.. .+.....||
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~~e~~---~l~~~~~Hp 79 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEME---MMKMIGKHK 79 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH--HHHHHHHHH---HHHHHCCCT
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH--HHHHHHHHH---HHHHhcCCC
Confidence 3457888899999999999999999999987654 4799999865322111 111111110 011111344
Q ss_pred eeeeccCc------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceec
Q psy4396 145 LLSSEEGY------------------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHR 182 (271)
Q Consensus 145 ~l~~~~~~------------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHr 182 (271)
+++...+. ..+++..+..++.||+.||+|||+.+|+||
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr 159 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence 44332221 236899999999999999999999999999
Q ss_pred cCCCCceEeCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q psy4396 183 DIKPENLLLTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPFE 257 (271)
Q Consensus 183 Dikp~Nili~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~ 257 (271)
||||+|||++.++.+||+|||+++..... ......+|+.|+|||.+.+..|+.++||||||+++|||++ |.+||.
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 99999999999999999999998754332 2334568999999999999999999999999999999998 899999
Q ss_pred CCCHHHHHHhh
Q psy4396 258 SKDQDTTLERI 268 (271)
Q Consensus 258 ~~~~~~~~~~I 268 (271)
+.+.+++++.|
T Consensus 240 ~~~~~~~~~~i 250 (299)
T d1fgka_ 240 GVPVEELFKLL 250 (299)
T ss_dssp TCCHHHHHHHH
T ss_pred CCCHHHHHHHH
Confidence 99998887665
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=280.05 Aligned_cols=185 Identities=21% Similarity=0.312 Sum_probs=132.9
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHH-----HHhhhhhhceeee--EEecCcCCCcceeeecc--
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIIN-----ERMTHQVHRERCC--QVHLSSSRRHPLLSSEE-- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~-- 150 (271)
++|++++.||+|+||+||+|++..+++.||||++....... ......+.....+ ...........+++...
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 46999999999999999999999999999999875421100 0111111100000 00000001111111111
Q ss_pred ---------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCC---CCCEEEeeccccccCCCC-------
Q psy4396 151 ---------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTM---HEDVKISDFGWSVHAPSL------- 211 (271)
Q Consensus 151 ---------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~---~~~~kl~Dfg~a~~~~~~------- 211 (271)
....+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+|+.....
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~ 166 (299)
T d1ckia_ 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166 (299)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCC
T ss_pred CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccccee
Confidence 1134899999999999999999999999999999999999753 457999999999754321
Q ss_pred --CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy4396 212 --HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTT 264 (271)
Q Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 264 (271)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~ 221 (299)
T d1ckia_ 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221 (299)
T ss_dssp CCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred ccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence 22345799999999999999999999999999999999999999987666544
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=277.47 Aligned_cols=192 Identities=18% Similarity=0.295 Sum_probs=153.0
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEcC-----CCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCccee
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEKT-----TQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLL 146 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 146 (271)
...|+++.++|++.+.||+|+||+||+|.++. ++..||||+++...... ....+.+| +.+.....||++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~--~~~~~~~E----~~il~~l~h~nI 85 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNE----ASVMKEFNCHHV 85 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHH----HHHGGGCCCTTB
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH--HHHHHHHH----HHHHHHcCCCCE
Confidence 34688889999999999999999999999863 34689999996532221 11223333 344445567766
Q ss_pred eeccCcc------------------------------------cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q psy4396 147 SSEEGYS------------------------------------LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLL 190 (271)
Q Consensus 147 ~~~~~~~------------------------------------~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nil 190 (271)
+...+.+ .++...+..++.|++.||.|||+++|+||||||+|||
T Consensus 86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 165 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCcee
Confidence 6554331 1467788999999999999999999999999999999
Q ss_pred eCCCCCEEEeeccccccCCCC----CcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q psy4396 191 LTMHEDVKISDFGWSVHAPSL----HRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVG-KPPFESKDQDTTL 265 (271)
Q Consensus 191 i~~~~~~kl~Dfg~a~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~ 265 (271)
++.++++||+|||+|+..... ......+|+.|+|||.+.+..++.++|+||||+++|||++| ++||.+.+..+++
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999754332 22334689999999999999999999999999999999997 6999999999988
Q ss_pred Hhhc
Q psy4396 266 ERIF 269 (271)
Q Consensus 266 ~~I~ 269 (271)
..|.
T Consensus 246 ~~i~ 249 (308)
T d1p4oa_ 246 RFVM 249 (308)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7763
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-40 Score=281.49 Aligned_cols=186 Identities=24% Similarity=0.329 Sum_probs=138.1
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
.++|++++.||+|+||+||+|.+..+++.||||++.+..... .....+.+| +.+.....||+++...+.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~-~~~~~~~~E----i~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRE----LVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH-HHHHHHHHH----HHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH-HHHHHHHHH----HHHHHhcCCCCeeEEEEEEecccc
Confidence 368999999999999999999999999999999986432211 111112222 122222244444332211
Q ss_pred -----------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 153 -----------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 153 -----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||+++...
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred cccCceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 237899999999999999999999999999999999999999999999999886554
Q ss_pred C-CCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 S-LHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
. ......++|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+......+|+
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~ 231 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 3 33345678999999999999999999999999999999999999999998888777664
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=273.15 Aligned_cols=185 Identities=26% Similarity=0.482 Sum_probs=144.0
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc------
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------ 152 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------ 152 (271)
+++|++++.||+|+||+||+|++..+++.||||+++.... .......+.+| +.++....||+++...+.
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E----~~il~~l~h~niv~~~~~~~~~~~ 75 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALRE----ICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHH----HHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHH----HHHHHhcCcCCEEeeccccccccc
Confidence 3689999999999999999999999999999999854321 11112222233 333444466665443322
Q ss_pred --------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCC-
Q psy4396 153 --------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSL- 211 (271)
Q Consensus 153 --------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~- 211 (271)
..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.....
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 34789999999999999999999999999999999999999999999999999765432
Q ss_pred -CcccccccccccCcceeccCC-CCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHhh
Q psy4396 212 -HRKTMCGTLDYLPPEMVTSQH-YGKEVDNWCIGILAYEFLVGKPP-FESKDQDTTLERI 268 (271)
Q Consensus 212 -~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~p-f~~~~~~~~~~~I 268 (271)
......+++.|+|||++.... ++.++|||||||++|||++|+.| |.+.+..+.+.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~ 215 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 233445788999999887665 68999999999999999999887 5566666666554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=279.60 Aligned_cols=184 Identities=28% Similarity=0.440 Sum_probs=140.1
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeecc---------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEE--------- 150 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------- 150 (271)
++|++++.||+|+||+||+|++..+++.||||++++...... ....+.+| +.++....||+++...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E----i~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRE----LRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHH-HHHHHHHH----HHHHHHCCCTTBCCCSEEECSCSST
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChH-HHHHHHHH----HHHHHhcCCCCeeeEEEEEeecccc
Confidence 689999999999999999999999999999999864321111 11111122 1111222333322211
Q ss_pred ---------------------CcccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 151 ---------------------GYSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 151 ---------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
....+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 11348999999999999999999999999999999999999999999999999986654
Q ss_pred CCCcccccccccccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhc
Q psy4396 210 SLHRKTMCGTLDYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLERIF 269 (271)
Q Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~I~ 269 (271)
.. .....||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+......+|+
T Consensus 173 ~~-~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~ 232 (348)
T d2gfsa1 173 DE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232 (348)
T ss_dssp GG-GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cc-cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 32 3446789999999987665 46889999999999999999999999999888877764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=275.69 Aligned_cols=191 Identities=25% Similarity=0.408 Sum_probs=146.5
Q ss_pred CCcccccccCeEEecccccCCceEEEEEEEc-----CCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcC-CCcce
Q psy4396 72 NKSYRWQMSDFEVGCPLGTGKFGHVYLAKEK-----TTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSS-RRHPL 145 (271)
Q Consensus 72 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 145 (271)
...|+++.++|++++.||+|+||.||+|++. .+++.||||+++....... ...+.+|. ..... ..||+
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~E~----~~~~~l~~Hpn 88 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSEL----KVLSYLGNHMN 88 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH--HHHHHHHH----HHHHHHCCCTT
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH--HHHHHHHH----HHHHhccCCCC
Confidence 4567788899999999999999999999874 3567899999865322111 11122221 11111 13554
Q ss_pred eeeccCc--------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy4396 146 LSSEEGY--------------------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIH 181 (271)
Q Consensus 146 l~~~~~~--------------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiH 181 (271)
++.+.+. ..+++..+..++.||+.||+|||+++++|
T Consensus 89 Iv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivH 168 (311)
T d1t46a_ 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH 168 (311)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 4433222 13678899999999999999999999999
Q ss_pred ccCCCCceEeCCCCCEEEeeccccccCCCCC----cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHh-CCCCC
Q psy4396 182 RDIKPENLLLTMHEDVKISDFGWSVHAPSLH----RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLV-GKPPF 256 (271)
Q Consensus 182 rDikp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf 256 (271)
|||||+|||++.++.+|++|||+++...... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||
T Consensus 169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997654322 234568999999999999999999999999999999998 78888
Q ss_pred CCCCHHHHHHhh
Q psy4396 257 ESKDQDTTLERI 268 (271)
Q Consensus 257 ~~~~~~~~~~~I 268 (271)
...+..+.+.++
T Consensus 249 ~~~~~~~~~~~~ 260 (311)
T d1t46a_ 249 PGMPVDSKFYKM 260 (311)
T ss_dssp TTCCSSHHHHHH
T ss_pred CCCCHHHHHHHH
Confidence 887776665554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=279.19 Aligned_cols=186 Identities=31% Similarity=0.542 Sum_probs=137.6
Q ss_pred ccccCeEEecccccCCceEEEEEEEc---CCCeEEEEEEcchhHHHHH-HhhhhhhceeeeEEecCcCCCc-ceeeeccC
Q psy4396 77 WQMSDFEVGCPLGTGKFGHVYLAKEK---TTQIMIALKVLYKVEIINE-RMTHQVHRERCCQVHLSSSRRH-PLLSSEEG 151 (271)
Q Consensus 77 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~ 151 (271)
+.+++|++++.||+|+||+||+|++. .+++.||||++++...... ...+.+.+| +.......| |+++...+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E----~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE----RQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCH----HHHHHHHHTCTTBCCEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHH----HHHHHhccCCCeEEEeee
Confidence 45689999999999999999999974 4688999999864322110 111111122 111122222 33322211
Q ss_pred --------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeecccc
Q psy4396 152 --------------------------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWS 205 (271)
Q Consensus 152 --------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a 205 (271)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 97 AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 134688999999999999999999999999999999999999999999999999
Q ss_pred ccCCCC---CcccccccccccCcceeccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy4396 206 VHAPSL---HRKTMCGTLDYLPPEMVTSQ--HYGKEVDNWCIGILAYEFLVGKPPFESKDQDTTLE 266 (271)
Q Consensus 206 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 266 (271)
+..... ......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.+..+...
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~ 242 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 242 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 765432 23456789999999998754 46889999999999999999999998776554433
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=275.20 Aligned_cols=188 Identities=22% Similarity=0.320 Sum_probs=145.5
Q ss_pred cccccCeEEecccccCCceEEEEEEEcCCCe--EEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCC-CcceeeeccCc
Q psy4396 76 RWQMSDFEVGCPLGTGKFGHVYLAKEKTTQI--MIALKVLYKVEIINERMTHQVHRERCCQVHLSSSR-RHPLLSSEEGY 152 (271)
Q Consensus 76 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~ 152 (271)
.++.++|++.+.||+|+||+||+|+++.++. .||||.++.... ......+.+| +..+... .||+|+...+.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E----~~~l~~l~~HpnIv~~~~~ 79 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGE----LEVLCKLGHHPNIINLLGA 79 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHH----HHHHTTCCCCTTBCCEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHH----HHHHHhccCCCCEeeEEEE
Confidence 3567899999999999999999999998876 467777643221 1112223333 2333333 57766655432
Q ss_pred ------------------------------------------ccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q psy4396 153 ------------------------------------------SLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLL 190 (271)
Q Consensus 153 ------------------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nil 190 (271)
..+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 80 ~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL 159 (309)
T d1fvra_ 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 159 (309)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEE
Confidence 23688899999999999999999999999999999999
Q ss_pred eCCCCCEEEeeccccccCCCCC-cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHhh
Q psy4396 191 LTMHEDVKISDFGWSVHAPSLH-RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVG-KPPFESKDQDTTLERI 268 (271)
Q Consensus 191 i~~~~~~kl~Dfg~a~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~I 268 (271)
++.++.+||+|||+|+...... .....||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++++.|
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999999999997654332 2345689999999999999999999999999999999995 5789999999988876
Q ss_pred c
Q psy4396 269 F 269 (271)
Q Consensus 269 ~ 269 (271)
.
T Consensus 240 ~ 240 (309)
T d1fvra_ 240 P 240 (309)
T ss_dssp G
T ss_pred H
Confidence 4
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-38 Score=271.37 Aligned_cols=183 Identities=23% Similarity=0.460 Sum_probs=134.8
Q ss_pred ccCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHH---HHH-hhhhhh-ceeeeE-Eec--CcCCCcceeeec-
Q psy4396 79 MSDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEII---NER-MTHQVH-RERCCQ-VHL--SSSRRHPLLSSE- 149 (271)
Q Consensus 79 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~-~~~~~~-~~~~~~-~~~--~~~~~~~~l~~~- 149 (271)
.++|++++.||+|+||+||+|++..+++.||||++++.... .+. ....+. ...... ... .....+..++..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 46899999999999999999999999999999998653221 110 111111 000000 000 001111111111
Q ss_pred -cC------cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCC-CEEEeeccccccCCC-CCcccccccc
Q psy4396 150 -EG------YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHE-DVKISDFGWSVHAPS-LHRKTMCGTL 220 (271)
Q Consensus 150 -~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~-~~kl~Dfg~a~~~~~-~~~~~~~gt~ 220 (271)
.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .......+|+
T Consensus 114 ~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~ 193 (328)
T d3bqca1 114 VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 193 (328)
T ss_dssp CCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCG
T ss_pred cCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCc
Confidence 11 13479999999999999999999999999999999999998765 589999999976554 3345567899
Q ss_pred cccCcceeccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy4396 221 DYLPPEMVTSQ-HYGKEVDNWCIGILAYEFLVGKPPFESKDQ 261 (271)
Q Consensus 221 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~ 261 (271)
.|+|||.+.+. .++.++|+||+||++|||++|+.||.....
T Consensus 194 ~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp GGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred cccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 99999998765 479999999999999999999999976543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=264.84 Aligned_cols=169 Identities=21% Similarity=0.253 Sum_probs=129.2
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCc-------
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGY------- 152 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------- 152 (271)
++|.+.+.||+|+||+||+|++. ++.||||+++.......... .+ +.......||+++...+.
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~~~~~~e----~e----i~~~~~~~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFRE----AE----IYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGHHHHHHH----HH----HHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhHHHHH----HH----HHHHhhCCCCcCcceEEEEEeCCCc
Confidence 57899999999999999999864 67899999865432211111 11 223333456666554332
Q ss_pred ----------------------ccCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCceEeCCCCCEEEeec
Q psy4396 153 ----------------------SLYTEKDAAKYIYQVADAIHYCHQ--------KKVIHRDIKPENLLLTMHEDVKISDF 202 (271)
Q Consensus 153 ----------------------~~~~~~~~~~~~~qi~~~L~~LH~--------~~iiHrDikp~Nili~~~~~~kl~Df 202 (271)
..++++.+..++.|++.||+|||+ +||+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 226888999999999999999996 59999999999999999999999999
Q ss_pred cccccCCCC------CcccccccccccCcceeccCC------CCCchhHHHHHHHHHHHHhCCCCCCC
Q psy4396 203 GWSVHAPSL------HRKTMCGTLDYLPPEMVTSQH------YGKEVDNWCIGILAYEFLVGKPPFES 258 (271)
Q Consensus 203 g~a~~~~~~------~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~el~~g~~pf~~ 258 (271)
|+++..... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 998654322 223467999999999987643 56789999999999999999988754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-38 Score=263.93 Aligned_cols=170 Identities=25% Similarity=0.358 Sum_probs=131.2
Q ss_pred EecccccCCceEEEEEEEcCC---CeEEEEEEcchhHHHHHHhhhhhhceeeeEEecCcCCCcceeeeccCcc-------
Q psy4396 84 VGCPLGTGKFGHVYLAKEKTT---QIMIALKVLYKVEIINERMTHQVHRERCCQVHLSSSRRHPLLSSEEGYS------- 153 (271)
Q Consensus 84 ~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~------- 153 (271)
..++||+|+||+||+|++..+ ...||||.+++.. .......+.+| +.++....||+++...+.+
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E----~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTE----GIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHH----HHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHH----HHHHHhCCCCCEeEEeEEEEecCCce
Confidence 357899999999999998654 3469999986422 11122233444 3444555778776665431
Q ss_pred ---------------------cCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCC
Q psy4396 154 ---------------------LYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLH 212 (271)
Q Consensus 154 ---------------------~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~ 212 (271)
.+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 14577889999999999999999999999999999999999999999999997644321
Q ss_pred ------cccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy4396 213 ------RKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESK 259 (271)
Q Consensus 213 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 259 (271)
.....||+.|+|||.+....++.++||||||+++|||++|..||...
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 22345899999999999999999999999999999999976666543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-37 Score=263.79 Aligned_cols=177 Identities=24% Similarity=0.361 Sum_probs=131.7
Q ss_pred cCeEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHHHhh------hhhhceeeeEEecCcCCCcceeeec----
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINERMT------HQVHRERCCQVHLSSSRRHPLLSSE---- 149 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~~---- 149 (271)
++|++++.||+|+||+||+|++..+++.||||++++......... ..+...... ......|++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~---~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT---KEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCS---HHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhh---hhhhcCcCceEEEEEEe
Confidence 469999999999999999999999999999999875432211111 111100000 0000011111111
Q ss_pred ---------------------------cCcccCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEeCCCCC-----
Q psy4396 150 ---------------------------EGYSLYTEKDAAKYIYQVADAIHYCHQ-KKVIHRDIKPENLLLTMHED----- 196 (271)
Q Consensus 150 ---------------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiHrDikp~Nili~~~~~----- 196 (271)
.....+++..++.++.|++.||+|||+ .||+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 112447899999999999999999998 89999999999999987654
Q ss_pred -EEEeeccccccCCCCCcccccccccccCcceeccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4396 197 -VKISDFGWSVHAPSLHRKTMCGTLDYLPPEMVTSQHYGKEVDNWCIGILAYEFLVGKPPFESKD 260 (271)
Q Consensus 197 -~kl~Dfg~a~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 260 (271)
++++|||.|..... .....+||+.|+|||++.+..++.++|+||+||++++|++|+.||...+
T Consensus 170 ~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeeEeeccccccccc-ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 89999999876543 3345679999999999999999999999999999999999999997654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.8e-24 Score=169.25 Aligned_cols=157 Identities=15% Similarity=0.087 Sum_probs=94.2
Q ss_pred eEEecccccCCceEEEEEEEcCCCeEEEEEEcchhHHHHH---------------HhhhhhhceeeeEEecCcC------
Q psy4396 82 FEVGCPLGTGKFGHVYLAKEKTTQIMIALKVLYKVEIINE---------------RMTHQVHRERCCQVHLSSS------ 140 (271)
Q Consensus 82 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~------ 140 (271)
+.+++.||+|+||+||+|++. +++.||||++........ ........+......+...
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 357899999999999999985 578899998643211000 0000000010000000000
Q ss_pred --CCcceeee-ccC--cccCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEeCCCCCEEEeeccccccCCCCCccc
Q psy4396 141 --RRHPLLSS-EEG--YSLYTEKDAAKYIYQVADAIHYCHQKKVIHRDIKPENLLLTMHEDVKISDFGWSVHAPSLHRKT 215 (271)
Q Consensus 141 --~~~~~l~~-~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 215 (271)
..+-++.. ..+ ...++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||+|+.........
T Consensus 81 ~~~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~ 159 (191)
T d1zara2 81 AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWRE 159 (191)
T ss_dssp EEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHH
T ss_pred EecCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHH
Confidence 00101111 111 1225667788999999999999999999999999999999954 58999999987654322111
Q ss_pred ccccccccCc--c---eeccCCCCCchhHHHHHHHH
Q psy4396 216 MCGTLDYLPP--E---MVTSQHYGKEVDNWCIGILA 246 (271)
Q Consensus 216 ~~gt~~y~aP--E---~~~~~~~~~~~DiwslG~il 246 (271)
|... + .+-.+.|+.++|+||+.--+
T Consensus 160 ------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 160 ------ILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ------HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 1110 0 01135678899999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.73 E-value=0.00099 Score=51.98 Aligned_cols=29 Identities=21% Similarity=0.254 Sum_probs=24.5
Q ss_pred ceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 179 VIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 179 iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCCceEEEeechhccc
Confidence 68999999999999766667999997644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.46 E-value=0.0027 Score=51.00 Aligned_cols=31 Identities=26% Similarity=0.381 Sum_probs=26.8
Q ss_pred CCceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 177 KKVIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 177 ~~iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
.|+||+|+.+.|++++.+...-+.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999877778999997643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.96 E-value=0.017 Score=47.85 Aligned_cols=31 Identities=23% Similarity=0.499 Sum_probs=26.2
Q ss_pred CceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
.++|+|+.|.|||++++ .++|+||..|...+
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G~ 254 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYGP 254 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEEEC
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcccCC
Confidence 58999999999999865 58999999876544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=93.64 E-value=0.0087 Score=46.06 Aligned_cols=29 Identities=21% Similarity=0.095 Sum_probs=24.8
Q ss_pred ceeccCCCCceEeCCCCCEEEeecccccc
Q psy4396 179 VIHRDIKPENLLLTMHEDVKISDFGWSVH 207 (271)
Q Consensus 179 iiHrDikp~Nili~~~~~~kl~Dfg~a~~ 207 (271)
++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 79999999999999766678999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.39 E-value=0.043 Score=43.92 Aligned_cols=30 Identities=20% Similarity=0.225 Sum_probs=24.1
Q ss_pred CceeccCCCCceEeCCCCCEEEeeccccccCC
Q psy4396 178 KVIHRDIKPENLLLTMHEDVKISDFGWSVHAP 209 (271)
Q Consensus 178 ~iiHrDikp~Nili~~~~~~kl~Dfg~a~~~~ 209 (271)
++||+|+.|.|||++. + ..++||+-+....
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~g~ 222 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDARNGP 222 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCCEEC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcccCc
Confidence 5899999999999973 3 4589999776543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=83.78 E-value=0.17 Score=41.50 Aligned_cols=34 Identities=12% Similarity=0.308 Sum_probs=23.0
Q ss_pred cCeEEecccccCCceEEEEEEEcC-------CCeEEEEEEcc
Q psy4396 80 SDFEVGCPLGTGKFGHVYLAKEKT-------TQIMIALKVLY 114 (271)
Q Consensus 80 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~ 114 (271)
+++++ +.|+-|-.-.+|++.... .++.|.+++.-
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g 83 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF 83 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC
Confidence 44554 457778889999998753 23557777753
|